*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 A 49 ASP B 144 ASP.? 18.90 CL CL B 384 A 86 HIS B 157 HIS~? 12.80 CL CL B 384 A 250 ALA B 154 ALA~? 9.41 CL CL B 384 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 1.70 18.75 65.96 3.42 18.04 64.94 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 0.17 24.88 70.38 1.86 23.62 70.32 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -4.85 25.78 67.69 -5.32 25.38 66.32 2wwt_o00 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 1 hits 2wwt_o00 naa= 3 ULMN 4 13pk_c00 3-PHOSPHOGLYCERATE KINASE user 1 4 # 1 A 39 ARG B 193 ARG.? 19.02 CL CL A 384 A 219 LYS A 288 LYS.? 12.57 CL CL A 384 A 376 GLY A 7 GLY.? 16.09 CL CL A 384 A 399 GLY A 285 GLY^? 9.46 CL CL A 384 coo -12.38 76.96 90.60 -12.31 75.41 87.97 -14.12 50.83 106.82 -12.70 50.89 109.57 coo -15.03 67.62 79.35 -16.01 71.68 83.38 -19.18 64.09 108.25 -14.44 63.70 112.45 coo -9.88 73.08 89.49 -9.40 72.65 89.00 -12.90 54.74 109.89 -12.31 54.99 110.52 coo -11.12 75.93 79.79 -10.82 76.54 80.30 -22.09 57.26 103.59 -22.19 58.16 103.73 13pk_c00 source 13pk 3-PHOSPHOGLYCERATE KINASE : 1 hits 13pk_c00 naa= 4 ULMN 4 13pk_c01 3-PHOSPHOGLYCERATE KINASE user 1 4 # 1 B 39 ARG B 193 ARG.? 19.02 CL CL A 384 B 219 LYS A 288 LYS.? 12.57 CL CL A 384 B 376 GLY A 7 GLY.? 16.09 CL CL A 384 B 399 GLY A 285 GLY^? 9.46 CL CL A 384 coo -2.66 39.94 47.71 -4.08 39.67 44.99 -14.12 50.83 106.82 -12.70 50.89 109.57 coo -12.62 42.34 36.27 -8.73 43.54 40.31 -19.18 64.09 108.25 -14.44 63.70 112.45 coo -6.85 37.45 46.42 -7.20 36.92 45.92 -12.90 54.74 109.89 -12.31 54.99 110.52 coo -4.26 38.64 36.66 -3.61 38.69 37.17 -22.09 57.26 103.59 -22.19 58.16 103.73 13pk_c01 source 13pk 3-PHOSPHOGLYCERATE KINASE : 1 hits 13pk_c01 naa= 4 ULMN 4 13pk_c02 3-PHOSPHOGLYCERATE KINASE user 1 4 # 1 C 39 ARG B 193 ARG.? 19.02 CL CL A 384 C 219 LYS A 288 LYS.? 12.57 CL CL A 384 C 376 GLY A 7 GLY.? 16.09 CL CL A 384 C 399 GLY A 285 GLY^? 9.46 CL CL A 384 coo -3.47 26.80 67.67 -1.24 26.00 69.62 -14.12 50.83 106.82 -12.70 50.89 109.57 coo 5.22 26.79 80.32 0.48 26.84 77.06 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 1.35 28.76 68.50 2.09 28.66 68.61 -12.90 54.74 109.89 -12.31 54.99 110.52 coo 2.85 20.10 73.72 2.25 20.01 73.15 -22.09 57.26 103.59 -22.19 58.16 103.73 13pk_c02 source 13pk 3-PHOSPHOGLYCERATE KINASE : 1 hits 13pk_c02 naa= 4 ULMN 4 13pk_c03 3-PHOSPHOGLYCERATE KINASE user 1 4 # 1 D 39 ARG B 193 ARG.? 19.02 CL CL A 384 D 219 LYS A 288 LYS.? 12.57 CL CL A 384 D 376 GLY A 7 GLY.? 16.09 CL CL A 384 D 399 GLY A 285 GLY^? 9.46 CL CL A 384 coo 0.59 75.69 110.95 1.51 77.84 112.93 -14.12 50.83 106.82 -12.70 50.89 109.57 coo 1.28 85.37 123.16 0.84 80.41 120.28 -19.18 64.09 108.25 -14.44 63.70 112.45 coo -1.06 80.88 111.45 -0.91 81.65 111.55 -12.90 54.74 109.89 -12.31 54.99 110.52 coo 7.52 81.86 116.81 7.49 81.18 116.34 -22.09 57.26 103.59 -22.19 58.16 103.73 13pk_c03 source 13pk 3-PHOSPHOGLYCERATE KINASE : 1 hits 13pk_c03 naa= 4 ULMN 4 1apt_c06 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 1 4 # 1 E 33 ASP B 306 ASP.? 19.57 CL CL A 384 E 36 SER B 192 SER.? 13.26 CL CL A 384 E 75 TYR A 6 TYR.? 20.79 CL CL A 384 E 213 ASP B 305 ASP^? 21.59 CL CL A 384 coo 26.30 12.96 16.78 25.46 12.99 18.72 -4.64 54.84 103.01 -3.71 56.24 101.58 coo 28.33 15.15 21.27 28.70 13.12 19.97 -11.80 54.65 102.27 -11.20 56.97 103.08 coo 26.74 7.85 22.76 28.93 8.53 21.17 -7.05 53.27 108.32 -4.25 53.35 108.15 coo 20.15 16.04 19.79 21.65 14.49 19.86 -6.28 49.81 99.79 -7.51 49.10 101.38 1apt_c06 source 1apt ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET (LYSTA IS : 1 hits 1apt_c06 naa= 4 ULMN 4 1avf_c06 GASTRICSIN user 1 4 # 1 J 32 ASP B 36 ASP.? -3.35 CL CL B 383s J 35 SER B 37 SER^? 9.16 CL CL B 383 J 75 TYR B 25 TYR^? 14.27 CL CL B 382 J 217 ASP B 30 ASP^? -6.72 CL CL B 383s coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -15.98 38.04 75.83 -14.00 38.51 76.08 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -19.96 36.46 76.97 -19.82 35.54 79.16 coo -41.81 -30.90 17.10 -43.71 -28.85 16.83 -26.62 44.42 81.68 -25.97 47.00 82.31 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -11.77 37.20 80.70 -10.35 36.55 82.15 1avf_c06 source 1avf GASTRICSIN : 1 hits 1avf_c06 naa= 4 ULMN 4 1bf2_c01 ISOAMYLASE user 1 4 # 1 375 ASP A 171 ASP.? 13.95 CL CL A 382 435 GLU A 169 GLU.? 11.07 CL CL A 382 437 TRP A 167 TRP^? 7.35 CL CL A 382 510 ASP A 93 ASP^? 5.15 CL CL A 382 coo 88.62 69.90 41.16 89.05 70.67 43.04 -21.72 70.05 125.28 -22.57 71.99 125.28 coo 89.52 76.11 40.17 89.01 75.16 41.97 -27.31 72.85 122.01 -26.32 74.11 120.63 coo 92.40 77.76 42.22 89.96 80.25 40.39 -31.10 71.99 120.30 -32.79 75.13 118.77 coo 84.89 77.60 46.67 85.63 75.79 46.03 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 4 1bf2_c01 ISOAMYLASE user 2 4 # 2 375 ASP A 306 ASP.? 16.66 CL CL A 384 435 GLU A 307 GLU.? 18.04 CL CL B 382 437 TRP A 191 TRP^? 15.13 CL CL A 384 510 ASP A 195 ASP.? 13.29 CL CL A 384 coo 88.62 69.90 41.16 89.05 70.67 43.04 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 89.52 76.11 40.17 89.01 75.16 41.97 -31.95 61.22 87.08 -31.47 59.40 88.12 coo 92.40 77.76 42.22 89.96 80.25 40.39 -30.01 60.84 91.30 -29.83 57.58 93.47 coo 84.89 77.60 46.67 85.63 75.79 46.03 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 4 1bf2_c01 ISOAMYLASE user 3 4 # 3 375 ASP B 171 ASP.? 13.77 CL CL B 383 435 GLU B 169 GLU.? 11.31 CL CL B 383 437 TRP B 167 TRP^? 7.30 CL CL B 383 510 ASP B 93 ASP^? 5.22 CL CL B 383 coo 88.62 69.90 41.16 89.05 70.67 43.04 -14.88 46.75 66.62 -12.79 46.40 66.16 coo 89.52 76.11 40.17 89.01 75.16 41.97 -9.49 44.22 70.62 -8.22 45.44 69.57 coo 92.40 77.76 42.22 89.96 80.25 40.39 -8.26 40.92 72.83 -4.37 40.96 73.30 coo 84.89 77.60 46.67 85.63 75.79 46.03 -17.13 37.76 71.68 -15.50 36.45 72.23 1bf2_c01 source 1bf2 ISOAMYLASE : 3 hits 1bf2_c01 naa= 4 ULMN 4 1bvz_c02 ALPHA-AMYLASE II user 1 4 # 1 A 325 ASP A 171 ASP.? 13.95 CL CL A 382 A 354 GLU A 169 GLU.? 11.07 CL CL A 382 A 356 TRP A 167 TRP^? 7.35 CL CL A 382 A 421 ASP A 36 ASP.? -3.33 CL CL A 382s coo 31.05 49.37 64.51 31.97 51.11 63.85 -21.72 70.05 125.28 -22.57 71.99 125.28 coo 29.07 50.42 58.36 29.02 52.18 59.49 -27.31 72.85 122.01 -26.32 74.11 120.63 coo 32.40 51.51 54.93 28.61 52.36 55.13 -31.10 71.99 120.30 -32.79 75.13 118.77 coo 30.82 59.76 58.47 31.12 59.02 60.40 -31.47 63.24 120.93 -31.90 65.07 119.91 ULMN 4 1bvz_c02 ALPHA-AMYLASE II user 2 4 # 2 A 325 ASP A 171 ASP.? 13.95 CL CL A 382 A 354 GLU A 169 GLU.? 11.07 CL CL A 382 A 356 TRP A 167 TRP^? 7.35 CL CL A 382 A 421 ASP A 93 ASP^? 5.15 CL CL A 382 coo 31.05 49.37 64.51 31.97 51.11 63.85 -21.72 70.05 125.28 -22.57 71.99 125.28 coo 29.07 50.42 58.36 29.02 52.18 59.49 -27.31 72.85 122.01 -26.32 74.11 120.63 coo 32.40 51.51 54.93 28.61 52.36 55.13 -31.10 71.99 120.30 -32.79 75.13 118.77 coo 30.82 59.76 58.47 31.12 59.02 60.40 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 4 1bvz_c02 ALPHA-AMYLASE II user 3 4 # 3 A 325 ASP B 171 ASP.? 13.77 CL CL B 383 A 354 GLU B 169 GLU.? 11.31 CL CL B 383 A 356 TRP B 167 TRP^? 7.30 CL CL B 383 A 421 ASP B 36 ASP.? -3.35 CL CL B 383s coo 31.05 49.37 64.51 31.97 51.11 63.85 -14.88 46.75 66.62 -12.79 46.40 66.16 coo 29.07 50.42 58.36 29.02 52.18 59.49 -9.49 44.22 70.62 -8.22 45.44 69.57 coo 32.40 51.51 54.93 28.61 52.36 55.13 -8.26 40.92 72.83 -4.37 40.96 73.30 coo 30.82 59.76 58.47 31.12 59.02 60.40 -15.98 38.04 75.83 -14.00 38.51 76.08 ULMN 4 1bvz_c02 ALPHA-AMYLASE II user 4 4 # 4 A 325 ASP B 171 ASP.? 13.77 CL CL B 383 A 354 GLU B 169 GLU.? 11.31 CL CL B 383 A 356 TRP B 167 TRP^? 7.30 CL CL B 383 A 421 ASP B 93 ASP^? 5.22 CL CL B 383 coo 31.05 49.37 64.51 31.97 51.11 63.85 -14.88 46.75 66.62 -12.79 46.40 66.16 coo 29.07 50.42 58.36 29.02 52.18 59.49 -9.49 44.22 70.62 -8.22 45.44 69.57 coo 32.40 51.51 54.93 28.61 52.36 55.13 -8.26 40.92 72.83 -4.37 40.96 73.30 coo 30.82 59.76 58.47 31.12 59.02 60.40 -17.13 37.76 71.68 -15.50 36.45 72.23 1bvz_c02 source 1bvz ALPHA-AMYLASE II : 4 hits 1bvz_c02 naa= 4 ULMN 4 1bvz_c03 ALPHA-AMYLASE II user 1 4 # 1 B 325 ASP A 171 ASP.? 13.95 CL CL A 382 B 354 GLU A 169 GLU.? 11.07 CL CL A 382 B 356 TRP A 167 TRP^? 7.35 CL CL A 382 B 421 ASP A 36 ASP.? -3.33 CL CL A 382s coo 25.90 8.19 53.87 25.36 6.97 52.29 -21.72 70.05 125.28 -22.57 71.99 125.28 coo 27.87 10.66 47.95 27.82 8.60 48.27 -27.31 72.85 122.01 -26.32 74.11 120.63 coo 24.60 10.88 44.33 28.44 10.20 44.29 -31.10 71.99 120.30 -32.79 75.13 118.77 coo 26.02 1.87 43.38 25.90 1.97 45.49 -31.47 63.24 120.93 -31.90 65.07 119.91 ULMN 4 1bvz_c03 ALPHA-AMYLASE II user 2 4 # 2 B 325 ASP A 171 ASP.? 13.95 CL CL A 382 B 354 GLU A 169 GLU.? 11.07 CL CL A 382 B 356 TRP A 167 TRP^? 7.35 CL CL A 382 B 421 ASP A 93 ASP^? 5.15 CL CL A 382 coo 25.90 8.19 53.87 25.36 6.97 52.29 -21.72 70.05 125.28 -22.57 71.99 125.28 coo 27.87 10.66 47.95 27.82 8.60 48.27 -27.31 72.85 122.01 -26.32 74.11 120.63 coo 24.60 10.88 44.33 28.44 10.20 44.29 -31.10 71.99 120.30 -32.79 75.13 118.77 coo 26.02 1.87 43.38 25.90 1.97 45.49 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 4 1bvz_c03 ALPHA-AMYLASE II user 3 4 # 3 B 325 ASP B 171 ASP.? 13.77 CL CL B 383 B 354 GLU B 169 GLU.? 11.31 CL CL B 383 B 356 TRP B 167 TRP^? 7.30 CL CL B 383 B 421 ASP B 36 ASP.? -3.35 CL CL B 383s coo 25.90 8.19 53.87 25.36 6.97 52.29 -14.88 46.75 66.62 -12.79 46.40 66.16 coo 27.87 10.66 47.95 27.82 8.60 48.27 -9.49 44.22 70.62 -8.22 45.44 69.57 coo 24.60 10.88 44.33 28.44 10.20 44.29 -8.26 40.92 72.83 -4.37 40.96 73.30 coo 26.02 1.87 43.38 25.90 1.97 45.49 -15.98 38.04 75.83 -14.00 38.51 76.08 ULMN 4 1bvz_c03 ALPHA-AMYLASE II user 4 4 # 4 B 325 ASP B 171 ASP.? 13.77 CL CL B 383 B 354 GLU B 169 GLU.? 11.31 CL CL B 383 B 356 TRP B 167 TRP^? 7.30 CL CL B 383 B 421 ASP B 93 ASP^? 5.22 CL CL B 383 coo 25.90 8.19 53.87 25.36 6.97 52.29 -14.88 46.75 66.62 -12.79 46.40 66.16 coo 27.87 10.66 47.95 27.82 8.60 48.27 -9.49 44.22 70.62 -8.22 45.44 69.57 coo 24.60 10.88 44.33 28.44 10.20 44.29 -8.26 40.92 72.83 -4.37 40.96 73.30 coo 26.02 1.87 43.38 25.90 1.97 45.49 -17.13 37.76 71.68 -15.50 36.45 72.23 1bvz_c03 source 1bvz ALPHA-AMYLASE II : 4 hits 1bvz_c03 naa= 4 ULMN 4 1d8c_c00 MALATE SYNTHASE G user 1 4 # 1 A 270 ASP A 28 ASP^? 9.02 CL CL A 382 A 272 GLU A 332 GLU^? 14.84 CL CL A 382 A 338 ARG A 320 ARG^? 16.18 CL CL A 382 A 631 ASP A 30 ASP^? -6.81 CL CL A 382s coo 15.32 0.58 -16.16 13.76 -0.65 -16.82 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 11.90 -5.17 -18.46 9.90 -4.77 -17.84 -32.41 59.20 107.78 -33.78 57.91 108.78 coo 11.94 -3.39 -13.78 10.23 -1.14 -15.20 -32.10 56.68 112.17 -32.95 53.99 110.90 coo 8.71 2.50 -20.96 7.71 1.86 -19.18 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 4 1d8c_c00 MALATE SYNTHASE G user 2 4 # 2 A 270 ASP B 28 ASP^? 9.00 CL CL B 383 A 272 GLU B 332 GLU^? 14.76 CL CL B 383 A 338 ARG B 320 ARG^? 13.22 CL CL B 383 A 631 ASP B 30 ASP^? -6.72 CL CL B 383s coo 15.32 0.58 -16.16 13.76 -0.65 -16.82 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 11.90 -5.17 -18.46 9.90 -4.77 -17.84 -15.56 41.56 89.17 -16.27 39.59 89.11 coo 11.94 -3.39 -13.78 10.23 -1.14 -15.20 -19.20 39.56 86.12 -20.64 37.04 85.01 coo 8.71 2.50 -20.96 7.71 1.86 -19.18 -11.77 37.20 80.70 -10.35 36.55 82.15 1d8c_c00 source 1d8c MALATE SYNTHASE G : 2 hits 1d8c_c00 naa= 4 ULMN 4 1doo_c00 HEAT SHOCK LOCUS U user 1 4 # 1 A 1 THR A 194 THR.? 13.30 CL CL B 382 A 33 LYS B 288 LYS.? 8.84 CL CL B 382 A 48 GLY B 285 GLY^? 18.43 CL CL A 384 A 124 SER A 192 SER.? 15.36 CL CL A 384 coo 20.60 80.81 78.25 19.93 81.48 80.23 -23.53 58.32 86.21 -24.61 58.92 84.44 coo 24.21 79.63 86.31 23.19 81.94 80.55 -16.76 54.22 83.25 -20.62 56.75 78.99 coo 18.07 85.03 84.32 18.49 84.59 84.79 -20.19 51.54 90.83 -19.46 51.66 90.42 coo 15.73 80.26 75.45 17.95 80.97 75.03 -26.48 60.82 89.96 -25.15 61.33 88.02 ULMN 4 1doo_c00 HEAT SHOCK LOCUS U user 2 4 # 2 A 1 THR B 194 THR.? 12.32 CL CL A 384 A 33 LYS A 288 LYS.? 12.57 CL CL A 384 A 48 GLY A 285 GLY^? 9.46 CL CL A 384 A 124 SER B 192 SER.? 13.26 CL CL A 384 coo 20.60 80.81 78.25 19.93 81.48 80.23 -14.07 57.99 105.37 -12.38 58.46 106.64 coo 24.21 79.63 86.31 23.19 81.94 80.55 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 18.07 85.03 84.32 18.49 84.59 84.79 -22.09 57.26 103.59 -22.19 58.16 103.73 coo 15.73 80.26 75.45 17.95 80.97 75.03 -11.80 54.65 102.27 -11.20 56.97 103.08 1doo_c00 source 1doo HEAT SHOCK LOCUS U : 2 hits 1doo_c00 naa= 4 ULMN 4 1doo_c01 HEAT SHOCK LOCUS U user 1 4 # 1 B 1 THR A 194 THR.? 13.30 CL CL B 382 B 33 LYS B 288 LYS.? 8.84 CL CL B 382 B 48 GLY B 285 GLY^? 18.43 CL CL A 384 B 124 SER A 192 SER.? 15.36 CL CL A 384 coo 26.69 108.13 78.57 25.70 107.69 80.43 -23.53 58.32 86.21 -24.61 58.92 84.44 coo 30.17 110.91 86.31 27.32 111.03 80.63 -16.76 54.22 83.25 -20.62 56.75 78.99 coo 22.32 108.46 85.29 22.91 108.64 85.71 -20.19 51.54 90.83 -19.46 51.66 90.42 coo 24.65 103.43 76.04 24.59 105.78 75.60 -26.48 60.82 89.96 -25.15 61.33 88.02 ULMN 4 1doo_c01 HEAT SHOCK LOCUS U user 2 4 # 2 B 1 THR B 194 THR.? 12.32 CL CL A 384 B 33 LYS A 288 LYS.? 12.57 CL CL A 384 B 48 GLY A 285 GLY^? 9.46 CL CL A 384 B 124 SER B 192 SER.? 13.26 CL CL A 384 coo 26.69 108.13 78.57 25.70 107.69 80.43 -14.07 57.99 105.37 -12.38 58.46 106.64 coo 30.17 110.91 86.31 27.32 111.03 80.63 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 22.32 108.46 85.29 22.91 108.64 85.71 -22.09 57.26 103.59 -22.19 58.16 103.73 coo 24.65 103.43 76.04 24.59 105.78 75.60 -11.80 54.65 102.27 -11.20 56.97 103.08 1doo_c01 source 1doo HEAT SHOCK LOCUS U : 2 hits 1doo_c01 naa= 4 ULMN 4 1doo_c02 HEAT SHOCK LOCUS U user 1 4 # 1 C 1 THR A 194 THR.? 13.30 CL CL B 382 C 33 LYS B 288 LYS.? 8.84 CL CL B 382 C 48 GLY B 285 GLY^? 18.43 CL CL A 384 C 124 SER A 192 SER.? 15.36 CL CL A 384 coo -5.30 26.59 199.66 -4.98 26.05 197.57 -23.53 58.32 86.21 -24.61 58.92 84.44 coo -4.62 30.60 191.94 -3.32 28.83 197.07 -16.76 54.22 83.25 -20.62 56.75 78.99 coo -3.44 22.13 193.22 -3.30 22.85 192.94 -20.19 51.54 90.83 -19.46 51.66 90.42 coo -8.31 23.03 202.48 -6.18 24.15 202.80 -26.48 60.82 89.96 -25.15 61.33 88.02 ULMN 4 1doo_c02 HEAT SHOCK LOCUS U user 2 4 # 2 C 1 THR B 194 THR.? 12.32 CL CL A 384 C 33 LYS A 288 LYS.? 12.57 CL CL A 384 C 48 GLY A 285 GLY^? 9.46 CL CL A 384 C 124 SER B 192 SER.? 13.26 CL CL A 384 coo -5.30 26.59 199.66 -4.98 26.05 197.57 -14.07 57.99 105.37 -12.38 58.46 106.64 coo -4.62 30.60 191.94 -3.32 28.83 197.07 -19.18 64.09 108.25 -14.44 63.70 112.45 coo -3.44 22.13 193.22 -3.30 22.85 192.94 -22.09 57.26 103.59 -22.19 58.16 103.73 coo -8.31 23.03 202.48 -6.18 24.15 202.80 -11.80 54.65 102.27 -11.20 56.97 103.08 1doo_c02 source 1doo HEAT SHOCK LOCUS U : 2 hits 1doo_c02 naa= 4 ULMN 4 1doo_c03 HEAT SHOCK LOCUS U user 1 4 # 1 D 1 THR A 194 THR.? 13.30 CL CL B 382 D 33 LYS B 288 LYS.? 8.84 CL CL B 382 D 48 GLY B 285 GLY^? 18.43 CL CL A 384 D 124 SER A 192 SER.? 15.36 CL CL A 384 coo 21.09 18.28 199.42 20.72 17.74 197.38 -23.53 58.32 86.21 -24.61 58.92 84.44 coo 25.54 20.08 191.91 24.21 17.77 197.54 -16.76 54.22 83.25 -20.62 56.75 78.99 coo 18.82 14.75 192.32 19.54 14.99 192.16 -20.19 51.54 90.83 -19.46 51.66 90.42 coo 16.26 18.98 201.87 18.32 18.00 202.67 -26.48 60.82 89.96 -25.15 61.33 88.02 ULMN 4 1doo_c03 HEAT SHOCK LOCUS U user 2 4 # 2 D 1 THR B 194 THR.? 12.32 CL CL A 384 D 33 LYS A 288 LYS.? 12.57 CL CL A 384 D 48 GLY A 285 GLY^? 9.46 CL CL A 384 D 124 SER B 192 SER.? 13.26 CL CL A 384 coo 21.09 18.28 199.42 20.72 17.74 197.38 -14.07 57.99 105.37 -12.38 58.46 106.64 coo 25.54 20.08 191.91 24.21 17.77 197.54 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 18.82 14.75 192.32 19.54 14.99 192.16 -22.09 57.26 103.59 -22.19 58.16 103.73 coo 16.26 18.98 201.87 18.32 18.00 202.67 -11.80 54.65 102.27 -11.20 56.97 103.08 1doo_c03 source 1doo HEAT SHOCK LOCUS U : 2 hits 1doo_c03 naa= 4 ULMN 4 1doo_c04 HEAT SHOCK LOCUS U user 1 4 # 1 A 1 THR A 194 THR.? 13.30 CL CL B 382 A 33 LYS B 288 LYS.? 8.84 CL CL B 382 A 45 GLY B 292 GLY.? 13.97 CL CL B 382 A 124 SER A 192 SER.? 15.36 CL CL A 384 coo 20.60 80.81 78.25 19.93 81.48 80.23 -23.53 58.32 86.21 -24.61 58.92 84.44 coo 24.21 79.63 86.31 23.19 81.94 80.55 -16.76 54.22 83.25 -20.62 56.75 78.99 coo 20.39 75.93 87.86 19.67 76.00 88.35 -15.38 58.60 80.90 -14.73 58.21 81.00 coo 15.73 80.26 75.45 17.95 80.97 75.03 -26.48 60.82 89.96 -25.15 61.33 88.02 ULMN 4 1doo_c04 HEAT SHOCK LOCUS U user 2 4 # 2 A 1 THR B 194 THR.? 12.32 CL CL A 384 A 33 LYS A 288 LYS.? 12.57 CL CL A 384 A 45 GLY A 292 GLY.? 8.59 CL CL A 384 A 124 SER B 192 SER.? 13.26 CL CL A 384 coo 20.60 80.81 78.25 19.93 81.48 80.23 -14.07 57.99 105.37 -12.38 58.46 106.64 coo 24.21 79.63 86.31 23.19 81.94 80.55 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 20.39 75.93 87.86 19.67 76.00 88.35 -15.25 67.65 108.46 -15.89 68.08 108.32 coo 15.73 80.26 75.45 17.95 80.97 75.03 -11.80 54.65 102.27 -11.20 56.97 103.08 1doo_c04 source 1doo HEAT SHOCK LOCUS U : 2 hits 1doo_c04 naa= 4 ULMN 4 1doo_c05 HEAT SHOCK LOCUS U user 1 4 # 1 B 1 THR A 194 THR.? 13.30 CL CL B 382 B 33 LYS B 288 LYS.? 8.84 CL CL B 382 B 45 GLY B 292 GLY.? 13.97 CL CL B 382 B 124 SER A 192 SER.? 15.36 CL CL A 384 coo 26.69 108.13 78.57 25.70 107.69 80.43 -23.53 58.32 86.21 -24.61 58.92 84.44 coo 30.17 110.91 86.31 27.32 111.03 80.63 -16.76 54.22 83.25 -20.62 56.75 78.99 coo 31.73 106.00 88.02 31.34 105.46 88.62 -15.38 58.60 80.90 -14.73 58.21 81.00 coo 24.65 103.43 76.04 24.59 105.78 75.60 -26.48 60.82 89.96 -25.15 61.33 88.02 ULMN 4 1doo_c05 HEAT SHOCK LOCUS U user 2 4 # 2 B 1 THR B 194 THR.? 12.32 CL CL A 384 B 33 LYS A 288 LYS.? 12.57 CL CL A 384 B 45 GLY A 292 GLY.? 8.59 CL CL A 384 B 124 SER B 192 SER.? 13.26 CL CL A 384 coo 26.69 108.13 78.57 25.70 107.69 80.43 -14.07 57.99 105.37 -12.38 58.46 106.64 coo 30.17 110.91 86.31 27.32 111.03 80.63 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 31.73 106.00 88.02 31.34 105.46 88.62 -15.25 67.65 108.46 -15.89 68.08 108.32 coo 24.65 103.43 76.04 24.59 105.78 75.60 -11.80 54.65 102.27 -11.20 56.97 103.08 1doo_c05 source 1doo HEAT SHOCK LOCUS U : 2 hits 1doo_c05 naa= 4 ULMN 4 1doo_c06 HEAT SHOCK LOCUS U user 1 4 # 1 C 1 THR A 194 THR.? 13.30 CL CL B 382 C 33 LYS B 288 LYS.? 8.84 CL CL B 382 C 45 GLY B 292 GLY.? 13.97 CL CL B 382 C 124 SER A 192 SER.? 15.36 CL CL A 384 coo -5.30 26.59 199.66 -4.98 26.05 197.57 -23.53 58.32 86.21 -24.61 58.92 84.44 coo -4.62 30.60 191.94 -3.32 28.83 197.07 -16.76 54.22 83.25 -20.62 56.75 78.99 coo -9.57 29.11 189.94 -9.84 28.44 189.46 -15.38 58.60 80.90 -14.73 58.21 81.00 coo -8.31 23.03 202.48 -6.18 24.15 202.80 -26.48 60.82 89.96 -25.15 61.33 88.02 ULMN 4 1doo_c06 HEAT SHOCK LOCUS U user 2 4 # 2 C 1 THR B 194 THR.? 12.32 CL CL A 384 C 33 LYS A 288 LYS.? 12.57 CL CL A 384 C 45 GLY A 292 GLY.? 8.59 CL CL A 384 C 124 SER B 192 SER.? 13.26 CL CL A 384 coo -5.30 26.59 199.66 -4.98 26.05 197.57 -14.07 57.99 105.37 -12.38 58.46 106.64 coo -4.62 30.60 191.94 -3.32 28.83 197.07 -19.18 64.09 108.25 -14.44 63.70 112.45 coo -9.57 29.11 189.94 -9.84 28.44 189.46 -15.25 67.65 108.46 -15.89 68.08 108.32 coo -8.31 23.03 202.48 -6.18 24.15 202.80 -11.80 54.65 102.27 -11.20 56.97 103.08 1doo_c06 source 1doo HEAT SHOCK LOCUS U : 2 hits 1doo_c06 naa= 4 ULMN 4 1doo_c07 HEAT SHOCK LOCUS U user 1 4 # 1 D 1 THR A 194 THR.? 13.30 CL CL B 382 D 33 LYS B 288 LYS.? 8.84 CL CL B 382 D 45 GLY B 292 GLY.? 13.97 CL CL B 382 D 124 SER A 192 SER.? 15.36 CL CL A 384 coo 21.09 18.28 199.42 20.72 17.74 197.38 -23.53 58.32 86.21 -24.61 58.92 84.44 coo 25.54 20.08 191.91 24.21 17.77 197.54 -16.76 54.22 83.25 -20.62 56.75 78.99 coo 21.95 23.77 189.96 21.30 23.70 189.39 -15.38 58.60 80.90 -14.73 58.21 81.00 coo 16.26 18.98 201.87 18.32 18.00 202.67 -26.48 60.82 89.96 -25.15 61.33 88.02 ULMN 4 1doo_c07 HEAT SHOCK LOCUS U user 2 4 # 2 D 1 THR B 194 THR.? 12.32 CL CL A 384 D 33 LYS A 288 LYS.? 12.57 CL CL A 384 D 45 GLY A 292 GLY.? 8.59 CL CL A 384 D 124 SER B 192 SER.? 13.26 CL CL A 384 coo 21.09 18.28 199.42 20.72 17.74 197.38 -14.07 57.99 105.37 -12.38 58.46 106.64 coo 25.54 20.08 191.91 24.21 17.77 197.54 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 21.95 23.77 189.96 21.30 23.70 189.39 -15.25 67.65 108.46 -15.89 68.08 108.32 coo 16.26 18.98 201.87 18.32 18.00 202.67 -11.80 54.65 102.27 -11.20 56.97 103.08 1doo_c07 source 1doo HEAT SHOCK LOCUS U : 2 hits 1doo_c07 naa= 4 ULMN 4 1e6e_c00 ADRENODOXIN user 1 4 # 1 A 55 HIS A 302 HIS^? 11.51 CL CL A 384 A 159 ASP A 311 ASP^? 15.19 CL CL A 384 A 376 ILE A 200 ILE.? 9.95 CL CL A 384 A 377 THR A 283 THR^? 13.40 CL CL A 384 coo 17.95 58.52 112.81 17.29 59.41 111.03 -27.17 73.50 97.06 -27.34 73.92 95.02 coo 11.32 57.46 110.35 12.85 58.48 111.39 -31.19 72.86 91.72 -29.44 73.97 92.12 coo 15.00 65.23 121.40 15.42 63.95 122.00 -27.51 61.27 97.30 -28.55 62.17 97.37 coo 15.65 69.77 121.40 17.38 70.64 120.41 -28.94 58.76 103.11 -29.59 56.83 103.84 ULMN 4 1e6e_c00 ADRENODOXIN user 2 4 # 2 A 55 HIS A 302 HIS^? 11.51 CL CL A 384 A 159 ASP A 311 ASP^? 15.19 CL CL A 384 A 376 ILE A 282 ILE^? 10.34 CL CL A 384 A 377 THR A 281 THR^? 16.66 CL CL A 384 coo 17.95 58.52 112.81 17.29 59.41 111.03 -27.17 73.50 97.06 -27.34 73.92 95.02 coo 11.32 57.46 110.35 12.85 58.48 111.39 -31.19 72.86 91.72 -29.44 73.97 92.12 coo 15.00 65.23 121.40 15.42 63.95 122.00 -30.54 62.79 101.68 -29.98 63.61 100.68 coo 15.65 69.77 121.40 17.38 70.64 120.41 -34.83 61.90 103.55 -35.70 60.62 105.09 ULMN 4 1e6e_c00 ADRENODOXIN user 3 4 # 3 A 55 HIS A 302 HIS^? 11.51 CL CL A 384 A 159 ASP A 311 ASP^? 15.19 CL CL A 384 A 376 ILE A 282 ILE^? 10.34 CL CL A 384 A 377 THR A 283 THR^? 13.40 CL CL A 384 coo 17.95 58.52 112.81 17.29 59.41 111.03 -27.17 73.50 97.06 -27.34 73.92 95.02 coo 11.32 57.46 110.35 12.85 58.48 111.39 -31.19 72.86 91.72 -29.44 73.97 92.12 coo 15.00 65.23 121.40 15.42 63.95 122.00 -30.54 62.79 101.68 -29.98 63.61 100.68 coo 15.65 69.77 121.40 17.38 70.64 120.41 -28.94 58.76 103.11 -29.59 56.83 103.84 ULMN 4 1e6e_c00 ADRENODOXIN user 4 4 # 4 A 55 HIS A 308 HIS.? 20.06 CL CL A 384 A 159 ASP A 306 ASP.? 16.66 CL CL A 384 A 376 ILE A 282 ILE^? 10.34 CL CL A 384 A 377 THR A 281 THR^? 16.66 CL CL A 384 coo 17.95 58.52 112.81 17.29 59.41 111.03 -37.01 64.37 91.64 -38.79 63.83 92.62 coo 11.32 57.46 110.35 12.85 58.48 111.39 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 15.00 65.23 121.40 15.42 63.95 122.00 -30.54 62.79 101.68 -29.98 63.61 100.68 coo 15.65 69.77 121.40 17.38 70.64 120.41 -34.83 61.90 103.55 -35.70 60.62 105.09 ULMN 4 1e6e_c00 ADRENODOXIN user 5 4 # 5 A 55 HIS A 308 HIS.? 20.06 CL CL A 384 A 159 ASP A 306 ASP.? 16.66 CL CL A 384 A 376 ILE A 282 ILE^? 10.34 CL CL A 384 A 377 THR A 283 THR^? 13.40 CL CL A 384 coo 17.95 58.52 112.81 17.29 59.41 111.03 -37.01 64.37 91.64 -38.79 63.83 92.62 coo 11.32 57.46 110.35 12.85 58.48 111.39 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 15.00 65.23 121.40 15.42 63.95 122.00 -30.54 62.79 101.68 -29.98 63.61 100.68 coo 15.65 69.77 121.40 17.38 70.64 120.41 -28.94 58.76 103.11 -29.59 56.83 103.84 ULMN 4 1e6e_c00 ADRENODOXIN user 6 4 # 6 A 55 HIS B 302 HIS^? 23.99 CL CL A 384 A 159 ASP B 311 ASP^? 24.66 CL CL A 384 A 376 ILE B 200 ILE^? 19.01 CL CL A 384 A 377 THR B 283 THR^? 20.21 CL CL B 383 coo 17.95 58.52 112.81 17.29 59.41 111.03 -2.27 54.46 91.30 -1.20 55.23 92.93 coo 11.32 57.46 110.35 12.85 58.48 111.39 0.41 52.81 97.17 0.37 54.52 95.85 coo 15.00 65.23 121.40 15.42 63.95 122.00 -12.94 50.54 95.99 -11.74 49.85 95.90 coo 15.65 69.77 121.40 17.38 70.64 120.41 -16.17 46.19 92.40 -17.74 44.83 92.78 ULMN 4 1e6e_c00 ADRENODOXIN user 7 4 # 7 A 55 HIS B 302 HIS^? 23.99 CL CL A 384 A 159 ASP B 311 ASP^? 24.66 CL CL A 384 A 376 ILE B 282 ILE^? 20.23 CL CL B 383 A 377 THR B 281 THR^? 16.75 CL CL B 383 coo 17.95 58.52 112.81 17.29 59.41 111.03 -2.27 54.46 91.30 -1.20 55.23 92.93 coo 11.32 57.46 110.35 12.85 58.48 111.39 0.41 52.81 97.17 0.37 54.52 95.85 coo 15.00 65.23 121.40 15.42 63.95 122.00 -11.55 46.51 92.54 -10.76 47.61 92.90 coo 15.65 69.77 121.40 17.38 70.64 120.41 -11.01 41.80 92.41 -12.17 40.05 91.86 ULMN 4 1e6e_c00 ADRENODOXIN user 8 4 # 8 A 55 HIS B 302 HIS^? 23.99 CL CL A 384 A 159 ASP B 311 ASP^? 24.66 CL CL A 384 A 376 ILE B 282 ILE^? 20.23 CL CL B 383 A 377 THR B 283 THR^? 20.21 CL CL B 383 coo 17.95 58.52 112.81 17.29 59.41 111.03 -2.27 54.46 91.30 -1.20 55.23 92.93 coo 11.32 57.46 110.35 12.85 58.48 111.39 0.41 52.81 97.17 0.37 54.52 95.85 coo 15.00 65.23 121.40 15.42 63.95 122.00 -11.55 46.51 92.54 -10.76 47.61 92.90 coo 15.65 69.77 121.40 17.38 70.64 120.41 -16.17 46.19 92.40 -17.74 44.83 92.78 1e6e_c00 source 1e6e ADRENODOXIN : 8 hits 1e6e_c00 naa= 4 ULMN 4 1e6e_c01 ADRENODOXIN user 1 4 # 1 C 55 HIS A 302 HIS^? 11.51 CL CL A 384 C 159 ASP A 311 ASP^? 15.19 CL CL A 384 C 376 ILE A 200 ILE.? 9.95 CL CL A 384 C 377 THR A 283 THR^? 13.40 CL CL A 384 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -27.17 73.50 97.06 -27.34 73.92 95.02 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -31.19 72.86 91.72 -29.44 73.97 92.12 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -27.51 61.27 97.30 -28.55 62.17 97.37 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -28.94 58.76 103.11 -29.59 56.83 103.84 ULMN 4 1e6e_c01 ADRENODOXIN user 2 4 # 2 C 55 HIS A 302 HIS^? 11.51 CL CL A 384 C 159 ASP A 311 ASP^? 15.19 CL CL A 384 C 376 ILE A 282 ILE^? 10.34 CL CL A 384 C 377 THR A 281 THR^? 16.66 CL CL A 384 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -27.17 73.50 97.06 -27.34 73.92 95.02 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -31.19 72.86 91.72 -29.44 73.97 92.12 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -30.54 62.79 101.68 -29.98 63.61 100.68 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -34.83 61.90 103.55 -35.70 60.62 105.09 ULMN 4 1e6e_c01 ADRENODOXIN user 3 4 # 3 C 55 HIS A 302 HIS^? 11.51 CL CL A 384 C 159 ASP A 311 ASP^? 15.19 CL CL A 384 C 376 ILE A 282 ILE^? 10.34 CL CL A 384 C 377 THR A 283 THR^? 13.40 CL CL A 384 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -27.17 73.50 97.06 -27.34 73.92 95.02 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -31.19 72.86 91.72 -29.44 73.97 92.12 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -30.54 62.79 101.68 -29.98 63.61 100.68 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -28.94 58.76 103.11 -29.59 56.83 103.84 ULMN 4 1e6e_c01 ADRENODOXIN user 4 4 # 4 C 55 HIS A 308 HIS.? 20.06 CL CL A 384 C 159 ASP A 306 ASP.? 16.66 CL CL A 384 C 376 ILE A 282 ILE^? 10.34 CL CL A 384 C 377 THR A 283 THR^? 13.40 CL CL A 384 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -37.01 64.37 91.64 -38.79 63.83 92.62 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -29.63 66.56 87.01 -28.35 68.29 87.20 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -30.54 62.79 101.68 -29.98 63.61 100.68 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -28.94 58.76 103.11 -29.59 56.83 103.84 ULMN 4 1e6e_c01 ADRENODOXIN user 5 4 # 5 C 55 HIS B 302 HIS^? 23.99 CL CL A 384 C 159 ASP B 311 ASP^? 24.66 CL CL A 384 C 376 ILE B 200 ILE^? 19.01 CL CL A 384 C 377 THR B 283 THR^? 20.21 CL CL B 383 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -2.27 54.46 91.30 -1.20 55.23 92.93 coo -23.44 38.39 138.46 -25.44 39.03 138.64 0.41 52.81 97.17 0.37 54.52 95.85 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -12.94 50.54 95.99 -11.74 49.85 95.90 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -16.17 46.19 92.40 -17.74 44.83 92.78 ULMN 4 1e6e_c01 ADRENODOXIN user 6 4 # 6 C 55 HIS B 302 HIS^? 23.99 CL CL A 384 C 159 ASP B 311 ASP^? 24.66 CL CL A 384 C 376 ILE B 282 ILE^? 20.23 CL CL B 383 C 377 THR B 281 THR^? 16.75 CL CL B 383 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -2.27 54.46 91.30 -1.20 55.23 92.93 coo -23.44 38.39 138.46 -25.44 39.03 138.64 0.41 52.81 97.17 0.37 54.52 95.85 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -11.55 46.51 92.54 -10.76 47.61 92.90 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -11.01 41.80 92.41 -12.17 40.05 91.86 ULMN 4 1e6e_c01 ADRENODOXIN user 7 4 # 7 C 55 HIS B 302 HIS^? 23.99 CL CL A 384 C 159 ASP B 311 ASP^? 24.66 CL CL A 384 C 376 ILE B 282 ILE^? 20.23 CL CL B 383 C 377 THR B 283 THR^? 20.21 CL CL B 383 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -2.27 54.46 91.30 -1.20 55.23 92.93 coo -23.44 38.39 138.46 -25.44 39.03 138.64 0.41 52.81 97.17 0.37 54.52 95.85 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -11.55 46.51 92.54 -10.76 47.61 92.90 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -16.17 46.19 92.40 -17.74 44.83 92.78 1e6e_c01 source 1e6e ADRENODOXIN : 7 hits 1e6e_c01 naa= 4 ULMN 4 1i8t_c02 UDP-GALACTOPYRANOSE MUTASE user 1 4 # 1 A 170 ARG A 202 ARG^? 19.65 CL CL A 384 A 278 ARG A 24 ARG^? 24.95 CL CL A 382 A 298 GLU A 23 GLU.? 27.24 CL CL A 382 A 348 ASP A 28 ASP^? 9.02 CL CL A 382 coo -23.99 -12.72 0.77 -26.03 -13.46 2.92 -32.39 54.22 100.96 -34.65 53.06 99.24 coo -18.98 -3.88 -14.05 -18.01 -5.56 -11.69 -27.53 46.21 115.11 -27.47 43.33 116.18 coo -18.09 -5.55 -18.88 -17.66 -5.99 -16.85 -22.84 44.28 116.17 -23.55 42.53 115.22 coo -11.04 -13.38 -5.15 -13.10 -12.92 -5.14 -32.19 59.08 116.32 -33.48 59.98 114.85 ULMN 4 1i8t_c02 UDP-GALACTOPYRANOSE MUTASE user 2 4 # 2 A 170 ARG A 274 ARG~? 23.93 CL CL A 382 A 278 ARG A 334 ARG^? 9.67 CL CL A 382 A 298 GLU A 332 GLU^? 14.84 CL CL A 382 A 348 ASP A 208 ASP.? 21.85 CL CL A 382 coo -23.99 -12.72 0.77 -26.03 -13.46 2.92 -45.43 76.09 104.31 -44.66 77.94 101.95 coo -18.98 -3.88 -14.05 -18.01 -5.56 -11.69 -35.93 61.76 109.91 -34.52 61.40 112.61 coo -18.09 -5.55 -18.88 -17.66 -5.99 -16.85 -32.41 59.20 107.78 -33.78 57.91 108.78 coo -11.04 -13.38 -5.15 -13.10 -12.92 -5.14 -48.25 63.81 104.00 -49.74 63.21 105.24 ULMN 4 1i8t_c02 UDP-GALACTOPYRANOSE MUTASE user 3 4 # 3 A 170 ARG A 319 ARG^? 9.49 CL CL A 382 A 278 ARG A 13 ARG^? 21.22 CL CL A 382 A 298 GLU A 18 GLU^? 23.23 CL CL A 382 A 348 ASP A 93 ASP^? 5.15 CL CL A 382 coo -23.99 -12.72 0.77 -26.03 -13.46 2.92 -27.23 63.29 112.77 -27.13 63.50 115.87 coo -18.98 -3.88 -14.05 -18.01 -5.56 -11.69 -15.61 60.27 127.72 -14.54 62.09 125.47 coo -18.09 -5.55 -18.88 -17.66 -5.99 -16.85 -12.62 56.10 125.83 -13.81 57.82 125.60 coo -11.04 -13.38 -5.15 -13.10 -12.92 -5.14 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 4 1i8t_c02 UDP-GALACTOPYRANOSE MUTASE user 4 4 # 4 A 170 ARG A 319 ARG^? 9.49 CL CL A 382 A 278 ARG A 20 ARG.? 25.24 CL CL A 384 A 298 GLU A 18 GLU^? 23.23 CL CL A 382 A 348 ASP A 39 ASP^? 16.51 CL CL A 382 coo -23.99 -12.72 0.77 -26.03 -13.46 2.92 -27.23 63.29 112.77 -27.13 63.50 115.87 coo -18.98 -3.88 -14.05 -18.01 -5.56 -11.69 -13.35 53.68 120.82 -11.33 55.30 122.50 coo -18.09 -5.55 -18.88 -17.66 -5.99 -16.85 -12.62 56.10 125.83 -13.81 57.82 125.60 coo -11.04 -13.38 -5.15 -13.10 -12.92 -5.14 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 4 1i8t_c02 UDP-GALACTOPYRANOSE MUTASE user 5 4 # 5 A 170 ARG A 325 ARG.? 29.26 CL CL A 384 A 278 ARG A 20 ARG.? 25.24 CL CL A 384 A 298 GLU A 18 GLU^? 23.23 CL CL A 382 A 348 ASP A 39 ASP^? 16.51 CL CL A 382 coo -23.99 -12.72 0.77 -26.03 -13.46 2.92 -22.19 42.21 111.60 -22.86 39.29 112.51 coo -18.98 -3.88 -14.05 -18.01 -5.56 -11.69 -13.35 53.68 120.82 -11.33 55.30 122.50 coo -18.09 -5.55 -18.88 -17.66 -5.99 -16.85 -12.62 56.10 125.83 -13.81 57.82 125.60 coo -11.04 -13.38 -5.15 -13.10 -12.92 -5.14 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 4 1i8t_c02 UDP-GALACTOPYRANOSE MUTASE user 6 4 # 6 A 170 ARG B 274 ARG~? 23.83 CL CL B 383 A 278 ARG B 334 ARG^? 9.65 CL CL B 383 A 298 GLU B 332 GLU^? 14.76 CL CL B 383 A 348 ASP B 208 ASP.? 21.56 CL CL B 383 coo -23.99 -12.72 0.77 -26.03 -13.46 2.92 5.51 36.33 89.03 7.35 38.65 89.98 coo -18.98 -3.88 -14.05 -18.01 -5.56 -11.69 -12.53 38.39 87.32 -14.06 38.36 84.61 coo -18.09 -5.55 -18.88 -17.66 -5.99 -16.85 -15.56 41.56 89.17 -16.27 39.59 89.11 coo -11.04 -13.38 -5.15 -13.10 -12.92 -5.14 -4.03 30.56 94.79 -4.11 28.51 94.21 1i8t_c02 source 1i8t UDP-GALACTOPYRANOSE MUTASE : 6 hits 1i8t_c02 naa= 4 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 1 4 # 1 B 170 ARG A 274 ARG~? 23.93 CL CL A 382 B 278 ARG A 334 ARG^? 9.67 CL CL A 382 B 298 GLU A 332 GLU^? 14.84 CL CL A 382 B 348 ASP A 208 ASP.? 21.85 CL CL A 382 coo -8.10 23.98 3.08 -8.58 21.04 2.27 -45.43 76.09 104.31 -44.66 77.94 101.95 coo -19.09 15.00 16.26 -16.38 15.21 14.84 -35.93 61.76 109.91 -34.52 61.40 112.61 coo -19.42 16.58 21.15 -18.01 16.20 19.59 -32.41 59.20 107.78 -33.78 57.91 108.78 coo -3.61 14.95 13.27 -5.31 15.62 12.23 -48.25 63.81 104.00 -49.74 63.21 105.24 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 2 4 # 2 B 170 ARG A 319 ARG^? 9.49 CL CL A 382 B 278 ARG A 13 ARG^? 21.22 CL CL A 382 B 298 GLU A 18 GLU^? 23.23 CL CL A 382 B 348 ASP A 93 ASP^? 5.15 CL CL A 382 coo -8.10 23.98 3.08 -8.58 21.04 2.27 -27.23 63.29 112.77 -27.13 63.50 115.87 coo -19.09 15.00 16.26 -16.38 15.21 14.84 -15.61 60.27 127.72 -14.54 62.09 125.47 coo -19.42 16.58 21.15 -18.01 16.20 19.59 -12.62 56.10 125.83 -13.81 57.82 125.60 coo -3.61 14.95 13.27 -5.31 15.62 12.23 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 3 4 # 3 B 170 ARG A 319 ARG^? 9.49 CL CL A 382 B 278 ARG A 20 ARG.? 25.24 CL CL A 384 B 298 GLU A 18 GLU^? 23.23 CL CL A 382 B 348 ASP A 39 ASP^? 16.51 CL CL A 382 coo -8.10 23.98 3.08 -8.58 21.04 2.27 -27.23 63.29 112.77 -27.13 63.50 115.87 coo -19.09 15.00 16.26 -16.38 15.21 14.84 -13.35 53.68 120.82 -11.33 55.30 122.50 coo -19.42 16.58 21.15 -18.01 16.20 19.59 -12.62 56.10 125.83 -13.81 57.82 125.60 coo -3.61 14.95 13.27 -5.31 15.62 12.23 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 4 4 # 4 B 170 ARG B 13 ARG^? 4.84 CL CL B 382 B 278 ARG B 320 ARG^? 13.22 CL CL B 383 B 298 GLU B 332 GLU^? 14.76 CL CL B 383 B 348 ASP B 93 ASP^? 5.22 CL CL B 383 coo -8.10 23.98 3.08 -8.58 21.04 2.27 -26.14 48.57 68.77 -25.79 51.69 68.63 coo -19.09 15.00 16.26 -16.38 15.21 14.84 -19.20 39.56 86.12 -20.64 37.04 85.01 coo -19.42 16.58 21.15 -18.01 16.20 19.59 -15.56 41.56 89.17 -16.27 39.59 89.11 coo -3.61 14.95 13.27 -5.31 15.62 12.23 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 5 4 # 5 B 170 ARG B 92 ARG^? 9.18 CL CL B 384 B 278 ARG B 13 ARG^? 4.84 CL CL B 382 B 298 GLU B 18 GLU^? 5.91 CL CL B 382 B 348 ASP B 26 ASP^? 16.51 CL CL B 383 coo -8.10 23.98 3.08 -8.58 21.04 2.27 -19.73 31.24 73.98 -19.77 29.09 71.81 coo -19.09 15.00 16.26 -16.38 15.21 14.84 -26.14 48.57 68.77 -25.79 51.69 68.63 coo -19.42 16.58 21.15 -18.01 16.20 19.59 -29.91 50.09 69.26 -29.49 51.30 70.99 coo -3.61 14.95 13.27 -5.31 15.62 12.23 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 4 1i8t_c03 UDP-GALACTOPYRANOSE MUTASE user 6 4 # 6 B 170 ARG B 320 ARG^? 13.22 CL CL B 383 B 278 ARG B 13 ARG^? 4.84 CL CL B 382 B 298 GLU B 18 GLU^? 5.91 CL CL B 382 B 348 ASP B 93 ASP^? 5.22 CL CL B 383 coo -8.10 23.98 3.08 -8.58 21.04 2.27 -19.20 39.56 86.12 -20.64 37.04 85.01 coo -19.09 15.00 16.26 -16.38 15.21 14.84 -26.14 48.57 68.77 -25.79 51.69 68.63 coo -19.42 16.58 21.15 -18.01 16.20 19.59 -29.91 50.09 69.26 -29.49 51.30 70.99 coo -3.61 14.95 13.27 -5.31 15.62 12.23 -17.13 37.76 71.68 -15.50 36.45 72.23 1i8t_c03 source 1i8t UDP-GALACTOPYRANOSE MUTASE : 6 hits 1i8t_c03 naa= 4 ULMN 4 1kim_c01 THYMIDINE KINASE user 1 4 # 1 B 59 GLY B 65 GLY.? -4.07 CL CL B 382s B 83 GLU B 18 GLU^? 5.91 CL CL B 382 B 163 ARG B 13 ARG^? 4.84 CL CL B 382 B 222 ARG B 20 ARG.? -3.56 CL CL B 382s coo 12.62 99.24 38.96 12.68 98.60 38.52 -21.30 55.60 72.20 -21.07 55.03 72.67 coo 14.40 90.04 44.78 14.76 92.05 44.57 -29.91 50.09 69.26 -29.49 51.30 70.99 coo 17.43 90.38 41.69 17.76 92.72 39.75 -26.14 48.57 68.77 -25.79 51.69 68.63 coo 13.56 96.78 47.94 12.87 95.13 45.44 -30.86 53.38 73.69 -28.77 54.55 71.62 1kim_c01 source 1kim THYMIDINE KINASE : 1 hits 1kim_c01 naa= 4 ULMN 4 1kzh_c00 PHOSPHOFRUCTOKINASE user 1 4 # 1 A 146 ARG B 197 ARG.? 10.56 CL CL A 384 A 203 LYS A 288 LYS.? 12.57 CL CL A 384 A 204 THR A 289 THR.? 4.96 CL CL A 384 A 206 ASP A 291 ASP.? 7.30 CL CL A 384 coo 25.62 33.56 45.31 27.90 32.69 47.16 -11.56 63.68 96.52 -11.06 66.80 96.90 coo 38.37 29.68 45.64 33.70 31.88 45.68 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 36.44 29.68 48.91 35.26 27.91 49.41 -19.38 66.54 105.44 -19.89 68.46 106.21 coo 33.39 27.17 52.78 32.04 28.76 52.44 -15.45 71.21 105.07 -17.40 71.77 105.62 1kzh_c00 source 1kzh PHOSPHOFRUCTOKINASE : 1 hits 1kzh_c00 naa= 4 ULMN 4 1kzh_c01 PHOSPHOFRUCTOKINASE user 1 4 # 1 B 146 ARG B 197 ARG.? 10.56 CL CL A 384 B 203 LYS A 288 LYS.? 12.57 CL CL A 384 B 204 THR A 289 THR.? 4.96 CL CL A 384 B 206 ASP A 291 ASP.? 7.30 CL CL A 384 coo 30.44 48.99 84.53 31.72 50.36 82.10 -11.56 63.68 96.52 -11.06 66.80 96.90 coo 41.12 55.31 79.75 37.30 52.17 81.04 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 38.33 54.75 77.25 36.67 56.16 77.22 -19.38 66.54 105.44 -19.89 68.46 106.21 coo 33.88 56.54 74.67 32.88 54.78 75.26 -15.45 71.21 105.07 -17.40 71.77 105.62 1kzh_c01 source 1kzh PHOSPHOFRUCTOKINASE : 1 hits 1kzh_c01 naa= 4 ULMN 4 1l7d_c00 NICOTINAMIDE NUCLEOTIDE TRANSHYDROGEuser 1 4 # 1 A 127 ARG A 202 ARG^? 19.65 CL CL A 384 A 132 GLN A 330 GLN^? 14.80 CL CL A 384 A 135 ASP A 327 ASP.? 19.04 CL CL A 384 A 138 SER A 324 SER^? 19.72 CL CL A 384 coo -5.87 -32.14 16.05 -5.08 -34.04 18.31 -32.39 54.22 100.96 -34.65 53.06 99.24 coo 0.32 -23.63 17.28 -0.45 -21.67 17.61 -24.70 54.33 105.30 -26.34 53.14 104.66 coo 2.58 -27.93 13.18 1.12 -28.64 11.82 -25.74 49.77 105.10 -27.34 48.80 104.08 coo 1.28 -26.11 8.70 -0.28 -25.96 10.56 -24.77 48.15 110.31 -26.00 48.61 108.19 ULMN 4 1l7d_c00 NICOTINAMIDE NUCLEOTIDE TRANSHYDROGEuser 2 4 # 2 A 127 ARG A 320 ARG^? 16.18 CL CL A 382 A 132 GLN A 330 GLN^? 14.80 CL CL A 384 A 135 ASP A 327 ASP.? 19.04 CL CL A 384 A 138 SER A 324 SER^? 19.72 CL CL A 384 coo -5.87 -32.14 16.05 -5.08 -34.04 18.31 -32.10 56.68 112.17 -32.95 53.99 110.90 coo 0.32 -23.63 17.28 -0.45 -21.67 17.61 -24.70 54.33 105.30 -26.34 53.14 104.66 coo 2.58 -27.93 13.18 1.12 -28.64 11.82 -25.74 49.77 105.10 -27.34 48.80 104.08 coo 1.28 -26.11 8.70 -0.28 -25.96 10.56 -24.77 48.15 110.31 -26.00 48.61 108.19 ULMN 4 1l7d_c00 NICOTINAMIDE NUCLEOTIDE TRANSHYDROGEuser 3 4 # 3 A 127 ARG B 193 ARG.? 19.02 CL CL A 384 A 132 GLN A 330 GLN^? 14.80 CL CL A 384 A 135 ASP A 327 ASP.? 19.04 CL CL A 384 A 138 SER A 324 SER^? 19.72 CL CL A 384 coo -5.87 -32.14 16.05 -5.08 -34.04 18.31 -14.12 50.83 106.82 -12.70 50.89 109.57 coo 0.32 -23.63 17.28 -0.45 -21.67 17.61 -24.70 54.33 105.30 -26.34 53.14 104.66 coo 2.58 -27.93 13.18 1.12 -28.64 11.82 -25.74 49.77 105.10 -27.34 48.80 104.08 coo 1.28 -26.11 8.70 -0.28 -25.96 10.56 -24.77 48.15 110.31 -26.00 48.61 108.19 ULMN 4 1l7d_c00 NICOTINAMIDE NUCLEOTIDE TRANSHYDROGEuser 4 4 # 4 A 127 ARG B 320 ARG^? 13.22 CL CL B 383 A 132 GLN B 330 GLN^? 22.15 CL CL A 384 A 135 ASP B 327 ASP.? 22.34 CL CL A 384 A 138 SER B 324 SER^? 22.60 CL CL B 382 coo -5.87 -32.14 16.05 -5.08 -34.04 18.31 -19.20 39.56 86.12 -20.64 37.04 85.01 coo 0.32 -23.63 17.28 -0.45 -21.67 17.61 -22.26 47.78 91.02 -22.35 46.33 92.55 coo 2.58 -27.93 13.18 1.12 -28.64 11.82 -25.62 46.25 93.54 -25.42 45.53 95.50 coo 1.28 -26.11 8.70 -0.28 -25.96 10.56 -28.77 44.19 89.22 -27.33 44.36 91.21 1l7d_c00 source 1l7d NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE, SUBU: 4 hits 1l7d_c00 naa= 4 ULMN 4 1ltq_c00 POLYNUCLEOTIDE KINASE user 1 4 # 1 A 15 LYS A 267 LYS~? 27.66 CL CL A 382 A 35 ASP A 240 ASP.? 30.06 CL CL A 382 A 126 ARG A 274 ARG~? 23.93 CL CL A 382 A 165 ASP A 26 ASP^? 16.59 CL CL A 382 coo 25.71 11.82 52.50 25.05 7.88 50.17 -49.43 81.28 111.60 -49.39 86.78 108.40 coo 23.50 1.36 54.56 23.86 1.61 52.50 -54.36 78.15 100.29 -55.09 76.20 100.68 coo 33.89 4.42 51.79 30.99 5.09 51.05 -45.43 76.09 104.31 -44.66 77.94 101.95 coo 42.34 11.15 22.32 43.58 12.11 23.75 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 4 1ltq_c00 POLYNUCLEOTIDE KINASE user 2 4 # 2 A 15 LYS A 267 LYS~? 27.66 CL CL A 382 A 35 ASP A 240 ASP.? 30.06 CL CL A 382 A 126 ARG A 274 ARG~? 23.93 CL CL A 382 A 165 ASP A 291 ASP.? 7.30 CL CL A 384 coo 25.71 11.82 52.50 25.05 7.88 50.17 -49.43 81.28 111.60 -49.39 86.78 108.40 coo 23.50 1.36 54.56 23.86 1.61 52.50 -54.36 78.15 100.29 -55.09 76.20 100.68 coo 33.89 4.42 51.79 30.99 5.09 51.05 -45.43 76.09 104.31 -44.66 77.94 101.95 coo 42.34 11.15 22.32 43.58 12.11 23.75 -15.45 71.21 105.07 -17.40 71.77 105.62 ULMN 4 1ltq_c00 POLYNUCLEOTIDE KINASE user 3 4 # 3 A 15 LYS B 267 LYS~? 27.57 CL CL B 383 A 35 ASP B 240 ASP.? 29.22 CL CL B 383 A 126 ARG B 274 ARG~? 23.83 CL CL B 383 A 165 ASP B 26 ASP^? 16.51 CL CL B 383 coo 25.71 11.82 52.50 25.05 7.88 50.17 9.46 31.45 81.02 15.36 33.08 81.01 coo 23.50 1.36 54.56 23.86 1.61 52.50 11.35 28.88 93.27 10.37 30.59 94.07 coo 33.89 4.42 51.79 30.99 5.09 51.05 5.51 36.33 89.03 7.35 38.65 89.98 coo 42.34 11.15 22.32 43.58 12.11 23.75 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 4 1ltq_c00 POLYNUCLEOTIDE KINASE user 4 4 # 4 A 15 LYS B 267 LYS~? 27.57 CL CL B 383 A 35 ASP B 240 ASP.? 29.22 CL CL B 383 A 126 ARG B 274 ARG~? 23.83 CL CL B 383 A 165 ASP B 39 ASP^? 17.51 CL CL B 383 coo 25.71 11.82 52.50 25.05 7.88 50.17 9.46 31.45 81.02 15.36 33.08 81.01 coo 23.50 1.36 54.56 23.86 1.61 52.50 11.35 28.88 93.27 10.37 30.59 94.07 coo 33.89 4.42 51.79 30.99 5.09 51.05 5.51 36.33 89.03 7.35 38.65 89.98 coo 42.34 11.15 22.32 43.58 12.11 23.75 -26.18 36.85 80.53 -27.97 36.10 81.34 ULMN 4 1ltq_c00 POLYNUCLEOTIDE KINASE user 5 4 # 5 A 15 LYS B 267 LYS~? 27.57 CL CL B 383 A 35 ASP B 240 ASP.? 29.22 CL CL B 383 A 126 ARG B 274 ARG~? 23.83 CL CL B 383 A 165 ASP B 291 ASP.? 20.64 CL CL B 382 coo 25.71 11.82 52.50 25.05 7.88 50.17 9.46 31.45 81.02 15.36 33.08 81.01 coo 23.50 1.36 54.56 23.86 1.61 52.50 11.35 28.88 93.27 10.37 30.59 94.07 coo 33.89 4.42 51.79 30.99 5.09 51.05 5.51 36.33 89.03 7.35 38.65 89.98 coo 42.34 11.15 22.32 43.58 12.11 23.75 -11.26 60.51 82.59 -9.94 61.37 84.03 1ltq_c00 source 1ltq POLYNUCLEOTIDE KINASE : 5 hits 1ltq_c00 naa= 4 ULMN 4 1p4n_c00 UDP-MURNAC-PENTAPEPTIDE user 1 4 # 1 A 36 LYS B 288 LYS.? 8.84 CL CL B 382 A 108 ASP A 306 ASP.? 16.66 CL CL A 384 A 211 ARG B 290 ARG.? 12.49 CL CL A 384 A 319 GLU A 307 GLU.? 18.04 CL CL B 382 coo 26.40 -0.07 5.65 25.70 1.89 10.82 -16.76 54.22 83.25 -20.62 56.75 78.99 coo 13.95 1.15 16.48 15.65 1.17 15.18 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 30.30 5.19 11.85 28.49 2.83 12.64 -13.01 59.15 90.41 -14.60 61.38 91.89 coo 15.01 -1.52 19.72 16.83 -2.42 20.27 -31.95 61.22 87.08 -31.47 59.40 88.12 1p4n_c00 source 1p4n UDP-MURNAC-PENTAPEPTIDE : 1 hits 1p4n_c00 naa= 4 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 B 151 VAL A 108 VAL.? 18.33 CL CL A 383 B 194 GLY A 110 GLY.? 23.75 CL CL A 383 B 417 ILE A 304 ILE^? 12.23 CL CL A 384 B 457 ALA A 312 ALA^? 16.34 CL CL A 384 coo 52.95 126.71 13.21 51.34 125.24 13.19 -43.69 83.14 133.54 -43.03 82.14 131.65 coo 50.40 126.23 20.48 50.46 127.00 20.75 -42.92 88.53 131.83 -42.63 88.59 132.69 coo 68.38 85.45 19.33 67.41 85.52 20.41 -27.88 69.28 92.71 -27.16 70.21 91.96 coo 65.50 91.13 17.77 64.65 89.88 18.00 -32.59 73.91 96.33 -34.10 73.68 96.50 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 B 151 VAL A 108 VAL.? 18.33 CL CL A 383 B 194 GLY A 110 GLY.? 23.75 CL CL A 383 B 417 ILE A 310 ILE^? 16.17 CL CL A 384 B 457 ALA A 312 ALA^? 16.34 CL CL A 384 coo 52.95 126.71 13.21 51.34 125.24 13.19 -43.69 83.14 133.54 -43.03 82.14 131.65 coo 50.40 126.23 20.48 50.46 127.00 20.75 -42.92 88.53 131.83 -42.63 88.59 132.69 coo 68.38 85.45 19.33 67.41 85.52 20.41 -34.33 68.55 93.53 -34.85 68.03 94.76 coo 65.50 91.13 17.77 64.65 89.88 18.00 -32.59 73.91 96.33 -34.10 73.68 96.50 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 B 151 VAL A 108 VAL.? 18.33 CL CL A 383 B 194 GLY A 141 GLY.? 21.64 CL CL A 383 B 417 ILE A 304 ILE^? 12.23 CL CL A 384 B 457 ALA A 312 ALA^? 16.34 CL CL A 384 coo 52.95 126.71 13.21 51.34 125.24 13.19 -43.69 83.14 133.54 -43.03 82.14 131.65 coo 50.40 126.23 20.48 50.46 127.00 20.75 -47.00 86.61 128.15 -46.60 85.98 128.53 coo 68.38 85.45 19.33 67.41 85.52 20.41 -27.88 69.28 92.71 -27.16 70.21 91.96 coo 65.50 91.13 17.77 64.65 89.88 18.00 -32.59 73.91 96.33 -34.10 73.68 96.50 1pix_c01 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 3 hits 1pix_c01 naa= 4 ULMN 4 1pma_c00 PROTEASOME user 1 4 # 1 B 1 THR B 194 THR.? 12.32 CL CL A 384 B 33 LYS A 288 LYS.? 12.57 CL CL A 384 B 47 GLY A 285 GLY^? 9.46 CL CL A 384 B 129 SER B 192 SER.? 13.26 CL CL A 384 coo 145.45 99.84 111.72 143.76 98.56 112.07 -14.07 57.99 105.37 -12.38 58.46 106.64 coo 136.79 102.27 111.59 142.67 100.98 109.47 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 140.77 93.29 113.52 140.45 93.77 112.93 -22.09 57.26 103.59 -22.19 58.16 103.73 coo 148.45 97.25 114.98 149.72 97.25 112.90 -11.80 54.65 102.27 -11.20 56.97 103.08 1pma_c00 source 1pma PROTEASOME : 1 hits 1pma_c00 naa= 4 ULMN 4 1pma_c01 PROTEASOME user 1 4 # 1 P 1 THR B 194 THR.? 12.32 CL CL A 384 P 33 LYS A 288 LYS.? 12.57 CL CL A 384 P 47 GLY A 285 GLY^? 9.46 CL CL A 384 P 129 SER B 192 SER.? 13.26 CL CL A 384 coo 142.15 84.99 86.79 140.56 84.37 88.13 -14.07 57.99 105.37 -12.38 58.46 106.64 coo 133.38 85.70 85.38 139.26 83.66 84.60 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 138.10 81.91 93.37 137.75 81.71 92.63 -22.09 57.26 103.59 -22.19 58.16 103.73 coo 145.29 86.16 90.67 146.68 84.74 89.28 -11.80 54.65 102.27 -11.20 56.97 103.08 1pma_c01 source 1pma PROTEASOME : 1 hits 1pma_c01 naa= 4 ULMN 4 1pma_c02 PROTEASOME user 1 4 # 1 Q 1 THR B 194 THR.? 12.32 CL CL A 384 Q 33 LYS A 288 LYS.? 12.57 CL CL A 384 Q 47 GLY A 285 GLY^? 9.46 CL CL A 384 Q 129 SER B 192 SER.? 13.26 CL CL A 384 coo 140.73 55.93 82.67 139.31 56.56 84.17 -14.07 57.99 105.37 -12.38 58.46 106.64 coo 131.97 54.44 81.72 138.04 53.15 82.45 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 136.89 58.65 89.43 136.55 57.93 89.18 -22.09 57.26 103.59 -22.19 58.16 103.73 coo 143.72 59.85 83.98 145.20 57.91 84.07 -11.80 54.65 102.27 -11.20 56.97 103.08 1pma_c02 source 1pma PROTEASOME : 1 hits 1pma_c02 naa= 4 ULMN 4 1pma_c03 PROTEASOME user 1 4 # 1 R 1 THR B 194 THR.? 12.32 CL CL A 384 R 33 LYS A 288 LYS.? 12.57 CL CL A 384 R 47 GLY A 285 GLY^? 9.46 CL CL A 384 R 129 SER B 192 SER.? 13.26 CL CL A 384 coo 142.38 34.41 102.60 140.86 35.75 103.29 -14.07 57.99 105.37 -12.38 58.46 106.64 coo 133.82 32.17 103.65 140.06 32.45 104.82 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 137.84 41.34 104.86 137.70 40.63 105.29 -22.09 57.26 103.59 -22.19 58.16 103.73 coo 144.81 38.28 100.19 146.44 37.17 101.53 -11.80 54.65 102.27 -11.20 56.97 103.08 1pma_c03 source 1pma PROTEASOME : 1 hits 1pma_c03 naa= 4 ULMN 4 1pma_c04 PROTEASOME user 1 4 # 1 S 1 THR B 194 THR.? 12.32 CL CL A 384 S 33 LYS A 288 LYS.? 12.57 CL CL A 384 S 47 GLY A 285 GLY^? 9.46 CL CL A 384 S 129 SER B 192 SER.? 13.26 CL CL A 384 coo 145.99 36.73 131.50 144.29 37.93 131.05 -14.07 57.99 105.37 -12.38 58.46 106.64 coo 137.54 35.66 134.42 143.74 36.95 134.69 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 140.84 42.46 127.91 140.66 42.32 128.74 -22.09 57.26 103.59 -22.19 58.16 103.73 coo 148.11 37.39 126.83 149.93 38.14 128.30 -11.80 54.65 102.27 -11.20 56.97 103.08 1pma_c04 source 1pma PROTEASOME : 1 hits 1pma_c04 naa= 4 ULMN 4 1pma_c05 PROTEASOME user 1 4 # 1 T 1 THR B 194 THR.? 12.32 CL CL A 384 T 33 LYS A 288 LYS.? 12.57 CL CL A 384 T 47 GLY A 285 GLY^? 9.46 CL CL A 384 T 129 SER B 192 SER.? 13.26 CL CL A 384 coo 148.59 61.06 147.60 146.72 61.19 146.49 -14.07 57.99 105.37 -12.38 58.46 106.64 coo 140.35 62.12 151.02 146.27 63.46 149.54 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 142.85 61.51 141.28 142.70 62.06 141.93 -22.09 57.26 103.59 -22.19 58.16 103.73 coo 150.80 57.97 144.10 152.46 59.79 144.30 -11.80 54.65 102.27 -11.20 56.97 103.08 1pma_c05 source 1pma PROTEASOME : 1 hits 1pma_c05 naa= 4 ULMN 4 1pma_c06 PROTEASOME user 1 4 # 1 U 1 THR B 194 THR.? 12.32 CL CL A 384 U 33 LYS A 288 LYS.? 12.57 CL CL A 384 U 47 GLY A 285 GLY^? 9.46 CL CL A 384 U 129 SER B 192 SER.? 13.26 CL CL A 384 coo 148.42 89.29 138.93 146.59 88.50 138.15 -14.07 57.99 105.37 -12.38 58.46 106.64 coo 140.15 91.82 140.86 145.77 92.05 138.33 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 143.01 84.16 135.00 142.77 84.96 134.97 -22.09 57.26 103.59 -22.19 58.16 103.73 coo 150.85 84.74 138.83 152.35 86.20 137.62 -11.80 54.65 102.27 -11.20 56.97 103.08 1pma_c06 source 1pma PROTEASOME : 1 hits 1pma_c06 naa= 4 ULMN 4 1pma_c07 PROTEASOME user 1 4 # 1 V 1 THR B 194 THR.? 12.32 CL CL A 384 V 33 LYS A 288 LYS.? 12.57 CL CL A 384 V 47 GLY A 285 GLY^? 9.46 CL CL A 384 V 129 SER B 192 SER.? 13.26 CL CL A 384 coo 160.31 31.63 111.03 162.05 32.90 110.99 -14.07 57.99 105.37 -12.38 58.46 106.64 coo 168.58 29.07 108.83 162.49 30.41 108.07 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 165.30 38.28 111.45 165.51 37.78 110.79 -22.09 57.26 103.59 -22.19 58.16 103.73 coo 158.15 34.28 114.77 156.42 34.20 113.07 -11.80 54.65 102.27 -11.20 56.97 103.08 1pma_c07 source 1pma PROTEASOME : 1 hits 1pma_c07 naa= 4 ULMN 4 1pma_c08 PROTEASOME user 1 4 # 1 W 1 THR B 194 THR.? 12.32 CL CL A 384 W 33 LYS A 288 LYS.? 12.57 CL CL A 384 W 47 GLY A 285 GLY^? 9.46 CL CL A 384 W 129 SER B 192 SER.? 13.26 CL CL A 384 coo 157.95 45.66 85.32 159.70 46.33 86.38 -14.07 57.99 105.37 -12.38 58.46 106.64 coo 166.07 44.81 82.01 160.13 46.94 82.57 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 163.23 48.87 90.83 163.39 49.06 90.01 -22.09 57.26 103.59 -22.19 58.16 103.73 coo 155.60 44.58 89.97 153.89 45.98 88.92 -11.80 54.65 102.27 -11.20 56.97 103.08 1pma_c08 source 1pma PROTEASOME : 1 hits 1pma_c08 naa= 4 ULMN 4 1pma_c09 PROTEASOME user 1 4 # 1 X 1 THR B 194 THR.? 12.32 CL CL A 384 X 33 LYS A 288 LYS.? 12.57 CL CL A 384 X 47 GLY A 285 GLY^? 9.46 CL CL A 384 X 129 SER B 192 SER.? 13.26 CL CL A 384 coo 158.06 74.74 80.29 159.87 74.24 81.32 -14.07 57.99 105.37 -12.38 58.46 106.64 coo 166.53 76.03 77.46 160.69 77.43 79.50 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 163.43 71.87 86.14 163.64 72.61 85.77 -22.09 57.26 103.59 -22.19 58.16 103.73 coo 155.48 70.66 82.49 154.03 72.56 83.11 -11.80 54.65 102.27 -11.20 56.97 103.08 1pma_c09 source 1pma PROTEASOME : 1 hits 1pma_c09 naa= 4 ULMN 4 1pma_c10 PROTEASOME user 1 4 # 1 Y 1 THR B 194 THR.? 12.32 CL CL A 384 Y 33 LYS A 288 LYS.? 12.57 CL CL A 384 Y 47 GLY A 285 GLY^? 9.46 CL CL A 384 Y 129 SER B 192 SER.? 13.26 CL CL A 384 coo 161.01 96.61 99.53 162.71 95.26 99.85 -14.07 57.99 105.37 -12.38 58.46 106.64 coo 169.59 99.02 98.57 163.79 98.75 101.06 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 165.73 89.82 100.87 166.04 90.54 101.24 -22.09 57.26 103.59 -22.19 58.16 103.73 coo 157.98 92.90 97.78 156.61 93.86 99.58 -11.80 54.65 102.27 -11.20 56.97 103.08 1pma_c10 source 1pma PROTEASOME : 1 hits 1pma_c10 naa= 4 ULMN 4 1pma_c11 PROTEASOME user 1 4 # 1 Z 1 THR B 194 THR.? 12.32 CL CL A 384 Z 33 LYS A 288 LYS.? 12.57 CL CL A 384 Z 47 GLY A 285 GLY^? 9.46 CL CL A 384 Z 129 SER B 192 SER.? 13.26 CL CL A 384 coo 164.44 95.20 128.49 165.90 93.95 127.46 -14.07 57.99 105.37 -12.38 58.46 106.64 coo 173.04 96.56 129.40 167.10 95.22 131.11 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 168.59 89.38 123.90 168.88 89.54 124.70 -22.09 57.26 103.59 -22.19 58.16 103.73 coo 161.09 94.40 124.50 159.85 93.81 126.51 -11.80 54.65 102.27 -11.20 56.97 103.08 1pma_c11 source 1pma PROTEASOME : 1 hits 1pma_c11 naa= 4 ULMN 4 1pma_c12 PROTEASOME user 1 4 # 1 1 1 THR B 194 THR.? 12.32 CL CL A 384 1 33 LYS A 288 LYS.? 12.57 CL CL A 384 1 47 GLY A 285 GLY^? 9.46 CL CL A 384 1 129 SER B 192 SER.? 13.26 CL CL A 384 coo 165.64 71.38 145.38 167.12 71.04 143.87 -14.07 57.99 105.37 -12.38 58.46 106.64 coo 174.42 70.53 146.91 168.32 69.05 146.87 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 169.45 70.72 138.12 169.78 70.22 138.68 -22.09 57.26 103.59 -22.19 58.16 103.73 coo 162.75 74.36 142.49 161.13 72.65 143.07 -11.80 54.65 102.27 -11.20 56.97 103.08 1pma_c12 source 1pma PROTEASOME : 1 hits 1pma_c12 naa= 4 ULMN 4 1pma_c13 PROTEASOME user 1 4 # 1 2 1 THR B 194 THR.? 12.32 CL CL A 384 2 33 LYS A 288 LYS.? 12.57 CL CL A 384 2 47 GLY A 285 GLY^? 9.46 CL CL A 384 2 129 SER B 192 SER.? 13.26 CL CL A 384 coo 163.80 43.09 137.65 165.35 44.06 136.49 -14.07 57.99 105.37 -12.38 58.46 106.64 coo 172.39 40.52 137.60 166.18 40.30 136.65 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 168.22 48.11 132.44 168.40 47.27 132.39 -22.09 57.26 103.59 -22.19 58.16 103.73 coo 161.33 47.56 138.08 159.59 46.11 137.23 -11.80 54.65 102.27 -11.20 56.97 103.08 1pma_c13 source 1pma PROTEASOME : 1 hits 1pma_c13 naa= 4 ULMN 4 1qq5_c02 L-2-HALOACID DEHALOGENASE user 1 4 # 1 A 8 ASP A 28 ASP^? 9.02 CL CL A 382 A 39 ARG A 92 ARG^? 9.37 CL CL A 383 A 114 SER A 29 SER^? 6.92 CL CL A 382 A 176 ASP A 26 ASP^? 16.59 CL CL A 382 coo 11.74 10.89 36.46 11.22 9.07 35.52 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 9.95 2.30 29.39 10.16 4.06 31.89 -35.59 58.66 126.41 -36.79 59.05 129.24 coo 14.04 6.15 40.29 15.11 4.90 38.49 -31.31 63.66 116.96 -29.07 63.86 117.79 coo 6.71 9.84 37.08 8.21 10.00 38.54 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 4 1qq5_c02 L-2-HALOACID DEHALOGENASE user 2 4 # 2 A 8 ASP B 28 ASP^? 9.00 CL CL B 383 A 39 ARG B 92 ARG^? 9.18 CL CL B 384 A 114 SER B 29 SER^? 6.98 CL CL B 383 A 176 ASP B 26 ASP^? 16.51 CL CL B 383 coo 11.74 10.89 36.46 11.22 9.07 35.52 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 9.95 2.30 29.39 10.16 4.06 31.89 -19.73 31.24 73.98 -19.77 29.09 71.81 coo 14.04 6.15 40.29 15.11 4.90 38.49 -14.55 40.12 78.88 -15.61 41.67 77.42 coo 6.71 9.84 37.08 8.21 10.00 38.54 -23.45 39.33 83.60 -24.23 39.48 85.53 1qq5_c02 source 1qq5 L-2-HALOACID DEHALOGENASE : 2 hits 1qq5_c02 naa= 4 ULMN 4 1qq5_c03 L-2-HALOACID DEHALOGENASE user 1 4 # 1 B 8 ASP A 28 ASP^? 9.02 CL CL A 382 B 39 ARG A 92 ARG^? 9.37 CL CL A 383 B 114 SER A 29 SER^? 6.92 CL CL A 382 B 176 ASP A 26 ASP^? 16.59 CL CL A 382 coo -12.56 -11.18 35.50 -11.97 -9.35 34.62 -32.19 59.08 116.32 -33.48 59.98 114.85 coo -10.21 -2.50 28.59 -10.64 -4.26 31.07 -35.59 58.66 126.41 -36.79 59.05 129.24 coo -15.18 -6.47 39.05 -16.09 -5.31 37.09 -31.31 63.66 116.96 -29.07 63.86 117.79 coo -7.57 -10.16 36.43 -9.20 -10.33 37.73 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 4 1qq5_c03 L-2-HALOACID DEHALOGENASE user 2 4 # 2 B 8 ASP B 28 ASP^? 9.00 CL CL B 383 B 39 ARG B 92 ARG^? 9.18 CL CL B 384 B 114 SER B 29 SER^? 6.98 CL CL B 383 B 176 ASP B 26 ASP^? 16.51 CL CL B 383 coo -12.56 -11.18 35.50 -11.97 -9.35 34.62 -18.06 38.42 81.61 -16.37 38.03 82.88 coo -10.21 -2.50 28.59 -10.64 -4.26 31.07 -19.73 31.24 73.98 -19.77 29.09 71.81 coo -15.18 -6.47 39.05 -16.09 -5.31 37.09 -14.55 40.12 78.88 -15.61 41.67 77.42 coo -7.57 -10.16 36.43 -9.20 -10.33 37.73 -23.45 39.33 83.60 -24.23 39.48 85.53 1qq5_c03 source 1qq5 L-2-HALOACID DEHALOGENASE : 2 hits 1qq5_c03 naa= 4 ULMN 4 1qrr_c00 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 1 4 # 1 A 145 THR B 331 THR^? 16.17 CL CL B 383 A 182 TYR B 8 TYR.? 11.88 CL CL B 382 A 183 HIS B 287 HIS.? 13.85 CL CL B 382 A 186 LYS B 288 LYS.? 8.84 CL CL B 382 coo 69.38 87.38 24.64 71.11 88.47 25.40 -18.10 46.86 87.19 -17.24 47.80 85.43 coo 73.61 90.42 31.12 71.36 89.66 29.64 -23.96 53.72 82.39 -21.76 54.53 83.93 coo 74.92 90.96 26.60 73.71 92.67 26.46 -21.22 50.04 83.35 -22.70 48.63 83.80 coo 73.54 84.00 28.64 69.01 86.68 29.71 -16.76 54.22 83.25 -20.62 56.75 78.99 1qrr_c00 source 1qrr SULFOLIPID BIOSYNTHESIS (SQD1) PROTEIN : 1 hits 1qrr_c00 naa= 4 ULMN 4 1qrz_c00 PLASMINOGEN user 1 4 # 1 A 603 HIS A 157 HIS~? 12.03 CL CL A 383 A 646 ASP A 144 ASP.? 19.38 CL CL A 383 A 739 GLY A 163 GLY.? 16.53 CL CL A 382 A 741 SER A 161 SER~? 16.95 CL CL A 383 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -47.82 75.77 126.56 -49.90 76.10 126.41 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -52.89 78.90 131.37 -53.77 80.20 132.79 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -42.13 81.34 118.16 -41.70 81.26 118.87 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -45.55 81.13 122.60 -44.57 82.20 124.58 1qrz_c00 source 1qrz PLASMINOGEN : 1 hits 1qrz_c00 naa= 4 ULMN 4 1qrz_c02 PLASMINOGEN user 1 4 # 1 C 603 HIS A 157 HIS~? 12.03 CL CL A 383 C 646 ASP A 144 ASP.? 19.38 CL CL A 383 C 739 GLY A 163 GLY.? 16.53 CL CL A 382 C 741 SER A 161 SER~? 16.95 CL CL A 383 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -47.82 75.77 126.56 -49.90 76.10 126.41 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -52.89 78.90 131.37 -53.77 80.20 132.79 coo 7.82 1.25 3.03 7.30 1.31 3.65 -42.13 81.34 118.16 -41.70 81.26 118.87 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -45.55 81.13 122.60 -44.57 82.20 124.58 1qrz_c02 source 1qrz PLASMINOGEN : 1 hits 1qrz_c02 naa= 4 ULMN 4 1qrz_c03 PLASMINOGEN user 1 4 # 1 D 603 HIS A 157 HIS~? 12.03 CL CL A 383 D 646 ASP A 144 ASP.? 19.38 CL CL A 383 D 739 GLY A 163 GLY.? 16.53 CL CL A 382 D 741 SER A 161 SER~? 16.95 CL CL A 383 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -47.82 75.77 126.56 -49.90 76.10 126.41 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -52.89 78.90 131.37 -53.77 80.20 132.79 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -42.13 81.34 118.16 -41.70 81.26 118.87 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -45.55 81.13 122.60 -44.57 82.20 124.58 1qrz_c03 source 1qrz PLASMINOGEN : 1 hits 1qrz_c03 naa= 4 ULMN 4 1rk2_c00 RIBOKINASE user 1 4 # 1 A 252 ALA A 35 ALA.? 6.30 CL CL A 382 A 253 ALA A 95 ALA~? 5.86 CL CL A 382 A 254 GLY A 96 GLY~? 8.65 CL CL A 383 A 255 ASP A 93 ASP^? 5.15 CL CL A 382 coo 19.22 5.40 78.99 19.00 6.90 79.25 -35.44 63.33 123.80 -35.72 62.35 124.94 coo 22.30 4.08 77.15 23.28 3.04 77.64 -34.32 65.97 127.91 -34.72 66.23 126.45 coo 20.04 2.01 74.92 19.93 2.78 75.17 -35.37 62.51 129.12 -35.27 63.21 129.50 coo 16.76 5.52 75.75 15.62 4.24 76.95 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 4 1rk2_c00 RIBOKINASE user 2 4 # 2 A 252 ALA A 95 ALA~? 5.86 CL CL A 382 A 253 ALA A 35 ALA.? 6.30 CL CL A 382 A 254 GLY A 96 GLY~? 8.65 CL CL A 383 A 255 ASP A 93 ASP^? 5.15 CL CL A 382 coo 19.22 5.40 78.99 19.00 6.90 79.25 -34.32 65.97 127.91 -34.72 66.23 126.45 coo 22.30 4.08 77.15 23.28 3.04 77.64 -35.44 63.33 123.80 -35.72 62.35 124.94 coo 20.04 2.01 74.92 19.93 2.78 75.17 -35.37 62.51 129.12 -35.27 63.21 129.50 coo 16.76 5.52 75.75 15.62 4.24 76.95 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 4 1rk2_c00 RIBOKINASE user 3 4 # 3 A 252 ALA B 35 ALA.? 6.30 CL CL B 383 A 253 ALA B 95 ALA~? 5.98 CL CL B 383 A 254 GLY B 96 GLY~? 8.80 CL CL B 384 A 255 ASP B 93 ASP^? 5.22 CL CL B 383 coo 19.22 5.40 78.99 19.00 6.90 79.25 -15.02 33.54 74.31 -16.10 32.59 73.63 coo 22.30 4.08 77.15 23.28 3.04 77.64 -14.44 33.46 69.35 -13.59 33.72 70.62 coo 20.04 2.01 74.92 19.93 2.78 75.17 -17.52 31.23 69.94 -17.03 31.31 69.27 coo 16.76 5.52 75.75 15.62 4.24 76.95 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 4 1rk2_c00 RIBOKINASE user 4 4 # 4 A 252 ALA B 95 ALA~? 5.98 CL CL B 383 A 253 ALA B 35 ALA.? 6.30 CL CL B 383 A 254 GLY B 96 GLY~? 8.80 CL CL B 384 A 255 ASP B 93 ASP^? 5.22 CL CL B 383 coo 19.22 5.40 78.99 19.00 6.90 79.25 -14.44 33.46 69.35 -13.59 33.72 70.62 coo 22.30 4.08 77.15 23.28 3.04 77.64 -15.02 33.54 74.31 -16.10 32.59 73.63 coo 20.04 2.01 74.92 19.93 2.78 75.17 -17.52 31.23 69.94 -17.03 31.31 69.27 coo 16.76 5.52 75.75 15.62 4.24 76.95 -17.13 37.76 71.68 -15.50 36.45 72.23 1rk2_c00 source 1rk2 RIBOKINASE : 4 hits 1rk2_c00 naa= 4 ULMN 4 1rk2_c01 RIBOKINASE user 1 4 # 1 B 252 ALA A 35 ALA.? 6.30 CL CL A 382 B 253 ALA A 95 ALA~? 5.86 CL CL A 382 B 254 GLY A 96 GLY~? 8.65 CL CL A 383 B 255 ASP A 93 ASP^? 5.15 CL CL A 382 coo 5.65 0.71 109.93 4.85 1.99 109.63 -35.44 63.33 123.80 -35.72 62.35 124.94 coo 4.16 -2.29 111.77 4.09 -3.72 111.27 -34.32 65.97 127.91 -34.72 66.23 126.45 coo 7.20 -2.36 114.01 6.78 -1.70 113.77 -35.37 62.51 129.12 -35.27 63.21 129.50 coo 7.39 2.43 113.17 9.13 2.23 112.02 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 4 1rk2_c01 RIBOKINASE user 2 4 # 2 B 252 ALA A 95 ALA~? 5.86 CL CL A 382 B 253 ALA A 35 ALA.? 6.30 CL CL A 382 B 254 GLY A 96 GLY~? 8.65 CL CL A 383 B 255 ASP A 93 ASP^? 5.15 CL CL A 382 coo 5.65 0.71 109.93 4.85 1.99 109.63 -34.32 65.97 127.91 -34.72 66.23 126.45 coo 4.16 -2.29 111.77 4.09 -3.72 111.27 -35.44 63.33 123.80 -35.72 62.35 124.94 coo 7.20 -2.36 114.01 6.78 -1.70 113.77 -35.37 62.51 129.12 -35.27 63.21 129.50 coo 7.39 2.43 113.17 9.13 2.23 112.02 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 4 1rk2_c01 RIBOKINASE user 3 4 # 3 B 252 ALA B 35 ALA.? 6.30 CL CL B 383 B 253 ALA B 95 ALA~? 5.98 CL CL B 383 B 254 GLY B 96 GLY~? 8.80 CL CL B 384 B 255 ASP B 93 ASP^? 5.22 CL CL B 383 coo 5.65 0.71 109.93 4.85 1.99 109.63 -15.02 33.54 74.31 -16.10 32.59 73.63 coo 4.16 -2.29 111.77 4.09 -3.72 111.27 -14.44 33.46 69.35 -13.59 33.72 70.62 coo 7.20 -2.36 114.01 6.78 -1.70 113.77 -17.52 31.23 69.94 -17.03 31.31 69.27 coo 7.39 2.43 113.17 9.13 2.23 112.02 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 4 1rk2_c01 RIBOKINASE user 4 4 # 4 B 252 ALA B 95 ALA~? 5.98 CL CL B 383 B 253 ALA B 35 ALA.? 6.30 CL CL B 383 B 254 GLY B 96 GLY~? 8.80 CL CL B 384 B 255 ASP B 93 ASP^? 5.22 CL CL B 383 coo 5.65 0.71 109.93 4.85 1.99 109.63 -14.44 33.46 69.35 -13.59 33.72 70.62 coo 4.16 -2.29 111.77 4.09 -3.72 111.27 -15.02 33.54 74.31 -16.10 32.59 73.63 coo 7.20 -2.36 114.01 6.78 -1.70 113.77 -17.52 31.23 69.94 -17.03 31.31 69.27 coo 7.39 2.43 113.17 9.13 2.23 112.02 -17.13 37.76 71.68 -15.50 36.45 72.23 1rk2_c01 source 1rk2 RIBOKINASE : 4 hits 1rk2_c01 naa= 4 ULMN 4 1rk2_c02 RIBOKINASE user 1 4 # 1 C 252 ALA A 35 ALA.? 6.30 CL CL A 382 C 253 ALA A 95 ALA~? 5.86 CL CL A 382 C 254 GLY A 96 GLY~? 8.65 CL CL A 383 C 255 ASP A 93 ASP^? 5.15 CL CL A 382 coo 11.35 5.28 194.49 12.50 6.27 194.18 -35.44 63.33 123.80 -35.72 62.35 124.94 coo 8.26 6.36 196.43 6.81 6.31 195.96 -34.32 65.97 127.91 -34.72 66.23 126.45 coo 8.52 3.23 198.55 9.13 3.73 198.31 -35.37 62.51 129.12 -35.27 63.21 129.50 coo 13.27 3.50 197.59 13.27 1.76 196.39 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 4 1rk2_c02 RIBOKINASE user 2 4 # 2 C 252 ALA A 95 ALA~? 5.86 CL CL A 382 C 253 ALA A 35 ALA.? 6.30 CL CL A 382 C 254 GLY A 96 GLY~? 8.65 CL CL A 383 C 255 ASP A 93 ASP^? 5.15 CL CL A 382 coo 11.35 5.28 194.49 12.50 6.27 194.18 -34.32 65.97 127.91 -34.72 66.23 126.45 coo 8.26 6.36 196.43 6.81 6.31 195.96 -35.44 63.33 123.80 -35.72 62.35 124.94 coo 8.52 3.23 198.55 9.13 3.73 198.31 -35.37 62.51 129.12 -35.27 63.21 129.50 coo 13.27 3.50 197.59 13.27 1.76 196.39 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 4 1rk2_c02 RIBOKINASE user 3 4 # 3 C 252 ALA B 35 ALA.? 6.30 CL CL B 383 C 253 ALA B 95 ALA~? 5.98 CL CL B 383 C 254 GLY B 96 GLY~? 8.80 CL CL B 384 C 255 ASP B 93 ASP^? 5.22 CL CL B 383 coo 11.35 5.28 194.49 12.50 6.27 194.18 -15.02 33.54 74.31 -16.10 32.59 73.63 coo 8.26 6.36 196.43 6.81 6.31 195.96 -14.44 33.46 69.35 -13.59 33.72 70.62 coo 8.52 3.23 198.55 9.13 3.73 198.31 -17.52 31.23 69.94 -17.03 31.31 69.27 coo 13.27 3.50 197.59 13.27 1.76 196.39 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 4 1rk2_c02 RIBOKINASE user 4 4 # 4 C 252 ALA B 95 ALA~? 5.98 CL CL B 383 C 253 ALA B 35 ALA.? 6.30 CL CL B 383 C 254 GLY B 96 GLY~? 8.80 CL CL B 384 C 255 ASP B 93 ASP^? 5.22 CL CL B 383 coo 11.35 5.28 194.49 12.50 6.27 194.18 -14.44 33.46 69.35 -13.59 33.72 70.62 coo 8.26 6.36 196.43 6.81 6.31 195.96 -15.02 33.54 74.31 -16.10 32.59 73.63 coo 8.52 3.23 198.55 9.13 3.73 198.31 -17.52 31.23 69.94 -17.03 31.31 69.27 coo 13.27 3.50 197.59 13.27 1.76 196.39 -17.13 37.76 71.68 -15.50 36.45 72.23 1rk2_c02 source 1rk2 RIBOKINASE : 4 hits 1rk2_c02 naa= 4 ULMN 4 1rk2_c03 RIBOKINASE user 1 4 # 1 D 252 ALA A 35 ALA.? 6.30 CL CL A 382 D 253 ALA A 95 ALA~? 5.86 CL CL A 382 D 254 GLY A 96 GLY~? 8.65 CL CL A 383 D 255 ASP A 93 ASP^? 5.15 CL CL A 382 coo 15.44 -6.06 163.02 16.93 -5.92 163.28 -35.44 63.33 123.80 -35.72 62.35 124.94 coo 13.90 -8.94 161.04 12.81 -9.89 161.50 -34.32 65.97 127.91 -34.72 66.23 126.45 coo 11.98 -6.40 159.00 12.77 -6.36 159.23 -35.37 62.51 129.12 -35.27 63.21 129.50 coo 15.72 -3.40 159.93 14.56 -2.20 161.19 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 4 1rk2_c03 RIBOKINASE user 2 4 # 2 D 252 ALA A 95 ALA~? 5.86 CL CL A 382 D 253 ALA A 35 ALA.? 6.30 CL CL A 382 D 254 GLY A 96 GLY~? 8.65 CL CL A 383 D 255 ASP A 93 ASP^? 5.15 CL CL A 382 coo 15.44 -6.06 163.02 16.93 -5.92 163.28 -34.32 65.97 127.91 -34.72 66.23 126.45 coo 13.90 -8.94 161.04 12.81 -9.89 161.50 -35.44 63.33 123.80 -35.72 62.35 124.94 coo 11.98 -6.40 159.00 12.77 -6.36 159.23 -35.37 62.51 129.12 -35.27 63.21 129.50 coo 15.72 -3.40 159.93 14.56 -2.20 161.19 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 4 1rk2_c03 RIBOKINASE user 3 4 # 3 D 252 ALA B 35 ALA.? 6.30 CL CL B 383 D 253 ALA B 95 ALA~? 5.98 CL CL B 383 D 254 GLY B 96 GLY~? 8.80 CL CL B 384 D 255 ASP B 93 ASP^? 5.22 CL CL B 383 coo 15.44 -6.06 163.02 16.93 -5.92 163.28 -15.02 33.54 74.31 -16.10 32.59 73.63 coo 13.90 -8.94 161.04 12.81 -9.89 161.50 -14.44 33.46 69.35 -13.59 33.72 70.62 coo 11.98 -6.40 159.00 12.77 -6.36 159.23 -17.52 31.23 69.94 -17.03 31.31 69.27 coo 15.72 -3.40 159.93 14.56 -2.20 161.19 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 4 1rk2_c03 RIBOKINASE user 4 4 # 4 D 252 ALA B 95 ALA~? 5.98 CL CL B 383 D 253 ALA B 35 ALA.? 6.30 CL CL B 383 D 254 GLY B 96 GLY~? 8.80 CL CL B 384 D 255 ASP B 93 ASP^? 5.22 CL CL B 383 coo 15.44 -6.06 163.02 16.93 -5.92 163.28 -14.44 33.46 69.35 -13.59 33.72 70.62 coo 13.90 -8.94 161.04 12.81 -9.89 161.50 -15.02 33.54 74.31 -16.10 32.59 73.63 coo 11.98 -6.40 159.00 12.77 -6.36 159.23 -17.52 31.23 69.94 -17.03 31.31 69.27 coo 15.72 -3.40 159.93 14.56 -2.20 161.19 -17.13 37.76 71.68 -15.50 36.45 72.23 1rk2_c03 source 1rk2 RIBOKINASE : 4 hits 1rk2_c03 naa= 4 ULMN 4 1rne_c05 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 1 4 # 1 32 ASP B 306 ASP.? 19.57 CL CL A 384 35 SER B 192 SER.? 13.26 CL CL A 384 75 TYR A 6 TYR.? 20.79 CL CL A 384 215 ASP B 305 ASP^? 21.59 CL CL A 384 coo 11.85 17.24 72.81 11.09 15.37 72.36 -4.64 54.84 103.01 -3.71 56.24 101.58 coo 12.20 12.71 75.45 13.69 13.84 74.03 -11.80 54.65 102.27 -11.20 56.97 103.08 coo 15.08 11.29 68.68 16.45 12.70 70.65 -7.05 53.27 108.32 -4.25 53.35 108.15 coo 5.22 15.03 71.43 7.19 14.88 70.83 -6.28 49.81 99.79 -7.51 49.10 101.38 1rne_c05 source 1rne RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) (E.: 1 hits 1rne_c05 naa= 4 ULMN 4 1sme_c07 PLASMEPSIN II user 1 4 # 1 B 34 ASP A 306 ASP.? 16.66 CL CL A 384 B 37 SER A 192 SER.? 15.36 CL CL A 384 B 77 TYR B 6 TYR.? 15.73 CL CL B 382 B 214 ASP A 305 ASP^? 16.01 CL CL A 384 coo 17.69 97.58 52.73 17.33 97.19 54.77 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 20.67 100.44 55.84 20.21 98.51 54.45 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 21.97 93.33 56.91 23.11 94.24 54.54 -31.00 62.22 83.89 -31.26 65.01 83.64 coo 12.41 98.71 58.47 14.37 98.17 58.05 -32.01 65.22 92.45 -32.49 63.34 91.63 1sme_c07 source 1sme PLASMEPSIN II : 1 hits 1sme_c07 naa= 4 ULMN 4 1x9h_c00 GLUCOSE-6-PHOSPHATE ISOMERASE user 1 4 # 1 A 135 ARG A 334 ARG^? 9.67 CL CL A 382 A 203 GLU A 332 GLU^? 14.84 CL CL A 382 A 219 HIS B 21 HIS.? 12.39 CL CL B 382 A 298 LYS A 288 LYS.? 12.57 CL CL A 384 coo 46.78 3.24 25.36 49.46 4.02 24.06 -35.93 61.76 109.91 -34.52 61.40 112.61 coo 45.62 7.41 24.38 46.18 6.66 26.27 -32.41 59.20 107.78 -33.78 57.91 108.78 coo 17.74 16.81 28.99 16.41 15.60 30.09 -35.26 51.10 78.45 -35.36 53.13 77.89 coo 54.03 15.54 30.62 51.73 9.72 31.19 -19.18 64.09 108.25 -14.44 63.70 112.45 ULMN 4 1x9h_c00 GLUCOSE-6-PHOSPHATE ISOMERASE user 2 4 # 2 A 135 ARG B 334 ARG^? 9.65 CL CL B 383 A 203 GLU B 332 GLU^? 14.76 CL CL B 383 A 219 HIS A 21 HIS.? 26.92 CL CL A 384 A 298 LYS B 288 LYS.? 8.84 CL CL B 382 coo 46.78 3.24 25.36 49.46 4.02 24.06 -12.53 38.39 87.32 -14.06 38.36 84.61 coo 45.62 7.41 24.38 46.18 6.66 26.27 -15.56 41.56 89.17 -16.27 39.59 89.11 coo 17.74 16.81 28.99 16.41 15.60 30.09 -13.56 47.86 119.72 -11.56 48.42 120.07 coo 54.03 15.54 30.62 51.73 9.72 31.19 -16.76 54.22 83.25 -20.62 56.75 78.99 1x9h_c00 source 1x9h GLUCOSE-6-PHOSPHATE ISOMERASE : 2 hits 1x9h_c00 naa= 4 ULMN 4 1x9h_c01 GLUCOSE-6-PHOSPHATE ISOMERASE user 1 4 # 1 B 135 ARG A 334 ARG^? 9.67 CL CL A 382 B 203 GLU A 332 GLU^? 14.84 CL CL A 382 B 219 HIS B 21 HIS.? 12.39 CL CL B 382 B 298 LYS A 288 LYS.? 12.57 CL CL A 384 coo 18.36 26.71 24.52 15.92 26.01 22.78 -35.93 61.76 109.91 -34.52 61.40 112.61 coo 19.67 22.60 23.25 18.70 23.07 25.03 -32.41 59.20 107.78 -33.78 57.91 108.78 coo 46.63 12.38 30.98 47.80 13.39 32.39 -35.26 51.10 78.45 -35.36 53.13 77.89 coo 10.17 13.56 26.79 12.26 19.06 29.15 -19.18 64.09 108.25 -14.44 63.70 112.45 ULMN 4 1x9h_c01 GLUCOSE-6-PHOSPHATE ISOMERASE user 2 4 # 2 B 135 ARG B 334 ARG^? 9.65 CL CL B 383 B 203 GLU B 332 GLU^? 14.76 CL CL B 383 B 219 HIS A 21 HIS.? 26.92 CL CL A 384 B 298 LYS B 288 LYS.? 8.84 CL CL B 382 coo 18.36 26.71 24.52 15.92 26.01 22.78 -12.53 38.39 87.32 -14.06 38.36 84.61 coo 19.67 22.60 23.25 18.70 23.07 25.03 -15.56 41.56 89.17 -16.27 39.59 89.11 coo 46.63 12.38 30.98 47.80 13.39 32.39 -13.56 47.86 119.72 -11.56 48.42 120.07 coo 10.17 13.56 26.79 12.26 19.06 29.15 -16.76 54.22 83.25 -20.62 56.75 78.99 1x9h_c01 source 1x9h GLUCOSE-6-PHOSPHATE ISOMERASE : 2 hits 1x9h_c01 naa= 4 ULMN 4 1xtc_c00 CHOLERA TOXIN user 1 4 # 1 A 7 ARG A 85 ARG^? 33.58 CL CL A 382 A 61 SER A 84 SER^? 34.22 CL CL A 382 A 110 GLU A 23 GLU.? 27.24 CL CL A 382 A 112 GLU A 86 GLU^? 27.08 CL CL A 382 coo 40.84 -12.81 5.27 43.40 -12.96 7.11 -20.06 35.34 124.61 -20.05 37.26 127.03 coo 43.36 -8.81 2.69 45.06 -10.01 1.28 -23.40 34.46 119.76 -25.32 33.97 118.30 coo 50.78 -11.66 -4.90 52.36 -12.10 -6.21 -22.84 44.28 116.17 -23.55 42.53 115.22 coo 46.91 -7.83 -2.12 47.28 -9.79 -1.54 -25.92 41.43 120.29 -26.81 40.98 118.43 ULMN 4 1xtc_c00 CHOLERA TOXIN user 2 4 # 2 A 7 ARG B 85 ARG^? 26.72 CL CL B 382 A 61 SER B 84 SER.? 30.17 CL CL B 382 A 110 GLU B 23 GLU.? 22.91 CL CL B 382 A 112 GLU B 86 GLU^? 25.45 CL CL B 382 coo 40.84 -12.81 5.27 43.40 -12.96 7.11 -45.61 37.84 80.13 -46.20 40.84 79.69 coo 43.36 -8.81 2.69 45.06 -10.01 1.28 -43.97 37.95 86.39 -42.48 36.42 87.54 coo 50.78 -11.66 -4.90 52.36 -12.10 -6.21 -35.83 43.78 85.87 -35.49 42.75 87.75 coo 46.91 -7.83 -2.12 47.28 -9.79 -1.54 -37.46 36.82 83.59 -36.60 37.35 85.50 1xtc_c00 source 1xtc CHOLERA TOXIN : 2 hits 1xtc_c00 naa= 4 ULMN 4 2hgs_c00 GLUTATHIONE SYNTHETASE user 1 4 # 1 A 125 ARG A 197 ARG.? 14.16 CL CL A 384 A 151 SER A 196 SER.? 14.25 CL CL A 384 A 369 GLY B 292 GLY.? 13.97 CL CL B 382 A 450 ARG B 290 ARG.? 12.49 CL CL A 384 coo 48.89 -0.02 20.42 48.11 2.83 21.18 -16.42 65.00 90.05 -16.47 67.55 88.20 coo 43.71 3.15 18.25 42.31 5.11 18.82 -19.39 59.32 90.69 -17.16 59.45 89.72 coo 46.80 10.26 23.98 47.38 10.43 24.45 -15.38 58.60 80.90 -14.73 58.21 81.00 coo 51.72 4.74 17.91 51.63 5.04 21.04 -13.01 59.15 90.41 -14.60 61.38 91.89 ULMN 4 2hgs_c00 GLUTATHIONE SYNTHETASE user 2 4 # 2 A 125 ARG B 290 ARG.? 12.49 CL CL A 384 A 151 SER A 196 SER.? 14.25 CL CL A 384 A 369 GLY B 292 GLY.? 13.97 CL CL B 382 A 450 ARG A 197 ARG.? 14.16 CL CL A 384 coo 48.89 -0.02 20.42 48.11 2.83 21.18 -13.01 59.15 90.41 -14.60 61.38 91.89 coo 43.71 3.15 18.25 42.31 5.11 18.82 -19.39 59.32 90.69 -17.16 59.45 89.72 coo 46.80 10.26 23.98 47.38 10.43 24.45 -15.38 58.60 80.90 -14.73 58.21 81.00 coo 51.72 4.74 17.91 51.63 5.04 21.04 -16.42 65.00 90.05 -16.47 67.55 88.20 2hgs_c00 source 2hgs GLUTATHIONE SYNTHETASE : 2 hits 2hgs_c00 naa= 4 ULMN 4 2tpl_c02 TYROSINE PHENOL-LYASE user 1 4 # 1 A 71 TYR A 181 TYR.? 17.32 CL CL A 382 A 123 PHE A 40 PHE^? 17.10 CL CL A 382 A 214 ASP A 26 ASP^? 16.59 CL CL A 382 A 381 ARG A 20 ARG.? 25.24 CL CL A 384 coo -18.26 14.59 1.38 -20.32 13.94 3.12 -33.79 79.99 107.82 -35.55 78.08 108.89 coo -30.08 -12.81 5.71 -28.04 -12.05 7.46 -23.96 52.42 120.97 -23.29 55.05 120.29 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -29.69 53.68 115.80 -29.91 52.24 114.24 coo -28.50 -18.89 13.52 -29.04 -16.11 14.56 -13.35 53.68 120.82 -11.33 55.30 122.50 ULMN 4 2tpl_c02 TYROSINE PHENOL-LYASE user 2 4 # 2 A 71 TYR A 181 TYR.? 17.32 CL CL A 382 A 123 PHE A 40 PHE^? 17.10 CL CL A 382 A 214 ASP A 39 ASP^? 16.51 CL CL A 382 A 381 ARG A 20 ARG.? 25.24 CL CL A 384 coo -18.26 14.59 1.38 -20.32 13.94 3.12 -33.79 79.99 107.82 -35.55 78.08 108.89 coo -30.08 -12.81 5.71 -28.04 -12.05 7.46 -23.96 52.42 120.97 -23.29 55.05 120.29 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -29.94 52.12 119.85 -30.97 50.72 120.81 coo -28.50 -18.89 13.52 -29.04 -16.11 14.56 -13.35 53.68 120.82 -11.33 55.30 122.50 2tpl_c02 source 2tpl TYROSINE PHENOL-LYASE : 2 hits 2tpl_c02 naa= 4 ULMN 4 2tpl_c03 TYROSINE PHENOL-LYASE user 1 4 # 1 B 71 TYR A 181 TYR.? 17.32 CL CL A 382 B 123 PHE A 40 PHE^? 17.10 CL CL A 382 B 214 ASP A 26 ASP^? 16.59 CL CL A 382 B 381 ARG A 20 ARG.? 25.24 CL CL A 384 coo -20.85 -10.53 13.88 -22.65 -9.60 11.98 -33.79 79.99 107.82 -35.55 78.08 108.89 coo -26.81 18.98 9.83 -25.06 17.93 7.94 -23.96 52.42 120.97 -23.29 55.05 120.29 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -29.69 53.68 115.80 -29.91 52.24 114.24 coo -23.89 24.28 2.03 -24.86 21.74 0.63 -13.35 53.68 120.82 -11.33 55.30 122.50 ULMN 4 2tpl_c03 TYROSINE PHENOL-LYASE user 2 4 # 2 B 71 TYR A 181 TYR.? 17.32 CL CL A 382 B 123 PHE A 40 PHE^? 17.10 CL CL A 382 B 214 ASP A 39 ASP^? 16.51 CL CL A 382 B 381 ARG A 20 ARG.? 25.24 CL CL A 384 coo -20.85 -10.53 13.88 -22.65 -9.60 11.98 -33.79 79.99 107.82 -35.55 78.08 108.89 coo -26.81 18.98 9.83 -25.06 17.93 7.94 -23.96 52.42 120.97 -23.29 55.05 120.29 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -29.94 52.12 119.85 -30.97 50.72 120.81 coo -23.89 24.28 2.03 -24.86 21.74 0.63 -13.35 53.68 120.82 -11.33 55.30 122.50 2tpl_c03 source 2tpl TYROSINE PHENOL-LYASE : 2 hits 2tpl_c03 naa= 4 ULMN 4 3csm_c00 CHORISMATE MUTASE user 1 4 # 1 A 16 ARG B 274 ARG~? 23.83 CL CL B 383 A 157 ARG B 212 ARG.? 28.47 CL CL B 383 A 168 LYS B 336 LYS^? 14.66 CL CL B 383 A 246 GLU B 276 GLU~? 15.94 CL CL B 384 coo 37.85 22.13 39.07 35.08 21.72 40.26 5.51 36.33 89.03 7.35 38.65 89.98 coo 42.53 17.43 30.59 39.80 18.74 31.20 3.61 30.30 95.57 4.45 30.88 98.48 coo 36.10 13.35 45.30 34.36 14.97 39.48 -3.40 41.24 88.18 -4.83 35.96 88.60 coo 36.95 11.32 36.89 36.00 13.20 36.97 -2.79 30.63 87.01 -2.36 28.59 86.68 3csm_c00 source 3csm CHORISMATE MUTASE : 1 hits 3csm_c00 naa= 4 ULMN 4 3csm_c01 CHORISMATE MUTASE user 1 4 # 1 B 16 ARG B 274 ARG~? 23.83 CL CL B 383 B 157 ARG B 212 ARG.? 28.47 CL CL B 383 B 168 LYS B 336 LYS^? 14.66 CL CL B 383 B 246 GLU B 276 GLU~? 15.94 CL CL B 384 coo 36.39 28.16 -15.11 39.30 27.67 -15.87 5.51 36.33 89.03 7.35 38.65 89.98 coo 30.58 24.11 -7.00 33.37 25.38 -7.33 3.61 30.30 95.57 4.45 30.88 98.48 coo 38.96 18.92 -20.31 39.88 21.02 -14.46 -3.40 41.24 88.18 -4.83 35.96 88.60 coo 36.95 17.56 -11.96 37.91 19.44 -12.06 -2.79 30.63 87.01 -2.36 28.59 86.68 3csm_c01 source 3csm CHORISMATE MUTASE : 1 hits 3csm_c01 naa= 4 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 1 3 # 1 A 46 ASP A 28 ASP^? 9.02 CL CL A 382 A 100 ARG A 319 ARG^? 9.49 CL CL A 382 A 116 GLN A 296 GLN.? 9.60 CL CL A 382 coo 32.24 20.09 5.34 30.38 19.04 5.27 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 26.40 25.34 6.28 26.15 22.33 7.25 -27.23 63.29 112.77 -27.13 63.50 115.87 coo 26.74 21.94 13.78 27.57 20.97 12.08 -25.90 69.07 115.31 -25.94 67.37 116.61 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 2 3 # 2 A 46 ASP A 30 ASP^? -6.81 CL CL A 382s A 100 ARG A 319 ARG^? 9.49 CL CL A 382 A 116 GLN A 296 GLN.? 9.60 CL CL A 382 coo 32.24 20.09 5.34 30.38 19.04 5.27 -35.52 64.63 115.87 -36.96 65.19 114.43 coo 26.40 25.34 6.28 26.15 22.33 7.25 -27.23 63.29 112.77 -27.13 63.50 115.87 coo 26.74 21.94 13.78 27.57 20.97 12.08 -25.90 69.07 115.31 -25.94 67.37 116.61 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 3 3 # 3 A 46 ASP A 36 ASP.? -3.33 CL CL A 382s A 100 ARG A 319 ARG^? 9.49 CL CL A 382 A 116 GLN A 296 GLN.? 9.60 CL CL A 382 coo 32.24 20.09 5.34 30.38 19.04 5.27 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 26.40 25.34 6.28 26.15 22.33 7.25 -27.23 63.29 112.77 -27.13 63.50 115.87 coo 26.74 21.94 13.78 27.57 20.97 12.08 -25.90 69.07 115.31 -25.94 67.37 116.61 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 4 3 # 4 A 46 ASP A 39 ASP^? 16.51 CL CL A 382 A 100 ARG A 77 ARG^? 19.95 CL CL A 382 A 116 GLN A 76 GLN^? 24.61 CL CL A 382 coo 32.24 20.09 5.34 30.38 19.04 5.27 -29.94 52.12 119.85 -30.97 50.72 120.81 coo 26.40 25.34 6.28 26.15 22.33 7.25 -32.32 44.63 125.30 -31.80 47.66 125.44 coo 26.74 21.94 13.78 27.57 20.97 12.08 -26.57 46.46 129.57 -24.86 46.70 130.88 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 5 3 # 5 A 46 ASP B 28 ASP^? 9.00 CL CL B 383 A 100 ARG B 319 ARG^? 9.63 CL CL B 383 A 116 GLN B 296 GLN.? 11.41 CL CL B 383 coo 32.24 20.09 5.34 30.38 19.04 5.27 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 26.40 25.34 6.28 26.15 22.33 7.25 -15.74 45.22 81.80 -15.96 44.19 78.93 coo 26.74 21.94 13.78 27.57 20.97 12.08 -11.66 46.90 76.64 -11.16 47.77 74.74 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 6 3 # 6 A 46 ASP B 30 ASP^? -6.72 CL CL B 383s A 100 ARG B 319 ARG^? 9.63 CL CL B 383 A 116 GLN B 296 GLN.? 11.41 CL CL B 383 coo 32.24 20.09 5.34 30.38 19.04 5.27 -11.77 37.20 80.70 -10.35 36.55 82.15 coo 26.40 25.34 6.28 26.15 22.33 7.25 -15.74 45.22 81.80 -15.96 44.19 78.93 coo 26.74 21.94 13.78 27.57 20.97 12.08 -11.66 46.90 76.64 -11.16 47.77 74.74 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 7 3 # 7 A 46 ASP B 36 ASP.? -3.35 CL CL B 383s A 100 ARG B 319 ARG^? 9.63 CL CL B 383 A 116 GLN B 296 GLN.? 11.41 CL CL B 383 coo 32.24 20.09 5.34 30.38 19.04 5.27 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 26.40 25.34 6.28 26.15 22.33 7.25 -15.74 45.22 81.80 -15.96 44.19 78.93 coo 26.74 21.94 13.78 27.57 20.97 12.08 -11.66 46.90 76.64 -11.16 47.77 74.74 12as_c00 source 12as ASPARAGINE SYNTHETASE : 7 hits 12as_c00 naa= 3 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 1 3 # 1 B 46 ASP A 28 ASP^? 9.02 CL CL A 382 B 100 ARG A 319 ARG^? 9.49 CL CL A 382 B 116 GLN A 296 GLN.? 9.60 CL CL A 382 coo 32.18 48.37 12.48 33.96 49.46 12.97 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 39.04 43.25 11.37 38.30 45.35 13.56 -27.23 63.29 112.77 -27.13 63.50 115.87 coo 37.43 42.63 19.41 36.76 44.08 17.97 -25.90 69.07 115.31 -25.94 67.37 116.61 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 2 3 # 2 B 46 ASP A 30 ASP^? -6.81 CL CL A 382s B 100 ARG A 319 ARG^? 9.49 CL CL A 382 B 116 GLN A 296 GLN.? 9.60 CL CL A 382 coo 32.18 48.37 12.48 33.96 49.46 12.97 -35.52 64.63 115.87 -36.96 65.19 114.43 coo 39.04 43.25 11.37 38.30 45.35 13.56 -27.23 63.29 112.77 -27.13 63.50 115.87 coo 37.43 42.63 19.41 36.76 44.08 17.97 -25.90 69.07 115.31 -25.94 67.37 116.61 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 3 3 # 3 B 46 ASP A 36 ASP.? -3.33 CL CL A 382s B 100 ARG A 319 ARG^? 9.49 CL CL A 382 B 116 GLN A 296 GLN.? 9.60 CL CL A 382 coo 32.18 48.37 12.48 33.96 49.46 12.97 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 39.04 43.25 11.37 38.30 45.35 13.56 -27.23 63.29 112.77 -27.13 63.50 115.87 coo 37.43 42.63 19.41 36.76 44.08 17.97 -25.90 69.07 115.31 -25.94 67.37 116.61 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 4 3 # 4 B 46 ASP A 39 ASP^? 16.51 CL CL A 382 B 100 ARG A 77 ARG^? 19.95 CL CL A 382 B 116 GLN A 76 GLN^? 24.61 CL CL A 382 coo 32.18 48.37 12.48 33.96 49.46 12.97 -29.94 52.12 119.85 -30.97 50.72 120.81 coo 39.04 43.25 11.37 38.30 45.35 13.56 -32.32 44.63 125.30 -31.80 47.66 125.44 coo 37.43 42.63 19.41 36.76 44.08 17.97 -26.57 46.46 129.57 -24.86 46.70 130.88 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 5 3 # 5 B 46 ASP B 28 ASP^? 9.00 CL CL B 383 B 100 ARG B 319 ARG^? 9.63 CL CL B 383 B 116 GLN B 296 GLN.? 11.41 CL CL B 383 coo 32.18 48.37 12.48 33.96 49.46 12.97 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 39.04 43.25 11.37 38.30 45.35 13.56 -15.74 45.22 81.80 -15.96 44.19 78.93 coo 37.43 42.63 19.41 36.76 44.08 17.97 -11.66 46.90 76.64 -11.16 47.77 74.74 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 6 3 # 6 B 46 ASP B 30 ASP^? -6.72 CL CL B 383s B 100 ARG B 319 ARG^? 9.63 CL CL B 383 B 116 GLN B 296 GLN.? 11.41 CL CL B 383 coo 32.18 48.37 12.48 33.96 49.46 12.97 -11.77 37.20 80.70 -10.35 36.55 82.15 coo 39.04 43.25 11.37 38.30 45.35 13.56 -15.74 45.22 81.80 -15.96 44.19 78.93 coo 37.43 42.63 19.41 36.76 44.08 17.97 -11.66 46.90 76.64 -11.16 47.77 74.74 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 7 3 # 7 B 46 ASP B 36 ASP.? -3.35 CL CL B 383s B 100 ARG B 319 ARG^? 9.63 CL CL B 383 B 116 GLN B 296 GLN.? 11.41 CL CL B 383 coo 32.18 48.37 12.48 33.96 49.46 12.97 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 39.04 43.25 11.37 38.30 45.35 13.56 -15.74 45.22 81.80 -15.96 44.19 78.93 coo 37.43 42.63 19.41 36.76 44.08 17.97 -11.66 46.90 76.64 -11.16 47.77 74.74 12as_c01 source 12as ASPARAGINE SYNTHETASE : 7 hits 12as_c01 naa= 3 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 140 TYR A 238 TYR^? 27.75 CL CL A 383 B 190 LYS A 267 LYS~? 27.66 CL CL A 382 B 222 ASP A 272 ASP~? 14.48 CL CL A 382 coo 7.17 16.59 41.26 8.01 19.20 40.73 -54.82 80.30 106.22 -53.19 79.11 104.29 coo 13.38 20.00 35.06 11.43 22.49 39.53 -49.43 81.28 111.60 -49.39 86.78 108.40 coo 9.76 26.58 38.10 11.63 25.78 38.76 -46.67 73.24 112.92 -45.43 74.19 114.38 1a05_c00 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 1 hits 1a05_c00 naa= 3 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 190 LYS A 267 LYS~? 27.66 CL CL A 382 A 222 ASP A 272 ASP~? 14.48 CL CL A 382 B 140 TYR A 238 TYR^? 27.75 CL CL A 383 coo -4.61 20.12 30.34 -2.74 22.65 25.95 -49.43 81.28 111.60 -49.39 86.78 108.40 coo -1.04 26.60 27.37 -2.94 25.93 26.69 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 1.51 16.60 24.17 0.82 19.23 24.79 -54.82 80.30 106.22 -53.19 79.11 104.29 1a05_c01 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 1 hits 1a05_c01 naa= 3 ULMN 3 1a41_c01 TOPOISOMERASE I user 1 3 # 1 223 ARG A 13 ARG^? 21.22 CL CL A 382 265 HIS A 19 HIS^? 24.55 CL CL A 382 274 TYR A 8 TYR.? 12.26 CL CL A 384 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -15.61 60.27 127.72 -14.54 62.09 125.47 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -17.70 51.01 127.32 -17.43 50.94 129.40 coo 0.94 52.26 9.16 1.95 54.78 9.91 -16.53 57.80 111.57 -17.14 59.34 109.36 ULMN 3 1a41_c01 TOPOISOMERASE I user 2 3 # 2 223 ARG A 77 ARG^? 19.95 CL CL A 382 265 HIS A 78 HIS^? 30.68 CL CL A 382 274 TYR A 25 TYR^? 18.63 CL CL A 382 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -32.32 44.63 125.30 -31.80 47.66 125.44 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -24.82 39.60 128.09 -23.39 38.20 127.48 coo 0.94 52.26 9.16 1.95 54.78 9.91 -23.49 53.13 116.11 -21.60 54.30 114.36 ULMN 3 1a41_c01 TOPOISOMERASE I user 3 3 # 3 223 ARG B 13 ARG^? 4.84 CL CL B 382 265 HIS B 19 HIS^? 13.92 CL CL B 382 274 TYR B 8 TYR.? 11.88 CL CL B 382 coo -15.18 55.46 8.55 -14.82 52.98 10.38 -26.14 48.57 68.77 -25.79 51.69 68.63 coo -14.48 45.59 11.18 -14.02 47.49 10.42 -33.46 45.18 72.05 -34.46 43.90 70.71 coo 0.94 52.26 9.16 1.95 54.78 9.91 -23.96 53.72 82.39 -21.76 54.53 83.93 1a41_c01 source 1a41 TOPOISOMERASE I : 3 hits 1a41_c01 naa= 3 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU A 23 GLU.? 27.24 CL CL A 382 A 60 ASP A 327 ASP.? 19.04 CL CL A 384 A 175 TYR A 25 TYR^? 18.63 CL CL A 382 coo 46.10 28.27 19.27 45.48 26.99 20.84 -22.84 44.28 116.17 -23.55 42.53 115.22 coo 56.42 28.06 12.93 55.01 27.92 14.50 -25.74 49.77 105.10 -27.34 48.80 104.08 coo 45.02 22.04 15.38 46.16 24.00 13.76 -23.49 53.13 116.11 -21.60 54.30 114.36 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 1 hits 1a50_c03 naa= 3 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 1 3 # 1 142 TRP A 167 TRP^? 7.35 CL CL A 382 223 ASP A 93 ASP^? 5.15 CL CL A 382 258 LYS A 128 LYS.? 19.46 CL CL A 382 coo 127.19 33.46 26.14 126.78 36.79 28.15 -31.10 71.99 120.30 -32.79 75.13 118.77 coo 126.95 41.66 23.38 128.48 40.72 24.51 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 138.83 37.95 25.17 133.50 36.37 26.52 -25.12 72.76 133.10 -20.68 68.32 134.09 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 2 3 # 2 142 TRP A 207 TRP^? 23.82 CL CL A 384 223 ASP A 208 ASP.? 21.85 CL CL A 382 258 LYS A 336 LYS^? 14.72 CL CL A 382 coo 127.19 33.46 26.14 126.78 36.79 28.15 -44.76 66.72 97.91 -42.73 64.04 95.92 coo 126.95 41.66 23.38 128.48 40.72 24.51 -48.25 63.81 104.00 -49.74 63.21 105.24 coo 138.83 37.95 25.17 133.50 36.37 26.52 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 3 3 # 3 142 TRP A 273 TRP~? 19.00 CL CL A 383 223 ASP A 210 ASP.? 21.69 CL CL A 383 258 LYS A 249 LYS^? 20.12 CL CL A 383 coo 127.19 33.46 26.14 126.78 36.79 28.15 -50.89 71.02 111.12 -54.05 73.34 111.49 coo 126.95 41.66 23.38 128.48 40.72 24.51 -52.58 64.68 106.89 -53.21 62.78 107.37 coo 138.83 37.95 25.17 133.50 36.37 26.52 -61.09 73.36 110.22 -57.90 69.98 113.58 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 4 3 # 4 142 TRP A 341 TRP.? 10.34 CL CL A 382 223 ASP A 272 ASP~? 14.48 CL CL A 382 258 LYS A 264 LYS~? 22.00 CL CL A 382 coo 127.19 33.46 26.14 126.78 36.79 28.15 -39.95 74.25 113.33 -36.58 74.16 115.41 coo 126.95 41.66 23.38 128.48 40.72 24.51 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 138.83 37.95 25.17 133.50 36.37 26.52 -48.92 85.08 115.29 -44.06 86.61 118.76 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 5 3 # 5 142 TRP B 167 TRP^? 7.30 CL CL B 383 223 ASP B 93 ASP^? 5.22 CL CL B 383 258 LYS B 128 LYS.? 19.37 CL CL B 383 coo 127.19 33.46 26.14 126.78 36.79 28.15 -8.26 40.92 72.83 -4.37 40.96 73.30 coo 126.95 41.66 23.38 128.48 40.72 24.51 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 138.83 37.95 25.17 133.50 36.37 26.52 -13.49 41.25 59.55 -18.50 40.98 58.08 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 6 3 # 6 142 TRP B 207 TRP^? 25.29 CL CL B 383 223 ASP B 208 ASP.? 21.56 CL CL B 383 258 LYS B 336 LYS^? 14.66 CL CL B 383 coo 127.19 33.46 26.14 126.78 36.79 28.15 -1.19 37.06 97.92 -3.78 38.84 100.32 coo 126.95 41.66 23.38 128.48 40.72 24.51 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 138.83 37.95 25.17 133.50 36.37 26.52 -3.40 41.24 88.18 -4.83 35.96 88.60 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 7 3 # 7 142 TRP B 341 TRP.? 10.39 CL CL B 383 223 ASP B 344 ASP.? 20.04 CL CL B 383 258 LYS B 133 LYS^? 13.08 CL CL B 383 coo 127.19 33.46 26.14 126.78 36.79 28.15 -0.76 36.74 80.33 -2.75 38.82 77.66 coo 126.95 41.66 23.38 128.48 40.72 24.51 7.59 38.09 74.22 8.59 36.72 75.50 coo 138.83 37.95 25.17 133.50 36.37 26.52 -0.84 43.73 69.01 -5.56 47.16 71.00 1aam_c01 source 1aam ASPARTATE AMINOTRANSFERASE : 7 hits 1aam_c01 naa= 3 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 1 3 # 1 22 ASN A 199 ASN.? 4.96 CL CL A 384 63 ARG A 290 ARG.? -7.44 CL CL A 384s 255 ARG B 290 ARG.? 12.49 CL CL A 384 coo 42.10 13.02 11.14 41.85 11.12 10.23 -21.75 61.84 97.70 -22.73 63.77 98.21 coo 44.36 11.24 3.39 41.81 12.78 4.00 -15.77 66.49 99.38 -13.63 64.23 99.65 coo 38.40 3.83 10.26 40.02 6.30 9.25 -13.01 59.15 90.41 -14.60 61.38 91.89 1aj0_c00 source 1aj0 DIHYDROPTEROATE SYNTHASE : 1 hits 1aj0_c00 naa= 3 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 1 3 # 1 33 ASP A 272 ASP~? 14.48 CL CL A 382 187 GLU A 337 GLU^? 21.89 CL CL A 382 229 LYS A 336 LYS^? 14.72 CL CL A 382 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -46.67 73.24 112.92 -45.43 74.19 114.38 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -40.07 74.65 102.17 -42.10 75.18 101.81 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 2 3 # 2 33 ASP B 272 ASP~? 14.11 CL CL B 383 187 GLU B 337 GLU^? 21.78 CL CL B 383 229 LYS B 336 LYS^? 14.66 CL CL B 383 coo -52.57 56.60 47.75 -51.52 54.87 46.95 0.88 31.47 82.51 1.09 32.47 80.67 coo -45.08 48.37 46.81 -46.53 49.74 45.96 2.60 41.45 89.80 4.03 40.00 90.41 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -3.40 41.24 88.18 -4.83 35.96 88.60 1ald_c00 source 1ald ALDOLASE A (E.C.4.1.2.13) : 2 hits 1ald_c00 naa= 3 ULMN 3 1am5_c04 PEPSIN user 1 3 # 1 32 ASP A 28 ASP^? 9.02 CL CL A 382 35 SER A 29 SER^? 6.92 CL CL A 382 215 ASP A 26 ASP^? 16.59 CL CL A 382 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -32.19 59.08 116.32 -33.48 59.98 114.85 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -31.31 63.66 116.96 -29.07 63.86 117.79 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1am5_c04 PEPSIN user 2 3 # 2 32 ASP A 28 ASP^? 9.02 CL CL A 382 35 SER A 37 SER^? 9.11 CL CL A 382 215 ASP A 26 ASP^? 16.59 CL CL A 382 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -32.19 59.08 116.32 -33.48 59.98 114.85 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -31.72 58.75 121.63 -33.32 57.82 120.12 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1am5_c04 PEPSIN user 3 3 # 3 32 ASP A 28 ASP^? 9.02 CL CL A 382 35 SER A 37 SER^? 9.11 CL CL A 382 215 ASP A 30 ASP^? -6.81 CL CL A 382s coo -7.18 8.92 145.10 -8.77 8.81 143.59 -32.19 59.08 116.32 -33.48 59.98 114.85 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -31.72 58.75 121.63 -33.32 57.82 120.12 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1am5_c04 PEPSIN user 4 3 # 4 32 ASP A 28 ASP^? 9.02 CL CL A 382 35 SER A 37 SER^? 9.11 CL CL A 382 215 ASP A 39 ASP^? 16.51 CL CL A 382 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -32.19 59.08 116.32 -33.48 59.98 114.85 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -31.72 58.75 121.63 -33.32 57.82 120.12 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1am5_c04 PEPSIN user 5 3 # 5 32 ASP A 36 ASP.? -3.33 CL CL A 382s 35 SER A 37 SER^? 9.11 CL CL A 382 215 ASP A 30 ASP^? -6.81 CL CL A 382s coo -7.18 8.92 145.10 -8.77 8.81 143.59 -31.47 63.24 120.93 -31.90 65.07 119.91 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -31.72 58.75 121.63 -33.32 57.82 120.12 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1am5_c04 PEPSIN user 6 3 # 6 32 ASP A 195 ASP.? 13.29 CL CL A 384 35 SER A 192 SER.? 15.36 CL CL A 384 215 ASP A 306 ASP.? 16.66 CL CL A 384 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -22.13 62.52 88.27 -20.53 63.80 88.70 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -26.48 60.82 89.96 -25.15 61.33 88.02 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -29.63 66.56 87.01 -28.35 68.29 87.20 ULMN 3 1am5_c04 PEPSIN user 7 3 # 7 32 ASP A 306 ASP.? 16.66 CL CL A 384 35 SER A 192 SER.? 15.36 CL CL A 384 215 ASP A 305 ASP^? 16.01 CL CL A 384 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -29.63 66.56 87.01 -28.35 68.29 87.20 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -26.48 60.82 89.96 -25.15 61.33 88.02 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -32.01 65.22 92.45 -32.49 63.34 91.63 ULMN 3 1am5_c04 PEPSIN user 8 3 # 8 32 ASP B 28 ASP^? 9.00 CL CL B 383 35 SER B 29 SER^? 6.98 CL CL B 383 215 ASP B 26 ASP^? 16.51 CL CL B 383 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -18.06 38.42 81.61 -16.37 38.03 82.88 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -14.55 40.12 78.88 -15.61 41.67 77.42 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1am5_c04 PEPSIN user 9 3 # 9 32 ASP B 28 ASP^? 9.00 CL CL B 383 35 SER B 37 SER^? 9.16 CL CL B 383 215 ASP B 26 ASP^? 16.51 CL CL B 383 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -18.06 38.42 81.61 -16.37 38.03 82.88 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -19.96 36.46 76.97 -19.82 35.54 79.16 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1am5_c04 PEPSIN user 10 3 # 10 32 ASP B 28 ASP^? 9.00 CL CL B 383 35 SER B 37 SER^? 9.16 CL CL B 383 215 ASP B 30 ASP^? -6.72 CL CL B 383s coo -7.18 8.92 145.10 -8.77 8.81 143.59 -18.06 38.42 81.61 -16.37 38.03 82.88 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -19.96 36.46 76.97 -19.82 35.54 79.16 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1am5_c04 PEPSIN user 11 3 # 11 32 ASP B 28 ASP^? 9.00 CL CL B 383 35 SER B 37 SER^? 9.16 CL CL B 383 215 ASP B 39 ASP^? 17.51 CL CL B 383 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -18.06 38.42 81.61 -16.37 38.03 82.88 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -19.96 36.46 76.97 -19.82 35.54 79.16 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -26.18 36.85 80.53 -27.97 36.10 81.34 ULMN 3 1am5_c04 PEPSIN user 12 3 # 12 32 ASP B 36 ASP.? -3.35 CL CL B 383s 35 SER B 37 SER^? 9.16 CL CL B 383 215 ASP B 30 ASP^? -6.72 CL CL B 383s coo -7.18 8.92 145.10 -8.77 8.81 143.59 -15.98 38.04 75.83 -14.00 38.51 76.08 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -19.96 36.46 76.97 -19.82 35.54 79.16 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1am5_c04 PEPSIN user 13 3 # 13 32 ASP B 195 ASP.? 10.47 CL CL A 384 35 SER B 192 SER.? 13.26 CL CL A 384 215 ASP B 306 ASP.? 19.57 CL CL A 384 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -11.82 59.91 101.57 -11.61 61.10 99.82 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -11.80 54.65 102.27 -11.20 56.97 103.08 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -4.64 54.84 103.01 -3.71 56.24 101.58 ULMN 3 1am5_c04 PEPSIN user 14 3 # 14 32 ASP B 306 ASP.? 19.57 CL CL A 384 35 SER B 192 SER.? 13.26 CL CL A 384 215 ASP B 305 ASP^? 21.59 CL CL A 384 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -4.64 54.84 103.01 -3.71 56.24 101.58 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -11.80 54.65 102.27 -11.20 56.97 103.08 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -6.28 49.81 99.79 -7.51 49.10 101.38 1am5_c04 source 1am5 PEPSIN : 14 hits 1am5_c04 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 26 ASP^? 16.59 CL CL A 382 214 ASP A 306 ASP.? 16.66 CL CL A 384 289 ASP A 327 ASP.? 19.04 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -29.69 53.68 115.80 -29.91 52.24 114.24 coo 26.86 59.76 46.36 25.42 58.23 45.92 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 9.42 68.07 30.27 7.35 68.27 30.10 -25.74 49.77 105.10 -27.34 48.80 104.08 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 26 ASP^? 16.59 CL CL A 382 214 ASP A 344 ASP.? 20.56 CL CL A 382 289 ASP A 36 ASP.? -3.33 CL CL A 382s coo -0.62 65.95 29.97 0.31 67.47 31.05 -29.69 53.68 115.80 -29.91 52.24 114.24 coo 26.86 59.76 46.36 25.42 58.23 45.92 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 9.42 68.07 30.27 7.35 68.27 30.10 -31.47 63.24 120.93 -31.90 65.07 119.91 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 36 ASP.? -3.33 CL CL A 382s 214 ASP B 327 ASP.? 22.34 CL CL A 384 289 ASP A 26 ASP^? 16.59 CL CL A 382 coo -0.62 65.95 29.97 0.31 67.47 31.05 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 26.86 59.76 46.36 25.42 58.23 45.92 -25.62 46.25 93.54 -25.42 45.53 95.50 coo 9.42 68.07 30.27 7.35 68.27 30.10 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP A 39 ASP^? 16.51 CL CL A 382 214 ASP A 344 ASP.? 20.56 CL CL A 382 289 ASP A 36 ASP.? -3.33 CL CL A 382s coo -0.62 65.95 29.97 0.31 67.47 31.05 -29.94 52.12 119.85 -30.97 50.72 120.81 coo 26.86 59.76 46.36 25.42 58.23 45.92 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 9.42 68.07 30.27 7.35 68.27 30.10 -31.47 63.24 120.93 -31.90 65.07 119.91 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP A 93 ASP^? 5.15 CL CL A 382 214 ASP A 305 ASP^? 16.01 CL CL A 384 289 ASP A 28 ASP^? 9.02 CL CL A 382 coo -0.62 65.95 29.97 0.31 67.47 31.05 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 26.86 59.76 46.36 25.42 58.23 45.92 -32.01 65.22 92.45 -32.49 63.34 91.63 coo 9.42 68.07 30.27 7.35 68.27 30.10 -32.19 59.08 116.32 -33.48 59.98 114.85 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP A 93 ASP^? 5.15 CL CL A 382 214 ASP A 305 ASP^? 16.01 CL CL A 384 289 ASP A 30 ASP^? -6.81 CL CL A 382s coo -0.62 65.95 29.97 0.31 67.47 31.05 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 26.86 59.76 46.36 25.42 58.23 45.92 -32.01 65.22 92.45 -32.49 63.34 91.63 coo 9.42 68.07 30.27 7.35 68.27 30.10 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP A 93 ASP^? 5.15 CL CL A 382 214 ASP A 311 ASP^? 15.19 CL CL A 384 289 ASP A 30 ASP^? -6.81 CL CL A 382s coo -0.62 65.95 29.97 0.31 67.47 31.05 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 26.86 59.76 46.36 25.42 58.23 45.92 -31.19 72.86 91.72 -29.44 73.97 92.12 coo 9.42 68.07 30.27 7.35 68.27 30.10 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP A 100 ASP~? 8.92 CL CL A 383 214 ASP A 204 ASP^? 18.76 CL CL A 384 289 ASP A 93 ASP^? 5.15 CL CL A 382 coo -0.62 65.95 29.97 0.31 67.47 31.05 -39.25 61.23 132.92 -38.42 59.82 131.54 coo 26.86 59.76 46.36 25.42 58.23 45.92 -37.06 58.40 100.88 -36.30 56.45 100.53 coo 9.42 68.07 30.27 7.35 68.27 30.10 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP A 100 ASP~? 8.92 CL CL A 383 214 ASP A 327 ASP.? 19.04 CL CL A 384 289 ASP A 93 ASP^? 5.15 CL CL A 382 coo -0.62 65.95 29.97 0.31 67.47 31.05 -39.25 61.23 132.92 -38.42 59.82 131.54 coo 26.86 59.76 46.36 25.42 58.23 45.92 -25.74 49.77 105.10 -27.34 48.80 104.08 coo 9.42 68.07 30.27 7.35 68.27 30.10 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP A 100 ASP~? 8.92 CL CL A 383 214 ASP A 338 ASP.? 17.28 CL CL A 384 289 ASP A 93 ASP^? 5.15 CL CL A 382 coo -0.62 65.95 29.97 0.31 67.47 31.05 -39.25 61.23 132.92 -38.42 59.82 131.54 coo 26.86 59.76 46.36 25.42 58.23 45.92 -35.06 76.37 102.96 -33.50 77.52 103.78 coo 9.42 68.07 30.27 7.35 68.27 30.10 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 11 3 # 11 179 ASP A 144 ASP.? 19.38 CL CL A 383 214 ASP A 240 ASP.? 30.06 CL CL A 382 289 ASP A 257 ASP.? 24.30 CL CL A 383 coo -0.62 65.95 29.97 0.31 67.47 31.05 -52.89 78.90 131.37 -53.77 80.20 132.79 coo 26.86 59.76 46.36 25.42 58.23 45.92 -54.36 78.15 100.29 -55.09 76.20 100.68 coo 9.42 68.07 30.27 7.35 68.27 30.10 -55.05 88.25 125.09 -55.04 86.55 126.35 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 12 3 # 12 179 ASP A 171 ASP.? 13.95 CL CL A 382 214 ASP A 204 ASP^? 18.76 CL CL A 384 289 ASP A 93 ASP^? 5.15 CL CL A 382 coo -0.62 65.95 29.97 0.31 67.47 31.05 -21.72 70.05 125.28 -22.57 71.99 125.28 coo 26.86 59.76 46.36 25.42 58.23 45.92 -37.06 58.40 100.88 -36.30 56.45 100.53 coo 9.42 68.07 30.27 7.35 68.27 30.10 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 13 3 # 13 179 ASP A 180 ASP.? 19.13 CL CL A 382 214 ASP A 195 ASP.? 13.29 CL CL A 384 289 ASP A 338 ASP.? 17.28 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -29.53 80.77 112.24 -28.62 82.54 111.55 coo 26.86 59.76 46.36 25.42 58.23 45.92 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 9.42 68.07 30.27 7.35 68.27 30.10 -35.06 76.37 102.96 -33.50 77.52 103.78 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 14 3 # 14 179 ASP A 195 ASP.? 13.29 CL CL A 384 214 ASP A 30 ASP^? -6.81 CL CL A 382s 289 ASP A 305 ASP^? 16.01 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 26.86 59.76 46.36 25.42 58.23 45.92 -35.52 64.63 115.87 -36.96 65.19 114.43 coo 9.42 68.07 30.27 7.35 68.27 30.10 -32.01 65.22 92.45 -32.49 63.34 91.63 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 15 3 # 15 179 ASP A 195 ASP.? 13.29 CL CL A 384 214 ASP A 180 ASP.? 19.13 CL CL A 382 289 ASP A 305 ASP^? 16.01 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 26.86 59.76 46.36 25.42 58.23 45.92 -29.53 80.77 112.24 -28.62 82.54 111.55 coo 9.42 68.07 30.27 7.35 68.27 30.10 -32.01 65.22 92.45 -32.49 63.34 91.63 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 16 3 # 16 179 ASP A 204 ASP^? 18.76 CL CL A 384 214 ASP B 291 ASP.? 20.64 CL CL B 382 289 ASP A 305 ASP^? 16.01 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -37.06 58.40 100.88 -36.30 56.45 100.53 coo 26.86 59.76 46.36 25.42 58.23 45.92 -11.26 60.51 82.59 -9.94 61.37 84.03 coo 9.42 68.07 30.27 7.35 68.27 30.10 -32.01 65.22 92.45 -32.49 63.34 91.63 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 17 3 # 17 179 ASP A 305 ASP^? 16.01 CL CL A 384 214 ASP A 93 ASP^? 5.15 CL CL A 382 289 ASP A 204 ASP^? 18.76 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -32.01 65.22 92.45 -32.49 63.34 91.63 coo 26.86 59.76 46.36 25.42 58.23 45.92 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 9.42 68.07 30.27 7.35 68.27 30.10 -37.06 58.40 100.88 -36.30 56.45 100.53 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 18 3 # 18 179 ASP A 305 ASP^? 16.01 CL CL A 384 214 ASP B 28 ASP^? 9.00 CL CL B 383 289 ASP A 195 ASP.? 13.29 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -32.01 65.22 92.45 -32.49 63.34 91.63 coo 26.86 59.76 46.36 25.42 58.23 45.92 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 9.42 68.07 30.27 7.35 68.27 30.10 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 19 3 # 19 179 ASP A 305 ASP^? 16.01 CL CL A 384 214 ASP B 204 ASP^? 22.18 CL CL B 383 289 ASP A 195 ASP.? 13.29 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -32.01 65.22 92.45 -32.49 63.34 91.63 coo 26.86 59.76 46.36 25.42 58.23 45.92 -12.38 39.84 96.49 -14.33 39.98 97.22 coo 9.42 68.07 30.27 7.35 68.27 30.10 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 20 3 # 20 179 ASP A 305 ASP^? 16.01 CL CL A 384 214 ASP B 305 ASP^? 21.59 CL CL A 384 289 ASP A 195 ASP.? 13.29 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -32.01 65.22 92.45 -32.49 63.34 91.63 coo 26.86 59.76 46.36 25.42 58.23 45.92 -6.28 49.81 99.79 -7.51 49.10 101.38 coo 9.42 68.07 30.27 7.35 68.27 30.10 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 21 3 # 21 179 ASP A 305 ASP^? 16.01 CL CL A 384 214 ASP B 306 ASP.? 19.57 CL CL A 384 289 ASP A 195 ASP.? 13.29 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -32.01 65.22 92.45 -32.49 63.34 91.63 coo 26.86 59.76 46.36 25.42 58.23 45.92 -4.64 54.84 103.01 -3.71 56.24 101.58 coo 9.42 68.07 30.27 7.35 68.27 30.10 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 22 3 # 22 179 ASP A 306 ASP.? 16.66 CL CL A 384 214 ASP B 28 ASP^? 9.00 CL CL B 383 289 ASP A 195 ASP.? 13.29 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 26.86 59.76 46.36 25.42 58.23 45.92 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 9.42 68.07 30.27 7.35 68.27 30.10 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 23 3 # 23 179 ASP A 306 ASP.? 16.66 CL CL A 384 214 ASP B 204 ASP^? 22.18 CL CL B 383 289 ASP A 195 ASP.? 13.29 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 26.86 59.76 46.36 25.42 58.23 45.92 -12.38 39.84 96.49 -14.33 39.98 97.22 coo 9.42 68.07 30.27 7.35 68.27 30.10 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 24 3 # 24 179 ASP A 306 ASP.? 16.66 CL CL A 384 214 ASP B 305 ASP^? 21.59 CL CL A 384 289 ASP A 195 ASP.? 13.29 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 26.86 59.76 46.36 25.42 58.23 45.92 -6.28 49.81 99.79 -7.51 49.10 101.38 coo 9.42 68.07 30.27 7.35 68.27 30.10 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 25 3 # 25 179 ASP A 306 ASP.? 16.66 CL CL A 384 214 ASP B 306 ASP.? 19.57 CL CL A 384 289 ASP A 195 ASP.? 13.29 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 26.86 59.76 46.36 25.42 58.23 45.92 -4.64 54.84 103.01 -3.71 56.24 101.58 coo 9.42 68.07 30.27 7.35 68.27 30.10 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 26 3 # 26 179 ASP A 306 ASP.? 16.66 CL CL A 384 214 ASP B 311 ASP^? 24.66 CL CL A 384 289 ASP A 195 ASP.? 13.29 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 26.86 59.76 46.36 25.42 58.23 45.92 0.41 52.81 97.17 0.37 54.52 95.85 coo 9.42 68.07 30.27 7.35 68.27 30.10 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 27 3 # 27 179 ASP A 327 ASP.? 19.04 CL CL A 384 214 ASP A 210 ASP.? 21.69 CL CL A 383 289 ASP A 26 ASP^? 16.59 CL CL A 382 coo -0.62 65.95 29.97 0.31 67.47 31.05 -25.74 49.77 105.10 -27.34 48.80 104.08 coo 26.86 59.76 46.36 25.42 58.23 45.92 -52.58 64.68 106.89 -53.21 62.78 107.37 coo 9.42 68.07 30.27 7.35 68.27 30.10 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 28 3 # 28 179 ASP A 327 ASP.? 19.04 CL CL A 384 214 ASP A 272 ASP~? 14.48 CL CL A 382 289 ASP A 26 ASP^? 16.59 CL CL A 382 coo -0.62 65.95 29.97 0.31 67.47 31.05 -25.74 49.77 105.10 -27.34 48.80 104.08 coo 26.86 59.76 46.36 25.42 58.23 45.92 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 9.42 68.07 30.27 7.35 68.27 30.10 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 29 3 # 29 179 ASP A 327 ASP.? 19.04 CL CL A 384 214 ASP B 208 ASP.? 21.56 CL CL B 383 289 ASP B 327 ASP.? 22.34 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -25.74 49.77 105.10 -27.34 48.80 104.08 coo 26.86 59.76 46.36 25.42 58.23 45.92 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 9.42 68.07 30.27 7.35 68.27 30.10 -25.62 46.25 93.54 -25.42 45.53 95.50 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 30 3 # 30 179 ASP A 344 ASP.? 20.56 CL CL A 382 214 ASP A 305 ASP^? 16.01 CL CL A 384 289 ASP A 180 ASP.? 19.13 CL CL A 382 coo -0.62 65.95 29.97 0.31 67.47 31.05 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 26.86 59.76 46.36 25.42 58.23 45.92 -32.01 65.22 92.45 -32.49 63.34 91.63 coo 9.42 68.07 30.27 7.35 68.27 30.10 -29.53 80.77 112.24 -28.62 82.54 111.55 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 31 3 # 31 179 ASP B 26 ASP^? 16.51 CL CL B 383 214 ASP B 344 ASP.? 20.04 CL CL B 383 289 ASP B 36 ASP.? -3.35 CL CL B 383s coo -0.62 65.95 29.97 0.31 67.47 31.05 -23.45 39.33 83.60 -24.23 39.48 85.53 coo 26.86 59.76 46.36 25.42 58.23 45.92 7.59 38.09 74.22 8.59 36.72 75.50 coo 9.42 68.07 30.27 7.35 68.27 30.10 -15.98 38.04 75.83 -14.00 38.51 76.08 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 32 3 # 32 179 ASP B 30 ASP^? -6.72 CL CL B 383s 214 ASP A 327 ASP.? 19.04 CL CL A 384 289 ASP B 26 ASP^? 16.51 CL CL B 383 coo -0.62 65.95 29.97 0.31 67.47 31.05 -11.77 37.20 80.70 -10.35 36.55 82.15 coo 26.86 59.76 46.36 25.42 58.23 45.92 -25.74 49.77 105.10 -27.34 48.80 104.08 coo 9.42 68.07 30.27 7.35 68.27 30.10 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 33 3 # 33 179 ASP B 36 ASP.? -3.35 CL CL B 383s 214 ASP A 327 ASP.? 19.04 CL CL A 384 289 ASP B 26 ASP^? 16.51 CL CL B 383 coo -0.62 65.95 29.97 0.31 67.47 31.05 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 26.86 59.76 46.36 25.42 58.23 45.92 -25.74 49.77 105.10 -27.34 48.80 104.08 coo 9.42 68.07 30.27 7.35 68.27 30.10 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 34 3 # 34 179 ASP B 39 ASP^? 17.51 CL CL B 383 214 ASP B 344 ASP.? 20.04 CL CL B 383 289 ASP B 28 ASP^? 9.00 CL CL B 383 coo -0.62 65.95 29.97 0.31 67.47 31.05 -26.18 36.85 80.53 -27.97 36.10 81.34 coo 26.86 59.76 46.36 25.42 58.23 45.92 7.59 38.09 74.22 8.59 36.72 75.50 coo 9.42 68.07 30.27 7.35 68.27 30.10 -18.06 38.42 81.61 -16.37 38.03 82.88 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 35 3 # 35 179 ASP B 39 ASP^? 17.51 CL CL B 383 214 ASP B 344 ASP.? 20.04 CL CL B 383 289 ASP B 36 ASP.? -3.35 CL CL B 383s coo -0.62 65.95 29.97 0.31 67.47 31.05 -26.18 36.85 80.53 -27.97 36.10 81.34 coo 26.86 59.76 46.36 25.42 58.23 45.92 7.59 38.09 74.22 8.59 36.72 75.50 coo 9.42 68.07 30.27 7.35 68.27 30.10 -15.98 38.04 75.83 -14.00 38.51 76.08 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 36 3 # 36 179 ASP B 93 ASP^? 5.22 CL CL B 383 214 ASP B 305 ASP^? 21.59 CL CL A 384 289 ASP B 28 ASP^? 9.00 CL CL B 383 coo -0.62 65.95 29.97 0.31 67.47 31.05 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 26.86 59.76 46.36 25.42 58.23 45.92 -6.28 49.81 99.79 -7.51 49.10 101.38 coo 9.42 68.07 30.27 7.35 68.27 30.10 -18.06 38.42 81.61 -16.37 38.03 82.88 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 37 3 # 37 179 ASP B 93 ASP^? 5.22 CL CL B 383 214 ASP B 305 ASP^? 21.59 CL CL A 384 289 ASP B 30 ASP^? -6.72 CL CL B 383s coo -0.62 65.95 29.97 0.31 67.47 31.05 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 26.86 59.76 46.36 25.42 58.23 45.92 -6.28 49.81 99.79 -7.51 49.10 101.38 coo 9.42 68.07 30.27 7.35 68.27 30.10 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 38 3 # 38 179 ASP B 93 ASP^? 5.22 CL CL B 383 214 ASP B 311 ASP^? 24.66 CL CL A 384 289 ASP B 30 ASP^? -6.72 CL CL B 383s coo -0.62 65.95 29.97 0.31 67.47 31.05 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 26.86 59.76 46.36 25.42 58.23 45.92 0.41 52.81 97.17 0.37 54.52 95.85 coo 9.42 68.07 30.27 7.35 68.27 30.10 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 39 3 # 39 179 ASP B 144 ASP.? 18.90 CL CL B 384 214 ASP B 240 ASP.? 29.22 CL CL B 383 289 ASP B 257 ASP.? 23.04 CL CL B 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 1.70 18.75 65.96 3.42 18.04 64.94 coo 26.86 59.76 46.36 25.42 58.23 45.92 11.35 28.88 93.27 10.37 30.59 94.07 coo 9.42 68.07 30.27 7.35 68.27 30.10 12.38 23.16 66.89 10.36 22.88 66.20 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 40 3 # 40 179 ASP B 171 ASP.? 13.77 CL CL B 383 214 ASP B 204 ASP^? 22.18 CL CL B 383 289 ASP B 93 ASP^? 5.22 CL CL B 383 coo -0.62 65.95 29.97 0.31 67.47 31.05 -14.88 46.75 66.62 -12.79 46.40 66.16 coo 26.86 59.76 46.36 25.42 58.23 45.92 -12.38 39.84 96.49 -14.33 39.98 97.22 coo 9.42 68.07 30.27 7.35 68.27 30.10 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 41 3 # 41 179 ASP B 180 ASP.? 19.08 CL CL B 383 214 ASP B 195 ASP.? 10.47 CL CL A 384 289 ASP B 338 ASP.? 19.77 CL CL B 383 coo -0.62 65.95 29.97 0.31 67.47 31.05 0.82 48.22 75.52 2.17 49.73 74.84 coo 26.86 59.76 46.36 25.42 58.23 45.92 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 9.42 68.07 30.27 7.35 68.27 30.10 1.84 46.00 86.98 1.86 47.25 85.31 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 42 3 # 42 179 ASP B 195 ASP.? 10.47 CL CL A 384 214 ASP B 30 ASP^? -6.72 CL CL B 383s 289 ASP B 305 ASP^? 21.59 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 26.86 59.76 46.36 25.42 58.23 45.92 -11.77 37.20 80.70 -10.35 36.55 82.15 coo 9.42 68.07 30.27 7.35 68.27 30.10 -6.28 49.81 99.79 -7.51 49.10 101.38 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 43 3 # 43 179 ASP B 195 ASP.? 10.47 CL CL A 384 214 ASP B 180 ASP.? 19.08 CL CL B 383 289 ASP B 305 ASP^? 21.59 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 26.86 59.76 46.36 25.42 58.23 45.92 0.82 48.22 75.52 2.17 49.73 74.84 coo 9.42 68.07 30.27 7.35 68.27 30.10 -6.28 49.81 99.79 -7.51 49.10 101.38 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 44 3 # 44 179 ASP B 195 ASP.? 10.47 CL CL A 384 214 ASP B 208 ASP.? 21.56 CL CL B 383 289 ASP B 306 ASP.? 19.57 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 26.86 59.76 46.36 25.42 58.23 45.92 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 9.42 68.07 30.27 7.35 68.27 30.10 -4.64 54.84 103.01 -3.71 56.24 101.58 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 45 3 # 45 179 ASP B 204 ASP^? 22.18 CL CL B 383 214 ASP A 291 ASP.? 7.30 CL CL A 384 289 ASP B 305 ASP^? 21.59 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -12.38 39.84 96.49 -14.33 39.98 97.22 coo 26.86 59.76 46.36 25.42 58.23 45.92 -15.45 71.21 105.07 -17.40 71.77 105.62 coo 9.42 68.07 30.27 7.35 68.27 30.10 -6.28 49.81 99.79 -7.51 49.10 101.38 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 46 3 # 46 179 ASP B 305 ASP^? 21.59 CL CL A 384 214 ASP A 28 ASP^? 9.02 CL CL A 382 289 ASP B 195 ASP.? 10.47 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -6.28 49.81 99.79 -7.51 49.10 101.38 coo 26.86 59.76 46.36 25.42 58.23 45.92 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 9.42 68.07 30.27 7.35 68.27 30.10 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 47 3 # 47 179 ASP B 305 ASP^? 21.59 CL CL A 384 214 ASP A 39 ASP^? 16.51 CL CL A 382 289 ASP B 195 ASP.? 10.47 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -6.28 49.81 99.79 -7.51 49.10 101.38 coo 26.86 59.76 46.36 25.42 58.23 45.92 -29.94 52.12 119.85 -30.97 50.72 120.81 coo 9.42 68.07 30.27 7.35 68.27 30.10 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 48 3 # 48 179 ASP B 305 ASP^? 21.59 CL CL A 384 214 ASP A 204 ASP^? 18.76 CL CL A 384 289 ASP B 195 ASP.? 10.47 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -6.28 49.81 99.79 -7.51 49.10 101.38 coo 26.86 59.76 46.36 25.42 58.23 45.92 -37.06 58.40 100.88 -36.30 56.45 100.53 coo 9.42 68.07 30.27 7.35 68.27 30.10 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 49 3 # 49 179 ASP B 305 ASP^? 21.59 CL CL A 384 214 ASP A 306 ASP.? 16.66 CL CL A 384 289 ASP B 195 ASP.? 10.47 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -6.28 49.81 99.79 -7.51 49.10 101.38 coo 26.86 59.76 46.36 25.42 58.23 45.92 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 9.42 68.07 30.27 7.35 68.27 30.10 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 50 3 # 50 179 ASP B 305 ASP^? 21.59 CL CL A 384 214 ASP B 93 ASP^? 5.22 CL CL B 383 289 ASP B 204 ASP^? 22.18 CL CL B 383 coo -0.62 65.95 29.97 0.31 67.47 31.05 -6.28 49.81 99.79 -7.51 49.10 101.38 coo 26.86 59.76 46.36 25.42 58.23 45.92 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 9.42 68.07 30.27 7.35 68.27 30.10 -12.38 39.84 96.49 -14.33 39.98 97.22 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 51 3 # 51 179 ASP B 306 ASP.? 19.57 CL CL A 384 214 ASP A 28 ASP^? 9.02 CL CL A 382 289 ASP B 195 ASP.? 10.47 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -4.64 54.84 103.01 -3.71 56.24 101.58 coo 26.86 59.76 46.36 25.42 58.23 45.92 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 9.42 68.07 30.27 7.35 68.27 30.10 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 52 3 # 52 179 ASP B 306 ASP.? 19.57 CL CL A 384 214 ASP A 204 ASP^? 18.76 CL CL A 384 289 ASP B 195 ASP.? 10.47 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -4.64 54.84 103.01 -3.71 56.24 101.58 coo 26.86 59.76 46.36 25.42 58.23 45.92 -37.06 58.40 100.88 -36.30 56.45 100.53 coo 9.42 68.07 30.27 7.35 68.27 30.10 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 53 3 # 53 179 ASP B 306 ASP.? 19.57 CL CL A 384 214 ASP A 306 ASP.? 16.66 CL CL A 384 289 ASP B 195 ASP.? 10.47 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -4.64 54.84 103.01 -3.71 56.24 101.58 coo 26.86 59.76 46.36 25.42 58.23 45.92 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 9.42 68.07 30.27 7.35 68.27 30.10 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 54 3 # 54 179 ASP B 306 ASP.? 19.57 CL CL A 384 214 ASP A 311 ASP^? 15.19 CL CL A 384 289 ASP B 195 ASP.? 10.47 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -4.64 54.84 103.01 -3.71 56.24 101.58 coo 26.86 59.76 46.36 25.42 58.23 45.92 -31.19 72.86 91.72 -29.44 73.97 92.12 coo 9.42 68.07 30.27 7.35 68.27 30.10 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 55 3 # 55 179 ASP B 306 ASP.? 19.57 CL CL A 384 214 ASP B 64 ASP.? 7.14 CL CL B 382 289 ASP B 195 ASP.? 10.47 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -4.64 54.84 103.01 -3.71 56.24 101.58 coo 26.86 59.76 46.36 25.42 58.23 45.92 -22.24 55.99 77.05 -23.77 56.03 78.56 coo 9.42 68.07 30.27 7.35 68.27 30.10 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 56 3 # 56 179 ASP B 344 ASP.? 20.04 CL CL B 383 214 ASP B 26 ASP^? 16.51 CL CL B 383 289 ASP B 180 ASP.? 19.08 CL CL B 383 coo -0.62 65.95 29.97 0.31 67.47 31.05 7.59 38.09 74.22 8.59 36.72 75.50 coo 26.86 59.76 46.36 25.42 58.23 45.92 -23.45 39.33 83.60 -24.23 39.48 85.53 coo 9.42 68.07 30.27 7.35 68.27 30.10 0.82 48.22 75.52 2.17 49.73 74.84 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 57 3 # 57 179 ASP B 344 ASP.? 20.04 CL CL B 383 214 ASP B 305 ASP^? 21.59 CL CL A 384 289 ASP B 180 ASP.? 19.08 CL CL B 383 coo -0.62 65.95 29.97 0.31 67.47 31.05 7.59 38.09 74.22 8.59 36.72 75.50 coo 26.86 59.76 46.36 25.42 58.23 45.92 -6.28 49.81 99.79 -7.51 49.10 101.38 coo 9.42 68.07 30.27 7.35 68.27 30.10 0.82 48.22 75.52 2.17 49.73 74.84 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 57 hits 1amy_c01 naa= 3 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 180 ASP.? 19.13 CL CL A 382 204 GLU A 135 GLU.? 22.99 CL CL A 382 289 ASP A 344 ASP.? 20.56 CL CL A 382 coo -0.62 65.95 29.97 0.31 67.47 31.05 -29.53 80.77 112.24 -28.62 82.54 111.55 coo 4.34 62.44 32.05 4.22 64.48 32.53 -31.98 87.75 115.72 -30.11 88.72 115.32 coo 9.42 68.07 30.27 7.35 68.27 30.10 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 210 ASP.? 21.69 CL CL A 383 204 GLU A 276 GLU~? 16.10 CL CL A 383 289 ASP A 272 ASP~? 14.48 CL CL A 382 coo -0.62 65.95 29.97 0.31 67.47 31.05 -52.58 64.68 106.89 -53.21 62.78 107.37 coo 4.34 62.44 32.05 4.22 64.48 32.53 -46.62 67.79 110.40 -48.46 68.09 111.43 coo 9.42 68.07 30.27 7.35 68.27 30.10 -46.67 73.24 112.92 -45.43 74.19 114.38 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 272 ASP~? 14.48 CL CL A 382 204 GLU A 276 GLU~? 16.10 CL CL A 383 289 ASP A 210 ASP.? 21.69 CL CL A 383 coo -0.62 65.95 29.97 0.31 67.47 31.05 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 4.34 62.44 32.05 4.22 64.48 32.53 -46.62 67.79 110.40 -48.46 68.09 111.43 coo 9.42 68.07 30.27 7.35 68.27 30.10 -52.58 64.68 106.89 -53.21 62.78 107.37 1amy_c05 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 3 hits 1amy_c05 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 39 ASP^? 16.51 CL CL A 382 227 GLU A 57 GLU.? 23.36 CL CL A 382 289 ASP A 36 ASP.? -3.33 CL CL A 382s coo -0.62 65.95 29.97 0.31 67.47 31.05 -29.94 52.12 119.85 -30.97 50.72 120.81 coo 3.96 55.76 41.24 4.83 57.69 41.17 -23.46 53.73 134.86 -22.94 54.54 136.68 coo 9.42 68.07 30.27 7.35 68.27 30.10 -31.47 63.24 120.93 -31.90 65.07 119.91 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 93 ASP^? 5.15 CL CL A 382 227 GLU A 57 GLU.? 23.36 CL CL A 382 289 ASP A 100 ASP~? 8.92 CL CL A 383 coo -0.62 65.95 29.97 0.31 67.47 31.05 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 3.96 55.76 41.24 4.83 57.69 41.17 -23.46 53.73 134.86 -22.94 54.54 136.68 coo 9.42 68.07 30.27 7.35 68.27 30.10 -39.25 61.23 132.92 -38.42 59.82 131.54 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 93 ASP^? 5.15 CL CL A 382 227 GLU A 57 GLU.? 23.36 CL CL A 382 289 ASP A 171 ASP.? 13.95 CL CL A 382 coo -0.62 65.95 29.97 0.31 67.47 31.05 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 3.96 55.76 41.24 4.83 57.69 41.17 -23.46 53.73 134.86 -22.94 54.54 136.68 coo 9.42 68.07 30.27 7.35 68.27 30.10 -21.72 70.05 125.28 -22.57 71.99 125.28 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP A 100 ASP~? 8.92 CL CL A 383 227 GLU A 57 GLU.? 23.36 CL CL A 382 289 ASP A 93 ASP^? 5.15 CL CL A 382 coo -0.62 65.95 29.97 0.31 67.47 31.05 -39.25 61.23 132.92 -38.42 59.82 131.54 coo 3.96 55.76 41.24 4.83 57.69 41.17 -23.46 53.73 134.86 -22.94 54.54 136.68 coo 9.42 68.07 30.27 7.35 68.27 30.10 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP A 171 ASP.? 13.95 CL CL A 382 227 GLU A 18 GLU^? 23.23 CL CL A 382 289 ASP A 93 ASP^? 5.15 CL CL A 382 coo -0.62 65.95 29.97 0.31 67.47 31.05 -21.72 70.05 125.28 -22.57 71.99 125.28 coo 3.96 55.76 41.24 4.83 57.69 41.17 -12.62 56.10 125.83 -13.81 57.82 125.60 coo 9.42 68.07 30.27 7.35 68.27 30.10 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP A 180 ASP.? 19.13 CL CL A 382 227 GLU A 337 GLU^? 21.89 CL CL A 382 289 ASP A 344 ASP.? 20.56 CL CL A 382 coo -0.62 65.95 29.97 0.31 67.47 31.05 -29.53 80.77 112.24 -28.62 82.54 111.55 coo 3.96 55.76 41.24 4.83 57.69 41.17 -40.07 74.65 102.17 -42.10 75.18 101.81 coo 9.42 68.07 30.27 7.35 68.27 30.10 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP A 204 ASP^? 18.76 CL CL A 384 227 GLU A 337 GLU^? 21.89 CL CL A 382 289 ASP A 305 ASP^? 16.01 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -37.06 58.40 100.88 -36.30 56.45 100.53 coo 3.96 55.76 41.24 4.83 57.69 41.17 -40.07 74.65 102.17 -42.10 75.18 101.81 coo 9.42 68.07 30.27 7.35 68.27 30.10 -32.01 65.22 92.45 -32.49 63.34 91.63 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP A 210 ASP.? 21.69 CL CL A 383 227 GLU A 215 GLU^? 33.84 CL CL A 383 289 ASP A 272 ASP~? 14.48 CL CL A 382 coo -0.62 65.95 29.97 0.31 67.47 31.05 -52.58 64.68 106.89 -53.21 62.78 107.37 coo 3.96 55.76 41.24 4.83 57.69 41.17 -61.95 78.59 103.72 -63.72 79.79 103.76 coo 9.42 68.07 30.27 7.35 68.27 30.10 -46.67 73.24 112.92 -45.43 74.19 114.38 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP A 305 ASP^? 16.01 CL CL A 384 227 GLU A 337 GLU^? 21.89 CL CL A 382 289 ASP A 204 ASP^? 18.76 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -32.01 65.22 92.45 -32.49 63.34 91.63 coo 3.96 55.76 41.24 4.83 57.69 41.17 -40.07 74.65 102.17 -42.10 75.18 101.81 coo 9.42 68.07 30.27 7.35 68.27 30.10 -37.06 58.40 100.88 -36.30 56.45 100.53 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP A 344 ASP.? 20.56 CL CL A 382 227 GLU A 337 GLU^? 21.89 CL CL A 382 289 ASP A 180 ASP.? 19.13 CL CL A 382 coo -0.62 65.95 29.97 0.31 67.47 31.05 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 3.96 55.76 41.24 4.83 57.69 41.17 -40.07 74.65 102.17 -42.10 75.18 101.81 coo 9.42 68.07 30.27 7.35 68.27 30.10 -29.53 80.77 112.24 -28.62 82.54 111.55 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 11 3 # 11 179 ASP B 26 ASP^? 16.51 CL CL B 383 227 GLU B 60 GLU^? 11.77 CL CL B 382 289 ASP B 30 ASP^? -6.72 CL CL B 383s coo -0.62 65.95 29.97 0.31 67.47 31.05 -23.45 39.33 83.60 -24.23 39.48 85.53 coo 3.96 55.76 41.24 4.83 57.69 41.17 -22.53 44.68 66.99 -22.71 45.90 65.28 coo 9.42 68.07 30.27 7.35 68.27 30.10 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 12 3 # 12 179 ASP B 28 ASP^? 9.00 CL CL B 383 227 GLU B 60 GLU^? 11.77 CL CL B 382 289 ASP B 39 ASP^? 17.51 CL CL B 383 coo -0.62 65.95 29.97 0.31 67.47 31.05 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 3.96 55.76 41.24 4.83 57.69 41.17 -22.53 44.68 66.99 -22.71 45.90 65.28 coo 9.42 68.07 30.27 7.35 68.27 30.10 -26.18 36.85 80.53 -27.97 36.10 81.34 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 13 3 # 13 179 ASP B 30 ASP^? -6.72 CL CL B 383s 227 GLU B 206 GLU^? 19.18 CL CL B 383 289 ASP B 26 ASP^? 16.51 CL CL B 383 coo -0.62 65.95 29.97 0.31 67.47 31.05 -11.77 37.20 80.70 -10.35 36.55 82.15 coo 3.96 55.76 41.24 4.83 57.69 41.17 -9.17 35.76 95.82 -10.61 34.74 94.62 coo 9.42 68.07 30.27 7.35 68.27 30.10 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 14 3 # 14 179 ASP B 39 ASP^? 17.51 CL CL B 383 227 GLU B 57 GLU.? 21.35 CL CL B 382 289 ASP B 36 ASP.? -3.35 CL CL B 383s coo -0.62 65.95 29.97 0.31 67.47 31.05 -26.18 36.85 80.53 -27.97 36.10 81.34 coo 3.96 55.76 41.24 4.83 57.69 41.17 -31.25 37.00 65.18 -31.15 36.75 63.13 coo 9.42 68.07 30.27 7.35 68.27 30.10 -15.98 38.04 75.83 -14.00 38.51 76.08 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 15 3 # 15 179 ASP B 39 ASP^? 17.51 CL CL B 383 227 GLU B 60 GLU^? 11.77 CL CL B 382 289 ASP B 28 ASP^? 9.00 CL CL B 383 coo -0.62 65.95 29.97 0.31 67.47 31.05 -26.18 36.85 80.53 -27.97 36.10 81.34 coo 3.96 55.76 41.24 4.83 57.69 41.17 -22.53 44.68 66.99 -22.71 45.90 65.28 coo 9.42 68.07 30.27 7.35 68.27 30.10 -18.06 38.42 81.61 -16.37 38.03 82.88 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 16 3 # 16 179 ASP B 93 ASP^? 5.22 CL CL B 383 227 GLU B 57 GLU.? 21.35 CL CL B 382 289 ASP B 171 ASP.? 13.77 CL CL B 383 coo -0.62 65.95 29.97 0.31 67.47 31.05 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 3.96 55.76 41.24 4.83 57.69 41.17 -31.25 37.00 65.18 -31.15 36.75 63.13 coo 9.42 68.07 30.27 7.35 68.27 30.10 -14.88 46.75 66.62 -12.79 46.40 66.16 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 17 3 # 17 179 ASP B 171 ASP.? 13.77 CL CL B 383 227 GLU B 18 GLU^? 5.91 CL CL B 382 289 ASP B 93 ASP^? 5.22 CL CL B 383 coo -0.62 65.95 29.97 0.31 67.47 31.05 -14.88 46.75 66.62 -12.79 46.40 66.16 coo 3.96 55.76 41.24 4.83 57.69 41.17 -29.91 50.09 69.26 -29.49 51.30 70.99 coo 9.42 68.07 30.27 7.35 68.27 30.10 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 18 3 # 18 179 ASP B 180 ASP.? 19.08 CL CL B 383 227 GLU B 337 GLU^? 21.78 CL CL B 383 289 ASP B 344 ASP.? 20.04 CL CL B 383 coo -0.62 65.95 29.97 0.31 67.47 31.05 0.82 48.22 75.52 2.17 49.73 74.84 coo 3.96 55.76 41.24 4.83 57.69 41.17 2.60 41.45 89.80 4.03 40.00 90.41 coo 9.42 68.07 30.27 7.35 68.27 30.10 7.59 38.09 74.22 8.59 36.72 75.50 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 19 3 # 19 179 ASP B 204 ASP^? 22.18 CL CL B 383 227 GLU B 337 GLU^? 21.78 CL CL B 383 289 ASP B 305 ASP^? 21.59 CL CL A 384 coo -0.62 65.95 29.97 0.31 67.47 31.05 -12.38 39.84 96.49 -14.33 39.98 97.22 coo 3.96 55.76 41.24 4.83 57.69 41.17 2.60 41.45 89.80 4.03 40.00 90.41 coo 9.42 68.07 30.27 7.35 68.27 30.10 -6.28 49.81 99.79 -7.51 49.10 101.38 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 20 3 # 20 179 ASP B 305 ASP^? 21.59 CL CL A 384 227 GLU B 337 GLU^? 21.78 CL CL B 383 289 ASP B 204 ASP^? 22.18 CL CL B 383 coo -0.62 65.95 29.97 0.31 67.47 31.05 -6.28 49.81 99.79 -7.51 49.10 101.38 coo 3.96 55.76 41.24 4.83 57.69 41.17 2.60 41.45 89.80 4.03 40.00 90.41 coo 9.42 68.07 30.27 7.35 68.27 30.10 -12.38 39.84 96.49 -14.33 39.98 97.22 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 21 3 # 21 179 ASP B 344 ASP.? 20.04 CL CL B 383 227 GLU B 337 GLU^? 21.78 CL CL B 383 289 ASP B 180 ASP.? 19.08 CL CL B 383 coo -0.62 65.95 29.97 0.31 67.47 31.05 7.59 38.09 74.22 8.59 36.72 75.50 coo 3.96 55.76 41.24 4.83 57.69 41.17 2.60 41.45 89.80 4.03 40.00 90.41 coo 9.42 68.07 30.27 7.35 68.27 30.10 0.82 48.22 75.52 2.17 49.73 74.84 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 21 hits 1amy_c06 naa= 3 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 1 3 # 1 E 33 ASP A 28 ASP^? 9.02 CL CL A 382 E 36 SER A 29 SER^? 6.92 CL CL A 382 E 213 ASP A 26 ASP^? 16.59 CL CL A 382 coo 26.30 12.96 16.78 25.46 12.99 18.72 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 28.33 15.15 21.27 28.70 13.12 19.97 -31.31 63.66 116.96 -29.07 63.86 117.79 coo 20.15 16.04 19.79 21.65 14.49 19.86 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 2 3 # 2 E 33 ASP A 28 ASP^? 9.02 CL CL A 382 E 36 SER A 37 SER^? 9.11 CL CL A 382 E 213 ASP A 26 ASP^? 16.59 CL CL A 382 coo 26.30 12.96 16.78 25.46 12.99 18.72 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 28.33 15.15 21.27 28.70 13.12 19.97 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 20.15 16.04 19.79 21.65 14.49 19.86 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 3 3 # 3 E 33 ASP A 28 ASP^? 9.02 CL CL A 382 E 36 SER A 37 SER^? 9.11 CL CL A 382 E 213 ASP A 30 ASP^? -6.81 CL CL A 382s coo 26.30 12.96 16.78 25.46 12.99 18.72 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 28.33 15.15 21.27 28.70 13.12 19.97 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 20.15 16.04 19.79 21.65 14.49 19.86 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 4 3 # 4 E 33 ASP A 28 ASP^? 9.02 CL CL A 382 E 36 SER A 37 SER^? 9.11 CL CL A 382 E 213 ASP A 39 ASP^? 16.51 CL CL A 382 coo 26.30 12.96 16.78 25.46 12.99 18.72 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 28.33 15.15 21.27 28.70 13.12 19.97 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 20.15 16.04 19.79 21.65 14.49 19.86 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 5 3 # 5 E 33 ASP A 36 ASP.? -3.33 CL CL A 382s E 36 SER A 37 SER^? 9.11 CL CL A 382 E 213 ASP A 30 ASP^? -6.81 CL CL A 382s coo 26.30 12.96 16.78 25.46 12.99 18.72 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 28.33 15.15 21.27 28.70 13.12 19.97 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 20.15 16.04 19.79 21.65 14.49 19.86 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 6 3 # 6 E 33 ASP A 195 ASP.? 13.29 CL CL A 384 E 36 SER A 192 SER.? 15.36 CL CL A 384 E 213 ASP A 306 ASP.? 16.66 CL CL A 384 coo 26.30 12.96 16.78 25.46 12.99 18.72 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 28.33 15.15 21.27 28.70 13.12 19.97 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 20.15 16.04 19.79 21.65 14.49 19.86 -29.63 66.56 87.01 -28.35 68.29 87.20 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 7 3 # 7 E 33 ASP A 306 ASP.? 16.66 CL CL A 384 E 36 SER A 192 SER.? 15.36 CL CL A 384 E 213 ASP A 305 ASP^? 16.01 CL CL A 384 coo 26.30 12.96 16.78 25.46 12.99 18.72 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 28.33 15.15 21.27 28.70 13.12 19.97 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 20.15 16.04 19.79 21.65 14.49 19.86 -32.01 65.22 92.45 -32.49 63.34 91.63 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 8 3 # 8 E 33 ASP B 28 ASP^? 9.00 CL CL B 383 E 36 SER B 29 SER^? 6.98 CL CL B 383 E 213 ASP B 26 ASP^? 16.51 CL CL B 383 coo 26.30 12.96 16.78 25.46 12.99 18.72 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 28.33 15.15 21.27 28.70 13.12 19.97 -14.55 40.12 78.88 -15.61 41.67 77.42 coo 20.15 16.04 19.79 21.65 14.49 19.86 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 9 3 # 9 E 33 ASP B 28 ASP^? 9.00 CL CL B 383 E 36 SER B 37 SER^? 9.16 CL CL B 383 E 213 ASP B 26 ASP^? 16.51 CL CL B 383 coo 26.30 12.96 16.78 25.46 12.99 18.72 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 28.33 15.15 21.27 28.70 13.12 19.97 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 20.15 16.04 19.79 21.65 14.49 19.86 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 10 3 # 10 E 33 ASP B 28 ASP^? 9.00 CL CL B 383 E 36 SER B 37 SER^? 9.16 CL CL B 383 E 213 ASP B 30 ASP^? -6.72 CL CL B 383s coo 26.30 12.96 16.78 25.46 12.99 18.72 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 28.33 15.15 21.27 28.70 13.12 19.97 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 20.15 16.04 19.79 21.65 14.49 19.86 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 11 3 # 11 E 33 ASP B 28 ASP^? 9.00 CL CL B 383 E 36 SER B 37 SER^? 9.16 CL CL B 383 E 213 ASP B 39 ASP^? 17.51 CL CL B 383 coo 26.30 12.96 16.78 25.46 12.99 18.72 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 28.33 15.15 21.27 28.70 13.12 19.97 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 20.15 16.04 19.79 21.65 14.49 19.86 -26.18 36.85 80.53 -27.97 36.10 81.34 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 12 3 # 12 E 33 ASP B 36 ASP.? -3.35 CL CL B 383s E 36 SER B 37 SER^? 9.16 CL CL B 383 E 213 ASP B 30 ASP^? -6.72 CL CL B 383s coo 26.30 12.96 16.78 25.46 12.99 18.72 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 28.33 15.15 21.27 28.70 13.12 19.97 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 20.15 16.04 19.79 21.65 14.49 19.86 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 13 3 # 13 E 33 ASP B 195 ASP.? 10.47 CL CL A 384 E 36 SER B 192 SER.? 13.26 CL CL A 384 E 213 ASP B 306 ASP.? 19.57 CL CL A 384 coo 26.30 12.96 16.78 25.46 12.99 18.72 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 28.33 15.15 21.27 28.70 13.12 19.97 -11.80 54.65 102.27 -11.20 56.97 103.08 coo 20.15 16.04 19.79 21.65 14.49 19.86 -4.64 54.84 103.01 -3.71 56.24 101.58 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 14 3 # 14 E 33 ASP B 306 ASP.? 19.57 CL CL A 384 E 36 SER B 192 SER.? 13.26 CL CL A 384 E 213 ASP B 305 ASP^? 21.59 CL CL A 384 coo 26.30 12.96 16.78 25.46 12.99 18.72 -4.64 54.84 103.01 -3.71 56.24 101.58 coo 28.33 15.15 21.27 28.70 13.12 19.97 -11.80 54.65 102.27 -11.20 56.97 103.08 coo 20.15 16.04 19.79 21.65 14.49 19.86 -6.28 49.81 99.79 -7.51 49.10 101.38 1apt_c04 source 1apt ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET (LYSTA IS : 14 hits 1apt_c04 naa= 3 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 1 3 # 1 232 HIS A 246 HIS.? 33.92 CL CL A 383 254 LYS A 249 LYS^? 20.12 CL CL A 383 333 ARG A 212 ARG.? 30.01 CL CL A 382 coo 28.11 -1.15 8.51 29.21 0.63 8.34 -65.97 72.19 102.08 -66.87 73.22 103.68 coo 26.09 4.87 14.60 27.89 3.33 10.26 -61.09 73.36 110.22 -57.90 69.98 113.58 coo 37.35 7.47 11.84 34.90 6.11 10.60 -52.31 71.44 100.68 -54.00 71.15 98.10 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 2 3 # 2 232 HIS B 246 HIS.? 32.95 CL CL B 384 254 LYS B 249 LYS^? 19.48 CL CL B 384 333 ARG B 212 ARG.? 28.47 CL CL B 383 coo 28.11 -1.15 8.51 29.21 0.63 8.34 10.60 18.26 97.26 11.24 17.08 95.63 coo 26.09 4.87 14.60 27.89 3.33 10.26 7.49 19.68 88.46 2.17 20.34 86.44 coo 37.35 7.47 11.84 34.90 6.11 10.60 3.61 30.30 95.57 4.45 30.88 98.48 1aq2_c00 source 1aq2 PHOSPHOENOLPYRUVATE CARBOXYKINASE : 2 hits 1aq2_c00 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER A 37 SER^? 9.11 CL CL A 382 A 292 ASP A 53 ASP.? 25.38 CL CL A 382 A 322 HIS A 165 HIS^? 7.64 CL CL A 382 coo 36.34 32.23 39.60 36.43 34.62 39.93 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 19.73 19.18 41.39 21.50 18.65 40.34 -25.09 46.58 135.54 -27.02 47.57 135.30 coo 41.69 45.14 46.60 41.78 47.19 46.18 -39.19 73.43 119.40 -40.10 71.56 119.72 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER A 37 SER^? 9.11 CL CL A 382 A 292 ASP A 204 ASP^? 18.76 CL CL A 384 A 322 HIS A 19 HIS^? 24.55 CL CL A 382 coo 36.34 32.23 39.60 36.43 34.62 39.93 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 19.73 19.18 41.39 21.50 18.65 40.34 -37.06 58.40 100.88 -36.30 56.45 100.53 coo 41.69 45.14 46.60 41.78 47.19 46.18 -17.70 51.01 127.32 -17.43 50.94 129.40 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 A 194 SER A 161 SER~? 16.95 CL CL A 383 A 292 ASP A 30 ASP^? -6.81 CL CL A 382s A 322 HIS A 223 HIS.? 29.08 CL CL A 383 coo 36.34 32.23 39.60 36.43 34.62 39.93 -45.55 81.13 122.60 -44.57 82.20 124.58 coo 19.73 19.18 41.39 21.50 18.65 40.34 -35.52 64.63 115.87 -36.96 65.19 114.43 coo 41.69 45.14 46.60 41.78 47.19 46.18 -56.62 90.70 129.56 -55.95 91.22 131.48 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 A 194 SER A 192 SER.? 15.36 CL CL A 384 A 292 ASP A 338 ASP.? 17.28 CL CL A 384 A 322 HIS B 21 HIS.? 12.39 CL CL B 382 coo 36.34 32.23 39.60 36.43 34.62 39.93 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 19.73 19.18 41.39 21.50 18.65 40.34 -35.06 76.37 102.96 -33.50 77.52 103.78 coo 41.69 45.14 46.60 41.78 47.19 46.18 -35.26 51.10 78.45 -35.36 53.13 77.89 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 A 194 SER A 192 SER.? 15.36 CL CL A 384 A 292 ASP A 338 ASP.? 17.28 CL CL A 384 A 322 HIS B 287 HIS.? 13.85 CL CL B 382 coo 36.34 32.23 39.60 36.43 34.62 39.93 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 19.73 19.18 41.39 21.50 18.65 40.34 -35.06 76.37 102.96 -33.50 77.52 103.78 coo 41.69 45.14 46.60 41.78 47.19 46.18 -21.22 50.04 83.35 -22.70 48.63 83.80 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 A 194 SER A 196 SER.? 14.25 CL CL A 384 A 292 ASP B 311 ASP^? 24.66 CL CL A 384 A 322 HIS A 302 HIS^? 11.51 CL CL A 384 coo 36.34 32.23 39.60 36.43 34.62 39.93 -19.39 59.32 90.69 -17.16 59.45 89.72 coo 19.73 19.18 41.39 21.50 18.65 40.34 0.41 52.81 97.17 0.37 54.52 95.85 coo 41.69 45.14 46.60 41.78 47.19 46.18 -27.17 73.50 97.06 -27.34 73.92 95.02 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 7 3 # 7 A 194 SER B 37 SER^? 9.16 CL CL B 383 A 292 ASP B 53 ASP.? 25.44 CL CL B 384 A 322 HIS B 165 HIS^? 7.69 CL CL B 383 coo 36.34 32.23 39.60 36.43 34.62 39.93 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 19.73 19.18 41.39 21.50 18.65 40.34 -37.14 32.94 67.80 -35.44 31.68 68.05 coo 41.69 45.14 46.60 41.78 47.19 46.18 -3.45 34.55 75.15 -4.91 33.27 75.93 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 8 3 # 8 A 194 SER B 37 SER^? 9.16 CL CL B 383 A 292 ASP B 204 ASP^? 22.18 CL CL B 383 A 322 HIS B 19 HIS^? 13.92 CL CL B 382 coo 36.34 32.23 39.60 36.43 34.62 39.93 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 19.73 19.18 41.39 21.50 18.65 40.34 -12.38 39.84 96.49 -14.33 39.98 97.22 coo 41.69 45.14 46.60 41.78 47.19 46.18 -33.46 45.18 72.05 -34.46 43.90 70.71 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 9 3 # 9 A 194 SER B 192 SER.? 13.26 CL CL A 384 A 292 ASP B 338 ASP.? 19.77 CL CL B 383 A 322 HIS A 287 HIS.? 12.74 CL CL A 384 coo 36.34 32.23 39.60 36.43 34.62 39.93 -11.80 54.65 102.27 -11.20 56.97 103.08 coo 19.73 19.18 41.39 21.50 18.65 40.34 1.84 46.00 86.98 1.86 47.25 85.31 coo 41.69 45.14 46.60 41.78 47.19 46.18 -21.23 59.04 111.08 -21.85 57.11 111.58 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 10 3 # 10 A 194 SER B 196 SER.? 5.60 CL CL A 384 A 292 ASP A 204 ASP^? 18.76 CL CL A 384 A 322 HIS B 302 HIS^? 23.99 CL CL A 384 coo 36.34 32.23 39.60 36.43 34.62 39.93 -16.29 59.80 99.85 -17.47 61.93 100.11 coo 19.73 19.18 41.39 21.50 18.65 40.34 -37.06 58.40 100.88 -36.30 56.45 100.53 coo 41.69 45.14 46.60 41.78 47.19 46.18 -2.27 54.46 91.30 -1.20 55.23 92.93 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 11 3 # 11 A 194 SER B 196 SER.? 5.60 CL CL A 384 A 292 ASP A 311 ASP^? 15.19 CL CL A 384 A 322 HIS B 302 HIS^? 23.99 CL CL A 384 coo 36.34 32.23 39.60 36.43 34.62 39.93 -16.29 59.80 99.85 -17.47 61.93 100.11 coo 19.73 19.18 41.39 21.50 18.65 40.34 -31.19 72.86 91.72 -29.44 73.97 92.12 coo 41.69 45.14 46.60 41.78 47.19 46.18 -2.27 54.46 91.30 -1.20 55.23 92.93 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 11 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER A 37 SER^? 9.11 CL CL A 382 B 292 ASP A 53 ASP.? 25.38 CL CL A 382 B 322 HIS A 165 HIS^? 7.64 CL CL A 382 coo 35.42 71.28 22.94 36.24 69.06 22.37 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 24.74 78.07 5.59 24.32 79.03 7.46 -25.09 46.58 135.54 -27.02 47.57 135.30 coo 48.81 64.16 26.34 49.30 62.16 26.73 -39.19 73.43 119.40 -40.10 71.56 119.72 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER A 37 SER^? 9.11 CL CL A 382 B 292 ASP A 204 ASP^? 18.76 CL CL A 384 B 322 HIS A 19 HIS^? 24.55 CL CL A 382 coo 35.42 71.28 22.94 36.24 69.06 22.37 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 24.74 78.07 5.59 24.32 79.03 7.46 -37.06 58.40 100.88 -36.30 56.45 100.53 coo 48.81 64.16 26.34 49.30 62.16 26.73 -17.70 51.01 127.32 -17.43 50.94 129.40 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 B 194 SER A 161 SER~? 16.95 CL CL A 383 B 292 ASP A 30 ASP^? -6.81 CL CL A 382s B 322 HIS A 223 HIS.? 29.08 CL CL A 383 coo 35.42 71.28 22.94 36.24 69.06 22.37 -45.55 81.13 122.60 -44.57 82.20 124.58 coo 24.74 78.07 5.59 24.32 79.03 7.46 -35.52 64.63 115.87 -36.96 65.19 114.43 coo 48.81 64.16 26.34 49.30 62.16 26.73 -56.62 90.70 129.56 -55.95 91.22 131.48 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 B 194 SER A 161 SER~? 16.95 CL CL A 383 B 292 ASP A 100 ASP~? 8.92 CL CL A 383 B 322 HIS A 223 HIS.? 29.08 CL CL A 383 coo 35.42 71.28 22.94 36.24 69.06 22.37 -45.55 81.13 122.60 -44.57 82.20 124.58 coo 24.74 78.07 5.59 24.32 79.03 7.46 -39.25 61.23 132.92 -38.42 59.82 131.54 coo 48.81 64.16 26.34 49.30 62.16 26.73 -56.62 90.70 129.56 -55.95 91.22 131.48 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 B 194 SER A 192 SER.? 15.36 CL CL A 384 B 292 ASP A 338 ASP.? 17.28 CL CL A 384 B 322 HIS B 21 HIS.? 12.39 CL CL B 382 coo 35.42 71.28 22.94 36.24 69.06 22.37 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 24.74 78.07 5.59 24.32 79.03 7.46 -35.06 76.37 102.96 -33.50 77.52 103.78 coo 48.81 64.16 26.34 49.30 62.16 26.73 -35.26 51.10 78.45 -35.36 53.13 77.89 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 B 194 SER A 192 SER.? 15.36 CL CL A 384 B 292 ASP A 338 ASP.? 17.28 CL CL A 384 B 322 HIS B 287 HIS.? 13.85 CL CL B 382 coo 35.42 71.28 22.94 36.24 69.06 22.37 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 24.74 78.07 5.59 24.32 79.03 7.46 -35.06 76.37 102.96 -33.50 77.52 103.78 coo 48.81 64.16 26.34 49.30 62.16 26.73 -21.22 50.04 83.35 -22.70 48.63 83.80 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 7 3 # 7 B 194 SER A 196 SER.? 14.25 CL CL A 384 B 292 ASP B 311 ASP^? 24.66 CL CL A 384 B 322 HIS A 302 HIS^? 11.51 CL CL A 384 coo 35.42 71.28 22.94 36.24 69.06 22.37 -19.39 59.32 90.69 -17.16 59.45 89.72 coo 24.74 78.07 5.59 24.32 79.03 7.46 0.41 52.81 97.17 0.37 54.52 95.85 coo 48.81 64.16 26.34 49.30 62.16 26.73 -27.17 73.50 97.06 -27.34 73.92 95.02 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 8 3 # 8 B 194 SER B 37 SER^? 9.16 CL CL B 383 B 292 ASP B 53 ASP.? 25.44 CL CL B 384 B 322 HIS B 165 HIS^? 7.69 CL CL B 383 coo 35.42 71.28 22.94 36.24 69.06 22.37 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 24.74 78.07 5.59 24.32 79.03 7.46 -37.14 32.94 67.80 -35.44 31.68 68.05 coo 48.81 64.16 26.34 49.30 62.16 26.73 -3.45 34.55 75.15 -4.91 33.27 75.93 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 9 3 # 9 B 194 SER B 37 SER^? 9.16 CL CL B 383 B 292 ASP B 204 ASP^? 22.18 CL CL B 383 B 322 HIS B 19 HIS^? 13.92 CL CL B 382 coo 35.42 71.28 22.94 36.24 69.06 22.37 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 24.74 78.07 5.59 24.32 79.03 7.46 -12.38 39.84 96.49 -14.33 39.98 97.22 coo 48.81 64.16 26.34 49.30 62.16 26.73 -33.46 45.18 72.05 -34.46 43.90 70.71 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 10 3 # 10 B 194 SER B 192 SER.? 13.26 CL CL A 384 B 292 ASP B 338 ASP.? 19.77 CL CL B 383 B 322 HIS A 287 HIS.? 12.74 CL CL A 384 coo 35.42 71.28 22.94 36.24 69.06 22.37 -11.80 54.65 102.27 -11.20 56.97 103.08 coo 24.74 78.07 5.59 24.32 79.03 7.46 1.84 46.00 86.98 1.86 47.25 85.31 coo 48.81 64.16 26.34 49.30 62.16 26.73 -21.23 59.04 111.08 -21.85 57.11 111.58 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 11 3 # 11 B 194 SER B 196 SER.? 5.60 CL CL A 384 B 292 ASP A 204 ASP^? 18.76 CL CL A 384 B 322 HIS B 302 HIS^? 23.99 CL CL A 384 coo 35.42 71.28 22.94 36.24 69.06 22.37 -16.29 59.80 99.85 -17.47 61.93 100.11 coo 24.74 78.07 5.59 24.32 79.03 7.46 -37.06 58.40 100.88 -36.30 56.45 100.53 coo 48.81 64.16 26.34 49.30 62.16 26.73 -2.27 54.46 91.30 -1.20 55.23 92.93 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 12 3 # 12 B 194 SER B 196 SER.? 5.60 CL CL A 384 B 292 ASP A 311 ASP^? 15.19 CL CL A 384 B 322 HIS B 302 HIS^? 23.99 CL CL A 384 coo 35.42 71.28 22.94 36.24 69.06 22.37 -16.29 59.80 99.85 -17.47 61.93 100.11 coo 24.74 78.07 5.59 24.32 79.03 7.46 -31.19 72.86 91.72 -29.44 73.97 92.12 coo 48.81 64.16 26.34 49.30 62.16 26.73 -2.27 54.46 91.30 -1.20 55.23 92.93 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 12 hits 1aql_c03 naa= 3 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 B 325 ARG A 319 ARG^? 9.49 CL CL A 382 B 342 ASP A 39 ASP^? 16.51 CL CL A 382 B 531 ARG A 334 ARG^? 9.67 CL CL A 382 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -27.23 63.29 112.77 -27.13 63.50 115.87 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -29.94 52.12 119.85 -30.97 50.72 120.81 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -35.93 61.76 109.91 -34.52 61.40 112.61 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 B 325 ARG A 319 ARG^? 9.49 CL CL A 382 B 342 ASP A 93 ASP^? 5.15 CL CL A 382 B 531 ARG A 334 ARG^? 9.67 CL CL A 382 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -27.23 63.29 112.77 -27.13 63.50 115.87 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -35.93 61.76 109.91 -34.52 61.40 112.61 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 B 325 ARG A 334 ARG^? 9.67 CL CL A 382 B 342 ASP A 26 ASP^? 16.59 CL CL A 382 B 531 ARG A 202 ARG^? 19.65 CL CL A 384 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -35.93 61.76 109.91 -34.52 61.40 112.61 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -29.69 53.68 115.80 -29.91 52.24 114.24 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -32.39 54.22 100.96 -34.65 53.06 99.24 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 B 325 ARG B 77 ARG^? 27.48 CL CL B 383 B 342 ASP B 53 ASP.? 25.44 CL CL B 384 B 531 ARG B 85 ARG^? 26.72 CL CL B 382 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -35.60 30.51 80.72 -37.43 31.47 83.02 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -37.14 32.94 67.80 -35.44 31.68 68.05 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -45.61 37.84 80.13 -46.20 40.84 79.69 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 5 3 # 5 B 325 ARG B 193 ARG.? 19.02 CL CL A 384 B 342 ASP A 327 ASP.? 19.04 CL CL A 384 B 531 ARG B 202 ARG^? 25.52 CL CL B 383 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -14.12 50.83 106.82 -12.70 50.89 109.57 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -25.74 49.77 105.10 -27.34 48.80 104.08 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -17.65 42.54 97.41 -16.79 41.14 100.03 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 6 3 # 6 B 325 ARG B 193 ARG.? 19.02 CL CL A 384 B 342 ASP B 305 ASP^? 21.59 CL CL A 384 B 531 ARG B 202 ARG^? 25.52 CL CL B 383 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -14.12 50.83 106.82 -12.70 50.89 109.57 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -6.28 49.81 99.79 -7.51 49.10 101.38 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -17.65 42.54 97.41 -16.79 41.14 100.03 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 7 3 # 7 B 325 ARG B 290 ARG.? 12.49 CL CL A 384 B 342 ASP A 195 ASP.? 13.29 CL CL A 384 B 531 ARG A 290 ARG.? -7.44 CL CL A 384s coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -13.01 59.15 90.41 -14.60 61.38 91.89 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -15.77 66.49 99.38 -13.63 64.23 99.65 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 8 3 # 8 B 325 ARG B 319 ARG^? 9.63 CL CL B 383 B 342 ASP B 39 ASP^? 17.51 CL CL B 383 B 531 ARG B 334 ARG^? 9.65 CL CL B 383 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -15.74 45.22 81.80 -15.96 44.19 78.93 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -26.18 36.85 80.53 -27.97 36.10 81.34 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -12.53 38.39 87.32 -14.06 38.36 84.61 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 9 3 # 9 B 325 ARG B 319 ARG^? 9.63 CL CL B 383 B 342 ASP B 93 ASP^? 5.22 CL CL B 383 B 531 ARG B 334 ARG^? 9.65 CL CL B 383 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -15.74 45.22 81.80 -15.96 44.19 78.93 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -12.53 38.39 87.32 -14.06 38.36 84.61 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 10 3 # 10 B 325 ARG B 334 ARG^? 9.65 CL CL B 383 B 342 ASP B 26 ASP^? 16.51 CL CL B 383 B 531 ARG B 202 ARG^? 25.52 CL CL B 383 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -12.53 38.39 87.32 -14.06 38.36 84.61 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -23.45 39.33 83.60 -24.23 39.48 85.53 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -17.65 42.54 97.41 -16.79 41.14 100.03 1asy_c00 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 10 hits 1asy_c00 naa= 3 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 A 325 ARG A 193 ARG.? 15.01 CL CL B 382 A 342 ASP A 204 ASP^? 18.76 CL CL A 384 A 531 ARG B 325 ARG.? 19.88 CL CL B 382 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -30.19 56.43 87.97 -31.59 55.92 85.25 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -37.06 58.40 100.88 -36.30 56.45 100.53 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -34.83 46.46 90.24 -34.50 47.08 87.15 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 A 325 ARG A 193 ARG.? 15.01 CL CL B 382 A 342 ASP B 327 ASP.? 22.34 CL CL A 384 A 531 ARG A 202 ARG^? 19.65 CL CL A 384 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -30.19 56.43 87.97 -31.59 55.92 85.25 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -25.62 46.25 93.54 -25.42 45.53 95.50 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -32.39 54.22 100.96 -34.65 53.06 99.24 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 A 325 ARG A 334 ARG^? 9.67 CL CL A 382 A 342 ASP A 26 ASP^? 16.59 CL CL A 382 A 531 ARG A 202 ARG^? 19.65 CL CL A 384 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -35.93 61.76 109.91 -34.52 61.40 112.61 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -29.69 53.68 115.80 -29.91 52.24 114.24 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -32.39 54.22 100.96 -34.65 53.06 99.24 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 A 325 ARG B 77 ARG^? 27.48 CL CL B 383 A 342 ASP B 53 ASP.? 25.44 CL CL B 384 A 531 ARG B 85 ARG^? 26.72 CL CL B 382 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -35.60 30.51 80.72 -37.43 31.47 83.02 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -37.14 32.94 67.80 -35.44 31.68 68.05 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -45.61 37.84 80.13 -46.20 40.84 79.69 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 5 3 # 5 A 325 ARG B 193 ARG.? 19.02 CL CL A 384 A 342 ASP A 327 ASP.? 19.04 CL CL A 384 A 531 ARG B 202 ARG^? 25.52 CL CL B 383 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -14.12 50.83 106.82 -12.70 50.89 109.57 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -25.74 49.77 105.10 -27.34 48.80 104.08 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -17.65 42.54 97.41 -16.79 41.14 100.03 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 6 3 # 6 A 325 ARG B 334 ARG^? 9.65 CL CL B 383 A 342 ASP B 26 ASP^? 16.51 CL CL B 383 A 531 ARG B 202 ARG^? 25.52 CL CL B 383 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -12.53 38.39 87.32 -14.06 38.36 84.61 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -23.45 39.33 83.60 -24.23 39.48 85.53 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -17.65 42.54 97.41 -16.79 41.14 100.03 1asy_c01 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 6 hits 1asy_c01 naa= 3 ULMN 3 1avf_c04 GASTRICSIN user 1 3 # 1 A 32 ASP A 28 ASP^? 9.02 CL CL A 382 A 35 SER A 29 SER^? 6.92 CL CL A 382 A 217 ASP A 93 ASP^? 5.15 CL CL A 382 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -32.19 59.08 116.32 -33.48 59.98 114.85 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -31.31 63.66 116.96 -29.07 63.86 117.79 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1avf_c04 GASTRICSIN user 2 3 # 2 A 32 ASP A 28 ASP^? 9.02 CL CL A 382 A 35 SER A 37 SER^? 9.11 CL CL A 382 A 217 ASP A 30 ASP^? -6.81 CL CL A 382s coo -10.06 2.54 49.69 -8.83 3.73 50.96 -32.19 59.08 116.32 -33.48 59.98 114.85 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -31.72 58.75 121.63 -33.32 57.82 120.12 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1avf_c04 GASTRICSIN user 3 3 # 3 A 32 ASP A 28 ASP^? 9.02 CL CL A 382 A 35 SER A 37 SER^? 9.11 CL CL A 382 A 217 ASP A 39 ASP^? 16.51 CL CL A 382 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -32.19 59.08 116.32 -33.48 59.98 114.85 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -31.72 58.75 121.63 -33.32 57.82 120.12 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1avf_c04 GASTRICSIN user 4 3 # 4 A 32 ASP A 36 ASP.? -3.33 CL CL A 382s A 35 SER A 37 SER^? 9.11 CL CL A 382 A 217 ASP A 30 ASP^? -6.81 CL CL A 382s coo -10.06 2.54 49.69 -8.83 3.73 50.96 -31.47 63.24 120.93 -31.90 65.07 119.91 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -31.72 58.75 121.63 -33.32 57.82 120.12 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1avf_c04 GASTRICSIN user 5 3 # 5 A 32 ASP A 195 ASP.? 13.29 CL CL A 384 A 35 SER A 192 SER.? 15.36 CL CL A 384 A 217 ASP A 306 ASP.? 16.66 CL CL A 384 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -22.13 62.52 88.27 -20.53 63.80 88.70 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -26.48 60.82 89.96 -25.15 61.33 88.02 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -29.63 66.56 87.01 -28.35 68.29 87.20 ULMN 3 1avf_c04 GASTRICSIN user 6 3 # 6 A 32 ASP B 28 ASP^? 9.00 CL CL B 383 A 35 SER B 29 SER^? 6.98 CL CL B 383 A 217 ASP B 93 ASP^? 5.22 CL CL B 383 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -18.06 38.42 81.61 -16.37 38.03 82.88 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -14.55 40.12 78.88 -15.61 41.67 77.42 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1avf_c04 GASTRICSIN user 7 3 # 7 A 32 ASP B 28 ASP^? 9.00 CL CL B 383 A 35 SER B 37 SER^? 9.16 CL CL B 383 A 217 ASP B 30 ASP^? -6.72 CL CL B 383s coo -10.06 2.54 49.69 -8.83 3.73 50.96 -18.06 38.42 81.61 -16.37 38.03 82.88 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -19.96 36.46 76.97 -19.82 35.54 79.16 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1avf_c04 GASTRICSIN user 8 3 # 8 A 32 ASP B 28 ASP^? 9.00 CL CL B 383 A 35 SER B 37 SER^? 9.16 CL CL B 383 A 217 ASP B 39 ASP^? 17.51 CL CL B 383 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -18.06 38.42 81.61 -16.37 38.03 82.88 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -19.96 36.46 76.97 -19.82 35.54 79.16 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -26.18 36.85 80.53 -27.97 36.10 81.34 ULMN 3 1avf_c04 GASTRICSIN user 9 3 # 9 A 32 ASP B 36 ASP.? -3.35 CL CL B 383s A 35 SER B 37 SER^? 9.16 CL CL B 383 A 217 ASP B 30 ASP^? -6.72 CL CL B 383s coo -10.06 2.54 49.69 -8.83 3.73 50.96 -15.98 38.04 75.83 -14.00 38.51 76.08 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -19.96 36.46 76.97 -19.82 35.54 79.16 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1avf_c04 GASTRICSIN user 10 3 # 10 A 32 ASP B 195 ASP.? 10.47 CL CL A 384 A 35 SER B 192 SER.? 13.26 CL CL A 384 A 217 ASP B 306 ASP.? 19.57 CL CL A 384 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -11.82 59.91 101.57 -11.61 61.10 99.82 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -11.80 54.65 102.27 -11.20 56.97 103.08 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -4.64 54.84 103.01 -3.71 56.24 101.58 1avf_c04 source 1avf GASTRICSIN : 10 hits 1avf_c04 naa= 3 ULMN 3 1avf_c05 GASTRICSIN user 1 3 # 1 J 32 ASP A 28 ASP^? 9.02 CL CL A 382 J 35 SER A 29 SER^? 6.92 CL CL A 382 J 217 ASP A 26 ASP^? 16.59 CL CL A 382 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -32.19 59.08 116.32 -33.48 59.98 114.85 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -31.31 63.66 116.96 -29.07 63.86 117.79 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1avf_c05 GASTRICSIN user 2 3 # 2 J 32 ASP A 28 ASP^? 9.02 CL CL A 382 J 35 SER A 37 SER^? 9.11 CL CL A 382 J 217 ASP A 26 ASP^? 16.59 CL CL A 382 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -32.19 59.08 116.32 -33.48 59.98 114.85 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -31.72 58.75 121.63 -33.32 57.82 120.12 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1avf_c05 GASTRICSIN user 3 3 # 3 J 32 ASP A 28 ASP^? 9.02 CL CL A 382 J 35 SER A 37 SER^? 9.11 CL CL A 382 J 217 ASP A 30 ASP^? -6.81 CL CL A 382s coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -32.19 59.08 116.32 -33.48 59.98 114.85 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -31.72 58.75 121.63 -33.32 57.82 120.12 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1avf_c05 GASTRICSIN user 4 3 # 4 J 32 ASP A 28 ASP^? 9.02 CL CL A 382 J 35 SER A 37 SER^? 9.11 CL CL A 382 J 217 ASP A 39 ASP^? 16.51 CL CL A 382 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -32.19 59.08 116.32 -33.48 59.98 114.85 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -31.72 58.75 121.63 -33.32 57.82 120.12 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1avf_c05 GASTRICSIN user 5 3 # 5 J 32 ASP A 36 ASP.? -3.33 CL CL A 382s J 35 SER A 37 SER^? 9.11 CL CL A 382 J 217 ASP A 30 ASP^? -6.81 CL CL A 382s coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -31.47 63.24 120.93 -31.90 65.07 119.91 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -31.72 58.75 121.63 -33.32 57.82 120.12 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1avf_c05 GASTRICSIN user 6 3 # 6 J 32 ASP A 195 ASP.? 13.29 CL CL A 384 J 35 SER A 192 SER.? 15.36 CL CL A 384 J 217 ASP A 306 ASP.? 16.66 CL CL A 384 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -22.13 62.52 88.27 -20.53 63.80 88.70 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -26.48 60.82 89.96 -25.15 61.33 88.02 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -29.63 66.56 87.01 -28.35 68.29 87.20 ULMN 3 1avf_c05 GASTRICSIN user 7 3 # 7 J 32 ASP B 28 ASP^? 9.00 CL CL B 383 J 35 SER B 37 SER^? 9.16 CL CL B 383 J 217 ASP B 30 ASP^? -6.72 CL CL B 383s coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -18.06 38.42 81.61 -16.37 38.03 82.88 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -19.96 36.46 76.97 -19.82 35.54 79.16 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1avf_c05 GASTRICSIN user 8 3 # 8 J 32 ASP B 28 ASP^? 9.00 CL CL B 383 J 35 SER B 37 SER^? 9.16 CL CL B 383 J 217 ASP B 39 ASP^? 17.51 CL CL B 383 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -18.06 38.42 81.61 -16.37 38.03 82.88 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -19.96 36.46 76.97 -19.82 35.54 79.16 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -26.18 36.85 80.53 -27.97 36.10 81.34 ULMN 3 1avf_c05 GASTRICSIN user 9 3 # 9 J 32 ASP B 36 ASP.? -3.35 CL CL B 383s J 35 SER B 37 SER^? 9.16 CL CL B 383 J 217 ASP B 30 ASP^? -6.72 CL CL B 383s coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -15.98 38.04 75.83 -14.00 38.51 76.08 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -19.96 36.46 76.97 -19.82 35.54 79.16 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1avf_c05 GASTRICSIN user 10 3 # 10 J 32 ASP B 195 ASP.? 10.47 CL CL A 384 J 35 SER B 192 SER.? 13.26 CL CL A 384 J 217 ASP B 306 ASP.? 19.57 CL CL A 384 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -11.82 59.91 101.57 -11.61 61.10 99.82 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -11.80 54.65 102.27 -11.20 56.97 103.08 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -4.64 54.84 103.01 -3.71 56.24 101.58 1avf_c05 source 1avf GASTRICSIN : 10 hits 1avf_c05 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE A 31 PHE.? 7.34 CL CL A 382 A 223 ASP A 93 ASP^? 5.15 CL CL A 382 A 265 LYS A 128 LYS.? 19.46 CL CL A 382 coo 39.74 52.86 65.74 41.15 55.14 66.52 -34.44 71.03 115.62 -32.10 72.45 115.10 coo 30.70 47.50 67.53 29.83 49.47 67.39 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 19.99 54.53 64.11 20.55 58.78 68.33 -25.12 72.76 133.10 -20.68 68.32 134.09 ULMN 3 1ax4_c04 TRYPTOPHANASE user 2 3 # 2 A 130 PHE A 213 PHE.? 23.30 CL CL A 383 A 223 ASP A 208 ASP.? 21.85 CL CL A 382 A 265 LYS A 336 LYS^? 14.72 CL CL A 382 coo 39.74 52.86 65.74 41.15 55.14 66.52 -56.84 71.96 107.29 -56.22 69.93 109.07 coo 30.70 47.50 67.53 29.83 49.47 67.39 -48.25 63.81 104.00 -49.74 63.21 105.24 coo 19.99 54.53 64.11 20.55 58.78 68.33 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1ax4_c04 TRYPTOPHANASE user 3 3 # 3 A 130 PHE A 213 PHE.? 23.30 CL CL A 383 A 223 ASP A 272 ASP~? 14.48 CL CL A 382 A 265 LYS A 336 LYS^? 14.72 CL CL A 382 coo 39.74 52.86 65.74 41.15 55.14 66.52 -56.84 71.96 107.29 -56.22 69.93 109.07 coo 30.70 47.50 67.53 29.83 49.47 67.39 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 19.99 54.53 64.11 20.55 58.78 68.33 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1ax4_c04 TRYPTOPHANASE user 4 3 # 4 A 130 PHE A 321 PHE^? 13.33 CL CL A 384 A 223 ASP A 30 ASP^? -6.81 CL CL A 382s A 265 LYS A 336 LYS^? 14.72 CL CL A 382 coo 39.74 52.86 65.74 41.15 55.14 66.52 -24.41 60.10 113.58 -23.51 62.82 113.64 coo 30.70 47.50 67.53 29.83 49.47 67.39 -35.52 64.63 115.87 -36.96 65.19 114.43 coo 19.99 54.53 64.11 20.55 58.78 68.33 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1ax4_c04 TRYPTOPHANASE user 5 3 # 5 A 130 PHE B 31 PHE.? 7.44 CL CL B 383 A 223 ASP B 93 ASP^? 5.22 CL CL B 383 A 265 LYS B 128 LYS.? 19.37 CL CL B 383 coo 39.74 52.86 65.74 41.15 55.14 66.52 -6.42 39.91 78.10 -6.19 42.61 77.46 coo 30.70 47.50 67.53 29.83 49.47 67.39 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 19.99 54.53 64.11 20.55 58.78 68.33 -13.49 41.25 59.55 -18.50 40.98 58.08 ULMN 3 1ax4_c04 TRYPTOPHANASE user 6 3 # 6 A 130 PHE B 31 PHE.? 7.44 CL CL B 383 A 223 ASP B 272 ASP~? 14.11 CL CL B 383 A 265 LYS B 264 LYS~? 21.76 CL CL B 383 coo 39.74 52.86 65.74 41.15 55.14 66.52 -6.42 39.91 78.10 -6.19 42.61 77.46 coo 30.70 47.50 67.53 29.83 49.47 67.39 0.88 31.47 82.51 1.09 32.47 80.67 coo 19.99 54.53 64.11 20.55 58.78 68.33 11.01 31.36 75.69 9.79 34.42 71.26 ULMN 3 1ax4_c04 TRYPTOPHANASE user 7 3 # 7 A 130 PHE B 213 PHE.? 22.76 CL CL B 384 A 223 ASP B 208 ASP.? 21.56 CL CL B 383 A 265 LYS B 336 LYS^? 14.66 CL CL B 383 coo 39.74 52.86 65.74 41.15 55.14 66.52 5.57 24.21 90.55 3.01 23.56 89.66 coo 30.70 47.50 67.53 29.83 49.47 67.39 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 19.99 54.53 64.11 20.55 58.78 68.33 -3.40 41.24 88.18 -4.83 35.96 88.60 ULMN 3 1ax4_c04 TRYPTOPHANASE user 8 3 # 8 A 130 PHE B 213 PHE.? 22.76 CL CL B 384 A 223 ASP B 272 ASP~? 14.11 CL CL B 383 A 265 LYS B 336 LYS^? 14.66 CL CL B 383 coo 39.74 52.86 65.74 41.15 55.14 66.52 5.57 24.21 90.55 3.01 23.56 89.66 coo 30.70 47.50 67.53 29.83 49.47 67.39 0.88 31.47 82.51 1.09 32.47 80.67 coo 19.99 54.53 64.11 20.55 58.78 68.33 -3.40 41.24 88.18 -4.83 35.96 88.60 ULMN 3 1ax4_c04 TRYPTOPHANASE user 9 3 # 9 A 130 PHE B 321 PHE^? 14.03 CL CL B 383 A 223 ASP B 30 ASP^? -6.72 CL CL B 383s A 265 LYS B 336 LYS^? 14.66 CL CL B 383 coo 39.74 52.86 65.74 41.15 55.14 66.52 -19.61 46.45 81.53 -17.64 47.96 80.19 coo 30.70 47.50 67.53 29.83 49.47 67.39 -11.77 37.20 80.70 -10.35 36.55 82.15 coo 19.99 54.53 64.11 20.55 58.78 68.33 -3.40 41.24 88.18 -4.83 35.96 88.60 1ax4_c04 source 1ax4 TRYPTOPHANASE : 9 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE A 31 PHE.? 7.34 CL CL A 382 B 223 ASP A 93 ASP^? 5.15 CL CL A 382 B 265 LYS A 128 LYS.? 19.46 CL CL A 382 coo 7.48 54.94 99.62 7.67 52.27 100.42 -34.44 71.03 115.62 -32.10 72.45 115.10 coo 10.43 61.66 91.81 9.80 60.04 90.61 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 5.43 58.06 80.08 8.57 53.00 79.37 -25.12 72.76 133.10 -20.68 68.32 134.09 ULMN 3 1ax4_c05 TRYPTOPHANASE user 2 3 # 2 B 130 PHE A 213 PHE.? 23.30 CL CL A 383 B 223 ASP A 208 ASP.? 21.85 CL CL A 382 B 265 LYS A 336 LYS^? 14.72 CL CL A 382 coo 7.48 54.94 99.62 7.67 52.27 100.42 -56.84 71.96 107.29 -56.22 69.93 109.07 coo 10.43 61.66 91.81 9.80 60.04 90.61 -48.25 63.81 104.00 -49.74 63.21 105.24 coo 5.43 58.06 80.08 8.57 53.00 79.37 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1ax4_c05 TRYPTOPHANASE user 3 3 # 3 B 130 PHE A 213 PHE.? 23.30 CL CL A 383 B 223 ASP A 272 ASP~? 14.48 CL CL A 382 B 265 LYS A 336 LYS^? 14.72 CL CL A 382 coo 7.48 54.94 99.62 7.67 52.27 100.42 -56.84 71.96 107.29 -56.22 69.93 109.07 coo 10.43 61.66 91.81 9.80 60.04 90.61 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 5.43 58.06 80.08 8.57 53.00 79.37 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1ax4_c05 TRYPTOPHANASE user 4 3 # 4 B 130 PHE A 321 PHE^? 13.33 CL CL A 384 B 223 ASP A 30 ASP^? -6.81 CL CL A 382s B 265 LYS A 336 LYS^? 14.72 CL CL A 382 coo 7.48 54.94 99.62 7.67 52.27 100.42 -24.41 60.10 113.58 -23.51 62.82 113.64 coo 10.43 61.66 91.81 9.80 60.04 90.61 -35.52 64.63 115.87 -36.96 65.19 114.43 coo 5.43 58.06 80.08 8.57 53.00 79.37 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1ax4_c05 TRYPTOPHANASE user 5 3 # 5 B 130 PHE B 31 PHE.? 7.44 CL CL B 383 B 223 ASP B 93 ASP^? 5.22 CL CL B 383 B 265 LYS B 128 LYS.? 19.37 CL CL B 383 coo 7.48 54.94 99.62 7.67 52.27 100.42 -6.42 39.91 78.10 -6.19 42.61 77.46 coo 10.43 61.66 91.81 9.80 60.04 90.61 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 5.43 58.06 80.08 8.57 53.00 79.37 -13.49 41.25 59.55 -18.50 40.98 58.08 ULMN 3 1ax4_c05 TRYPTOPHANASE user 6 3 # 6 B 130 PHE B 31 PHE.? 7.44 CL CL B 383 B 223 ASP B 272 ASP~? 14.11 CL CL B 383 B 265 LYS B 264 LYS~? 21.76 CL CL B 383 coo 7.48 54.94 99.62 7.67 52.27 100.42 -6.42 39.91 78.10 -6.19 42.61 77.46 coo 10.43 61.66 91.81 9.80 60.04 90.61 0.88 31.47 82.51 1.09 32.47 80.67 coo 5.43 58.06 80.08 8.57 53.00 79.37 11.01 31.36 75.69 9.79 34.42 71.26 ULMN 3 1ax4_c05 TRYPTOPHANASE user 7 3 # 7 B 130 PHE B 213 PHE.? 22.76 CL CL B 384 B 223 ASP B 208 ASP.? 21.56 CL CL B 383 B 265 LYS B 336 LYS^? 14.66 CL CL B 383 coo 7.48 54.94 99.62 7.67 52.27 100.42 5.57 24.21 90.55 3.01 23.56 89.66 coo 10.43 61.66 91.81 9.80 60.04 90.61 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 5.43 58.06 80.08 8.57 53.00 79.37 -3.40 41.24 88.18 -4.83 35.96 88.60 ULMN 3 1ax4_c05 TRYPTOPHANASE user 8 3 # 8 B 130 PHE B 213 PHE.? 22.76 CL CL B 384 B 223 ASP B 272 ASP~? 14.11 CL CL B 383 B 265 LYS B 336 LYS^? 14.66 CL CL B 383 coo 7.48 54.94 99.62 7.67 52.27 100.42 5.57 24.21 90.55 3.01 23.56 89.66 coo 10.43 61.66 91.81 9.80 60.04 90.61 0.88 31.47 82.51 1.09 32.47 80.67 coo 5.43 58.06 80.08 8.57 53.00 79.37 -3.40 41.24 88.18 -4.83 35.96 88.60 ULMN 3 1ax4_c05 TRYPTOPHANASE user 9 3 # 9 B 130 PHE B 321 PHE^? 14.03 CL CL B 383 B 223 ASP B 30 ASP^? -6.72 CL CL B 383s B 265 LYS B 336 LYS^? 14.66 CL CL B 383 coo 7.48 54.94 99.62 7.67 52.27 100.42 -19.61 46.45 81.53 -17.64 47.96 80.19 coo 10.43 61.66 91.81 9.80 60.04 90.61 -11.77 37.20 80.70 -10.35 36.55 82.15 coo 5.43 58.06 80.08 8.57 53.00 79.37 -3.40 41.24 88.18 -4.83 35.96 88.60 1ax4_c05 source 1ax4 TRYPTOPHANASE : 9 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE A 31 PHE.? 7.34 CL CL A 382 C 223 ASP A 93 ASP^? 5.15 CL CL A 382 C 265 LYS A 128 LYS.? 19.46 CL CL A 382 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -34.44 71.03 115.62 -32.10 72.45 115.10 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -30.23 63.77 124.99 -32.09 64.66 124.54 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -25.12 72.76 133.10 -20.68 68.32 134.09 ULMN 3 1ax4_c06 TRYPTOPHANASE user 2 3 # 2 C 130 PHE A 213 PHE.? 23.30 CL CL A 383 C 223 ASP A 208 ASP.? 21.85 CL CL A 382 C 265 LYS A 336 LYS^? 14.72 CL CL A 382 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -56.84 71.96 107.29 -56.22 69.93 109.07 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -48.25 63.81 104.00 -49.74 63.21 105.24 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1ax4_c06 TRYPTOPHANASE user 3 3 # 3 C 130 PHE A 213 PHE.? 23.30 CL CL A 383 C 223 ASP A 272 ASP~? 14.48 CL CL A 382 C 265 LYS A 336 LYS^? 14.72 CL CL A 382 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -56.84 71.96 107.29 -56.22 69.93 109.07 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -46.67 73.24 112.92 -45.43 74.19 114.38 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1ax4_c06 TRYPTOPHANASE user 4 3 # 4 C 130 PHE A 321 PHE^? 13.33 CL CL A 384 C 223 ASP A 30 ASP^? -6.81 CL CL A 382s C 265 LYS A 336 LYS^? 14.72 CL CL A 382 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -24.41 60.10 113.58 -23.51 62.82 113.64 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -35.52 64.63 115.87 -36.96 65.19 114.43 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1ax4_c06 TRYPTOPHANASE user 5 3 # 5 C 130 PHE B 31 PHE.? 7.44 CL CL B 383 C 223 ASP B 93 ASP^? 5.22 CL CL B 383 C 265 LYS B 128 LYS.? 19.37 CL CL B 383 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -6.42 39.91 78.10 -6.19 42.61 77.46 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -17.13 37.76 71.68 -15.50 36.45 72.23 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -13.49 41.25 59.55 -18.50 40.98 58.08 ULMN 3 1ax4_c06 TRYPTOPHANASE user 6 3 # 6 C 130 PHE B 31 PHE.? 7.44 CL CL B 383 C 223 ASP B 272 ASP~? 14.11 CL CL B 383 C 265 LYS B 264 LYS~? 21.76 CL CL B 383 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -6.42 39.91 78.10 -6.19 42.61 77.46 coo -9.52 75.74 33.62 -8.85 73.74 33.93 0.88 31.47 82.51 1.09 32.47 80.67 coo -4.44 67.20 42.32 -7.50 62.41 40.49 11.01 31.36 75.69 9.79 34.42 71.26 ULMN 3 1ax4_c06 TRYPTOPHANASE user 7 3 # 7 C 130 PHE B 213 PHE.? 22.76 CL CL B 384 C 223 ASP B 208 ASP.? 21.56 CL CL B 383 C 265 LYS B 336 LYS^? 14.66 CL CL B 383 coo -6.55 73.45 23.60 -6.77 71.48 21.66 5.57 24.21 90.55 3.01 23.56 89.66 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -4.03 30.56 94.79 -4.11 28.51 94.21 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -3.40 41.24 88.18 -4.83 35.96 88.60 ULMN 3 1ax4_c06 TRYPTOPHANASE user 8 3 # 8 C 130 PHE B 213 PHE.? 22.76 CL CL B 384 C 223 ASP B 272 ASP~? 14.11 CL CL B 383 C 265 LYS B 336 LYS^? 14.66 CL CL B 383 coo -6.55 73.45 23.60 -6.77 71.48 21.66 5.57 24.21 90.55 3.01 23.56 89.66 coo -9.52 75.74 33.62 -8.85 73.74 33.93 0.88 31.47 82.51 1.09 32.47 80.67 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -3.40 41.24 88.18 -4.83 35.96 88.60 ULMN 3 1ax4_c06 TRYPTOPHANASE user 9 3 # 9 C 130 PHE B 321 PHE^? 14.03 CL CL B 383 C 223 ASP B 30 ASP^? -6.72 CL CL B 383s C 265 LYS B 336 LYS^? 14.66 CL CL B 383 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -19.61 46.45 81.53 -17.64 47.96 80.19 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -11.77 37.20 80.70 -10.35 36.55 82.15 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -3.40 41.24 88.18 -4.83 35.96 88.60 1ax4_c06 source 1ax4 TRYPTOPHANASE : 9 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE A 31 PHE.? 7.34 CL CL A 382 D 223 ASP A 93 ASP^? 5.15 CL CL A 382 D 265 LYS A 128 LYS.? 19.46 CL CL A 382 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -34.44 71.03 115.62 -32.10 72.45 115.10 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -30.23 63.77 124.99 -32.09 64.66 124.54 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -25.12 72.76 133.10 -20.68 68.32 134.09 ULMN 3 1ax4_c07 TRYPTOPHANASE user 2 3 # 2 D 130 PHE A 213 PHE.? 23.30 CL CL A 383 D 223 ASP A 208 ASP.? 21.85 CL CL A 382 D 265 LYS A 336 LYS^? 14.72 CL CL A 382 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -56.84 71.96 107.29 -56.22 69.93 109.07 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -48.25 63.81 104.00 -49.74 63.21 105.24 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1ax4_c07 TRYPTOPHANASE user 3 3 # 3 D 130 PHE A 213 PHE.? 23.30 CL CL A 383 D 223 ASP A 272 ASP~? 14.48 CL CL A 382 D 265 LYS A 336 LYS^? 14.72 CL CL A 382 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -56.84 71.96 107.29 -56.22 69.93 109.07 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -46.67 73.24 112.92 -45.43 74.19 114.38 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1ax4_c07 TRYPTOPHANASE user 4 3 # 4 D 130 PHE A 321 PHE^? 13.33 CL CL A 384 D 223 ASP A 30 ASP^? -6.81 CL CL A 382s D 265 LYS A 336 LYS^? 14.72 CL CL A 382 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -24.41 60.10 113.58 -23.51 62.82 113.64 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -35.52 64.63 115.87 -36.96 65.19 114.43 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1ax4_c07 TRYPTOPHANASE user 5 3 # 5 D 130 PHE B 31 PHE.? 7.44 CL CL B 383 D 223 ASP B 93 ASP^? 5.22 CL CL B 383 D 265 LYS B 128 LYS.? 19.37 CL CL B 383 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -6.42 39.91 78.10 -6.19 42.61 77.46 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -17.13 37.76 71.68 -15.50 36.45 72.23 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -13.49 41.25 59.55 -18.50 40.98 58.08 ULMN 3 1ax4_c07 TRYPTOPHANASE user 6 3 # 6 D 130 PHE B 31 PHE.? 7.44 CL CL B 383 D 223 ASP B 272 ASP~? 14.11 CL CL B 383 D 265 LYS B 264 LYS~? 21.76 CL CL B 383 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -6.42 39.91 78.10 -6.19 42.61 77.46 coo -29.46 51.67 48.51 -28.63 53.31 49.56 0.88 31.47 82.51 1.09 32.47 80.67 coo -18.87 56.53 54.79 -19.47 62.22 53.03 11.01 31.36 75.69 9.79 34.42 71.26 ULMN 3 1ax4_c07 TRYPTOPHANASE user 7 3 # 7 D 130 PHE B 213 PHE.? 22.76 CL CL B 384 D 223 ASP B 208 ASP.? 21.56 CL CL B 383 D 265 LYS B 336 LYS^? 14.66 CL CL B 383 coo -38.60 55.38 52.70 -40.06 57.72 53.04 5.57 24.21 90.55 3.01 23.56 89.66 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -4.03 30.56 94.79 -4.11 28.51 94.21 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -3.40 41.24 88.18 -4.83 35.96 88.60 ULMN 3 1ax4_c07 TRYPTOPHANASE user 8 3 # 8 D 130 PHE B 213 PHE.? 22.76 CL CL B 384 D 223 ASP B 272 ASP~? 14.11 CL CL B 383 D 265 LYS B 336 LYS^? 14.66 CL CL B 383 coo -38.60 55.38 52.70 -40.06 57.72 53.04 5.57 24.21 90.55 3.01 23.56 89.66 coo -29.46 51.67 48.51 -28.63 53.31 49.56 0.88 31.47 82.51 1.09 32.47 80.67 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -3.40 41.24 88.18 -4.83 35.96 88.60 ULMN 3 1ax4_c07 TRYPTOPHANASE user 9 3 # 9 D 130 PHE B 321 PHE^? 14.03 CL CL B 383 D 223 ASP B 30 ASP^? -6.72 CL CL B 383s D 265 LYS B 336 LYS^? 14.66 CL CL B 383 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -19.61 46.45 81.53 -17.64 47.96 80.19 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -11.77 37.20 80.70 -10.35 36.55 82.15 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -3.40 41.24 88.18 -4.83 35.96 88.60 1ax4_c07 source 1ax4 TRYPTOPHANASE : 9 hits 1ax4_c07 naa= 3 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 3 # 1 A 140 TRP A 167 TRP^? 7.35 CL CL A 382 A 222 ASP A 93 ASP^? 5.15 CL CL A 382 A 258 LYS A 128 LYS.? 19.46 CL CL A 382 coo 89.83 15.40 0.01 90.61 18.86 1.71 -31.10 71.99 120.30 -32.79 75.13 118.77 coo 82.92 20.43 2.47 84.82 20.45 1.55 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -25.12 72.76 133.10 -20.68 68.32 134.09 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 2 3 # 2 A 140 TRP A 207 TRP^? 23.82 CL CL A 384 A 222 ASP A 208 ASP.? 21.85 CL CL A 382 A 258 LYS A 336 LYS^? 14.72 CL CL A 382 coo 89.83 15.40 0.01 90.61 18.86 1.71 -44.76 66.72 97.91 -42.73 64.04 95.92 coo 82.92 20.43 2.47 84.82 20.45 1.55 -48.25 63.81 104.00 -49.74 63.21 105.24 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 3 3 # 3 A 140 TRP A 273 TRP~? 19.00 CL CL A 383 A 222 ASP A 210 ASP.? 21.69 CL CL A 383 A 258 LYS A 249 LYS^? 20.12 CL CL A 383 coo 89.83 15.40 0.01 90.61 18.86 1.71 -50.89 71.02 111.12 -54.05 73.34 111.49 coo 82.92 20.43 2.47 84.82 20.45 1.55 -52.58 64.68 106.89 -53.21 62.78 107.37 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -61.09 73.36 110.22 -57.90 69.98 113.58 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 4 3 # 4 A 140 TRP A 341 TRP.? 10.34 CL CL A 382 A 222 ASP A 344 ASP.? 20.56 CL CL A 382 A 258 LYS A 133 LYS^? 12.95 CL CL A 382 coo 89.83 15.40 0.01 90.61 18.86 1.71 -39.95 74.25 113.33 -36.58 74.16 115.41 coo 82.92 20.43 2.47 84.82 20.45 1.55 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -30.69 80.61 120.28 -26.75 77.00 119.43 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 5 3 # 5 A 140 TRP B 167 TRP^? 7.30 CL CL B 383 A 222 ASP B 93 ASP^? 5.22 CL CL B 383 A 258 LYS B 128 LYS.? 19.37 CL CL B 383 coo 89.83 15.40 0.01 90.61 18.86 1.71 -8.26 40.92 72.83 -4.37 40.96 73.30 coo 82.92 20.43 2.47 84.82 20.45 1.55 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -13.49 41.25 59.55 -18.50 40.98 58.08 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 6 3 # 6 A 140 TRP B 207 TRP^? 25.29 CL CL B 383 A 222 ASP B 208 ASP.? 21.56 CL CL B 383 A 258 LYS B 336 LYS^? 14.66 CL CL B 383 coo 89.83 15.40 0.01 90.61 18.86 1.71 -1.19 37.06 97.92 -3.78 38.84 100.32 coo 82.92 20.43 2.47 84.82 20.45 1.55 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -3.40 41.24 88.18 -4.83 35.96 88.60 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 7 3 # 7 A 140 TRP B 273 TRP~? 18.41 CL CL B 384 A 222 ASP B 210 ASP.? 22.05 CL CL B 384 A 258 LYS B 249 LYS^? 19.48 CL CL B 384 coo 89.83 15.40 0.01 90.61 18.86 1.71 1.07 27.51 86.17 4.21 25.26 85.33 coo 82.92 20.43 2.47 84.82 20.45 1.55 -2.53 25.11 93.69 -2.62 22.87 93.62 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 7.49 19.68 88.46 2.17 20.34 86.44 ULMN 3 1ay4_c02 AROMATIC AMINO ACID AMINOTRANSFERASEuser 8 3 # 8 A 140 TRP B 341 TRP.? 10.39 CL CL B 383 A 222 ASP B 344 ASP.? 20.04 CL CL B 383 A 258 LYS B 133 LYS^? 13.08 CL CL B 383 coo 89.83 15.40 0.01 90.61 18.86 1.71 -0.76 36.74 80.33 -2.75 38.82 77.66 coo 82.92 20.43 2.47 84.82 20.45 1.55 7.59 38.09 74.22 8.59 36.72 75.50 coo 89.09 24.00 -8.81 89.39 20.33 -4.16 -0.84 43.73 69.01 -5.56 47.16 71.00 1ay4_c02 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 8 hits 1ay4_c02 naa= 3 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 3 # 1 B 140 TRP A 167 TRP^? 7.35 CL CL A 382 B 222 ASP A 93 ASP^? 5.15 CL CL A 382 B 258 LYS A 128 LYS.? 19.46 CL CL A 382 coo 103.45 44.39 16.20 102.66 41.02 14.32 -31.10 71.99 120.30 -32.79 75.13 118.77 coo 110.10 38.66 15.58 108.40 39.41 14.53 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 107.51 45.54 4.76 105.41 44.51 10.25 -25.12 72.76 133.10 -20.68 68.32 134.09 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 2 3 # 2 B 140 TRP A 207 TRP^? 23.82 CL CL A 384 B 222 ASP A 208 ASP.? 21.85 CL CL A 382 B 258 LYS A 336 LYS^? 14.72 CL CL A 382 coo 103.45 44.39 16.20 102.66 41.02 14.32 -44.76 66.72 97.91 -42.73 64.04 95.92 coo 110.10 38.66 15.58 108.40 39.41 14.53 -48.25 63.81 104.00 -49.74 63.21 105.24 coo 107.51 45.54 4.76 105.41 44.51 10.25 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 3 3 # 3 B 140 TRP A 273 TRP~? 19.00 CL CL A 383 B 222 ASP A 210 ASP.? 21.69 CL CL A 383 B 258 LYS A 249 LYS^? 20.12 CL CL A 383 coo 103.45 44.39 16.20 102.66 41.02 14.32 -50.89 71.02 111.12 -54.05 73.34 111.49 coo 110.10 38.66 15.58 108.40 39.41 14.53 -52.58 64.68 106.89 -53.21 62.78 107.37 coo 107.51 45.54 4.76 105.41 44.51 10.25 -61.09 73.36 110.22 -57.90 69.98 113.58 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 4 3 # 4 B 140 TRP A 341 TRP.? 10.34 CL CL A 382 B 222 ASP A 272 ASP~? 14.48 CL CL A 382 B 258 LYS A 264 LYS~? 22.00 CL CL A 382 coo 103.45 44.39 16.20 102.66 41.02 14.32 -39.95 74.25 113.33 -36.58 74.16 115.41 coo 110.10 38.66 15.58 108.40 39.41 14.53 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 107.51 45.54 4.76 105.41 44.51 10.25 -48.92 85.08 115.29 -44.06 86.61 118.76 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 5 3 # 5 B 140 TRP A 341 TRP.? 10.34 CL CL A 382 B 222 ASP A 344 ASP.? 20.56 CL CL A 382 B 258 LYS A 133 LYS^? 12.95 CL CL A 382 coo 103.45 44.39 16.20 102.66 41.02 14.32 -39.95 74.25 113.33 -36.58 74.16 115.41 coo 110.10 38.66 15.58 108.40 39.41 14.53 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 107.51 45.54 4.76 105.41 44.51 10.25 -30.69 80.61 120.28 -26.75 77.00 119.43 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 6 3 # 6 B 140 TRP B 207 TRP^? 25.29 CL CL B 383 B 222 ASP B 208 ASP.? 21.56 CL CL B 383 B 258 LYS B 336 LYS^? 14.66 CL CL B 383 coo 103.45 44.39 16.20 102.66 41.02 14.32 -1.19 37.06 97.92 -3.78 38.84 100.32 coo 110.10 38.66 15.58 108.40 39.41 14.53 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 107.51 45.54 4.76 105.41 44.51 10.25 -3.40 41.24 88.18 -4.83 35.96 88.60 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 7 3 # 7 B 140 TRP B 273 TRP~? 18.41 CL CL B 384 B 222 ASP B 210 ASP.? 22.05 CL CL B 384 B 258 LYS B 249 LYS^? 19.48 CL CL B 384 coo 103.45 44.39 16.20 102.66 41.02 14.32 1.07 27.51 86.17 4.21 25.26 85.33 coo 110.10 38.66 15.58 108.40 39.41 14.53 -2.53 25.11 93.69 -2.62 22.87 93.62 coo 107.51 45.54 4.76 105.41 44.51 10.25 7.49 19.68 88.46 2.17 20.34 86.44 ULMN 3 1ay4_c03 AROMATIC AMINO ACID AMINOTRANSFERASEuser 8 3 # 8 B 140 TRP B 341 TRP.? 10.39 CL CL B 383 B 222 ASP B 344 ASP.? 20.04 CL CL B 383 B 258 LYS B 133 LYS^? 13.08 CL CL B 383 coo 103.45 44.39 16.20 102.66 41.02 14.32 -0.76 36.74 80.33 -2.75 38.82 77.66 coo 110.10 38.66 15.58 108.40 39.41 14.53 7.59 38.09 74.22 8.59 36.72 75.50 coo 107.51 45.54 4.76 105.41 44.51 10.25 -0.84 43.73 69.01 -5.56 47.16 71.00 1ay4_c03 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 8 hits 1ay4_c03 naa= 3 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 1 3 # 1 A 85 HIS A 78 HIS^? 30.68 CL CL A 382 A 171 ARG A 325 ARG.? 29.26 CL CL A 384 A 190 LYS A 80 LYS^? 36.93 CL CL A 382 coo 22.59 2.26 43.22 21.17 3.47 42.27 -24.82 39.60 128.09 -23.39 38.20 127.48 coo 13.63 3.81 28.83 14.49 2.91 31.59 -22.19 42.21 111.60 -22.86 39.29 112.51 coo 24.97 7.47 37.69 21.24 10.69 35.89 -26.02 34.53 124.81 -22.64 33.14 129.86 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 2 3 # 2 A 85 HIS A 287 HIS.? 12.74 CL CL A 384 A 171 ARG B 197 ARG.? 10.56 CL CL A 384 A 190 LYS A 288 LYS.? 12.57 CL CL A 384 coo 22.59 2.26 43.22 21.17 3.47 42.27 -21.23 59.04 111.08 -21.85 57.11 111.58 coo 13.63 3.81 28.83 14.49 2.91 31.59 -11.56 63.68 96.52 -11.06 66.80 96.90 coo 24.97 7.47 37.69 21.24 10.69 35.89 -19.18 64.09 108.25 -14.44 63.70 112.45 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 3 3 # 3 A 85 HIS B 78 HIS^? 26.83 CL CL B 382 A 171 ARG B 24 ARG^? 24.13 CL CL B 382 A 190 LYS B 80 LYS^? 31.45 CL CL B 382 coo 22.59 2.26 43.22 21.17 3.47 42.27 -41.15 34.55 77.14 -42.58 35.82 77.99 coo 13.63 3.81 28.83 14.49 2.91 31.59 -30.86 40.03 86.77 -33.42 38.25 86.47 coo 24.97 7.47 37.69 21.24 10.69 35.89 -43.65 33.60 82.90 -47.69 34.28 78.00 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 4 3 # 4 A 85 HIS B 287 HIS.? 13.85 CL CL B 382 A 171 ARG B 334 ARG^? 9.65 CL CL B 383 A 190 LYS B 288 LYS.? 8.84 CL CL B 382 coo 22.59 2.26 43.22 21.17 3.47 42.27 -21.22 50.04 83.35 -22.70 48.63 83.80 coo 13.63 3.81 28.83 14.49 2.91 31.59 -12.53 38.39 87.32 -14.06 38.36 84.61 coo 24.97 7.47 37.69 21.24 10.69 35.89 -16.76 54.22 83.25 -20.62 56.75 78.99 1azy_c00 source 1azy THYMIDINE PHOSPHORYLASE : 4 hits 1azy_c00 naa= 3 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 1 3 # 1 B 85 HIS A 78 HIS^? 30.68 CL CL A 382 B 171 ARG A 325 ARG.? 29.26 CL CL A 384 B 190 LYS A 80 LYS^? 36.93 CL CL A 382 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -24.82 39.60 128.09 -23.39 38.20 127.48 coo 2.83 4.83 10.84 1.96 4.32 7.97 -22.19 42.21 111.60 -22.86 39.29 112.51 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -26.02 34.53 124.81 -22.64 33.14 129.86 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 2 3 # 2 B 85 HIS A 287 HIS.? 12.74 CL CL A 384 B 171 ARG B 197 ARG.? 10.56 CL CL A 384 B 190 LYS A 288 LYS.? 12.57 CL CL A 384 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -21.23 59.04 111.08 -21.85 57.11 111.58 coo 2.83 4.83 10.84 1.96 4.32 7.97 -11.56 63.68 96.52 -11.06 66.80 96.90 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -19.18 64.09 108.25 -14.44 63.70 112.45 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 3 3 # 3 B 85 HIS B 78 HIS^? 26.83 CL CL B 382 B 171 ARG B 24 ARG^? 24.13 CL CL B 382 B 190 LYS B 80 LYS^? 31.45 CL CL B 382 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -41.15 34.55 77.14 -42.58 35.82 77.99 coo 2.83 4.83 10.84 1.96 4.32 7.97 -30.86 40.03 86.77 -33.42 38.25 86.47 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -43.65 33.60 82.90 -47.69 34.28 78.00 1azy_c01 source 1azy THYMIDINE PHOSPHORYLASE : 3 hits 1azy_c01 naa= 3 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 1 3 # 1 A 133 GLU B 201 GLU^? 17.46 CL CL A 384 B 88 ASP A 257 ASP.? 24.30 CL CL A 383 B 89 HIS A 223 HIS.? 29.08 CL CL A 383 coo 44.53 38.98 5.35 43.53 40.60 6.22 -19.06 50.53 95.26 -20.94 50.61 94.28 coo 58.74 13.49 55.78 58.72 14.38 57.67 -55.05 88.25 125.09 -55.04 86.55 126.35 coo 60.89 12.20 60.42 60.43 13.81 61.68 -56.62 90.70 129.56 -55.95 91.22 131.48 1b66_c00 source 1b66 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE : 1 hits 1b66_c00 naa= 3 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 1 3 # 1 A 133 GLU B 201 GLU^? 17.46 CL CL A 384 B 88 ASP A 257 ASP.? 24.30 CL CL A 383 B 89 HIS A 223 HIS.? 29.08 CL CL A 383 coo 44.53 38.98 5.35 43.53 40.60 6.22 -19.06 50.53 95.26 -20.94 50.61 94.28 coo 58.74 13.49 55.78 58.72 14.38 57.67 -55.05 88.25 125.09 -55.04 86.55 126.35 coo 60.89 12.20 60.42 60.43 13.81 61.68 -56.62 90.70 129.56 -55.95 91.22 131.48 1b66_c02 source 1b66 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE : 1 hits 1b66_c02 naa= 3 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 1 3 # 1 A 18 HIS A 19 HIS^? 24.55 CL CL A 382 A 91 ARG A 13 ARG^? 21.22 CL CL A 382 A 129 SER A 11 SER^? 21.10 CL CL A 382 coo 24.39 47.01 49.70 26.42 47.04 49.21 -17.70 51.01 127.32 -17.43 50.94 129.40 coo 25.98 44.20 42.23 28.53 42.98 43.43 -15.61 60.27 127.72 -14.54 62.09 125.47 coo 30.00 49.76 45.68 28.73 48.72 47.47 -17.58 55.42 121.82 -16.10 56.98 122.78 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 2 3 # 2 A 18 HIS A 78 HIS^? 30.68 CL CL A 382 A 91 ARG A 77 ARG^? 19.95 CL CL A 382 A 129 SER A 88 SER^? 22.34 CL CL A 382 coo 24.39 47.01 49.70 26.42 47.04 49.21 -24.82 39.60 128.09 -23.39 38.20 127.48 coo 25.98 44.20 42.23 28.53 42.98 43.43 -32.32 44.63 125.30 -31.80 47.66 125.44 coo 30.00 49.76 45.68 28.73 48.72 47.47 -26.75 46.25 123.96 -28.99 45.42 123.71 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 3 3 # 3 A 18 HIS A 246 HIS.? 33.92 CL CL A 383 A 91 ARG A 247 ARG.? 25.12 CL CL A 383 A 129 SER A 214 SER.? 31.20 CL CL A 383 coo 24.39 47.01 49.70 26.42 47.04 49.21 -65.97 72.19 102.08 -66.87 73.22 103.68 coo 25.98 44.20 42.23 28.53 42.98 43.43 -59.24 68.01 103.62 -57.26 66.97 105.71 coo 30.00 49.76 45.68 28.73 48.72 47.47 -59.02 74.87 102.57 -61.42 74.47 102.83 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 4 3 # 4 A 18 HIS B 78 HIS^? 26.83 CL CL B 382 A 91 ARG B 77 ARG^? 27.48 CL CL B 383 A 129 SER B 88 SER^? 22.31 CL CL B 383 coo 24.39 47.01 49.70 26.42 47.04 49.21 -41.15 34.55 77.14 -42.58 35.82 77.99 coo 25.98 44.20 42.23 28.53 42.98 43.43 -35.60 30.51 80.72 -37.43 31.47 83.02 coo 30.00 49.76 45.68 28.73 48.72 47.47 -33.45 36.60 78.54 -33.30 34.49 79.66 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 5 3 # 5 A 18 HIS B 246 HIS.? 32.95 CL CL B 384 A 91 ARG B 247 ARG.? 24.65 CL CL B 384 A 129 SER B 214 SER.? 30.49 CL CL B 384 coo 24.39 47.01 49.70 26.42 47.04 49.21 10.60 18.26 97.26 11.24 17.08 95.63 coo 25.98 44.20 42.23 28.53 42.98 43.43 4.27 22.84 96.19 1.85 22.99 94.25 coo 30.00 49.76 45.68 28.73 48.72 47.47 10.35 24.86 94.00 10.52 22.52 94.66 1b6t_c00 source 1b6t PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE : 5 hits 1b6t_c00 naa= 3 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 1 3 # 1 B 18 HIS A 19 HIS^? 24.55 CL CL A 382 B 91 ARG A 13 ARG^? 21.22 CL CL A 382 B 129 SER A 11 SER^? 21.10 CL CL A 382 coo 18.19 17.03 40.71 18.55 17.18 38.64 -17.70 51.01 127.32 -17.43 50.94 129.40 coo 25.60 21.10 38.54 23.57 20.93 36.25 -15.61 60.27 127.72 -14.54 62.09 125.47 coo 21.33 14.29 34.62 19.25 14.88 35.71 -17.58 55.42 121.82 -16.10 56.98 122.78 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 2 3 # 2 B 18 HIS A 246 HIS.? 33.92 CL CL A 383 B 91 ARG A 247 ARG.? 25.12 CL CL A 383 B 129 SER A 214 SER.? 31.20 CL CL A 383 coo 18.19 17.03 40.71 18.55 17.18 38.64 -65.97 72.19 102.08 -66.87 73.22 103.68 coo 25.60 21.10 38.54 23.57 20.93 36.25 -59.24 68.01 103.62 -57.26 66.97 105.71 coo 21.33 14.29 34.62 19.25 14.88 35.71 -59.02 74.87 102.57 -61.42 74.47 102.83 1b6t_c01 source 1b6t PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE : 2 hits 1b6t_c01 naa= 3 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 B 145 TYR A 238 TYR^? 27.75 CL CL A 383 B 230 ASP A 240 ASP.? 30.06 CL CL A 382 B 273 LYS A 249 LYS^? 20.12 CL CL A 383 coo 11.81 13.41 73.03 10.00 13.03 75.12 -54.82 80.30 106.22 -53.19 79.11 104.29 coo 19.17 11.01 76.14 17.26 10.42 76.77 -54.36 78.15 100.29 -55.09 76.20 100.68 coo 11.10 2.31 76.60 10.24 7.24 75.62 -61.09 73.36 110.22 -57.90 69.98 113.58 1b8g_c05 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 1 hits 1b8g_c05 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 31 PHE.? 7.34 CL CL A 382 A 159 ASP A 180 ASP.? 19.13 CL CL A 382 A 188 LYS A 336 LYS^? 14.72 CL CL A 382 coo 13.91 34.58 14.67 12.95 36.00 12.47 -34.44 71.03 115.62 -32.10 72.45 115.10 coo 20.97 28.40 16.26 20.19 30.15 15.34 -29.53 80.77 112.24 -28.62 82.54 111.55 coo 22.55 41.65 15.60 18.92 37.20 14.63 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE A 97 PHE~? 13.64 CL CL A 383 A 159 ASP A 93 ASP^? 5.15 CL CL A 382 A 188 LYS A 128 LYS.? 19.46 CL CL A 382 coo 13.91 34.58 14.67 12.95 36.00 12.47 -33.26 63.92 133.83 -31.10 62.40 134.75 coo 20.97 28.40 16.26 20.19 30.15 15.34 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 22.55 41.65 15.60 18.92 37.20 14.63 -25.12 72.76 133.10 -20.68 68.32 134.09 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 3 3 # 3 A 88 PHE A 213 PHE.? 23.30 CL CL A 383 A 159 ASP A 240 ASP.? 30.06 CL CL A 382 A 188 LYS A 267 LYS~? 27.66 CL CL A 382 coo 13.91 34.58 14.67 12.95 36.00 12.47 -56.84 71.96 107.29 -56.22 69.93 109.07 coo 20.97 28.40 16.26 20.19 30.15 15.34 -54.36 78.15 100.29 -55.09 76.20 100.68 coo 22.55 41.65 15.60 18.92 37.20 14.63 -49.43 81.28 111.60 -49.39 86.78 108.40 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 4 3 # 4 A 88 PHE B 31 PHE.? 7.44 CL CL B 383 A 159 ASP B 180 ASP.? 19.08 CL CL B 383 A 188 LYS B 336 LYS^? 14.66 CL CL B 383 coo 13.91 34.58 14.67 12.95 36.00 12.47 -6.42 39.91 78.10 -6.19 42.61 77.46 coo 20.97 28.40 16.26 20.19 30.15 15.34 0.82 48.22 75.52 2.17 49.73 74.84 coo 22.55 41.65 15.60 18.92 37.20 14.63 -3.40 41.24 88.18 -4.83 35.96 88.60 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 5 3 # 5 A 88 PHE B 97 PHE~? 13.75 CL CL B 384 A 159 ASP B 93 ASP^? 5.22 CL CL B 383 A 188 LYS B 128 LYS.? 19.37 CL CL B 383 coo 13.91 34.58 14.67 12.95 36.00 12.47 -18.35 31.53 64.75 -20.77 32.66 63.92 coo 20.97 28.40 16.26 20.19 30.15 15.34 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 22.55 41.65 15.60 18.92 37.20 14.63 -13.49 41.25 59.55 -18.50 40.98 58.08 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 6 3 # 6 A 88 PHE B 213 PHE.? 22.76 CL CL B 384 A 159 ASP B 240 ASP.? 29.22 CL CL B 383 A 188 LYS B 267 LYS~? 27.57 CL CL B 383 coo 13.91 34.58 14.67 12.95 36.00 12.47 5.57 24.21 90.55 3.01 23.56 89.66 coo 20.97 28.40 16.26 20.19 30.15 15.34 11.35 28.88 93.27 10.37 30.59 94.07 coo 22.55 41.65 15.60 18.92 37.20 14.63 9.46 31.45 81.02 15.36 33.08 81.01 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 6 hits 1b9h_c02 naa= 3 ULMN 3 1bbs_c06 RENIN user 1 3 # 1 32 ASP A 28 ASP^? 9.02 CL CL A 382 35 SER A 29 SER^? 6.92 CL CL A 382 215 ASP A 26 ASP^? 16.59 CL CL A 382 coo 61.19 45.85 78.73 62.86 45.48 77.48 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 66.00 46.17 80.29 64.31 47.92 79.91 -31.31 63.66 116.96 -29.07 63.86 117.79 coo 63.61 40.10 74.06 64.05 42.07 74.70 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1bbs_c06 RENIN user 2 3 # 2 32 ASP A 28 ASP^? 9.02 CL CL A 382 35 SER A 37 SER^? 9.11 CL CL A 382 215 ASP A 26 ASP^? 16.59 CL CL A 382 coo 61.19 45.85 78.73 62.86 45.48 77.48 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 66.00 46.17 80.29 64.31 47.92 79.91 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 63.61 40.10 74.06 64.05 42.07 74.70 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1bbs_c06 RENIN user 3 3 # 3 32 ASP A 28 ASP^? 9.02 CL CL A 382 35 SER A 37 SER^? 9.11 CL CL A 382 215 ASP A 30 ASP^? -6.81 CL CL A 382s coo 61.19 45.85 78.73 62.86 45.48 77.48 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 66.00 46.17 80.29 64.31 47.92 79.91 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 63.61 40.10 74.06 64.05 42.07 74.70 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1bbs_c06 RENIN user 4 3 # 4 32 ASP A 28 ASP^? 9.02 CL CL A 382 35 SER A 37 SER^? 9.11 CL CL A 382 215 ASP A 39 ASP^? 16.51 CL CL A 382 coo 61.19 45.85 78.73 62.86 45.48 77.48 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 66.00 46.17 80.29 64.31 47.92 79.91 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 63.61 40.10 74.06 64.05 42.07 74.70 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1bbs_c06 RENIN user 5 3 # 5 32 ASP A 36 ASP.? -3.33 CL CL A 382s 35 SER A 37 SER^? 9.11 CL CL A 382 215 ASP A 30 ASP^? -6.81 CL CL A 382s coo 61.19 45.85 78.73 62.86 45.48 77.48 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 66.00 46.17 80.29 64.31 47.92 79.91 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 63.61 40.10 74.06 64.05 42.07 74.70 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1bbs_c06 RENIN user 6 3 # 6 32 ASP A 195 ASP.? 13.29 CL CL A 384 35 SER A 192 SER.? 15.36 CL CL A 384 215 ASP A 306 ASP.? 16.66 CL CL A 384 coo 61.19 45.85 78.73 62.86 45.48 77.48 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 66.00 46.17 80.29 64.31 47.92 79.91 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 63.61 40.10 74.06 64.05 42.07 74.70 -29.63 66.56 87.01 -28.35 68.29 87.20 ULMN 3 1bbs_c06 RENIN user 7 3 # 7 32 ASP B 28 ASP^? 9.00 CL CL B 383 35 SER B 29 SER^? 6.98 CL CL B 383 215 ASP B 26 ASP^? 16.51 CL CL B 383 coo 61.19 45.85 78.73 62.86 45.48 77.48 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 66.00 46.17 80.29 64.31 47.92 79.91 -14.55 40.12 78.88 -15.61 41.67 77.42 coo 63.61 40.10 74.06 64.05 42.07 74.70 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1bbs_c06 RENIN user 8 3 # 8 32 ASP B 28 ASP^? 9.00 CL CL B 383 35 SER B 37 SER^? 9.16 CL CL B 383 215 ASP B 26 ASP^? 16.51 CL CL B 383 coo 61.19 45.85 78.73 62.86 45.48 77.48 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 66.00 46.17 80.29 64.31 47.92 79.91 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 63.61 40.10 74.06 64.05 42.07 74.70 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1bbs_c06 RENIN user 9 3 # 9 32 ASP B 28 ASP^? 9.00 CL CL B 383 35 SER B 37 SER^? 9.16 CL CL B 383 215 ASP B 30 ASP^? -6.72 CL CL B 383s coo 61.19 45.85 78.73 62.86 45.48 77.48 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 66.00 46.17 80.29 64.31 47.92 79.91 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 63.61 40.10 74.06 64.05 42.07 74.70 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1bbs_c06 RENIN user 10 3 # 10 32 ASP B 28 ASP^? 9.00 CL CL B 383 35 SER B 37 SER^? 9.16 CL CL B 383 215 ASP B 39 ASP^? 17.51 CL CL B 383 coo 61.19 45.85 78.73 62.86 45.48 77.48 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 66.00 46.17 80.29 64.31 47.92 79.91 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 63.61 40.10 74.06 64.05 42.07 74.70 -26.18 36.85 80.53 -27.97 36.10 81.34 ULMN 3 1bbs_c06 RENIN user 11 3 # 11 32 ASP B 36 ASP.? -3.35 CL CL B 383s 35 SER B 37 SER^? 9.16 CL CL B 383 215 ASP B 30 ASP^? -6.72 CL CL B 383s coo 61.19 45.85 78.73 62.86 45.48 77.48 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 66.00 46.17 80.29 64.31 47.92 79.91 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 63.61 40.10 74.06 64.05 42.07 74.70 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1bbs_c06 RENIN user 12 3 # 12 32 ASP B 195 ASP.? 10.47 CL CL A 384 35 SER B 192 SER.? 13.26 CL CL A 384 215 ASP B 306 ASP.? 19.57 CL CL A 384 coo 61.19 45.85 78.73 62.86 45.48 77.48 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 66.00 46.17 80.29 64.31 47.92 79.91 -11.80 54.65 102.27 -11.20 56.97 103.08 coo 63.61 40.10 74.06 64.05 42.07 74.70 -4.64 54.84 103.01 -3.71 56.24 101.58 1bbs_c06 source 1bbs RENIN : 12 hits 1bbs_c06 naa= 3 ULMN 3 1bbs_c07 RENIN user 1 3 # 1 32 ASP A 28 ASP^? 9.02 CL CL A 382 35 SER A 29 SER^? 6.92 CL CL A 382 215 ASP A 26 ASP^? 16.59 CL CL A 382 coo 61.19 45.85 78.73 62.86 45.48 77.48 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 66.00 46.17 80.29 64.31 47.92 79.91 -31.31 63.66 116.96 -29.07 63.86 117.79 coo 63.61 40.10 74.06 64.05 42.07 74.70 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1bbs_c07 RENIN user 2 3 # 2 32 ASP A 28 ASP^? 9.02 CL CL A 382 35 SER A 37 SER^? 9.11 CL CL A 382 215 ASP A 26 ASP^? 16.59 CL CL A 382 coo 61.19 45.85 78.73 62.86 45.48 77.48 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 66.00 46.17 80.29 64.31 47.92 79.91 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 63.61 40.10 74.06 64.05 42.07 74.70 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1bbs_c07 RENIN user 3 3 # 3 32 ASP A 28 ASP^? 9.02 CL CL A 382 35 SER A 37 SER^? 9.11 CL CL A 382 215 ASP A 30 ASP^? -6.81 CL CL A 382s coo 61.19 45.85 78.73 62.86 45.48 77.48 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 66.00 46.17 80.29 64.31 47.92 79.91 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 63.61 40.10 74.06 64.05 42.07 74.70 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1bbs_c07 RENIN user 4 3 # 4 32 ASP A 28 ASP^? 9.02 CL CL A 382 35 SER A 37 SER^? 9.11 CL CL A 382 215 ASP A 39 ASP^? 16.51 CL CL A 382 coo 61.19 45.85 78.73 62.86 45.48 77.48 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 66.00 46.17 80.29 64.31 47.92 79.91 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 63.61 40.10 74.06 64.05 42.07 74.70 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1bbs_c07 RENIN user 5 3 # 5 32 ASP A 36 ASP.? -3.33 CL CL A 382s 35 SER A 37 SER^? 9.11 CL CL A 382 215 ASP A 30 ASP^? -6.81 CL CL A 382s coo 61.19 45.85 78.73 62.86 45.48 77.48 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 66.00 46.17 80.29 64.31 47.92 79.91 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 63.61 40.10 74.06 64.05 42.07 74.70 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1bbs_c07 RENIN user 6 3 # 6 32 ASP A 195 ASP.? 13.29 CL CL A 384 35 SER A 192 SER.? 15.36 CL CL A 384 215 ASP A 306 ASP.? 16.66 CL CL A 384 coo 61.19 45.85 78.73 62.86 45.48 77.48 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 66.00 46.17 80.29 64.31 47.92 79.91 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 63.61 40.10 74.06 64.05 42.07 74.70 -29.63 66.56 87.01 -28.35 68.29 87.20 ULMN 3 1bbs_c07 RENIN user 7 3 # 7 32 ASP B 28 ASP^? 9.00 CL CL B 383 35 SER B 29 SER^? 6.98 CL CL B 383 215 ASP B 26 ASP^? 16.51 CL CL B 383 coo 61.19 45.85 78.73 62.86 45.48 77.48 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 66.00 46.17 80.29 64.31 47.92 79.91 -14.55 40.12 78.88 -15.61 41.67 77.42 coo 63.61 40.10 74.06 64.05 42.07 74.70 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1bbs_c07 RENIN user 8 3 # 8 32 ASP B 28 ASP^? 9.00 CL CL B 383 35 SER B 37 SER^? 9.16 CL CL B 383 215 ASP B 26 ASP^? 16.51 CL CL B 383 coo 61.19 45.85 78.73 62.86 45.48 77.48 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 66.00 46.17 80.29 64.31 47.92 79.91 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 63.61 40.10 74.06 64.05 42.07 74.70 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1bbs_c07 RENIN user 9 3 # 9 32 ASP B 28 ASP^? 9.00 CL CL B 383 35 SER B 37 SER^? 9.16 CL CL B 383 215 ASP B 30 ASP^? -6.72 CL CL B 383s coo 61.19 45.85 78.73 62.86 45.48 77.48 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 66.00 46.17 80.29 64.31 47.92 79.91 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 63.61 40.10 74.06 64.05 42.07 74.70 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1bbs_c07 RENIN user 10 3 # 10 32 ASP B 28 ASP^? 9.00 CL CL B 383 35 SER B 37 SER^? 9.16 CL CL B 383 215 ASP B 39 ASP^? 17.51 CL CL B 383 coo 61.19 45.85 78.73 62.86 45.48 77.48 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 66.00 46.17 80.29 64.31 47.92 79.91 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 63.61 40.10 74.06 64.05 42.07 74.70 -26.18 36.85 80.53 -27.97 36.10 81.34 ULMN 3 1bbs_c07 RENIN user 11 3 # 11 32 ASP B 36 ASP.? -3.35 CL CL B 383s 35 SER B 37 SER^? 9.16 CL CL B 383 215 ASP B 30 ASP^? -6.72 CL CL B 383s coo 61.19 45.85 78.73 62.86 45.48 77.48 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 66.00 46.17 80.29 64.31 47.92 79.91 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 63.61 40.10 74.06 64.05 42.07 74.70 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1bbs_c07 RENIN user 12 3 # 12 32 ASP B 195 ASP.? 10.47 CL CL A 384 35 SER B 192 SER.? 13.26 CL CL A 384 215 ASP B 306 ASP.? 19.57 CL CL A 384 coo 61.19 45.85 78.73 62.86 45.48 77.48 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 66.00 46.17 80.29 64.31 47.92 79.91 -11.80 54.65 102.27 -11.20 56.97 103.08 coo 63.61 40.10 74.06 64.05 42.07 74.70 -4.64 54.84 103.01 -3.71 56.24 101.58 1bbs_c07 source 1bbs RENIN : 12 hits 1bbs_c07 naa= 3 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 A 137 ARG A 193 ARG.? 15.01 CL CL B 382 A 141 THR A 194 THR.? 13.30 CL CL B 382 A 235 ASP A 204 ASP^? 18.76 CL CL A 384 coo 6.21 93.81 36.58 4.58 96.33 37.17 -30.19 56.43 87.97 -31.59 55.92 85.25 coo 6.80 92.87 28.33 4.91 92.74 27.40 -23.53 58.32 86.21 -24.61 58.92 84.44 coo 12.98 90.36 47.57 11.26 89.62 46.62 -37.06 58.40 100.88 -36.30 56.45 100.53 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 A 137 ARG A 193 ARG.? 15.01 CL CL B 382 A 141 THR B 329 THR^? 15.42 CL CL B 382 A 235 ASP A 204 ASP^? 18.76 CL CL A 384 coo 6.21 93.81 36.58 4.58 96.33 37.17 -30.19 56.43 87.97 -31.59 55.92 85.25 coo 6.80 92.87 28.33 4.91 92.74 27.40 -24.83 49.33 87.66 -25.34 51.01 86.38 coo 12.98 90.36 47.57 11.26 89.62 46.62 -37.06 58.40 100.88 -36.30 56.45 100.53 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 A 137 ARG A 202 ARG^? 19.65 CL CL A 384 A 141 THR A 281 THR^? 16.66 CL CL A 384 A 235 ASP B 327 ASP.? 22.34 CL CL A 384 coo 6.21 93.81 36.58 4.58 96.33 37.17 -32.39 54.22 100.96 -34.65 53.06 99.24 coo 6.80 92.87 28.33 4.91 92.74 27.40 -34.83 61.90 103.55 -35.70 60.62 105.09 coo 12.98 90.36 47.57 11.26 89.62 46.62 -25.62 46.25 93.54 -25.42 45.53 95.50 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 A 137 ARG A 212 ARG.? 30.01 CL CL A 382 A 141 THR A 242 THR.? 33.58 CL CL A 382 A 235 ASP A 272 ASP~? 14.48 CL CL A 382 coo 6.21 93.81 36.58 4.58 96.33 37.17 -52.31 71.44 100.68 -54.00 71.15 98.10 coo 6.80 92.87 28.33 4.91 92.74 27.40 -55.37 77.04 95.46 -53.34 77.12 94.70 coo 12.98 90.36 47.57 11.26 89.62 46.62 -46.67 73.24 112.92 -45.43 74.19 114.38 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 A 137 ARG A 212 ARG.? 30.01 CL CL A 382 A 141 THR A 244 THR.? 37.53 CL CL A 382 A 235 ASP A 272 ASP~? 14.48 CL CL A 382 coo 6.21 93.81 36.58 4.58 96.33 37.17 -52.31 71.44 100.68 -54.00 71.15 98.10 coo 6.80 92.87 28.33 4.91 92.74 27.40 -60.54 73.51 95.50 -59.95 72.82 93.56 coo 12.98 90.36 47.57 11.26 89.62 46.62 -46.67 73.24 112.92 -45.43 74.19 114.38 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 A 137 ARG A 319 ARG^? 9.49 CL CL A 382 A 141 THR A 331 THR^? 10.31 CL CL A 384 A 235 ASP A 171 ASP.? 13.95 CL CL A 382 coo 6.21 93.81 36.58 4.58 96.33 37.17 -27.23 63.29 112.77 -27.13 63.50 115.87 coo 6.80 92.87 28.33 4.91 92.74 27.40 -26.18 59.17 108.07 -25.19 60.90 109.06 coo 12.98 90.36 47.57 11.26 89.62 46.62 -21.72 70.05 125.28 -22.57 71.99 125.28 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 A 137 ARG A 334 ARG^? 9.67 CL CL A 382 A 141 THR A 279 THR^? 15.90 CL CL A 382 A 235 ASP A 26 ASP^? 16.59 CL CL A 382 coo 6.21 93.81 36.58 4.58 96.33 37.17 -35.93 61.76 109.91 -34.52 61.40 112.61 coo 6.80 92.87 28.33 4.91 92.74 27.40 -40.03 65.40 103.95 -40.07 64.36 105.87 coo 12.98 90.36 47.57 11.26 89.62 46.62 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 A 137 ARG A 334 ARG^? 9.67 CL CL A 382 A 141 THR A 279 THR^? 15.90 CL CL A 382 A 235 ASP A 36 ASP.? -3.33 CL CL A 382s coo 6.21 93.81 36.58 4.58 96.33 37.17 -35.93 61.76 109.91 -34.52 61.40 112.61 coo 6.80 92.87 28.33 4.91 92.74 27.40 -40.03 65.40 103.95 -40.07 64.36 105.87 coo 12.98 90.36 47.57 11.26 89.62 46.62 -31.47 63.24 120.93 -31.90 65.07 119.91 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 A 137 ARG A 334 ARG^? 9.67 CL CL A 382 A 141 THR A 281 THR^? 16.66 CL CL A 384 A 235 ASP A 39 ASP^? 16.51 CL CL A 382 coo 6.21 93.81 36.58 4.58 96.33 37.17 -35.93 61.76 109.91 -34.52 61.40 112.61 coo 6.80 92.87 28.33 4.91 92.74 27.40 -34.83 61.90 103.55 -35.70 60.62 105.09 coo 12.98 90.36 47.57 11.26 89.62 46.62 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 A 137 ARG A 334 ARG^? 9.67 CL CL A 382 A 141 THR A 283 THR^? 13.40 CL CL A 384 A 235 ASP A 36 ASP.? -3.33 CL CL A 382s coo 6.21 93.81 36.58 4.58 96.33 37.17 -35.93 61.76 109.91 -34.52 61.40 112.61 coo 6.80 92.87 28.33 4.91 92.74 27.40 -28.94 58.76 103.11 -29.59 56.83 103.84 coo 12.98 90.36 47.57 11.26 89.62 46.62 -31.47 63.24 120.93 -31.90 65.07 119.91 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 A 137 ARG A 334 ARG^? 9.67 CL CL A 382 A 141 THR A 283 THR^? 13.40 CL CL A 384 A 235 ASP A 208 ASP.? 21.85 CL CL A 382 coo 6.21 93.81 36.58 4.58 96.33 37.17 -35.93 61.76 109.91 -34.52 61.40 112.61 coo 6.80 92.87 28.33 4.91 92.74 27.40 -28.94 58.76 103.11 -29.59 56.83 103.84 coo 12.98 90.36 47.57 11.26 89.62 46.62 -48.25 63.81 104.00 -49.74 63.21 105.24 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 A 137 ARG B 193 ARG.? 19.02 CL CL A 384 A 141 THR A 329 THR^? 14.14 CL CL A 384 A 235 ASP B 204 ASP^? 22.18 CL CL B 383 coo 6.21 93.81 36.58 4.58 96.33 37.17 -14.12 50.83 106.82 -12.70 50.89 109.57 coo 6.80 92.87 28.33 4.91 92.74 27.40 -21.38 53.78 108.30 -19.71 54.59 109.49 coo 12.98 90.36 47.57 11.26 89.62 46.62 -12.38 39.84 96.49 -14.33 39.98 97.22 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 A 137 ARG B 193 ARG.? 19.02 CL CL A 384 A 141 THR B 194 THR.? 12.32 CL CL A 384 A 235 ASP B 204 ASP^? 22.18 CL CL B 383 coo 6.21 93.81 36.58 4.58 96.33 37.17 -14.12 50.83 106.82 -12.70 50.89 109.57 coo 6.80 92.87 28.33 4.91 92.74 27.40 -14.07 57.99 105.37 -12.38 58.46 106.64 coo 12.98 90.36 47.57 11.26 89.62 46.62 -12.38 39.84 96.49 -14.33 39.98 97.22 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 14 3 # 14 A 137 ARG B 202 ARG^? 25.52 CL CL B 383 A 141 THR B 281 THR^? 16.75 CL CL B 383 A 235 ASP A 327 ASP.? 19.04 CL CL A 384 coo 6.21 93.81 36.58 4.58 96.33 37.17 -17.65 42.54 97.41 -16.79 41.14 100.03 coo 6.80 92.87 28.33 4.91 92.74 27.40 -11.01 41.80 92.41 -12.17 40.05 91.86 coo 12.98 90.36 47.57 11.26 89.62 46.62 -25.74 49.77 105.10 -27.34 48.80 104.08 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 15 3 # 15 A 137 ARG B 212 ARG.? 28.47 CL CL B 383 A 141 THR B 242 THR.? 33.18 CL CL B 383 A 235 ASP B 272 ASP~? 14.11 CL CL B 383 coo 6.21 93.81 36.58 4.58 96.33 37.17 3.61 30.30 95.57 4.45 30.88 98.48 coo 6.80 92.87 28.33 4.91 92.74 27.40 12.86 31.45 98.38 12.27 33.54 98.54 coo 12.98 90.36 47.57 11.26 89.62 46.62 0.88 31.47 82.51 1.09 32.47 80.67 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 16 3 # 16 A 137 ARG B 320 ARG^? 13.22 CL CL B 383 A 141 THR B 283 THR^? 20.21 CL CL B 383 A 235 ASP B 93 ASP^? 5.22 CL CL B 383 coo 6.21 93.81 36.58 4.58 96.33 37.17 -19.20 39.56 86.12 -20.64 37.04 85.01 coo 6.80 92.87 28.33 4.91 92.74 27.40 -16.17 46.19 92.40 -17.74 44.83 92.78 coo 12.98 90.36 47.57 11.26 89.62 46.62 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 17 3 # 17 A 137 ARG B 334 ARG^? 9.65 CL CL B 383 A 141 THR B 279 THR^? 15.64 CL CL B 383 A 235 ASP B 26 ASP^? 16.51 CL CL B 383 coo 6.21 93.81 36.58 4.58 96.33 37.17 -12.53 38.39 87.32 -14.06 38.36 84.61 coo 6.80 92.87 28.33 4.91 92.74 27.40 -5.97 38.16 91.98 -7.29 37.14 90.58 coo 12.98 90.36 47.57 11.26 89.62 46.62 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 18 3 # 18 A 137 ARG B 334 ARG^? 9.65 CL CL B 383 A 141 THR B 279 THR^? 15.64 CL CL B 383 A 235 ASP B 36 ASP.? -3.35 CL CL B 383s coo 6.21 93.81 36.58 4.58 96.33 37.17 -12.53 38.39 87.32 -14.06 38.36 84.61 coo 6.80 92.87 28.33 4.91 92.74 27.40 -5.97 38.16 91.98 -7.29 37.14 90.58 coo 12.98 90.36 47.57 11.26 89.62 46.62 -15.98 38.04 75.83 -14.00 38.51 76.08 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 19 3 # 19 A 137 ARG B 334 ARG^? 9.65 CL CL B 383 A 141 THR B 281 THR^? 16.75 CL CL B 383 A 235 ASP B 39 ASP^? 17.51 CL CL B 383 coo 6.21 93.81 36.58 4.58 96.33 37.17 -12.53 38.39 87.32 -14.06 38.36 84.61 coo 6.80 92.87 28.33 4.91 92.74 27.40 -11.01 41.80 92.41 -12.17 40.05 91.86 coo 12.98 90.36 47.57 11.26 89.62 46.62 -26.18 36.85 80.53 -27.97 36.10 81.34 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 20 3 # 20 A 137 ARG B 334 ARG^? 9.65 CL CL B 383 A 141 THR B 283 THR^? 20.21 CL CL B 383 A 235 ASP B 36 ASP.? -3.35 CL CL B 383s coo 6.21 93.81 36.58 4.58 96.33 37.17 -12.53 38.39 87.32 -14.06 38.36 84.61 coo 6.80 92.87 28.33 4.91 92.74 27.40 -16.17 46.19 92.40 -17.74 44.83 92.78 coo 12.98 90.36 47.57 11.26 89.62 46.62 -15.98 38.04 75.83 -14.00 38.51 76.08 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 21 3 # 21 A 137 ARG B 334 ARG^? 9.65 CL CL B 383 A 141 THR B 283 THR^? 20.21 CL CL B 383 A 235 ASP B 208 ASP.? 21.56 CL CL B 383 coo 6.21 93.81 36.58 4.58 96.33 37.17 -12.53 38.39 87.32 -14.06 38.36 84.61 coo 6.80 92.87 28.33 4.91 92.74 27.40 -16.17 46.19 92.40 -17.74 44.83 92.78 coo 12.98 90.36 47.57 11.26 89.62 46.62 -4.03 30.56 94.79 -4.11 28.51 94.21 1bd3_c00 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 21 hits 1bd3_c00 naa= 3 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 D 137 ARG A 193 ARG.? 15.01 CL CL B 382 D 141 THR A 194 THR.? 13.30 CL CL B 382 D 235 ASP A 204 ASP^? 18.76 CL CL A 384 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -30.19 56.43 87.97 -31.59 55.92 85.25 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -23.53 58.32 86.21 -24.61 58.92 84.44 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -37.06 58.40 100.88 -36.30 56.45 100.53 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 D 137 ARG A 193 ARG.? 15.01 CL CL B 382 D 141 THR B 329 THR^? 15.42 CL CL B 382 D 235 ASP A 204 ASP^? 18.76 CL CL A 384 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -30.19 56.43 87.97 -31.59 55.92 85.25 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -24.83 49.33 87.66 -25.34 51.01 86.38 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -37.06 58.40 100.88 -36.30 56.45 100.53 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 D 137 ARG A 197 ARG.? 14.16 CL CL A 384 D 141 THR A 194 THR.? 13.30 CL CL B 382 D 235 ASP B 195 ASP.? 10.47 CL CL A 384 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -16.42 65.00 90.05 -16.47 67.55 88.20 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -23.53 58.32 86.21 -24.61 58.92 84.44 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 D 137 ARG A 202 ARG^? 19.65 CL CL A 384 D 141 THR A 281 THR^? 16.66 CL CL A 384 D 235 ASP B 327 ASP.? 22.34 CL CL A 384 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -32.39 54.22 100.96 -34.65 53.06 99.24 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -34.83 61.90 103.55 -35.70 60.62 105.09 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -25.62 46.25 93.54 -25.42 45.53 95.50 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 D 137 ARG A 202 ARG^? 19.65 CL CL A 384 D 141 THR A 331 THR^? 10.31 CL CL A 384 D 235 ASP B 327 ASP.? 22.34 CL CL A 384 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -32.39 54.22 100.96 -34.65 53.06 99.24 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -26.18 59.17 108.07 -25.19 60.90 109.06 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -25.62 46.25 93.54 -25.42 45.53 95.50 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 D 137 ARG A 212 ARG.? 30.01 CL CL A 382 D 141 THR A 242 THR.? 33.58 CL CL A 382 D 235 ASP A 272 ASP~? 14.48 CL CL A 382 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -52.31 71.44 100.68 -54.00 71.15 98.10 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -55.37 77.04 95.46 -53.34 77.12 94.70 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -46.67 73.24 112.92 -45.43 74.19 114.38 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 D 137 ARG A 212 ARG.? 30.01 CL CL A 382 D 141 THR A 244 THR.? 37.53 CL CL A 382 D 235 ASP A 272 ASP~? 14.48 CL CL A 382 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -52.31 71.44 100.68 -54.00 71.15 98.10 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -60.54 73.51 95.50 -59.95 72.82 93.56 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -46.67 73.24 112.92 -45.43 74.19 114.38 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 D 137 ARG A 290 ARG.? -7.44 CL CL A 384s D 141 THR B 194 THR.? 12.32 CL CL A 384 D 235 ASP A 195 ASP.? 13.29 CL CL A 384 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -15.77 66.49 99.38 -13.63 64.23 99.65 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -14.07 57.99 105.37 -12.38 58.46 106.64 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 D 137 ARG A 320 ARG^? 16.18 CL CL A 382 D 141 THR A 281 THR^? 16.66 CL CL A 384 D 235 ASP A 93 ASP^? 5.15 CL CL A 382 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -32.10 56.68 112.17 -32.95 53.99 110.90 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -34.83 61.90 103.55 -35.70 60.62 105.09 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 D 137 ARG A 320 ARG^? 16.18 CL CL A 382 D 141 THR A 283 THR^? 13.40 CL CL A 384 D 235 ASP A 93 ASP^? 5.15 CL CL A 382 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -32.10 56.68 112.17 -32.95 53.99 110.90 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -28.94 58.76 103.11 -29.59 56.83 103.84 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 D 137 ARG A 334 ARG^? 9.67 CL CL A 382 D 141 THR A 279 THR^? 15.90 CL CL A 382 D 235 ASP A 26 ASP^? 16.59 CL CL A 382 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -35.93 61.76 109.91 -34.52 61.40 112.61 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -40.03 65.40 103.95 -40.07 64.36 105.87 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 D 137 ARG A 334 ARG^? 9.67 CL CL A 382 D 141 THR A 279 THR^? 15.90 CL CL A 382 D 235 ASP A 36 ASP.? -3.33 CL CL A 382s coo -8.33 92.80 100.06 -7.71 95.33 98.44 -35.93 61.76 109.91 -34.52 61.40 112.61 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -40.03 65.40 103.95 -40.07 64.36 105.87 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -31.47 63.24 120.93 -31.90 65.07 119.91 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 D 137 ARG A 334 ARG^? 9.67 CL CL A 382 D 141 THR A 283 THR^? 13.40 CL CL A 384 D 235 ASP A 208 ASP.? 21.85 CL CL A 382 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -35.93 61.76 109.91 -34.52 61.40 112.61 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -28.94 58.76 103.11 -29.59 56.83 103.84 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -48.25 63.81 104.00 -49.74 63.21 105.24 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 14 3 # 14 D 137 ARG B 193 ARG.? 19.02 CL CL A 384 D 141 THR A 329 THR^? 14.14 CL CL A 384 D 235 ASP B 204 ASP^? 22.18 CL CL B 383 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -14.12 50.83 106.82 -12.70 50.89 109.57 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -21.38 53.78 108.30 -19.71 54.59 109.49 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -12.38 39.84 96.49 -14.33 39.98 97.22 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 15 3 # 15 D 137 ARG B 193 ARG.? 19.02 CL CL A 384 D 141 THR B 194 THR.? 12.32 CL CL A 384 D 235 ASP B 204 ASP^? 22.18 CL CL B 383 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -14.12 50.83 106.82 -12.70 50.89 109.57 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -14.07 57.99 105.37 -12.38 58.46 106.64 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -12.38 39.84 96.49 -14.33 39.98 97.22 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 16 3 # 16 D 137 ARG B 202 ARG^? 25.52 CL CL B 383 D 141 THR B 281 THR^? 16.75 CL CL B 383 D 235 ASP A 327 ASP.? 19.04 CL CL A 384 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -17.65 42.54 97.41 -16.79 41.14 100.03 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -11.01 41.80 92.41 -12.17 40.05 91.86 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -25.74 49.77 105.10 -27.34 48.80 104.08 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 17 3 # 17 D 137 ARG B 212 ARG.? 28.47 CL CL B 383 D 141 THR B 242 THR.? 33.18 CL CL B 383 D 235 ASP B 272 ASP~? 14.11 CL CL B 383 coo -8.33 92.80 100.06 -7.71 95.33 98.44 3.61 30.30 95.57 4.45 30.88 98.48 coo -9.24 93.49 108.77 -7.37 94.21 109.61 12.86 31.45 98.38 12.27 33.54 98.54 coo -14.64 87.74 89.51 -12.89 87.43 90.65 0.88 31.47 82.51 1.09 32.47 80.67 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 18 3 # 18 D 137 ARG B 212 ARG.? 28.47 CL CL B 383 D 141 THR B 244 THR.? 36.65 CL CL B 383 D 235 ASP B 272 ASP~? 14.11 CL CL B 383 coo -8.33 92.80 100.06 -7.71 95.33 98.44 3.61 30.30 95.57 4.45 30.88 98.48 coo -9.24 93.49 108.77 -7.37 94.21 109.61 11.74 26.22 101.11 11.25 27.41 102.85 coo -14.64 87.74 89.51 -12.89 87.43 90.65 0.88 31.47 82.51 1.09 32.47 80.67 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 19 3 # 19 D 137 ARG B 319 ARG^? 9.63 CL CL B 383 D 141 THR B 283 THR^? 20.21 CL CL B 383 D 235 ASP B 64 ASP.? 7.14 CL CL B 382 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -15.74 45.22 81.80 -15.96 44.19 78.93 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -16.17 46.19 92.40 -17.74 44.83 92.78 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -22.24 55.99 77.05 -23.77 56.03 78.56 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 20 3 # 20 D 137 ARG B 319 ARG^? 9.63 CL CL B 383 D 141 THR B 283 THR^? 20.21 CL CL B 383 D 235 ASP B 93 ASP^? 5.22 CL CL B 383 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -15.74 45.22 81.80 -15.96 44.19 78.93 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -16.17 46.19 92.40 -17.74 44.83 92.78 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 21 3 # 21 D 137 ARG B 320 ARG^? 13.22 CL CL B 383 D 141 THR B 281 THR^? 16.75 CL CL B 383 D 235 ASP B 93 ASP^? 5.22 CL CL B 383 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -19.20 39.56 86.12 -20.64 37.04 85.01 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -11.01 41.80 92.41 -12.17 40.05 91.86 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 22 3 # 22 D 137 ARG B 320 ARG^? 13.22 CL CL B 383 D 141 THR B 283 THR^? 20.21 CL CL B 383 D 235 ASP B 93 ASP^? 5.22 CL CL B 383 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -19.20 39.56 86.12 -20.64 37.04 85.01 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -16.17 46.19 92.40 -17.74 44.83 92.78 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 23 3 # 23 D 137 ARG B 334 ARG^? 9.65 CL CL B 383 D 141 THR B 279 THR^? 15.64 CL CL B 383 D 235 ASP B 26 ASP^? 16.51 CL CL B 383 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -12.53 38.39 87.32 -14.06 38.36 84.61 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -5.97 38.16 91.98 -7.29 37.14 90.58 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 24 3 # 24 D 137 ARG B 334 ARG^? 9.65 CL CL B 383 D 141 THR B 279 THR^? 15.64 CL CL B 383 D 235 ASP B 36 ASP.? -3.35 CL CL B 383s coo -8.33 92.80 100.06 -7.71 95.33 98.44 -12.53 38.39 87.32 -14.06 38.36 84.61 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -5.97 38.16 91.98 -7.29 37.14 90.58 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -15.98 38.04 75.83 -14.00 38.51 76.08 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 25 3 # 25 D 137 ARG B 334 ARG^? 9.65 CL CL B 383 D 141 THR B 283 THR^? 20.21 CL CL B 383 D 235 ASP B 208 ASP.? 21.56 CL CL B 383 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -12.53 38.39 87.32 -14.06 38.36 84.61 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -16.17 46.19 92.40 -17.74 44.83 92.78 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -4.03 30.56 94.79 -4.11 28.51 94.21 1bd3_c01 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 25 hits 1bd3_c01 naa= 3 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG A 193 ARG.? 15.01 CL CL B 382 C 141 THR A 194 THR.? 13.30 CL CL B 382 C 235 ASP A 204 ASP^? 18.76 CL CL A 384 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -30.19 56.43 87.97 -31.59 55.92 85.25 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -23.53 58.32 86.21 -24.61 58.92 84.44 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -37.06 58.40 100.88 -36.30 56.45 100.53 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 C 137 ARG A 193 ARG.? 15.01 CL CL B 382 C 141 THR B 329 THR^? 15.42 CL CL B 382 C 235 ASP A 204 ASP^? 18.76 CL CL A 384 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -30.19 56.43 87.97 -31.59 55.92 85.25 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -24.83 49.33 87.66 -25.34 51.01 86.38 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -37.06 58.40 100.88 -36.30 56.45 100.53 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 C 137 ARG A 197 ARG.? 14.16 CL CL A 384 C 141 THR A 194 THR.? 13.30 CL CL B 382 C 235 ASP B 195 ASP.? 10.47 CL CL A 384 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -16.42 65.00 90.05 -16.47 67.55 88.20 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -23.53 58.32 86.21 -24.61 58.92 84.44 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 C 137 ARG A 202 ARG^? 19.65 CL CL A 384 C 141 THR A 281 THR^? 16.66 CL CL A 384 C 235 ASP B 327 ASP.? 22.34 CL CL A 384 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -32.39 54.22 100.96 -34.65 53.06 99.24 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -34.83 61.90 103.55 -35.70 60.62 105.09 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -25.62 46.25 93.54 -25.42 45.53 95.50 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 C 137 ARG A 202 ARG^? 19.65 CL CL A 384 C 141 THR A 331 THR^? 10.31 CL CL A 384 C 235 ASP B 327 ASP.? 22.34 CL CL A 384 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -32.39 54.22 100.96 -34.65 53.06 99.24 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -26.18 59.17 108.07 -25.19 60.90 109.06 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -25.62 46.25 93.54 -25.42 45.53 95.50 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 C 137 ARG A 212 ARG.? 30.01 CL CL A 382 C 141 THR A 242 THR.? 33.58 CL CL A 382 C 235 ASP A 272 ASP~? 14.48 CL CL A 382 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -52.31 71.44 100.68 -54.00 71.15 98.10 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -55.37 77.04 95.46 -53.34 77.12 94.70 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -46.67 73.24 112.92 -45.43 74.19 114.38 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 C 137 ARG A 212 ARG.? 30.01 CL CL A 382 C 141 THR A 244 THR.? 37.53 CL CL A 382 C 235 ASP A 272 ASP~? 14.48 CL CL A 382 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -52.31 71.44 100.68 -54.00 71.15 98.10 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -60.54 73.51 95.50 -59.95 72.82 93.56 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -46.67 73.24 112.92 -45.43 74.19 114.38 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 C 137 ARG A 290 ARG.? -7.44 CL CL A 384s C 141 THR B 194 THR.? 12.32 CL CL A 384 C 235 ASP A 195 ASP.? 13.29 CL CL A 384 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -15.77 66.49 99.38 -13.63 64.23 99.65 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -14.07 57.99 105.37 -12.38 58.46 106.64 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 C 137 ARG A 320 ARG^? 16.18 CL CL A 382 C 141 THR A 281 THR^? 16.66 CL CL A 384 C 235 ASP A 93 ASP^? 5.15 CL CL A 382 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -32.10 56.68 112.17 -32.95 53.99 110.90 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -34.83 61.90 103.55 -35.70 60.62 105.09 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 C 137 ARG A 334 ARG^? 9.67 CL CL A 382 C 141 THR A 279 THR^? 15.90 CL CL A 382 C 235 ASP A 26 ASP^? 16.59 CL CL A 382 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -35.93 61.76 109.91 -34.52 61.40 112.61 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -40.03 65.40 103.95 -40.07 64.36 105.87 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 C 137 ARG A 334 ARG^? 9.67 CL CL A 382 C 141 THR A 279 THR^? 15.90 CL CL A 382 C 235 ASP A 36 ASP.? -3.33 CL CL A 382s coo -5.79 67.26 36.83 -4.57 64.58 37.74 -35.93 61.76 109.91 -34.52 61.40 112.61 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -40.03 65.40 103.95 -40.07 64.36 105.87 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -31.47 63.24 120.93 -31.90 65.07 119.91 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 C 137 ARG A 334 ARG^? 9.67 CL CL A 382 C 141 THR A 283 THR^? 13.40 CL CL A 384 C 235 ASP A 36 ASP.? -3.33 CL CL A 382s coo -5.79 67.26 36.83 -4.57 64.58 37.74 -35.93 61.76 109.91 -34.52 61.40 112.61 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -28.94 58.76 103.11 -29.59 56.83 103.84 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -31.47 63.24 120.93 -31.90 65.07 119.91 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 C 137 ARG A 334 ARG^? 9.67 CL CL A 382 C 141 THR A 283 THR^? 13.40 CL CL A 384 C 235 ASP A 208 ASP.? 21.85 CL CL A 382 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -35.93 61.76 109.91 -34.52 61.40 112.61 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -28.94 58.76 103.11 -29.59 56.83 103.84 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -48.25 63.81 104.00 -49.74 63.21 105.24 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 14 3 # 14 C 137 ARG B 193 ARG.? 19.02 CL CL A 384 C 141 THR A 329 THR^? 14.14 CL CL A 384 C 235 ASP B 204 ASP^? 22.18 CL CL B 383 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -14.12 50.83 106.82 -12.70 50.89 109.57 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -21.38 53.78 108.30 -19.71 54.59 109.49 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -12.38 39.84 96.49 -14.33 39.98 97.22 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 15 3 # 15 C 137 ARG B 193 ARG.? 19.02 CL CL A 384 C 141 THR B 194 THR.? 12.32 CL CL A 384 C 235 ASP B 204 ASP^? 22.18 CL CL B 383 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -14.12 50.83 106.82 -12.70 50.89 109.57 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -14.07 57.99 105.37 -12.38 58.46 106.64 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -12.38 39.84 96.49 -14.33 39.98 97.22 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 16 3 # 16 C 137 ARG B 202 ARG^? 25.52 CL CL B 383 C 141 THR B 281 THR^? 16.75 CL CL B 383 C 235 ASP A 327 ASP.? 19.04 CL CL A 384 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -17.65 42.54 97.41 -16.79 41.14 100.03 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -11.01 41.80 92.41 -12.17 40.05 91.86 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -25.74 49.77 105.10 -27.34 48.80 104.08 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 17 3 # 17 C 137 ARG B 212 ARG.? 28.47 CL CL B 383 C 141 THR B 242 THR.? 33.18 CL CL B 383 C 235 ASP B 272 ASP~? 14.11 CL CL B 383 coo -5.79 67.26 36.83 -4.57 64.58 37.74 3.61 30.30 95.57 4.45 30.88 98.48 coo -6.81 68.31 28.28 -4.82 68.47 27.57 12.86 31.45 98.38 12.27 33.54 98.54 coo -13.01 70.96 47.58 -11.44 71.65 46.34 0.88 31.47 82.51 1.09 32.47 80.67 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 18 3 # 18 C 137 ARG B 212 ARG.? 28.47 CL CL B 383 C 141 THR B 244 THR.? 36.65 CL CL B 383 C 235 ASP B 272 ASP~? 14.11 CL CL B 383 coo -5.79 67.26 36.83 -4.57 64.58 37.74 3.61 30.30 95.57 4.45 30.88 98.48 coo -6.81 68.31 28.28 -4.82 68.47 27.57 11.74 26.22 101.11 11.25 27.41 102.85 coo -13.01 70.96 47.58 -11.44 71.65 46.34 0.88 31.47 82.51 1.09 32.47 80.67 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 19 3 # 19 C 137 ARG B 319 ARG^? 9.63 CL CL B 383 C 141 THR B 283 THR^? 20.21 CL CL B 383 C 235 ASP B 64 ASP.? 7.14 CL CL B 382 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -15.74 45.22 81.80 -15.96 44.19 78.93 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -16.17 46.19 92.40 -17.74 44.83 92.78 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -22.24 55.99 77.05 -23.77 56.03 78.56 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 20 3 # 20 C 137 ARG B 319 ARG^? 9.63 CL CL B 383 C 141 THR B 283 THR^? 20.21 CL CL B 383 C 235 ASP B 93 ASP^? 5.22 CL CL B 383 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -15.74 45.22 81.80 -15.96 44.19 78.93 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -16.17 46.19 92.40 -17.74 44.83 92.78 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 21 3 # 21 C 137 ARG B 320 ARG^? 13.22 CL CL B 383 C 141 THR B 281 THR^? 16.75 CL CL B 383 C 235 ASP B 93 ASP^? 5.22 CL CL B 383 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -19.20 39.56 86.12 -20.64 37.04 85.01 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -11.01 41.80 92.41 -12.17 40.05 91.86 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 22 3 # 22 C 137 ARG B 320 ARG^? 13.22 CL CL B 383 C 141 THR B 283 THR^? 20.21 CL CL B 383 C 235 ASP B 93 ASP^? 5.22 CL CL B 383 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -19.20 39.56 86.12 -20.64 37.04 85.01 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -16.17 46.19 92.40 -17.74 44.83 92.78 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 23 3 # 23 C 137 ARG B 334 ARG^? 9.65 CL CL B 383 C 141 THR B 279 THR^? 15.64 CL CL B 383 C 235 ASP B 26 ASP^? 16.51 CL CL B 383 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -12.53 38.39 87.32 -14.06 38.36 84.61 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -5.97 38.16 91.98 -7.29 37.14 90.58 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 24 3 # 24 C 137 ARG B 334 ARG^? 9.65 CL CL B 383 C 141 THR B 279 THR^? 15.64 CL CL B 383 C 235 ASP B 36 ASP.? -3.35 CL CL B 383s coo -5.79 67.26 36.83 -4.57 64.58 37.74 -12.53 38.39 87.32 -14.06 38.36 84.61 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -5.97 38.16 91.98 -7.29 37.14 90.58 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -15.98 38.04 75.83 -14.00 38.51 76.08 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 25 3 # 25 C 137 ARG B 334 ARG^? 9.65 CL CL B 383 C 141 THR B 283 THR^? 20.21 CL CL B 383 C 235 ASP B 36 ASP.? -3.35 CL CL B 383s coo -5.79 67.26 36.83 -4.57 64.58 37.74 -12.53 38.39 87.32 -14.06 38.36 84.61 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -16.17 46.19 92.40 -17.74 44.83 92.78 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -15.98 38.04 75.83 -14.00 38.51 76.08 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 26 3 # 26 C 137 ARG B 334 ARG^? 9.65 CL CL B 383 C 141 THR B 283 THR^? 20.21 CL CL B 383 C 235 ASP B 208 ASP.? 21.56 CL CL B 383 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -12.53 38.39 87.32 -14.06 38.36 84.61 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -16.17 46.19 92.40 -17.74 44.83 92.78 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -4.03 30.56 94.79 -4.11 28.51 94.21 1bd3_c02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 26 hits 1bd3_c02 naa= 3 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 B 137 ARG A 193 ARG.? 15.01 CL CL B 382 B 141 THR A 194 THR.? 13.30 CL CL B 382 B 235 ASP A 204 ASP^? 18.76 CL CL A 384 coo 8.13 67.41 100.27 7.18 68.35 97.45 -30.19 56.43 87.97 -31.59 55.92 85.25 coo 8.28 67.78 108.81 6.22 67.65 109.43 -23.53 58.32 86.21 -24.61 58.92 84.44 coo 14.55 73.52 89.47 12.81 73.95 90.56 -37.06 58.40 100.88 -36.30 56.45 100.53 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 B 137 ARG A 193 ARG.? 15.01 CL CL B 382 B 141 THR B 329 THR^? 15.42 CL CL B 382 B 235 ASP A 204 ASP^? 18.76 CL CL A 384 coo 8.13 67.41 100.27 7.18 68.35 97.45 -30.19 56.43 87.97 -31.59 55.92 85.25 coo 8.28 67.78 108.81 6.22 67.65 109.43 -24.83 49.33 87.66 -25.34 51.01 86.38 coo 14.55 73.52 89.47 12.81 73.95 90.56 -37.06 58.40 100.88 -36.30 56.45 100.53 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 B 137 ARG A 197 ARG.? 14.16 CL CL A 384 B 141 THR A 194 THR.? 13.30 CL CL B 382 B 235 ASP B 195 ASP.? 10.47 CL CL A 384 coo 8.13 67.41 100.27 7.18 68.35 97.45 -16.42 65.00 90.05 -16.47 67.55 88.20 coo 8.28 67.78 108.81 6.22 67.65 109.43 -23.53 58.32 86.21 -24.61 58.92 84.44 coo 14.55 73.52 89.47 12.81 73.95 90.56 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 B 137 ARG A 202 ARG^? 19.65 CL CL A 384 B 141 THR A 281 THR^? 16.66 CL CL A 384 B 235 ASP B 327 ASP.? 22.34 CL CL A 384 coo 8.13 67.41 100.27 7.18 68.35 97.45 -32.39 54.22 100.96 -34.65 53.06 99.24 coo 8.28 67.78 108.81 6.22 67.65 109.43 -34.83 61.90 103.55 -35.70 60.62 105.09 coo 14.55 73.52 89.47 12.81 73.95 90.56 -25.62 46.25 93.54 -25.42 45.53 95.50 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 B 137 ARG A 212 ARG.? 30.01 CL CL A 382 B 141 THR A 242 THR.? 33.58 CL CL A 382 B 235 ASP A 272 ASP~? 14.48 CL CL A 382 coo 8.13 67.41 100.27 7.18 68.35 97.45 -52.31 71.44 100.68 -54.00 71.15 98.10 coo 8.28 67.78 108.81 6.22 67.65 109.43 -55.37 77.04 95.46 -53.34 77.12 94.70 coo 14.55 73.52 89.47 12.81 73.95 90.56 -46.67 73.24 112.92 -45.43 74.19 114.38 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 B 137 ARG A 212 ARG.? 30.01 CL CL A 382 B 141 THR A 244 THR.? 37.53 CL CL A 382 B 235 ASP A 272 ASP~? 14.48 CL CL A 382 coo 8.13 67.41 100.27 7.18 68.35 97.45 -52.31 71.44 100.68 -54.00 71.15 98.10 coo 8.28 67.78 108.81 6.22 67.65 109.43 -60.54 73.51 95.50 -59.95 72.82 93.56 coo 14.55 73.52 89.47 12.81 73.95 90.56 -46.67 73.24 112.92 -45.43 74.19 114.38 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 B 137 ARG A 320 ARG^? 16.18 CL CL A 382 B 141 THR A 281 THR^? 16.66 CL CL A 384 B 235 ASP A 93 ASP^? 5.15 CL CL A 382 coo 8.13 67.41 100.27 7.18 68.35 97.45 -32.10 56.68 112.17 -32.95 53.99 110.90 coo 8.28 67.78 108.81 6.22 67.65 109.43 -34.83 61.90 103.55 -35.70 60.62 105.09 coo 14.55 73.52 89.47 12.81 73.95 90.56 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 B 137 ARG A 320 ARG^? 16.18 CL CL A 382 B 141 THR A 283 THR^? 13.40 CL CL A 384 B 235 ASP A 93 ASP^? 5.15 CL CL A 382 coo 8.13 67.41 100.27 7.18 68.35 97.45 -32.10 56.68 112.17 -32.95 53.99 110.90 coo 8.28 67.78 108.81 6.22 67.65 109.43 -28.94 58.76 103.11 -29.59 56.83 103.84 coo 14.55 73.52 89.47 12.81 73.95 90.56 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 B 137 ARG A 334 ARG^? 9.67 CL CL A 382 B 141 THR A 279 THR^? 15.90 CL CL A 382 B 235 ASP A 39 ASP^? 16.51 CL CL A 382 coo 8.13 67.41 100.27 7.18 68.35 97.45 -35.93 61.76 109.91 -34.52 61.40 112.61 coo 8.28 67.78 108.81 6.22 67.65 109.43 -40.03 65.40 103.95 -40.07 64.36 105.87 coo 14.55 73.52 89.47 12.81 73.95 90.56 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 B 137 ARG A 334 ARG^? 9.67 CL CL A 382 B 141 THR A 283 THR^? 13.40 CL CL A 384 B 235 ASP A 208 ASP.? 21.85 CL CL A 382 coo 8.13 67.41 100.27 7.18 68.35 97.45 -35.93 61.76 109.91 -34.52 61.40 112.61 coo 8.28 67.78 108.81 6.22 67.65 109.43 -28.94 58.76 103.11 -29.59 56.83 103.84 coo 14.55 73.52 89.47 12.81 73.95 90.56 -48.25 63.81 104.00 -49.74 63.21 105.24 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 B 137 ARG A 334 ARG^? 9.67 CL CL A 382 B 141 THR A 331 THR^? 10.31 CL CL A 384 B 235 ASP A 208 ASP.? 21.85 CL CL A 382 coo 8.13 67.41 100.27 7.18 68.35 97.45 -35.93 61.76 109.91 -34.52 61.40 112.61 coo 8.28 67.78 108.81 6.22 67.65 109.43 -26.18 59.17 108.07 -25.19 60.90 109.06 coo 14.55 73.52 89.47 12.81 73.95 90.56 -48.25 63.81 104.00 -49.74 63.21 105.24 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 B 137 ARG B 193 ARG.? 19.02 CL CL A 384 B 141 THR A 329 THR^? 14.14 CL CL A 384 B 235 ASP B 204 ASP^? 22.18 CL CL B 383 coo 8.13 67.41 100.27 7.18 68.35 97.45 -14.12 50.83 106.82 -12.70 50.89 109.57 coo 8.28 67.78 108.81 6.22 67.65 109.43 -21.38 53.78 108.30 -19.71 54.59 109.49 coo 14.55 73.52 89.47 12.81 73.95 90.56 -12.38 39.84 96.49 -14.33 39.98 97.22 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 B 137 ARG B 193 ARG.? 19.02 CL CL A 384 B 141 THR B 194 THR.? 12.32 CL CL A 384 B 235 ASP B 204 ASP^? 22.18 CL CL B 383 coo 8.13 67.41 100.27 7.18 68.35 97.45 -14.12 50.83 106.82 -12.70 50.89 109.57 coo 8.28 67.78 108.81 6.22 67.65 109.43 -14.07 57.99 105.37 -12.38 58.46 106.64 coo 14.55 73.52 89.47 12.81 73.95 90.56 -12.38 39.84 96.49 -14.33 39.98 97.22 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 14 3 # 14 B 137 ARG B 202 ARG^? 25.52 CL CL B 383 B 141 THR B 281 THR^? 16.75 CL CL B 383 B 235 ASP A 327 ASP.? 19.04 CL CL A 384 coo 8.13 67.41 100.27 7.18 68.35 97.45 -17.65 42.54 97.41 -16.79 41.14 100.03 coo 8.28 67.78 108.81 6.22 67.65 109.43 -11.01 41.80 92.41 -12.17 40.05 91.86 coo 14.55 73.52 89.47 12.81 73.95 90.56 -25.74 49.77 105.10 -27.34 48.80 104.08 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 15 3 # 15 B 137 ARG B 212 ARG.? 28.47 CL CL B 383 B 141 THR B 242 THR.? 33.18 CL CL B 383 B 235 ASP B 272 ASP~? 14.11 CL CL B 383 coo 8.13 67.41 100.27 7.18 68.35 97.45 3.61 30.30 95.57 4.45 30.88 98.48 coo 8.28 67.78 108.81 6.22 67.65 109.43 12.86 31.45 98.38 12.27 33.54 98.54 coo 14.55 73.52 89.47 12.81 73.95 90.56 0.88 31.47 82.51 1.09 32.47 80.67 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 16 3 # 16 B 137 ARG B 290 ARG.? 12.49 CL CL A 384 B 141 THR B 289 THR.? 17.67 CL CL B 382 B 235 ASP B 306 ASP.? 19.57 CL CL A 384 coo 8.13 67.41 100.27 7.18 68.35 97.45 -13.01 59.15 90.41 -14.60 61.38 91.89 coo 8.28 67.78 108.81 6.22 67.65 109.43 -13.61 55.64 84.71 -12.04 55.51 83.26 coo 14.55 73.52 89.47 12.81 73.95 90.56 -4.64 54.84 103.01 -3.71 56.24 101.58 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 17 3 # 17 B 137 ARG B 320 ARG^? 13.22 CL CL B 383 B 141 THR B 283 THR^? 20.21 CL CL B 383 B 235 ASP B 93 ASP^? 5.22 CL CL B 383 coo 8.13 67.41 100.27 7.18 68.35 97.45 -19.20 39.56 86.12 -20.64 37.04 85.01 coo 8.28 67.78 108.81 6.22 67.65 109.43 -16.17 46.19 92.40 -17.74 44.83 92.78 coo 14.55 73.52 89.47 12.81 73.95 90.56 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 18 3 # 18 B 137 ARG B 334 ARG^? 9.65 CL CL B 383 B 141 THR B 283 THR^? 20.21 CL CL B 383 B 235 ASP B 208 ASP.? 21.56 CL CL B 383 coo 8.13 67.41 100.27 7.18 68.35 97.45 -12.53 38.39 87.32 -14.06 38.36 84.61 coo 8.28 67.78 108.81 6.22 67.65 109.43 -16.17 46.19 92.40 -17.74 44.83 92.78 coo 14.55 73.52 89.47 12.81 73.95 90.56 -4.03 30.56 94.79 -4.11 28.51 94.21 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 19 3 # 19 B 137 ARG B 334 ARG^? 9.65 CL CL B 383 B 141 THR B 331 THR^? 16.17 CL CL B 383 B 235 ASP B 208 ASP.? 21.56 CL CL B 383 coo 8.13 67.41 100.27 7.18 68.35 97.45 -12.53 38.39 87.32 -14.06 38.36 84.61 coo 8.28 67.78 108.81 6.22 67.65 109.43 -18.10 46.86 87.19 -17.24 47.80 85.43 coo 14.55 73.52 89.47 12.81 73.95 90.56 -4.03 30.56 94.79 -4.11 28.51 94.21 1bd3_c03 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 19 hits 1bd3_c03 naa= 3 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 1 3 # 1 14 ASP A 311 ASP^? 15.19 CL CL A 384 16 HIS A 302 HIS^? 11.51 CL CL A 384 67 GLY A 277 GLY~? 20.14 CL CL A 382 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -31.19 72.86 91.72 -29.44 73.97 92.12 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -27.17 73.50 97.06 -27.34 73.92 95.02 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -46.60 67.89 104.45 -45.85 67.87 104.64 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 2 3 # 2 14 ASP A 311 ASP^? 15.19 CL CL A 384 16 HIS A 302 HIS^? 11.51 CL CL A 384 67 GLY A 285 GLY^? 9.46 CL CL A 384 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -31.19 72.86 91.72 -29.44 73.97 92.12 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -27.17 73.50 97.06 -27.34 73.92 95.02 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -22.09 57.26 103.59 -22.19 58.16 103.73 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 3 3 # 3 14 ASP A 311 ASP^? 15.19 CL CL A 384 16 HIS A 302 HIS^? 11.51 CL CL A 384 67 GLY A 286 GLY.? 9.30 CL CL A 384 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -31.19 72.86 91.72 -29.44 73.97 92.12 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -27.17 73.50 97.06 -27.34 73.92 95.02 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -20.05 58.49 106.62 -20.88 58.44 106.59 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 4 3 # 4 14 ASP A 311 ASP^? 15.19 CL CL A 384 16 HIS A 302 HIS^? 11.51 CL CL A 384 67 GLY A 318 GLY^? 8.74 CL CL A 382 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -31.19 72.86 91.72 -29.44 73.97 92.12 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -27.17 73.50 97.06 -27.34 73.92 95.02 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -33.39 65.39 112.09 -32.99 65.64 111.42 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 5 3 # 5 14 ASP B 144 ASP.? 18.90 CL CL B 384 16 HIS B 157 HIS~? 12.80 CL CL B 384 67 GLY B 96 GLY~? 8.80 CL CL B 384 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 1.70 18.75 65.96 3.42 18.04 64.94 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 0.17 24.88 70.38 1.86 23.62 70.32 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -17.52 31.23 69.94 -17.03 31.31 69.27 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 6 3 # 6 14 ASP B 311 ASP^? 24.66 CL CL A 384 16 HIS B 302 HIS^? 23.99 CL CL A 384 67 GLY B 277 GLY~? 19.92 CL CL B 383 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 0.41 52.81 97.17 0.37 54.52 95.85 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -2.27 54.46 91.30 -1.20 55.23 92.93 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -1.21 33.00 92.27 -1.59 33.59 91.90 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 7 3 # 7 14 ASP B 311 ASP^? 24.66 CL CL A 384 16 HIS B 302 HIS^? 23.99 CL CL A 384 67 GLY B 285 GLY^? 18.43 CL CL A 384 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 0.41 52.81 97.17 0.37 54.52 95.85 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -2.27 54.46 91.30 -1.20 55.23 92.93 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -20.19 51.54 90.83 -19.46 51.66 90.42 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 8 3 # 8 14 ASP B 311 ASP^? 24.66 CL CL A 384 16 HIS B 302 HIS^? 23.99 CL CL A 384 67 GLY B 286 GLY.? 16.50 CL CL B 382 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 0.41 52.81 97.17 0.37 54.52 95.85 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -2.27 54.46 91.30 -1.20 55.23 92.93 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -20.98 52.54 87.27 -20.62 51.84 87.46 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 9 3 # 9 14 ASP B 311 ASP^? 24.66 CL CL A 384 16 HIS B 302 HIS^? 23.99 CL CL A 384 67 GLY B 318 GLY^? 8.69 CL CL B 383 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 0.41 52.81 97.17 0.37 54.52 95.85 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -2.27 54.46 91.30 -1.20 55.23 92.93 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -10.95 40.65 83.09 -10.71 41.37 83.45 1be1_c02 source 1be1 GLUTAMATE MUTASE : 9 hits 1be1_c02 naa= 3 ULMN 3 1bf2_c00 ISOAMYLASE user 1 3 # 1 375 ASP A 171 ASP.? 13.95 CL CL A 382 435 GLU A 60 GLU^? 17.84 CL CL A 382 510 ASP A 93 ASP^? 5.15 CL CL A 382 coo 88.62 69.90 41.16 89.05 70.67 43.04 -21.72 70.05 125.28 -22.57 71.99 125.28 coo 89.52 76.11 40.17 89.01 75.16 41.97 -20.60 62.82 127.64 -18.87 63.84 128.41 coo 84.89 77.60 46.67 85.63 75.79 46.03 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1bf2_c00 ISOAMYLASE user 2 3 # 2 375 ASP A 171 ASP.? 13.95 CL CL A 382 435 GLU A 169 GLU.? 11.07 CL CL A 382 510 ASP A 93 ASP^? 5.15 CL CL A 382 coo 88.62 69.90 41.16 89.05 70.67 43.04 -21.72 70.05 125.28 -22.57 71.99 125.28 coo 89.52 76.11 40.17 89.01 75.16 41.97 -27.31 72.85 122.01 -26.32 74.11 120.63 coo 84.89 77.60 46.67 85.63 75.79 46.03 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1bf2_c00 ISOAMYLASE user 3 3 # 3 375 ASP A 180 ASP.? 19.13 CL CL A 382 435 GLU A 135 GLU.? 22.99 CL CL A 382 510 ASP A 344 ASP.? 20.56 CL CL A 382 coo 88.62 69.90 41.16 89.05 70.67 43.04 -29.53 80.77 112.24 -28.62 82.54 111.55 coo 89.52 76.11 40.17 89.01 75.16 41.97 -31.98 87.75 115.72 -30.11 88.72 115.32 coo 84.89 77.60 46.67 85.63 75.79 46.03 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 1bf2_c00 ISOAMYLASE user 4 3 # 4 375 ASP A 272 ASP~? 14.48 CL CL A 382 435 GLU A 276 GLU~? 16.10 CL CL A 383 510 ASP A 210 ASP.? 21.69 CL CL A 383 coo 88.62 69.90 41.16 89.05 70.67 43.04 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 89.52 76.11 40.17 89.01 75.16 41.97 -46.62 67.79 110.40 -48.46 68.09 111.43 coo 84.89 77.60 46.67 85.63 75.79 46.03 -52.58 64.68 106.89 -53.21 62.78 107.37 ULMN 3 1bf2_c00 ISOAMYLASE user 5 3 # 5 375 ASP A 305 ASP^? 16.01 CL CL A 384 435 GLU A 307 GLU.? 18.04 CL CL B 382 510 ASP A 195 ASP.? 13.29 CL CL A 384 coo 88.62 69.90 41.16 89.05 70.67 43.04 -32.01 65.22 92.45 -32.49 63.34 91.63 coo 89.52 76.11 40.17 89.01 75.16 41.97 -31.95 61.22 87.08 -31.47 59.40 88.12 coo 84.89 77.60 46.67 85.63 75.79 46.03 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1bf2_c00 ISOAMYLASE user 6 3 # 6 375 ASP A 306 ASP.? 16.66 CL CL A 384 435 GLU A 307 GLU.? 18.04 CL CL B 382 510 ASP A 195 ASP.? 13.29 CL CL A 384 coo 88.62 69.90 41.16 89.05 70.67 43.04 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 89.52 76.11 40.17 89.01 75.16 41.97 -31.95 61.22 87.08 -31.47 59.40 88.12 coo 84.89 77.60 46.67 85.63 75.79 46.03 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1bf2_c00 ISOAMYLASE user 7 3 # 7 375 ASP B 171 ASP.? 13.77 CL CL B 383 435 GLU B 60 GLU^? 11.77 CL CL B 382 510 ASP B 93 ASP^? 5.22 CL CL B 383 coo 88.62 69.90 41.16 89.05 70.67 43.04 -14.88 46.75 66.62 -12.79 46.40 66.16 coo 89.52 76.11 40.17 89.01 75.16 41.97 -22.53 44.68 66.99 -22.71 45.90 65.28 coo 84.89 77.60 46.67 85.63 75.79 46.03 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1bf2_c00 ISOAMYLASE user 8 3 # 8 375 ASP B 171 ASP.? 13.77 CL CL B 383 435 GLU B 169 GLU.? 11.31 CL CL B 383 510 ASP B 93 ASP^? 5.22 CL CL B 383 coo 88.62 69.90 41.16 89.05 70.67 43.04 -14.88 46.75 66.62 -12.79 46.40 66.16 coo 89.52 76.11 40.17 89.01 75.16 41.97 -9.49 44.22 70.62 -8.22 45.44 69.57 coo 84.89 77.60 46.67 85.63 75.79 46.03 -17.13 37.76 71.68 -15.50 36.45 72.23 1bf2_c00 source 1bf2 ISOAMYLASE : 8 hits 1bf2_c00 naa= 3 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 1 3 # 1 28 GLU A 149 GLU.? 9.19 CL CL A 383 70 HIS A 157 HIS~? 12.03 CL CL A 383 281 HIS A 287 HIS.? 12.74 CL CL A 384 coo 66.09 46.17 155.81 66.77 48.19 155.70 -48.79 70.20 130.85 -48.75 71.87 129.52 coo 69.05 50.55 157.03 68.00 52.29 156.51 -47.82 75.77 126.56 -49.90 76.10 126.41 coo 100.93 36.73 156.02 100.47 38.42 157.18 -21.23 59.04 111.08 -21.85 57.11 111.58 1bfd_c00 source 1bfd BENZOYLFORMATE DECARBOXYLASE : 1 hits 1bfd_c00 naa= 3 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 1 3 # 1 A 382 ARG A 44 ARG.? 27.19 CL CL A 384 A 451 GLU A 86 GLU^? 27.08 CL CL A 382 A 540 GLU A 23 GLU.? 27.24 CL CL A 382 coo 79.04 80.20 80.81 79.58 81.40 83.63 -16.06 41.78 118.55 -16.27 43.65 116.05 coo 81.34 87.29 87.22 82.36 86.09 88.61 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 79.94 80.46 88.84 81.11 81.36 87.27 -22.84 44.28 116.17 -23.55 42.53 115.22 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 2 3 # 2 A 382 ARG B 24 ARG^? 24.13 CL CL B 382 A 451 GLU B 86 GLU^? 25.45 CL CL B 382 A 540 GLU B 23 GLU.? 22.91 CL CL B 382 coo 79.04 80.20 80.81 79.58 81.40 83.63 -30.86 40.03 86.77 -33.42 38.25 86.47 coo 81.34 87.29 87.22 82.36 86.09 88.61 -37.46 36.82 83.59 -36.60 37.35 85.50 coo 79.94 80.46 88.84 81.11 81.36 87.27 -35.83 43.78 85.87 -35.49 42.75 87.75 1bhg_c04 source 1bhg BETA-GLUCURONIDASE : 2 hits 1bhg_c04 naa= 3 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 1 3 # 1 B 382 ARG A 44 ARG.? 27.19 CL CL A 384 B 451 GLU A 86 GLU^? 27.08 CL CL A 382 B 540 GLU A 23 GLU.? 27.24 CL CL A 382 coo 82.21 41.07 119.14 83.95 40.66 116.59 -16.06 41.78 118.55 -16.27 43.65 116.05 coo 86.52 35.28 112.74 87.08 36.38 110.99 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 83.38 41.19 112.55 85.47 40.59 112.72 -22.84 44.28 116.17 -23.55 42.53 115.22 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 2 3 # 2 B 382 ARG A 325 ARG.? 29.26 CL CL A 384 B 451 GLU A 86 GLU^? 27.08 CL CL A 382 B 540 GLU A 23 GLU.? 27.24 CL CL A 382 coo 82.21 41.07 119.14 83.95 40.66 116.59 -22.19 42.21 111.60 -22.86 39.29 112.51 coo 86.52 35.28 112.74 87.08 36.38 110.99 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 83.38 41.19 112.55 85.47 40.59 112.72 -22.84 44.28 116.17 -23.55 42.53 115.22 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 3 3 # 3 B 382 ARG B 24 ARG^? 24.13 CL CL B 382 B 451 GLU B 86 GLU^? 25.45 CL CL B 382 B 540 GLU B 23 GLU.? 22.91 CL CL B 382 coo 82.21 41.07 119.14 83.95 40.66 116.59 -30.86 40.03 86.77 -33.42 38.25 86.47 coo 86.52 35.28 112.74 87.08 36.38 110.99 -37.46 36.82 83.59 -36.60 37.35 85.50 coo 83.38 41.19 112.55 85.47 40.59 112.72 -35.83 43.78 85.87 -35.49 42.75 87.75 1bhg_c05 source 1bhg BETA-GLUCURONIDASE : 3 hits 1bhg_c05 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG A 197 ARG.? 14.16 CL CL A 384 183 LYS B 288 LYS.? 8.84 CL CL B 382 317 ARG B 202 ARG^? 25.52 CL CL B 383 coo 76.57 109.19 73.41 73.86 110.26 72.16 -16.42 65.00 90.05 -16.47 67.55 88.20 coo 82.09 117.51 66.37 80.60 114.32 71.44 -16.76 54.22 83.25 -20.62 56.75 78.99 coo 65.21 120.62 58.76 63.62 123.14 59.66 -17.65 42.54 97.41 -16.79 41.14 100.03 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 2 3 # 2 118 ARG B 20 ARG.? -3.56 CL CL B 382s 183 LYS B 17 LYS^? 18.67 CL CL B 382 317 ARG B 85 ARG^? 26.72 CL CL B 382 coo 76.57 109.19 73.41 73.86 110.26 72.16 -30.86 53.38 73.69 -28.77 54.55 71.62 coo 82.09 117.51 66.37 80.60 114.32 71.44 -33.42 46.60 66.26 -37.89 44.12 63.72 coo 65.21 120.62 58.76 63.62 123.14 59.66 -45.61 37.84 80.13 -46.20 40.84 79.69 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 3 3 # 3 118 ARG B 197 ARG.? 10.56 CL CL A 384 183 LYS A 288 LYS.? 12.57 CL CL A 384 317 ARG A 202 ARG^? 19.65 CL CL A 384 coo 76.57 109.19 73.41 73.86 110.26 72.16 -11.56 63.68 96.52 -11.06 66.80 96.90 coo 82.09 117.51 66.37 80.60 114.32 71.44 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 65.21 120.62 58.76 63.62 123.14 59.66 -32.39 54.22 100.96 -34.65 53.06 99.24 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 3 hits 1bib_c00 naa= 3 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 1 3 # 1 A 102 TRP A 207 TRP^? 23.82 CL CL A 384 A 174 ASP A 208 ASP.? 21.85 CL CL A 382 A 198 LYS A 336 LYS^? 14.72 CL CL A 382 coo 21.59 67.76 35.19 19.10 64.95 36.34 -44.76 66.72 97.91 -42.73 64.04 95.92 coo 19.39 73.14 39.98 19.70 71.07 40.14 -48.25 63.81 104.00 -49.74 63.21 105.24 coo 27.94 65.10 43.55 24.20 64.94 40.01 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 2 3 # 2 A 102 TRP A 273 TRP~? 19.00 CL CL A 383 A 174 ASP A 210 ASP.? 21.69 CL CL A 383 A 198 LYS A 249 LYS^? 20.12 CL CL A 383 coo 21.59 67.76 35.19 19.10 64.95 36.34 -50.89 71.02 111.12 -54.05 73.34 111.49 coo 19.39 73.14 39.98 19.70 71.07 40.14 -52.58 64.68 106.89 -53.21 62.78 107.37 coo 27.94 65.10 43.55 24.20 64.94 40.01 -61.09 73.36 110.22 -57.90 69.98 113.58 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 3 3 # 3 A 102 TRP A 341 TRP.? 10.34 CL CL A 382 A 174 ASP A 272 ASP~? 14.48 CL CL A 382 A 198 LYS A 336 LYS^? 14.72 CL CL A 382 coo 21.59 67.76 35.19 19.10 64.95 36.34 -39.95 74.25 113.33 -36.58 74.16 115.41 coo 19.39 73.14 39.98 19.70 71.07 40.14 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 27.94 65.10 43.55 24.20 64.94 40.01 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 4 3 # 4 A 102 TRP B 207 TRP^? 25.29 CL CL B 383 A 174 ASP B 208 ASP.? 21.56 CL CL B 383 A 198 LYS B 336 LYS^? 14.66 CL CL B 383 coo 21.59 67.76 35.19 19.10 64.95 36.34 -1.19 37.06 97.92 -3.78 38.84 100.32 coo 19.39 73.14 39.98 19.70 71.07 40.14 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 27.94 65.10 43.55 24.20 64.94 40.01 -3.40 41.24 88.18 -4.83 35.96 88.60 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 5 3 # 5 A 102 TRP B 273 TRP~? 18.41 CL CL B 384 A 174 ASP B 210 ASP.? 22.05 CL CL B 384 A 198 LYS B 249 LYS^? 19.48 CL CL B 384 coo 21.59 67.76 35.19 19.10 64.95 36.34 1.07 27.51 86.17 4.21 25.26 85.33 coo 19.39 73.14 39.98 19.70 71.07 40.14 -2.53 25.11 93.69 -2.62 22.87 93.62 coo 27.94 65.10 43.55 24.20 64.94 40.01 7.49 19.68 88.46 2.17 20.34 86.44 ULMN 3 1bjo_c00 PHOSPHOSERINE AMINOTRANSFERASE user 6 3 # 6 A 102 TRP B 341 TRP.? 10.39 CL CL B 383 A 174 ASP B 272 ASP~? 14.11 CL CL B 383 A 198 LYS B 336 LYS^? 14.66 CL CL B 383 coo 21.59 67.76 35.19 19.10 64.95 36.34 -0.76 36.74 80.33 -2.75 38.82 77.66 coo 19.39 73.14 39.98 19.70 71.07 40.14 0.88 31.47 82.51 1.09 32.47 80.67 coo 27.94 65.10 43.55 24.20 64.94 40.01 -3.40 41.24 88.18 -4.83 35.96 88.60 1bjo_c00 source 1bjo PHOSPHOSERINE AMINOTRANSFERASE : 6 hits 1bjo_c00 naa= 3 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 1 3 # 1 A 757 ASP A 233 ASP.? 30.79 CL CL A 383 A 759 HIS A 232 HIS.? 26.22 CL CL A 383 A 810 SER A 222 SER.? 30.25 CL CL A 383 coo 30.11 61.02 29.12 29.36 59.77 27.63 -64.45 88.75 121.31 -62.88 88.68 122.75 coo 30.94 56.62 25.28 29.94 54.94 26.14 -64.09 81.45 120.95 -63.65 79.66 121.95 coo 25.05 62.74 29.97 26.88 61.45 29.19 -59.78 88.32 124.78 -60.21 90.11 123.17 1bmt_c04 source 1bmt METHIONINE SYNTHASE (B12-BINDING DOMAINS) (E.C: 1 hits 1bmt_c04 naa= 3 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 1 3 # 1 B 757 ASP A 233 ASP.? 30.79 CL CL A 383 B 759 HIS A 232 HIS.? 26.22 CL CL A 383 B 810 SER A 222 SER.? 30.25 CL CL A 383 coo -2.30 64.08 6.41 -0.36 64.72 6.26 -64.45 88.75 121.31 -62.88 88.68 122.75 coo 1.96 66.39 3.07 2.10 68.48 3.58 -64.09 81.45 120.95 -63.65 79.66 121.95 coo -1.50 63.90 11.86 -1.31 64.33 9.52 -59.78 88.32 124.78 -60.21 90.11 123.17 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 2 3 # 2 B 757 ASP A 305 ASP^? 16.01 CL CL A 384 B 759 HIS A 308 HIS.? 20.06 CL CL A 384 B 810 SER A 192 SER.? 15.36 CL CL A 384 coo -2.30 64.08 6.41 -0.36 64.72 6.26 -32.01 65.22 92.45 -32.49 63.34 91.63 coo 1.96 66.39 3.07 2.10 68.48 3.58 -37.01 64.37 91.64 -38.79 63.83 92.62 coo -1.50 63.90 11.86 -1.31 64.33 9.52 -26.48 60.82 89.96 -25.15 61.33 88.02 1bmt_c05 source 1bmt METHIONINE SYNTHASE (B12-BINDING DOMAINS) (E.C: 2 hits 1bmt_c05 naa= 3 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 1 3 # 1 A 53 SER A 29 SER^? 6.92 CL CL A 382 A 54 PRO A 297 PRO.? 8.38 CL CL A 382 A 96 ASP A 28 ASP^? 9.02 CL CL A 382 coo -9.03 45.15 44.45 -7.51 43.26 44.28 -31.31 63.66 116.96 -29.07 63.86 117.79 coo -12.82 46.62 43.11 -11.69 44.75 42.79 -30.58 67.43 114.39 -29.32 68.86 113.23 coo -5.86 47.39 44.34 -4.55 46.60 42.83 -32.19 59.08 116.32 -33.48 59.98 114.85 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 2 3 # 2 A 53 SER A 29 SER^? 6.92 CL CL A 382 A 54 PRO A 297 PRO.? 8.38 CL CL A 382 A 96 ASP A 30 ASP^? -6.81 CL CL A 382s coo -9.03 45.15 44.45 -7.51 43.26 44.28 -31.31 63.66 116.96 -29.07 63.86 117.79 coo -12.82 46.62 43.11 -11.69 44.75 42.79 -30.58 67.43 114.39 -29.32 68.86 113.23 coo -5.86 47.39 44.34 -4.55 46.60 42.83 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 3 3 # 3 A 53 SER A 29 SER^? 6.92 CL CL A 382 A 54 PRO A 297 PRO.? 8.38 CL CL A 382 A 96 ASP A 36 ASP.? -3.33 CL CL A 382s coo -9.03 45.15 44.45 -7.51 43.26 44.28 -31.31 63.66 116.96 -29.07 63.86 117.79 coo -12.82 46.62 43.11 -11.69 44.75 42.79 -30.58 67.43 114.39 -29.32 68.86 113.23 coo -5.86 47.39 44.34 -4.55 46.60 42.83 -31.47 63.24 120.93 -31.90 65.07 119.91 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 4 3 # 4 A 53 SER B 29 SER^? 6.98 CL CL B 383 A 54 PRO B 297 PRO.? 8.56 CL CL B 383 A 96 ASP B 28 ASP^? 9.00 CL CL B 383 coo -9.03 45.15 44.45 -7.51 43.26 44.28 -14.55 40.12 78.88 -15.61 41.67 77.42 coo -12.82 46.62 43.11 -11.69 44.75 42.79 -10.95 42.88 79.53 -9.83 44.84 79.61 coo -5.86 47.39 44.34 -4.55 46.60 42.83 -18.06 38.42 81.61 -16.37 38.03 82.88 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 5 3 # 5 A 53 SER B 29 SER^? 6.98 CL CL B 383 A 54 PRO B 297 PRO.? 8.56 CL CL B 383 A 96 ASP B 30 ASP^? -6.72 CL CL B 383s coo -9.03 45.15 44.45 -7.51 43.26 44.28 -14.55 40.12 78.88 -15.61 41.67 77.42 coo -12.82 46.62 43.11 -11.69 44.75 42.79 -10.95 42.88 79.53 -9.83 44.84 79.61 coo -5.86 47.39 44.34 -4.55 46.60 42.83 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 6 3 # 6 A 53 SER B 29 SER^? 6.98 CL CL B 383 A 54 PRO B 297 PRO.? 8.56 CL CL B 383 A 96 ASP B 36 ASP.? -3.35 CL CL B 383s coo -9.03 45.15 44.45 -7.51 43.26 44.28 -14.55 40.12 78.88 -15.61 41.67 77.42 coo -12.82 46.62 43.11 -11.69 44.75 42.79 -10.95 42.88 79.53 -9.83 44.84 79.61 coo -5.86 47.39 44.34 -4.55 46.60 42.83 -15.98 38.04 75.83 -14.00 38.51 76.08 1boo_c00 source 1boo N-4 CYTOSINE-SPECIFIC METHYLTRANSFERASE PVU II: 6 hits 1boo_c00 naa= 3 ULMN 3 1bqc_c01 BETA-MANNANASE user 1 3 # 1 A 50 ARG A 24 ARG^? 24.95 CL CL A 382 A 128 GLU A 86 GLU^? 27.08 CL CL A 382 A 225 GLU A 23 GLU.? 27.24 CL CL A 382 coo 38.56 19.11 14.83 37.12 21.00 16.76 -27.53 46.21 115.11 -27.47 43.33 116.18 coo 36.48 24.43 22.02 36.86 26.34 21.13 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 40.16 23.71 17.01 38.52 24.96 17.40 -22.84 44.28 116.17 -23.55 42.53 115.22 ULMN 3 1bqc_c01 BETA-MANNANASE user 2 3 # 2 A 50 ARG A 325 ARG.? 29.26 CL CL A 384 A 128 GLU A 86 GLU^? 27.08 CL CL A 382 A 225 GLU A 23 GLU.? 27.24 CL CL A 382 coo 38.56 19.11 14.83 37.12 21.00 16.76 -22.19 42.21 111.60 -22.86 39.29 112.51 coo 36.48 24.43 22.02 36.86 26.34 21.13 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 40.16 23.71 17.01 38.52 24.96 17.40 -22.84 44.28 116.17 -23.55 42.53 115.22 ULMN 3 1bqc_c01 BETA-MANNANASE user 3 3 # 3 A 50 ARG B 24 ARG^? 24.13 CL CL B 382 A 128 GLU B 86 GLU^? 25.45 CL CL B 382 A 225 GLU B 23 GLU.? 22.91 CL CL B 382 coo 38.56 19.11 14.83 37.12 21.00 16.76 -30.86 40.03 86.77 -33.42 38.25 86.47 coo 36.48 24.43 22.02 36.86 26.34 21.13 -37.46 36.82 83.59 -36.60 37.35 85.50 coo 40.16 23.71 17.01 38.52 24.96 17.40 -35.83 43.78 85.87 -35.49 42.75 87.75 1bqc_c01 source 1bqc BETA-MANNANASE : 3 hits 1bqc_c01 naa= 3 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 1 3 # 1 A 82 HIS A 78 HIS^? 30.68 CL CL A 382 A 168 ARG A 24 ARG^? 24.95 CL CL A 382 A 187 LYS A 80 LYS^? 36.93 CL CL A 382 coo 62.47 12.00 59.65 61.76 10.14 60.31 -24.82 39.60 128.09 -23.39 38.20 127.48 coo 55.10 8.37 73.00 55.48 9.59 70.20 -27.53 46.21 115.11 -27.47 43.33 116.18 coo 66.76 10.09 66.23 61.80 8.06 65.82 -26.02 34.53 124.81 -22.64 33.14 129.86 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 2 3 # 2 A 82 HIS A 246 HIS.? 33.92 CL CL A 383 A 168 ARG A 212 ARG.? 30.01 CL CL A 382 A 187 LYS A 249 LYS^? 20.12 CL CL A 383 coo 62.47 12.00 59.65 61.76 10.14 60.31 -65.97 72.19 102.08 -66.87 73.22 103.68 coo 55.10 8.37 73.00 55.48 9.59 70.20 -52.31 71.44 100.68 -54.00 71.15 98.10 coo 66.76 10.09 66.23 61.80 8.06 65.82 -61.09 73.36 110.22 -57.90 69.98 113.58 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 3 3 # 3 A 82 HIS B 78 HIS^? 26.83 CL CL B 382 A 168 ARG B 24 ARG^? 24.13 CL CL B 382 A 187 LYS B 80 LYS^? 31.45 CL CL B 382 coo 62.47 12.00 59.65 61.76 10.14 60.31 -41.15 34.55 77.14 -42.58 35.82 77.99 coo 55.10 8.37 73.00 55.48 9.59 70.20 -30.86 40.03 86.77 -33.42 38.25 86.47 coo 66.76 10.09 66.23 61.80 8.06 65.82 -43.65 33.60 82.90 -47.69 34.28 78.00 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 4 3 # 4 A 82 HIS B 246 HIS.? 32.95 CL CL B 384 A 168 ARG B 212 ARG.? 28.47 CL CL B 383 A 187 LYS B 249 LYS^? 19.48 CL CL B 384 coo 62.47 12.00 59.65 61.76 10.14 60.31 10.60 18.26 97.26 11.24 17.08 95.63 coo 55.10 8.37 73.00 55.48 9.59 70.20 3.61 30.30 95.57 4.45 30.88 98.48 coo 66.76 10.09 66.23 61.80 8.06 65.82 7.49 19.68 88.46 2.17 20.34 86.44 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 5 3 # 5 A 82 HIS B 287 HIS.? 13.85 CL CL B 382 A 168 ARG A 197 ARG.? 14.16 CL CL A 384 A 187 LYS B 288 LYS.? 8.84 CL CL B 382 coo 62.47 12.00 59.65 61.76 10.14 60.31 -21.22 50.04 83.35 -22.70 48.63 83.80 coo 55.10 8.37 73.00 55.48 9.59 70.20 -16.42 65.00 90.05 -16.47 67.55 88.20 coo 66.76 10.09 66.23 61.80 8.06 65.82 -16.76 54.22 83.25 -20.62 56.75 78.99 1brw_c00 source 1brw PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE : 5 hits 1brw_c00 naa= 3 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 1 3 # 1 B1082 HIS A 78 HIS^? 30.68 CL CL A 382 B1168 ARG A 44 ARG.? 27.19 CL CL A 384 B1187 LYS A 80 LYS^? 36.93 CL CL A 382 coo 35.03 5.72 103.61 36.82 5.00 102.79 -24.82 39.60 128.09 -23.39 38.20 127.48 coo 41.91 5.48 91.85 40.59 6.81 94.28 -16.06 41.78 118.55 -16.27 43.65 116.05 coo 32.93 -0.12 99.60 37.71 2.39 99.23 -26.02 34.53 124.81 -22.64 33.14 129.86 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 2 3 # 2 B1082 HIS A 287 HIS.? 12.74 CL CL A 384 B1168 ARG B 193 ARG.? 19.02 CL CL A 384 B1187 LYS A 288 LYS.? 12.57 CL CL A 384 coo 35.03 5.72 103.61 36.82 5.00 102.79 -21.23 59.04 111.08 -21.85 57.11 111.58 coo 41.91 5.48 91.85 40.59 6.81 94.28 -14.12 50.83 106.82 -12.70 50.89 109.57 coo 32.93 -0.12 99.60 37.71 2.39 99.23 -19.18 64.09 108.25 -14.44 63.70 112.45 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 3 3 # 3 B1082 HIS B 78 HIS^? 26.83 CL CL B 382 B1168 ARG B 24 ARG^? 24.13 CL CL B 382 B1187 LYS B 80 LYS^? 31.45 CL CL B 382 coo 35.03 5.72 103.61 36.82 5.00 102.79 -41.15 34.55 77.14 -42.58 35.82 77.99 coo 41.91 5.48 91.85 40.59 6.81 94.28 -30.86 40.03 86.77 -33.42 38.25 86.47 coo 32.93 -0.12 99.60 37.71 2.39 99.23 -43.65 33.60 82.90 -47.69 34.28 78.00 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 4 3 # 4 B1082 HIS B 287 HIS.? 13.85 CL CL B 382 B1168 ARG A 193 ARG.? 15.01 CL CL B 382 B1187 LYS B 288 LYS.? 8.84 CL CL B 382 coo 35.03 5.72 103.61 36.82 5.00 102.79 -21.22 50.04 83.35 -22.70 48.63 83.80 coo 41.91 5.48 91.85 40.59 6.81 94.28 -30.19 56.43 87.97 -31.59 55.92 85.25 coo 32.93 -0.12 99.60 37.71 2.39 99.23 -16.76 54.22 83.25 -20.62 56.75 78.99 1brw_c01 source 1brw PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE : 4 hits 1brw_c01 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 31 PHE.? 7.34 CL CL A 382 A 205 ASP A 344 ASP.? 20.56 CL CL A 382 A 236 LYS A 268 LYS~? 13.60 CL CL A 382 coo 4.14 2.10 36.34 6.69 3.08 36.92 -34.44 71.03 115.62 -32.10 72.45 115.10 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -47.11 79.10 113.63 -43.53 76.03 116.02 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 2 3 # 2 A 109 PHE A 315 PHE^? 12.88 CL CL A 382 A 205 ASP A 344 ASP.? 20.56 CL CL A 382 A 236 LYS A 133 LYS^? 12.95 CL CL A 382 coo 4.14 2.10 36.34 6.69 3.08 36.92 -33.90 73.75 108.57 -33.36 74.13 111.32 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -30.69 80.61 120.28 -26.75 77.00 119.43 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 3 3 # 3 A 109 PHE A 315 PHE^? 12.88 CL CL A 382 A 205 ASP A 344 ASP.? 20.56 CL CL A 382 A 236 LYS A 268 LYS~? 13.60 CL CL A 382 coo 4.14 2.10 36.34 6.69 3.08 36.92 -33.90 73.75 108.57 -33.36 74.13 111.32 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -47.11 79.10 113.63 -43.53 76.03 116.02 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 4 3 # 4 A 109 PHE B 315 PHE^? 13.01 CL CL B 383 A 205 ASP B 344 ASP.? 20.04 CL CL B 383 A 236 LYS B 133 LYS^? 13.08 CL CL B 383 coo 4.14 2.10 36.34 6.69 3.08 36.92 -2.29 44.04 82.93 -2.92 43.47 80.26 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 7.59 38.09 74.22 8.59 36.72 75.50 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -0.84 43.73 69.01 -5.56 47.16 71.00 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 4 hits 1bs0_c01 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 76 GLN^? 24.61 CL CL A 382 A 91 LEU A 89 LEU^? 19.96 CL CL A 382 A 133 GLU A 57 GLU.? 23.36 CL CL A 382 coo 43.58 43.67 66.73 42.32 42.78 68.15 -26.57 46.46 129.57 -24.86 46.70 130.88 coo 38.58 45.09 70.44 38.28 45.21 72.59 -25.95 50.50 125.76 -24.34 50.00 127.08 coo 44.05 36.87 70.65 43.15 38.64 69.97 -23.46 53.73 134.86 -22.94 54.54 136.68 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 105 GLN.? 15.43 CL CL A 383 A 91 LEU A 106 LEU.? 17.03 CL CL A 383 A 133 GLU A 149 GLU.? 9.19 CL CL A 383 coo 43.58 43.67 66.73 42.32 42.78 68.15 -48.66 74.56 138.50 -49.02 75.36 136.52 coo 38.58 45.09 70.44 38.28 45.21 72.59 -42.89 78.30 136.95 -41.13 79.50 136.43 coo 44.05 36.87 70.65 43.15 38.64 69.97 -48.79 70.20 130.85 -48.75 71.87 129.52 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN A 269 GLN~? 16.14 CL CL A 383 A 91 LEU A 270 LEU~? 23.55 CL CL A 383 A 133 GLU A 276 GLU~? 16.10 CL CL A 383 coo 43.58 43.67 66.73 42.32 42.78 68.15 -51.90 74.98 113.67 -51.01 73.36 114.78 coo 38.58 45.09 70.44 38.28 45.21 72.59 -50.44 78.04 108.85 -52.50 78.70 108.33 coo 44.05 36.87 70.65 43.15 38.64 69.97 -46.62 67.79 110.40 -48.46 68.09 111.43 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN B 76 GLN^? 22.74 CL CL B 382 A 91 LEU B 89 LEU^? 18.66 CL CL B 382 A 133 GLU B 57 GLU.? 21.35 CL CL B 382 coo 43.58 43.67 66.73 42.32 42.78 68.15 -34.98 34.32 73.52 -35.81 35.28 71.77 coo 38.58 45.09 70.44 38.28 45.21 72.59 -30.76 37.74 74.88 -32.34 38.38 73.55 coo 44.05 36.87 70.65 43.15 38.64 69.97 -31.25 37.00 65.18 -31.15 36.75 63.13 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN B 269 GLN~? 15.69 CL CL B 384 A 91 LEU B 270 LEU~? 23.21 CL CL B 383 A 133 GLU B 276 GLU~? 15.94 CL CL B 384 coo 43.58 43.67 66.73 42.32 42.78 68.15 4.24 26.64 82.24 2.13 26.75 81.88 coo 38.58 45.09 70.44 38.28 45.21 72.59 7.84 30.73 84.95 9.38 29.37 85.70 coo 44.05 36.87 70.65 43.15 38.64 69.97 -2.79 30.63 87.01 -2.36 28.59 86.68 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 5 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN A 76 GLN^? 24.61 CL CL A 382 B 591 LEU A 89 LEU^? 19.96 CL CL A 382 B 633 GLU A 57 GLU.? 23.36 CL CL A 382 coo 88.06 44.34 57.19 89.06 45.53 55.74 -26.57 46.46 129.57 -24.86 46.70 130.88 coo 86.70 48.66 52.61 87.15 48.69 50.51 -25.95 50.50 125.76 -24.34 50.00 127.08 coo 95.42 44.52 54.43 93.46 45.31 54.70 -23.46 53.73 134.86 -22.94 54.54 136.68 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 2 3 # 2 B 550 GLN A 105 GLN.? 15.43 CL CL A 383 B 591 LEU A 106 LEU.? 17.03 CL CL A 383 B 633 GLU A 149 GLU.? 9.19 CL CL A 383 coo 88.06 44.34 57.19 89.06 45.53 55.74 -48.66 74.56 138.50 -49.02 75.36 136.52 coo 86.70 48.66 52.61 87.15 48.69 50.51 -42.89 78.30 136.95 -41.13 79.50 136.43 coo 95.42 44.52 54.43 93.46 45.31 54.70 -48.79 70.20 130.85 -48.75 71.87 129.52 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 3 3 # 3 B 550 GLN A 269 GLN~? 16.14 CL CL A 383 B 591 LEU A 270 LEU~? 23.55 CL CL A 383 B 633 GLU A 276 GLU~? 16.10 CL CL A 383 coo 88.06 44.34 57.19 89.06 45.53 55.74 -51.90 74.98 113.67 -51.01 73.36 114.78 coo 86.70 48.66 52.61 87.15 48.69 50.51 -50.44 78.04 108.85 -52.50 78.70 108.33 coo 95.42 44.52 54.43 93.46 45.31 54.70 -46.62 67.79 110.40 -48.46 68.09 111.43 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 4 3 # 4 B 550 GLN B 76 GLN^? 22.74 CL CL B 382 B 591 LEU B 89 LEU^? 18.66 CL CL B 382 B 633 GLU B 57 GLU.? 21.35 CL CL B 382 coo 88.06 44.34 57.19 89.06 45.53 55.74 -34.98 34.32 73.52 -35.81 35.28 71.77 coo 86.70 48.66 52.61 87.15 48.69 50.51 -30.76 37.74 74.88 -32.34 38.38 73.55 coo 95.42 44.52 54.43 93.46 45.31 54.70 -31.25 37.00 65.18 -31.15 36.75 63.13 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 5 3 # 5 B 550 GLN B 269 GLN~? 15.69 CL CL B 384 B 591 LEU B 270 LEU~? 23.21 CL CL B 383 B 633 GLU B 276 GLU~? 15.94 CL CL B 384 coo 88.06 44.34 57.19 89.06 45.53 55.74 4.24 26.64 82.24 2.13 26.75 81.88 coo 86.70 48.66 52.61 87.15 48.69 50.51 7.84 30.73 84.95 9.38 29.37 85.70 coo 95.42 44.52 54.43 93.46 45.31 54.70 -2.79 30.63 87.01 -2.36 28.59 86.68 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 5 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN A 76 GLN^? 24.61 CL CL A 382 C1091 LEU A 89 LEU^? 19.96 CL CL A 382 C1133 GLU A 57 GLU.? 23.36 CL CL A 382 coo 68.29 34.44 43.03 66.67 34.74 44.37 -26.57 46.46 129.57 -24.86 46.70 130.88 coo 65.83 38.95 47.05 65.46 38.90 49.20 -25.95 50.50 125.76 -24.34 50.00 127.08 coo 63.14 29.39 46.25 63.84 31.31 45.74 -23.46 53.73 134.86 -22.94 54.54 136.68 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 2 3 # 2 C1050 GLN A 105 GLN.? 15.43 CL CL A 383 C1091 LEU A 106 LEU.? 17.03 CL CL A 383 C1133 GLU A 149 GLU.? 9.19 CL CL A 383 coo 68.29 34.44 43.03 66.67 34.74 44.37 -48.66 74.56 138.50 -49.02 75.36 136.52 coo 65.83 38.95 47.05 65.46 38.90 49.20 -42.89 78.30 136.95 -41.13 79.50 136.43 coo 63.14 29.39 46.25 63.84 31.31 45.74 -48.79 70.20 130.85 -48.75 71.87 129.52 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 3 3 # 3 C1050 GLN A 269 GLN~? 16.14 CL CL A 383 C1091 LEU A 270 LEU~? 23.55 CL CL A 383 C1133 GLU A 276 GLU~? 16.10 CL CL A 383 coo 68.29 34.44 43.03 66.67 34.74 44.37 -51.90 74.98 113.67 -51.01 73.36 114.78 coo 65.83 38.95 47.05 65.46 38.90 49.20 -50.44 78.04 108.85 -52.50 78.70 108.33 coo 63.14 29.39 46.25 63.84 31.31 45.74 -46.62 67.79 110.40 -48.46 68.09 111.43 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 4 3 # 4 C1050 GLN B 76 GLN^? 22.74 CL CL B 382 C1091 LEU B 89 LEU^? 18.66 CL CL B 382 C1133 GLU B 57 GLU.? 21.35 CL CL B 382 coo 68.29 34.44 43.03 66.67 34.74 44.37 -34.98 34.32 73.52 -35.81 35.28 71.77 coo 65.83 38.95 47.05 65.46 38.90 49.20 -30.76 37.74 74.88 -32.34 38.38 73.55 coo 63.14 29.39 46.25 63.84 31.31 45.74 -31.25 37.00 65.18 -31.15 36.75 63.13 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 5 3 # 5 C1050 GLN B 269 GLN~? 15.69 CL CL B 384 C1091 LEU B 270 LEU~? 23.21 CL CL B 383 C1133 GLU B 276 GLU~? 15.94 CL CL B 384 coo 68.29 34.44 43.03 66.67 34.74 44.37 4.24 26.64 82.24 2.13 26.75 81.88 coo 65.83 38.95 47.05 65.46 38.90 49.20 7.84 30.73 84.95 9.38 29.37 85.70 coo 63.14 29.39 46.25 63.84 31.31 45.74 -2.79 30.63 87.01 -2.36 28.59 86.68 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 5 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 76 GLN^? 24.61 CL CL A 382 A 91 LEU A 89 LEU^? 19.96 CL CL A 382 A 133 GLU A 57 GLU.? 23.36 CL CL A 382 coo 38.23 53.34 67.59 38.84 53.87 69.56 -26.57 46.46 129.57 -24.86 46.70 130.88 coo 35.40 53.22 73.30 35.37 54.87 74.74 -25.95 50.50 125.76 -24.34 50.00 127.08 coo 45.08 56.04 70.60 43.15 55.19 70.77 -23.46 53.73 134.86 -22.94 54.54 136.68 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 105 GLN.? 15.43 CL CL A 383 A 91 LEU A 106 LEU.? 17.03 CL CL A 383 A 133 GLU A 149 GLU.? 9.19 CL CL A 383 coo 38.23 53.34 67.59 38.84 53.87 69.56 -48.66 74.56 138.50 -49.02 75.36 136.52 coo 35.40 53.22 73.30 35.37 54.87 74.74 -42.89 78.30 136.95 -41.13 79.50 136.43 coo 45.08 56.04 70.60 43.15 55.19 70.77 -48.79 70.20 130.85 -48.75 71.87 129.52 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN A 269 GLN~? 16.14 CL CL A 383 A 91 LEU A 270 LEU~? 23.55 CL CL A 383 A 133 GLU A 276 GLU~? 16.10 CL CL A 383 coo 38.23 53.34 67.59 38.84 53.87 69.56 -51.90 74.98 113.67 -51.01 73.36 114.78 coo 35.40 53.22 73.30 35.37 54.87 74.74 -50.44 78.04 108.85 -52.50 78.70 108.33 coo 45.08 56.04 70.60 43.15 55.19 70.77 -46.62 67.79 110.40 -48.46 68.09 111.43 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN B 76 GLN^? 22.74 CL CL B 382 A 91 LEU B 89 LEU^? 18.66 CL CL B 382 A 133 GLU B 57 GLU.? 21.35 CL CL B 382 coo 38.23 53.34 67.59 38.84 53.87 69.56 -34.98 34.32 73.52 -35.81 35.28 71.77 coo 35.40 53.22 73.30 35.37 54.87 74.74 -30.76 37.74 74.88 -32.34 38.38 73.55 coo 45.08 56.04 70.60 43.15 55.19 70.77 -31.25 37.00 65.18 -31.15 36.75 63.13 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN B 105 GLN.? 16.65 CL CL B 384 A 91 LEU B 106 LEU.? 16.93 CL CL B 384 A 133 GLU B 146 GLU.? 15.61 CL CL B 384 coo 38.23 53.34 67.59 38.84 53.87 69.56 -4.78 17.78 59.33 -3.82 17.92 61.27 coo 35.40 53.22 73.30 35.37 54.87 74.74 -3.18 24.68 59.43 -3.52 26.14 57.82 coo 45.08 56.04 70.60 43.15 55.19 70.77 -2.82 16.82 69.01 -1.28 15.52 68.26 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 6 3 # 6 A 50 GLN B 269 GLN~? 15.69 CL CL B 384 A 91 LEU B 270 LEU~? 23.21 CL CL B 383 A 133 GLU B 276 GLU~? 15.94 CL CL B 384 coo 38.23 53.34 67.59 38.84 53.87 69.56 4.24 26.64 82.24 2.13 26.75 81.88 coo 35.40 53.22 73.30 35.37 54.87 74.74 7.84 30.73 84.95 9.38 29.37 85.70 coo 45.08 56.04 70.60 43.15 55.19 70.77 -2.79 30.63 87.01 -2.36 28.59 86.68 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 7 3 # 7 A 50 GLN B 296 GLN.? 11.41 CL CL B 383 A 91 LEU B 299 LEU.? 15.29 CL CL B 383 A 133 GLU B 169 GLU.? 11.31 CL CL B 383 coo 38.23 53.34 67.59 38.84 53.87 69.56 -11.66 46.90 76.64 -11.16 47.77 74.74 coo 35.40 53.22 73.30 35.37 54.87 74.74 -7.09 49.81 81.40 -8.48 50.80 80.04 coo 45.08 56.04 70.60 43.15 55.19 70.77 -9.49 44.22 70.62 -8.22 45.44 69.57 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 7 hits 1bsj_c00 naa= 3 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 1 3 # 1 A 325 ASP A 171 ASP.? 13.95 CL CL A 382 A 354 GLU A 60 GLU^? 17.84 CL CL A 382 A 421 ASP A 93 ASP^? 5.15 CL CL A 382 coo 31.05 49.37 64.51 31.97 51.11 63.85 -21.72 70.05 125.28 -22.57 71.99 125.28 coo 29.07 50.42 58.36 29.02 52.18 59.49 -20.60 62.82 127.64 -18.87 63.84 128.41 coo 30.82 59.76 58.47 31.12 59.02 60.40 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 2 3 # 2 A 325 ASP A 171 ASP.? 13.95 CL CL A 382 A 354 GLU A 169 GLU.? 11.07 CL CL A 382 A 421 ASP A 36 ASP.? -3.33 CL CL A 382s coo 31.05 49.37 64.51 31.97 51.11 63.85 -21.72 70.05 125.28 -22.57 71.99 125.28 coo 29.07 50.42 58.36 29.02 52.18 59.49 -27.31 72.85 122.01 -26.32 74.11 120.63 coo 30.82 59.76 58.47 31.12 59.02 60.40 -31.47 63.24 120.93 -31.90 65.07 119.91 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 3 3 # 3 A 325 ASP A 171 ASP.? 13.95 CL CL A 382 A 354 GLU A 169 GLU.? 11.07 CL CL A 382 A 421 ASP A 93 ASP^? 5.15 CL CL A 382 coo 31.05 49.37 64.51 31.97 51.11 63.85 -21.72 70.05 125.28 -22.57 71.99 125.28 coo 29.07 50.42 58.36 29.02 52.18 59.49 -27.31 72.85 122.01 -26.32 74.11 120.63 coo 30.82 59.76 58.47 31.12 59.02 60.40 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 4 3 # 4 A 325 ASP A 180 ASP.? 19.13 CL CL A 382 A 354 GLU A 135 GLU.? 22.99 CL CL A 382 A 421 ASP A 344 ASP.? 20.56 CL CL A 382 coo 31.05 49.37 64.51 31.97 51.11 63.85 -29.53 80.77 112.24 -28.62 82.54 111.55 coo 29.07 50.42 58.36 29.02 52.18 59.49 -31.98 87.75 115.72 -30.11 88.72 115.32 coo 30.82 59.76 58.47 31.12 59.02 60.40 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 5 3 # 5 A 325 ASP A 272 ASP~? 14.48 CL CL A 382 A 354 GLU A 276 GLU~? 16.10 CL CL A 383 A 421 ASP A 208 ASP.? 21.85 CL CL A 382 coo 31.05 49.37 64.51 31.97 51.11 63.85 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 29.07 50.42 58.36 29.02 52.18 59.49 -46.62 67.79 110.40 -48.46 68.09 111.43 coo 30.82 59.76 58.47 31.12 59.02 60.40 -48.25 63.81 104.00 -49.74 63.21 105.24 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 6 3 # 6 A 325 ASP A 272 ASP~? 14.48 CL CL A 382 A 354 GLU A 276 GLU~? 16.10 CL CL A 383 A 421 ASP A 210 ASP.? 21.69 CL CL A 383 coo 31.05 49.37 64.51 31.97 51.11 63.85 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 29.07 50.42 58.36 29.02 52.18 59.49 -46.62 67.79 110.40 -48.46 68.09 111.43 coo 30.82 59.76 58.47 31.12 59.02 60.40 -52.58 64.68 106.89 -53.21 62.78 107.37 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 7 3 # 7 A 325 ASP A 305 ASP^? 16.01 CL CL A 384 A 354 GLU A 307 GLU.? 18.04 CL CL B 382 A 421 ASP A 195 ASP.? 13.29 CL CL A 384 coo 31.05 49.37 64.51 31.97 51.11 63.85 -32.01 65.22 92.45 -32.49 63.34 91.63 coo 29.07 50.42 58.36 29.02 52.18 59.49 -31.95 61.22 87.08 -31.47 59.40 88.12 coo 30.82 59.76 58.47 31.12 59.02 60.40 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 8 3 # 8 A 325 ASP B 171 ASP.? 13.77 CL CL B 383 A 354 GLU B 60 GLU^? 11.77 CL CL B 382 A 421 ASP B 93 ASP^? 5.22 CL CL B 383 coo 31.05 49.37 64.51 31.97 51.11 63.85 -14.88 46.75 66.62 -12.79 46.40 66.16 coo 29.07 50.42 58.36 29.02 52.18 59.49 -22.53 44.68 66.99 -22.71 45.90 65.28 coo 30.82 59.76 58.47 31.12 59.02 60.40 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 9 3 # 9 A 325 ASP B 171 ASP.? 13.77 CL CL B 383 A 354 GLU B 169 GLU.? 11.31 CL CL B 383 A 421 ASP B 36 ASP.? -3.35 CL CL B 383s coo 31.05 49.37 64.51 31.97 51.11 63.85 -14.88 46.75 66.62 -12.79 46.40 66.16 coo 29.07 50.42 58.36 29.02 52.18 59.49 -9.49 44.22 70.62 -8.22 45.44 69.57 coo 30.82 59.76 58.47 31.12 59.02 60.40 -15.98 38.04 75.83 -14.00 38.51 76.08 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 10 3 # 10 A 325 ASP B 171 ASP.? 13.77 CL CL B 383 A 354 GLU B 169 GLU.? 11.31 CL CL B 383 A 421 ASP B 93 ASP^? 5.22 CL CL B 383 coo 31.05 49.37 64.51 31.97 51.11 63.85 -14.88 46.75 66.62 -12.79 46.40 66.16 coo 29.07 50.42 58.36 29.02 52.18 59.49 -9.49 44.22 70.62 -8.22 45.44 69.57 coo 30.82 59.76 58.47 31.12 59.02 60.40 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 11 3 # 11 A 325 ASP B 272 ASP~? 14.11 CL CL B 383 A 354 GLU B 276 GLU~? 15.94 CL CL B 384 A 421 ASP B 208 ASP.? 21.56 CL CL B 383 coo 31.05 49.37 64.51 31.97 51.11 63.85 0.88 31.47 82.51 1.09 32.47 80.67 coo 29.07 50.42 58.36 29.02 52.18 59.49 -2.79 30.63 87.01 -2.36 28.59 86.68 coo 30.82 59.76 58.47 31.12 59.02 60.40 -4.03 30.56 94.79 -4.11 28.51 94.21 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 12 3 # 12 A 325 ASP B 272 ASP~? 14.11 CL CL B 383 A 354 GLU B 276 GLU~? 15.94 CL CL B 384 A 421 ASP B 210 ASP.? 22.05 CL CL B 384 coo 31.05 49.37 64.51 31.97 51.11 63.85 0.88 31.47 82.51 1.09 32.47 80.67 coo 29.07 50.42 58.36 29.02 52.18 59.49 -2.79 30.63 87.01 -2.36 28.59 86.68 coo 30.82 59.76 58.47 31.12 59.02 60.40 -2.53 25.11 93.69 -2.62 22.87 93.62 1bvz_c08 source 1bvz ALPHA-AMYLASE II : 12 hits 1bvz_c08 naa= 3 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 1 3 # 1 B 325 ASP A 171 ASP.? 13.95 CL CL A 382 B 354 GLU A 60 GLU^? 17.84 CL CL A 382 B 421 ASP A 93 ASP^? 5.15 CL CL A 382 coo 25.90 8.19 53.87 25.36 6.97 52.29 -21.72 70.05 125.28 -22.57 71.99 125.28 coo 27.87 10.66 47.95 27.82 8.60 48.27 -20.60 62.82 127.64 -18.87 63.84 128.41 coo 26.02 1.87 43.38 25.90 1.97 45.49 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 2 3 # 2 B 325 ASP A 171 ASP.? 13.95 CL CL A 382 B 354 GLU A 169 GLU.? 11.07 CL CL A 382 B 421 ASP A 36 ASP.? -3.33 CL CL A 382s coo 25.90 8.19 53.87 25.36 6.97 52.29 -21.72 70.05 125.28 -22.57 71.99 125.28 coo 27.87 10.66 47.95 27.82 8.60 48.27 -27.31 72.85 122.01 -26.32 74.11 120.63 coo 26.02 1.87 43.38 25.90 1.97 45.49 -31.47 63.24 120.93 -31.90 65.07 119.91 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 3 3 # 3 B 325 ASP A 171 ASP.? 13.95 CL CL A 382 B 354 GLU A 169 GLU.? 11.07 CL CL A 382 B 421 ASP A 93 ASP^? 5.15 CL CL A 382 coo 25.90 8.19 53.87 25.36 6.97 52.29 -21.72 70.05 125.28 -22.57 71.99 125.28 coo 27.87 10.66 47.95 27.82 8.60 48.27 -27.31 72.85 122.01 -26.32 74.11 120.63 coo 26.02 1.87 43.38 25.90 1.97 45.49 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 4 3 # 4 B 325 ASP A 180 ASP.? 19.13 CL CL A 382 B 354 GLU A 135 GLU.? 22.99 CL CL A 382 B 421 ASP A 344 ASP.? 20.56 CL CL A 382 coo 25.90 8.19 53.87 25.36 6.97 52.29 -29.53 80.77 112.24 -28.62 82.54 111.55 coo 27.87 10.66 47.95 27.82 8.60 48.27 -31.98 87.75 115.72 -30.11 88.72 115.32 coo 26.02 1.87 43.38 25.90 1.97 45.49 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 5 3 # 5 B 325 ASP A 305 ASP^? 16.01 CL CL A 384 B 354 GLU A 307 GLU.? 18.04 CL CL B 382 B 421 ASP A 195 ASP.? 13.29 CL CL A 384 coo 25.90 8.19 53.87 25.36 6.97 52.29 -32.01 65.22 92.45 -32.49 63.34 91.63 coo 27.87 10.66 47.95 27.82 8.60 48.27 -31.95 61.22 87.08 -31.47 59.40 88.12 coo 26.02 1.87 43.38 25.90 1.97 45.49 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 6 3 # 6 B 325 ASP A 327 ASP.? 19.04 CL CL A 384 B 354 GLU A 201 GLU.? 12.07 CL CL A 384 B 421 ASP B 327 ASP.? 22.34 CL CL A 384 coo 25.90 8.19 53.87 25.36 6.97 52.29 -25.74 49.77 105.10 -27.34 48.80 104.08 coo 27.87 10.66 47.95 27.82 8.60 48.27 -24.87 56.03 99.70 -24.21 54.93 101.40 coo 26.02 1.87 43.38 25.90 1.97 45.49 -25.62 46.25 93.54 -25.42 45.53 95.50 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 7 3 # 7 B 325 ASP A 344 ASP.? 20.56 CL CL A 382 B 354 GLU A 135 GLU.? 22.99 CL CL A 382 B 421 ASP A 180 ASP.? 19.13 CL CL A 382 coo 25.90 8.19 53.87 25.36 6.97 52.29 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 27.87 10.66 47.95 27.82 8.60 48.27 -31.98 87.75 115.72 -30.11 88.72 115.32 coo 26.02 1.87 43.38 25.90 1.97 45.49 -29.53 80.77 112.24 -28.62 82.54 111.55 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 8 3 # 8 B 325 ASP B 171 ASP.? 13.77 CL CL B 383 B 354 GLU B 60 GLU^? 11.77 CL CL B 382 B 421 ASP B 93 ASP^? 5.22 CL CL B 383 coo 25.90 8.19 53.87 25.36 6.97 52.29 -14.88 46.75 66.62 -12.79 46.40 66.16 coo 27.87 10.66 47.95 27.82 8.60 48.27 -22.53 44.68 66.99 -22.71 45.90 65.28 coo 26.02 1.87 43.38 25.90 1.97 45.49 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 9 3 # 9 B 325 ASP B 171 ASP.? 13.77 CL CL B 383 B 354 GLU B 169 GLU.? 11.31 CL CL B 383 B 421 ASP B 36 ASP.? -3.35 CL CL B 383s coo 25.90 8.19 53.87 25.36 6.97 52.29 -14.88 46.75 66.62 -12.79 46.40 66.16 coo 27.87 10.66 47.95 27.82 8.60 48.27 -9.49 44.22 70.62 -8.22 45.44 69.57 coo 26.02 1.87 43.38 25.90 1.97 45.49 -15.98 38.04 75.83 -14.00 38.51 76.08 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 10 3 # 10 B 325 ASP B 171 ASP.? 13.77 CL CL B 383 B 354 GLU B 169 GLU.? 11.31 CL CL B 383 B 421 ASP B 93 ASP^? 5.22 CL CL B 383 coo 25.90 8.19 53.87 25.36 6.97 52.29 -14.88 46.75 66.62 -12.79 46.40 66.16 coo 27.87 10.66 47.95 27.82 8.60 48.27 -9.49 44.22 70.62 -8.22 45.44 69.57 coo 26.02 1.87 43.38 25.90 1.97 45.49 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 11 3 # 11 B 325 ASP B 272 ASP~? 14.11 CL CL B 383 B 354 GLU B 276 GLU~? 15.94 CL CL B 384 B 421 ASP B 210 ASP.? 22.05 CL CL B 384 coo 25.90 8.19 53.87 25.36 6.97 52.29 0.88 31.47 82.51 1.09 32.47 80.67 coo 27.87 10.66 47.95 27.82 8.60 48.27 -2.79 30.63 87.01 -2.36 28.59 86.68 coo 26.02 1.87 43.38 25.90 1.97 45.49 -2.53 25.11 93.69 -2.62 22.87 93.62 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 12 3 # 12 B 325 ASP B 305 ASP^? 21.59 CL CL A 384 B 354 GLU B 307 GLU.? 20.03 CL CL A 384 B 421 ASP B 195 ASP.? 10.47 CL CL A 384 coo 25.90 8.19 53.87 25.36 6.97 52.29 -6.28 49.81 99.79 -7.51 49.10 101.38 coo 27.87 10.66 47.95 27.82 8.60 48.27 -8.15 49.66 106.11 -10.31 49.68 106.12 coo 26.02 1.87 43.38 25.90 1.97 45.49 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 13 3 # 13 B 325 ASP B 327 ASP.? 22.34 CL CL A 384 B 354 GLU B 201 GLU^? 17.46 CL CL A 384 B 421 ASP A 327 ASP.? 19.04 CL CL A 384 coo 25.90 8.19 53.87 25.36 6.97 52.29 -25.62 46.25 93.54 -25.42 45.53 95.50 coo 27.87 10.66 47.95 27.82 8.60 48.27 -19.06 50.53 95.26 -20.94 50.61 94.28 coo 26.02 1.87 43.38 25.90 1.97 45.49 -25.74 49.77 105.10 -27.34 48.80 104.08 1bvz_c09 source 1bvz ALPHA-AMYLASE II : 13 hits 1bvz_c09 naa= 3 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 1 3 # 1 104 ASN B 199 ASN.? 15.74 CL CL A 384 192 ASP B 311 ASP^? 24.66 CL CL A 384 195 HIS B 302 HIS^? 23.99 CL CL A 384 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -14.23 54.82 92.98 -12.33 56.04 93.07 coo 56.18 0.19 32.76 56.16 -1.23 31.19 0.41 52.81 97.17 0.37 54.52 95.85 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -2.27 54.46 91.30 -1.20 55.23 92.93 1bwp_c01 source 1bwp PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE : 1 hits 1bwp_c01 naa= 3 ULMN 3 1c54_c00 RIBONUCLEASE SA user 1 3 # 1 A 54 GLU A 332 GLU^? 14.84 CL CL A 382 A 65 ARG A 319 ARG^? 9.49 CL CL A 382 A 85 HIS A 287 HIS.? 12.74 CL CL A 384 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -32.41 59.20 107.78 -33.78 57.91 108.78 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -27.23 63.29 112.77 -27.13 63.50 115.87 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -21.23 59.04 111.08 -21.85 57.11 111.58 ULMN 3 1c54_c00 RIBONUCLEASE SA user 2 3 # 2 A 54 GLU B 332 GLU^? 14.76 CL CL B 383 A 65 ARG B 319 ARG^? 9.63 CL CL B 383 A 85 HIS B 287 HIS.? 13.85 CL CL B 382 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -15.56 41.56 89.17 -16.27 39.59 89.11 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -15.74 45.22 81.80 -15.96 44.19 78.93 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -21.22 50.04 83.35 -22.70 48.63 83.80 1c54_c00 source 1c54 RIBONUCLEASE SA : 2 hits 1c54_c00 naa= 3 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 1 3 # 1 A 14 ASP A 233 ASP.? 30.79 CL CL A 383 A 16 HIS A 232 HIS.? 26.22 CL CL A 383 A 67 GLY A 224 GLY.? 32.04 CL CL A 383 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -64.45 88.75 121.31 -62.88 88.68 122.75 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -64.09 81.45 120.95 -63.65 79.66 121.95 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -61.49 91.50 128.60 -61.32 91.54 127.81 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 2 3 # 2 A 14 ASP A 257 ASP.? 24.30 CL CL A 383 A 16 HIS A 223 HIS.? 29.08 CL CL A 383 A 67 GLY A 141 GLY.? 21.64 CL CL A 383 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -55.05 88.25 125.09 -55.04 86.55 126.35 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -56.62 90.70 129.56 -55.95 91.22 131.48 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -47.00 86.61 128.15 -46.60 85.98 128.53 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 3 3 # 3 A 14 ASP A 311 ASP^? 15.19 CL CL A 384 A 16 HIS A 302 HIS^? 11.51 CL CL A 384 A 67 GLY A 309 GLY.? 19.85 CL CL A 384 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -31.19 72.86 91.72 -29.44 73.97 92.12 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -27.17 73.50 97.06 -27.34 73.92 95.02 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -35.24 68.60 88.70 -35.11 68.24 89.40 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 4 3 # 4 A 14 ASP B 311 ASP^? 24.66 CL CL A 384 A 16 HIS B 302 HIS^? 23.99 CL CL A 384 A 67 GLY B 309 GLY.? 25.52 CL CL A 384 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 0.41 52.81 97.17 0.37 54.52 95.85 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -2.27 54.46 91.30 -1.20 55.23 92.93 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -1.34 49.50 102.80 -1.84 49.15 102.26 1cb7_c06 source 1cb7 GLUTAMATE MUTASE : 4 hits 1cb7_c06 naa= 3 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 1 3 # 1 C 14 ASP A 233 ASP.? 30.79 CL CL A 383 C 16 HIS A 232 HIS.? 26.22 CL CL A 383 C 67 GLY A 224 GLY.? 32.04 CL CL A 383 coo 10.04 44.27 88.44 9.47 42.32 89.03 -64.45 88.75 121.31 -62.88 88.68 122.75 coo 6.38 39.80 88.71 6.88 38.89 86.87 -64.09 81.45 120.95 -63.65 79.66 121.95 coo 17.63 42.50 89.25 18.11 42.29 88.64 -61.49 91.50 128.60 -61.32 91.54 127.81 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 2 3 # 2 C 14 ASP A 257 ASP.? 24.30 CL CL A 383 C 16 HIS A 223 HIS.? 29.08 CL CL A 383 C 67 GLY A 141 GLY.? 21.64 CL CL A 383 coo 10.04 44.27 88.44 9.47 42.32 89.03 -55.05 88.25 125.09 -55.04 86.55 126.35 coo 6.38 39.80 88.71 6.88 38.89 86.87 -56.62 90.70 129.56 -55.95 91.22 131.48 coo 17.63 42.50 89.25 18.11 42.29 88.64 -47.00 86.61 128.15 -46.60 85.98 128.53 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 3 3 # 3 C 14 ASP A 311 ASP^? 15.19 CL CL A 384 C 16 HIS A 302 HIS^? 11.51 CL CL A 384 C 67 GLY A 309 GLY.? 19.85 CL CL A 384 coo 10.04 44.27 88.44 9.47 42.32 89.03 -31.19 72.86 91.72 -29.44 73.97 92.12 coo 6.38 39.80 88.71 6.88 38.89 86.87 -27.17 73.50 97.06 -27.34 73.92 95.02 coo 17.63 42.50 89.25 18.11 42.29 88.64 -35.24 68.60 88.70 -35.11 68.24 89.40 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 4 3 # 4 C 14 ASP B 311 ASP^? 24.66 CL CL A 384 C 16 HIS B 302 HIS^? 23.99 CL CL A 384 C 67 GLY B 309 GLY.? 25.52 CL CL A 384 coo 10.04 44.27 88.44 9.47 42.32 89.03 0.41 52.81 97.17 0.37 54.52 95.85 coo 6.38 39.80 88.71 6.88 38.89 86.87 -2.27 54.46 91.30 -1.20 55.23 92.93 coo 17.63 42.50 89.25 18.11 42.29 88.64 -1.34 49.50 102.80 -1.84 49.15 102.26 1cb7_c07 source 1cb7 GLUTAMATE MUTASE : 4 hits 1cb7_c07 naa= 3 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 1 3 # 1 71 ARG B 212 ARG.? 28.47 CL CL B 383 127 ARG B 247 ARG.? 24.65 CL CL B 384 270 GLU B 215 GLU^? 32.93 CL CL B 384 coo -0.83 25.63 1.57 0.97 28.05 0.90 3.61 30.30 95.57 4.45 30.88 98.48 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 4.27 22.84 96.19 1.85 22.99 94.25 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 14.09 22.76 92.11 15.77 21.48 91.87 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 2 3 # 2 71 ARG B 247 ARG.? 24.65 CL CL B 384 127 ARG B 212 ARG.? 28.47 CL CL B 383 270 GLU B 276 GLU~? 15.94 CL CL B 384 coo -0.83 25.63 1.57 0.97 28.05 0.90 4.27 22.84 96.19 1.85 22.99 94.25 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 3.61 30.30 95.57 4.45 30.88 98.48 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -2.79 30.63 87.01 -2.36 28.59 86.68 1cbx_c01 source 1cbx CARBOXYPEPTIDASE A (E.C.3.4.17.1) COMPLEX WITH: 2 hits 1cbx_c01 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 26 ASP^? 16.59 CL CL A 382 264 GLU A 60 GLU^? 17.84 CL CL A 382 328 ASP A 36 ASP.? -3.33 CL CL A 382s coo 45.62 80.42 43.69 45.65 82.01 45.07 -29.69 53.68 115.80 -29.91 52.24 114.24 coo 59.69 92.71 39.85 58.53 92.03 41.47 -20.60 62.82 127.64 -18.87 63.84 128.41 coo 45.39 90.72 40.63 45.07 89.14 41.90 -31.47 63.24 120.93 -31.90 65.07 119.91 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP A 26 ASP^? 16.59 CL CL A 382 264 GLU A 169 GLU.? 11.07 CL CL A 382 328 ASP A 30 ASP^? -6.81 CL CL A 382s coo 45.62 80.42 43.69 45.65 82.01 45.07 -29.69 53.68 115.80 -29.91 52.24 114.24 coo 59.69 92.71 39.85 58.53 92.03 41.47 -27.31 72.85 122.01 -26.32 74.11 120.63 coo 45.39 90.72 40.63 45.07 89.14 41.90 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP A 26 ASP^? 16.59 CL CL A 382 264 GLU A 206 GLU^? 19.04 CL CL A 382 328 ASP A 30 ASP^? -6.81 CL CL A 382s coo 45.62 80.42 43.69 45.65 82.01 45.07 -29.69 53.68 115.80 -29.91 52.24 114.24 coo 59.69 92.71 39.85 58.53 92.03 41.47 -42.05 60.33 102.60 -42.22 59.82 104.62 coo 45.39 90.72 40.63 45.07 89.14 41.90 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP A 36 ASP.? -3.33 CL CL A 382s 264 GLU A 57 GLU.? 23.36 CL CL A 382 328 ASP A 39 ASP^? 16.51 CL CL A 382 coo 45.62 80.42 43.69 45.65 82.01 45.07 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 59.69 92.71 39.85 58.53 92.03 41.47 -23.46 53.73 134.86 -22.94 54.54 136.68 coo 45.39 90.72 40.63 45.07 89.14 41.90 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 3 # 5 229 ASP A 93 ASP^? 5.15 CL CL A 382 264 GLU A 149 GLU.? 9.19 CL CL A 383 328 ASP A 100 ASP~? 8.92 CL CL A 383 coo 45.62 80.42 43.69 45.65 82.01 45.07 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 59.69 92.71 39.85 58.53 92.03 41.47 -48.79 70.20 130.85 -48.75 71.87 129.52 coo 45.39 90.72 40.63 45.07 89.14 41.90 -39.25 61.23 132.92 -38.42 59.82 131.54 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 6 3 # 6 229 ASP A 100 ASP~? 8.92 CL CL A 383 264 GLU A 57 GLU.? 23.36 CL CL A 382 328 ASP A 93 ASP^? 5.15 CL CL A 382 coo 45.62 80.42 43.69 45.65 82.01 45.07 -39.25 61.23 132.92 -38.42 59.82 131.54 coo 59.69 92.71 39.85 58.53 92.03 41.47 -23.46 53.73 134.86 -22.94 54.54 136.68 coo 45.39 90.72 40.63 45.07 89.14 41.90 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 7 3 # 7 229 ASP A 171 ASP.? 13.95 CL CL A 382 264 GLU A 57 GLU.? 23.36 CL CL A 382 328 ASP A 93 ASP^? 5.15 CL CL A 382 coo 45.62 80.42 43.69 45.65 82.01 45.07 -21.72 70.05 125.28 -22.57 71.99 125.28 coo 59.69 92.71 39.85 58.53 92.03 41.47 -23.46 53.73 134.86 -22.94 54.54 136.68 coo 45.39 90.72 40.63 45.07 89.14 41.90 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 8 3 # 8 229 ASP A 291 ASP.? 7.30 CL CL A 384 264 GLU A 201 GLU.? 12.07 CL CL A 384 328 ASP B 195 ASP.? 10.47 CL CL A 384 coo 45.62 80.42 43.69 45.65 82.01 45.07 -15.45 71.21 105.07 -17.40 71.77 105.62 coo 59.69 92.71 39.85 58.53 92.03 41.47 -24.87 56.03 99.70 -24.21 54.93 101.40 coo 45.39 90.72 40.63 45.07 89.14 41.90 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 9 3 # 9 229 ASP A 305 ASP^? 16.01 CL CL A 384 264 GLU B 201 GLU^? 17.46 CL CL A 384 328 ASP A 195 ASP.? 13.29 CL CL A 384 coo 45.62 80.42 43.69 45.65 82.01 45.07 -32.01 65.22 92.45 -32.49 63.34 91.63 coo 59.69 92.71 39.85 58.53 92.03 41.47 -19.06 50.53 95.26 -20.94 50.61 94.28 coo 45.39 90.72 40.63 45.07 89.14 41.90 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 10 3 # 10 229 ASP A 327 ASP.? 19.04 CL CL A 384 264 GLU A 86 GLU^? 27.08 CL CL A 382 328 ASP A 26 ASP^? 16.59 CL CL A 382 coo 45.62 80.42 43.69 45.65 82.01 45.07 -25.74 49.77 105.10 -27.34 48.80 104.08 coo 59.69 92.71 39.85 58.53 92.03 41.47 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 45.39 90.72 40.63 45.07 89.14 41.90 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 11 3 # 11 229 ASP A 338 ASP.? 17.28 CL CL A 384 264 GLU A 169 GLU.? 11.07 CL CL A 382 328 ASP A 180 ASP.? 19.13 CL CL A 382 coo 45.62 80.42 43.69 45.65 82.01 45.07 -35.06 76.37 102.96 -33.50 77.52 103.78 coo 59.69 92.71 39.85 58.53 92.03 41.47 -27.31 72.85 122.01 -26.32 74.11 120.63 coo 45.39 90.72 40.63 45.07 89.14 41.90 -29.53 80.77 112.24 -28.62 82.54 111.55 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 12 3 # 12 229 ASP A 344 ASP.? 20.56 CL CL A 382 264 GLU A 169 GLU.? 11.07 CL CL A 382 328 ASP A 180 ASP.? 19.13 CL CL A 382 coo 45.62 80.42 43.69 45.65 82.01 45.07 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 59.69 92.71 39.85 58.53 92.03 41.47 -27.31 72.85 122.01 -26.32 74.11 120.63 coo 45.39 90.72 40.63 45.07 89.14 41.90 -29.53 80.77 112.24 -28.62 82.54 111.55 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 13 3 # 13 229 ASP B 26 ASP^? 16.51 CL CL B 383 264 GLU B 60 GLU^? 11.77 CL CL B 382 328 ASP B 36 ASP.? -3.35 CL CL B 383s coo 45.62 80.42 43.69 45.65 82.01 45.07 -23.45 39.33 83.60 -24.23 39.48 85.53 coo 59.69 92.71 39.85 58.53 92.03 41.47 -22.53 44.68 66.99 -22.71 45.90 65.28 coo 45.39 90.72 40.63 45.07 89.14 41.90 -15.98 38.04 75.83 -14.00 38.51 76.08 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 14 3 # 14 229 ASP B 26 ASP^? 16.51 CL CL B 383 264 GLU B 206 GLU^? 19.18 CL CL B 383 328 ASP B 30 ASP^? -6.72 CL CL B 383s coo 45.62 80.42 43.69 45.65 82.01 45.07 -23.45 39.33 83.60 -24.23 39.48 85.53 coo 59.69 92.71 39.85 58.53 92.03 41.47 -9.17 35.76 95.82 -10.61 34.74 94.62 coo 45.39 90.72 40.63 45.07 89.14 41.90 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 15 3 # 15 229 ASP B 36 ASP.? -3.35 CL CL B 383s 264 GLU B 57 GLU.? 21.35 CL CL B 382 328 ASP B 39 ASP^? 17.51 CL CL B 383 coo 45.62 80.42 43.69 45.65 82.01 45.07 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 59.69 92.71 39.85 58.53 92.03 41.47 -31.25 37.00 65.18 -31.15 36.75 63.13 coo 45.39 90.72 40.63 45.07 89.14 41.90 -26.18 36.85 80.53 -27.97 36.10 81.34 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 16 3 # 16 229 ASP B 93 ASP^? 5.22 CL CL B 383 264 GLU B 18 GLU^? 5.91 CL CL B 382 328 ASP B 171 ASP.? 13.77 CL CL B 383 coo 45.62 80.42 43.69 45.65 82.01 45.07 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 59.69 92.71 39.85 58.53 92.03 41.47 -29.91 50.09 69.26 -29.49 51.30 70.99 coo 45.39 90.72 40.63 45.07 89.14 41.90 -14.88 46.75 66.62 -12.79 46.40 66.16 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 17 3 # 17 229 ASP B 93 ASP^? 5.22 CL CL B 383 264 GLU B 149 GLU.? 9.91 CL CL B 384 328 ASP B 100 ASP~? 8.80 CL CL B 384 coo 45.62 80.42 43.69 45.65 82.01 45.07 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 59.69 92.71 39.85 58.53 92.03 41.47 -6.14 20.54 69.48 -4.10 21.06 69.10 coo 45.39 90.72 40.63 45.07 89.14 41.90 -18.20 25.71 68.46 -19.22 26.77 70.02 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 18 3 # 18 229 ASP B 93 ASP^? 5.22 CL CL B 383 264 GLU B 332 GLU^? 14.76 CL CL B 383 328 ASP B 39 ASP^? 17.51 CL CL B 383 coo 45.62 80.42 43.69 45.65 82.01 45.07 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 59.69 92.71 39.85 58.53 92.03 41.47 -15.56 41.56 89.17 -16.27 39.59 89.11 coo 45.39 90.72 40.63 45.07 89.14 41.90 -26.18 36.85 80.53 -27.97 36.10 81.34 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 19 3 # 19 229 ASP B 100 ASP~? 8.80 CL CL B 384 264 GLU B 57 GLU.? 21.35 CL CL B 382 328 ASP B 93 ASP^? 5.22 CL CL B 383 coo 45.62 80.42 43.69 45.65 82.01 45.07 -18.20 25.71 68.46 -19.22 26.77 70.02 coo 59.69 92.71 39.85 58.53 92.03 41.47 -31.25 37.00 65.18 -31.15 36.75 63.13 coo 45.39 90.72 40.63 45.07 89.14 41.90 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 20 3 # 20 229 ASP B 171 ASP.? 13.77 CL CL B 383 264 GLU B 57 GLU.? 21.35 CL CL B 382 328 ASP B 93 ASP^? 5.22 CL CL B 383 coo 45.62 80.42 43.69 45.65 82.01 45.07 -14.88 46.75 66.62 -12.79 46.40 66.16 coo 59.69 92.71 39.85 58.53 92.03 41.47 -31.25 37.00 65.18 -31.15 36.75 63.13 coo 45.39 90.72 40.63 45.07 89.14 41.90 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 21 3 # 21 229 ASP B 291 ASP.? 20.64 CL CL B 382 264 GLU B 201 GLU^? 17.46 CL CL A 384 328 ASP A 195 ASP.? 13.29 CL CL A 384 coo 45.62 80.42 43.69 45.65 82.01 45.07 -11.26 60.51 82.59 -9.94 61.37 84.03 coo 59.69 92.71 39.85 58.53 92.03 41.47 -19.06 50.53 95.26 -20.94 50.61 94.28 coo 45.39 90.72 40.63 45.07 89.14 41.90 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 22 3 # 22 229 ASP B 305 ASP^? 21.59 CL CL A 384 264 GLU A 201 GLU.? 12.07 CL CL A 384 328 ASP B 195 ASP.? 10.47 CL CL A 384 coo 45.62 80.42 43.69 45.65 82.01 45.07 -6.28 49.81 99.79 -7.51 49.10 101.38 coo 59.69 92.71 39.85 58.53 92.03 41.47 -24.87 56.03 99.70 -24.21 54.93 101.40 coo 45.39 90.72 40.63 45.07 89.14 41.90 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 23 3 # 23 229 ASP B 306 ASP.? 19.57 CL CL A 384 264 GLU A 201 GLU.? 12.07 CL CL A 384 328 ASP B 195 ASP.? 10.47 CL CL A 384 coo 45.62 80.42 43.69 45.65 82.01 45.07 -4.64 54.84 103.01 -3.71 56.24 101.58 coo 59.69 92.71 39.85 58.53 92.03 41.47 -24.87 56.03 99.70 -24.21 54.93 101.40 coo 45.39 90.72 40.63 45.07 89.14 41.90 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 24 3 # 24 229 ASP B 327 ASP.? 22.34 CL CL A 384 264 GLU B 86 GLU^? 25.45 CL CL B 382 328 ASP B 26 ASP^? 16.51 CL CL B 383 coo 45.62 80.42 43.69 45.65 82.01 45.07 -25.62 46.25 93.54 -25.42 45.53 95.50 coo 59.69 92.71 39.85 58.53 92.03 41.47 -37.46 36.82 83.59 -36.60 37.35 85.50 coo 45.39 90.72 40.63 45.07 89.14 41.90 -23.45 39.33 83.60 -24.23 39.48 85.53 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 24 hits 1cdg_c00 naa= 3 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 180 ASP.? 19.13 CL CL A 382 257 GLU A 135 GLU.? 22.99 CL CL A 382 328 ASP A 344 ASP.? 20.56 CL CL A 382 coo 45.62 80.42 43.69 45.65 82.01 45.07 -29.53 80.77 112.24 -28.62 82.54 111.55 coo 48.97 85.16 40.39 47.18 86.25 40.47 -31.98 87.75 115.72 -30.11 88.72 115.32 coo 45.39 90.72 40.63 45.07 89.14 41.90 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP A 210 ASP.? 21.69 CL CL A 383 257 GLU A 276 GLU~? 16.10 CL CL A 383 328 ASP A 272 ASP~? 14.48 CL CL A 382 coo 45.62 80.42 43.69 45.65 82.01 45.07 -52.58 64.68 106.89 -53.21 62.78 107.37 coo 48.97 85.16 40.39 47.18 86.25 40.47 -46.62 67.79 110.40 -48.46 68.09 111.43 coo 45.39 90.72 40.63 45.07 89.14 41.90 -46.67 73.24 112.92 -45.43 74.19 114.38 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP A 272 ASP~? 14.48 CL CL A 382 257 GLU A 276 GLU~? 16.10 CL CL A 383 328 ASP A 210 ASP.? 21.69 CL CL A 383 coo 45.62 80.42 43.69 45.65 82.01 45.07 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 48.97 85.16 40.39 47.18 86.25 40.47 -46.62 67.79 110.40 -48.46 68.09 111.43 coo 45.39 90.72 40.63 45.07 89.14 41.90 -52.58 64.68 106.89 -53.21 62.78 107.37 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP A 344 ASP.? 20.56 CL CL A 382 257 GLU A 135 GLU.? 22.99 CL CL A 382 328 ASP A 180 ASP.? 19.13 CL CL A 382 coo 45.62 80.42 43.69 45.65 82.01 45.07 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 48.97 85.16 40.39 47.18 86.25 40.47 -31.98 87.75 115.72 -30.11 88.72 115.32 coo 45.39 90.72 40.63 45.07 89.14 41.90 -29.53 80.77 112.24 -28.62 82.54 111.55 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 3 # 5 229 ASP B 204 ASP^? 22.18 CL CL B 383 257 GLU B 206 GLU^? 19.18 CL CL B 383 328 ASP B 208 ASP.? 21.56 CL CL B 383 coo 45.62 80.42 43.69 45.65 82.01 45.07 -12.38 39.84 96.49 -14.33 39.98 97.22 coo 48.97 85.16 40.39 47.18 86.25 40.47 -9.17 35.76 95.82 -10.61 34.74 94.62 coo 45.39 90.72 40.63 45.07 89.14 41.90 -4.03 30.56 94.79 -4.11 28.51 94.21 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 6 3 # 6 229 ASP B 208 ASP.? 21.56 CL CL B 383 257 GLU B 206 GLU^? 19.18 CL CL B 383 328 ASP B 204 ASP^? 22.18 CL CL B 383 coo 45.62 80.42 43.69 45.65 82.01 45.07 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 48.97 85.16 40.39 47.18 86.25 40.47 -9.17 35.76 95.82 -10.61 34.74 94.62 coo 45.39 90.72 40.63 45.07 89.14 41.90 -12.38 39.84 96.49 -14.33 39.98 97.22 1cdg_c04 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 6 hits 1cdg_c04 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 7 GLY.? 16.09 CL CL A 384 A 228 SER B 192 SER.? 13.26 CL CL A 384 A 549 ASP B 195 ASP.? 10.47 CL CL A 384 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -12.90 54.74 109.89 -12.31 54.99 110.52 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -11.80 54.65 102.27 -11.20 56.97 103.08 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 A 198 GLY A 7 GLY.? 16.09 CL CL A 384 A 228 SER B 192 SER.? 13.26 CL CL A 384 A 549 ASP B 306 ASP.? 19.57 CL CL A 384 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -12.90 54.74 109.89 -12.31 54.99 110.52 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -11.80 54.65 102.27 -11.20 56.97 103.08 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -4.64 54.84 103.01 -3.71 56.24 101.58 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 A 198 GLY A 71 GLY^? 11.87 CL CL A 382 A 228 SER A 37 SER^? 9.11 CL CL A 382 A 549 ASP A 36 ASP.? -3.33 CL CL A 382s coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -27.35 61.47 128.32 -26.64 61.26 128.60 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -31.47 63.24 120.93 -31.90 65.07 119.91 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 A 198 GLY A 74 GLY^? 16.51 CL CL A 382 A 228 SER A 55 SER.? 23.04 CL CL A 383 A 549 ASP A 53 ASP.? 25.38 CL CL A 382 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -31.70 53.74 130.27 -31.13 53.19 130.05 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -27.78 51.03 133.17 -28.81 49.24 134.52 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -25.09 46.58 135.54 -27.02 47.57 135.30 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 A 198 GLY A 74 GLY^? 16.51 CL CL A 382 A 228 SER A 90 SER^? 16.73 CL CL A 382 A 549 ASP A 39 ASP^? 16.51 CL CL A 382 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -31.70 53.74 130.27 -31.13 53.19 130.05 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -29.94 52.31 124.96 -31.33 50.74 123.89 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 6 3 # 6 A 198 GLY A 91 GLY^? 13.11 CL CL A 382 A 228 SER A 37 SER^? 9.11 CL CL A 382 A 549 ASP A 28 ASP^? 9.02 CL CL A 382 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -30.66 55.67 126.28 -30.79 55.70 125.50 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -32.19 59.08 116.32 -33.48 59.98 114.85 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 7 3 # 7 A 198 GLY A 91 GLY^? 13.11 CL CL A 382 A 228 SER A 37 SER^? 9.11 CL CL A 382 A 549 ASP A 36 ASP.? -3.33 CL CL A 382s coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -30.66 55.67 126.28 -30.79 55.70 125.50 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -31.47 63.24 120.93 -31.90 65.07 119.91 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 8 3 # 8 A 198 GLY A 91 GLY^? 13.11 CL CL A 382 A 228 SER A 37 SER^? 9.11 CL CL A 382 A 549 ASP A 93 ASP^? 5.15 CL CL A 382 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -30.66 55.67 126.28 -30.79 55.70 125.50 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 9 3 # 9 A 198 GLY A 224 GLY.? 32.04 CL CL A 383 A 228 SER A 222 SER.? 30.25 CL CL A 383 A 549 ASP A 233 ASP.? 30.79 CL CL A 383 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -61.49 91.50 128.60 -61.32 91.54 127.81 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -59.78 88.32 124.78 -60.21 90.11 123.17 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -64.45 88.75 121.31 -62.88 88.68 122.75 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 10 3 # 10 A 198 GLY A 224 GLY.? 32.04 CL CL A 383 A 228 SER A 222 SER.? 30.25 CL CL A 383 A 549 ASP A 257 ASP.? 24.30 CL CL A 383 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -61.49 91.50 128.60 -61.32 91.54 127.81 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -59.78 88.32 124.78 -60.21 90.11 123.17 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -55.05 88.25 125.09 -55.04 86.55 126.35 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 11 3 # 11 A 198 GLY A 285 GLY^? 9.46 CL CL A 384 A 228 SER B 196 SER.? 5.60 CL CL A 384 A 549 ASP B 195 ASP.? 10.47 CL CL A 384 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -22.09 57.26 103.59 -22.19 58.16 103.73 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -16.29 59.80 99.85 -17.47 61.93 100.11 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 12 3 # 12 A 198 GLY A 286 GLY.? 9.30 CL CL A 384 A 228 SER B 196 SER.? 5.60 CL CL A 384 A 549 ASP B 195 ASP.? 10.47 CL CL A 384 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -20.05 58.49 106.62 -20.88 58.44 106.59 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -16.29 59.80 99.85 -17.47 61.93 100.11 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 13 3 # 13 A 198 GLY A 318 GLY^? 8.74 CL CL A 382 A 228 SER A 29 SER^? 6.92 CL CL A 382 A 549 ASP A 36 ASP.? -3.33 CL CL A 382s coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -33.39 65.39 112.09 -32.99 65.64 111.42 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -31.31 63.66 116.96 -29.07 63.86 117.79 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -31.47 63.24 120.93 -31.90 65.07 119.91 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 14 3 # 14 A 198 GLY B 7 GLY.? 12.08 CL CL B 382 A 228 SER A 192 SER.? 15.36 CL CL A 384 A 549 ASP A 195 ASP.? 13.29 CL CL A 384 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -28.36 56.59 83.26 -28.24 57.01 82.53 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 15 3 # 15 A 198 GLY B 7 GLY.? 12.08 CL CL B 382 A 228 SER A 192 SER.? 15.36 CL CL A 384 A 549 ASP A 306 ASP.? 16.66 CL CL A 384 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -28.36 56.59 83.26 -28.24 57.01 82.53 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -29.63 66.56 87.01 -28.35 68.29 87.20 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 16 3 # 16 A 198 GLY B 71 GLY^? 12.01 CL CL B 383 A 228 SER B 37 SER^? 9.16 CL CL B 383 A 549 ASP B 36 ASP.? -3.35 CL CL B 383s coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -21.31 38.41 68.97 -21.84 38.86 68.63 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -15.98 38.04 75.83 -14.00 38.51 76.08 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 17 3 # 17 A 198 GLY B 74 GLY^? 16.45 CL CL B 383 A 228 SER B 55 SER.? 22.28 CL CL B 384 A 549 ASP B 53 ASP.? 25.44 CL CL B 384 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -26.68 31.63 71.52 -27.33 32.04 71.74 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -31.36 33.02 68.90 -32.51 30.85 68.96 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -37.14 32.94 67.80 -35.44 31.68 68.05 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 18 3 # 18 A 198 GLY B 74 GLY^? 16.45 CL CL B 383 A 228 SER B 90 SER^? 16.63 CL CL B 383 A 549 ASP B 39 ASP^? 17.51 CL CL B 383 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -26.68 31.63 71.52 -27.33 32.04 71.74 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -27.25 35.25 76.13 -27.68 33.11 77.15 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -26.18 36.85 80.53 -27.97 36.10 81.34 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 19 3 # 19 A 198 GLY B 91 GLY^? 13.05 CL CL B 383 A 228 SER B 37 SER^? 9.16 CL CL B 383 A 549 ASP B 28 ASP^? 9.00 CL CL B 383 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -24.29 34.63 73.94 -24.01 34.96 74.63 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -18.06 38.42 81.61 -16.37 38.03 82.88 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 20 3 # 20 A 198 GLY B 91 GLY^? 13.05 CL CL B 383 A 228 SER B 37 SER^? 9.16 CL CL B 383 A 549 ASP B 36 ASP.? -3.35 CL CL B 383s coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -24.29 34.63 73.94 -24.01 34.96 74.63 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -15.98 38.04 75.83 -14.00 38.51 76.08 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 21 3 # 21 A 198 GLY B 91 GLY^? 13.05 CL CL B 383 A 228 SER B 37 SER^? 9.16 CL CL B 383 A 549 ASP B 93 ASP^? 5.22 CL CL B 383 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -24.29 34.63 73.94 -24.01 34.96 74.63 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 22 3 # 22 A 198 GLY B 285 GLY^? 18.43 CL CL A 384 A 228 SER A 196 SER.? 14.25 CL CL A 384 A 549 ASP A 195 ASP.? 13.29 CL CL A 384 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -20.19 51.54 90.83 -19.46 51.66 90.42 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -19.39 59.32 90.69 -17.16 59.45 89.72 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 23 3 # 23 A 198 GLY B 286 GLY.? 16.50 CL CL B 382 A 228 SER A 196 SER.? 14.25 CL CL A 384 A 549 ASP A 195 ASP.? 13.29 CL CL A 384 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -20.98 52.54 87.27 -20.62 51.84 87.46 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -19.39 59.32 90.69 -17.16 59.45 89.72 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 24 3 # 24 A 198 GLY B 318 GLY^? 8.69 CL CL B 383 A 228 SER B 29 SER^? 6.98 CL CL B 383 A 549 ASP B 36 ASP.? -3.35 CL CL B 383s coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -10.95 40.65 83.09 -10.71 41.37 83.45 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -14.55 40.12 78.88 -15.61 41.67 77.42 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -15.98 38.04 75.83 -14.00 38.51 76.08 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 24 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY A 7 GLY.? 16.09 CL CL A 384 B1228 SER B 192 SER.? 13.26 CL CL A 384 B1549 ASP B 195 ASP.? 10.47 CL CL A 384 coo 126.34 72.75 125.66 125.95 73.27 126.11 -12.90 54.74 109.89 -12.31 54.99 110.52 coo 131.65 74.68 129.41 130.31 72.73 128.82 -11.80 54.65 102.27 -11.20 56.97 103.08 coo 134.72 69.43 130.42 133.03 70.65 130.08 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY A 7 GLY.? 16.09 CL CL A 384 B1228 SER B 192 SER.? 13.26 CL CL A 384 B1549 ASP B 306 ASP.? 19.57 CL CL A 384 coo 126.34 72.75 125.66 125.95 73.27 126.11 -12.90 54.74 109.89 -12.31 54.99 110.52 coo 131.65 74.68 129.41 130.31 72.73 128.82 -11.80 54.65 102.27 -11.20 56.97 103.08 coo 134.72 69.43 130.42 133.03 70.65 130.08 -4.64 54.84 103.01 -3.71 56.24 101.58 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 B1198 GLY A 71 GLY^? 11.87 CL CL A 382 B1228 SER A 37 SER^? 9.11 CL CL A 382 B1549 ASP A 36 ASP.? -3.33 CL CL A 382s coo 126.34 72.75 125.66 125.95 73.27 126.11 -27.35 61.47 128.32 -26.64 61.26 128.60 coo 131.65 74.68 129.41 130.31 72.73 128.82 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 134.72 69.43 130.42 133.03 70.65 130.08 -31.47 63.24 120.93 -31.90 65.07 119.91 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 B1198 GLY A 74 GLY^? 16.51 CL CL A 382 B1228 SER A 55 SER.? 23.04 CL CL A 383 B1549 ASP A 53 ASP.? 25.38 CL CL A 382 coo 126.34 72.75 125.66 125.95 73.27 126.11 -31.70 53.74 130.27 -31.13 53.19 130.05 coo 131.65 74.68 129.41 130.31 72.73 128.82 -27.78 51.03 133.17 -28.81 49.24 134.52 coo 134.72 69.43 130.42 133.03 70.65 130.08 -25.09 46.58 135.54 -27.02 47.57 135.30 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 B1198 GLY A 74 GLY^? 16.51 CL CL A 382 B1228 SER A 90 SER^? 16.73 CL CL A 382 B1549 ASP A 39 ASP^? 16.51 CL CL A 382 coo 126.34 72.75 125.66 125.95 73.27 126.11 -31.70 53.74 130.27 -31.13 53.19 130.05 coo 131.65 74.68 129.41 130.31 72.73 128.82 -29.94 52.31 124.96 -31.33 50.74 123.89 coo 134.72 69.43 130.42 133.03 70.65 130.08 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 6 3 # 6 B1198 GLY A 91 GLY^? 13.11 CL CL A 382 B1228 SER A 37 SER^? 9.11 CL CL A 382 B1549 ASP A 26 ASP^? 16.59 CL CL A 382 coo 126.34 72.75 125.66 125.95 73.27 126.11 -30.66 55.67 126.28 -30.79 55.70 125.50 coo 131.65 74.68 129.41 130.31 72.73 128.82 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 134.72 69.43 130.42 133.03 70.65 130.08 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 7 3 # 7 B1198 GLY A 91 GLY^? 13.11 CL CL A 382 B1228 SER A 37 SER^? 9.11 CL CL A 382 B1549 ASP A 28 ASP^? 9.02 CL CL A 382 coo 126.34 72.75 125.66 125.95 73.27 126.11 -30.66 55.67 126.28 -30.79 55.70 125.50 coo 131.65 74.68 129.41 130.31 72.73 128.82 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 134.72 69.43 130.42 133.03 70.65 130.08 -32.19 59.08 116.32 -33.48 59.98 114.85 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 8 3 # 8 B1198 GLY A 91 GLY^? 13.11 CL CL A 382 B1228 SER A 37 SER^? 9.11 CL CL A 382 B1549 ASP A 36 ASP.? -3.33 CL CL A 382s coo 126.34 72.75 125.66 125.95 73.27 126.11 -30.66 55.67 126.28 -30.79 55.70 125.50 coo 131.65 74.68 129.41 130.31 72.73 128.82 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 134.72 69.43 130.42 133.03 70.65 130.08 -31.47 63.24 120.93 -31.90 65.07 119.91 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 9 3 # 9 B1198 GLY A 91 GLY^? 13.11 CL CL A 382 B1228 SER A 37 SER^? 9.11 CL CL A 382 B1549 ASP A 93 ASP^? 5.15 CL CL A 382 coo 126.34 72.75 125.66 125.95 73.27 126.11 -30.66 55.67 126.28 -30.79 55.70 125.50 coo 131.65 74.68 129.41 130.31 72.73 128.82 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 134.72 69.43 130.42 133.03 70.65 130.08 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 10 3 # 10 B1198 GLY A 148 GLY.? 11.08 CL CL A 383 B1228 SER A 102 SER.? 10.64 CL CL A 383 B1549 ASP A 100 ASP~? 8.92 CL CL A 383 coo 126.34 72.75 125.66 125.95 73.27 126.11 -49.51 66.91 135.22 -49.43 67.62 134.85 coo 131.65 74.68 129.41 130.31 72.73 128.82 -43.16 67.12 136.34 -45.34 66.31 136.69 coo 134.72 69.43 130.42 133.03 70.65 130.08 -39.25 61.23 132.92 -38.42 59.82 131.54 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 11 3 # 11 B1198 GLY A 224 GLY.? 32.04 CL CL A 383 B1228 SER A 222 SER.? 30.25 CL CL A 383 B1549 ASP A 233 ASP.? 30.79 CL CL A 383 coo 126.34 72.75 125.66 125.95 73.27 126.11 -61.49 91.50 128.60 -61.32 91.54 127.81 coo 131.65 74.68 129.41 130.31 72.73 128.82 -59.78 88.32 124.78 -60.21 90.11 123.17 coo 134.72 69.43 130.42 133.03 70.65 130.08 -64.45 88.75 121.31 -62.88 88.68 122.75 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 12 3 # 12 B1198 GLY A 285 GLY^? 9.46 CL CL A 384 B1228 SER B 196 SER.? 5.60 CL CL A 384 B1549 ASP B 195 ASP.? 10.47 CL CL A 384 coo 126.34 72.75 125.66 125.95 73.27 126.11 -22.09 57.26 103.59 -22.19 58.16 103.73 coo 131.65 74.68 129.41 130.31 72.73 128.82 -16.29 59.80 99.85 -17.47 61.93 100.11 coo 134.72 69.43 130.42 133.03 70.65 130.08 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 13 3 # 13 B1198 GLY A 286 GLY.? 9.30 CL CL A 384 B1228 SER B 196 SER.? 5.60 CL CL A 384 B1549 ASP B 195 ASP.? 10.47 CL CL A 384 coo 126.34 72.75 125.66 125.95 73.27 126.11 -20.05 58.49 106.62 -20.88 58.44 106.59 coo 131.65 74.68 129.41 130.31 72.73 128.82 -16.29 59.80 99.85 -17.47 61.93 100.11 coo 134.72 69.43 130.42 133.03 70.65 130.08 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 14 3 # 14 B1198 GLY B 7 GLY.? 12.08 CL CL B 382 B1228 SER A 192 SER.? 15.36 CL CL A 384 B1549 ASP A 195 ASP.? 13.29 CL CL A 384 coo 126.34 72.75 125.66 125.95 73.27 126.11 -28.36 56.59 83.26 -28.24 57.01 82.53 coo 131.65 74.68 129.41 130.31 72.73 128.82 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 134.72 69.43 130.42 133.03 70.65 130.08 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 15 3 # 15 B1198 GLY B 7 GLY.? 12.08 CL CL B 382 B1228 SER A 192 SER.? 15.36 CL CL A 384 B1549 ASP A 306 ASP.? 16.66 CL CL A 384 coo 126.34 72.75 125.66 125.95 73.27 126.11 -28.36 56.59 83.26 -28.24 57.01 82.53 coo 131.65 74.68 129.41 130.31 72.73 128.82 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 134.72 69.43 130.42 133.03 70.65 130.08 -29.63 66.56 87.01 -28.35 68.29 87.20 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 16 3 # 16 B1198 GLY B 71 GLY^? 12.01 CL CL B 383 B1228 SER B 37 SER^? 9.16 CL CL B 383 B1549 ASP B 36 ASP.? -3.35 CL CL B 383s coo 126.34 72.75 125.66 125.95 73.27 126.11 -21.31 38.41 68.97 -21.84 38.86 68.63 coo 131.65 74.68 129.41 130.31 72.73 128.82 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 134.72 69.43 130.42 133.03 70.65 130.08 -15.98 38.04 75.83 -14.00 38.51 76.08 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 17 3 # 17 B1198 GLY B 74 GLY^? 16.45 CL CL B 383 B1228 SER B 55 SER.? 22.28 CL CL B 384 B1549 ASP B 53 ASP.? 25.44 CL CL B 384 coo 126.34 72.75 125.66 125.95 73.27 126.11 -26.68 31.63 71.52 -27.33 32.04 71.74 coo 131.65 74.68 129.41 130.31 72.73 128.82 -31.36 33.02 68.90 -32.51 30.85 68.96 coo 134.72 69.43 130.42 133.03 70.65 130.08 -37.14 32.94 67.80 -35.44 31.68 68.05 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 18 3 # 18 B1198 GLY B 74 GLY^? 16.45 CL CL B 383 B1228 SER B 90 SER^? 16.63 CL CL B 383 B1549 ASP B 39 ASP^? 17.51 CL CL B 383 coo 126.34 72.75 125.66 125.95 73.27 126.11 -26.68 31.63 71.52 -27.33 32.04 71.74 coo 131.65 74.68 129.41 130.31 72.73 128.82 -27.25 35.25 76.13 -27.68 33.11 77.15 coo 134.72 69.43 130.42 133.03 70.65 130.08 -26.18 36.85 80.53 -27.97 36.10 81.34 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 19 3 # 19 B1198 GLY B 91 GLY^? 13.05 CL CL B 383 B1228 SER B 37 SER^? 9.16 CL CL B 383 B1549 ASP B 26 ASP^? 16.51 CL CL B 383 coo 126.34 72.75 125.66 125.95 73.27 126.11 -24.29 34.63 73.94 -24.01 34.96 74.63 coo 131.65 74.68 129.41 130.31 72.73 128.82 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 134.72 69.43 130.42 133.03 70.65 130.08 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 20 3 # 20 B1198 GLY B 91 GLY^? 13.05 CL CL B 383 B1228 SER B 37 SER^? 9.16 CL CL B 383 B1549 ASP B 28 ASP^? 9.00 CL CL B 383 coo 126.34 72.75 125.66 125.95 73.27 126.11 -24.29 34.63 73.94 -24.01 34.96 74.63 coo 131.65 74.68 129.41 130.31 72.73 128.82 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 134.72 69.43 130.42 133.03 70.65 130.08 -18.06 38.42 81.61 -16.37 38.03 82.88 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 21 3 # 21 B1198 GLY B 91 GLY^? 13.05 CL CL B 383 B1228 SER B 37 SER^? 9.16 CL CL B 383 B1549 ASP B 36 ASP.? -3.35 CL CL B 383s coo 126.34 72.75 125.66 125.95 73.27 126.11 -24.29 34.63 73.94 -24.01 34.96 74.63 coo 131.65 74.68 129.41 130.31 72.73 128.82 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 134.72 69.43 130.42 133.03 70.65 130.08 -15.98 38.04 75.83 -14.00 38.51 76.08 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 22 3 # 22 B1198 GLY B 148 GLY.? 11.16 CL CL B 384 B1228 SER B 102 SER.? 11.35 CL CL B 384 B1549 ASP B 100 ASP~? 8.80 CL CL B 384 coo 126.34 72.75 125.66 125.95 73.27 126.11 -10.37 17.04 67.47 -9.78 17.53 67.22 coo 131.65 74.68 129.41 130.31 72.73 128.82 -12.47 21.91 64.46 -13.46 19.75 64.64 coo 134.72 69.43 130.42 133.03 70.65 130.08 -18.20 25.71 68.46 -19.22 26.77 70.02 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 23 3 # 23 B1198 GLY B 285 GLY^? 18.43 CL CL A 384 B1228 SER A 196 SER.? 14.25 CL CL A 384 B1549 ASP A 195 ASP.? 13.29 CL CL A 384 coo 126.34 72.75 125.66 125.95 73.27 126.11 -20.19 51.54 90.83 -19.46 51.66 90.42 coo 131.65 74.68 129.41 130.31 72.73 128.82 -19.39 59.32 90.69 -17.16 59.45 89.72 coo 134.72 69.43 130.42 133.03 70.65 130.08 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 24 3 # 24 B1198 GLY B 286 GLY.? 16.50 CL CL B 382 B1228 SER A 196 SER.? 14.25 CL CL A 384 B1549 ASP A 195 ASP.? 13.29 CL CL A 384 coo 126.34 72.75 125.66 125.95 73.27 126.11 -20.98 52.54 87.27 -20.62 51.84 87.46 coo 131.65 74.68 129.41 130.31 72.73 128.82 -19.39 59.32 90.69 -17.16 59.45 89.72 coo 134.72 69.43 130.42 133.03 70.65 130.08 -22.13 62.52 88.27 -20.53 63.80 88.70 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 24 hits 1cjy_c01 naa= 3 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 1 3 # 1 34 ASP A 28 ASP^? 9.02 CL CL A 382 37 SER A 37 SER^? 9.11 CL CL A 382 216 ASP A 30 ASP^? -6.81 CL CL A 382s coo 16.90 26.20 29.49 16.22 24.50 28.41 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 12.23 24.31 30.40 14.55 23.96 31.03 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 13.93 25.52 22.10 14.75 24.44 23.75 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 2 3 # 2 34 ASP A 28 ASP^? 9.02 CL CL A 382 37 SER A 37 SER^? 9.11 CL CL A 382 216 ASP A 39 ASP^? 16.51 CL CL A 382 coo 16.90 26.20 29.49 16.22 24.50 28.41 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 12.23 24.31 30.40 14.55 23.96 31.03 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 13.93 25.52 22.10 14.75 24.44 23.75 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 3 3 # 3 34 ASP A 36 ASP.? -3.33 CL CL A 382s 37 SER A 37 SER^? 9.11 CL CL A 382 216 ASP A 30 ASP^? -6.81 CL CL A 382s coo 16.90 26.20 29.49 16.22 24.50 28.41 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 12.23 24.31 30.40 14.55 23.96 31.03 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 13.93 25.52 22.10 14.75 24.44 23.75 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 4 3 # 4 34 ASP A 195 ASP.? 13.29 CL CL A 384 37 SER A 192 SER.? 15.36 CL CL A 384 216 ASP A 306 ASP.? 16.66 CL CL A 384 coo 16.90 26.20 29.49 16.22 24.50 28.41 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 12.23 24.31 30.40 14.55 23.96 31.03 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 13.93 25.52 22.10 14.75 24.44 23.75 -29.63 66.56 87.01 -28.35 68.29 87.20 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 5 3 # 5 34 ASP B 28 ASP^? 9.00 CL CL B 383 37 SER B 29 SER^? 6.98 CL CL B 383 216 ASP B 93 ASP^? 5.22 CL CL B 383 coo 16.90 26.20 29.49 16.22 24.50 28.41 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 12.23 24.31 30.40 14.55 23.96 31.03 -14.55 40.12 78.88 -15.61 41.67 77.42 coo 13.93 25.52 22.10 14.75 24.44 23.75 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 6 3 # 6 34 ASP B 28 ASP^? 9.00 CL CL B 383 37 SER B 37 SER^? 9.16 CL CL B 383 216 ASP B 30 ASP^? -6.72 CL CL B 383s coo 16.90 26.20 29.49 16.22 24.50 28.41 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 12.23 24.31 30.40 14.55 23.96 31.03 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 13.93 25.52 22.10 14.75 24.44 23.75 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 7 3 # 7 34 ASP B 28 ASP^? 9.00 CL CL B 383 37 SER B 37 SER^? 9.16 CL CL B 383 216 ASP B 39 ASP^? 17.51 CL CL B 383 coo 16.90 26.20 29.49 16.22 24.50 28.41 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 12.23 24.31 30.40 14.55 23.96 31.03 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 13.93 25.52 22.10 14.75 24.44 23.75 -26.18 36.85 80.53 -27.97 36.10 81.34 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 8 3 # 8 34 ASP B 36 ASP.? -3.35 CL CL B 383s 37 SER B 37 SER^? 9.16 CL CL B 383 216 ASP B 30 ASP^? -6.72 CL CL B 383s coo 16.90 26.20 29.49 16.22 24.50 28.41 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 12.23 24.31 30.40 14.55 23.96 31.03 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 13.93 25.52 22.10 14.75 24.44 23.75 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 9 3 # 9 34 ASP B 195 ASP.? 10.47 CL CL A 384 37 SER B 192 SER.? 13.26 CL CL A 384 216 ASP B 306 ASP.? 19.57 CL CL A 384 coo 16.90 26.20 29.49 16.22 24.50 28.41 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 12.23 24.31 30.40 14.55 23.96 31.03 -11.80 54.65 102.27 -11.20 56.97 103.08 coo 13.93 25.52 22.10 14.75 24.44 23.75 -4.64 54.84 103.01 -3.71 56.24 101.58 1cms_c04 source 1cms CHYMOSIN B (FORMERLY KNOWN AS RENNIN) (E.C.3.4: 9 hits 1cms_c04 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU A 60 GLU^? 17.84 CL CL A 382 A 89 GLU A 18 GLU^? 23.23 CL CL A 382 A 120 SER A 11 SER^? 21.10 CL CL A 382 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -20.60 62.82 127.64 -18.87 63.84 128.41 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -12.62 56.10 125.83 -13.81 57.82 125.60 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -17.58 55.42 121.82 -16.10 56.98 122.78 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU A 201 GLU.? 12.07 CL CL A 384 A 89 GLU B 201 GLU^? 17.46 CL CL A 384 A 120 SER A 196 SER.? 14.25 CL CL A 384 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -24.87 56.03 99.70 -24.21 54.93 101.40 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -19.06 50.53 95.26 -20.94 50.61 94.28 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -19.39 59.32 90.69 -17.16 59.45 89.72 ULMN 3 1cns_c00 CHITINASE user 3 3 # 3 A 67 GLU B 201 GLU^? 17.46 CL CL A 384 A 89 GLU A 201 GLU.? 12.07 CL CL A 384 A 120 SER B 196 SER.? 5.60 CL CL A 384 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -19.06 50.53 95.26 -20.94 50.61 94.28 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -24.87 56.03 99.70 -24.21 54.93 101.40 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -16.29 59.80 99.85 -17.47 61.93 100.11 1cns_c00 source 1cns CHITINASE : 3 hits 1cns_c00 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 8 TYR.? 12.26 CL CL A 384 A 173 ASP A 64 ASP.? 15.21 CL CL A 384 C 48 ARG B 193 ARG.? 19.02 CL CL A 384 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -16.53 57.80 111.57 -17.14 59.34 109.36 coo 24.35 4.55 25.11 25.94 3.23 25.53 -13.50 61.63 115.26 -13.45 60.20 113.75 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -14.12 50.83 106.82 -12.70 50.89 109.57 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR A 25 TYR^? 18.63 CL CL A 382 A 173 ASP A 39 ASP^? 16.51 CL CL A 382 C 48 ARG A 319 ARG^? 9.49 CL CL A 382 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -23.49 53.13 116.11 -21.60 54.30 114.36 coo 24.35 4.55 25.11 25.94 3.23 25.53 -29.94 52.12 119.85 -30.97 50.72 120.81 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -27.23 63.29 112.77 -27.13 63.50 115.87 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 101 TYR A 346 TYR.? 17.61 CL CL A 382 A 173 ASP A 344 ASP.? 20.56 CL CL A 382 C 48 ARG A 300 ARG^? 15.75 CL CL A 384 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -31.44 83.83 114.39 -30.05 82.53 116.45 coo 24.35 4.55 25.11 25.94 3.23 25.53 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -30.16 77.29 106.40 -29.79 78.90 103.79 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 101 TYR B 8 TYR.? 11.88 CL CL B 382 A 173 ASP B 64 ASP.? 7.14 CL CL B 382 C 48 ARG A 193 ARG.? 15.01 CL CL B 382 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -23.96 53.72 82.39 -21.76 54.53 83.93 coo 24.35 4.55 25.11 25.94 3.23 25.53 -22.24 55.99 77.05 -23.77 56.03 78.56 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -30.19 56.43 87.97 -31.59 55.92 85.25 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 101 TYR B 25 TYR^? 14.27 CL CL B 382 A 173 ASP B 39 ASP^? 17.51 CL CL B 383 C 48 ARG B 319 ARG^? 9.63 CL CL B 383 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -26.62 44.42 81.68 -25.97 47.00 82.31 coo 24.35 4.55 25.11 25.94 3.23 25.53 -26.18 36.85 80.53 -27.97 36.10 81.34 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -15.74 45.22 81.80 -15.96 44.19 78.93 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 101 TYR B 346 TYR.? 17.60 CL CL B 383 A 173 ASP B 344 ASP.? 20.04 CL CL B 383 C 48 ARG B 300 ARG^? 21.49 CL CL B 383 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 3.94 45.97 72.94 1.71 46.24 71.30 coo 24.35 4.55 25.11 25.94 3.23 25.53 7.59 38.09 74.22 8.59 36.72 75.50 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 0.10 48.73 83.03 1.88 51.20 83.58 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 6 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG A 193 ARG.? 15.01 CL CL B 382 C 101 TYR B 8 TYR.? 11.88 CL CL B 382 C 173 ASP B 64 ASP.? 7.14 CL CL B 382 coo 32.27 5.62 48.15 31.93 6.48 51.06 -30.19 56.43 87.97 -31.59 55.92 85.25 coo 29.64 3.64 57.39 31.22 5.14 55.65 -23.96 53.72 82.39 -21.76 54.53 83.93 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -22.24 55.99 77.05 -23.77 56.03 78.56 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 48 ARG A 300 ARG^? 15.75 CL CL A 384 C 101 TYR A 346 TYR.? 17.61 CL CL A 382 C 173 ASP A 344 ASP.? 20.56 CL CL A 382 coo 32.27 5.62 48.15 31.93 6.48 51.06 -30.16 77.29 106.40 -29.79 78.90 103.79 coo 29.64 3.64 57.39 31.22 5.14 55.65 -31.44 83.83 114.39 -30.05 82.53 116.45 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 48 ARG A 319 ARG^? 9.49 CL CL A 382 C 101 TYR A 25 TYR^? 18.63 CL CL A 382 C 173 ASP A 39 ASP^? 16.51 CL CL A 382 coo 32.27 5.62 48.15 31.93 6.48 51.06 -27.23 63.29 112.77 -27.13 63.50 115.87 coo 29.64 3.64 57.39 31.22 5.14 55.65 -23.49 53.13 116.11 -21.60 54.30 114.36 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 48 ARG B 193 ARG.? 19.02 CL CL A 384 C 101 TYR A 8 TYR.? 12.26 CL CL A 384 C 173 ASP A 64 ASP.? 15.21 CL CL A 384 coo 32.27 5.62 48.15 31.93 6.48 51.06 -14.12 50.83 106.82 -12.70 50.89 109.57 coo 29.64 3.64 57.39 31.22 5.14 55.65 -16.53 57.80 111.57 -17.14 59.34 109.36 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -13.50 61.63 115.26 -13.45 60.20 113.75 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 48 ARG B 300 ARG^? 21.49 CL CL B 383 C 101 TYR B 346 TYR.? 17.60 CL CL B 383 C 173 ASP B 344 ASP.? 20.04 CL CL B 383 coo 32.27 5.62 48.15 31.93 6.48 51.06 0.10 48.73 83.03 1.88 51.20 83.58 coo 29.64 3.64 57.39 31.22 5.14 55.65 3.94 45.97 72.94 1.71 46.24 71.30 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 7.59 38.09 74.22 8.59 36.72 75.50 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 48 ARG B 319 ARG^? 9.63 CL CL B 383 C 101 TYR B 25 TYR^? 14.27 CL CL B 382 C 173 ASP B 39 ASP^? 17.51 CL CL B 383 coo 32.27 5.62 48.15 31.93 6.48 51.06 -15.74 45.22 81.80 -15.96 44.19 78.93 coo 29.64 3.64 57.39 31.22 5.14 55.65 -26.62 44.42 81.68 -25.97 47.00 82.31 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -26.18 36.85 80.53 -27.97 36.10 81.34 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 6 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 193 ARG.? 15.01 CL CL B 382 D 101 TYR B 8 TYR.? 11.88 CL CL B 382 D 173 ASP B 64 ASP.? 7.14 CL CL B 382 coo 69.08 8.58 32.60 69.70 10.81 30.58 -30.19 56.43 87.97 -31.59 55.92 85.25 coo 71.77 11.86 24.26 70.23 12.22 26.56 -23.96 53.72 82.39 -21.76 54.53 83.93 coo 71.60 6.14 19.25 70.26 6.87 20.69 -22.24 55.99 77.05 -23.77 56.03 78.56 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG A 300 ARG^? 15.75 CL CL A 384 D 101 TYR A 346 TYR.? 17.61 CL CL A 382 D 173 ASP A 344 ASP.? 20.56 CL CL A 382 coo 69.08 8.58 32.60 69.70 10.81 30.58 -30.16 77.29 106.40 -29.79 78.90 103.79 coo 71.77 11.86 24.26 70.23 12.22 26.56 -31.44 83.83 114.39 -30.05 82.53 116.45 coo 71.60 6.14 19.25 70.26 6.87 20.69 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 48 ARG A 319 ARG^? 9.49 CL CL A 382 D 101 TYR A 25 TYR^? 18.63 CL CL A 382 D 173 ASP A 39 ASP^? 16.51 CL CL A 382 coo 69.08 8.58 32.60 69.70 10.81 30.58 -27.23 63.29 112.77 -27.13 63.50 115.87 coo 71.77 11.86 24.26 70.23 12.22 26.56 -23.49 53.13 116.11 -21.60 54.30 114.36 coo 71.60 6.14 19.25 70.26 6.87 20.69 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 48 ARG B 193 ARG.? 19.02 CL CL A 384 D 101 TYR A 8 TYR.? 12.26 CL CL A 384 D 173 ASP A 64 ASP.? 15.21 CL CL A 384 coo 69.08 8.58 32.60 69.70 10.81 30.58 -14.12 50.83 106.82 -12.70 50.89 109.57 coo 71.77 11.86 24.26 70.23 12.22 26.56 -16.53 57.80 111.57 -17.14 59.34 109.36 coo 71.60 6.14 19.25 70.26 6.87 20.69 -13.50 61.63 115.26 -13.45 60.20 113.75 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 48 ARG B 300 ARG^? 21.49 CL CL B 383 D 101 TYR B 346 TYR.? 17.60 CL CL B 383 D 173 ASP B 344 ASP.? 20.04 CL CL B 383 coo 69.08 8.58 32.60 69.70 10.81 30.58 0.10 48.73 83.03 1.88 51.20 83.58 coo 71.77 11.86 24.26 70.23 12.22 26.56 3.94 45.97 72.94 1.71 46.24 71.30 coo 71.60 6.14 19.25 70.26 6.87 20.69 7.59 38.09 74.22 8.59 36.72 75.50 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 48 ARG B 319 ARG^? 9.63 CL CL B 383 D 101 TYR B 25 TYR^? 14.27 CL CL B 382 D 173 ASP B 39 ASP^? 17.51 CL CL B 383 coo 69.08 8.58 32.60 69.70 10.81 30.58 -15.74 45.22 81.80 -15.96 44.19 78.93 coo 71.77 11.86 24.26 70.23 12.22 26.56 -26.62 44.42 81.68 -25.97 47.00 82.31 coo 71.60 6.14 19.25 70.26 6.87 20.69 -26.18 36.85 80.53 -27.97 36.10 81.34 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 6 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR A 8 TYR.? 12.26 CL CL A 384 B 173 ASP A 64 ASP.? 15.21 CL CL A 384 D 48 ARG B 193 ARG.? 19.02 CL CL A 384 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -16.53 57.80 111.57 -17.14 59.34 109.36 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -13.50 61.63 115.26 -13.45 60.20 113.75 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -14.12 50.83 106.82 -12.70 50.89 109.57 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR A 25 TYR^? 18.63 CL CL A 382 B 173 ASP A 26 ASP^? 16.59 CL CL A 382 D 48 ARG A 325 ARG.? 29.26 CL CL A 384 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -23.49 53.13 116.11 -21.60 54.30 114.36 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -29.69 53.68 115.80 -29.91 52.24 114.24 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -22.19 42.21 111.60 -22.86 39.29 112.51 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 101 TYR A 25 TYR^? 18.63 CL CL A 382 B 173 ASP A 39 ASP^? 16.51 CL CL A 382 D 48 ARG A 319 ARG^? 9.49 CL CL A 382 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -23.49 53.13 116.11 -21.60 54.30 114.36 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -29.94 52.12 119.85 -30.97 50.72 120.81 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -27.23 63.29 112.77 -27.13 63.50 115.87 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 101 TYR A 25 TYR^? 18.63 CL CL A 382 B 173 ASP A 39 ASP^? 16.51 CL CL A 382 D 48 ARG A 325 ARG.? 29.26 CL CL A 384 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -23.49 53.13 116.11 -21.60 54.30 114.36 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -29.94 52.12 119.85 -30.97 50.72 120.81 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -22.19 42.21 111.60 -22.86 39.29 112.51 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 101 TYR A 346 TYR.? 17.61 CL CL A 382 B 173 ASP A 344 ASP.? 20.56 CL CL A 382 D 48 ARG A 300 ARG^? 15.75 CL CL A 384 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -31.44 83.83 114.39 -30.05 82.53 116.45 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -30.16 77.29 106.40 -29.79 78.90 103.79 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 101 TYR B 8 TYR.? 11.88 CL CL B 382 B 173 ASP B 64 ASP.? 7.14 CL CL B 382 D 48 ARG A 193 ARG.? 15.01 CL CL B 382 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -23.96 53.72 82.39 -21.76 54.53 83.93 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -22.24 55.99 77.05 -23.77 56.03 78.56 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -30.19 56.43 87.97 -31.59 55.92 85.25 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 101 TYR B 8 TYR.? 11.88 CL CL B 382 B 173 ASP B 64 ASP.? 7.14 CL CL B 382 D 48 ARG B 319 ARG^? 9.63 CL CL B 383 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -23.96 53.72 82.39 -21.76 54.53 83.93 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -22.24 55.99 77.05 -23.77 56.03 78.56 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -15.74 45.22 81.80 -15.96 44.19 78.93 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 101 TYR B 25 TYR^? 14.27 CL CL B 382 B 173 ASP B 39 ASP^? 17.51 CL CL B 383 D 48 ARG B 319 ARG^? 9.63 CL CL B 383 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -26.62 44.42 81.68 -25.97 47.00 82.31 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -26.18 36.85 80.53 -27.97 36.10 81.34 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -15.74 45.22 81.80 -15.96 44.19 78.93 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 101 TYR B 346 TYR.? 17.60 CL CL B 383 B 173 ASP B 344 ASP.? 20.04 CL CL B 383 D 48 ARG B 300 ARG^? 21.49 CL CL B 383 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 3.94 45.97 72.94 1.71 46.24 71.30 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 7.59 38.09 74.22 8.59 36.72 75.50 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 0.10 48.73 83.03 1.88 51.20 83.58 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1cs1_c03 naa= 3 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 1 3 # 1 A 1 ALA A 159 ALA~? 12.04 CL CL A 382 A 74 ASN A 160 ASN~? 11.40 CL CL A 383 A 75 GLY A 163 GLY.? 16.53 CL CL A 382 coo -1.80 62.71 122.76 -1.88 63.70 123.92 -40.97 78.44 123.91 -40.05 77.14 123.62 coo 1.20 66.40 122.20 2.03 64.53 121.46 -44.47 76.84 121.01 -43.38 75.08 120.31 coo 4.68 65.84 125.52 4.11 65.60 126.05 -42.13 81.34 118.16 -41.70 81.26 118.87 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 2 3 # 2 A 1 ALA B 159 ALA~? 12.15 CL CL B 383 A 74 ASN B 160 ASN~? 11.23 CL CL B 384 A 75 GLY B 163 GLY.? 16.55 CL CL B 383 coo -1.80 62.71 122.76 -1.88 63.70 123.92 0.19 32.47 69.55 -1.13 33.12 70.03 coo 1.20 66.40 122.20 2.03 64.53 121.46 0.91 30.00 73.77 -0.90 30.65 74.84 coo 4.68 65.84 125.52 4.11 65.60 126.05 4.89 34.51 73.70 4.40 34.50 73.10 1ct9_c04 source 1ct9 ASPARAGINE SYNTHETASE B : 2 hits 1ct9_c04 naa= 3 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 1 3 # 1 B 1 ALA A 159 ALA~? 12.04 CL CL A 382 B 74 ASN A 160 ASN~? 11.40 CL CL A 383 B 75 GLY A 163 GLY.? 16.53 CL CL A 382 coo 39.21 14.97 27.55 40.19 16.01 27.08 -40.97 78.44 123.91 -40.05 77.14 123.62 coo 43.06 12.94 25.74 42.26 11.81 27.44 -44.47 76.84 121.01 -43.38 75.08 120.31 coo 46.38 13.54 29.18 46.14 14.29 29.26 -42.13 81.34 118.16 -41.70 81.26 118.87 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 2 3 # 2 B 1 ALA B 159 ALA~? 12.15 CL CL B 383 B 74 ASN B 160 ASN~? 11.23 CL CL B 384 B 75 GLY B 163 GLY.? 16.55 CL CL B 383 coo 39.21 14.97 27.55 40.19 16.01 27.08 0.19 32.47 69.55 -1.13 33.12 70.03 coo 43.06 12.94 25.74 42.26 11.81 27.44 0.91 30.00 73.77 -0.90 30.65 74.84 coo 46.38 13.54 29.18 46.14 14.29 29.26 4.89 34.51 73.70 4.40 34.50 73.10 1ct9_c05 source 1ct9 ASPARAGINE SYNTHETASE B : 2 hits 1ct9_c05 naa= 3 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 1 3 # 1 C 1 ALA A 159 ALA~? 12.04 CL CL A 382 C 74 ASN A 160 ASN~? 11.40 CL CL A 383 C 75 GLY A 163 GLY.? 16.53 CL CL A 382 coo 16.14 15.08 36.63 15.28 14.65 37.81 -40.97 78.44 123.91 -40.05 77.14 123.62 coo 11.60 16.13 36.70 12.80 17.74 35.96 -44.47 76.84 121.01 -43.38 75.08 120.31 coo 10.99 19.23 40.32 11.50 18.77 40.74 -42.13 81.34 118.16 -41.70 81.26 118.87 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 2 3 # 2 C 1 ALA B 159 ALA~? 12.15 CL CL B 383 C 74 ASN B 160 ASN~? 11.23 CL CL B 384 C 75 GLY B 163 GLY.? 16.55 CL CL B 383 coo 16.14 15.08 36.63 15.28 14.65 37.81 0.19 32.47 69.55 -1.13 33.12 70.03 coo 11.60 16.13 36.70 12.80 17.74 35.96 0.91 30.00 73.77 -0.90 30.65 74.84 coo 10.99 19.23 40.32 11.50 18.77 40.74 4.89 34.51 73.70 4.40 34.50 73.10 1ct9_c06 source 1ct9 ASPARAGINE SYNTHETASE B : 2 hits 1ct9_c06 naa= 3 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 1 3 # 1 D 1 ALA A 159 ALA~? 12.04 CL CL A 382 D 74 ASN A 160 ASN~? 11.40 CL CL A 383 D 75 GLY A 163 GLY.? 16.53 CL CL A 382 coo -13.31 41.90 116.45 -13.05 40.39 116.25 -40.97 78.44 123.91 -40.05 77.14 123.62 coo -16.85 39.36 115.26 -17.55 40.58 116.90 -44.47 76.84 121.01 -43.38 75.08 120.31 coo -17.65 36.37 119.00 -16.85 36.22 119.00 -42.13 81.34 118.16 -41.70 81.26 118.87 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 2 3 # 2 D 1 ALA B 159 ALA~? 12.15 CL CL B 383 D 74 ASN B 160 ASN~? 11.23 CL CL B 384 D 75 GLY B 163 GLY.? 16.55 CL CL B 383 coo -13.31 41.90 116.45 -13.05 40.39 116.25 0.19 32.47 69.55 -1.13 33.12 70.03 coo -16.85 39.36 115.26 -17.55 40.58 116.90 0.91 30.00 73.77 -0.90 30.65 74.84 coo -17.65 36.37 119.00 -16.85 36.22 119.00 4.89 34.51 73.70 4.40 34.50 73.10 1ct9_c07 source 1ct9 ASPARAGINE SYNTHETASE B : 2 hits 1ct9_c07 naa= 3 ULMN 3 1cwy_c00 AMYLOMALTASE user 1 3 # 1 A 293 ASP A 171 ASP.? 13.95 CL CL A 382 A 340 GLU A 169 GLU.? 11.07 CL CL A 382 A 395 ASP A 93 ASP^? 5.15 CL CL A 382 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 -21.72 70.05 125.28 -22.57 71.99 125.28 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 -27.31 72.85 122.01 -26.32 74.11 120.63 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1cwy_c00 AMYLOMALTASE user 2 3 # 2 A 293 ASP A 305 ASP^? 16.01 CL CL A 384 A 340 GLU A 307 GLU.? 18.04 CL CL B 382 A 395 ASP A 195 ASP.? 13.29 CL CL A 384 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 -32.01 65.22 92.45 -32.49 63.34 91.63 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 -31.95 61.22 87.08 -31.47 59.40 88.12 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1cwy_c00 AMYLOMALTASE user 3 3 # 3 A 293 ASP A 306 ASP.? 16.66 CL CL A 384 A 340 GLU A 307 GLU.? 18.04 CL CL B 382 A 395 ASP A 195 ASP.? 13.29 CL CL A 384 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 -29.63 66.56 87.01 -28.35 68.29 87.20 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 -31.95 61.22 87.08 -31.47 59.40 88.12 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 -22.13 62.52 88.27 -20.53 63.80 88.70 1cwy_c00 source 1cwy AMYLOMALTASE : 3 hits 1cwy_c00 naa= 3 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 138 TRP A 207 TRP^? 23.82 CL CL A 384 A 243 ASP A 208 ASP.? 21.85 CL CL A 382 A 272 LYS A 336 LYS^? 14.72 CL CL A 382 coo 18.21 54.75 18.05 19.91 55.17 21.59 -44.76 66.72 97.91 -42.73 64.04 95.92 coo 16.93 55.67 9.65 17.16 54.23 11.19 -48.25 63.81 104.00 -49.74 63.21 105.24 coo 14.13 45.79 13.40 14.25 49.41 18.30 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 138 TRP A 273 TRP~? 19.00 CL CL A 383 A 243 ASP A 210 ASP.? 21.69 CL CL A 383 A 272 LYS A 249 LYS^? 20.12 CL CL A 383 coo 18.21 54.75 18.05 19.91 55.17 21.59 -50.89 71.02 111.12 -54.05 73.34 111.49 coo 16.93 55.67 9.65 17.16 54.23 11.19 -52.58 64.68 106.89 -53.21 62.78 107.37 coo 14.13 45.79 13.40 14.25 49.41 18.30 -61.09 73.36 110.22 -57.90 69.98 113.58 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 138 TRP A 341 TRP.? 10.34 CL CL A 382 A 243 ASP A 272 ASP~? 14.48 CL CL A 382 A 272 LYS A 336 LYS^? 14.72 CL CL A 382 coo 18.21 54.75 18.05 19.91 55.17 21.59 -39.95 74.25 113.33 -36.58 74.16 115.41 coo 16.93 55.67 9.65 17.16 54.23 11.19 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 14.13 45.79 13.40 14.25 49.41 18.30 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 4 3 # 4 A 138 TRP B 207 TRP^? 25.29 CL CL B 383 A 243 ASP B 208 ASP.? 21.56 CL CL B 383 A 272 LYS B 336 LYS^? 14.66 CL CL B 383 coo 18.21 54.75 18.05 19.91 55.17 21.59 -1.19 37.06 97.92 -3.78 38.84 100.32 coo 16.93 55.67 9.65 17.16 54.23 11.19 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 14.13 45.79 13.40 14.25 49.41 18.30 -3.40 41.24 88.18 -4.83 35.96 88.60 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 5 3 # 5 A 138 TRP B 273 TRP~? 18.41 CL CL B 384 A 243 ASP B 210 ASP.? 22.05 CL CL B 384 A 272 LYS B 249 LYS^? 19.48 CL CL B 384 coo 18.21 54.75 18.05 19.91 55.17 21.59 1.07 27.51 86.17 4.21 25.26 85.33 coo 16.93 55.67 9.65 17.16 54.23 11.19 -2.53 25.11 93.69 -2.62 22.87 93.62 coo 14.13 45.79 13.40 14.25 49.41 18.30 7.49 19.68 88.46 2.17 20.34 86.44 ULMN 3 1d7r_c01 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 6 3 # 6 A 138 TRP B 341 TRP.? 10.39 CL CL B 383 A 243 ASP B 344 ASP.? 20.04 CL CL B 383 A 272 LYS B 267 LYS~? 27.57 CL CL B 383 coo 18.21 54.75 18.05 19.91 55.17 21.59 -0.76 36.74 80.33 -2.75 38.82 77.66 coo 16.93 55.67 9.65 17.16 54.23 11.19 7.59 38.09 74.22 8.59 36.72 75.50 coo 14.13 45.79 13.40 14.25 49.41 18.30 9.46 31.45 81.02 15.36 33.08 81.01 1d7r_c01 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 6 hits 1d7r_c01 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR A 8 TYR.? 12.26 CL CL A 384 A 243 ASP A 195 ASP.? 13.29 CL CL A 384 A 272 LYS B 288 LYS.? 8.84 CL CL B 382 coo 2.03 68.31 21.46 0.66 68.36 23.90 -16.53 57.80 111.57 -17.14 59.34 109.36 coo 16.93 55.67 9.65 17.16 54.23 11.19 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 14.13 45.79 13.40 14.25 49.41 18.30 -16.76 54.22 83.25 -20.62 56.75 78.99 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 173 TYR A 8 TYR.? 12.26 CL CL A 384 A 243 ASP A 204 ASP^? 18.76 CL CL A 384 A 272 LYS A 336 LYS^? 14.72 CL CL A 382 coo 2.03 68.31 21.46 0.66 68.36 23.90 -16.53 57.80 111.57 -17.14 59.34 109.36 coo 16.93 55.67 9.65 17.16 54.23 11.19 -37.06 58.40 100.88 -36.30 56.45 100.53 coo 14.13 45.79 13.40 14.25 49.41 18.30 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 173 TYR A 181 TYR.? 17.32 CL CL A 382 A 243 ASP A 171 ASP.? 13.95 CL CL A 382 A 272 LYS A 128 LYS.? 19.46 CL CL A 382 coo 2.03 68.31 21.46 0.66 68.36 23.90 -33.79 79.99 107.82 -35.55 78.08 108.89 coo 16.93 55.67 9.65 17.16 54.23 11.19 -21.72 70.05 125.28 -22.57 71.99 125.28 coo 14.13 45.79 13.40 14.25 49.41 18.30 -25.12 72.76 133.10 -20.68 68.32 134.09 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 4 3 # 4 A 173 TYR A 181 TYR.? 17.32 CL CL A 382 A 243 ASP A 210 ASP.? 21.69 CL CL A 383 A 272 LYS A 249 LYS^? 20.12 CL CL A 383 coo 2.03 68.31 21.46 0.66 68.36 23.90 -33.79 79.99 107.82 -35.55 78.08 108.89 coo 16.93 55.67 9.65 17.16 54.23 11.19 -52.58 64.68 106.89 -53.21 62.78 107.37 coo 14.13 45.79 13.40 14.25 49.41 18.30 -61.09 73.36 110.22 -57.90 69.98 113.58 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 5 3 # 5 A 173 TYR B 8 TYR.? 11.88 CL CL B 382 A 243 ASP B 195 ASP.? 10.47 CL CL A 384 A 272 LYS A 288 LYS.? 12.57 CL CL A 384 coo 2.03 68.31 21.46 0.66 68.36 23.90 -23.96 53.72 82.39 -21.76 54.53 83.93 coo 16.93 55.67 9.65 17.16 54.23 11.19 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 14.13 45.79 13.40 14.25 49.41 18.30 -19.18 64.09 108.25 -14.44 63.70 112.45 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 6 3 # 6 A 173 TYR B 181 TYR.? 17.17 CL CL B 383 A 243 ASP B 171 ASP.? 13.77 CL CL B 383 A 272 LYS B 128 LYS.? 19.37 CL CL B 383 coo 2.03 68.31 21.46 0.66 68.36 23.90 3.07 45.96 80.85 1.96 43.49 81.23 coo 16.93 55.67 9.65 17.16 54.23 11.19 -14.88 46.75 66.62 -12.79 46.40 66.16 coo 14.13 45.79 13.40 14.25 49.41 18.30 -13.49 41.25 59.55 -18.50 40.98 58.08 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 7 3 # 7 A 173 TYR B 181 TYR.? 17.17 CL CL B 383 A 243 ASP B 240 ASP.? 29.22 CL CL B 383 A 272 LYS B 249 LYS^? 19.48 CL CL B 384 coo 2.03 68.31 21.46 0.66 68.36 23.90 3.07 45.96 80.85 1.96 43.49 81.23 coo 16.93 55.67 9.65 17.16 54.23 11.19 11.35 28.88 93.27 10.37 30.59 94.07 coo 14.13 45.79 13.40 14.25 49.41 18.30 7.49 19.68 88.46 2.17 20.34 86.44 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 8 3 # 8 A 173 TYR B 238 TYR^? 27.53 CL CL B 384 A 243 ASP B 257 ASP.? 23.04 CL CL B 384 A 272 LYS B 109 LYS.? 27.05 CL CL B 384 coo 2.03 68.31 21.46 0.66 68.36 23.90 12.27 28.31 87.43 11.42 30.17 89.32 coo 16.93 55.67 9.65 17.16 54.23 11.19 12.38 23.16 66.89 10.36 22.88 66.20 coo 14.13 45.79 13.40 14.25 49.41 18.30 5.83 26.41 59.87 10.67 23.27 57.97 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 8 hits 1d7r_c02 naa= 3 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 A 145 LYS A 336 LYS^? 14.72 CL CL A 382 A 177 GLU A 276 GLU~? 16.10 CL CL A 383 A 201 LEU A 275 LEU~? 15.03 CL CL A 382 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -37.43 70.02 105.34 -41.47 67.12 107.58 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -46.62 67.79 110.40 -48.46 68.09 111.43 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -42.94 71.56 108.70 -41.37 73.02 108.92 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 A 145 LYS B 336 LYS^? 14.66 CL CL B 383 A 177 GLU B 206 GLU^? 19.18 CL CL B 383 A 201 LEU B 280 LEU^? 20.12 CL CL B 383 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -3.40 41.24 88.18 -4.83 35.96 88.60 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -9.17 35.76 95.82 -10.61 34.74 94.62 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -6.39 42.76 93.04 -6.62 44.50 94.24 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 A 145 LYS B 336 LYS^? 14.66 CL CL B 383 A 177 GLU B 276 GLU~? 15.94 CL CL B 384 A 201 LEU B 275 LEU~? 14.82 CL CL B 383 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -3.40 41.24 88.18 -4.83 35.96 88.60 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -2.79 30.63 87.01 -2.36 28.59 86.68 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -0.68 35.60 86.07 -0.26 37.33 84.87 1daa_c00 source 1daa D-AMINO ACID AMINOTRANSFERASE : 3 hits 1daa_c00 naa= 3 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 B 145 LYS A 336 LYS^? 14.72 CL CL A 382 B 177 GLU A 276 GLU~? 16.10 CL CL A 383 B 201 LEU A 275 LEU~? 15.03 CL CL A 382 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -37.43 70.02 105.34 -41.47 67.12 107.58 coo 27.00 6.35 51.01 26.30 4.53 50.18 -46.62 67.79 110.40 -48.46 68.09 111.43 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -42.94 71.56 108.70 -41.37 73.02 108.92 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 B 145 LYS B 336 LYS^? 14.66 CL CL B 383 B 177 GLU B 276 GLU~? 15.94 CL CL B 384 B 201 LEU B 275 LEU~? 14.82 CL CL B 383 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -3.40 41.24 88.18 -4.83 35.96 88.60 coo 27.00 6.35 51.01 26.30 4.53 50.18 -2.79 30.63 87.01 -2.36 28.59 86.68 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -0.68 35.60 86.07 -0.26 37.33 84.87 1daa_c01 source 1daa D-AMINO ACID AMINOTRANSFERASE : 2 hits 1daa_c01 naa= 3 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 1 3 # 1 A 132 THR A 331 THR^? 10.31 CL CL A 384 A 156 TYR A 8 TYR.? 12.26 CL CL A 384 A 160 LYS A 288 LYS.? 12.57 CL CL A 384 coo 10.50 56.87 17.73 11.24 57.93 19.43 -26.18 59.17 108.07 -25.19 60.90 109.06 coo 11.64 63.07 23.95 11.76 62.47 21.20 -16.53 57.80 111.57 -17.14 59.34 109.36 coo 5.78 61.30 21.65 8.04 62.89 17.54 -19.18 64.09 108.25 -14.44 63.70 112.45 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 2 3 # 2 A 132 THR B 331 THR^? 16.17 CL CL B 383 A 156 TYR B 8 TYR.? 11.88 CL CL B 382 A 160 LYS B 288 LYS.? 8.84 CL CL B 382 coo 10.50 56.87 17.73 11.24 57.93 19.43 -18.10 46.86 87.19 -17.24 47.80 85.43 coo 11.64 63.07 23.95 11.76 62.47 21.20 -23.96 53.72 82.39 -21.76 54.53 83.93 coo 5.78 61.30 21.65 8.04 62.89 17.54 -16.76 54.22 83.25 -20.62 56.75 78.99 1db3_c01 source 1db3 GDP-MANNOSE 4,6-DEHYDRATASE : 2 hits 1db3_c01 naa= 3 ULMN 3 1ddj_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS A 157 HIS~? 12.03 CL CL A 383 A 646 ASP A 144 ASP.? 19.38 CL CL A 383 A 739 GLY A 110 GLY.? 23.75 CL CL A 383 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -47.82 75.77 126.56 -49.90 76.10 126.41 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -52.89 78.90 131.37 -53.77 80.20 132.79 coo 11.37 50.89 2.29 11.05 51.63 2.25 -42.92 88.53 131.83 -42.63 88.59 132.69 ULMN 3 1ddj_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS A 157 HIS~? 12.03 CL CL A 383 A 646 ASP A 144 ASP.? 19.38 CL CL A 383 A 739 GLY A 148 GLY.? 11.08 CL CL A 383 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -47.82 75.77 126.56 -49.90 76.10 126.41 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -52.89 78.90 131.37 -53.77 80.20 132.79 coo 11.37 50.89 2.29 11.05 51.63 2.25 -49.51 66.91 135.22 -49.43 67.62 134.85 ULMN 3 1ddj_c12 PLASMINOGEN user 3 3 # 3 A 603 HIS A 223 HIS.? 29.08 CL CL A 383 A 646 ASP A 257 ASP.? 24.30 CL CL A 383 A 739 GLY A 110 GLY.? 23.75 CL CL A 383 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -56.62 90.70 129.56 -55.95 91.22 131.48 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -55.05 88.25 125.09 -55.04 86.55 126.35 coo 11.37 50.89 2.29 11.05 51.63 2.25 -42.92 88.53 131.83 -42.63 88.59 132.69 ULMN 3 1ddj_c12 PLASMINOGEN user 4 3 # 4 A 603 HIS A 308 HIS.? 20.06 CL CL A 384 A 646 ASP A 305 ASP^? 16.01 CL CL A 384 A 739 GLY B 7 GLY.? 12.08 CL CL B 382 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -37.01 64.37 91.64 -38.79 63.83 92.62 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -32.01 65.22 92.45 -32.49 63.34 91.63 coo 11.37 50.89 2.29 11.05 51.63 2.25 -28.36 56.59 83.26 -28.24 57.01 82.53 ULMN 3 1ddj_c12 PLASMINOGEN user 5 3 # 5 A 603 HIS B 157 HIS~? 12.80 CL CL B 384 A 646 ASP B 144 ASP.? 18.90 CL CL B 384 A 739 GLY B 110 GLY.? 24.37 CL CL B 384 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 0.17 24.88 70.38 1.86 23.62 70.32 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 1.70 18.75 65.96 3.42 18.04 64.94 coo 11.37 50.89 2.29 11.05 51.63 2.25 7.47 29.44 58.24 6.74 29.50 58.60 ULMN 3 1ddj_c12 PLASMINOGEN user 6 3 # 6 A 603 HIS B 157 HIS~? 12.80 CL CL B 384 A 646 ASP B 144 ASP.? 18.90 CL CL B 384 A 739 GLY B 148 GLY.? 11.16 CL CL B 384 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 0.17 24.88 70.38 1.86 23.62 70.32 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 1.70 18.75 65.96 3.42 18.04 64.94 coo 11.37 50.89 2.29 11.05 51.63 2.25 -10.37 17.04 67.47 -9.78 17.53 67.22 ULMN 3 1ddj_c12 PLASMINOGEN user 7 3 # 7 A 603 HIS B 308 HIS.? 26.99 CL CL A 384 A 646 ASP B 305 ASP^? 21.59 CL CL A 384 A 739 GLY A 7 GLY.? 16.09 CL CL A 384 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -5.09 45.35 102.63 -4.80 43.27 102.76 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -6.28 49.81 99.79 -7.51 49.10 101.38 coo 11.37 50.89 2.29 11.05 51.63 2.25 -12.90 54.74 109.89 -12.31 54.99 110.52 1ddj_c12 source 1ddj PLASMINOGEN : 7 hits 1ddj_c12 naa= 3 ULMN 3 1ddj_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS A 157 HIS~? 12.03 CL CL A 383 B 646 ASP A 144 ASP.? 19.38 CL CL A 383 B 739 GLY A 110 GLY.? 23.75 CL CL A 383 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -47.82 75.77 126.56 -49.90 76.10 126.41 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -52.89 78.90 131.37 -53.77 80.20 132.79 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -42.92 88.53 131.83 -42.63 88.59 132.69 ULMN 3 1ddj_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS A 157 HIS~? 12.03 CL CL A 383 B 646 ASP A 144 ASP.? 19.38 CL CL A 383 B 739 GLY A 148 GLY.? 11.08 CL CL A 383 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -47.82 75.77 126.56 -49.90 76.10 126.41 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -52.89 78.90 131.37 -53.77 80.20 132.79 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -49.51 66.91 135.22 -49.43 67.62 134.85 ULMN 3 1ddj_c13 PLASMINOGEN user 3 3 # 3 B 603 HIS A 223 HIS.? 29.08 CL CL A 383 B 646 ASP A 257 ASP.? 24.30 CL CL A 383 B 739 GLY A 110 GLY.? 23.75 CL CL A 383 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -56.62 90.70 129.56 -55.95 91.22 131.48 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -55.05 88.25 125.09 -55.04 86.55 126.35 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -42.92 88.53 131.83 -42.63 88.59 132.69 ULMN 3 1ddj_c13 PLASMINOGEN user 4 3 # 4 B 603 HIS A 308 HIS.? 20.06 CL CL A 384 B 646 ASP A 305 ASP^? 16.01 CL CL A 384 B 739 GLY B 7 GLY.? 12.08 CL CL B 382 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -37.01 64.37 91.64 -38.79 63.83 92.62 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -32.01 65.22 92.45 -32.49 63.34 91.63 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -28.36 56.59 83.26 -28.24 57.01 82.53 ULMN 3 1ddj_c13 PLASMINOGEN user 5 3 # 5 B 603 HIS B 157 HIS~? 12.80 CL CL B 384 B 646 ASP B 144 ASP.? 18.90 CL CL B 384 B 739 GLY B 110 GLY.? 24.37 CL CL B 384 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 0.17 24.88 70.38 1.86 23.62 70.32 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 1.70 18.75 65.96 3.42 18.04 64.94 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 7.47 29.44 58.24 6.74 29.50 58.60 ULMN 3 1ddj_c13 PLASMINOGEN user 6 3 # 6 B 603 HIS B 308 HIS.? 26.99 CL CL A 384 B 646 ASP B 305 ASP^? 21.59 CL CL A 384 B 739 GLY A 7 GLY.? 16.09 CL CL A 384 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -5.09 45.35 102.63 -4.80 43.27 102.76 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -6.28 49.81 99.79 -7.51 49.10 101.38 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -12.90 54.74 109.89 -12.31 54.99 110.52 1ddj_c13 source 1ddj PLASMINOGEN : 6 hits 1ddj_c13 naa= 3 ULMN 3 1ddj_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS A 157 HIS~? 12.03 CL CL A 383 C 646 ASP A 144 ASP.? 19.38 CL CL A 383 C 739 GLY A 110 GLY.? 23.75 CL CL A 383 coo 15.33 59.81 59.60 13.98 60.99 60.69 -47.82 75.77 126.56 -49.90 76.10 126.41 coo 16.06 55.72 54.73 15.97 56.49 56.70 -52.89 78.90 131.37 -53.77 80.20 132.79 coo 9.38 49.29 65.28 9.01 50.03 65.31 -42.92 88.53 131.83 -42.63 88.59 132.69 ULMN 3 1ddj_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS A 157 HIS~? 12.03 CL CL A 383 C 646 ASP A 144 ASP.? 19.38 CL CL A 383 C 739 GLY A 148 GLY.? 11.08 CL CL A 383 coo 15.33 59.81 59.60 13.98 60.99 60.69 -47.82 75.77 126.56 -49.90 76.10 126.41 coo 16.06 55.72 54.73 15.97 56.49 56.70 -52.89 78.90 131.37 -53.77 80.20 132.79 coo 9.38 49.29 65.28 9.01 50.03 65.31 -49.51 66.91 135.22 -49.43 67.62 134.85 ULMN 3 1ddj_c14 PLASMINOGEN user 3 3 # 3 C 603 HIS A 223 HIS.? 29.08 CL CL A 383 C 646 ASP A 257 ASP.? 24.30 CL CL A 383 C 739 GLY A 110 GLY.? 23.75 CL CL A 383 coo 15.33 59.81 59.60 13.98 60.99 60.69 -56.62 90.70 129.56 -55.95 91.22 131.48 coo 16.06 55.72 54.73 15.97 56.49 56.70 -55.05 88.25 125.09 -55.04 86.55 126.35 coo 9.38 49.29 65.28 9.01 50.03 65.31 -42.92 88.53 131.83 -42.63 88.59 132.69 ULMN 3 1ddj_c14 PLASMINOGEN user 4 3 # 4 C 603 HIS A 308 HIS.? 20.06 CL CL A 384 C 646 ASP A 305 ASP^? 16.01 CL CL A 384 C 739 GLY B 7 GLY.? 12.08 CL CL B 382 coo 15.33 59.81 59.60 13.98 60.99 60.69 -37.01 64.37 91.64 -38.79 63.83 92.62 coo 16.06 55.72 54.73 15.97 56.49 56.70 -32.01 65.22 92.45 -32.49 63.34 91.63 coo 9.38 49.29 65.28 9.01 50.03 65.31 -28.36 56.59 83.26 -28.24 57.01 82.53 ULMN 3 1ddj_c14 PLASMINOGEN user 5 3 # 5 C 603 HIS B 157 HIS~? 12.80 CL CL B 384 C 646 ASP B 144 ASP.? 18.90 CL CL B 384 C 739 GLY B 110 GLY.? 24.37 CL CL B 384 coo 15.33 59.81 59.60 13.98 60.99 60.69 0.17 24.88 70.38 1.86 23.62 70.32 coo 16.06 55.72 54.73 15.97 56.49 56.70 1.70 18.75 65.96 3.42 18.04 64.94 coo 9.38 49.29 65.28 9.01 50.03 65.31 7.47 29.44 58.24 6.74 29.50 58.60 ULMN 3 1ddj_c14 PLASMINOGEN user 6 3 # 6 C 603 HIS B 157 HIS~? 12.80 CL CL B 384 C 646 ASP B 144 ASP.? 18.90 CL CL B 384 C 739 GLY B 148 GLY.? 11.16 CL CL B 384 coo 15.33 59.81 59.60 13.98 60.99 60.69 0.17 24.88 70.38 1.86 23.62 70.32 coo 16.06 55.72 54.73 15.97 56.49 56.70 1.70 18.75 65.96 3.42 18.04 64.94 coo 9.38 49.29 65.28 9.01 50.03 65.31 -10.37 17.04 67.47 -9.78 17.53 67.22 ULMN 3 1ddj_c14 PLASMINOGEN user 7 3 # 7 C 603 HIS B 308 HIS.? 26.99 CL CL A 384 C 646 ASP B 305 ASP^? 21.59 CL CL A 384 C 739 GLY A 7 GLY.? 16.09 CL CL A 384 coo 15.33 59.81 59.60 13.98 60.99 60.69 -5.09 45.35 102.63 -4.80 43.27 102.76 coo 16.06 55.72 54.73 15.97 56.49 56.70 -6.28 49.81 99.79 -7.51 49.10 101.38 coo 9.38 49.29 65.28 9.01 50.03 65.31 -12.90 54.74 109.89 -12.31 54.99 110.52 1ddj_c14 source 1ddj PLASMINOGEN : 7 hits 1ddj_c14 naa= 3 ULMN 3 1ddj_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 157 HIS~? 12.03 CL CL A 383 D 646 ASP A 144 ASP.? 19.38 CL CL A 383 D 739 GLY A 110 GLY.? 23.75 CL CL A 383 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -47.82 75.77 126.56 -49.90 76.10 126.41 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -52.89 78.90 131.37 -53.77 80.20 132.79 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -42.92 88.53 131.83 -42.63 88.59 132.69 ULMN 3 1ddj_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS A 157 HIS~? 12.03 CL CL A 383 D 646 ASP A 144 ASP.? 19.38 CL CL A 383 D 739 GLY A 148 GLY.? 11.08 CL CL A 383 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -47.82 75.77 126.56 -49.90 76.10 126.41 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -52.89 78.90 131.37 -53.77 80.20 132.79 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -49.51 66.91 135.22 -49.43 67.62 134.85 ULMN 3 1ddj_c15 PLASMINOGEN user 3 3 # 3 D 603 HIS A 223 HIS.? 29.08 CL CL A 383 D 646 ASP A 257 ASP.? 24.30 CL CL A 383 D 739 GLY A 110 GLY.? 23.75 CL CL A 383 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -56.62 90.70 129.56 -55.95 91.22 131.48 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -55.05 88.25 125.09 -55.04 86.55 126.35 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -42.92 88.53 131.83 -42.63 88.59 132.69 ULMN 3 1ddj_c15 PLASMINOGEN user 4 3 # 4 D 603 HIS A 308 HIS.? 20.06 CL CL A 384 D 646 ASP A 305 ASP^? 16.01 CL CL A 384 D 739 GLY B 7 GLY.? 12.08 CL CL B 382 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -37.01 64.37 91.64 -38.79 63.83 92.62 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -32.01 65.22 92.45 -32.49 63.34 91.63 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -28.36 56.59 83.26 -28.24 57.01 82.53 ULMN 3 1ddj_c15 PLASMINOGEN user 5 3 # 5 D 603 HIS B 157 HIS~? 12.80 CL CL B 384 D 646 ASP B 144 ASP.? 18.90 CL CL B 384 D 739 GLY B 110 GLY.? 24.37 CL CL B 384 coo -30.51 33.83 43.05 -30.50 33.12 45.03 0.17 24.88 70.38 1.86 23.62 70.32 coo -25.73 33.05 39.28 -27.50 34.05 39.88 1.70 18.75 65.96 3.42 18.04 64.94 coo -27.66 47.32 40.66 -27.81 47.01 41.41 7.47 29.44 58.24 6.74 29.50 58.60 ULMN 3 1ddj_c15 PLASMINOGEN user 6 3 # 6 D 603 HIS B 308 HIS.? 26.99 CL CL A 384 D 646 ASP B 305 ASP^? 21.59 CL CL A 384 D 739 GLY A 7 GLY.? 16.09 CL CL A 384 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -5.09 45.35 102.63 -4.80 43.27 102.76 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -6.28 49.81 99.79 -7.51 49.10 101.38 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -12.90 54.74 109.89 -12.31 54.99 110.52 1ddj_c15 source 1ddj PLASMINOGEN : 6 hits 1ddj_c15 naa= 3 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 57 GLU A 86 GLU^? 27.08 CL CL A 382 A 226 THR A 331 THR^? 10.31 CL CL A 384 A 229 LYS A 288 LYS.? 12.57 CL CL A 384 coo 9.66 102.78 70.07 9.79 101.18 71.42 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 7.24 97.46 49.60 8.11 95.69 48.80 -26.18 59.17 108.07 -25.19 60.90 109.06 coo 10.53 97.56 43.71 9.33 93.71 47.17 -19.18 64.09 108.25 -14.44 63.70 112.45 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 57 GLU A 201 GLU.? 12.07 CL CL A 384 A 226 THR B 281 THR^? 16.75 CL CL B 383 A 229 LYS B 336 LYS^? 14.66 CL CL B 383 coo 9.66 102.78 70.07 9.79 101.18 71.42 -24.87 56.03 99.70 -24.21 54.93 101.40 coo 7.24 97.46 49.60 8.11 95.69 48.80 -11.01 41.80 92.41 -12.17 40.05 91.86 coo 10.53 97.56 43.71 9.33 93.71 47.17 -3.40 41.24 88.18 -4.83 35.96 88.60 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 57 GLU A 206 GLU^? 19.04 CL CL A 382 A 226 THR A 242 THR.? 33.58 CL CL A 382 A 229 LYS A 239 LYS^? 36.81 CL CL A 383 coo 9.66 102.78 70.07 9.79 101.18 71.42 -42.05 60.33 102.60 -42.22 59.82 104.62 coo 7.24 97.46 49.60 8.11 95.69 48.80 -55.37 77.04 95.46 -53.34 77.12 94.70 coo 10.53 97.56 43.71 9.33 93.71 47.17 -57.66 80.60 103.08 -61.70 85.06 101.44 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 A 57 GLU A 276 GLU~? 16.10 CL CL A 383 A 226 THR A 331 THR^? 10.31 CL CL A 384 A 229 LYS A 288 LYS.? 12.57 CL CL A 384 coo 9.66 102.78 70.07 9.79 101.18 71.42 -46.62 67.79 110.40 -48.46 68.09 111.43 coo 7.24 97.46 49.60 8.11 95.69 48.80 -26.18 59.17 108.07 -25.19 60.90 109.06 coo 10.53 97.56 43.71 9.33 93.71 47.17 -19.18 64.09 108.25 -14.44 63.70 112.45 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 A 57 GLU A 332 GLU^? 14.84 CL CL A 382 A 226 THR A 342 THR.? 12.75 CL CL A 382 A 229 LYS A 268 LYS~? 13.60 CL CL A 382 coo 9.66 102.78 70.07 9.79 101.18 71.42 -32.41 59.20 107.78 -33.78 57.91 108.78 coo 7.24 97.46 49.60 8.11 95.69 48.80 -39.29 79.06 113.77 -38.09 77.69 114.94 coo 10.53 97.56 43.71 9.33 93.71 47.17 -47.11 79.10 113.63 -43.53 76.03 116.02 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 A 57 GLU A 337 GLU^? 21.89 CL CL A 382 A 226 THR A 217 THR^? 28.81 CL CL A 383 A 229 LYS A 235 LYS^? 33.41 CL CL A 383 coo 9.66 102.78 70.07 9.79 101.18 71.42 -40.07 74.65 102.17 -42.10 75.18 101.81 coo 7.24 97.46 49.60 8.11 95.69 48.80 -60.85 79.57 111.25 -62.93 79.16 110.68 coo 10.53 97.56 43.71 9.33 93.71 47.17 -61.15 85.56 115.05 -65.37 84.74 110.73 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 A 57 GLU B 86 GLU^? 25.45 CL CL B 382 A 226 THR B 331 THR^? 16.17 CL CL B 383 A 229 LYS B 288 LYS.? 8.84 CL CL B 382 coo 9.66 102.78 70.07 9.79 101.18 71.42 -37.46 36.82 83.59 -36.60 37.35 85.50 coo 7.24 97.46 49.60 8.11 95.69 48.80 -18.10 46.86 87.19 -17.24 47.80 85.43 coo 10.53 97.56 43.71 9.33 93.71 47.17 -16.76 54.22 83.25 -20.62 56.75 78.99 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 A 57 GLU B 169 GLU.? 11.31 CL CL B 383 A 226 THR B 112 THR~? 22.40 CL CL B 383 A 229 LYS B 109 LYS.? 27.05 CL CL B 384 coo 9.66 102.78 70.07 9.79 101.18 71.42 -9.49 44.22 70.62 -8.22 45.44 69.57 coo 7.24 97.46 49.60 8.11 95.69 48.80 4.03 34.63 60.23 4.00 36.61 59.32 coo 10.53 97.56 43.71 9.33 93.71 47.17 5.83 26.41 59.87 10.67 23.27 57.97 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 A 57 GLU B 201 GLU^? 17.46 CL CL A 384 A 226 THR A 281 THR^? 16.66 CL CL A 384 A 229 LYS A 336 LYS^? 14.72 CL CL A 382 coo 9.66 102.78 70.07 9.79 101.18 71.42 -19.06 50.53 95.26 -20.94 50.61 94.28 coo 7.24 97.46 49.60 8.11 95.69 48.80 -34.83 61.90 103.55 -35.70 60.62 105.09 coo 10.53 97.56 43.71 9.33 93.71 47.17 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 A 57 GLU B 276 GLU~? 15.94 CL CL B 384 A 226 THR B 331 THR^? 16.17 CL CL B 383 A 229 LYS B 288 LYS.? 8.84 CL CL B 382 coo 9.66 102.78 70.07 9.79 101.18 71.42 -2.79 30.63 87.01 -2.36 28.59 86.68 coo 7.24 97.46 49.60 8.11 95.69 48.80 -18.10 46.86 87.19 -17.24 47.80 85.43 coo 10.53 97.56 43.71 9.33 93.71 47.17 -16.76 54.22 83.25 -20.62 56.75 78.99 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 A 57 GLU B 332 GLU^? 14.76 CL CL B 383 A 226 THR B 342 THR.? 12.70 CL CL B 383 A 229 LYS B 268 LYS~? 13.29 CL CL B 383 coo 9.66 102.78 70.07 9.79 101.18 71.42 -15.56 41.56 89.17 -16.27 39.59 89.11 coo 7.24 97.46 49.60 8.11 95.69 48.80 2.93 38.40 77.77 1.00 38.51 76.85 coo 10.53 97.56 43.71 9.33 93.71 47.17 5.99 32.14 79.72 1.11 32.64 77.72 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 A 57 GLU B 337 GLU^? 21.78 CL CL B 383 A 226 THR B 217 THR^? 28.18 CL CL B 384 A 229 LYS B 235 LYS.? 32.14 CL CL B 384 coo 9.66 102.78 70.07 9.79 101.18 71.42 2.60 41.45 89.80 4.03 40.00 90.41 coo 7.24 97.46 49.60 8.11 95.69 48.80 12.24 20.91 84.68 13.60 19.27 85.00 coo 10.53 97.56 43.71 9.33 93.71 47.17 16.30 20.77 78.71 18.07 18.48 84.31 1dfo_c04 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 12 hits 1dfo_c04 naa= 3 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 57 GLU A 86 GLU^? 27.08 CL CL A 382 B 226 THR A 331 THR^? 10.31 CL CL A 384 B 229 LYS A 288 LYS.? 12.57 CL CL A 384 coo 15.90 87.61 49.61 13.92 86.96 49.36 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 20.74 95.78 68.68 19.29 96.84 69.83 -26.18 59.17 108.07 -25.19 60.90 109.06 coo 22.32 101.61 71.64 17.89 98.63 71.55 -19.18 64.09 108.25 -14.44 63.70 112.45 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 57 GLU A 276 GLU~? 16.10 CL CL A 383 B 226 THR A 331 THR^? 10.31 CL CL A 384 B 229 LYS A 288 LYS.? 12.57 CL CL A 384 coo 15.90 87.61 49.61 13.92 86.96 49.36 -46.62 67.79 110.40 -48.46 68.09 111.43 coo 20.74 95.78 68.68 19.29 96.84 69.83 -26.18 59.17 108.07 -25.19 60.90 109.06 coo 22.32 101.61 71.64 17.89 98.63 71.55 -19.18 64.09 108.25 -14.44 63.70 112.45 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 57 GLU A 332 GLU^? 14.84 CL CL A 382 B 226 THR A 342 THR.? 12.75 CL CL A 382 B 229 LYS A 268 LYS~? 13.60 CL CL A 382 coo 15.90 87.61 49.61 13.92 86.96 49.36 -32.41 59.20 107.78 -33.78 57.91 108.78 coo 20.74 95.78 68.68 19.29 96.84 69.83 -39.29 79.06 113.77 -38.09 77.69 114.94 coo 22.32 101.61 71.64 17.89 98.63 71.55 -47.11 79.10 113.63 -43.53 76.03 116.02 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 B 57 GLU A 337 GLU^? 21.89 CL CL A 382 B 226 THR A 217 THR^? 28.81 CL CL A 383 B 229 LYS A 235 LYS^? 33.41 CL CL A 383 coo 15.90 87.61 49.61 13.92 86.96 49.36 -40.07 74.65 102.17 -42.10 75.18 101.81 coo 20.74 95.78 68.68 19.29 96.84 69.83 -60.85 79.57 111.25 -62.93 79.16 110.68 coo 22.32 101.61 71.64 17.89 98.63 71.55 -61.15 85.56 115.05 -65.37 84.74 110.73 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 B 57 GLU B 86 GLU^? 25.45 CL CL B 382 B 226 THR B 331 THR^? 16.17 CL CL B 383 B 229 LYS B 288 LYS.? 8.84 CL CL B 382 coo 15.90 87.61 49.61 13.92 86.96 49.36 -37.46 36.82 83.59 -36.60 37.35 85.50 coo 20.74 95.78 68.68 19.29 96.84 69.83 -18.10 46.86 87.19 -17.24 47.80 85.43 coo 22.32 101.61 71.64 17.89 98.63 71.55 -16.76 54.22 83.25 -20.62 56.75 78.99 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 B 57 GLU B 169 GLU.? 11.31 CL CL B 383 B 226 THR B 112 THR~? 22.40 CL CL B 383 B 229 LYS B 109 LYS.? 27.05 CL CL B 384 coo 15.90 87.61 49.61 13.92 86.96 49.36 -9.49 44.22 70.62 -8.22 45.44 69.57 coo 20.74 95.78 68.68 19.29 96.84 69.83 4.03 34.63 60.23 4.00 36.61 59.32 coo 22.32 101.61 71.64 17.89 98.63 71.55 5.83 26.41 59.87 10.67 23.27 57.97 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 B 57 GLU B 276 GLU~? 15.94 CL CL B 384 B 226 THR B 331 THR^? 16.17 CL CL B 383 B 229 LYS B 288 LYS.? 8.84 CL CL B 382 coo 15.90 87.61 49.61 13.92 86.96 49.36 -2.79 30.63 87.01 -2.36 28.59 86.68 coo 20.74 95.78 68.68 19.29 96.84 69.83 -18.10 46.86 87.19 -17.24 47.80 85.43 coo 22.32 101.61 71.64 17.89 98.63 71.55 -16.76 54.22 83.25 -20.62 56.75 78.99 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 B 57 GLU B 332 GLU^? 14.76 CL CL B 383 B 226 THR B 342 THR.? 12.70 CL CL B 383 B 229 LYS B 268 LYS~? 13.29 CL CL B 383 coo 15.90 87.61 49.61 13.92 86.96 49.36 -15.56 41.56 89.17 -16.27 39.59 89.11 coo 20.74 95.78 68.68 19.29 96.84 69.83 2.93 38.40 77.77 1.00 38.51 76.85 coo 22.32 101.61 71.64 17.89 98.63 71.55 5.99 32.14 79.72 1.11 32.64 77.72 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 B 57 GLU B 337 GLU^? 21.78 CL CL B 383 B 226 THR B 217 THR^? 28.18 CL CL B 384 B 229 LYS B 235 LYS.? 32.14 CL CL B 384 coo 15.90 87.61 49.61 13.92 86.96 49.36 2.60 41.45 89.80 4.03 40.00 90.41 coo 20.74 95.78 68.68 19.29 96.84 69.83 12.24 20.91 84.68 13.60 19.27 85.00 coo 22.32 101.61 71.64 17.89 98.63 71.55 16.30 20.77 78.71 18.07 18.48 84.31 1dfo_c05 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 9 hits 1dfo_c05 naa= 3 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 57 GLU A 86 GLU^? 27.08 CL CL A 382 C 226 THR A 331 THR^? 10.31 CL CL A 384 C 229 LYS A 288 LYS.? 12.57 CL CL A 384 coo 5.43 40.40 61.63 4.27 41.99 60.90 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 22.16 45.88 73.63 23.23 47.70 73.25 -26.18 59.17 108.07 -25.19 60.90 109.06 coo 28.90 45.91 73.55 25.22 49.72 72.97 -19.18 64.09 108.25 -14.44 63.70 112.45 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 57 GLU A 276 GLU~? 16.10 CL CL A 383 C 226 THR A 331 THR^? 10.31 CL CL A 384 C 229 LYS A 288 LYS.? 12.57 CL CL A 384 coo 5.43 40.40 61.63 4.27 41.99 60.90 -46.62 67.79 110.40 -48.46 68.09 111.43 coo 22.16 45.88 73.63 23.23 47.70 73.25 -26.18 59.17 108.07 -25.19 60.90 109.06 coo 28.90 45.91 73.55 25.22 49.72 72.97 -19.18 64.09 108.25 -14.44 63.70 112.45 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 57 GLU A 332 GLU^? 14.84 CL CL A 382 C 226 THR A 342 THR.? 12.75 CL CL A 382 C 229 LYS A 268 LYS~? 13.60 CL CL A 382 coo 5.43 40.40 61.63 4.27 41.99 60.90 -32.41 59.20 107.78 -33.78 57.91 108.78 coo 22.16 45.88 73.63 23.23 47.70 73.25 -39.29 79.06 113.77 -38.09 77.69 114.94 coo 28.90 45.91 73.55 25.22 49.72 72.97 -47.11 79.10 113.63 -43.53 76.03 116.02 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 C 57 GLU A 337 GLU^? 21.89 CL CL A 382 C 226 THR A 217 THR^? 28.81 CL CL A 383 C 229 LYS A 235 LYS^? 33.41 CL CL A 383 coo 5.43 40.40 61.63 4.27 41.99 60.90 -40.07 74.65 102.17 -42.10 75.18 101.81 coo 22.16 45.88 73.63 23.23 47.70 73.25 -60.85 79.57 111.25 -62.93 79.16 110.68 coo 28.90 45.91 73.55 25.22 49.72 72.97 -61.15 85.56 115.05 -65.37 84.74 110.73 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 C 57 GLU B 86 GLU^? 25.45 CL CL B 382 C 226 THR B 331 THR^? 16.17 CL CL B 383 C 229 LYS B 288 LYS.? 8.84 CL CL B 382 coo 5.43 40.40 61.63 4.27 41.99 60.90 -37.46 36.82 83.59 -36.60 37.35 85.50 coo 22.16 45.88 73.63 23.23 47.70 73.25 -18.10 46.86 87.19 -17.24 47.80 85.43 coo 28.90 45.91 73.55 25.22 49.72 72.97 -16.76 54.22 83.25 -20.62 56.75 78.99 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 C 57 GLU B 169 GLU.? 11.31 CL CL B 383 C 226 THR B 112 THR~? 22.40 CL CL B 383 C 229 LYS B 109 LYS.? 27.05 CL CL B 384 coo 5.43 40.40 61.63 4.27 41.99 60.90 -9.49 44.22 70.62 -8.22 45.44 69.57 coo 22.16 45.88 73.63 23.23 47.70 73.25 4.03 34.63 60.23 4.00 36.61 59.32 coo 28.90 45.91 73.55 25.22 49.72 72.97 5.83 26.41 59.87 10.67 23.27 57.97 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 C 57 GLU B 276 GLU~? 15.94 CL CL B 384 C 226 THR B 331 THR^? 16.17 CL CL B 383 C 229 LYS B 288 LYS.? 8.84 CL CL B 382 coo 5.43 40.40 61.63 4.27 41.99 60.90 -2.79 30.63 87.01 -2.36 28.59 86.68 coo 22.16 45.88 73.63 23.23 47.70 73.25 -18.10 46.86 87.19 -17.24 47.80 85.43 coo 28.90 45.91 73.55 25.22 49.72 72.97 -16.76 54.22 83.25 -20.62 56.75 78.99 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 C 57 GLU B 332 GLU^? 14.76 CL CL B 383 C 226 THR B 342 THR.? 12.70 CL CL B 383 C 229 LYS B 268 LYS~? 13.29 CL CL B 383 coo 5.43 40.40 61.63 4.27 41.99 60.90 -15.56 41.56 89.17 -16.27 39.59 89.11 coo 22.16 45.88 73.63 23.23 47.70 73.25 2.93 38.40 77.77 1.00 38.51 76.85 coo 28.90 45.91 73.55 25.22 49.72 72.97 5.99 32.14 79.72 1.11 32.64 77.72 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 C 57 GLU B 337 GLU^? 21.78 CL CL B 383 C 226 THR B 217 THR^? 28.18 CL CL B 384 C 229 LYS B 235 LYS.? 32.14 CL CL B 384 coo 5.43 40.40 61.63 4.27 41.99 60.90 2.60 41.45 89.80 4.03 40.00 90.41 coo 22.16 45.88 73.63 23.23 47.70 73.25 12.24 20.91 84.68 13.60 19.27 85.00 coo 28.90 45.91 73.55 25.22 49.72 72.97 16.30 20.77 78.71 18.07 18.48 84.31 1dfo_c06 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 9 hits 1dfo_c06 naa= 3 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 57 GLU A 86 GLU^? 27.08 CL CL A 382 D 226 THR A 331 THR^? 10.31 CL CL A 384 D 229 LYS A 288 LYS.? 12.57 CL CL A 384 coo 26.07 55.89 66.14 25.33 56.50 68.01 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 11.79 47.62 52.67 10.10 46.51 53.39 -26.18 59.17 108.07 -25.19 60.90 109.06 coo 10.05 41.79 49.80 7.94 44.71 53.76 -19.18 64.09 108.25 -14.44 63.70 112.45 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 57 GLU A 276 GLU~? 16.10 CL CL A 383 D 226 THR A 331 THR^? 10.31 CL CL A 384 D 229 LYS A 288 LYS.? 12.57 CL CL A 384 coo 26.07 55.89 66.14 25.33 56.50 68.01 -46.62 67.79 110.40 -48.46 68.09 111.43 coo 11.79 47.62 52.67 10.10 46.51 53.39 -26.18 59.17 108.07 -25.19 60.90 109.06 coo 10.05 41.79 49.80 7.94 44.71 53.76 -19.18 64.09 108.25 -14.44 63.70 112.45 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 57 GLU A 332 GLU^? 14.84 CL CL A 382 D 226 THR A 342 THR.? 12.75 CL CL A 382 D 229 LYS A 268 LYS~? 13.60 CL CL A 382 coo 26.07 55.89 66.14 25.33 56.50 68.01 -32.41 59.20 107.78 -33.78 57.91 108.78 coo 11.79 47.62 52.67 10.10 46.51 53.39 -39.29 79.06 113.77 -38.09 77.69 114.94 coo 10.05 41.79 49.80 7.94 44.71 53.76 -47.11 79.10 113.63 -43.53 76.03 116.02 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 D 57 GLU A 337 GLU^? 21.89 CL CL A 382 D 226 THR A 217 THR^? 28.81 CL CL A 383 D 229 LYS A 235 LYS^? 33.41 CL CL A 383 coo 26.07 55.89 66.14 25.33 56.50 68.01 -40.07 74.65 102.17 -42.10 75.18 101.81 coo 11.79 47.62 52.67 10.10 46.51 53.39 -60.85 79.57 111.25 -62.93 79.16 110.68 coo 10.05 41.79 49.80 7.94 44.71 53.76 -61.15 85.56 115.05 -65.37 84.74 110.73 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 D 57 GLU B 86 GLU^? 25.45 CL CL B 382 D 226 THR B 331 THR^? 16.17 CL CL B 383 D 229 LYS B 288 LYS.? 8.84 CL CL B 382 coo 26.07 55.89 66.14 25.33 56.50 68.01 -37.46 36.82 83.59 -36.60 37.35 85.50 coo 11.79 47.62 52.67 10.10 46.51 53.39 -18.10 46.86 87.19 -17.24 47.80 85.43 coo 10.05 41.79 49.80 7.94 44.71 53.76 -16.76 54.22 83.25 -20.62 56.75 78.99 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 D 57 GLU B 169 GLU.? 11.31 CL CL B 383 D 226 THR B 112 THR~? 22.40 CL CL B 383 D 229 LYS B 109 LYS.? 27.05 CL CL B 384 coo 26.07 55.89 66.14 25.33 56.50 68.01 -9.49 44.22 70.62 -8.22 45.44 69.57 coo 11.79 47.62 52.67 10.10 46.51 53.39 4.03 34.63 60.23 4.00 36.61 59.32 coo 10.05 41.79 49.80 7.94 44.71 53.76 5.83 26.41 59.87 10.67 23.27 57.97 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 D 57 GLU B 276 GLU~? 15.94 CL CL B 384 D 226 THR B 331 THR^? 16.17 CL CL B 383 D 229 LYS B 288 LYS.? 8.84 CL CL B 382 coo 26.07 55.89 66.14 25.33 56.50 68.01 -2.79 30.63 87.01 -2.36 28.59 86.68 coo 11.79 47.62 52.67 10.10 46.51 53.39 -18.10 46.86 87.19 -17.24 47.80 85.43 coo 10.05 41.79 49.80 7.94 44.71 53.76 -16.76 54.22 83.25 -20.62 56.75 78.99 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 D 57 GLU B 332 GLU^? 14.76 CL CL B 383 D 226 THR B 342 THR.? 12.70 CL CL B 383 D 229 LYS B 268 LYS~? 13.29 CL CL B 383 coo 26.07 55.89 66.14 25.33 56.50 68.01 -15.56 41.56 89.17 -16.27 39.59 89.11 coo 11.79 47.62 52.67 10.10 46.51 53.39 2.93 38.40 77.77 1.00 38.51 76.85 coo 10.05 41.79 49.80 7.94 44.71 53.76 5.99 32.14 79.72 1.11 32.64 77.72 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 D 57 GLU B 337 GLU^? 21.78 CL CL B 383 D 226 THR B 217 THR^? 28.18 CL CL B 384 D 229 LYS B 235 LYS.? 32.14 CL CL B 384 coo 26.07 55.89 66.14 25.33 56.50 68.01 2.60 41.45 89.80 4.03 40.00 90.41 coo 11.79 47.62 52.67 10.10 46.51 53.39 12.24 20.91 84.68 13.60 19.27 85.00 coo 10.05 41.79 49.80 7.94 44.71 53.76 16.30 20.77 78.71 18.07 18.48 84.31 1dfo_c07 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 9 hits 1dfo_c07 naa= 3 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 123 HIS A 19 HIS^? 24.55 CL CL A 382 A 200 ASP A 93 ASP^? 5.15 CL CL A 382 A 229 LYS A 128 LYS.? 19.46 CL CL A 382 coo 1.13 77.49 40.64 0.62 75.57 39.98 -17.70 51.01 127.32 -17.43 50.94 129.40 coo 0.84 91.24 49.01 2.91 91.61 49.23 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 10.53 97.56 43.71 9.33 93.71 47.17 -25.12 72.76 133.10 -20.68 68.32 134.09 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 123 HIS A 232 HIS.? 26.22 CL CL A 383 A 200 ASP A 144 ASP.? 19.38 CL CL A 383 A 229 LYS A 109 LYS.? 23.73 CL CL A 383 coo 1.13 77.49 40.64 0.62 75.57 39.98 -64.09 81.45 120.95 -63.65 79.66 121.95 coo 0.84 91.24 49.01 2.91 91.61 49.23 -52.89 78.90 131.37 -53.77 80.20 132.79 coo 10.53 97.56 43.71 9.33 93.71 47.17 -45.10 86.58 132.81 -50.69 86.17 134.93 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 123 HIS A 308 HIS.? 20.06 CL CL A 384 A 200 ASP A 195 ASP.? 13.29 CL CL A 384 A 229 LYS B 288 LYS.? 8.84 CL CL B 382 coo 1.13 77.49 40.64 0.62 75.57 39.98 -37.01 64.37 91.64 -38.79 63.83 92.62 coo 0.84 91.24 49.01 2.91 91.61 49.23 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 10.53 97.56 43.71 9.33 93.71 47.17 -16.76 54.22 83.25 -20.62 56.75 78.99 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 A 123 HIS B 19 HIS^? 13.92 CL CL B 382 A 200 ASP B 93 ASP^? 5.22 CL CL B 383 A 229 LYS B 128 LYS.? 19.37 CL CL B 383 coo 1.13 77.49 40.64 0.62 75.57 39.98 -33.46 45.18 72.05 -34.46 43.90 70.71 coo 0.84 91.24 49.01 2.91 91.61 49.23 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 10.53 97.56 43.71 9.33 93.71 47.17 -13.49 41.25 59.55 -18.50 40.98 58.08 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 A 123 HIS B 287 HIS.? 13.85 CL CL B 382 A 200 ASP B 30 ASP^? -6.72 CL CL B 383s A 229 LYS B 336 LYS^? 14.66 CL CL B 383 coo 1.13 77.49 40.64 0.62 75.57 39.98 -21.22 50.04 83.35 -22.70 48.63 83.80 coo 0.84 91.24 49.01 2.91 91.61 49.23 -11.77 37.20 80.70 -10.35 36.55 82.15 coo 10.53 97.56 43.71 9.33 93.71 47.17 -3.40 41.24 88.18 -4.83 35.96 88.60 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 A 123 HIS B 308 HIS.? 26.99 CL CL A 384 A 200 ASP B 195 ASP.? 10.47 CL CL A 384 A 229 LYS A 288 LYS.? 12.57 CL CL A 384 coo 1.13 77.49 40.64 0.62 75.57 39.98 -5.09 45.35 102.63 -4.80 43.27 102.76 coo 0.84 91.24 49.01 2.91 91.61 49.23 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 10.53 97.56 43.71 9.33 93.71 47.17 -19.18 64.09 108.25 -14.44 63.70 112.45 1dfo_c12 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 6 hits 1dfo_c12 naa= 3 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 123 HIS A 19 HIS^? 24.55 CL CL A 382 B 200 ASP A 93 ASP^? 5.15 CL CL A 382 B 229 LYS A 128 LYS.? 19.46 CL CL A 382 coo 9.24 94.26 88.22 8.02 94.07 89.92 -17.70 51.01 127.32 -17.43 50.94 129.40 coo 17.54 90.31 75.01 17.17 92.01 73.80 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 22.32 101.61 71.64 17.89 98.63 71.55 -25.12 72.76 133.10 -20.68 68.32 134.09 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 123 HIS A 232 HIS.? 26.22 CL CL A 383 B 200 ASP A 144 ASP.? 19.38 CL CL A 383 B 229 LYS A 109 LYS.? 23.73 CL CL A 383 coo 9.24 94.26 88.22 8.02 94.07 89.92 -64.09 81.45 120.95 -63.65 79.66 121.95 coo 17.54 90.31 75.01 17.17 92.01 73.80 -52.89 78.90 131.37 -53.77 80.20 132.79 coo 22.32 101.61 71.64 17.89 98.63 71.55 -45.10 86.58 132.81 -50.69 86.17 134.93 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 123 HIS A 308 HIS.? 20.06 CL CL A 384 B 200 ASP A 195 ASP.? 13.29 CL CL A 384 B 229 LYS B 288 LYS.? 8.84 CL CL B 382 coo 9.24 94.26 88.22 8.02 94.07 89.92 -37.01 64.37 91.64 -38.79 63.83 92.62 coo 17.54 90.31 75.01 17.17 92.01 73.80 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 22.32 101.61 71.64 17.89 98.63 71.55 -16.76 54.22 83.25 -20.62 56.75 78.99 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 B 123 HIS B 19 HIS^? 13.92 CL CL B 382 B 200 ASP B 93 ASP^? 5.22 CL CL B 383 B 229 LYS B 128 LYS.? 19.37 CL CL B 383 coo 9.24 94.26 88.22 8.02 94.07 89.92 -33.46 45.18 72.05 -34.46 43.90 70.71 coo 17.54 90.31 75.01 17.17 92.01 73.80 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 22.32 101.61 71.64 17.89 98.63 71.55 -13.49 41.25 59.55 -18.50 40.98 58.08 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 B 123 HIS B 287 HIS.? 13.85 CL CL B 382 B 200 ASP B 30 ASP^? -6.72 CL CL B 383s B 229 LYS B 336 LYS^? 14.66 CL CL B 383 coo 9.24 94.26 88.22 8.02 94.07 89.92 -21.22 50.04 83.35 -22.70 48.63 83.80 coo 17.54 90.31 75.01 17.17 92.01 73.80 -11.77 37.20 80.70 -10.35 36.55 82.15 coo 22.32 101.61 71.64 17.89 98.63 71.55 -3.40 41.24 88.18 -4.83 35.96 88.60 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 B 123 HIS B 308 HIS.? 26.99 CL CL A 384 B 200 ASP B 195 ASP.? 10.47 CL CL A 384 B 229 LYS A 288 LYS.? 12.57 CL CL A 384 coo 9.24 94.26 88.22 8.02 94.07 89.92 -5.09 45.35 102.63 -4.80 43.27 102.76 coo 17.54 90.31 75.01 17.17 92.01 73.80 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 22.32 101.61 71.64 17.89 98.63 71.55 -19.18 64.09 108.25 -14.44 63.70 112.45 1dfo_c13 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 6 hits 1dfo_c13 naa= 3 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 123 HIS A 19 HIS^? 24.55 CL CL A 382 C 200 ASP A 93 ASP^? 5.15 CL CL A 382 C 229 LYS A 128 LYS.? 19.46 CL CL A 382 coo 26.77 65.84 83.49 27.06 67.76 84.27 -17.70 51.01 127.32 -17.43 50.94 129.40 coo 19.52 52.01 79.59 20.28 51.65 77.65 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 28.90 45.91 73.55 25.22 49.72 72.97 -25.12 72.76 133.10 -20.68 68.32 134.09 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 123 HIS A 232 HIS.? 26.22 CL CL A 383 C 200 ASP A 144 ASP.? 19.38 CL CL A 383 C 229 LYS A 109 LYS.? 23.73 CL CL A 383 coo 26.77 65.84 83.49 27.06 67.76 84.27 -64.09 81.45 120.95 -63.65 79.66 121.95 coo 19.52 52.01 79.59 20.28 51.65 77.65 -52.89 78.90 131.37 -53.77 80.20 132.79 coo 28.90 45.91 73.55 25.22 49.72 72.97 -45.10 86.58 132.81 -50.69 86.17 134.93 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 123 HIS A 308 HIS.? 20.06 CL CL A 384 C 200 ASP A 195 ASP.? 13.29 CL CL A 384 C 229 LYS B 288 LYS.? 8.84 CL CL B 382 coo 26.77 65.84 83.49 27.06 67.76 84.27 -37.01 64.37 91.64 -38.79 63.83 92.62 coo 19.52 52.01 79.59 20.28 51.65 77.65 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 28.90 45.91 73.55 25.22 49.72 72.97 -16.76 54.22 83.25 -20.62 56.75 78.99 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 C 123 HIS B 19 HIS^? 13.92 CL CL B 382 C 200 ASP B 93 ASP^? 5.22 CL CL B 383 C 229 LYS B 128 LYS.? 19.37 CL CL B 383 coo 26.77 65.84 83.49 27.06 67.76 84.27 -33.46 45.18 72.05 -34.46 43.90 70.71 coo 19.52 52.01 79.59 20.28 51.65 77.65 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 28.90 45.91 73.55 25.22 49.72 72.97 -13.49 41.25 59.55 -18.50 40.98 58.08 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 C 123 HIS B 287 HIS.? 13.85 CL CL B 382 C 200 ASP B 30 ASP^? -6.72 CL CL B 383s C 229 LYS B 336 LYS^? 14.66 CL CL B 383 coo 26.77 65.84 83.49 27.06 67.76 84.27 -21.22 50.04 83.35 -22.70 48.63 83.80 coo 19.52 52.01 79.59 20.28 51.65 77.65 -11.77 37.20 80.70 -10.35 36.55 82.15 coo 28.90 45.91 73.55 25.22 49.72 72.97 -3.40 41.24 88.18 -4.83 35.96 88.60 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 C 123 HIS B 308 HIS.? 26.99 CL CL A 384 C 200 ASP B 195 ASP.? 10.47 CL CL A 384 C 229 LYS A 288 LYS.? 12.57 CL CL A 384 coo 26.77 65.84 83.49 27.06 67.76 84.27 -5.09 45.35 102.63 -4.80 43.27 102.76 coo 19.52 52.01 79.59 20.28 51.65 77.65 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 28.90 45.91 73.55 25.22 49.72 72.97 -19.18 64.09 108.25 -14.44 63.70 112.45 1dfo_c14 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 6 hits 1dfo_c14 naa= 3 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 123 HIS A 19 HIS^? 24.55 CL CL A 382 D 200 ASP A 93 ASP^? 5.15 CL CL A 382 D 229 LYS A 128 LYS.? 19.46 CL CL A 382 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -17.70 51.01 127.32 -17.43 50.94 129.40 coo 4.60 52.95 52.50 5.57 51.29 53.40 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 10.05 41.79 49.80 7.94 44.71 53.76 -25.12 72.76 133.10 -20.68 68.32 134.09 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 123 HIS A 232 HIS.? 26.22 CL CL A 383 D 200 ASP A 144 ASP.? 19.38 CL CL A 383 D 229 LYS A 109 LYS.? 23.73 CL CL A 383 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -64.09 81.45 120.95 -63.65 79.66 121.95 coo 4.60 52.95 52.50 5.57 51.29 53.40 -52.89 78.90 131.37 -53.77 80.20 132.79 coo 10.05 41.79 49.80 7.94 44.71 53.76 -45.10 86.58 132.81 -50.69 86.17 134.93 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 123 HIS A 308 HIS.? 20.06 CL CL A 384 D 200 ASP A 195 ASP.? 13.29 CL CL A 384 D 229 LYS B 288 LYS.? 8.84 CL CL B 382 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -37.01 64.37 91.64 -38.79 63.83 92.62 coo 4.60 52.95 52.50 5.57 51.29 53.40 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 10.05 41.79 49.80 7.94 44.71 53.76 -16.76 54.22 83.25 -20.62 56.75 78.99 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 D 123 HIS B 19 HIS^? 13.92 CL CL B 382 D 200 ASP B 93 ASP^? 5.22 CL CL B 383 D 229 LYS B 128 LYS.? 19.37 CL CL B 383 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -33.46 45.18 72.05 -34.46 43.90 70.71 coo 4.60 52.95 52.50 5.57 51.29 53.40 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 10.05 41.79 49.80 7.94 44.71 53.76 -13.49 41.25 59.55 -18.50 40.98 58.08 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 D 123 HIS B 287 HIS.? 13.85 CL CL B 382 D 200 ASP B 30 ASP^? -6.72 CL CL B 383s D 229 LYS B 336 LYS^? 14.66 CL CL B 383 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -21.22 50.04 83.35 -22.70 48.63 83.80 coo 4.60 52.95 52.50 5.57 51.29 53.40 -11.77 37.20 80.70 -10.35 36.55 82.15 coo 10.05 41.79 49.80 7.94 44.71 53.76 -3.40 41.24 88.18 -4.83 35.96 88.60 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 D 123 HIS B 308 HIS.? 26.99 CL CL A 384 D 200 ASP B 195 ASP.? 10.47 CL CL A 384 D 229 LYS A 288 LYS.? 12.57 CL CL A 384 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -5.09 45.35 102.63 -4.80 43.27 102.76 coo 4.60 52.95 52.50 5.57 51.29 53.40 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 10.05 41.79 49.80 7.94 44.71 53.76 -19.18 64.09 108.25 -14.44 63.70 112.45 1dfo_c15 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 6 hits 1dfo_c15 naa= 3 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 44 THR A 217 THR^? 28.81 CL CL A 383 A 45 THR A 250 THR^? 26.09 CL CL A 383 A 161 LYS A 267 LYS~? 27.66 CL CL A 382 coo 26.16 88.25 79.16 25.22 89.47 80.71 -60.85 79.57 111.25 -62.93 79.16 110.68 coo 27.73 89.90 76.08 29.24 91.46 75.95 -61.67 75.47 113.25 -63.75 75.29 113.93 coo 33.83 91.15 88.62 31.07 91.06 83.02 -49.43 81.28 111.60 -49.39 86.78 108.40 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 44 THR A 217 THR^? 28.81 CL CL A 383 A 45 THR A 250 THR^? 26.09 CL CL A 383 A 161 LYS A 268 LYS~? 13.60 CL CL A 382 coo 26.16 88.25 79.16 25.22 89.47 80.71 -60.85 79.57 111.25 -62.93 79.16 110.68 coo 27.73 89.90 76.08 29.24 91.46 75.95 -61.67 75.47 113.25 -63.75 75.29 113.93 coo 33.83 91.15 88.62 31.07 91.06 83.02 -47.11 79.10 113.63 -43.53 76.03 116.02 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 A 44 THR A 283 THR^? 13.40 CL CL A 384 A 45 THR A 331 THR^? 10.31 CL CL A 384 A 161 LYS A 336 LYS^? 14.72 CL CL A 382 coo 26.16 88.25 79.16 25.22 89.47 80.71 -28.94 58.76 103.11 -29.59 56.83 103.84 coo 27.73 89.90 76.08 29.24 91.46 75.95 -26.18 59.17 108.07 -25.19 60.90 109.06 coo 33.83 91.15 88.62 31.07 91.06 83.02 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 A 44 THR B 217 THR^? 28.18 CL CL B 384 A 45 THR B 250 THR^? 25.32 CL CL B 384 A 161 LYS B 267 LYS~? 27.57 CL CL B 383 coo 26.16 88.25 79.16 25.22 89.47 80.71 12.24 20.91 84.68 13.60 19.27 85.00 coo 27.73 89.90 76.08 29.24 91.46 75.95 8.39 18.49 84.99 9.57 16.79 84.51 coo 33.83 91.15 88.62 31.07 91.06 83.02 9.46 31.45 81.02 15.36 33.08 81.01 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 A 44 THR B 217 THR^? 28.18 CL CL B 384 A 45 THR B 250 THR^? 25.32 CL CL B 384 A 161 LYS B 268 LYS~? 13.29 CL CL B 383 coo 26.16 88.25 79.16 25.22 89.47 80.71 12.24 20.91 84.68 13.60 19.27 85.00 coo 27.73 89.90 76.08 29.24 91.46 75.95 8.39 18.49 84.99 9.57 16.79 84.51 coo 33.83 91.15 88.62 31.07 91.06 83.02 5.99 32.14 79.72 1.11 32.64 77.72 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 6 3 # 6 A 44 THR B 283 THR^? 20.21 CL CL B 383 A 45 THR B 331 THR^? 16.17 CL CL B 383 A 161 LYS B 336 LYS^? 14.66 CL CL B 383 coo 26.16 88.25 79.16 25.22 89.47 80.71 -16.17 46.19 92.40 -17.74 44.83 92.78 coo 27.73 89.90 76.08 29.24 91.46 75.95 -18.10 46.86 87.19 -17.24 47.80 85.43 coo 33.83 91.15 88.62 31.07 91.06 83.02 -3.40 41.24 88.18 -4.83 35.96 88.60 1dhp_c02 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 6 hits 1dhp_c02 naa= 3 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 44 THR A 217 THR^? 28.81 CL CL A 383 B 45 THR A 250 THR^? 26.09 CL CL A 383 B 161 LYS A 267 LYS~? 27.66 CL CL A 382 coo 7.39 128.28 94.56 8.34 126.36 94.79 -60.85 79.57 111.25 -62.93 79.16 110.68 coo 5.75 129.25 91.25 4.29 128.16 90.07 -61.67 75.47 113.25 -63.75 75.29 113.93 coo -0.17 119.75 99.65 2.51 123.83 95.70 -49.43 81.28 111.60 -49.39 86.78 108.40 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 44 THR A 217 THR^? 28.81 CL CL A 383 B 45 THR A 250 THR^? 26.09 CL CL A 383 B 161 LYS A 268 LYS~? 13.60 CL CL A 382 coo 7.39 128.28 94.56 8.34 126.36 94.79 -60.85 79.57 111.25 -62.93 79.16 110.68 coo 5.75 129.25 91.25 4.29 128.16 90.07 -61.67 75.47 113.25 -63.75 75.29 113.93 coo -0.17 119.75 99.65 2.51 123.83 95.70 -47.11 79.10 113.63 -43.53 76.03 116.02 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 B 44 THR A 283 THR^? 13.40 CL CL A 384 B 45 THR A 331 THR^? 10.31 CL CL A 384 B 161 LYS A 336 LYS^? 14.72 CL CL A 382 coo 7.39 128.28 94.56 8.34 126.36 94.79 -28.94 58.76 103.11 -29.59 56.83 103.84 coo 5.75 129.25 91.25 4.29 128.16 90.07 -26.18 59.17 108.07 -25.19 60.90 109.06 coo -0.17 119.75 99.65 2.51 123.83 95.70 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 B 44 THR B 217 THR^? 28.18 CL CL B 384 B 45 THR B 250 THR^? 25.32 CL CL B 384 B 161 LYS B 267 LYS~? 27.57 CL CL B 383 coo 7.39 128.28 94.56 8.34 126.36 94.79 12.24 20.91 84.68 13.60 19.27 85.00 coo 5.75 129.25 91.25 4.29 128.16 90.07 8.39 18.49 84.99 9.57 16.79 84.51 coo -0.17 119.75 99.65 2.51 123.83 95.70 9.46 31.45 81.02 15.36 33.08 81.01 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 B 44 THR B 217 THR^? 28.18 CL CL B 384 B 45 THR B 250 THR^? 25.32 CL CL B 384 B 161 LYS B 268 LYS~? 13.29 CL CL B 383 coo 7.39 128.28 94.56 8.34 126.36 94.79 12.24 20.91 84.68 13.60 19.27 85.00 coo 5.75 129.25 91.25 4.29 128.16 90.07 8.39 18.49 84.99 9.57 16.79 84.51 coo -0.17 119.75 99.65 2.51 123.83 95.70 5.99 32.14 79.72 1.11 32.64 77.72 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 6 3 # 6 B 44 THR B 283 THR^? 20.21 CL CL B 383 B 45 THR B 331 THR^? 16.17 CL CL B 383 B 161 LYS B 336 LYS^? 14.66 CL CL B 383 coo 7.39 128.28 94.56 8.34 126.36 94.79 -16.17 46.19 92.40 -17.74 44.83 92.78 coo 5.75 129.25 91.25 4.29 128.16 90.07 -18.10 46.86 87.19 -17.24 47.80 85.43 coo -0.17 119.75 99.65 2.51 123.83 95.70 -3.40 41.24 88.18 -4.83 35.96 88.60 1dhp_c03 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 6 hits 1dhp_c03 naa= 3 ULMN 3 1dj1_c00 CYTOCHROME C PEROXIDASE user 1 3 # 1 A 48 ALA A 159 ALA~? 12.04 CL CL A 382 A 52 HIS A 157 HIS~? 12.03 CL CL A 383 A 191 TRP A 341 TRP.? 10.34 CL CL A 382 coo 0.32 19.13 2.10 -0.45 20.12 1.22 -40.97 78.44 123.91 -40.05 77.14 123.62 coo 0.08 14.87 -2.02 -1.94 15.16 -2.48 -47.82 75.77 126.56 -49.90 76.10 126.41 coo -12.27 21.19 4.26 -8.94 21.66 2.22 -39.95 74.25 113.33 -36.58 74.16 115.41 ULMN 3 1dj1_c00 CYTOCHROME C PEROXIDASE user 2 3 # 2 A 48 ALA A 220 ALA^? 24.28 CL CL A 383 A 52 HIS A 232 HIS.? 26.22 CL CL A 383 A 191 TRP A 236 TRP^? 28.53 CL CL A 383 coo 0.32 19.13 2.10 -0.45 20.12 1.22 -59.62 83.10 120.76 -58.13 83.57 120.73 coo 0.08 14.87 -2.02 -1.94 15.16 -2.48 -64.09 81.45 120.95 -63.65 79.66 121.95 coo -12.27 21.19 4.26 -8.94 21.66 2.22 -56.51 86.75 110.37 -54.08 83.80 109.52 ULMN 3 1dj1_c00 CYTOCHROME C PEROXIDASE user 3 3 # 3 A 48 ALA A 312 ALA^? 16.34 CL CL A 384 A 52 HIS A 302 HIS^? 11.51 CL CL A 384 A 191 TRP A 191 TRP^? 15.13 CL CL A 384 coo 0.32 19.13 2.10 -0.45 20.12 1.22 -32.59 73.91 96.33 -34.10 73.68 96.50 coo 0.08 14.87 -2.02 -1.94 15.16 -2.48 -27.17 73.50 97.06 -27.34 73.92 95.02 coo -12.27 21.19 4.26 -8.94 21.66 2.22 -30.01 60.84 91.30 -29.83 57.58 93.47 ULMN 3 1dj1_c00 CYTOCHROME C PEROXIDASE user 4 3 # 4 A 48 ALA B 159 ALA~? 12.15 CL CL B 383 A 52 HIS B 157 HIS~? 12.80 CL CL B 384 A 191 TRP B 341 TRP.? 10.39 CL CL B 383 coo 0.32 19.13 2.10 -0.45 20.12 1.22 0.19 32.47 69.55 -1.13 33.12 70.03 coo 0.08 14.87 -2.02 -1.94 15.16 -2.48 0.17 24.88 70.38 1.86 23.62 70.32 coo -12.27 21.19 4.26 -8.94 21.66 2.22 -0.76 36.74 80.33 -2.75 38.82 77.66 ULMN 3 1dj1_c00 CYTOCHROME C PEROXIDASE user 5 3 # 5 A 48 ALA B 312 ALA^? 24.95 CL CL B 383 A 52 HIS B 302 HIS^? 23.99 CL CL A 384 A 191 TRP B 191 TRP^? 18.38 CL CL A 384 coo 0.32 19.13 2.10 -0.45 20.12 1.22 0.48 49.99 93.21 0.84 48.52 93.53 coo 0.08 14.87 -2.02 -1.94 15.16 -2.48 -2.27 54.46 91.30 -1.20 55.23 92.93 coo -12.27 21.19 4.26 -8.94 21.66 2.22 -10.49 50.73 102.31 -13.97 49.16 101.58 1dj1_c00 source 1dj1 CYTOCHROME C PEROXIDASE : 5 hits 1dj1_c00 naa= 3 ULMN 3 1do8_c00 MALIC ENZYME user 1 3 # 1 A 112 TYR A 238 TYR^? 27.75 CL CL A 383 A 183 LYS A 267 LYS~? 27.66 CL CL A 382 A 278 ASP A 272 ASP~? 14.48 CL CL A 382 coo 19.43 18.53 42.32 17.66 18.80 40.15 -54.82 80.30 106.22 -53.19 79.11 104.29 coo 21.92 15.80 36.19 17.64 19.44 36.35 -49.43 81.28 111.60 -49.39 86.78 108.40 coo 15.46 19.03 31.40 15.01 18.25 33.31 -46.67 73.24 112.92 -45.43 74.19 114.38 ULMN 3 1do8_c00 MALIC ENZYME user 2 3 # 2 A 112 TYR B 238 TYR^? 27.53 CL CL B 384 A 183 LYS B 267 LYS~? 27.57 CL CL B 383 A 278 ASP B 272 ASP~? 14.11 CL CL B 383 coo 19.43 18.53 42.32 17.66 18.80 40.15 12.27 28.31 87.43 11.42 30.17 89.32 coo 21.92 15.80 36.19 17.64 19.44 36.35 9.46 31.45 81.02 15.36 33.08 81.01 coo 15.46 19.03 31.40 15.01 18.25 33.31 0.88 31.47 82.51 1.09 32.47 80.67 1do8_c00 source 1do8 MALIC ENZYME : 2 hits 1do8_c00 naa= 3 ULMN 3 1do8_c01 MALIC ENZYME user 1 3 # 1 B 112 TYR A 238 TYR^? 27.75 CL CL A 383 B 183 LYS A 267 LYS~? 27.66 CL CL A 382 B 278 ASP A 272 ASP~? 14.48 CL CL A 382 coo 58.62 15.99 58.34 60.98 14.60 58.93 -54.82 80.30 106.22 -53.19 79.11 104.29 coo 60.11 10.60 53.63 62.59 10.74 58.67 -49.43 81.28 111.60 -49.39 86.78 108.40 coo 66.50 7.32 58.45 66.26 9.42 58.23 -46.67 73.24 112.92 -45.43 74.19 114.38 ULMN 3 1do8_c01 MALIC ENZYME user 2 3 # 2 B 112 TYR B 238 TYR^? 27.53 CL CL B 384 B 183 LYS B 267 LYS~? 27.57 CL CL B 383 B 278 ASP B 272 ASP~? 14.11 CL CL B 383 coo 58.62 15.99 58.34 60.98 14.60 58.93 12.27 28.31 87.43 11.42 30.17 89.32 coo 60.11 10.60 53.63 62.59 10.74 58.67 9.46 31.45 81.02 15.36 33.08 81.01 coo 66.50 7.32 58.45 66.26 9.42 58.23 0.88 31.47 82.51 1.09 32.47 80.67 1do8_c01 source 1do8 MALIC ENZYME : 2 hits 1do8_c01 naa= 3 ULMN 3 1do8_c02 MALIC ENZYME user 1 3 # 1 C 112 TYR A 238 TYR^? 27.75 CL CL A 383 C 183 LYS A 267 LYS~? 27.66 CL CL A 382 C 278 ASP A 272 ASP~? 14.48 CL CL A 382 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 -54.82 80.30 106.22 -53.19 79.11 104.29 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 -49.43 81.28 111.60 -49.39 86.78 108.40 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 -46.67 73.24 112.92 -45.43 74.19 114.38 ULMN 3 1do8_c02 MALIC ENZYME user 2 3 # 2 C 112 TYR B 238 TYR^? 27.53 CL CL B 384 C 183 LYS B 267 LYS~? 27.57 CL CL B 383 C 278 ASP B 272 ASP~? 14.11 CL CL B 383 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 12.27 28.31 87.43 11.42 30.17 89.32 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 9.46 31.45 81.02 15.36 33.08 81.01 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 0.88 31.47 82.51 1.09 32.47 80.67 1do8_c02 source 1do8 MALIC ENZYME : 2 hits 1do8_c02 naa= 3 ULMN 3 1do8_c03 MALIC ENZYME user 1 3 # 1 D 112 TYR A 238 TYR^? 27.75 CL CL A 383 D 183 LYS A 267 LYS~? 27.66 CL CL A 382 D 278 ASP A 272 ASP~? 14.48 CL CL A 382 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 -54.82 80.30 106.22 -53.19 79.11 104.29 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 -49.43 81.28 111.60 -49.39 86.78 108.40 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 -46.67 73.24 112.92 -45.43 74.19 114.38 ULMN 3 1do8_c03 MALIC ENZYME user 2 3 # 2 D 112 TYR B 238 TYR^? 27.53 CL CL B 384 D 183 LYS B 267 LYS~? 27.57 CL CL B 383 D 278 ASP B 272 ASP~? 14.11 CL CL B 383 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 12.27 28.31 87.43 11.42 30.17 89.32 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 9.46 31.45 81.02 15.36 33.08 81.01 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 0.88 31.47 82.51 1.09 32.47 80.67 1do8_c03 source 1do8 MALIC ENZYME : 2 hits 1do8_c03 naa= 3 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 1 3 # 1 C 141 GLY B 148 GLY.? 11.16 CL CL B 384 C 144 GLU B 149 GLU.? 9.91 CL CL B 384 C 164 GLU B 146 GLU.? 15.61 CL CL B 384 coo 56.28 104.55 135.84 56.09 105.34 136.05 -10.37 17.04 67.47 -9.78 17.53 67.22 coo 58.46 103.90 139.48 57.57 102.00 139.16 -6.14 20.54 69.48 -4.10 21.06 69.10 coo 51.71 102.03 140.09 53.02 103.62 140.54 -2.82 16.82 69.01 -1.28 15.52 68.26 1dub_c14 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c14 naa= 3 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 1 3 # 1 D 141 GLY B 148 GLY.? 11.16 CL CL B 384 D 144 GLU B 149 GLU.? 9.91 CL CL B 384 D 164 GLU B 146 GLU.? 15.61 CL CL B 384 coo 86.19 80.64 132.77 86.38 79.85 132.93 -10.37 17.04 67.47 -9.78 17.53 67.22 coo 84.75 81.24 136.88 85.62 83.14 136.43 -6.14 20.54 69.48 -4.10 21.06 69.10 coo 91.47 83.05 136.24 90.35 81.38 136.84 -2.82 16.82 69.01 -1.28 15.52 68.26 1dub_c15 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c15 naa= 3 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 1 3 # 1 E 141 GLY B 148 GLY.? 11.16 CL CL B 384 E 144 GLU B 149 GLU.? 9.91 CL CL B 384 E 164 GLU B 146 GLU.? 15.61 CL CL B 384 coo 90.07 81.07 170.50 90.23 80.26 170.38 -10.37 17.04 67.47 -9.78 17.53 67.22 coo 87.05 81.30 167.53 86.38 82.74 168.94 -6.14 20.54 69.48 -4.10 21.06 69.10 coo 84.40 80.02 173.80 85.08 79.06 172.03 -2.82 16.82 69.01 -1.28 15.52 68.26 1dub_c16 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c16 naa= 3 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 A 131 LYS A 133 LYS^? 12.95 CL CL A 382 A 215 LYS A 118 LYS~? 20.77 CL CL A 382 A 277 LYS A 128 LYS.? 19.46 CL CL A 382 coo 0.50 24.09 51.68 1.51 29.34 52.35 -30.69 80.61 120.28 -26.75 77.00 119.43 coo 13.06 30.79 51.73 11.40 35.76 53.48 -33.32 78.46 133.27 -29.10 83.17 132.15 coo 13.04 31.88 60.72 10.57 35.34 57.49 -25.12 72.76 133.10 -20.68 68.32 134.09 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 A 131 LYS A 264 LYS~? 22.00 CL CL A 382 A 215 LYS A 239 LYS^? 36.81 CL CL A 383 A 277 LYS A 249 LYS^? 20.12 CL CL A 383 coo 0.50 24.09 51.68 1.51 29.34 52.35 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 13.06 30.79 51.73 11.40 35.76 53.48 -57.66 80.60 103.08 -61.70 85.06 101.44 coo 13.04 31.88 60.72 10.57 35.34 57.49 -61.09 73.36 110.22 -57.90 69.98 113.58 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 3 3 # 3 A 131 LYS A 268 LYS~? 13.60 CL CL A 382 A 215 LYS A 239 LYS^? 36.81 CL CL A 383 A 277 LYS A 249 LYS^? 20.12 CL CL A 383 coo 0.50 24.09 51.68 1.51 29.34 52.35 -47.11 79.10 113.63 -43.53 76.03 116.02 coo 13.06 30.79 51.73 11.40 35.76 53.48 -57.66 80.60 103.08 -61.70 85.06 101.44 coo 13.04 31.88 60.72 10.57 35.34 57.49 -61.09 73.36 110.22 -57.90 69.98 113.58 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 4 3 # 4 A 131 LYS B 133 LYS^? 13.08 CL CL B 383 A 215 LYS B 118 LYS~? 18.42 CL CL B 383 A 277 LYS B 128 LYS.? 19.37 CL CL B 383 coo 0.50 24.09 51.68 1.51 29.34 52.35 -0.84 43.73 69.01 -5.56 47.16 71.00 coo 13.06 30.79 51.73 11.40 35.76 53.48 -5.67 35.14 59.53 -5.83 40.14 58.40 coo 13.04 31.88 60.72 10.57 35.34 57.49 -13.49 41.25 59.55 -18.50 40.98 58.08 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 5 3 # 5 A 131 LYS B 264 LYS~? 21.76 CL CL B 383 A 215 LYS B 239 LYS^? 36.78 CL CL B 384 A 277 LYS B 249 LYS^? 19.48 CL CL B 384 coo 0.50 24.09 51.68 1.51 29.34 52.35 11.01 31.36 75.69 9.79 34.42 71.26 coo 13.06 30.79 51.73 11.40 35.76 53.48 14.68 26.82 90.55 20.12 26.10 92.90 coo 13.04 31.88 60.72 10.57 35.34 57.49 7.49 19.68 88.46 2.17 20.34 86.44 1e19_c00 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 5 hits 1e19_c00 naa= 3 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 B 131 LYS A 133 LYS^? 12.95 CL CL A 382 B 215 LYS A 118 LYS~? 20.77 CL CL A 382 B 277 LYS A 128 LYS.? 19.46 CL CL A 382 coo 6.78 45.91 16.15 7.82 40.81 15.84 -30.69 80.61 120.28 -26.75 77.00 119.43 coo 17.88 38.77 19.81 16.38 34.23 17.24 -33.32 78.46 133.27 -29.10 83.17 132.15 coo 20.33 37.78 11.20 16.77 34.53 13.47 -25.12 72.76 133.10 -20.68 68.32 134.09 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 B 131 LYS A 264 LYS~? 22.00 CL CL A 382 B 215 LYS A 239 LYS^? 36.81 CL CL A 383 B 277 LYS A 249 LYS^? 20.12 CL CL A 383 coo 6.78 45.91 16.15 7.82 40.81 15.84 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 17.88 38.77 19.81 16.38 34.23 17.24 -57.66 80.60 103.08 -61.70 85.06 101.44 coo 20.33 37.78 11.20 16.77 34.53 13.47 -61.09 73.36 110.22 -57.90 69.98 113.58 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 3 3 # 3 B 131 LYS A 268 LYS~? 13.60 CL CL A 382 B 215 LYS A 239 LYS^? 36.81 CL CL A 383 B 277 LYS A 249 LYS^? 20.12 CL CL A 383 coo 6.78 45.91 16.15 7.82 40.81 15.84 -47.11 79.10 113.63 -43.53 76.03 116.02 coo 17.88 38.77 19.81 16.38 34.23 17.24 -57.66 80.60 103.08 -61.70 85.06 101.44 coo 20.33 37.78 11.20 16.77 34.53 13.47 -61.09 73.36 110.22 -57.90 69.98 113.58 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 4 3 # 4 B 131 LYS A 268 LYS~? 13.60 CL CL A 382 B 215 LYS A 249 LYS^? 20.12 CL CL A 383 B 277 LYS A 239 LYS^? 36.81 CL CL A 383 coo 6.78 45.91 16.15 7.82 40.81 15.84 -47.11 79.10 113.63 -43.53 76.03 116.02 coo 17.88 38.77 19.81 16.38 34.23 17.24 -61.09 73.36 110.22 -57.90 69.98 113.58 coo 20.33 37.78 11.20 16.77 34.53 13.47 -57.66 80.60 103.08 -61.70 85.06 101.44 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 5 3 # 5 B 131 LYS B 133 LYS^? 13.08 CL CL B 383 B 215 LYS B 118 LYS~? 18.42 CL CL B 383 B 277 LYS B 128 LYS.? 19.37 CL CL B 383 coo 6.78 45.91 16.15 7.82 40.81 15.84 -0.84 43.73 69.01 -5.56 47.16 71.00 coo 17.88 38.77 19.81 16.38 34.23 17.24 -5.67 35.14 59.53 -5.83 40.14 58.40 coo 20.33 37.78 11.20 16.77 34.53 13.47 -13.49 41.25 59.55 -18.50 40.98 58.08 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 6 3 # 6 B 131 LYS B 268 LYS~? 13.29 CL CL B 383 B 215 LYS B 239 LYS^? 36.78 CL CL B 384 B 277 LYS B 249 LYS^? 19.48 CL CL B 384 coo 6.78 45.91 16.15 7.82 40.81 15.84 5.99 32.14 79.72 1.11 32.64 77.72 coo 17.88 38.77 19.81 16.38 34.23 17.24 14.68 26.82 90.55 20.12 26.10 92.90 coo 20.33 37.78 11.20 16.77 34.53 13.47 7.49 19.68 88.46 2.17 20.34 86.44 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 7 3 # 7 B 131 LYS B 268 LYS~? 13.29 CL CL B 383 B 215 LYS B 249 LYS^? 19.48 CL CL B 384 B 277 LYS B 239 LYS^? 36.78 CL CL B 384 coo 6.78 45.91 16.15 7.82 40.81 15.84 5.99 32.14 79.72 1.11 32.64 77.72 coo 17.88 38.77 19.81 16.38 34.23 17.24 7.49 19.68 88.46 2.17 20.34 86.44 coo 20.33 37.78 11.20 16.77 34.53 13.47 14.68 26.82 90.55 20.12 26.10 92.90 1e19_c01 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 7 hits 1e19_c01 naa= 3 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 6 TYR.? 20.79 CL CL A 384 A 40 ASP B 195 ASP.? 10.47 CL CL A 384 A 103 ASP B 306 ASP.? 19.57 CL CL A 384 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -7.05 53.27 108.32 -4.25 53.35 108.15 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -4.64 54.84 103.01 -3.71 56.24 101.58 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR A 25 TYR^? 18.63 CL CL A 382 A 40 ASP A 28 ASP^? 9.02 CL CL A 382 A 103 ASP A 39 ASP^? 16.51 CL CL A 382 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -23.49 53.13 116.11 -21.60 54.30 114.36 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR B 6 TYR.? 15.73 CL CL B 382 A 40 ASP A 195 ASP.? 13.29 CL CL A 384 A 103 ASP A 306 ASP.? 16.66 CL CL A 384 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -31.00 62.22 83.89 -31.26 65.01 83.64 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -29.63 66.56 87.01 -28.35 68.29 87.20 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR B 6 TYR.? 15.73 CL CL B 382 A 40 ASP A 311 ASP^? 15.19 CL CL A 384 A 103 ASP A 306 ASP.? 16.66 CL CL A 384 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -31.00 62.22 83.89 -31.26 65.01 83.64 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -31.19 72.86 91.72 -29.44 73.97 92.12 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -29.63 66.56 87.01 -28.35 68.29 87.20 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 5 3 # 5 A 16 TYR B 25 TYR^? 14.27 CL CL B 382 A 40 ASP B 28 ASP^? 9.00 CL CL B 383 A 103 ASP B 39 ASP^? 17.51 CL CL B 383 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -26.62 44.42 81.68 -25.97 47.00 82.31 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -26.18 36.85 80.53 -27.97 36.10 81.34 1e3v_c02 source 1e3v STEROID DELTA-ISOMERASE : 5 hits 1e3v_c02 naa= 3 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 6 TYR.? 20.79 CL CL A 384 B 40 ASP B 195 ASP.? 10.47 CL CL A 384 B 103 ASP B 306 ASP.? 19.57 CL CL A 384 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -7.05 53.27 108.32 -4.25 53.35 108.15 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -4.64 54.84 103.01 -3.71 56.24 101.58 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR A 25 TYR^? 18.63 CL CL A 382 B 40 ASP A 28 ASP^? 9.02 CL CL A 382 B 103 ASP A 39 ASP^? 16.51 CL CL A 382 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -23.49 53.13 116.11 -21.60 54.30 114.36 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR B 6 TYR.? 15.73 CL CL B 382 B 40 ASP A 195 ASP.? 13.29 CL CL A 384 B 103 ASP A 306 ASP.? 16.66 CL CL A 384 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -31.00 62.22 83.89 -31.26 65.01 83.64 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -29.63 66.56 87.01 -28.35 68.29 87.20 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR B 6 TYR.? 15.73 CL CL B 382 B 40 ASP A 311 ASP^? 15.19 CL CL A 384 B 103 ASP A 306 ASP.? 16.66 CL CL A 384 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -31.00 62.22 83.89 -31.26 65.01 83.64 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -31.19 72.86 91.72 -29.44 73.97 92.12 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -29.63 66.56 87.01 -28.35 68.29 87.20 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 5 3 # 5 B 16 TYR B 25 TYR^? 14.27 CL CL B 382 B 40 ASP B 28 ASP^? 9.00 CL CL B 383 B 103 ASP B 39 ASP^? 17.51 CL CL B 383 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -26.62 44.42 81.68 -25.97 47.00 82.31 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -26.18 36.85 80.53 -27.97 36.10 81.34 1e3v_c03 source 1e3v STEROID DELTA-ISOMERASE : 5 hits 1e3v_c03 naa= 3 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 1 3 # 1 A 107 ALA A 179 ALA.? 13.90 CL CL A 382 A 136 TYR A 346 TYR.? 17.61 CL CL A 382 A 140 LYS A 133 LYS^? 12.95 CL CL A 382 coo 55.90 7.49 23.83 56.71 8.23 22.76 -33.44 78.17 113.04 -34.16 77.56 111.82 coo 59.38 10.02 17.51 59.95 9.89 20.21 -31.44 83.83 114.39 -30.05 82.53 116.45 coo 59.52 3.69 18.67 62.31 6.19 22.58 -30.69 80.61 120.28 -26.75 77.00 119.43 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 2 3 # 2 A 107 ALA B 179 ALA.? 13.78 CL CL B 383 A 136 TYR B 346 TYR.? 17.60 CL CL B 383 A 140 LYS B 133 LYS^? 13.08 CL CL B 383 coo 55.90 7.49 23.83 56.71 8.23 22.76 0.07 43.70 77.00 0.03 43.44 78.44 coo 59.38 10.02 17.51 59.95 9.89 20.21 3.94 45.97 72.94 1.71 46.24 71.30 coo 59.52 3.69 18.67 62.31 6.19 22.58 -0.84 43.73 69.01 -5.56 47.16 71.00 1e7q_c01 source 1e7q GDP-FUCOSE SYNTHETASE : 2 hits 1e7q_c01 naa= 3 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 1 3 # 1 A 32 ASP A 28 ASP^? 9.02 CL CL A 382 A 35 SER A 29 SER^? 6.92 CL CL A 382 A 218 ASP A 26 ASP^? 16.59 CL CL A 382 coo 47.22 22.34 8.57 45.16 22.02 9.13 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 43.58 20.85 5.15 44.62 23.01 5.76 -31.31 63.66 116.96 -29.07 63.86 117.79 coo 44.05 16.99 12.67 44.05 18.89 11.74 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 2 3 # 2 A 32 ASP A 28 ASP^? 9.02 CL CL A 382 A 35 SER A 37 SER^? 9.11 CL CL A 382 A 218 ASP A 26 ASP^? 16.59 CL CL A 382 coo 47.22 22.34 8.57 45.16 22.02 9.13 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 43.58 20.85 5.15 44.62 23.01 5.76 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 44.05 16.99 12.67 44.05 18.89 11.74 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 3 3 # 3 A 32 ASP A 28 ASP^? 9.02 CL CL A 382 A 35 SER A 37 SER^? 9.11 CL CL A 382 A 218 ASP A 30 ASP^? -6.81 CL CL A 382s coo 47.22 22.34 8.57 45.16 22.02 9.13 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 43.58 20.85 5.15 44.62 23.01 5.76 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 44.05 16.99 12.67 44.05 18.89 11.74 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 4 3 # 4 A 32 ASP A 28 ASP^? 9.02 CL CL A 382 A 35 SER A 37 SER^? 9.11 CL CL A 382 A 218 ASP A 39 ASP^? 16.51 CL CL A 382 coo 47.22 22.34 8.57 45.16 22.02 9.13 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 43.58 20.85 5.15 44.62 23.01 5.76 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 44.05 16.99 12.67 44.05 18.89 11.74 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 5 3 # 5 A 32 ASP A 36 ASP.? -3.33 CL CL A 382s A 35 SER A 37 SER^? 9.11 CL CL A 382 A 218 ASP A 30 ASP^? -6.81 CL CL A 382s coo 47.22 22.34 8.57 45.16 22.02 9.13 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 43.58 20.85 5.15 44.62 23.01 5.76 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 44.05 16.99 12.67 44.05 18.89 11.74 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 6 3 # 6 A 32 ASP A 195 ASP.? 13.29 CL CL A 384 A 35 SER A 192 SER.? 15.36 CL CL A 384 A 218 ASP A 306 ASP.? 16.66 CL CL A 384 coo 47.22 22.34 8.57 45.16 22.02 9.13 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 43.58 20.85 5.15 44.62 23.01 5.76 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 44.05 16.99 12.67 44.05 18.89 11.74 -29.63 66.56 87.01 -28.35 68.29 87.20 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 7 3 # 7 A 32 ASP A 306 ASP.? 16.66 CL CL A 384 A 35 SER A 192 SER.? 15.36 CL CL A 384 A 218 ASP A 305 ASP^? 16.01 CL CL A 384 coo 47.22 22.34 8.57 45.16 22.02 9.13 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 43.58 20.85 5.15 44.62 23.01 5.76 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 44.05 16.99 12.67 44.05 18.89 11.74 -32.01 65.22 92.45 -32.49 63.34 91.63 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 8 3 # 8 A 32 ASP B 28 ASP^? 9.00 CL CL B 383 A 35 SER B 29 SER^? 6.98 CL CL B 383 A 218 ASP B 26 ASP^? 16.51 CL CL B 383 coo 47.22 22.34 8.57 45.16 22.02 9.13 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 43.58 20.85 5.15 44.62 23.01 5.76 -14.55 40.12 78.88 -15.61 41.67 77.42 coo 44.05 16.99 12.67 44.05 18.89 11.74 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 9 3 # 9 A 32 ASP B 28 ASP^? 9.00 CL CL B 383 A 35 SER B 37 SER^? 9.16 CL CL B 383 A 218 ASP B 26 ASP^? 16.51 CL CL B 383 coo 47.22 22.34 8.57 45.16 22.02 9.13 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 43.58 20.85 5.15 44.62 23.01 5.76 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 44.05 16.99 12.67 44.05 18.89 11.74 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 10 3 # 10 A 32 ASP B 28 ASP^? 9.00 CL CL B 383 A 35 SER B 37 SER^? 9.16 CL CL B 383 A 218 ASP B 30 ASP^? -6.72 CL CL B 383s coo 47.22 22.34 8.57 45.16 22.02 9.13 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 43.58 20.85 5.15 44.62 23.01 5.76 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 44.05 16.99 12.67 44.05 18.89 11.74 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 11 3 # 11 A 32 ASP B 28 ASP^? 9.00 CL CL B 383 A 35 SER B 37 SER^? 9.16 CL CL B 383 A 218 ASP B 39 ASP^? 17.51 CL CL B 383 coo 47.22 22.34 8.57 45.16 22.02 9.13 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 43.58 20.85 5.15 44.62 23.01 5.76 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 44.05 16.99 12.67 44.05 18.89 11.74 -26.18 36.85 80.53 -27.97 36.10 81.34 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 12 3 # 12 A 32 ASP B 36 ASP.? -3.35 CL CL B 383s A 35 SER B 37 SER^? 9.16 CL CL B 383 A 218 ASP B 30 ASP^? -6.72 CL CL B 383s coo 47.22 22.34 8.57 45.16 22.02 9.13 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 43.58 20.85 5.15 44.62 23.01 5.76 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 44.05 16.99 12.67 44.05 18.89 11.74 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 13 3 # 13 A 32 ASP B 195 ASP.? 10.47 CL CL A 384 A 35 SER B 192 SER.? 13.26 CL CL A 384 A 218 ASP B 306 ASP.? 19.57 CL CL A 384 coo 47.22 22.34 8.57 45.16 22.02 9.13 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 43.58 20.85 5.15 44.62 23.01 5.76 -11.80 54.65 102.27 -11.20 56.97 103.08 coo 44.05 16.99 12.67 44.05 18.89 11.74 -4.64 54.84 103.01 -3.71 56.24 101.58 1eag_c04 source 1eag PEPTIDE INHIBITOR : 13 hits 1eag_c04 naa= 3 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 1 3 # 1 A 205 LYS A 142 LYS.? 24.15 CL CL A 383 A 207 LYS A 109 LYS.? 23.73 CL CL A 383 A 366 ASP A 144 ASP.? 19.38 CL CL A 383 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -49.53 84.63 130.17 -55.13 85.19 133.14 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -45.10 86.58 132.81 -50.69 86.17 134.93 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -52.89 78.90 131.37 -53.77 80.20 132.79 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 2 3 # 2 A 205 LYS A 264 LYS~? 22.00 CL CL A 382 A 207 LYS A 267 LYS~? 27.66 CL CL A 382 A 366 ASP A 344 ASP.? 20.56 CL CL A 382 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -48.92 85.08 115.29 -44.06 86.61 118.76 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -49.43 81.28 111.60 -49.39 86.78 108.40 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 3 3 # 3 A 205 LYS A 264 LYS~? 22.00 CL CL A 382 A 207 LYS A 268 LYS~? 13.60 CL CL A 382 A 366 ASP A 344 ASP.? 20.56 CL CL A 382 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -48.92 85.08 115.29 -44.06 86.61 118.76 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -47.11 79.10 113.63 -43.53 76.03 116.02 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 4 3 # 4 A 205 LYS A 267 LYS~? 27.66 CL CL A 382 A 207 LYS A 264 LYS~? 22.00 CL CL A 382 A 366 ASP A 272 ASP~? 14.48 CL CL A 382 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -49.43 81.28 111.60 -49.39 86.78 108.40 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -48.92 85.08 115.29 -44.06 86.61 118.76 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -46.67 73.24 112.92 -45.43 74.19 114.38 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 5 3 # 5 A 205 LYS A 268 LYS~? 13.60 CL CL A 382 A 207 LYS A 264 LYS~? 22.00 CL CL A 382 A 366 ASP A 344 ASP.? 20.56 CL CL A 382 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 -47.11 79.10 113.63 -43.53 76.03 116.02 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 -48.92 85.08 115.29 -44.06 86.61 118.76 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 6 3 # 6 A 205 LYS B 142 LYS.? 25.17 CL CL B 384 A 207 LYS B 109 LYS.? 27.05 CL CL B 384 A 366 ASP B 144 ASP.? 18.90 CL CL B 384 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 6.28 23.32 63.35 7.97 19.73 58.68 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 5.83 26.41 59.87 10.67 23.27 57.97 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 1.70 18.75 65.96 3.42 18.04 64.94 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 7 3 # 7 A 205 LYS B 142 LYS.? 25.17 CL CL B 384 A 207 LYS B 109 LYS.? 27.05 CL CL B 384 A 366 ASP B 257 ASP.? 23.04 CL CL B 384 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 6.28 23.32 63.35 7.97 19.73 58.68 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 5.83 26.41 59.87 10.67 23.27 57.97 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 12.38 23.16 66.89 10.36 22.88 66.20 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 8 3 # 8 A 205 LYS B 264 LYS~? 21.76 CL CL B 383 A 207 LYS B 267 LYS~? 27.57 CL CL B 383 A 366 ASP B 344 ASP.? 20.04 CL CL B 383 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 11.01 31.36 75.69 9.79 34.42 71.26 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 9.46 31.45 81.02 15.36 33.08 81.01 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 7.59 38.09 74.22 8.59 36.72 75.50 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 9 3 # 9 A 205 LYS B 267 LYS~? 27.57 CL CL B 383 A 207 LYS B 264 LYS~? 21.76 CL CL B 383 A 366 ASP B 272 ASP~? 14.11 CL CL B 383 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 9.46 31.45 81.02 15.36 33.08 81.01 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 11.01 31.36 75.69 9.79 34.42 71.26 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 0.88 31.47 82.51 1.09 32.47 80.67 1ec9_c04 source 1ec9 GLUCARATE DEHYDRATASE : 9 hits 1ec9_c04 naa= 3 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 1 3 # 1 B 205 LYS A 142 LYS.? 24.15 CL CL A 383 B 207 LYS A 109 LYS.? 23.73 CL CL A 383 B 366 ASP A 144 ASP.? 19.38 CL CL A 383 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -49.53 84.63 130.17 -55.13 85.19 133.14 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -45.10 86.58 132.81 -50.69 86.17 134.93 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -52.89 78.90 131.37 -53.77 80.20 132.79 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 2 3 # 2 B 205 LYS A 264 LYS~? 22.00 CL CL A 382 B 207 LYS A 267 LYS~? 27.66 CL CL A 382 B 366 ASP A 344 ASP.? 20.56 CL CL A 382 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -48.92 85.08 115.29 -44.06 86.61 118.76 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -49.43 81.28 111.60 -49.39 86.78 108.40 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 3 3 # 3 B 205 LYS A 264 LYS~? 22.00 CL CL A 382 B 207 LYS A 268 LYS~? 13.60 CL CL A 382 B 366 ASP A 344 ASP.? 20.56 CL CL A 382 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -48.92 85.08 115.29 -44.06 86.61 118.76 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -47.11 79.10 113.63 -43.53 76.03 116.02 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 4 3 # 4 B 205 LYS A 267 LYS~? 27.66 CL CL A 382 B 207 LYS A 264 LYS~? 22.00 CL CL A 382 B 366 ASP A 272 ASP~? 14.48 CL CL A 382 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -49.43 81.28 111.60 -49.39 86.78 108.40 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -48.92 85.08 115.29 -44.06 86.61 118.76 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -46.67 73.24 112.92 -45.43 74.19 114.38 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 5 3 # 5 B 205 LYS A 268 LYS~? 13.60 CL CL A 382 B 207 LYS A 264 LYS~? 22.00 CL CL A 382 B 366 ASP A 344 ASP.? 20.56 CL CL A 382 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 -47.11 79.10 113.63 -43.53 76.03 116.02 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 -48.92 85.08 115.29 -44.06 86.61 118.76 coo -11.13 25.71 4.86 -10.82 24.43 3.24 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 6 3 # 6 B 205 LYS B 142 LYS.? 25.17 CL CL B 384 B 207 LYS B 109 LYS.? 27.05 CL CL B 384 B 366 ASP B 144 ASP.? 18.90 CL CL B 384 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 6.28 23.32 63.35 7.97 19.73 58.68 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 5.83 26.41 59.87 10.67 23.27 57.97 coo -11.13 25.71 4.86 -10.82 24.43 3.24 1.70 18.75 65.96 3.42 18.04 64.94 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 7 3 # 7 B 205 LYS B 142 LYS.? 25.17 CL CL B 384 B 207 LYS B 109 LYS.? 27.05 CL CL B 384 B 366 ASP B 257 ASP.? 23.04 CL CL B 384 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 6.28 23.32 63.35 7.97 19.73 58.68 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 5.83 26.41 59.87 10.67 23.27 57.97 coo -11.13 25.71 4.86 -10.82 24.43 3.24 12.38 23.16 66.89 10.36 22.88 66.20 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 8 3 # 8 B 205 LYS B 264 LYS~? 21.76 CL CL B 383 B 207 LYS B 267 LYS~? 27.57 CL CL B 383 B 366 ASP B 344 ASP.? 20.04 CL CL B 383 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 11.01 31.36 75.69 9.79 34.42 71.26 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 9.46 31.45 81.02 15.36 33.08 81.01 coo -11.13 25.71 4.86 -10.82 24.43 3.24 7.59 38.09 74.22 8.59 36.72 75.50 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 9 3 # 9 B 205 LYS B 267 LYS~? 27.57 CL CL B 383 B 207 LYS B 264 LYS~? 21.76 CL CL B 383 B 366 ASP B 272 ASP~? 14.11 CL CL B 383 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 9.46 31.45 81.02 15.36 33.08 81.01 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 11.01 31.36 75.69 9.79 34.42 71.26 coo -11.13 25.71 4.86 -10.82 24.43 3.24 0.88 31.47 82.51 1.09 32.47 80.67 1ec9_c05 source 1ec9 GLUCARATE DEHYDRATASE : 9 hits 1ec9_c05 naa= 3 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 1 3 # 1 C 205 LYS A 142 LYS.? 24.15 CL CL A 383 C 207 LYS A 109 LYS.? 23.73 CL CL A 383 C 366 ASP A 144 ASP.? 19.38 CL CL A 383 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -49.53 84.63 130.17 -55.13 85.19 133.14 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -45.10 86.58 132.81 -50.69 86.17 134.93 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -52.89 78.90 131.37 -53.77 80.20 132.79 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 2 3 # 2 C 205 LYS A 264 LYS~? 22.00 CL CL A 382 C 207 LYS A 267 LYS~? 27.66 CL CL A 382 C 366 ASP A 344 ASP.? 20.56 CL CL A 382 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -49.43 81.28 111.60 -49.39 86.78 108.40 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 3 3 # 3 C 205 LYS A 264 LYS~? 22.00 CL CL A 382 C 207 LYS A 268 LYS~? 13.60 CL CL A 382 C 366 ASP A 344 ASP.? 20.56 CL CL A 382 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -47.11 79.10 113.63 -43.53 76.03 116.02 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 4 3 # 4 C 205 LYS A 267 LYS~? 27.66 CL CL A 382 C 207 LYS A 264 LYS~? 22.00 CL CL A 382 C 366 ASP A 272 ASP~? 14.48 CL CL A 382 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -49.43 81.28 111.60 -49.39 86.78 108.40 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -46.67 73.24 112.92 -45.43 74.19 114.38 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 5 3 # 5 C 205 LYS A 268 LYS~? 13.60 CL CL A 382 C 207 LYS A 264 LYS~? 22.00 CL CL A 382 C 366 ASP A 272 ASP~? 14.48 CL CL A 382 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -47.11 79.10 113.63 -43.53 76.03 116.02 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -46.67 73.24 112.92 -45.43 74.19 114.38 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 6 3 # 6 C 205 LYS A 268 LYS~? 13.60 CL CL A 382 C 207 LYS A 264 LYS~? 22.00 CL CL A 382 C 366 ASP A 344 ASP.? 20.56 CL CL A 382 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 -47.11 79.10 113.63 -43.53 76.03 116.02 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 7 3 # 7 C 205 LYS B 142 LYS.? 25.17 CL CL B 384 C 207 LYS B 109 LYS.? 27.05 CL CL B 384 C 366 ASP B 144 ASP.? 18.90 CL CL B 384 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 6.28 23.32 63.35 7.97 19.73 58.68 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 5.83 26.41 59.87 10.67 23.27 57.97 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 1.70 18.75 65.96 3.42 18.04 64.94 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 8 3 # 8 C 205 LYS B 142 LYS.? 25.17 CL CL B 384 C 207 LYS B 109 LYS.? 27.05 CL CL B 384 C 366 ASP B 257 ASP.? 23.04 CL CL B 384 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 6.28 23.32 63.35 7.97 19.73 58.68 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 5.83 26.41 59.87 10.67 23.27 57.97 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 12.38 23.16 66.89 10.36 22.88 66.20 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 9 3 # 9 C 205 LYS B 264 LYS~? 21.76 CL CL B 383 C 207 LYS B 267 LYS~? 27.57 CL CL B 383 C 366 ASP B 344 ASP.? 20.04 CL CL B 383 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 11.01 31.36 75.69 9.79 34.42 71.26 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 9.46 31.45 81.02 15.36 33.08 81.01 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 7.59 38.09 74.22 8.59 36.72 75.50 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 10 3 # 10 C 205 LYS B 267 LYS~? 27.57 CL CL B 383 C 207 LYS B 264 LYS~? 21.76 CL CL B 383 C 366 ASP B 272 ASP~? 14.11 CL CL B 383 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 9.46 31.45 81.02 15.36 33.08 81.01 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 11.01 31.36 75.69 9.79 34.42 71.26 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 0.88 31.47 82.51 1.09 32.47 80.67 1ec9_c06 source 1ec9 GLUCARATE DEHYDRATASE : 10 hits 1ec9_c06 naa= 3 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 1 3 # 1 D 205 LYS A 142 LYS.? 24.15 CL CL A 383 D 207 LYS A 109 LYS.? 23.73 CL CL A 383 D 366 ASP A 144 ASP.? 19.38 CL CL A 383 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -49.53 84.63 130.17 -55.13 85.19 133.14 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -45.10 86.58 132.81 -50.69 86.17 134.93 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -52.89 78.90 131.37 -53.77 80.20 132.79 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 2 3 # 2 D 205 LYS A 264 LYS~? 22.00 CL CL A 382 D 207 LYS A 267 LYS~? 27.66 CL CL A 382 D 366 ASP A 344 ASP.? 20.56 CL CL A 382 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -49.43 81.28 111.60 -49.39 86.78 108.40 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 3 3 # 3 D 205 LYS A 264 LYS~? 22.00 CL CL A 382 D 207 LYS A 268 LYS~? 13.60 CL CL A 382 D 366 ASP A 344 ASP.? 20.56 CL CL A 382 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -47.11 79.10 113.63 -43.53 76.03 116.02 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 4 3 # 4 D 205 LYS A 267 LYS~? 27.66 CL CL A 382 D 207 LYS A 264 LYS~? 22.00 CL CL A 382 D 366 ASP A 272 ASP~? 14.48 CL CL A 382 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -49.43 81.28 111.60 -49.39 86.78 108.40 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -46.67 73.24 112.92 -45.43 74.19 114.38 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 5 3 # 5 D 205 LYS A 268 LYS~? 13.60 CL CL A 382 D 207 LYS A 264 LYS~? 22.00 CL CL A 382 D 366 ASP A 344 ASP.? 20.56 CL CL A 382 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 -47.11 79.10 113.63 -43.53 76.03 116.02 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 6 3 # 6 D 205 LYS B 142 LYS.? 25.17 CL CL B 384 D 207 LYS B 109 LYS.? 27.05 CL CL B 384 D 366 ASP B 144 ASP.? 18.90 CL CL B 384 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 6.28 23.32 63.35 7.97 19.73 58.68 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 5.83 26.41 59.87 10.67 23.27 57.97 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 1.70 18.75 65.96 3.42 18.04 64.94 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 7 3 # 7 D 205 LYS B 142 LYS.? 25.17 CL CL B 384 D 207 LYS B 109 LYS.? 27.05 CL CL B 384 D 366 ASP B 257 ASP.? 23.04 CL CL B 384 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 6.28 23.32 63.35 7.97 19.73 58.68 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 5.83 26.41 59.87 10.67 23.27 57.97 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 12.38 23.16 66.89 10.36 22.88 66.20 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 8 3 # 8 D 205 LYS B 264 LYS~? 21.76 CL CL B 383 D 207 LYS B 267 LYS~? 27.57 CL CL B 383 D 366 ASP B 344 ASP.? 20.04 CL CL B 383 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 11.01 31.36 75.69 9.79 34.42 71.26 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 9.46 31.45 81.02 15.36 33.08 81.01 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 7.59 38.09 74.22 8.59 36.72 75.50 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 9 3 # 9 D 205 LYS B 267 LYS~? 27.57 CL CL B 383 D 207 LYS B 264 LYS~? 21.76 CL CL B 383 D 366 ASP B 272 ASP~? 14.11 CL CL B 383 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 9.46 31.45 81.02 15.36 33.08 81.01 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 11.01 31.36 75.69 9.79 34.42 71.26 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 0.88 31.47 82.51 1.09 32.47 80.67 1ec9_c07 source 1ec9 GLUCARATE DEHYDRATASE : 9 hits 1ec9_c07 naa= 3 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 1 3 # 1 A 99 HIS A 157 HIS~? 12.03 CL CL A 383 A 177 ASP A 144 ASP.? 19.38 CL CL A 383 A 203 LYS A 109 LYS.? 23.73 CL CL A 383 coo 8.74 45.76 47.19 9.33 46.93 45.56 -47.82 75.77 126.56 -49.90 76.10 126.41 coo 11.68 42.31 52.96 12.05 43.92 51.65 -52.89 78.90 131.37 -53.77 80.20 132.79 coo 18.07 52.81 49.62 14.17 49.99 48.07 -45.10 86.58 132.81 -50.69 86.17 134.93 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 2 3 # 2 A 99 HIS A 223 HIS.? 29.08 CL CL A 383 A 177 ASP A 257 ASP.? 24.30 CL CL A 383 A 203 LYS A 109 LYS.? 23.73 CL CL A 383 coo 8.74 45.76 47.19 9.33 46.93 45.56 -56.62 90.70 129.56 -55.95 91.22 131.48 coo 11.68 42.31 52.96 12.05 43.92 51.65 -55.05 88.25 125.09 -55.04 86.55 126.35 coo 18.07 52.81 49.62 14.17 49.99 48.07 -45.10 86.58 132.81 -50.69 86.17 134.93 1ecx_c02 source 1ecx AMINOTRANSFERASE : 2 hits 1ecx_c02 naa= 3 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 1 3 # 1 B 99 HIS A 157 HIS~? 12.03 CL CL A 383 B 177 ASP A 144 ASP.? 19.38 CL CL A 383 B 203 LYS A 109 LYS.? 23.73 CL CL A 383 coo 14.87 88.04 21.51 13.64 87.90 19.81 -47.82 75.77 126.56 -49.90 76.10 126.41 coo 15.87 92.46 27.37 14.46 91.76 25.94 -52.89 78.90 131.37 -53.77 80.20 132.79 coo 3.60 91.42 23.52 8.20 89.55 22.63 -45.10 86.58 132.81 -50.69 86.17 134.93 1ecx_c03 source 1ecx AMINOTRANSFERASE : 1 hits 1ecx_c03 naa= 3 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 1 3 # 1 P 32 ASP A 28 ASP^? 9.02 CL CL A 382 P 35 SER A 29 SER^? 6.92 CL CL A 382 P 215 ASP A 26 ASP^? 16.59 CL CL A 382 coo 10.15 33.41 11.98 7.98 33.66 12.07 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 7.57 37.60 10.00 8.86 37.02 12.03 -31.31 63.66 116.96 -29.07 63.86 117.79 coo 4.04 29.97 8.82 4.78 31.15 10.46 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 2 3 # 2 P 32 ASP A 28 ASP^? 9.02 CL CL A 382 P 35 SER A 37 SER^? 9.11 CL CL A 382 P 215 ASP A 26 ASP^? 16.59 CL CL A 382 coo 10.15 33.41 11.98 7.98 33.66 12.07 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 7.57 37.60 10.00 8.86 37.02 12.03 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 4.04 29.97 8.82 4.78 31.15 10.46 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 3 3 # 3 P 32 ASP A 28 ASP^? 9.02 CL CL A 382 P 35 SER A 37 SER^? 9.11 CL CL A 382 P 215 ASP A 30 ASP^? -6.81 CL CL A 382s coo 10.15 33.41 11.98 7.98 33.66 12.07 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 7.57 37.60 10.00 8.86 37.02 12.03 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 4.04 29.97 8.82 4.78 31.15 10.46 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 4 3 # 4 P 32 ASP A 28 ASP^? 9.02 CL CL A 382 P 35 SER A 37 SER^? 9.11 CL CL A 382 P 215 ASP A 39 ASP^? 16.51 CL CL A 382 coo 10.15 33.41 11.98 7.98 33.66 12.07 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 7.57 37.60 10.00 8.86 37.02 12.03 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 4.04 29.97 8.82 4.78 31.15 10.46 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 5 3 # 5 P 32 ASP A 36 ASP.? -3.33 CL CL A 382s P 35 SER A 37 SER^? 9.11 CL CL A 382 P 215 ASP A 30 ASP^? -6.81 CL CL A 382s coo 10.15 33.41 11.98 7.98 33.66 12.07 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 7.57 37.60 10.00 8.86 37.02 12.03 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 4.04 29.97 8.82 4.78 31.15 10.46 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 6 3 # 6 P 32 ASP A 195 ASP.? 13.29 CL CL A 384 P 35 SER A 192 SER.? 15.36 CL CL A 384 P 215 ASP A 306 ASP.? 16.66 CL CL A 384 coo 10.15 33.41 11.98 7.98 33.66 12.07 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 7.57 37.60 10.00 8.86 37.02 12.03 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 4.04 29.97 8.82 4.78 31.15 10.46 -29.63 66.56 87.01 -28.35 68.29 87.20 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 7 3 # 7 P 32 ASP A 306 ASP.? 16.66 CL CL A 384 P 35 SER A 192 SER.? 15.36 CL CL A 384 P 215 ASP A 305 ASP^? 16.01 CL CL A 384 coo 10.15 33.41 11.98 7.98 33.66 12.07 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 7.57 37.60 10.00 8.86 37.02 12.03 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 4.04 29.97 8.82 4.78 31.15 10.46 -32.01 65.22 92.45 -32.49 63.34 91.63 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 8 3 # 8 P 32 ASP B 28 ASP^? 9.00 CL CL B 383 P 35 SER B 29 SER^? 6.98 CL CL B 383 P 215 ASP B 26 ASP^? 16.51 CL CL B 383 coo 10.15 33.41 11.98 7.98 33.66 12.07 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 7.57 37.60 10.00 8.86 37.02 12.03 -14.55 40.12 78.88 -15.61 41.67 77.42 coo 4.04 29.97 8.82 4.78 31.15 10.46 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 9 3 # 9 P 32 ASP B 28 ASP^? 9.00 CL CL B 383 P 35 SER B 37 SER^? 9.16 CL CL B 383 P 215 ASP B 26 ASP^? 16.51 CL CL B 383 coo 10.15 33.41 11.98 7.98 33.66 12.07 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 7.57 37.60 10.00 8.86 37.02 12.03 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 4.04 29.97 8.82 4.78 31.15 10.46 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 10 3 # 10 P 32 ASP B 28 ASP^? 9.00 CL CL B 383 P 35 SER B 37 SER^? 9.16 CL CL B 383 P 215 ASP B 30 ASP^? -6.72 CL CL B 383s coo 10.15 33.41 11.98 7.98 33.66 12.07 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 7.57 37.60 10.00 8.86 37.02 12.03 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 4.04 29.97 8.82 4.78 31.15 10.46 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 11 3 # 11 P 32 ASP B 28 ASP^? 9.00 CL CL B 383 P 35 SER B 37 SER^? 9.16 CL CL B 383 P 215 ASP B 39 ASP^? 17.51 CL CL B 383 coo 10.15 33.41 11.98 7.98 33.66 12.07 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 7.57 37.60 10.00 8.86 37.02 12.03 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 4.04 29.97 8.82 4.78 31.15 10.46 -26.18 36.85 80.53 -27.97 36.10 81.34 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 12 3 # 12 P 32 ASP B 36 ASP.? -3.35 CL CL B 383s P 35 SER B 37 SER^? 9.16 CL CL B 383 P 215 ASP B 30 ASP^? -6.72 CL CL B 383s coo 10.15 33.41 11.98 7.98 33.66 12.07 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 7.57 37.60 10.00 8.86 37.02 12.03 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 4.04 29.97 8.82 4.78 31.15 10.46 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 13 3 # 13 P 32 ASP B 195 ASP.? 10.47 CL CL A 384 P 35 SER B 192 SER.? 13.26 CL CL A 384 P 215 ASP B 306 ASP.? 19.57 CL CL A 384 coo 10.15 33.41 11.98 7.98 33.66 12.07 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 7.57 37.60 10.00 8.86 37.02 12.03 -11.80 54.65 102.27 -11.20 56.97 103.08 coo 4.04 29.97 8.82 4.78 31.15 10.46 -4.64 54.84 103.01 -3.71 56.24 101.58 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 14 3 # 14 P 32 ASP B 306 ASP.? 19.57 CL CL A 384 P 35 SER B 192 SER.? 13.26 CL CL A 384 P 215 ASP B 305 ASP^? 21.59 CL CL A 384 coo 10.15 33.41 11.98 7.98 33.66 12.07 -4.64 54.84 103.01 -3.71 56.24 101.58 coo 7.57 37.60 10.00 8.86 37.02 12.03 -11.80 54.65 102.27 -11.20 56.97 103.08 coo 4.04 29.97 8.82 4.78 31.15 10.46 -6.28 49.81 99.79 -7.51 49.10 101.38 1eed_c04 source 1eed ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLEX WITH TH: 14 hits 1eed_c04 naa= 3 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 B 66 HIS A 308 HIS.? 20.06 CL CL A 384 B 110 GLY A 309 GLY.? 19.85 CL CL A 384 B 140 TYR B 6 TYR.? 15.73 CL CL B 382 coo 15.25 42.02 9.50 15.08 40.17 8.54 -37.01 64.37 91.64 -38.79 63.83 92.62 coo 16.54 37.86 10.86 17.07 37.78 11.48 -35.24 68.60 88.70 -35.11 68.24 89.40 coo 8.70 35.97 10.91 11.44 36.02 10.35 -31.00 62.22 83.89 -31.26 65.01 83.64 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 2 3 # 2 B 66 HIS B 308 HIS.? 26.99 CL CL A 384 B 110 GLY B 309 GLY.? 25.52 CL CL A 384 B 140 TYR A 6 TYR.? 20.79 CL CL A 384 coo 15.25 42.02 9.50 15.08 40.17 8.54 -5.09 45.35 102.63 -4.80 43.27 102.76 coo 16.54 37.86 10.86 17.07 37.78 11.48 -1.34 49.50 102.80 -1.84 49.15 102.26 coo 8.70 35.97 10.91 11.44 36.02 10.35 -7.05 53.27 108.32 -4.25 53.35 108.15 1ef8_c01 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 2 hits 1ef8_c01 naa= 3 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 C 66 HIS A 308 HIS.? 20.06 CL CL A 384 C 110 GLY A 309 GLY.? 19.85 CL CL A 384 C 140 TYR B 6 TYR.? 15.73 CL CL B 382 coo -9.82 10.01 28.41 -9.17 11.02 26.71 -37.01 64.37 91.64 -38.79 63.83 92.62 coo -5.73 12.49 27.77 -5.15 12.61 28.37 -35.24 68.60 88.70 -35.11 68.24 89.40 coo -4.68 8.05 21.05 -4.91 10.19 22.84 -31.00 62.22 83.89 -31.26 65.01 83.64 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 2 3 # 2 C 66 HIS B 308 HIS.? 26.99 CL CL A 384 C 110 GLY B 309 GLY.? 25.52 CL CL A 384 C 140 TYR A 6 TYR.? 20.79 CL CL A 384 coo -9.82 10.01 28.41 -9.17 11.02 26.71 -5.09 45.35 102.63 -4.80 43.27 102.76 coo -5.73 12.49 27.77 -5.15 12.61 28.37 -1.34 49.50 102.80 -1.84 49.15 102.26 coo -4.68 8.05 21.05 -4.91 10.19 22.84 -7.05 53.27 108.32 -4.25 53.35 108.15 1ef8_c02 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 2 hits 1ef8_c02 naa= 3 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 A 114 HIS B 165 HIS^? 7.69 CL CL B 383 A 197 ASP B 272 ASP~? 14.11 CL CL B 383 A 223 LYS B 336 LYS^? 14.66 CL CL B 383 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -3.45 34.55 75.15 -4.91 33.27 75.93 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 0.88 31.47 82.51 1.09 32.47 80.67 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -3.40 41.24 88.18 -4.83 35.96 88.60 1elq_c02 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 1 hits 1elq_c02 naa= 3 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 B 114 HIS B 165 HIS^? 7.69 CL CL B 383 B 197 ASP B 272 ASP~? 14.11 CL CL B 383 B 223 LYS B 264 LYS~? 21.76 CL CL B 383 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -3.45 34.55 75.15 -4.91 33.27 75.93 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 0.88 31.47 82.51 1.09 32.47 80.67 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 11.01 31.36 75.69 9.79 34.42 71.26 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 B 114 HIS B 165 HIS^? 7.69 CL CL B 383 B 197 ASP B 272 ASP~? 14.11 CL CL B 383 B 223 LYS B 336 LYS^? 14.66 CL CL B 383 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -3.45 34.55 75.15 -4.91 33.27 75.93 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 0.88 31.47 82.51 1.09 32.47 80.67 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -3.40 41.24 88.18 -4.83 35.96 88.60 1elq_c03 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 2 hits 1elq_c03 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA A 35 ALA.? 6.30 CL CL A 382 A 257 ALA A 95 ALA~? 5.86 CL CL A 382 A 328 ASP A 100 ASP~? 8.92 CL CL A 383 coo 39.84 24.12 8.44 38.50 24.23 9.11 -35.44 63.33 123.80 -35.72 62.35 124.94 coo 43.22 26.73 5.37 41.81 27.09 5.79 -34.32 65.97 127.91 -34.72 66.23 126.45 coo 38.17 34.10 6.67 37.72 32.06 6.84 -39.25 61.23 132.92 -38.42 59.82 131.54 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA A 95 ALA~? 5.86 CL CL A 382 A 257 ALA A 35 ALA.? 6.30 CL CL A 382 A 328 ASP A 30 ASP^? -6.81 CL CL A 382s coo 39.84 24.12 8.44 38.50 24.23 9.11 -34.32 65.97 127.91 -34.72 66.23 126.45 coo 43.22 26.73 5.37 41.81 27.09 5.79 -35.44 63.33 123.80 -35.72 62.35 124.94 coo 38.17 34.10 6.67 37.72 32.06 6.84 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 3 3 # 3 A 229 ALA A 95 ALA~? 5.86 CL CL A 382 A 257 ALA A 35 ALA.? 6.30 CL CL A 382 A 328 ASP A 100 ASP~? 8.92 CL CL A 383 coo 39.84 24.12 8.44 38.50 24.23 9.11 -34.32 65.97 127.91 -34.72 66.23 126.45 coo 43.22 26.73 5.37 41.81 27.09 5.79 -35.44 63.33 123.80 -35.72 62.35 124.94 coo 38.17 34.10 6.67 37.72 32.06 6.84 -39.25 61.23 132.92 -38.42 59.82 131.54 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 4 3 # 4 A 229 ALA A 260 ALA~? 28.69 CL CL A 383 A 257 ALA A 261 ALA~? 24.23 CL CL A 383 A 328 ASP A 257 ASP.? 24.30 CL CL A 383 coo 39.84 24.12 8.44 38.50 24.23 9.11 -51.98 90.24 116.77 -51.20 91.41 117.38 coo 43.22 26.73 5.37 41.81 27.09 5.79 -51.30 87.37 119.20 -51.49 87.39 120.67 coo 38.17 34.10 6.67 37.72 32.06 6.84 -55.05 88.25 125.09 -55.04 86.55 126.35 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 5 3 # 5 A 229 ALA B 35 ALA.? 6.30 CL CL B 383 A 257 ALA B 95 ALA~? 5.98 CL CL B 383 A 328 ASP B 100 ASP~? 8.80 CL CL B 384 coo 39.84 24.12 8.44 38.50 24.23 9.11 -15.02 33.54 74.31 -16.10 32.59 73.63 coo 43.22 26.73 5.37 41.81 27.09 5.79 -14.44 33.46 69.35 -13.59 33.72 70.62 coo 38.17 34.10 6.67 37.72 32.06 6.84 -18.20 25.71 68.46 -19.22 26.77 70.02 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 6 3 # 6 A 229 ALA B 95 ALA~? 5.98 CL CL B 383 A 257 ALA B 35 ALA.? 6.30 CL CL B 383 A 328 ASP B 30 ASP^? -6.72 CL CL B 383s coo 39.84 24.12 8.44 38.50 24.23 9.11 -14.44 33.46 69.35 -13.59 33.72 70.62 coo 43.22 26.73 5.37 41.81 27.09 5.79 -15.02 33.54 74.31 -16.10 32.59 73.63 coo 38.17 34.10 6.67 37.72 32.06 6.84 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 7 3 # 7 A 229 ALA B 95 ALA~? 5.98 CL CL B 383 A 257 ALA B 35 ALA.? 6.30 CL CL B 383 A 328 ASP B 100 ASP~? 8.80 CL CL B 384 coo 39.84 24.12 8.44 38.50 24.23 9.11 -14.44 33.46 69.35 -13.59 33.72 70.62 coo 43.22 26.73 5.37 41.81 27.09 5.79 -15.02 33.54 74.31 -16.10 32.59 73.63 coo 38.17 34.10 6.67 37.72 32.06 6.84 -18.20 25.71 68.46 -19.22 26.77 70.02 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 8 3 # 8 A 229 ALA B 103 ALA.? 10.27 CL CL B 384 A 257 ALA B 154 ALA~? 9.41 CL CL B 384 A 328 ASP B 144 ASP.? 18.90 CL CL B 384 coo 39.84 24.12 8.44 38.50 24.23 9.11 -9.13 23.29 63.46 -7.92 23.41 64.32 coo 43.22 26.73 5.37 41.81 27.09 5.79 -4.85 25.78 67.69 -5.32 25.38 66.32 coo 38.17 34.10 6.67 37.72 32.06 6.84 1.70 18.75 65.96 3.42 18.04 64.94 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 9 3 # 9 A 229 ALA B 260 ALA~? 27.92 CL CL B 384 A 257 ALA B 261 ALA~? 23.36 CL CL B 384 A 328 ASP B 257 ASP.? 23.04 CL CL B 384 coo 39.84 24.12 8.44 38.50 24.23 9.11 15.92 29.33 72.54 16.37 30.18 71.35 coo 43.22 26.73 5.37 41.81 27.09 5.79 12.35 28.11 71.85 11.96 27.24 70.64 coo 38.17 34.10 6.67 37.72 32.06 6.84 12.38 23.16 66.89 10.36 22.88 66.20 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 9 hits 1eo7_c00 naa= 3 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 159 LYS A 17 LYS^? 30.54 CL CL A 382 A 193 GLU A 57 GLU.? 23.36 CL CL A 382 A 217 VAL A 14 VAL^? 21.39 CL CL A 382 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -13.97 54.79 130.31 -12.29 50.22 133.16 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -23.46 53.73 134.86 -22.94 54.54 136.68 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -19.01 56.20 130.97 -20.69 54.82 131.33 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 159 LYS A 17 LYS^? 30.54 CL CL A 382 A 193 GLU A 60 GLU^? 17.84 CL CL A 382 A 217 VAL A 14 VAL^? 21.39 CL CL A 382 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -13.97 54.79 130.31 -12.29 50.22 133.16 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -20.60 62.82 127.64 -18.87 63.84 128.41 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -19.01 56.20 130.97 -20.69 54.82 131.33 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 159 LYS B 17 LYS^? 18.67 CL CL B 382 A 193 GLU B 57 GLU.? 21.35 CL CL B 382 A 217 VAL B 14 VAL^? 14.99 CL CL B 382 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -33.42 46.60 66.26 -37.89 44.12 63.72 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -31.25 37.00 65.18 -31.15 36.75 63.13 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -29.95 42.68 66.90 -30.31 40.99 68.30 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 159 LYS B 17 LYS^? 18.67 CL CL B 382 A 193 GLU B 60 GLU^? 11.77 CL CL B 382 A 217 VAL B 14 VAL^? 14.99 CL CL B 382 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -33.42 46.60 66.26 -37.89 44.12 63.72 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -22.53 44.68 66.99 -22.71 45.90 65.28 coo 0.07 12.29 66.53 -0.24 11.95 64.38 -29.95 42.68 66.90 -30.31 40.99 68.30 1et0_c00 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 4 hits 1et0_c00 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 281 THR^? 16.66 CL CL A 384 A 159 LYS A 336 LYS^? 14.72 CL CL A 382 A 193 GLU A 276 GLU~? 16.10 CL CL A 383 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -34.83 61.90 103.55 -35.70 60.62 105.09 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -37.43 70.02 105.34 -41.47 67.12 107.58 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -46.62 67.79 110.40 -48.46 68.09 111.43 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR B 281 THR^? 16.75 CL CL B 383 A 159 LYS B 336 LYS^? 14.66 CL CL B 383 A 193 GLU B 276 GLU~? 15.94 CL CL B 384 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -11.01 41.80 92.41 -12.17 40.05 91.86 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -3.40 41.24 88.18 -4.83 35.96 88.60 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -2.79 30.63 87.01 -2.36 28.59 86.68 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 2 hits 1et0_c02 naa= 3 ULMN 3 1euu_c00 SIALIDASE user 1 3 # 1 92 ASP A 327 ASP.? 19.04 CL CL A 384 260 GLU A 23 GLU.? 27.24 CL CL A 382 370 TYR A 25 TYR^? 18.63 CL CL A 382 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -25.74 49.77 105.10 -27.34 48.80 104.08 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -22.84 44.28 116.17 -23.55 42.53 115.22 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -23.49 53.13 116.11 -21.60 54.30 114.36 1euu_c00 source 1euu SIALIDASE : 1 hits 1euu_c00 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU A 60 GLU^? 17.84 CL CL A 382 A 260 ARG A 20 ARG.? 25.24 CL CL A 384 A 270 LYS A 17 LYS^? 30.54 CL CL A 382 coo 50.99 29.43 12.86 52.11 29.45 14.65 -20.60 62.82 127.64 -18.87 63.84 128.41 coo 39.80 27.50 22.98 42.20 26.56 21.34 -13.35 53.68 120.82 -11.33 55.30 122.50 coo 48.83 21.70 19.50 47.44 24.99 15.25 -13.97 54.79 130.31 -12.29 50.22 133.16 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 2 3 # 2 A 34 GLU A 206 GLU^? 19.04 CL CL A 382 A 260 ARG A 274 ARG~? 23.93 CL CL A 382 A 270 LYS A 336 LYS^? 14.72 CL CL A 382 coo 50.99 29.43 12.86 52.11 29.45 14.65 -42.05 60.33 102.60 -42.22 59.82 104.62 coo 39.80 27.50 22.98 42.20 26.56 21.34 -45.43 76.09 104.31 -44.66 77.94 101.95 coo 48.83 21.70 19.50 47.44 24.99 15.25 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 3 3 # 3 A 34 GLU B 60 GLU^? 11.77 CL CL B 382 A 260 ARG B 20 ARG.? -3.56 CL CL B 382s A 270 LYS B 17 LYS^? 18.67 CL CL B 382 coo 50.99 29.43 12.86 52.11 29.45 14.65 -22.53 44.68 66.99 -22.71 45.90 65.28 coo 39.80 27.50 22.98 42.20 26.56 21.34 -30.86 53.38 73.69 -28.77 54.55 71.62 coo 48.83 21.70 19.50 47.44 24.99 15.25 -33.42 46.60 66.26 -37.89 44.12 63.72 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 4 3 # 4 A 34 GLU B 206 GLU^? 19.18 CL CL B 383 A 260 ARG B 274 ARG~? 23.83 CL CL B 383 A 270 LYS B 336 LYS^? 14.66 CL CL B 383 coo 50.99 29.43 12.86 52.11 29.45 14.65 -9.17 35.76 95.82 -10.61 34.74 94.62 coo 39.80 27.50 22.98 42.20 26.56 21.34 5.51 36.33 89.03 7.35 38.65 89.98 coo 48.83 21.70 19.50 47.44 24.99 15.25 -3.40 41.24 88.18 -4.83 35.96 88.60 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 4 hits 1euy_c00 naa= 3 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 1 3 # 1 A 68 ASP A 195 ASP.? 13.29 CL CL A 384 A 74 ASP A 306 ASP.? 16.66 CL CL A 384 A 98 GLU A 307 GLU.? 18.04 CL CL B 382 coo 17.19 9.05 25.28 15.77 9.98 26.53 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 15.99 8.54 17.36 14.96 7.80 19.05 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 16.31 12.85 18.11 16.71 11.79 19.90 -31.95 61.22 87.08 -31.47 59.40 88.12 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 2 3 # 2 A 68 ASP A 305 ASP^? 16.01 CL CL A 384 A 74 ASP A 306 ASP.? 16.66 CL CL A 384 A 98 GLU A 307 GLU.? 18.04 CL CL B 382 coo 17.19 9.05 25.28 15.77 9.98 26.53 -32.01 65.22 92.45 -32.49 63.34 91.63 coo 15.99 8.54 17.36 14.96 7.80 19.05 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 16.31 12.85 18.11 16.71 11.79 19.90 -31.95 61.22 87.08 -31.47 59.40 88.12 1eyi_c00 source 1eyi FRUCTOSE-1,6-BISPHOSPHATASE : 2 hits 1eyi_c00 naa= 3 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 1 3 # 1 C 95 ASP A 204 ASP^? 18.76 CL CL A 384 C 117 GLU A 332 GLU^? 14.84 CL CL A 382 C 131 GLU A 206 GLU^? 19.04 CL CL A 382 coo 68.01 56.37 72.57 68.42 56.10 70.51 -37.06 58.40 100.88 -36.30 56.45 100.53 coo 66.59 62.50 67.44 67.57 60.64 67.12 -32.41 59.20 107.78 -33.78 57.91 108.78 coo 69.24 52.27 71.96 69.91 50.26 71.89 -42.05 60.33 102.60 -42.22 59.82 104.62 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 2 3 # 2 C 95 ASP B 204 ASP^? 22.18 CL CL B 383 C 117 GLU B 332 GLU^? 14.76 CL CL B 383 C 131 GLU B 206 GLU^? 19.18 CL CL B 383 coo 68.01 56.37 72.57 68.42 56.10 70.51 -12.38 39.84 96.49 -14.33 39.98 97.22 coo 66.59 62.50 67.44 67.57 60.64 67.12 -15.56 41.56 89.17 -16.27 39.59 89.11 coo 69.24 52.27 71.96 69.91 50.26 71.89 -9.17 35.76 95.82 -10.61 34.74 94.62 1f6d_c02 source 1f6d UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE : 2 hits 1f6d_c02 naa= 3 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 1 3 # 1 A 105 HIS A 302 HIS^? 11.51 CL CL A 384 C 62 LYS A 336 LYS^? 14.72 CL CL A 382 F 35 ASP A 311 ASP^? 15.19 CL CL A 384 coo 15.40 22.79 16.66 13.93 24.10 15.98 -27.17 73.50 97.06 -27.34 73.92 95.02 coo 19.95 18.98 4.81 18.82 20.94 10.49 -37.43 70.02 105.34 -41.47 67.12 107.58 coo 16.32 15.30 17.19 17.71 14.73 18.69 -31.19 72.86 91.72 -29.44 73.97 92.12 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 2 3 # 2 A 105 HIS B 165 HIS^? 7.69 CL CL B 383 C 62 LYS B 264 LYS~? 21.76 CL CL B 383 F 35 ASP B 272 ASP~? 14.11 CL CL B 383 coo 15.40 22.79 16.66 13.93 24.10 15.98 -3.45 34.55 75.15 -4.91 33.27 75.93 coo 19.95 18.98 4.81 18.82 20.94 10.49 11.01 31.36 75.69 9.79 34.42 71.26 coo 16.32 15.30 17.19 17.71 14.73 18.69 0.88 31.47 82.51 1.09 32.47 80.67 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 3 3 # 3 A 105 HIS B 165 HIS^? 7.69 CL CL B 383 C 62 LYS B 336 LYS^? 14.66 CL CL B 383 F 35 ASP B 272 ASP~? 14.11 CL CL B 383 coo 15.40 22.79 16.66 13.93 24.10 15.98 -3.45 34.55 75.15 -4.91 33.27 75.93 coo 19.95 18.98 4.81 18.82 20.94 10.49 -3.40 41.24 88.18 -4.83 35.96 88.60 coo 16.32 15.30 17.19 17.71 14.73 18.69 0.88 31.47 82.51 1.09 32.47 80.67 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 4 3 # 4 A 105 HIS B 302 HIS^? 23.99 CL CL A 384 C 62 LYS B 336 LYS^? 14.66 CL CL B 383 F 35 ASP B 311 ASP^? 24.66 CL CL A 384 coo 15.40 22.79 16.66 13.93 24.10 15.98 -2.27 54.46 91.30 -1.20 55.23 92.93 coo 19.95 18.98 4.81 18.82 20.94 10.49 -3.40 41.24 88.18 -4.83 35.96 88.60 coo 16.32 15.30 17.19 17.71 14.73 18.69 0.41 52.81 97.17 0.37 54.52 95.85 1f80_c03 source 1f80 ACYL CARRIER PROTEIN : 4 hits 1f80_c03 naa= 3 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 1 3 # 1 B 62 LYS A 336 LYS^? 14.72 CL CL A 382 C 105 HIS A 302 HIS^? 11.51 CL CL A 384 D 35 ASP A 311 ASP^? 15.19 CL CL A 384 coo 38.76 28.25 7.87 36.33 26.41 13.58 -37.43 70.02 105.34 -41.47 67.12 107.58 coo 34.93 19.72 17.37 34.72 18.17 15.98 -27.17 73.50 97.06 -27.34 73.92 95.02 coo 41.01 23.02 20.83 40.65 24.26 22.55 -31.19 72.86 91.72 -29.44 73.97 92.12 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 2 3 # 2 B 62 LYS B 264 LYS~? 21.76 CL CL B 383 C 105 HIS B 165 HIS^? 7.69 CL CL B 383 D 35 ASP B 272 ASP~? 14.11 CL CL B 383 coo 38.76 28.25 7.87 36.33 26.41 13.58 11.01 31.36 75.69 9.79 34.42 71.26 coo 34.93 19.72 17.37 34.72 18.17 15.98 -3.45 34.55 75.15 -4.91 33.27 75.93 coo 41.01 23.02 20.83 40.65 24.26 22.55 0.88 31.47 82.51 1.09 32.47 80.67 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 3 3 # 3 B 62 LYS B 336 LYS^? 14.66 CL CL B 383 C 105 HIS B 302 HIS^? 23.99 CL CL A 384 D 35 ASP B 311 ASP^? 24.66 CL CL A 384 coo 38.76 28.25 7.87 36.33 26.41 13.58 -3.40 41.24 88.18 -4.83 35.96 88.60 coo 34.93 19.72 17.37 34.72 18.17 15.98 -2.27 54.46 91.30 -1.20 55.23 92.93 coo 41.01 23.02 20.83 40.65 24.26 22.55 0.41 52.81 97.17 0.37 54.52 95.85 1f80_c04 source 1f80 ACYL CARRIER PROTEIN : 3 hits 1f80_c04 naa= 3 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 1 3 # 1 A 62 LYS A 264 LYS~? 22.00 CL CL A 382 B 105 HIS A 165 HIS^? 7.64 CL CL A 382 E 35 ASP A 272 ASP~? 14.48 CL CL A 382 coo 20.51 39.76 8.83 21.23 37.38 14.18 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 27.18 37.56 20.68 29.07 38.28 20.13 -39.19 73.43 119.40 -40.10 71.56 119.72 coo 19.97 40.39 22.03 18.53 39.30 23.18 -46.67 73.24 112.92 -45.43 74.19 114.38 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 2 3 # 2 A 62 LYS A 336 LYS^? 14.72 CL CL A 382 B 105 HIS A 165 HIS^? 7.64 CL CL A 382 E 35 ASP A 272 ASP~? 14.48 CL CL A 382 coo 20.51 39.76 8.83 21.23 37.38 14.18 -37.43 70.02 105.34 -41.47 67.12 107.58 coo 27.18 37.56 20.68 29.07 38.28 20.13 -39.19 73.43 119.40 -40.10 71.56 119.72 coo 19.97 40.39 22.03 18.53 39.30 23.18 -46.67 73.24 112.92 -45.43 74.19 114.38 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 3 3 # 3 A 62 LYS B 264 LYS~? 21.76 CL CL B 383 B 105 HIS B 165 HIS^? 7.69 CL CL B 383 E 35 ASP B 272 ASP~? 14.11 CL CL B 383 coo 20.51 39.76 8.83 21.23 37.38 14.18 11.01 31.36 75.69 9.79 34.42 71.26 coo 27.18 37.56 20.68 29.07 38.28 20.13 -3.45 34.55 75.15 -4.91 33.27 75.93 coo 19.97 40.39 22.03 18.53 39.30 23.18 0.88 31.47 82.51 1.09 32.47 80.67 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 4 3 # 4 A 62 LYS B 336 LYS^? 14.66 CL CL B 383 B 105 HIS B 165 HIS^? 7.69 CL CL B 383 E 35 ASP B 272 ASP~? 14.11 CL CL B 383 coo 20.51 39.76 8.83 21.23 37.38 14.18 -3.40 41.24 88.18 -4.83 35.96 88.60 coo 27.18 37.56 20.68 29.07 38.28 20.13 -3.45 34.55 75.15 -4.91 33.27 75.93 coo 19.97 40.39 22.03 18.53 39.30 23.18 0.88 31.47 82.51 1.09 32.47 80.67 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 5 3 # 5 A 62 LYS B 336 LYS^? 14.66 CL CL B 383 B 105 HIS B 302 HIS^? 23.99 CL CL A 384 E 35 ASP B 311 ASP^? 24.66 CL CL A 384 coo 20.51 39.76 8.83 21.23 37.38 14.18 -3.40 41.24 88.18 -4.83 35.96 88.60 coo 27.18 37.56 20.68 29.07 38.28 20.13 -2.27 54.46 91.30 -1.20 55.23 92.93 coo 19.97 40.39 22.03 18.53 39.30 23.18 0.41 52.81 97.17 0.37 54.52 95.85 1f80_c05 source 1f80 ACYL CARRIER PROTEIN : 5 hits 1f80_c05 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 97 PHE~? 13.64 CL CL A 383 A 210 ASP A 93 ASP^? 5.15 CL CL A 382 A 244 LYS A 128 LYS.? 19.46 CL CL A 382 coo 9.23 46.77 25.11 11.48 48.39 24.76 -33.26 63.92 133.83 -31.10 62.40 134.75 coo 10.51 37.86 19.71 9.07 39.38 20.04 -30.23 63.77 124.99 -32.09 64.66 124.54 coo -1.20 42.34 17.67 3.19 45.13 19.06 -25.12 72.76 133.10 -20.68 68.32 134.09 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE A 213 PHE.? 23.30 CL CL A 383 A 210 ASP A 240 ASP.? 30.06 CL CL A 382 A 244 LYS A 267 LYS~? 27.66 CL CL A 382 coo 9.23 46.77 25.11 11.48 48.39 24.76 -56.84 71.96 107.29 -56.22 69.93 109.07 coo 10.51 37.86 19.71 9.07 39.38 20.04 -54.36 78.15 100.29 -55.09 76.20 100.68 coo -1.20 42.34 17.67 3.19 45.13 19.06 -49.43 81.28 111.60 -49.39 86.78 108.40 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 112 PHE B 97 PHE~? 13.75 CL CL B 384 A 210 ASP B 93 ASP^? 5.22 CL CL B 383 A 244 LYS B 128 LYS.? 19.37 CL CL B 383 coo 9.23 46.77 25.11 11.48 48.39 24.76 -18.35 31.53 64.75 -20.77 32.66 63.92 coo 10.51 37.86 19.71 9.07 39.38 20.04 -17.13 37.76 71.68 -15.50 36.45 72.23 coo -1.20 42.34 17.67 3.19 45.13 19.06 -13.49 41.25 59.55 -18.50 40.98 58.08 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 3 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 97 PHE~? 13.64 CL CL A 383 B 210 ASP A 93 ASP^? 5.15 CL CL A 382 B 244 LYS A 128 LYS.? 19.46 CL CL A 382 coo 8.76 47.85 34.91 11.08 46.36 35.41 -33.26 63.92 133.83 -31.10 62.40 134.75 coo 9.06 56.85 40.30 7.71 55.27 39.90 -30.23 63.77 124.99 -32.09 64.66 124.54 coo -2.38 51.82 41.62 2.07 49.19 40.42 -25.12 72.76 133.10 -20.68 68.32 134.09 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE A 213 PHE.? 23.30 CL CL A 383 B 210 ASP A 240 ASP.? 30.06 CL CL A 382 B 244 LYS A 267 LYS~? 27.66 CL CL A 382 coo 8.76 47.85 34.91 11.08 46.36 35.41 -56.84 71.96 107.29 -56.22 69.93 109.07 coo 9.06 56.85 40.30 7.71 55.27 39.90 -54.36 78.15 100.29 -55.09 76.20 100.68 coo -2.38 51.82 41.62 2.07 49.19 40.42 -49.43 81.28 111.60 -49.39 86.78 108.40 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 112 PHE B 97 PHE~? 13.75 CL CL B 384 B 210 ASP B 93 ASP^? 5.22 CL CL B 383 B 244 LYS B 128 LYS.? 19.37 CL CL B 383 coo 8.76 47.85 34.91 11.08 46.36 35.41 -18.35 31.53 64.75 -20.77 32.66 63.92 coo 9.06 56.85 40.30 7.71 55.27 39.90 -17.13 37.76 71.68 -15.50 36.45 72.23 coo -2.38 51.82 41.62 2.07 49.19 40.42 -13.49 41.25 59.55 -18.50 40.98 58.08 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 3 hits 1fc4_c03 naa= 3 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 136 HIS A 157 HIS~? 12.03 CL CL A 383 A 210 ASP A 144 ASP.? 19.38 CL CL A 383 A 244 LYS A 109 LYS.? 23.73 CL CL A 383 coo 11.28 44.53 18.60 9.91 46.00 19.20 -47.82 75.77 126.56 -49.90 76.10 126.41 coo 10.51 37.86 19.71 9.07 39.38 20.04 -52.89 78.90 131.37 -53.77 80.20 132.79 coo -1.20 42.34 17.67 3.19 45.13 19.06 -45.10 86.58 132.81 -50.69 86.17 134.93 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 136 HIS A 223 HIS.? 29.08 CL CL A 383 A 210 ASP A 257 ASP.? 24.30 CL CL A 383 A 244 LYS A 109 LYS.? 23.73 CL CL A 383 coo 11.28 44.53 18.60 9.91 46.00 19.20 -56.62 90.70 129.56 -55.95 91.22 131.48 coo 10.51 37.86 19.71 9.07 39.38 20.04 -55.05 88.25 125.09 -55.04 86.55 126.35 coo -1.20 42.34 17.67 3.19 45.13 19.06 -45.10 86.58 132.81 -50.69 86.17 134.93 1fc4_c04 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 2 hits 1fc4_c04 naa= 3 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 136 HIS A 157 HIS~? 12.03 CL CL A 383 B 210 ASP A 144 ASP.? 19.38 CL CL A 383 B 244 LYS A 109 LYS.? 23.73 CL CL A 383 coo 10.08 50.18 41.78 8.91 48.61 41.04 -47.82 75.77 126.56 -49.90 76.10 126.41 coo 9.06 56.85 40.30 7.71 55.27 39.90 -52.89 78.90 131.37 -53.77 80.20 132.79 coo -2.38 51.82 41.62 2.07 49.19 40.42 -45.10 86.58 132.81 -50.69 86.17 134.93 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 136 HIS A 223 HIS.? 29.08 CL CL A 383 B 210 ASP A 257 ASP.? 24.30 CL CL A 383 B 244 LYS A 109 LYS.? 23.73 CL CL A 383 coo 10.08 50.18 41.78 8.91 48.61 41.04 -56.62 90.70 129.56 -55.95 91.22 131.48 coo 9.06 56.85 40.30 7.71 55.27 39.90 -55.05 88.25 125.09 -55.04 86.55 126.35 coo -2.38 51.82 41.62 2.07 49.19 40.42 -45.10 86.58 132.81 -50.69 86.17 134.93 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 136 HIS B 157 HIS~? 12.80 CL CL B 384 B 210 ASP B 144 ASP.? 18.90 CL CL B 384 B 244 LYS B 109 LYS.? 27.05 CL CL B 384 coo 10.08 50.18 41.78 8.91 48.61 41.04 0.17 24.88 70.38 1.86 23.62 70.32 coo 9.06 56.85 40.30 7.71 55.27 39.90 1.70 18.75 65.96 3.42 18.04 64.94 coo -2.38 51.82 41.62 2.07 49.19 40.42 5.83 26.41 59.87 10.67 23.27 57.97 1fc4_c05 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 3 hits 1fc4_c05 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR A 8 TYR.? 12.26 CL CL A 384 A 142 LEU A 323 LEU^? 19.04 CL CL A 384 A 165 LYS A 288 LYS.? 12.57 CL CL A 384 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -16.53 57.80 111.57 -17.14 59.34 109.36 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -22.58 51.36 112.63 -20.70 50.22 112.53 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -19.18 64.09 108.25 -14.44 63.70 112.45 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 137 TYR B 8 TYR.? 11.88 CL CL B 382 A 142 LEU B 323 LEU^? 16.52 CL CL B 382 A 165 LYS B 288 LYS.? 8.84 CL CL B 382 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -23.96 53.72 82.39 -21.76 54.53 83.93 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -27.55 46.14 85.26 -29.30 47.54 85.46 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -16.76 54.22 83.25 -20.62 56.75 78.99 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c00 naa= 3 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 137 TYR A 8 TYR.? 12.26 CL CL A 384 B 142 LEU A 323 LEU^? 19.04 CL CL A 384 B 165 LYS A 288 LYS.? 12.57 CL CL A 384 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -16.53 57.80 111.57 -17.14 59.34 109.36 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -22.58 51.36 112.63 -20.70 50.22 112.53 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -19.18 64.09 108.25 -14.44 63.70 112.45 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 137 TYR B 8 TYR.? 11.88 CL CL B 382 B 142 LEU B 323 LEU^? 16.52 CL CL B 382 B 165 LYS B 288 LYS.? 8.84 CL CL B 382 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -23.96 53.72 82.39 -21.76 54.53 83.93 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -27.55 46.14 85.26 -29.30 47.54 85.46 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -16.76 54.22 83.25 -20.62 56.75 78.99 1fdy_c01 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c01 naa= 3 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 137 TYR A 8 TYR.? 12.26 CL CL A 384 C 142 LEU A 323 LEU^? 19.04 CL CL A 384 C 165 LYS A 288 LYS.? 12.57 CL CL A 384 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -16.53 57.80 111.57 -17.14 59.34 109.36 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -22.58 51.36 112.63 -20.70 50.22 112.53 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -19.18 64.09 108.25 -14.44 63.70 112.45 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 137 TYR B 8 TYR.? 11.88 CL CL B 382 C 142 LEU B 323 LEU^? 16.52 CL CL B 382 C 165 LYS B 288 LYS.? 8.84 CL CL B 382 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -23.96 53.72 82.39 -21.76 54.53 83.93 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -27.55 46.14 85.26 -29.30 47.54 85.46 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -16.76 54.22 83.25 -20.62 56.75 78.99 1fdy_c02 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c02 naa= 3 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 137 TYR A 8 TYR.? 12.26 CL CL A 384 D 142 LEU A 323 LEU^? 19.04 CL CL A 384 D 165 LYS A 288 LYS.? 12.57 CL CL A 384 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -16.53 57.80 111.57 -17.14 59.34 109.36 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -22.58 51.36 112.63 -20.70 50.22 112.53 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -19.18 64.09 108.25 -14.44 63.70 112.45 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 137 TYR B 8 TYR.? 11.88 CL CL B 382 D 142 LEU B 323 LEU^? 16.52 CL CL B 382 D 165 LYS B 288 LYS.? 8.84 CL CL B 382 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -23.96 53.72 82.39 -21.76 54.53 83.93 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -27.55 46.14 85.26 -29.30 47.54 85.46 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -16.76 54.22 83.25 -20.62 56.75 78.99 1fdy_c03 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c03 naa= 3 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 47 SER A 102 SER.? 10.64 CL CL A 383 A 48 THR A 150 THR~? 4.16 CL CL A 383 A 165 LYS A 119 LYS~? 19.74 CL CL A 383 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -43.16 67.12 136.34 -45.34 66.31 136.69 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -43.99 67.57 132.08 -44.02 66.23 130.30 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -35.93 78.09 135.99 -38.76 78.15 140.81 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 47 SER B 102 SER.? 11.35 CL CL B 384 A 48 THR B 150 THR~? 4.38 CL CL B 384 A 165 LYS B 119 LYS~? 21.97 CL CL B 384 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -12.47 21.91 64.46 -13.46 19.75 64.64 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -10.60 23.36 68.09 -11.46 23.86 70.00 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -5.81 31.71 57.90 -4.87 29.30 52.77 1fdy_c04 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c04 naa= 3 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 47 SER A 102 SER.? 10.64 CL CL A 383 B 48 THR A 150 THR~? 4.16 CL CL A 383 B 165 LYS A 119 LYS~? 19.74 CL CL A 383 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -43.16 67.12 136.34 -45.34 66.31 136.69 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -43.99 67.57 132.08 -44.02 66.23 130.30 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -35.93 78.09 135.99 -38.76 78.15 140.81 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 47 SER B 102 SER.? 11.35 CL CL B 384 B 48 THR B 150 THR~? 4.38 CL CL B 384 B 165 LYS B 119 LYS~? 21.97 CL CL B 384 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -12.47 21.91 64.46 -13.46 19.75 64.64 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -10.60 23.36 68.09 -11.46 23.86 70.00 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -5.81 31.71 57.90 -4.87 29.30 52.77 1fdy_c05 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c05 naa= 3 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 47 SER A 102 SER.? 10.64 CL CL A 383 C 48 THR A 150 THR~? 4.16 CL CL A 383 C 165 LYS A 119 LYS~? 19.74 CL CL A 383 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -43.16 67.12 136.34 -45.34 66.31 136.69 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -43.99 67.57 132.08 -44.02 66.23 130.30 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -35.93 78.09 135.99 -38.76 78.15 140.81 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 47 SER B 102 SER.? 11.35 CL CL B 384 C 48 THR B 150 THR~? 4.38 CL CL B 384 C 165 LYS B 119 LYS~? 21.97 CL CL B 384 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -12.47 21.91 64.46 -13.46 19.75 64.64 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -10.60 23.36 68.09 -11.46 23.86 70.00 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -5.81 31.71 57.90 -4.87 29.30 52.77 1fdy_c06 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c06 naa= 3 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 47 SER A 102 SER.? 10.64 CL CL A 383 D 48 THR A 150 THR~? 4.16 CL CL A 383 D 165 LYS A 119 LYS~? 19.74 CL CL A 383 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -43.16 67.12 136.34 -45.34 66.31 136.69 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -43.99 67.57 132.08 -44.02 66.23 130.30 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -35.93 78.09 135.99 -38.76 78.15 140.81 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 47 SER B 102 SER.? 11.35 CL CL B 384 D 48 THR B 150 THR~? 4.38 CL CL B 384 D 165 LYS B 119 LYS~? 21.97 CL CL B 384 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -12.47 21.91 64.46 -13.46 19.75 64.64 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -10.60 23.36 68.09 -11.46 23.86 70.00 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -5.81 31.71 57.90 -4.87 29.30 52.77 1fdy_c07 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c07 naa= 3 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 325 ARG.? 29.26 CL CL A 384 A 136 GLU A 86 GLU^? 27.08 CL CL A 382 A 246 GLU A 23 GLU.? 27.24 CL CL A 382 coo 13.48 30.30 107.06 11.75 30.99 109.44 -22.19 42.21 111.60 -22.86 39.29 112.51 coo 9.46 32.37 115.82 8.50 34.20 115.47 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 11.99 34.33 109.92 10.08 34.19 110.77 -22.84 44.28 116.17 -23.55 42.53 115.22 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG B 24 ARG^? 24.13 CL CL B 382 A 136 GLU B 86 GLU^? 25.45 CL CL B 382 A 246 GLU B 23 GLU.? 22.91 CL CL B 382 coo 13.48 30.30 107.06 11.75 30.99 109.44 -30.86 40.03 86.77 -33.42 38.25 86.47 coo 9.46 32.37 115.82 8.50 34.20 115.47 -37.46 36.82 83.59 -36.60 37.35 85.50 coo 11.99 34.33 109.92 10.08 34.19 110.77 -35.83 43.78 85.87 -35.49 42.75 87.75 1fhl_c00 source 1fhl BETA-1,4-GALACTANASE : 2 hits 1fhl_c00 naa= 3 ULMN 3 1fnb_c00 FERREDOXIN:NADP+ OXIDOREDUCTASE (FERuser 1 3 # 1 96 SER A 55 SER.? 23.04 CL CL A 383 272 CYH A 59 CYH^? 15.29 CL CL A 382 312 GLU A 57 GLU.? 23.36 CL CL A 382 coo 27.57 5.78 14.13 25.30 6.31 13.99 -27.78 51.03 133.17 -28.81 49.24 134.52 coo 18.48 7.50 15.98 21.17 6.92 15.38 -22.72 58.93 129.41 -24.70 57.69 127.81 coo 22.30 10.15 12.52 24.07 9.52 13.47 -23.46 53.73 134.86 -22.94 54.54 136.68 ULMN 3 1fnb_c00 FERREDOXIN:NADP+ OXIDOREDUCTASE (FERuser 2 3 # 2 96 SER B 55 SER.? 22.28 CL CL B 384 272 CYH B 59 CYH^? 15.58 CL CL B 383 312 GLU B 57 GLU.? 21.35 CL CL B 382 coo 27.57 5.78 14.13 25.30 6.31 13.99 -31.36 33.02 68.90 -32.51 30.85 68.96 coo 18.48 7.50 15.98 21.17 6.92 15.38 -25.66 41.31 67.81 -25.65 39.78 70.09 coo 22.30 10.15 12.52 24.07 9.52 13.47 -31.25 37.00 65.18 -31.15 36.75 63.13 1fnb_c00 source 1fnb FERREDOXIN:NADP+ OXIDOREDUCTASE (FERREDOXIN RE: 2 hits 1fnb_c00 naa= 3 ULMN 3 1fo6_c00 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLuser 1 3 # 1 A 47 GLU B 57 GLU.? 21.35 CL CL B 382 A 127 LYS B 17 LYS^? 18.67 CL CL B 382 A 172 CYH B 59 CYH^? 15.58 CL CL B 383 coo 14.84 17.73 17.72 12.66 18.02 17.60 -31.25 37.00 65.18 -31.15 36.75 63.13 coo 13.59 13.62 10.66 10.48 17.11 15.01 -33.42 46.60 66.26 -37.89 44.12 63.72 coo 10.73 13.80 18.28 9.65 16.43 18.61 -25.66 41.31 67.81 -25.65 39.78 70.09 1fo6_c00 source 1fo6 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLASE : 1 hits 1fo6_c00 naa= 3 ULMN 3 1fo6_c01 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLuser 1 3 # 1 B 47 GLU B 57 GLU.? 21.35 CL CL B 382 B 127 LYS B 17 LYS^? 18.67 CL CL B 382 B 172 CYH B 59 CYH^? 15.58 CL CL B 383 coo -11.43 -15.11 20.71 -9.41 -15.34 21.12 -31.25 37.00 65.18 -31.15 36.75 63.13 coo -8.59 -13.62 12.98 -6.65 -15.32 18.82 -33.42 46.60 66.26 -37.89 44.12 63.72 coo -7.53 -11.08 20.68 -6.56 -13.38 22.13 -25.66 41.31 67.81 -25.65 39.78 70.09 1fo6_c01 source 1fo6 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLASE : 1 hits 1fo6_c01 naa= 3 ULMN 3 1fo6_c02 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLuser 1 3 # 1 C 47 GLU B 57 GLU.? 21.35 CL CL B 382 C 127 LYS B 17 LYS^? 18.67 CL CL B 382 C 172 CYH B 59 CYH^? 15.58 CL CL B 383 coo -14.75 22.68 45.73 -12.65 22.97 45.86 -31.25 37.00 65.18 -31.15 36.75 63.13 coo -13.46 21.30 53.90 -10.36 22.98 48.58 -33.42 46.60 66.26 -37.89 44.12 63.72 coo -10.67 18.91 46.59 -9.50 21.20 45.39 -25.66 41.31 67.81 -25.65 39.78 70.09 1fo6_c02 source 1fo6 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLASE : 1 hits 1fo6_c02 naa= 3 ULMN 3 1fo6_c03 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLuser 1 3 # 1 D 47 GLU B 57 GLU.? 21.35 CL CL B 382 D 127 LYS B 17 LYS^? 18.67 CL CL B 382 D 172 CYH B 59 CYH^? 15.58 CL CL B 383 coo 11.48 -9.38 54.24 9.40 -9.76 53.86 -31.25 37.00 65.18 -31.15 36.75 63.13 coo 8.59 -5.45 60.90 6.67 -8.84 55.89 -33.42 46.60 66.26 -37.89 44.12 63.72 coo 7.45 -5.79 52.90 6.67 -8.39 52.10 -25.66 41.31 67.81 -25.65 39.78 70.09 1fo6_c03 source 1fo6 N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLASE : 1 hits 1fo6_c03 naa= 3 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 325 ARG.? 29.26 CL CL A 384 A 136 GLU A 86 GLU^? 27.08 CL CL A 382 A 246 GLU A 23 GLU.? 27.24 CL CL A 382 coo 13.94 29.84 106.80 11.67 30.40 108.79 -22.19 42.21 111.60 -22.86 39.29 112.51 coo 9.52 31.97 115.23 8.45 33.74 114.72 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 11.92 33.82 109.35 10.10 33.50 110.39 -22.84 44.28 116.17 -23.55 42.53 115.22 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG B 24 ARG^? 24.13 CL CL B 382 A 136 GLU B 86 GLU^? 25.45 CL CL B 382 A 246 GLU B 23 GLU.? 22.91 CL CL B 382 coo 13.94 29.84 106.80 11.67 30.40 108.79 -30.86 40.03 86.77 -33.42 38.25 86.47 coo 9.52 31.97 115.23 8.45 33.74 114.72 -37.46 36.82 83.59 -36.60 37.35 85.50 coo 11.92 33.82 109.35 10.10 33.50 110.39 -35.83 43.78 85.87 -35.49 42.75 87.75 1fob_c00 source 1fob BETA-1,4-GALACTANASE : 2 hits 1fob_c00 naa= 3 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 1 3 # 1 A 54 ASP A 28 ASP^? 9.02 CL CL A 382 A 281 ARG A 320 ARG^? 16.18 CL CL A 382 A 289 TYR A 25 TYR^? 18.63 CL CL A 382 coo 54.86 40.00 47.23 55.57 38.60 48.67 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 52.08 40.18 50.14 50.83 38.93 47.73 -32.10 56.68 112.17 -32.95 53.99 110.90 coo 57.82 31.70 50.73 57.94 34.00 49.17 -23.49 53.13 116.11 -21.60 54.30 114.36 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 2 3 # 2 A 54 ASP B 28 ASP^? 9.00 CL CL B 383 A 281 ARG B 320 ARG^? 13.22 CL CL B 383 A 289 TYR B 25 TYR^? 14.27 CL CL B 382 coo 54.86 40.00 47.23 55.57 38.60 48.67 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 52.08 40.18 50.14 50.83 38.93 47.73 -19.20 39.56 86.12 -20.64 37.04 85.01 coo 57.82 31.70 50.73 57.94 34.00 49.17 -26.62 44.42 81.68 -25.97 47.00 82.31 1foh_c00 source 1foh PHENOL HYDROXYLASE : 2 hits 1foh_c00 naa= 3 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 1 3 # 1 B 54 ASP A 28 ASP^? 9.02 CL CL A 382 B 281 ARG A 320 ARG^? 16.18 CL CL A 382 B 289 TYR A 25 TYR^? 18.63 CL CL A 382 coo 90.56 80.24 98.04 90.36 81.53 96.34 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 86.62 80.67 97.51 87.37 82.00 100.10 -32.10 56.68 112.17 -32.95 53.99 110.90 coo 91.83 88.28 92.88 92.60 85.93 94.14 -23.49 53.13 116.11 -21.60 54.30 114.36 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 2 3 # 2 B 54 ASP B 28 ASP^? 9.00 CL CL B 383 B 281 ARG B 320 ARG^? 13.22 CL CL B 383 B 289 TYR B 25 TYR^? 14.27 CL CL B 382 coo 90.56 80.24 98.04 90.36 81.53 96.34 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 86.62 80.67 97.51 87.37 82.00 100.10 -19.20 39.56 86.12 -20.64 37.04 85.01 coo 91.83 88.28 92.88 92.60 85.93 94.14 -26.62 44.42 81.68 -25.97 47.00 82.31 1foh_c01 source 1foh PHENOL HYDROXYLASE : 2 hits 1foh_c01 naa= 3 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 1 3 # 1 C 54 ASP A 28 ASP^? 9.02 CL CL A 382 C 281 ARG A 320 ARG^? 16.18 CL CL A 382 C 289 TYR A 25 TYR^? 18.63 CL CL A 382 coo 42.34 76.83 49.10 43.06 78.59 50.01 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 46.12 77.15 48.13 44.44 77.61 45.70 -32.10 56.68 112.17 -32.95 53.99 110.90 coo 42.69 86.18 51.69 41.59 83.63 51.54 -23.49 53.13 116.11 -21.60 54.30 114.36 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 2 3 # 2 C 54 ASP B 28 ASP^? 9.00 CL CL B 383 C 281 ARG B 320 ARG^? 13.22 CL CL B 383 C 289 TYR B 25 TYR^? 14.27 CL CL B 382 coo 42.34 76.83 49.10 43.06 78.59 50.01 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 46.12 77.15 48.13 44.44 77.61 45.70 -19.20 39.56 86.12 -20.64 37.04 85.01 coo 42.69 86.18 51.69 41.59 83.63 51.54 -26.62 44.42 81.68 -25.97 47.00 82.31 1foh_c02 source 1foh PHENOL HYDROXYLASE : 2 hits 1foh_c02 naa= 3 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 1 3 # 1 D 54 ASP A 28 ASP^? 9.02 CL CL A 382 D 281 ARG A 320 ARG^? 16.18 CL CL A 382 D 289 TYR A 25 TYR^? 18.63 CL CL A 382 coo 75.05 45.80 106.18 74.73 43.88 105.51 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 78.52 44.93 104.78 78.72 44.49 107.76 -32.10 56.68 112.17 -32.95 53.99 110.90 coo 72.35 36.51 104.82 72.00 39.20 105.46 -23.49 53.13 116.11 -21.60 54.30 114.36 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 2 3 # 2 D 54 ASP B 28 ASP^? 9.00 CL CL B 383 D 281 ARG B 320 ARG^? 13.22 CL CL B 383 D 289 TYR B 25 TYR^? 14.27 CL CL B 382 coo 75.05 45.80 106.18 74.73 43.88 105.51 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 78.52 44.93 104.78 78.72 44.49 107.76 -19.20 39.56 86.12 -20.64 37.04 85.01 coo 72.35 36.51 104.82 72.00 39.20 105.46 -26.62 44.42 81.68 -25.97 47.00 82.31 1foh_c03 source 1foh PHENOL HYDROXYLASE : 2 hits 1foh_c03 naa= 3 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 A 317 GLU A 135 GLU.? 22.99 CL CL A 382 A 319 ASP A 180 ASP.? 19.13 CL CL A 382 A 359 ARG A 300 ARG^? 15.75 CL CL A 384 coo 14.41 12.40 16.42 12.92 13.74 15.71 -31.98 87.75 115.72 -30.11 88.72 115.32 coo 12.25 13.04 23.85 11.56 15.02 23.93 -29.53 80.77 112.24 -28.62 82.54 111.55 coo 10.89 14.95 28.28 12.39 12.53 29.31 -30.16 77.29 106.40 -29.79 78.90 103.79 1fr8_c00 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 1 hits 1fr8_c00 naa= 3 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 B 317 GLU A 135 GLU.? 22.99 CL CL A 382 B 319 ASP A 180 ASP.? 19.13 CL CL A 382 B 359 ARG A 300 ARG^? 15.75 CL CL A 384 coo 10.77 13.13 40.94 11.03 14.73 39.51 -31.98 87.75 115.72 -30.11 88.72 115.32 coo 3.77 12.64 38.21 3.35 14.53 37.39 -29.53 80.77 112.24 -28.62 82.54 111.55 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -30.16 77.29 106.40 -29.79 78.90 103.79 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 B 317 GLU A 206 GLU^? 19.04 CL CL A 382 B 319 ASP A 204 ASP^? 18.76 CL CL A 384 B 359 ARG A 202 ARG^? 19.65 CL CL A 384 coo 10.77 13.13 40.94 11.03 14.73 39.51 -42.05 60.33 102.60 -42.22 59.82 104.62 coo 3.77 12.64 38.21 3.35 14.53 37.39 -37.06 58.40 100.88 -36.30 56.45 100.53 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -32.39 54.22 100.96 -34.65 53.06 99.24 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 B 317 GLU A 215 GLU^? 33.84 CL CL A 383 B 319 ASP A 240 ASP.? 30.06 CL CL A 382 B 359 ARG A 212 ARG.? 30.01 CL CL A 382 coo 10.77 13.13 40.94 11.03 14.73 39.51 -61.95 78.59 103.72 -63.72 79.79 103.76 coo 3.77 12.64 38.21 3.35 14.53 37.39 -54.36 78.15 100.29 -55.09 76.20 100.68 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -52.31 71.44 100.68 -54.00 71.15 98.10 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 4 3 # 4 B 317 GLU A 276 GLU~? 16.10 CL CL A 383 B 319 ASP A 210 ASP.? 21.69 CL CL A 383 B 359 ARG A 247 ARG.? 25.12 CL CL A 383 coo 10.77 13.13 40.94 11.03 14.73 39.51 -46.62 67.79 110.40 -48.46 68.09 111.43 coo 3.77 12.64 38.21 3.35 14.53 37.39 -52.58 64.68 106.89 -53.21 62.78 107.37 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -59.24 68.01 103.62 -57.26 66.97 105.71 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 5 3 # 5 B 317 GLU B 135 GLU.? 23.43 CL CL B 383 B 319 ASP B 180 ASP.? 19.08 CL CL B 383 B 359 ARG B 300 ARG^? 21.49 CL CL B 383 coo 10.77 13.13 40.94 11.03 14.73 39.51 7.28 45.80 70.11 9.12 46.58 70.84 coo 3.77 12.64 38.21 3.35 14.53 37.39 0.82 48.22 75.52 2.17 49.73 74.84 coo -1.16 15.32 35.60 -3.32 13.56 36.98 0.10 48.73 83.03 1.88 51.20 83.58 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 6 3 # 6 B 317 GLU B 206 GLU^? 19.18 CL CL B 383 B 319 ASP B 208 ASP.? 21.56 CL CL B 383 B 359 ARG B 212 ARG.? 28.47 CL CL B 383 coo 10.77 13.13 40.94 11.03 14.73 39.51 -9.17 35.76 95.82 -10.61 34.74 94.62 coo 3.77 12.64 38.21 3.35 14.53 37.39 -4.03 30.56 94.79 -4.11 28.51 94.21 coo -1.16 15.32 35.60 -3.32 13.56 36.98 3.61 30.30 95.57 4.45 30.88 98.48 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 7 3 # 7 B 317 GLU B 215 GLU^? 32.93 CL CL B 384 B 319 ASP B 240 ASP.? 29.22 CL CL B 383 B 359 ARG B 212 ARG.? 28.47 CL CL B 383 coo 10.77 13.13 40.94 11.03 14.73 39.51 14.09 22.76 92.11 15.77 21.48 91.87 coo 3.77 12.64 38.21 3.35 14.53 37.39 11.35 28.88 93.27 10.37 30.59 94.07 coo -1.16 15.32 35.60 -3.32 13.56 36.98 3.61 30.30 95.57 4.45 30.88 98.48 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 8 3 # 8 B 317 GLU B 276 GLU~? 15.94 CL CL B 384 B 319 ASP B 210 ASP.? 22.05 CL CL B 384 B 359 ARG B 247 ARG.? 24.65 CL CL B 384 coo 10.77 13.13 40.94 11.03 14.73 39.51 -2.79 30.63 87.01 -2.36 28.59 86.68 coo 3.77 12.64 38.21 3.35 14.53 37.39 -2.53 25.11 93.69 -2.62 22.87 93.62 coo -1.16 15.32 35.60 -3.32 13.56 36.98 4.27 22.84 96.19 1.85 22.99 94.25 1fr8_c01 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 8 hits 1fr8_c01 naa= 3 ULMN 3 1fuq_c00 FUMARASE C user 1 3 # 1 A 324 LYS A 142 LYS.? 24.15 CL CL A 383 A 331 GLU A 149 GLU.? 9.19 CL CL A 383 B 188 HIS A 157 HIS~? 12.03 CL CL A 383 coo 130.22 155.23 83.49 125.21 153.71 84.04 -49.53 84.63 130.17 -55.13 85.19 133.14 coo 120.90 152.23 75.28 120.94 153.09 77.19 -48.79 70.20 130.85 -48.75 71.87 129.52 coo 122.04 152.80 81.06 120.71 154.37 81.46 -47.82 75.77 126.56 -49.90 76.10 126.41 ULMN 3 1fuq_c00 FUMARASE C user 2 3 # 2 A 324 LYS B 142 LYS.? 25.17 CL CL B 384 A 331 GLU B 149 GLU.? 9.91 CL CL B 384 B 188 HIS B 157 HIS~? 12.80 CL CL B 384 coo 130.22 155.23 83.49 125.21 153.71 84.04 6.28 23.32 63.35 7.97 19.73 58.68 coo 120.90 152.23 75.28 120.94 153.09 77.19 -6.14 20.54 69.48 -4.10 21.06 69.10 coo 122.04 152.80 81.06 120.71 154.37 81.46 0.17 24.88 70.38 1.86 23.62 70.32 1fuq_c00 source 1fuq FUMARASE C : 2 hits 1fuq_c00 naa= 3 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 1 3 # 1 A 314 TRP A 167 TRP^? 7.35 CL CL A 382 A 317 GLU A 169 GLU.? 11.07 CL CL A 382 A 365 ARG A 319 ARG^? 9.49 CL CL A 382 coo 79.91 26.87 38.77 78.95 23.18 37.81 -31.10 71.99 120.30 -32.79 75.13 118.77 coo 85.55 26.30 41.25 85.59 24.97 39.65 -27.31 72.85 122.01 -26.32 74.11 120.63 coo 83.47 25.30 27.10 83.44 27.82 25.29 -27.23 63.29 112.77 -27.13 63.50 115.87 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 2 3 # 2 A 314 TRP A 191 TRP^? 15.13 CL CL A 384 A 317 GLU A 307 GLU.? 18.04 CL CL B 382 A 365 ARG A 197 ARG.? 14.16 CL CL A 384 coo 79.91 26.87 38.77 78.95 23.18 37.81 -30.01 60.84 91.30 -29.83 57.58 93.47 coo 85.55 26.30 41.25 85.59 24.97 39.65 -31.95 61.22 87.08 -31.47 59.40 88.12 coo 83.47 25.30 27.10 83.44 27.82 25.29 -16.42 65.00 90.05 -16.47 67.55 88.20 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 3 3 # 3 A 314 TRP A 191 TRP^? 15.13 CL CL A 384 A 317 GLU A 307 GLU.? 18.04 CL CL B 382 A 365 ARG A 202 ARG^? 19.65 CL CL A 384 coo 79.91 26.87 38.77 78.95 23.18 37.81 -30.01 60.84 91.30 -29.83 57.58 93.47 coo 85.55 26.30 41.25 85.59 24.97 39.65 -31.95 61.22 87.08 -31.47 59.40 88.12 coo 83.47 25.30 27.10 83.44 27.82 25.29 -32.39 54.22 100.96 -34.65 53.06 99.24 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 4 3 # 4 A 314 TRP A 273 TRP~? 19.00 CL CL A 383 A 317 GLU A 276 GLU~? 16.10 CL CL A 383 A 365 ARG A 247 ARG.? 25.12 CL CL A 383 coo 79.91 26.87 38.77 78.95 23.18 37.81 -50.89 71.02 111.12 -54.05 73.34 111.49 coo 85.55 26.30 41.25 85.59 24.97 39.65 -46.62 67.79 110.40 -48.46 68.09 111.43 coo 83.47 25.30 27.10 83.44 27.82 25.29 -59.24 68.01 103.62 -57.26 66.97 105.71 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 5 3 # 5 A 314 TRP B 191 TRP^? 18.38 CL CL A 384 A 317 GLU B 307 GLU.? 20.03 CL CL A 384 A 365 ARG B 202 ARG^? 25.52 CL CL B 383 coo 79.91 26.87 38.77 78.95 23.18 37.81 -10.49 50.73 102.31 -13.97 49.16 101.58 coo 85.55 26.30 41.25 85.59 24.97 39.65 -8.15 49.66 106.11 -10.31 49.68 106.12 coo 83.47 25.30 27.10 83.44 27.82 25.29 -17.65 42.54 97.41 -16.79 41.14 100.03 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 6 3 # 6 A 314 TRP B 273 TRP~? 18.41 CL CL B 384 A 317 GLU B 276 GLU~? 15.94 CL CL B 384 A 365 ARG B 247 ARG.? 24.65 CL CL B 384 coo 79.91 26.87 38.77 78.95 23.18 37.81 1.07 27.51 86.17 4.21 25.26 85.33 coo 85.55 26.30 41.25 85.59 24.97 39.65 -2.79 30.63 87.01 -2.36 28.59 86.68 coo 83.47 25.30 27.10 83.44 27.82 25.29 4.27 22.84 96.19 1.85 22.99 94.25 1g8o_c01 source 1g8o N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALACTOSYLTRA: 6 hits 1g8o_c01 naa= 3 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 1 3 # 1 13 ASP A 64 ASP.? 15.21 CL CL A 384 41 HIS A 287 HIS.? 12.74 CL CL A 384 224 GLN A 66 GLN^? 15.17 CL CL A 384 coo -3.80 50.71 49.48 -5.59 51.85 49.27 -13.50 61.63 115.26 -13.45 60.20 113.75 coo -6.45 47.32 41.99 -8.32 46.87 42.83 -21.23 59.04 111.08 -21.85 57.11 111.58 coo -12.35 49.13 49.89 -13.38 48.89 48.03 -17.45 66.76 118.28 -17.51 68.00 116.53 1gim_c00 source 1gim ADENYLOSUCCINATE SYNTHETASE : 1 hits 1gim_c00 naa= 3 ULMN 3 1gns_c00 SUBTILISIN BPN' user 1 3 # 1 A 32 ASP A 311 ASP^? 15.19 CL CL A 384 A 64 HIS A 302 HIS^? 11.51 CL CL A 384 A 155 ASN A 199 ASN.? 4.96 CL CL A 384 coo 3.12 38.70 24.20 3.24 38.59 26.33 -31.19 72.86 91.72 -29.44 73.97 92.12 coo 1.90 38.00 29.77 3.91 38.35 29.95 -27.17 73.50 97.06 -27.34 73.92 95.02 coo 9.89 36.55 37.38 9.27 37.99 36.08 -21.75 61.84 97.70 -22.73 63.77 98.21 ULMN 3 1gns_c00 SUBTILISIN BPN' user 2 3 # 2 A 32 ASP B 311 ASP^? 24.66 CL CL A 384 A 64 HIS B 302 HIS^? 23.99 CL CL A 384 A 155 ASN B 199 ASN.? 15.74 CL CL A 384 coo 3.12 38.70 24.20 3.24 38.59 26.33 0.41 52.81 97.17 0.37 54.52 95.85 coo 1.90 38.00 29.77 3.91 38.35 29.95 -2.27 54.46 91.30 -1.20 55.23 92.93 coo 9.89 36.55 37.38 9.27 37.99 36.08 -14.23 54.82 92.98 -12.33 56.04 93.07 1gns_c00 source 1gns SUBTILISIN BPN' : 2 hits 1gns_c00 naa= 3 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 1 3 # 1 160 LYS A 82 LYS.? 41.47 CL CL A 382 210 ARG A 24 ARG^? 24.95 CL CL A 382 225 ARG A 325 ARG.? 29.26 CL CL A 384 coo 17.51 28.50 73.42 17.24 23.02 75.86 -24.27 28.84 121.34 -24.33 26.99 125.88 coo 24.74 11.56 73.05 25.29 14.32 71.80 -27.53 46.21 115.11 -27.47 43.33 116.18 coo 27.81 15.44 77.10 25.66 16.50 75.19 -22.19 42.21 111.60 -22.86 39.29 112.51 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 2 3 # 2 160 LYS A 82 LYS.? 41.47 CL CL A 382 210 ARG A 325 ARG.? 29.26 CL CL A 384 225 ARG A 24 ARG^? 24.95 CL CL A 382 coo 17.51 28.50 73.42 17.24 23.02 75.86 -24.27 28.84 121.34 -24.33 26.99 125.88 coo 24.74 11.56 73.05 25.29 14.32 71.80 -22.19 42.21 111.60 -22.86 39.29 112.51 coo 27.81 15.44 77.10 25.66 16.50 75.19 -27.53 46.21 115.11 -27.47 43.33 116.18 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 3 3 # 3 160 LYS A 268 LYS~? 13.60 CL CL A 382 210 ARG A 247 ARG.? 25.12 CL CL A 383 225 ARG A 212 ARG.? 30.01 CL CL A 382 coo 17.51 28.50 73.42 17.24 23.02 75.86 -47.11 79.10 113.63 -43.53 76.03 116.02 coo 24.74 11.56 73.05 25.29 14.32 71.80 -59.24 68.01 103.62 -57.26 66.97 105.71 coo 27.81 15.44 77.10 25.66 16.50 75.19 -52.31 71.44 100.68 -54.00 71.15 98.10 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 4 3 # 4 160 LYS A 288 LYS.? 12.57 CL CL A 384 210 ARG A 334 ARG^? 9.67 CL CL A 382 225 ARG A 320 ARG^? 16.18 CL CL A 382 coo 17.51 28.50 73.42 17.24 23.02 75.86 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 24.74 11.56 73.05 25.29 14.32 71.80 -35.93 61.76 109.91 -34.52 61.40 112.61 coo 27.81 15.44 77.10 25.66 16.50 75.19 -32.10 56.68 112.17 -32.95 53.99 110.90 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 5 3 # 5 160 LYS A 288 LYS.? 12.57 CL CL A 384 210 ARG B 290 ARG.? 12.49 CL CL A 384 225 ARG A 197 ARG.? 14.16 CL CL A 384 coo 17.51 28.50 73.42 17.24 23.02 75.86 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 24.74 11.56 73.05 25.29 14.32 71.80 -13.01 59.15 90.41 -14.60 61.38 91.89 coo 27.81 15.44 77.10 25.66 16.50 75.19 -16.42 65.00 90.05 -16.47 67.55 88.20 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 6 3 # 6 160 LYS B 82 LYS.? 37.97 CL CL B 382 210 ARG B 24 ARG^? 24.13 CL CL B 382 225 ARG B 325 ARG.? 19.88 CL CL B 382 coo 17.51 28.50 73.42 17.24 23.02 75.86 -48.91 34.74 87.29 -47.83 32.98 92.37 coo 24.74 11.56 73.05 25.29 14.32 71.80 -30.86 40.03 86.77 -33.42 38.25 86.47 coo 27.81 15.44 77.10 25.66 16.50 75.19 -34.83 46.46 90.24 -34.50 47.08 87.15 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 7 3 # 7 160 LYS B 82 LYS.? 37.97 CL CL B 382 210 ARG B 325 ARG.? 19.88 CL CL B 382 225 ARG B 24 ARG^? 24.13 CL CL B 382 coo 17.51 28.50 73.42 17.24 23.02 75.86 -48.91 34.74 87.29 -47.83 32.98 92.37 coo 24.74 11.56 73.05 25.29 14.32 71.80 -34.83 46.46 90.24 -34.50 47.08 87.15 coo 27.81 15.44 77.10 25.66 16.50 75.19 -30.86 40.03 86.77 -33.42 38.25 86.47 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 8 3 # 8 160 LYS B 267 LYS~? 27.57 CL CL B 383 210 ARG B 247 ARG.? 24.65 CL CL B 384 225 ARG B 212 ARG.? 28.47 CL CL B 383 coo 17.51 28.50 73.42 17.24 23.02 75.86 9.46 31.45 81.02 15.36 33.08 81.01 coo 24.74 11.56 73.05 25.29 14.32 71.80 4.27 22.84 96.19 1.85 22.99 94.25 coo 27.81 15.44 77.10 25.66 16.50 75.19 3.61 30.30 95.57 4.45 30.88 98.48 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 9 3 # 9 160 LYS B 268 LYS~? 13.29 CL CL B 383 210 ARG B 247 ARG.? 24.65 CL CL B 384 225 ARG B 212 ARG.? 28.47 CL CL B 383 coo 17.51 28.50 73.42 17.24 23.02 75.86 5.99 32.14 79.72 1.11 32.64 77.72 coo 24.74 11.56 73.05 25.29 14.32 71.80 4.27 22.84 96.19 1.85 22.99 94.25 coo 27.81 15.44 77.10 25.66 16.50 75.19 3.61 30.30 95.57 4.45 30.88 98.48 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 10 3 # 10 160 LYS B 288 LYS.? 8.84 CL CL B 382 210 ARG A 290 ARG.? -7.44 CL CL A 384s 225 ARG B 197 ARG.? 10.56 CL CL A 384 coo 17.51 28.50 73.42 17.24 23.02 75.86 -16.76 54.22 83.25 -20.62 56.75 78.99 coo 24.74 11.56 73.05 25.29 14.32 71.80 -15.77 66.49 99.38 -13.63 64.23 99.65 coo 27.81 15.44 77.10 25.66 16.50 75.19 -11.56 63.68 96.52 -11.06 66.80 96.90 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 11 3 # 11 160 LYS B 288 LYS.? 8.84 CL CL B 382 210 ARG B 13 ARG^? 4.84 CL CL B 382 225 ARG B 20 ARG.? -3.56 CL CL B 382s coo 17.51 28.50 73.42 17.24 23.02 75.86 -16.76 54.22 83.25 -20.62 56.75 78.99 coo 24.74 11.56 73.05 25.29 14.32 71.80 -26.14 48.57 68.77 -25.79 51.69 68.63 coo 27.81 15.44 77.10 25.66 16.50 75.19 -30.86 53.38 73.69 -28.77 54.55 71.62 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 12 3 # 12 160 LYS B 288 LYS.? 8.84 CL CL B 382 210 ARG B 20 ARG.? -3.56 CL CL B 382s 225 ARG B 13 ARG^? 4.84 CL CL B 382 coo 17.51 28.50 73.42 17.24 23.02 75.86 -16.76 54.22 83.25 -20.62 56.75 78.99 coo 24.74 11.56 73.05 25.29 14.32 71.80 -30.86 53.38 73.69 -28.77 54.55 71.62 coo 27.81 15.44 77.10 25.66 16.50 75.19 -26.14 48.57 68.77 -25.79 51.69 68.63 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 13 3 # 13 160 LYS B 288 LYS.? 8.84 CL CL B 382 210 ARG B 334 ARG^? 9.65 CL CL B 383 225 ARG B 320 ARG^? 13.22 CL CL B 383 coo 17.51 28.50 73.42 17.24 23.02 75.86 -16.76 54.22 83.25 -20.62 56.75 78.99 coo 24.74 11.56 73.05 25.29 14.32 71.80 -12.53 38.39 87.32 -14.06 38.36 84.61 coo 27.81 15.44 77.10 25.66 16.50 75.19 -19.20 39.56 86.12 -20.64 37.04 85.01 1gsa_c00 source 1gsa GLUTATHIONE SYNTHETASE : 13 hits 1gsa_c00 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 97 PHE~? 13.64 CL CL A 383 A 298 ASP A 93 ASP^? 5.15 CL CL A 382 A 329 LYS A 128 LYS.? 19.46 CL CL A 382 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -33.26 63.92 133.83 -31.10 62.40 134.75 coo 2.59 0.29 25.55 4.65 0.18 25.07 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 12.42 6.10 23.27 9.95 1.57 20.16 -25.12 72.76 133.10 -20.68 68.32 134.09 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 A 189 PHE A 213 PHE.? 23.30 CL CL A 383 A 298 ASP A 240 ASP.? 30.06 CL CL A 382 A 329 LYS A 267 LYS~? 27.66 CL CL A 382 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -56.84 71.96 107.29 -56.22 69.93 109.07 coo 2.59 0.29 25.55 4.65 0.18 25.07 -54.36 78.15 100.29 -55.09 76.20 100.68 coo 12.42 6.10 23.27 9.95 1.57 20.16 -49.43 81.28 111.60 -49.39 86.78 108.40 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 A 189 PHE B 97 PHE~? 13.75 CL CL B 384 A 298 ASP B 93 ASP^? 5.22 CL CL B 383 A 329 LYS B 128 LYS.? 19.37 CL CL B 383 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -18.35 31.53 64.75 -20.77 32.66 63.92 coo 2.59 0.29 25.55 4.65 0.18 25.07 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 12.42 6.10 23.27 9.95 1.57 20.16 -13.49 41.25 59.55 -18.50 40.98 58.08 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 A 189 PHE B 213 PHE.? 22.76 CL CL B 384 A 298 ASP B 240 ASP.? 29.22 CL CL B 383 A 329 LYS B 267 LYS~? 27.57 CL CL B 383 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 5.57 24.21 90.55 3.01 23.56 89.66 coo 2.59 0.29 25.55 4.65 0.18 25.07 11.35 28.88 93.27 10.37 30.59 94.07 coo 12.42 6.10 23.27 9.95 1.57 20.16 9.46 31.45 81.02 15.36 33.08 81.01 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 4 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 97 PHE~? 13.64 CL CL A 383 B 298 ASP A 93 ASP^? 5.15 CL CL A 382 B 329 LYS A 128 LYS.? 19.46 CL CL A 382 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -33.26 63.92 133.83 -31.10 62.40 134.75 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -25.12 72.76 133.10 -20.68 68.32 134.09 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 B 189 PHE A 213 PHE.? 23.30 CL CL A 383 B 298 ASP A 240 ASP.? 30.06 CL CL A 382 B 329 LYS A 267 LYS~? 27.66 CL CL A 382 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -56.84 71.96 107.29 -56.22 69.93 109.07 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -54.36 78.15 100.29 -55.09 76.20 100.68 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -49.43 81.28 111.60 -49.39 86.78 108.40 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 B 189 PHE B 97 PHE~? 13.75 CL CL B 384 B 298 ASP B 93 ASP^? 5.22 CL CL B 383 B 329 LYS B 128 LYS.? 19.37 CL CL B 383 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -18.35 31.53 64.75 -20.77 32.66 63.92 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -13.49 41.25 59.55 -18.50 40.98 58.08 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 B 189 PHE B 213 PHE.? 22.76 CL CL B 384 B 298 ASP B 240 ASP.? 29.22 CL CL B 383 B 329 LYS B 267 LYS~? 27.57 CL CL B 383 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 5.57 24.21 90.55 3.01 23.56 89.66 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 11.35 28.88 93.27 10.37 30.59 94.07 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 9.46 31.45 81.02 15.36 33.08 81.01 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 4 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 97 PHE~? 13.64 CL CL A 383 C 298 ASP A 93 ASP^? 5.15 CL CL A 382 C 329 LYS A 128 LYS.? 19.46 CL CL A 382 coo 17.41 60.57 64.39 18.40 58.12 65.34 -33.26 63.92 133.83 -31.10 62.40 134.75 coo 24.10 66.43 63.33 24.18 64.30 63.40 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 27.64 56.61 58.17 22.18 57.92 60.36 -25.12 72.76 133.10 -20.68 68.32 134.09 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 C 189 PHE A 213 PHE.? 23.30 CL CL A 383 C 298 ASP A 240 ASP.? 30.06 CL CL A 382 C 329 LYS A 267 LYS~? 27.66 CL CL A 382 coo 17.41 60.57 64.39 18.40 58.12 65.34 -56.84 71.96 107.29 -56.22 69.93 109.07 coo 24.10 66.43 63.33 24.18 64.30 63.40 -54.36 78.15 100.29 -55.09 76.20 100.68 coo 27.64 56.61 58.17 22.18 57.92 60.36 -49.43 81.28 111.60 -49.39 86.78 108.40 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 C 189 PHE B 97 PHE~? 13.75 CL CL B 384 C 298 ASP B 93 ASP^? 5.22 CL CL B 383 C 329 LYS B 128 LYS.? 19.37 CL CL B 383 coo 17.41 60.57 64.39 18.40 58.12 65.34 -18.35 31.53 64.75 -20.77 32.66 63.92 coo 24.10 66.43 63.33 24.18 64.30 63.40 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 27.64 56.61 58.17 22.18 57.92 60.36 -13.49 41.25 59.55 -18.50 40.98 58.08 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 C 189 PHE B 213 PHE.? 22.76 CL CL B 384 C 298 ASP B 240 ASP.? 29.22 CL CL B 383 C 329 LYS B 267 LYS~? 27.57 CL CL B 383 coo 17.41 60.57 64.39 18.40 58.12 65.34 5.57 24.21 90.55 3.01 23.56 89.66 coo 24.10 66.43 63.33 24.18 64.30 63.40 11.35 28.88 93.27 10.37 30.59 94.07 coo 27.64 56.61 58.17 22.18 57.92 60.36 9.46 31.45 81.02 15.36 33.08 81.01 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 4 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 97 PHE~? 13.64 CL CL A 383 D 298 ASP A 93 ASP^? 5.15 CL CL A 382 D 329 LYS A 128 LYS.? 19.46 CL CL A 382 coo 35.44 53.35 83.81 35.65 54.53 81.28 -33.26 63.92 133.83 -31.10 62.40 134.75 coo 29.72 46.46 83.60 30.79 47.36 81.99 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 36.89 44.91 74.55 37.33 48.94 79.01 -25.12 72.76 133.10 -20.68 68.32 134.09 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 D 189 PHE A 213 PHE.? 23.30 CL CL A 383 D 298 ASP A 240 ASP.? 30.06 CL CL A 382 D 329 LYS A 267 LYS~? 27.66 CL CL A 382 coo 35.44 53.35 83.81 35.65 54.53 81.28 -56.84 71.96 107.29 -56.22 69.93 109.07 coo 29.72 46.46 83.60 30.79 47.36 81.99 -54.36 78.15 100.29 -55.09 76.20 100.68 coo 36.89 44.91 74.55 37.33 48.94 79.01 -49.43 81.28 111.60 -49.39 86.78 108.40 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 D 189 PHE B 97 PHE~? 13.75 CL CL B 384 D 298 ASP B 93 ASP^? 5.22 CL CL B 383 D 329 LYS B 128 LYS.? 19.37 CL CL B 383 coo 35.44 53.35 83.81 35.65 54.53 81.28 -18.35 31.53 64.75 -20.77 32.66 63.92 coo 29.72 46.46 83.60 30.79 47.36 81.99 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 36.89 44.91 74.55 37.33 48.94 79.01 -13.49 41.25 59.55 -18.50 40.98 58.08 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 D 189 PHE B 213 PHE.? 22.76 CL CL B 384 D 298 ASP B 240 ASP.? 29.22 CL CL B 383 D 329 LYS B 267 LYS~? 27.57 CL CL B 383 coo 35.44 53.35 83.81 35.65 54.53 81.28 5.57 24.21 90.55 3.01 23.56 89.66 coo 29.72 46.46 83.60 30.79 47.36 81.99 11.35 28.88 93.27 10.37 30.59 94.07 coo 36.89 44.91 74.55 37.33 48.94 79.01 9.46 31.45 81.02 15.36 33.08 81.01 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 4 hits 1gtx_c03 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP A 26 ASP^? 16.59 CL CL A 382 A 327 GLU B 60 GLU^? 11.77 CL CL B 382 A 339 ARG B 13 ARG^? 4.84 CL CL B 382 coo 85.81 57.99 116.01 86.03 55.86 115.89 -29.69 53.68 115.80 -29.91 52.24 114.24 coo 75.11 41.01 160.30 76.65 40.06 161.41 -22.53 44.68 66.99 -22.71 45.90 65.28 coo 82.23 40.35 159.87 85.09 40.67 161.01 -26.14 48.57 68.77 -25.79 51.69 68.63 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 2 3 # 2 A 50 ASP A 64 ASP.? 15.21 CL CL A 384 A 327 GLU B 18 GLU^? 5.91 CL CL B 382 A 339 ARG B 20 ARG.? -3.56 CL CL B 382s coo 85.81 57.99 116.01 86.03 55.86 115.89 -13.50 61.63 115.26 -13.45 60.20 113.75 coo 75.11 41.01 160.30 76.65 40.06 161.41 -29.91 50.09 69.26 -29.49 51.30 70.99 coo 82.23 40.35 159.87 85.09 40.67 161.01 -30.86 53.38 73.69 -28.77 54.55 71.62 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 3 3 # 3 A 50 ASP A 144 ASP.? 19.38 CL CL A 383 A 327 GLU A 18 GLU^? 23.23 CL CL A 382 A 339 ARG A 20 ARG.? 25.24 CL CL A 384 coo 85.81 57.99 116.01 86.03 55.86 115.89 -52.89 78.90 131.37 -53.77 80.20 132.79 coo 75.11 41.01 160.30 76.65 40.06 161.41 -12.62 56.10 125.83 -13.81 57.82 125.60 coo 82.23 40.35 159.87 85.09 40.67 161.01 -13.35 53.68 120.82 -11.33 55.30 122.50 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 4 3 # 4 A 50 ASP A 180 ASP.? 19.13 CL CL A 382 A 327 GLU B 332 GLU^? 14.76 CL CL B 383 A 339 ARG B 319 ARG^? 9.63 CL CL B 383 coo 85.81 57.99 116.01 86.03 55.86 115.89 -29.53 80.77 112.24 -28.62 82.54 111.55 coo 75.11 41.01 160.30 76.65 40.06 161.41 -15.56 41.56 89.17 -16.27 39.59 89.11 coo 82.23 40.35 159.87 85.09 40.67 161.01 -15.74 45.22 81.80 -15.96 44.19 78.93 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 5 3 # 5 A 50 ASP A 210 ASP.? 21.69 CL CL A 383 A 327 GLU B 332 GLU^? 14.76 CL CL B 383 A 339 ARG B 319 ARG^? 9.63 CL CL B 383 coo 85.81 57.99 116.01 86.03 55.86 115.89 -52.58 64.68 106.89 -53.21 62.78 107.37 coo 75.11 41.01 160.30 76.65 40.06 161.41 -15.56 41.56 89.17 -16.27 39.59 89.11 coo 82.23 40.35 159.87 85.09 40.67 161.01 -15.74 45.22 81.80 -15.96 44.19 78.93 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 6 3 # 6 A 50 ASP A 240 ASP.? 30.06 CL CL A 382 A 327 GLU A 86 GLU^? 27.08 CL CL A 382 A 339 ARG A 77 ARG^? 19.95 CL CL A 382 coo 85.81 57.99 116.01 86.03 55.86 115.89 -54.36 78.15 100.29 -55.09 76.20 100.68 coo 75.11 41.01 160.30 76.65 40.06 161.41 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 82.23 40.35 159.87 85.09 40.67 161.01 -32.32 44.63 125.30 -31.80 47.66 125.44 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 7 3 # 7 A 50 ASP A 240 ASP.? 30.06 CL CL A 382 A 327 GLU B 86 GLU^? 25.45 CL CL B 382 A 339 ARG B 24 ARG^? 24.13 CL CL B 382 coo 85.81 57.99 116.01 86.03 55.86 115.89 -54.36 78.15 100.29 -55.09 76.20 100.68 coo 75.11 41.01 160.30 76.65 40.06 161.41 -37.46 36.82 83.59 -36.60 37.35 85.50 coo 82.23 40.35 159.87 85.09 40.67 161.01 -30.86 40.03 86.77 -33.42 38.25 86.47 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 8 3 # 8 A 50 ASP A 240 ASP.? 30.06 CL CL A 382 A 327 GLU B 86 GLU^? 25.45 CL CL B 382 A 339 ARG B 85 ARG^? 26.72 CL CL B 382 coo 85.81 57.99 116.01 86.03 55.86 115.89 -54.36 78.15 100.29 -55.09 76.20 100.68 coo 75.11 41.01 160.30 76.65 40.06 161.41 -37.46 36.82 83.59 -36.60 37.35 85.50 coo 82.23 40.35 159.87 85.09 40.67 161.01 -45.61 37.84 80.13 -46.20 40.84 79.69 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 9 3 # 9 A 50 ASP A 272 ASP~? 14.48 CL CL A 382 A 327 GLU B 86 GLU^? 25.45 CL CL B 382 A 339 ARG B 85 ARG^? 26.72 CL CL B 382 coo 85.81 57.99 116.01 86.03 55.86 115.89 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 75.11 41.01 160.30 76.65 40.06 161.41 -37.46 36.82 83.59 -36.60 37.35 85.50 coo 82.23 40.35 159.87 85.09 40.67 161.01 -45.61 37.84 80.13 -46.20 40.84 79.69 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 10 3 # 10 A 50 ASP B 93 ASP^? 5.22 CL CL B 383 A 327 GLU A 86 GLU^? 27.08 CL CL A 382 A 339 ARG A 24 ARG^? 24.95 CL CL A 382 coo 85.81 57.99 116.01 86.03 55.86 115.89 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 75.11 41.01 160.30 76.65 40.06 161.41 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 82.23 40.35 159.87 85.09 40.67 161.01 -27.53 46.21 115.11 -27.47 43.33 116.18 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 11 3 # 11 A 50 ASP B 115 ASP~? 22.59 CL CL B 383 A 327 GLU B 23 GLU.? 22.91 CL CL B 382 A 339 ARG B 325 ARG.? 19.88 CL CL B 382 coo 85.81 57.99 116.01 86.03 55.86 115.89 0.29 34.85 57.65 0.95 36.59 56.65 coo 75.11 41.01 160.30 76.65 40.06 161.41 -35.83 43.78 85.87 -35.49 42.75 87.75 coo 82.23 40.35 159.87 85.09 40.67 161.01 -34.83 46.46 90.24 -34.50 47.08 87.15 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 12 3 # 12 A 50 ASP B 180 ASP.? 19.08 CL CL B 383 A 327 GLU A 23 GLU.? 27.24 CL CL A 382 A 339 ARG A 44 ARG.? 27.19 CL CL A 384 coo 85.81 57.99 116.01 86.03 55.86 115.89 0.82 48.22 75.52 2.17 49.73 74.84 coo 75.11 41.01 160.30 76.65 40.06 161.41 -22.84 44.28 116.17 -23.55 42.53 115.22 coo 82.23 40.35 159.87 85.09 40.67 161.01 -16.06 41.78 118.55 -16.27 43.65 116.05 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 13 3 # 13 A 50 ASP B 180 ASP.? 19.08 CL CL B 383 A 327 GLU A 332 GLU^? 14.84 CL CL A 382 A 339 ARG A 319 ARG^? 9.49 CL CL A 382 coo 85.81 57.99 116.01 86.03 55.86 115.89 0.82 48.22 75.52 2.17 49.73 74.84 coo 75.11 41.01 160.30 76.65 40.06 161.41 -32.41 59.20 107.78 -33.78 57.91 108.78 coo 82.23 40.35 159.87 85.09 40.67 161.01 -27.23 63.29 112.77 -27.13 63.50 115.87 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 14 3 # 14 A 50 ASP B 208 ASP.? 21.56 CL CL B 383 A 327 GLU A 60 GLU^? 17.84 CL CL A 382 A 339 ARG A 13 ARG^? 21.22 CL CL A 382 coo 85.81 57.99 116.01 86.03 55.86 115.89 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 75.11 41.01 160.30 76.65 40.06 161.41 -20.60 62.82 127.64 -18.87 63.84 128.41 coo 82.23 40.35 159.87 85.09 40.67 161.01 -15.61 60.27 127.72 -14.54 62.09 125.47 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 15 3 # 15 A 50 ASP B 210 ASP.? 22.05 CL CL B 384 A 327 GLU A 332 GLU^? 14.84 CL CL A 382 A 339 ARG A 319 ARG^? 9.49 CL CL A 382 coo 85.81 57.99 116.01 86.03 55.86 115.89 -2.53 25.11 93.69 -2.62 22.87 93.62 coo 75.11 41.01 160.30 76.65 40.06 161.41 -32.41 59.20 107.78 -33.78 57.91 108.78 coo 82.23 40.35 159.87 85.09 40.67 161.01 -27.23 63.29 112.77 -27.13 63.50 115.87 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 16 3 # 16 A 50 ASP B 240 ASP.? 29.22 CL CL B 383 A 327 GLU A 86 GLU^? 27.08 CL CL A 382 A 339 ARG A 24 ARG^? 24.95 CL CL A 382 coo 85.81 57.99 116.01 86.03 55.86 115.89 11.35 28.88 93.27 10.37 30.59 94.07 coo 75.11 41.01 160.30 76.65 40.06 161.41 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 82.23 40.35 159.87 85.09 40.67 161.01 -27.53 46.21 115.11 -27.47 43.33 116.18 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 17 3 # 17 A 50 ASP B 240 ASP.? 29.22 CL CL B 383 A 327 GLU B 86 GLU^? 25.45 CL CL B 382 A 339 ARG B 77 ARG^? 27.48 CL CL B 383 coo 85.81 57.99 116.01 86.03 55.86 115.89 11.35 28.88 93.27 10.37 30.59 94.07 coo 75.11 41.01 160.30 76.65 40.06 161.41 -37.46 36.82 83.59 -36.60 37.35 85.50 coo 82.23 40.35 159.87 85.09 40.67 161.01 -35.60 30.51 80.72 -37.43 31.47 83.02 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 18 3 # 18 A 50 ASP B 257 ASP.? 23.04 CL CL B 384 A 327 GLU B 201 GLU^? 17.46 CL CL A 384 A 339 ARG B 202 ARG^? 25.52 CL CL B 383 coo 85.81 57.99 116.01 86.03 55.86 115.89 12.38 23.16 66.89 10.36 22.88 66.20 coo 75.11 41.01 160.30 76.65 40.06 161.41 -19.06 50.53 95.26 -20.94 50.61 94.28 coo 82.23 40.35 159.87 85.09 40.67 161.01 -17.65 42.54 97.41 -16.79 41.14 100.03 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 19 3 # 19 A 50 ASP B 272 ASP~? 14.11 CL CL B 383 A 327 GLU A 86 GLU^? 27.08 CL CL A 382 A 339 ARG A 24 ARG^? 24.95 CL CL A 382 coo 85.81 57.99 116.01 86.03 55.86 115.89 0.88 31.47 82.51 1.09 32.47 80.67 coo 75.11 41.01 160.30 76.65 40.06 161.41 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 82.23 40.35 159.87 85.09 40.67 161.01 -27.53 46.21 115.11 -27.47 43.33 116.18 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 20 3 # 20 A 50 ASP B 338 ASP.? 19.77 CL CL B 383 A 327 GLU A 60 GLU^? 17.84 CL CL A 382 A 339 ARG A 13 ARG^? 21.22 CL CL A 382 coo 85.81 57.99 116.01 86.03 55.86 115.89 1.84 46.00 86.98 1.86 47.25 85.31 coo 75.11 41.01 160.30 76.65 40.06 161.41 -20.60 62.82 127.64 -18.87 63.84 128.41 coo 82.23 40.35 159.87 85.09 40.67 161.01 -15.61 60.27 127.72 -14.54 62.09 125.47 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 20 hits 1hto_c00 naa= 3 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 1 3 # 1 A 311 GLU A 23 GLU.? 27.24 CL CL A 382 A 475 GLU A 86 GLU^? 27.08 CL CL A 382 A 477 ARG A 24 ARG^? 24.95 CL CL A 382 coo 13.27 46.15 59.96 13.96 44.19 59.76 -22.84 44.28 116.17 -23.55 42.53 115.22 coo 9.69 44.01 59.12 10.58 42.11 58.89 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 13.49 45.17 55.56 13.84 42.22 54.75 -27.53 46.21 115.11 -27.47 43.33 116.18 1i19_c00 source 1i19 CHOLESTEROL OXIDASE : 1 hits 1i19_c00 naa= 3 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 1 3 # 1 B 311 GLU A 23 GLU.? 27.24 CL CL A 382 B 475 GLU A 86 GLU^? 27.08 CL CL A 382 B 477 ARG A 24 ARG^? 24.95 CL CL A 382 coo 42.69 29.93 84.57 42.00 28.96 82.83 -22.84 44.28 116.17 -23.55 42.53 115.22 coo 46.14 28.45 82.89 45.10 27.86 81.15 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 42.47 25.53 85.29 42.25 23.66 82.85 -27.53 46.21 115.11 -27.47 43.33 116.18 1i19_c01 source 1i19 CHOLESTEROL OXIDASE : 1 hits 1i19_c01 naa= 3 ULMN 3 1i29_c01 CSDB user 1 3 # 1 A 123 HIS A 302 HIS^? 11.51 CL CL A 384 A 200 ASP A 311 ASP^? 15.19 CL CL A 384 A 226 LYS A 336 LYS^? 14.72 CL CL A 382 coo 23.24 46.58 4.39 24.43 46.59 2.66 -27.17 73.50 97.06 -27.34 73.92 95.02 coo 24.51 43.28 11.18 25.17 44.50 9.58 -31.19 72.86 91.72 -29.44 73.97 92.12 coo 34.47 51.09 7.19 28.58 51.18 7.53 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1i29_c01 CSDB user 2 3 # 2 A 123 HIS B 302 HIS^? 23.99 CL CL A 384 A 200 ASP B 311 ASP^? 24.66 CL CL A 384 A 226 LYS B 336 LYS^? 14.66 CL CL B 383 coo 23.24 46.58 4.39 24.43 46.59 2.66 -2.27 54.46 91.30 -1.20 55.23 92.93 coo 24.51 43.28 11.18 25.17 44.50 9.58 0.41 52.81 97.17 0.37 54.52 95.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 -3.40 41.24 88.18 -4.83 35.96 88.60 1i29_c01 source 1i29 CSDB : 2 hits 1i29_c01 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 12 VAL^? 18.58 CL CL A 382 A 200 ASP A 93 ASP^? 5.15 CL CL A 382 A 226 LYS A 128 LYS.? 19.46 CL CL A 382 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -19.98 55.50 124.75 -21.91 54.50 124.99 coo 24.51 43.28 11.18 25.17 44.50 9.58 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 34.47 51.09 7.19 28.58 51.18 7.53 -25.12 72.76 133.10 -20.68 68.32 134.09 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL A 68 VAL^? 13.05 CL CL A 382 A 200 ASP A 30 ASP^? -6.81 CL CL A 382s A 226 LYS A 336 LYS^? 14.72 CL CL A 382 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -22.41 64.28 119.84 -21.83 62.71 118.29 coo 24.51 43.28 11.18 25.17 44.50 9.58 -35.52 64.63 115.87 -36.96 65.19 114.43 coo 34.47 51.09 7.19 28.58 51.18 7.53 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL A 131 VAL^? 15.03 CL CL A 382 A 200 ASP A 115 ASP~? 22.59 CL CL A 382 A 226 LYS A 142 LYS.? 24.15 CL CL A 383 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -28.79 79.30 126.21 -26.88 79.17 125.05 coo 24.51 43.28 11.18 25.17 44.50 9.58 -35.38 84.29 133.21 -33.68 85.51 133.25 coo 34.47 51.09 7.19 28.58 51.18 7.53 -49.53 84.63 130.17 -55.13 85.19 133.14 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL A 162 VAL~? 18.39 CL CL A 382 A 200 ASP A 257 ASP.? 24.30 CL CL A 383 A 226 LYS A 235 LYS^? 33.41 CL CL A 383 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -42.67 83.28 121.41 -41.61 83.75 123.27 coo 24.51 43.28 11.18 25.17 44.50 9.58 -55.05 88.25 125.09 -55.04 86.55 126.35 coo 34.47 51.09 7.19 28.58 51.18 7.53 -61.15 85.56 115.05 -65.37 84.74 110.73 ULMN 3 1i29_c03 CSDB user 5 3 # 5 A 128 VAL A 162 VAL~? 18.39 CL CL A 382 A 200 ASP A 272 ASP~? 14.48 CL CL A 382 A 226 LYS A 336 LYS^? 14.72 CL CL A 382 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -42.67 83.28 121.41 -41.61 83.75 123.27 coo 24.51 43.28 11.18 25.17 44.50 9.58 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 34.47 51.09 7.19 28.58 51.18 7.53 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1i29_c03 CSDB user 6 3 # 6 A 128 VAL A 175 VAL^? 10.15 CL CL A 382 A 200 ASP A 115 ASP~? 22.59 CL CL A 382 A 226 LYS A 142 LYS.? 24.15 CL CL A 383 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -31.40 75.68 124.08 -30.23 76.03 122.31 coo 24.51 43.28 11.18 25.17 44.50 9.58 -35.38 84.29 133.21 -33.68 85.51 133.25 coo 34.47 51.09 7.19 28.58 51.18 7.53 -49.53 84.63 130.17 -55.13 85.19 133.14 ULMN 3 1i29_c03 CSDB user 7 3 # 7 A 128 VAL A 175 VAL^? 10.15 CL CL A 382 A 200 ASP A 180 ASP.? 19.13 CL CL A 382 A 226 LYS A 336 LYS^? 14.72 CL CL A 382 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -31.40 75.68 124.08 -30.23 76.03 122.31 coo 24.51 43.28 11.18 25.17 44.50 9.58 -29.53 80.77 112.24 -28.62 82.54 111.55 coo 34.47 51.09 7.19 28.58 51.18 7.53 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1i29_c03 CSDB user 8 3 # 8 A 128 VAL A 176 VAL^? 11.59 CL CL A 382 A 200 ASP A 180 ASP.? 19.13 CL CL A 382 A 226 LYS A 336 LYS^? 14.72 CL CL A 382 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -34.64 77.63 123.58 -36.48 78.00 124.71 coo 24.51 43.28 11.18 25.17 44.50 9.58 -29.53 80.77 112.24 -28.62 82.54 111.55 coo 34.47 51.09 7.19 28.58 51.18 7.53 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1i29_c03 CSDB user 9 3 # 9 A 128 VAL A 252 VAL^? 21.67 CL CL A 383 A 200 ASP A 257 ASP.? 24.30 CL CL A 383 A 226 LYS A 109 LYS.? 23.73 CL CL A 383 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -59.21 77.41 119.40 -60.72 77.55 121.04 coo 24.51 43.28 11.18 25.17 44.50 9.58 -55.05 88.25 125.09 -55.04 86.55 126.35 coo 34.47 51.09 7.19 28.58 51.18 7.53 -45.10 86.58 132.81 -50.69 86.17 134.93 ULMN 3 1i29_c03 CSDB user 10 3 # 10 A 128 VAL B 12 VAL^? 10.38 CL CL B 382 A 200 ASP B 93 ASP^? 5.22 CL CL B 383 A 226 LYS B 128 LYS.? 19.37 CL CL B 383 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -27.81 46.39 72.24 -27.99 44.56 73.33 coo 24.51 43.28 11.18 25.17 44.50 9.58 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 34.47 51.09 7.19 28.58 51.18 7.53 -13.49 41.25 59.55 -18.50 40.98 58.08 ULMN 3 1i29_c03 CSDB user 11 3 # 11 A 128 VAL B 61 VAL^? 10.73 CL CL B 382 A 200 ASP B 171 ASP.? 13.77 CL CL B 383 A 226 LYS B 133 LYS^? 13.08 CL CL B 383 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -23.32 45.79 72.66 -23.39 44.41 74.45 coo 24.51 43.28 11.18 25.17 44.50 9.58 -14.88 46.75 66.62 -12.79 46.40 66.16 coo 34.47 51.09 7.19 28.58 51.18 7.53 -0.84 43.73 69.01 -5.56 47.16 71.00 ULMN 3 1i29_c03 CSDB user 12 3 # 12 A 128 VAL B 62 VAL^? 6.02 CL CL B 382 A 200 ASP B 171 ASP.? 13.77 CL CL B 383 A 226 LYS B 133 LYS^? 13.08 CL CL B 383 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -22.61 49.46 73.08 -23.32 50.43 71.18 coo 24.51 43.28 11.18 25.17 44.50 9.58 -14.88 46.75 66.62 -12.79 46.40 66.16 coo 34.47 51.09 7.19 28.58 51.18 7.53 -0.84 43.73 69.01 -5.56 47.16 71.00 ULMN 3 1i29_c03 CSDB user 13 3 # 13 A 128 VAL B 68 VAL^? 11.20 CL CL B 382 A 200 ASP B 30 ASP^? -6.72 CL CL B 383s A 226 LYS B 336 LYS^? 14.66 CL CL B 383 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -18.30 46.87 73.83 -18.97 47.30 75.92 coo 24.51 43.28 11.18 25.17 44.50 9.58 -11.77 37.20 80.70 -10.35 36.55 82.15 coo 34.47 51.09 7.19 28.58 51.18 7.53 -3.40 41.24 88.18 -4.83 35.96 88.60 ULMN 3 1i29_c03 CSDB user 14 3 # 14 A 128 VAL B 131 VAL^? 14.70 CL CL B 383 A 200 ASP B 115 ASP~? 22.59 CL CL B 383 A 226 LYS B 142 LYS.? 25.17 CL CL B 384 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -4.45 42.31 63.82 -5.75 43.99 64.43 coo 24.51 43.28 11.18 25.17 44.50 9.58 0.29 34.85 57.65 0.95 36.59 56.65 coo 34.47 51.09 7.19 28.58 51.18 7.53 6.28 23.32 63.35 7.97 19.73 58.68 ULMN 3 1i29_c03 CSDB user 15 3 # 15 A 128 VAL B 162 VAL~? 18.49 CL CL B 383 A 200 ASP B 272 ASP~? 14.11 CL CL B 383 A 226 LYS B 249 LYS^? 19.48 CL CL B 384 coo 19.13 38.05 1.41 19.72 38.80 -0.53 5.87 33.01 70.31 5.41 33.44 68.14 coo 24.51 43.28 11.18 25.17 44.50 9.58 0.88 31.47 82.51 1.09 32.47 80.67 coo 34.47 51.09 7.19 28.58 51.18 7.53 7.49 19.68 88.46 2.17 20.34 86.44 ULMN 3 1i29_c03 CSDB user 16 3 # 16 A 128 VAL B 162 VAL~? 18.49 CL CL B 383 A 200 ASP B 272 ASP~? 14.11 CL CL B 383 A 226 LYS B 336 LYS^? 14.66 CL CL B 383 coo 19.13 38.05 1.41 19.72 38.80 -0.53 5.87 33.01 70.31 5.41 33.44 68.14 coo 24.51 43.28 11.18 25.17 44.50 9.58 0.88 31.47 82.51 1.09 32.47 80.67 coo 34.47 51.09 7.19 28.58 51.18 7.53 -3.40 41.24 88.18 -4.83 35.96 88.60 ULMN 3 1i29_c03 CSDB user 17 3 # 17 A 128 VAL B 175 VAL^? 9.78 CL CL B 383 A 200 ASP B 30 ASP^? -6.72 CL CL B 383s A 226 LYS B 336 LYS^? 14.66 CL CL B 383 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -5.97 39.95 67.93 -5.84 41.48 69.53 coo 24.51 43.28 11.18 25.17 44.50 9.58 -11.77 37.20 80.70 -10.35 36.55 82.15 coo 34.47 51.09 7.19 28.58 51.18 7.53 -3.40 41.24 88.18 -4.83 35.96 88.60 ULMN 3 1i29_c03 CSDB user 18 3 # 18 A 128 VAL B 175 VAL^? 9.78 CL CL B 383 A 200 ASP B 115 ASP~? 22.59 CL CL B 383 A 226 LYS B 142 LYS.? 25.17 CL CL B 384 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -5.97 39.95 67.93 -5.84 41.48 69.53 coo 24.51 43.28 11.18 25.17 44.50 9.58 0.29 34.85 57.65 0.95 36.59 56.65 coo 34.47 51.09 7.19 28.58 51.18 7.53 6.28 23.32 63.35 7.97 19.73 58.68 ULMN 3 1i29_c03 CSDB user 19 3 # 19 A 128 VAL B 175 VAL^? 9.78 CL CL B 383 A 200 ASP B 180 ASP.? 19.08 CL CL B 383 A 226 LYS B 336 LYS^? 14.66 CL CL B 383 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -5.97 39.95 67.93 -5.84 41.48 69.53 coo 24.51 43.28 11.18 25.17 44.50 9.58 0.82 48.22 75.52 2.17 49.73 74.84 coo 34.47 51.09 7.19 28.58 51.18 7.53 -3.40 41.24 88.18 -4.83 35.96 88.60 ULMN 3 1i29_c03 CSDB user 20 3 # 20 A 128 VAL B 176 VAL^? 11.60 CL CL B 383 A 200 ASP B 180 ASP.? 19.08 CL CL B 383 A 226 LYS B 336 LYS^? 14.66 CL CL B 383 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -2.86 38.00 68.54 -2.15 36.06 67.82 coo 24.51 43.28 11.18 25.17 44.50 9.58 0.82 48.22 75.52 2.17 49.73 74.84 coo 34.47 51.09 7.19 28.58 51.18 7.53 -3.40 41.24 88.18 -4.83 35.96 88.60 1i29_c03 source 1i29 CSDB : 20 hits 1i29_c03 naa= 3 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 A 14 LYS A 80 LYS^? 36.93 CL CL A 382 A 74 LYS A 82 LYS.? 41.47 CL CL A 382 A 165 GLU A 23 GLU.? 27.24 CL CL A 382 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -26.02 34.53 124.81 -22.64 33.14 129.86 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -24.27 28.84 121.34 -24.33 26.99 125.88 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -22.84 44.28 116.17 -23.55 42.53 115.22 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 A 14 LYS A 82 LYS.? 41.47 CL CL A 382 A 74 LYS A 80 LYS^? 36.93 CL CL A 382 A 165 GLU A 23 GLU.? 27.24 CL CL A 382 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -24.27 28.84 121.34 -24.33 26.99 125.88 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -26.02 34.53 124.81 -22.64 33.14 129.86 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -22.84 44.28 116.17 -23.55 42.53 115.22 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 A 14 LYS A 109 LYS.? 23.73 CL CL A 383 A 74 LYS A 142 LYS.? 24.15 CL CL A 383 A 165 GLU A 149 GLU.? 9.19 CL CL A 383 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -45.10 86.58 132.81 -50.69 86.17 134.93 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -49.53 84.63 130.17 -55.13 85.19 133.14 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -48.79 70.20 130.85 -48.75 71.87 129.52 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 A 14 LYS B 82 LYS.? 37.97 CL CL B 382 A 74 LYS B 80 LYS^? 31.45 CL CL B 382 A 165 GLU B 23 GLU.? 22.91 CL CL B 382 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 -48.91 34.74 87.29 -47.83 32.98 92.37 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 -43.65 33.60 82.90 -47.69 34.28 78.00 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 -35.83 43.78 85.87 -35.49 42.75 87.75 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 A 14 LYS B 268 LYS~? 13.29 CL CL B 383 A 74 LYS B 264 LYS~? 21.76 CL CL B 383 A 165 GLU B 135 GLU.? 23.43 CL CL B 383 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 5.99 32.14 79.72 1.11 32.64 77.72 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 11.01 31.36 75.69 9.79 34.42 71.26 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 7.28 45.80 70.11 9.12 46.58 70.84 1idt_c00 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 5 hits 1idt_c00 naa= 3 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 B 14 LYS A 82 LYS.? 41.47 CL CL A 382 B 74 LYS A 80 LYS^? 36.93 CL CL A 382 B 165 GLU A 23 GLU.? 27.24 CL CL A 382 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -24.27 28.84 121.34 -24.33 26.99 125.88 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -26.02 34.53 124.81 -22.64 33.14 129.86 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -22.84 44.28 116.17 -23.55 42.53 115.22 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 B 14 LYS A 109 LYS.? 23.73 CL CL A 383 B 74 LYS A 142 LYS.? 24.15 CL CL A 383 B 165 GLU A 146 GLU.? 12.63 CL CL A 383 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -45.10 86.58 132.81 -50.69 86.17 134.93 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -49.53 84.63 130.17 -55.13 85.19 133.14 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -52.58 70.92 131.34 -54.15 69.93 130.28 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 B 14 LYS A 109 LYS.? 23.73 CL CL A 383 B 74 LYS A 142 LYS.? 24.15 CL CL A 383 B 165 GLU A 149 GLU.? 9.19 CL CL A 383 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -45.10 86.58 132.81 -50.69 86.17 134.93 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -49.53 84.63 130.17 -55.13 85.19 133.14 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -48.79 70.20 130.85 -48.75 71.87 129.52 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 B 14 LYS A 142 LYS.? 24.15 CL CL A 383 B 74 LYS A 109 LYS.? 23.73 CL CL A 383 B 165 GLU A 149 GLU.? 9.19 CL CL A 383 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -49.53 84.63 130.17 -55.13 85.19 133.14 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -45.10 86.58 132.81 -50.69 86.17 134.93 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -48.79 70.20 130.85 -48.75 71.87 129.52 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 B 14 LYS B 82 LYS.? 37.97 CL CL B 382 B 74 LYS B 80 LYS^? 31.45 CL CL B 382 B 165 GLU B 23 GLU.? 22.91 CL CL B 382 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -48.91 34.74 87.29 -47.83 32.98 92.37 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -43.65 33.60 82.90 -47.69 34.28 78.00 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -35.83 43.78 85.87 -35.49 42.75 87.75 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 B 14 LYS B 264 LYS~? 21.76 CL CL B 383 B 74 LYS B 268 LYS~? 13.29 CL CL B 383 B 165 GLU B 135 GLU.? 23.43 CL CL B 383 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 11.01 31.36 75.69 9.79 34.42 71.26 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 5.99 32.14 79.72 1.11 32.64 77.72 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 7.28 45.80 70.11 9.12 46.58 70.84 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 B 14 LYS B 268 LYS~? 13.29 CL CL B 383 B 74 LYS B 264 LYS~? 21.76 CL CL B 383 B 165 GLU B 135 GLU.? 23.43 CL CL B 383 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 5.99 32.14 79.72 1.11 32.64 77.72 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 11.01 31.36 75.69 9.79 34.42 71.26 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 7.28 45.80 70.11 9.12 46.58 70.84 1idt_c01 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 7 hits 1idt_c01 naa= 3 ULMN 3 1ig8_c00 HEXOKINASE PII user 1 3 # 1 A 158 SER A 37 SER^? 9.11 CL CL A 382 A 173 ARG A 334 ARG^? 9.67 CL CL A 382 A 211 ASP A 93 ASP^? 5.15 CL CL A 382 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 18.77 77.82 11.69 20.55 80.22 10.73 -35.93 61.76 109.91 -34.52 61.40 112.61 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1ig8_c00 HEXOKINASE PII user 2 3 # 2 A 158 SER A 55 SER.? 23.04 CL CL A 383 A 173 ARG A 92 ARG^? 9.37 CL CL A 383 A 211 ASP A 53 ASP.? 25.38 CL CL A 382 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -27.78 51.03 133.17 -28.81 49.24 134.52 coo 18.77 77.82 11.69 20.55 80.22 10.73 -35.59 58.66 126.41 -36.79 59.05 129.24 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -25.09 46.58 135.54 -27.02 47.57 135.30 ULMN 3 1ig8_c00 HEXOKINASE PII user 3 3 # 3 A 158 SER A 88 SER^? 22.34 CL CL A 382 A 173 ARG A 44 ARG.? 27.19 CL CL A 384 A 211 ASP A 39 ASP^? 16.51 CL CL A 382 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -26.75 46.25 123.96 -28.99 45.42 123.71 coo 18.77 77.82 11.69 20.55 80.22 10.73 -16.06 41.78 118.55 -16.27 43.65 116.05 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1ig8_c00 HEXOKINASE PII user 4 3 # 4 A 158 SER A 192 SER.? 15.36 CL CL A 384 A 173 ARG A 197 ARG.? 14.16 CL CL A 384 A 211 ASP A 305 ASP^? 16.01 CL CL A 384 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 18.77 77.82 11.69 20.55 80.22 10.73 -16.42 65.00 90.05 -16.47 67.55 88.20 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -32.01 65.22 92.45 -32.49 63.34 91.63 ULMN 3 1ig8_c00 HEXOKINASE PII user 5 3 # 5 A 158 SER A 192 SER.? 15.36 CL CL A 384 A 173 ARG A 202 ARG^? 19.65 CL CL A 384 A 211 ASP A 195 ASP.? 13.29 CL CL A 384 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 18.77 77.82 11.69 20.55 80.22 10.73 -32.39 54.22 100.96 -34.65 53.06 99.24 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1ig8_c00 HEXOKINASE PII user 6 3 # 6 A 158 SER A 192 SER.? 15.36 CL CL A 384 A 173 ARG A 202 ARG^? 19.65 CL CL A 384 A 211 ASP A 306 ASP.? 16.66 CL CL A 384 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 18.77 77.82 11.69 20.55 80.22 10.73 -32.39 54.22 100.96 -34.65 53.06 99.24 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -29.63 66.56 87.01 -28.35 68.29 87.20 ULMN 3 1ig8_c00 HEXOKINASE PII user 7 3 # 7 A 158 SER A 192 SER.? 15.36 CL CL A 384 A 173 ARG B 290 ARG.? 12.49 CL CL A 384 A 211 ASP A 306 ASP.? 16.66 CL CL A 384 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 18.77 77.82 11.69 20.55 80.22 10.73 -13.01 59.15 90.41 -14.60 61.38 91.89 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -29.63 66.56 87.01 -28.35 68.29 87.20 ULMN 3 1ig8_c00 HEXOKINASE PII user 8 3 # 8 A 158 SER A 324 SER^? 19.72 CL CL A 384 A 173 ARG A 44 ARG.? 27.19 CL CL A 384 A 211 ASP A 327 ASP.? 19.04 CL CL A 384 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -24.77 48.15 110.31 -26.00 48.61 108.19 coo 18.77 77.82 11.69 20.55 80.22 10.73 -16.06 41.78 118.55 -16.27 43.65 116.05 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -25.74 49.77 105.10 -27.34 48.80 104.08 ULMN 3 1ig8_c00 HEXOKINASE PII user 9 3 # 9 A 158 SER B 37 SER^? 9.16 CL CL B 383 A 173 ARG B 334 ARG^? 9.65 CL CL B 383 A 211 ASP B 93 ASP^? 5.22 CL CL B 383 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 18.77 77.82 11.69 20.55 80.22 10.73 -12.53 38.39 87.32 -14.06 38.36 84.61 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1ig8_c00 HEXOKINASE PII user 10 3 # 10 A 158 SER B 55 SER.? 22.28 CL CL B 384 A 173 ARG B 92 ARG^? 9.18 CL CL B 384 A 211 ASP B 53 ASP.? 25.44 CL CL B 384 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -31.36 33.02 68.90 -32.51 30.85 68.96 coo 18.77 77.82 11.69 20.55 80.22 10.73 -19.73 31.24 73.98 -19.77 29.09 71.81 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -37.14 32.94 67.80 -35.44 31.68 68.05 ULMN 3 1ig8_c00 HEXOKINASE PII user 11 3 # 11 A 158 SER B 88 SER^? 22.31 CL CL B 383 A 173 ARG B 85 ARG^? 26.72 CL CL B 382 A 211 ASP B 39 ASP^? 17.51 CL CL B 383 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -33.45 36.60 78.54 -33.30 34.49 79.66 coo 18.77 77.82 11.69 20.55 80.22 10.73 -45.61 37.84 80.13 -46.20 40.84 79.69 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -26.18 36.85 80.53 -27.97 36.10 81.34 ULMN 3 1ig8_c00 HEXOKINASE PII user 12 3 # 12 A 158 SER B 192 SER.? 13.26 CL CL A 384 A 173 ARG A 290 ARG.? -7.44 CL CL A 384s A 211 ASP B 305 ASP^? 21.59 CL CL A 384 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -11.80 54.65 102.27 -11.20 56.97 103.08 coo 18.77 77.82 11.69 20.55 80.22 10.73 -15.77 66.49 99.38 -13.63 64.23 99.65 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -6.28 49.81 99.79 -7.51 49.10 101.38 ULMN 3 1ig8_c00 HEXOKINASE PII user 13 3 # 13 A 158 SER B 192 SER.? 13.26 CL CL A 384 A 173 ARG A 290 ARG.? -7.44 CL CL A 384s A 211 ASP B 306 ASP.? 19.57 CL CL A 384 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -11.80 54.65 102.27 -11.20 56.97 103.08 coo 18.77 77.82 11.69 20.55 80.22 10.73 -15.77 66.49 99.38 -13.63 64.23 99.65 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -4.64 54.84 103.01 -3.71 56.24 101.58 ULMN 3 1ig8_c00 HEXOKINASE PII user 14 3 # 14 A 158 SER B 192 SER.? 13.26 CL CL A 384 A 173 ARG B 290 ARG.? 12.49 CL CL A 384 A 211 ASP B 306 ASP.? 19.57 CL CL A 384 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -11.80 54.65 102.27 -11.20 56.97 103.08 coo 18.77 77.82 11.69 20.55 80.22 10.73 -13.01 59.15 90.41 -14.60 61.38 91.89 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -4.64 54.84 103.01 -3.71 56.24 101.58 1ig8_c00 source 1ig8 HEXOKINASE PII : 14 hits 1ig8_c00 naa= 3 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 3 # 1 54 ASP A 26 ASP^? 16.59 CL CL A 382 158 THR A 331 THR^? 10.31 CL CL A 384 317 ASP A 30 ASP^? -6.81 CL CL A 382s coo -2.63 8.40 35.07 -3.66 9.81 36.17 -29.69 53.68 115.80 -29.91 52.24 114.24 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -26.18 59.17 108.07 -25.19 60.90 109.06 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 3 # 2 54 ASP A 204 ASP^? 18.76 CL CL A 384 158 THR A 283 THR^? 13.40 CL CL A 384 317 ASP A 305 ASP^? 16.01 CL CL A 384 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -37.06 58.40 100.88 -36.30 56.45 100.53 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -28.94 58.76 103.11 -29.59 56.83 103.84 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -32.01 65.22 92.45 -32.49 63.34 91.63 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 3 3 # 3 54 ASP A 208 ASP.? 21.85 CL CL A 382 158 THR A 279 THR^? 15.90 CL CL A 382 317 ASP A 272 ASP~? 14.48 CL CL A 382 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -48.25 63.81 104.00 -49.74 63.21 105.24 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -40.03 65.40 103.95 -40.07 64.36 105.87 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -46.67 73.24 112.92 -45.43 74.19 114.38 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 4 3 # 4 54 ASP A 272 ASP~? 14.48 CL CL A 382 158 THR A 342 THR.? 12.75 CL CL A 382 317 ASP A 338 ASP.? 17.28 CL CL A 384 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -46.67 73.24 112.92 -45.43 74.19 114.38 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -39.29 79.06 113.77 -38.09 77.69 114.94 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -35.06 76.37 102.96 -33.50 77.52 103.78 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 5 3 # 5 54 ASP A 311 ASP^? 15.19 CL CL A 384 158 THR A 188 THR^? 7.94 CL CL A 384 317 ASP A 195 ASP.? 13.29 CL CL A 384 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -31.19 72.86 91.72 -29.44 73.97 92.12 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -23.96 70.36 98.57 -23.94 71.57 96.84 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 6 3 # 6 54 ASP A 311 ASP^? 15.19 CL CL A 384 158 THR A 188 THR^? 7.94 CL CL A 384 317 ASP A 338 ASP.? 17.28 CL CL A 384 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -31.19 72.86 91.72 -29.44 73.97 92.12 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -23.96 70.36 98.57 -23.94 71.57 96.84 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -35.06 76.37 102.96 -33.50 77.52 103.78 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 7 3 # 7 54 ASP A 327 ASP.? 19.04 CL CL A 384 158 THR A 283 THR^? 13.40 CL CL A 384 317 ASP A 26 ASP^? 16.59 CL CL A 382 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -25.74 49.77 105.10 -27.34 48.80 104.08 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -28.94 58.76 103.11 -29.59 56.83 103.84 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 8 3 # 8 54 ASP A 327 ASP.? 19.04 CL CL A 384 158 THR A 329 THR^? 14.14 CL CL A 384 317 ASP A 26 ASP^? 16.59 CL CL A 382 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -25.74 49.77 105.10 -27.34 48.80 104.08 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -21.38 53.78 108.30 -19.71 54.59 109.49 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 9 3 # 9 54 ASP A 327 ASP.? 19.04 CL CL A 384 158 THR A 331 THR^? 10.31 CL CL A 384 317 ASP A 26 ASP^? 16.59 CL CL A 382 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -25.74 49.77 105.10 -27.34 48.80 104.08 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -26.18 59.17 108.07 -25.19 60.90 109.06 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 10 3 # 10 54 ASP A 327 ASP.? 19.04 CL CL A 384 158 THR A 331 THR^? 10.31 CL CL A 384 317 ASP A 204 ASP^? 18.76 CL CL A 384 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -25.74 49.77 105.10 -27.34 48.80 104.08 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -26.18 59.17 108.07 -25.19 60.90 109.06 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -37.06 58.40 100.88 -36.30 56.45 100.53 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 11 3 # 11 54 ASP B 26 ASP^? 16.51 CL CL B 383 158 THR B 331 THR^? 16.17 CL CL B 383 317 ASP B 30 ASP^? -6.72 CL CL B 383s coo -2.63 8.40 35.07 -3.66 9.81 36.17 -23.45 39.33 83.60 -24.23 39.48 85.53 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -18.10 46.86 87.19 -17.24 47.80 85.43 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 12 3 # 12 54 ASP B 64 ASP.? 7.14 CL CL B 382 158 THR A 194 THR.? 13.30 CL CL B 382 317 ASP B 291 ASP.? 20.64 CL CL B 382 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -22.24 55.99 77.05 -23.77 56.03 78.56 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -23.53 58.32 86.21 -24.61 58.92 84.44 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -11.26 60.51 82.59 -9.94 61.37 84.03 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 13 3 # 13 54 ASP B 180 ASP.? 19.08 CL CL B 383 158 THR B 342 THR.? 12.70 CL CL B 383 317 ASP B 338 ASP.? 19.77 CL CL B 383 coo -2.63 8.40 35.07 -3.66 9.81 36.17 0.82 48.22 75.52 2.17 49.73 74.84 coo -5.30 12.75 41.86 -4.34 13.05 39.99 2.93 38.40 77.77 1.00 38.51 76.85 coo -12.63 17.64 33.66 -10.65 17.90 34.40 1.84 46.00 86.98 1.86 47.25 85.31 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 14 3 # 14 54 ASP B 204 ASP^? 22.18 CL CL B 383 158 THR B 283 THR^? 20.21 CL CL B 383 317 ASP B 305 ASP^? 21.59 CL CL A 384 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -12.38 39.84 96.49 -14.33 39.98 97.22 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -16.17 46.19 92.40 -17.74 44.83 92.78 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -6.28 49.81 99.79 -7.51 49.10 101.38 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 15 3 # 15 54 ASP B 208 ASP.? 21.56 CL CL B 383 158 THR B 279 THR^? 15.64 CL CL B 383 317 ASP B 272 ASP~? 14.11 CL CL B 383 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -4.03 30.56 94.79 -4.11 28.51 94.21 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -5.97 38.16 91.98 -7.29 37.14 90.58 coo -12.63 17.64 33.66 -10.65 17.90 34.40 0.88 31.47 82.51 1.09 32.47 80.67 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 16 3 # 16 54 ASP B 272 ASP~? 14.11 CL CL B 383 158 THR B 342 THR.? 12.70 CL CL B 383 317 ASP B 338 ASP.? 19.77 CL CL B 383 coo -2.63 8.40 35.07 -3.66 9.81 36.17 0.88 31.47 82.51 1.09 32.47 80.67 coo -5.30 12.75 41.86 -4.34 13.05 39.99 2.93 38.40 77.77 1.00 38.51 76.85 coo -12.63 17.64 33.66 -10.65 17.90 34.40 1.84 46.00 86.98 1.86 47.25 85.31 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 17 3 # 17 54 ASP B 311 ASP^? 24.66 CL CL A 384 158 THR B 188 THR^? 20.79 CL CL A 384 317 ASP B 195 ASP.? 10.47 CL CL A 384 coo -2.63 8.40 35.07 -3.66 9.81 36.17 0.41 52.81 97.17 0.37 54.52 95.85 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -6.82 55.65 90.16 -5.30 56.81 91.19 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 18 3 # 18 54 ASP B 311 ASP^? 24.66 CL CL A 384 158 THR B 188 THR^? 20.79 CL CL A 384 317 ASP B 338 ASP.? 19.77 CL CL B 383 coo -2.63 8.40 35.07 -3.66 9.81 36.17 0.41 52.81 97.17 0.37 54.52 95.85 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -6.82 55.65 90.16 -5.30 56.81 91.19 coo -12.63 17.64 33.66 -10.65 17.90 34.40 1.84 46.00 86.98 1.86 47.25 85.31 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 19 3 # 19 54 ASP B 327 ASP.? 22.34 CL CL A 384 158 THR B 283 THR^? 20.21 CL CL B 383 317 ASP B 26 ASP^? 16.51 CL CL B 383 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -25.62 46.25 93.54 -25.42 45.53 95.50 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -16.17 46.19 92.40 -17.74 44.83 92.78 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 20 3 # 20 54 ASP B 327 ASP.? 22.34 CL CL A 384 158 THR B 329 THR^? 15.42 CL CL B 382 317 ASP B 26 ASP^? 16.51 CL CL B 383 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -25.62 46.25 93.54 -25.42 45.53 95.50 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -24.83 49.33 87.66 -25.34 51.01 86.38 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 21 3 # 21 54 ASP B 327 ASP.? 22.34 CL CL A 384 158 THR B 331 THR^? 16.17 CL CL B 383 317 ASP B 204 ASP^? 22.18 CL CL B 383 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -25.62 46.25 93.54 -25.42 45.53 95.50 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -18.10 46.86 87.19 -17.24 47.80 85.43 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -12.38 39.84 96.49 -14.33 39.98 97.22 1inp_c02 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 21 hits 1inp_c02 naa= 3 ULMN 3 1iph_c00 CATALASE HPII user 1 3 # 1 A 128 HIS A 223 HIS.? 29.08 CL CL A 383 A 167 SER A 222 SER.? 30.25 CL CL A 383 A 201 ASN A 258 ASN~? 27.57 CL CL A 383 coo 12.95 4.49 19.05 14.87 4.39 19.77 -56.62 90.70 129.56 -55.95 91.22 131.48 coo 10.44 7.96 22.51 12.16 7.57 20.82 -59.78 88.32 124.78 -60.21 90.11 123.17 coo 19.43 6.74 22.83 19.09 5.15 21.60 -54.65 91.43 120.94 -52.65 90.78 121.44 1iph_c00 source 1iph CATALASE HPII : 1 hits 1iph_c00 naa= 3 ULMN 3 1iph_c01 CATALASE HPII user 1 3 # 1 B 128 HIS A 223 HIS.? 29.08 CL CL A 383 B 167 SER A 222 SER.? 30.25 CL CL A 383 B 201 ASN A 258 ASN~? 27.57 CL CL A 383 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -56.62 90.70 129.56 -55.95 91.22 131.48 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -59.78 88.32 124.78 -60.21 90.11 123.17 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -54.65 91.43 120.94 -52.65 90.78 121.44 1iph_c01 source 1iph CATALASE HPII : 1 hits 1iph_c01 naa= 3 ULMN 3 1iph_c02 CATALASE HPII user 1 3 # 1 C 128 HIS A 223 HIS.? 29.08 CL CL A 383 C 167 SER A 222 SER.? 30.25 CL CL A 383 C 201 ASN A 258 ASN~? 27.57 CL CL A 383 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -56.62 90.70 129.56 -55.95 91.22 131.48 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -59.78 88.32 124.78 -60.21 90.11 123.17 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -54.65 91.43 120.94 -52.65 90.78 121.44 1iph_c02 source 1iph CATALASE HPII : 1 hits 1iph_c02 naa= 3 ULMN 3 1iph_c03 CATALASE HPII user 1 3 # 1 D 128 HIS A 223 HIS.? 29.08 CL CL A 383 D 167 SER A 222 SER.? 30.25 CL CL A 383 D 201 ASN A 258 ASN~? 27.57 CL CL A 383 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -56.62 90.70 129.56 -55.95 91.22 131.48 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -59.78 88.32 124.78 -60.21 90.11 123.17 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -54.65 91.43 120.94 -52.65 90.78 121.44 1iph_c03 source 1iph CATALASE HPII : 1 hits 1iph_c03 naa= 3 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 1 3 # 1 A1132 ASP A 257 ASP.? 24.30 CL CL A 383 A1134 ALA A 261 ALA~? 24.23 CL CL A 383 A1137 ASN A 258 ASN~? 27.57 CL CL A 383 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -55.05 88.25 125.09 -55.04 86.55 126.35 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -51.30 87.37 119.20 -51.49 87.39 120.67 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -54.65 91.43 120.94 -52.65 90.78 121.44 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 2 3 # 2 A1132 ASP B 257 ASP.? 23.04 CL CL B 384 A1134 ALA B 261 ALA~? 23.36 CL CL B 384 A1137 ASN B 258 ASN.? 28.97 CL CL B 384 coo -27.05 34.58 17.12 -25.81 32.84 17.16 12.38 23.16 66.89 10.36 22.88 66.20 coo -20.53 36.39 15.81 -20.80 35.01 16.40 12.35 28.11 71.85 11.96 27.24 70.64 coo -23.72 34.69 12.49 -24.32 32.83 13.34 15.59 26.49 68.84 17.44 27.50 69.35 1ir3_c02 source 1ir3 INSULIN RECEPTOR : 2 hits 1ir3_c02 naa= 3 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 1 3 # 1 A 14 GLU A 18 GLU^? 23.23 CL CL A 382 A 61 GLU A 57 GLU.? 23.36 CL CL A 382 A 162 HIS A 19 HIS^? 24.55 CL CL A 382 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -12.62 56.10 125.83 -13.81 57.82 125.60 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -23.46 53.73 134.86 -22.94 54.54 136.68 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -17.70 51.01 127.32 -17.43 50.94 129.40 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 2 3 # 2 A 14 GLU B 18 GLU^? 5.91 CL CL B 382 A 61 GLU B 57 GLU.? 21.35 CL CL B 382 A 162 HIS B 19 HIS^? 13.92 CL CL B 382 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -29.91 50.09 69.26 -29.49 51.30 70.99 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -31.25 37.00 65.18 -31.15 36.75 63.13 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -33.46 45.18 72.05 -34.46 43.90 70.71 1j53_c00 source 1j53 DNA POLYMERASE III, EPSILON CHAIN : 2 hits 1j53_c00 naa= 3 ULMN 3 1joa_c00 NADH PEROXIDASE user 1 3 # 1 10 HIS B 78 HIS^? 26.83 CL CL B 382 41 SER B 88 SER^? 22.31 CL CL B 383 303 ARG B 85 ARG^? 26.72 CL CL B 382 coo 62.94 54.74 73.45 64.13 56.17 74.27 -41.15 34.55 77.14 -42.58 35.82 77.99 coo 65.67 62.51 70.93 64.56 61.94 68.74 -33.45 36.60 78.54 -33.30 34.49 79.66 coo 63.38 52.38 77.01 66.48 52.75 76.49 -45.61 37.84 80.13 -46.20 40.84 79.69 1joa_c00 source 1joa NADH PEROXIDASE : 1 hits 1joa_c00 naa= 3 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 1 3 # 1 A 55 ASP A 26 ASP^? 16.59 CL CL A 382 A 58 ASP A 28 ASP^? 9.02 CL CL A 382 A 424 GLU A 332 GLU^? 14.84 CL CL A 382 coo 58.42 47.76 20.67 58.01 49.10 19.12 -29.69 53.68 115.80 -29.91 52.24 114.24 coo 58.59 41.80 18.81 58.94 43.89 18.94 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 52.85 46.34 13.34 54.09 44.97 14.42 -32.41 59.20 107.78 -33.78 57.91 108.78 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 2 3 # 2 A 55 ASP A 28 ASP^? 9.02 CL CL A 382 A 58 ASP A 26 ASP^? 16.59 CL CL A 382 A 424 GLU A 332 GLU^? 14.84 CL CL A 382 coo 58.42 47.76 20.67 58.01 49.10 19.12 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 58.59 41.80 18.81 58.94 43.89 18.94 -29.69 53.68 115.80 -29.91 52.24 114.24 coo 52.85 46.34 13.34 54.09 44.97 14.42 -32.41 59.20 107.78 -33.78 57.91 108.78 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 3 3 # 3 A 55 ASP A 28 ASP^? 9.02 CL CL A 382 A 58 ASP A 30 ASP^? -6.81 CL CL A 382s A 424 GLU A 332 GLU^? 14.84 CL CL A 382 coo 58.42 47.76 20.67 58.01 49.10 19.12 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 58.59 41.80 18.81 58.94 43.89 18.94 -35.52 64.63 115.87 -36.96 65.19 114.43 coo 52.85 46.34 13.34 54.09 44.97 14.42 -32.41 59.20 107.78 -33.78 57.91 108.78 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 4 3 # 4 A 55 ASP A 30 ASP^? -6.81 CL CL A 382s A 58 ASP A 28 ASP^? 9.02 CL CL A 382 A 424 GLU A 332 GLU^? 14.84 CL CL A 382 coo 58.42 47.76 20.67 58.01 49.10 19.12 -35.52 64.63 115.87 -36.96 65.19 114.43 coo 58.59 41.80 18.81 58.94 43.89 18.94 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 52.85 46.34 13.34 54.09 44.97 14.42 -32.41 59.20 107.78 -33.78 57.91 108.78 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 5 3 # 5 A 55 ASP A 36 ASP.? -3.33 CL CL A 382s A 58 ASP A 93 ASP^? 5.15 CL CL A 382 A 424 GLU A 169 GLU.? 11.07 CL CL A 382 coo 58.42 47.76 20.67 58.01 49.10 19.12 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 58.59 41.80 18.81 58.94 43.89 18.94 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 52.85 46.34 13.34 54.09 44.97 14.42 -27.31 72.85 122.01 -26.32 74.11 120.63 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 6 3 # 6 A 55 ASP A 93 ASP^? 5.15 CL CL A 382 A 58 ASP A 36 ASP.? -3.33 CL CL A 382s A 424 GLU A 169 GLU.? 11.07 CL CL A 382 coo 58.42 47.76 20.67 58.01 49.10 19.12 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 58.59 41.80 18.81 58.94 43.89 18.94 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 52.85 46.34 13.34 54.09 44.97 14.42 -27.31 72.85 122.01 -26.32 74.11 120.63 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 7 3 # 7 A 55 ASP A 208 ASP.? 21.85 CL CL A 382 A 58 ASP A 210 ASP.? 21.69 CL CL A 383 A 424 GLU A 276 GLU~? 16.10 CL CL A 383 coo 58.42 47.76 20.67 58.01 49.10 19.12 -48.25 63.81 104.00 -49.74 63.21 105.24 coo 58.59 41.80 18.81 58.94 43.89 18.94 -52.58 64.68 106.89 -53.21 62.78 107.37 coo 52.85 46.34 13.34 54.09 44.97 14.42 -46.62 67.79 110.40 -48.46 68.09 111.43 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 8 3 # 8 A 55 ASP A 210 ASP.? 21.69 CL CL A 383 A 58 ASP A 208 ASP.? 21.85 CL CL A 382 A 424 GLU A 276 GLU~? 16.10 CL CL A 383 coo 58.42 47.76 20.67 58.01 49.10 19.12 -52.58 64.68 106.89 -53.21 62.78 107.37 coo 58.59 41.80 18.81 58.94 43.89 18.94 -48.25 63.81 104.00 -49.74 63.21 105.24 coo 52.85 46.34 13.34 54.09 44.97 14.42 -46.62 67.79 110.40 -48.46 68.09 111.43 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 9 3 # 9 A 55 ASP B 26 ASP^? 16.51 CL CL B 383 A 58 ASP B 28 ASP^? 9.00 CL CL B 383 A 424 GLU B 332 GLU^? 14.76 CL CL B 383 coo 58.42 47.76 20.67 58.01 49.10 19.12 -23.45 39.33 83.60 -24.23 39.48 85.53 coo 58.59 41.80 18.81 58.94 43.89 18.94 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 52.85 46.34 13.34 54.09 44.97 14.42 -15.56 41.56 89.17 -16.27 39.59 89.11 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 10 3 # 10 A 55 ASP B 28 ASP^? 9.00 CL CL B 383 A 58 ASP B 26 ASP^? 16.51 CL CL B 383 A 424 GLU B 332 GLU^? 14.76 CL CL B 383 coo 58.42 47.76 20.67 58.01 49.10 19.12 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 58.59 41.80 18.81 58.94 43.89 18.94 -23.45 39.33 83.60 -24.23 39.48 85.53 coo 52.85 46.34 13.34 54.09 44.97 14.42 -15.56 41.56 89.17 -16.27 39.59 89.11 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 11 3 # 11 A 55 ASP B 28 ASP^? 9.00 CL CL B 383 A 58 ASP B 30 ASP^? -6.72 CL CL B 383s A 424 GLU B 332 GLU^? 14.76 CL CL B 383 coo 58.42 47.76 20.67 58.01 49.10 19.12 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 58.59 41.80 18.81 58.94 43.89 18.94 -11.77 37.20 80.70 -10.35 36.55 82.15 coo 52.85 46.34 13.34 54.09 44.97 14.42 -15.56 41.56 89.17 -16.27 39.59 89.11 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 12 3 # 12 A 55 ASP B 30 ASP^? -6.72 CL CL B 383s A 58 ASP B 28 ASP^? 9.00 CL CL B 383 A 424 GLU B 332 GLU^? 14.76 CL CL B 383 coo 58.42 47.76 20.67 58.01 49.10 19.12 -11.77 37.20 80.70 -10.35 36.55 82.15 coo 58.59 41.80 18.81 58.94 43.89 18.94 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 52.85 46.34 13.34 54.09 44.97 14.42 -15.56 41.56 89.17 -16.27 39.59 89.11 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 13 3 # 13 A 55 ASP B 36 ASP.? -3.35 CL CL B 383s A 58 ASP B 93 ASP^? 5.22 CL CL B 383 A 424 GLU B 169 GLU.? 11.31 CL CL B 383 coo 58.42 47.76 20.67 58.01 49.10 19.12 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 58.59 41.80 18.81 58.94 43.89 18.94 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 52.85 46.34 13.34 54.09 44.97 14.42 -9.49 44.22 70.62 -8.22 45.44 69.57 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 14 3 # 14 A 55 ASP B 93 ASP^? 5.22 CL CL B 383 A 58 ASP B 36 ASP.? -3.35 CL CL B 383s A 424 GLU B 169 GLU.? 11.31 CL CL B 383 coo 58.42 47.76 20.67 58.01 49.10 19.12 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 58.59 41.80 18.81 58.94 43.89 18.94 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 52.85 46.34 13.34 54.09 44.97 14.42 -9.49 44.22 70.62 -8.22 45.44 69.57 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 15 3 # 15 A 55 ASP B 208 ASP.? 21.56 CL CL B 383 A 58 ASP B 210 ASP.? 22.05 CL CL B 384 A 424 GLU B 276 GLU~? 15.94 CL CL B 384 coo 58.42 47.76 20.67 58.01 49.10 19.12 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 58.59 41.80 18.81 58.94 43.89 18.94 -2.53 25.11 93.69 -2.62 22.87 93.62 coo 52.85 46.34 13.34 54.09 44.97 14.42 -2.79 30.63 87.01 -2.36 28.59 86.68 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 16 3 # 16 A 55 ASP B 210 ASP.? 22.05 CL CL B 384 A 58 ASP B 208 ASP.? 21.56 CL CL B 383 A 424 GLU B 276 GLU~? 15.94 CL CL B 384 coo 58.42 47.76 20.67 58.01 49.10 19.12 -2.53 25.11 93.69 -2.62 22.87 93.62 coo 58.59 41.80 18.81 58.94 43.89 18.94 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 52.85 46.34 13.34 54.09 44.97 14.42 -2.79 30.63 87.01 -2.36 28.59 86.68 1js4_c00 source 1js4 ENDO-EXOCELLULASE E4 : 16 hits 1js4_c00 naa= 3 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 1 3 # 1 B 55 ASP A 26 ASP^? 16.59 CL CL A 382 B 58 ASP A 28 ASP^? 9.02 CL CL A 382 B 424 GLU A 332 GLU^? 14.84 CL CL A 382 coo 112.10 61.46 19.99 111.82 60.65 18.07 -29.69 53.68 115.80 -29.91 52.24 114.24 coo 117.85 63.62 21.08 115.96 63.25 20.18 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 118.47 57.23 15.57 119.32 58.77 16.73 -32.41 59.20 107.78 -33.78 57.91 108.78 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 2 3 # 2 B 55 ASP A 28 ASP^? 9.02 CL CL A 382 B 58 ASP A 26 ASP^? 16.59 CL CL A 382 B 424 GLU A 332 GLU^? 14.84 CL CL A 382 coo 112.10 61.46 19.99 111.82 60.65 18.07 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 117.85 63.62 21.08 115.96 63.25 20.18 -29.69 53.68 115.80 -29.91 52.24 114.24 coo 118.47 57.23 15.57 119.32 58.77 16.73 -32.41 59.20 107.78 -33.78 57.91 108.78 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 3 3 # 3 B 55 ASP A 28 ASP^? 9.02 CL CL A 382 B 58 ASP A 30 ASP^? -6.81 CL CL A 382s B 424 GLU A 332 GLU^? 14.84 CL CL A 382 coo 112.10 61.46 19.99 111.82 60.65 18.07 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 117.85 63.62 21.08 115.96 63.25 20.18 -35.52 64.63 115.87 -36.96 65.19 114.43 coo 118.47 57.23 15.57 119.32 58.77 16.73 -32.41 59.20 107.78 -33.78 57.91 108.78 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 4 3 # 4 B 55 ASP A 30 ASP^? -6.81 CL CL A 382s B 58 ASP A 28 ASP^? 9.02 CL CL A 382 B 424 GLU A 332 GLU^? 14.84 CL CL A 382 coo 112.10 61.46 19.99 111.82 60.65 18.07 -35.52 64.63 115.87 -36.96 65.19 114.43 coo 117.85 63.62 21.08 115.96 63.25 20.18 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 118.47 57.23 15.57 119.32 58.77 16.73 -32.41 59.20 107.78 -33.78 57.91 108.78 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 5 3 # 5 B 55 ASP A 36 ASP.? -3.33 CL CL A 382s B 58 ASP A 93 ASP^? 5.15 CL CL A 382 B 424 GLU A 169 GLU.? 11.07 CL CL A 382 coo 112.10 61.46 19.99 111.82 60.65 18.07 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 117.85 63.62 21.08 115.96 63.25 20.18 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 118.47 57.23 15.57 119.32 58.77 16.73 -27.31 72.85 122.01 -26.32 74.11 120.63 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 6 3 # 6 B 55 ASP A 208 ASP.? 21.85 CL CL A 382 B 58 ASP A 210 ASP.? 21.69 CL CL A 383 B 424 GLU A 276 GLU~? 16.10 CL CL A 383 coo 112.10 61.46 19.99 111.82 60.65 18.07 -48.25 63.81 104.00 -49.74 63.21 105.24 coo 117.85 63.62 21.08 115.96 63.25 20.18 -52.58 64.68 106.89 -53.21 62.78 107.37 coo 118.47 57.23 15.57 119.32 58.77 16.73 -46.62 67.79 110.40 -48.46 68.09 111.43 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 7 3 # 7 B 55 ASP A 210 ASP.? 21.69 CL CL A 383 B 58 ASP A 208 ASP.? 21.85 CL CL A 382 B 424 GLU A 276 GLU~? 16.10 CL CL A 383 coo 112.10 61.46 19.99 111.82 60.65 18.07 -52.58 64.68 106.89 -53.21 62.78 107.37 coo 117.85 63.62 21.08 115.96 63.25 20.18 -48.25 63.81 104.00 -49.74 63.21 105.24 coo 118.47 57.23 15.57 119.32 58.77 16.73 -46.62 67.79 110.40 -48.46 68.09 111.43 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 8 3 # 8 B 55 ASP B 26 ASP^? 16.51 CL CL B 383 B 58 ASP B 28 ASP^? 9.00 CL CL B 383 B 424 GLU B 332 GLU^? 14.76 CL CL B 383 coo 112.10 61.46 19.99 111.82 60.65 18.07 -23.45 39.33 83.60 -24.23 39.48 85.53 coo 117.85 63.62 21.08 115.96 63.25 20.18 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 118.47 57.23 15.57 119.32 58.77 16.73 -15.56 41.56 89.17 -16.27 39.59 89.11 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 9 3 # 9 B 55 ASP B 28 ASP^? 9.00 CL CL B 383 B 58 ASP B 26 ASP^? 16.51 CL CL B 383 B 424 GLU B 332 GLU^? 14.76 CL CL B 383 coo 112.10 61.46 19.99 111.82 60.65 18.07 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 117.85 63.62 21.08 115.96 63.25 20.18 -23.45 39.33 83.60 -24.23 39.48 85.53 coo 118.47 57.23 15.57 119.32 58.77 16.73 -15.56 41.56 89.17 -16.27 39.59 89.11 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 10 3 # 10 B 55 ASP B 28 ASP^? 9.00 CL CL B 383 B 58 ASP B 30 ASP^? -6.72 CL CL B 383s B 424 GLU B 332 GLU^? 14.76 CL CL B 383 coo 112.10 61.46 19.99 111.82 60.65 18.07 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 117.85 63.62 21.08 115.96 63.25 20.18 -11.77 37.20 80.70 -10.35 36.55 82.15 coo 118.47 57.23 15.57 119.32 58.77 16.73 -15.56 41.56 89.17 -16.27 39.59 89.11 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 11 3 # 11 B 55 ASP B 30 ASP^? -6.72 CL CL B 383s B 58 ASP B 28 ASP^? 9.00 CL CL B 383 B 424 GLU B 332 GLU^? 14.76 CL CL B 383 coo 112.10 61.46 19.99 111.82 60.65 18.07 -11.77 37.20 80.70 -10.35 36.55 82.15 coo 117.85 63.62 21.08 115.96 63.25 20.18 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 118.47 57.23 15.57 119.32 58.77 16.73 -15.56 41.56 89.17 -16.27 39.59 89.11 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 12 3 # 12 B 55 ASP B 36 ASP.? -3.35 CL CL B 383s B 58 ASP B 93 ASP^? 5.22 CL CL B 383 B 424 GLU B 169 GLU.? 11.31 CL CL B 383 coo 112.10 61.46 19.99 111.82 60.65 18.07 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 117.85 63.62 21.08 115.96 63.25 20.18 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 118.47 57.23 15.57 119.32 58.77 16.73 -9.49 44.22 70.62 -8.22 45.44 69.57 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 13 3 # 13 B 55 ASP B 93 ASP^? 5.22 CL CL B 383 B 58 ASP B 36 ASP.? -3.35 CL CL B 383s B 424 GLU B 169 GLU.? 11.31 CL CL B 383 coo 112.10 61.46 19.99 111.82 60.65 18.07 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 117.85 63.62 21.08 115.96 63.25 20.18 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 118.47 57.23 15.57 119.32 58.77 16.73 -9.49 44.22 70.62 -8.22 45.44 69.57 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 14 3 # 14 B 55 ASP B 208 ASP.? 21.56 CL CL B 383 B 58 ASP B 210 ASP.? 22.05 CL CL B 384 B 424 GLU B 276 GLU~? 15.94 CL CL B 384 coo 112.10 61.46 19.99 111.82 60.65 18.07 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 117.85 63.62 21.08 115.96 63.25 20.18 -2.53 25.11 93.69 -2.62 22.87 93.62 coo 118.47 57.23 15.57 119.32 58.77 16.73 -2.79 30.63 87.01 -2.36 28.59 86.68 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 15 3 # 15 B 55 ASP B 210 ASP.? 22.05 CL CL B 384 B 58 ASP B 208 ASP.? 21.56 CL CL B 383 B 424 GLU B 276 GLU~? 15.94 CL CL B 384 coo 112.10 61.46 19.99 111.82 60.65 18.07 -2.53 25.11 93.69 -2.62 22.87 93.62 coo 117.85 63.62 21.08 115.96 63.25 20.18 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 118.47 57.23 15.57 119.32 58.77 16.73 -2.79 30.63 87.01 -2.36 28.59 86.68 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 16 3 # 16 B 55 ASP B 306 ASP.? 19.57 CL CL A 384 B 58 ASP B 305 ASP^? 21.59 CL CL A 384 B 424 GLU B 307 GLU.? 20.03 CL CL A 384 coo 112.10 61.46 19.99 111.82 60.65 18.07 -4.64 54.84 103.01 -3.71 56.24 101.58 coo 117.85 63.62 21.08 115.96 63.25 20.18 -6.28 49.81 99.79 -7.51 49.10 101.38 coo 118.47 57.23 15.57 119.32 58.77 16.73 -8.15 49.66 106.11 -10.31 49.68 106.12 1js4_c01 source 1js4 ENDO-EXOCELLULASE E4 : 16 hits 1js4_c01 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU A 86 GLU^? 27.08 CL CL A 382 A 56 LYS A 80 LYS^? 36.93 CL CL A 382 A 258 ARG A 44 ARG.? 27.19 CL CL A 384 coo 42.33 1.56 26.99 42.38 2.91 28.66 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -26.02 34.53 124.81 -22.64 33.14 129.86 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -16.06 41.78 118.55 -16.27 43.65 116.05 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU A 86 GLU^? 27.08 CL CL A 382 A 56 LYS A 80 LYS^? 36.93 CL CL A 382 A 258 ARG A 325 ARG.? 29.26 CL CL A 384 coo 42.33 1.56 26.99 42.38 2.91 28.66 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -26.02 34.53 124.81 -22.64 33.14 129.86 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -22.19 42.21 111.60 -22.86 39.29 112.51 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 A 2 GLU B 86 GLU^? 25.45 CL CL B 382 A 56 LYS B 80 LYS^? 31.45 CL CL B 382 A 258 ARG B 325 ARG.? 19.88 CL CL B 382 coo 42.33 1.56 26.99 42.38 2.91 28.66 -37.46 36.82 83.59 -36.60 37.35 85.50 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -43.65 33.60 82.90 -47.69 34.28 78.00 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -34.83 46.46 90.24 -34.50 47.08 87.15 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 3 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU A 86 GLU^? 27.08 CL CL A 382 B 56 LYS A 80 LYS^? 36.93 CL CL A 382 B 258 ARG A 44 ARG.? 27.19 CL CL A 384 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -26.02 34.53 124.81 -22.64 33.14 129.86 coo 2.64 1.83 34.81 1.56 1.13 32.02 -16.06 41.78 118.55 -16.27 43.65 116.05 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU A 86 GLU^? 27.08 CL CL A 382 B 56 LYS A 80 LYS^? 36.93 CL CL A 382 B 258 ARG A 325 ARG.? 29.26 CL CL A 384 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -26.02 34.53 124.81 -22.64 33.14 129.86 coo 2.64 1.83 34.81 1.56 1.13 32.02 -22.19 42.21 111.60 -22.86 39.29 112.51 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 B 2 GLU B 86 GLU^? 25.45 CL CL B 382 B 56 LYS B 80 LYS^? 31.45 CL CL B 382 B 258 ARG B 325 ARG.? 19.88 CL CL B 382 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -37.46 36.82 83.59 -36.60 37.35 85.50 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -43.65 33.60 82.90 -47.69 34.28 78.00 coo 2.64 1.83 34.81 1.56 1.13 32.02 -34.83 46.46 90.24 -34.50 47.08 87.15 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 3 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU A 86 GLU^? 27.08 CL CL A 382 C 56 LYS A 80 LYS^? 36.93 CL CL A 382 C 258 ARG A 44 ARG.? 27.19 CL CL A 384 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -26.02 34.53 124.81 -22.64 33.14 129.86 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -16.06 41.78 118.55 -16.27 43.65 116.05 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU A 86 GLU^? 27.08 CL CL A 382 C 56 LYS A 80 LYS^? 36.93 CL CL A 382 C 258 ARG A 325 ARG.? 29.26 CL CL A 384 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -26.02 34.53 124.81 -22.64 33.14 129.86 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -22.19 42.21 111.60 -22.86 39.29 112.51 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 C 2 GLU B 86 GLU^? 25.45 CL CL B 382 C 56 LYS B 80 LYS^? 31.45 CL CL B 382 C 258 ARG B 325 ARG.? 19.88 CL CL B 382 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -37.46 36.82 83.59 -36.60 37.35 85.50 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -43.65 33.60 82.90 -47.69 34.28 78.00 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -34.83 46.46 90.24 -34.50 47.08 87.15 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 3 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU A 86 GLU^? 27.08 CL CL A 382 D 56 LYS A 80 LYS^? 36.93 CL CL A 382 D 258 ARG A 44 ARG.? 27.19 CL CL A 384 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -26.02 34.53 124.81 -22.64 33.14 129.86 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -16.06 41.78 118.55 -16.27 43.65 116.05 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU A 86 GLU^? 27.08 CL CL A 382 D 56 LYS A 80 LYS^? 36.93 CL CL A 382 D 258 ARG A 325 ARG.? 29.26 CL CL A 384 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -26.02 34.53 124.81 -22.64 33.14 129.86 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -22.19 42.21 111.60 -22.86 39.29 112.51 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 D 2 GLU B 86 GLU^? 25.45 CL CL B 382 D 56 LYS B 80 LYS^? 31.45 CL CL B 382 D 258 ARG B 325 ARG.? 19.88 CL CL B 382 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -37.46 36.82 83.59 -36.60 37.35 85.50 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -43.65 33.60 82.90 -47.69 34.28 78.00 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -34.83 46.46 90.24 -34.50 47.08 87.15 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 3 hits 1k82_c03 naa= 3 ULMN 3 1kim_c00 THYMIDINE KINASE user 1 3 # 1 A 83 GLU A 18 GLU^? 23.23 CL CL A 382 A 163 ARG A 13 ARG^? 21.22 CL CL A 382 A 222 ARG A 20 ARG.? 25.24 CL CL A 384 coo 51.27 81.34 48.31 51.67 80.79 50.28 -12.62 56.10 125.83 -13.81 57.82 125.60 coo 48.06 78.22 50.94 48.51 78.27 53.98 -15.61 60.27 127.72 -14.54 62.09 125.47 coo 54.85 84.16 52.60 54.26 81.23 53.34 -13.35 53.68 120.82 -11.33 55.30 122.50 ULMN 3 1kim_c00 THYMIDINE KINASE user 2 3 # 2 A 83 GLU A 18 GLU^? 23.23 CL CL A 382 A 163 ARG A 20 ARG.? 25.24 CL CL A 384 A 222 ARG A 13 ARG^? 21.22 CL CL A 382 coo 51.27 81.34 48.31 51.67 80.79 50.28 -12.62 56.10 125.83 -13.81 57.82 125.60 coo 48.06 78.22 50.94 48.51 78.27 53.98 -13.35 53.68 120.82 -11.33 55.30 122.50 coo 54.85 84.16 52.60 54.26 81.23 53.34 -15.61 60.27 127.72 -14.54 62.09 125.47 ULMN 3 1kim_c00 THYMIDINE KINASE user 3 3 # 3 A 83 GLU A 23 GLU.? 27.24 CL CL A 382 A 163 ARG A 24 ARG^? 24.95 CL CL A 382 A 222 ARG A 325 ARG.? 29.26 CL CL A 384 coo 51.27 81.34 48.31 51.67 80.79 50.28 -22.84 44.28 116.17 -23.55 42.53 115.22 coo 48.06 78.22 50.94 48.51 78.27 53.98 -27.53 46.21 115.11 -27.47 43.33 116.18 coo 54.85 84.16 52.60 54.26 81.23 53.34 -22.19 42.21 111.60 -22.86 39.29 112.51 ULMN 3 1kim_c00 THYMIDINE KINASE user 4 3 # 4 A 83 GLU A 23 GLU.? 27.24 CL CL A 382 A 163 ARG A 325 ARG.? 29.26 CL CL A 384 A 222 ARG A 24 ARG^? 24.95 CL CL A 382 coo 51.27 81.34 48.31 51.67 80.79 50.28 -22.84 44.28 116.17 -23.55 42.53 115.22 coo 48.06 78.22 50.94 48.51 78.27 53.98 -22.19 42.21 111.60 -22.86 39.29 112.51 coo 54.85 84.16 52.60 54.26 81.23 53.34 -27.53 46.21 115.11 -27.47 43.33 116.18 ULMN 3 1kim_c00 THYMIDINE KINASE user 5 3 # 5 A 83 GLU A 23 GLU.? 27.24 CL CL A 382 A 163 ARG A 325 ARG.? 29.26 CL CL A 384 A 222 ARG A 44 ARG.? 27.19 CL CL A 384 coo 51.27 81.34 48.31 51.67 80.79 50.28 -22.84 44.28 116.17 -23.55 42.53 115.22 coo 48.06 78.22 50.94 48.51 78.27 53.98 -22.19 42.21 111.60 -22.86 39.29 112.51 coo 54.85 84.16 52.60 54.26 81.23 53.34 -16.06 41.78 118.55 -16.27 43.65 116.05 ULMN 3 1kim_c00 THYMIDINE KINASE user 6 3 # 6 A 83 GLU A 332 GLU^? 14.84 CL CL A 382 A 163 ARG A 320 ARG^? 16.18 CL CL A 382 A 222 ARG A 319 ARG^? 9.49 CL CL A 382 coo 51.27 81.34 48.31 51.67 80.79 50.28 -32.41 59.20 107.78 -33.78 57.91 108.78 coo 48.06 78.22 50.94 48.51 78.27 53.98 -32.10 56.68 112.17 -32.95 53.99 110.90 coo 54.85 84.16 52.60 54.26 81.23 53.34 -27.23 63.29 112.77 -27.13 63.50 115.87 ULMN 3 1kim_c00 THYMIDINE KINASE user 7 3 # 7 A 83 GLU A 332 GLU^? 14.84 CL CL A 382 A 163 ARG A 334 ARG^? 9.67 CL CL A 382 A 222 ARG A 319 ARG^? 9.49 CL CL A 382 coo 51.27 81.34 48.31 51.67 80.79 50.28 -32.41 59.20 107.78 -33.78 57.91 108.78 coo 48.06 78.22 50.94 48.51 78.27 53.98 -35.93 61.76 109.91 -34.52 61.40 112.61 coo 54.85 84.16 52.60 54.26 81.23 53.34 -27.23 63.29 112.77 -27.13 63.50 115.87 ULMN 3 1kim_c00 THYMIDINE KINASE user 8 3 # 8 A 83 GLU B 18 GLU^? 5.91 CL CL B 382 A 163 ARG B 13 ARG^? 4.84 CL CL B 382 A 222 ARG B 20 ARG.? -3.56 CL CL B 382s coo 51.27 81.34 48.31 51.67 80.79 50.28 -29.91 50.09 69.26 -29.49 51.30 70.99 coo 48.06 78.22 50.94 48.51 78.27 53.98 -26.14 48.57 68.77 -25.79 51.69 68.63 coo 54.85 84.16 52.60 54.26 81.23 53.34 -30.86 53.38 73.69 -28.77 54.55 71.62 ULMN 3 1kim_c00 THYMIDINE KINASE user 9 3 # 9 A 83 GLU B 23 GLU.? 22.91 CL CL B 382 A 163 ARG B 24 ARG^? 24.13 CL CL B 382 A 222 ARG B 325 ARG.? 19.88 CL CL B 382 coo 51.27 81.34 48.31 51.67 80.79 50.28 -35.83 43.78 85.87 -35.49 42.75 87.75 coo 48.06 78.22 50.94 48.51 78.27 53.98 -30.86 40.03 86.77 -33.42 38.25 86.47 coo 54.85 84.16 52.60 54.26 81.23 53.34 -34.83 46.46 90.24 -34.50 47.08 87.15 ULMN 3 1kim_c00 THYMIDINE KINASE user 10 3 # 10 A 83 GLU B 23 GLU.? 22.91 CL CL B 382 A 163 ARG B 325 ARG.? 19.88 CL CL B 382 A 222 ARG B 24 ARG^? 24.13 CL CL B 382 coo 51.27 81.34 48.31 51.67 80.79 50.28 -35.83 43.78 85.87 -35.49 42.75 87.75 coo 48.06 78.22 50.94 48.51 78.27 53.98 -34.83 46.46 90.24 -34.50 47.08 87.15 coo 54.85 84.16 52.60 54.26 81.23 53.34 -30.86 40.03 86.77 -33.42 38.25 86.47 ULMN 3 1kim_c00 THYMIDINE KINASE user 11 3 # 11 A 83 GLU B 332 GLU^? 14.76 CL CL B 383 A 163 ARG B 320 ARG^? 13.22 CL CL B 383 A 222 ARG B 319 ARG^? 9.63 CL CL B 383 coo 51.27 81.34 48.31 51.67 80.79 50.28 -15.56 41.56 89.17 -16.27 39.59 89.11 coo 48.06 78.22 50.94 48.51 78.27 53.98 -19.20 39.56 86.12 -20.64 37.04 85.01 coo 54.85 84.16 52.60 54.26 81.23 53.34 -15.74 45.22 81.80 -15.96 44.19 78.93 ULMN 3 1kim_c00 THYMIDINE KINASE user 12 3 # 12 A 83 GLU B 332 GLU^? 14.76 CL CL B 383 A 163 ARG B 334 ARG^? 9.65 CL CL B 383 A 222 ARG B 319 ARG^? 9.63 CL CL B 383 coo 51.27 81.34 48.31 51.67 80.79 50.28 -15.56 41.56 89.17 -16.27 39.59 89.11 coo 48.06 78.22 50.94 48.51 78.27 53.98 -12.53 38.39 87.32 -14.06 38.36 84.61 coo 54.85 84.16 52.60 54.26 81.23 53.34 -15.74 45.22 81.80 -15.96 44.19 78.93 1kim_c00 source 1kim THYMIDINE KINASE : 12 hits 1kim_c00 naa= 3 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 1 3 # 1 A 290 ARG A 247 ARG.? 25.12 CL CL A 383 A 351 HIS A 246 HIS.? 33.92 CL CL A 383 A 386 LEU A 245 LEU.? 33.80 CL CL A 383 coo 57.36 53.34 128.83 58.45 50.56 128.34 -59.24 68.01 103.62 -57.26 66.97 105.71 coo 60.60 50.64 133.59 60.63 48.82 132.56 -65.97 72.19 102.08 -66.87 73.22 103.68 coo 63.28 54.23 126.45 63.53 52.07 126.70 -60.73 69.50 98.26 -60.25 67.84 96.92 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 2 3 # 2 A 290 ARG A 319 ARG^? 9.49 CL CL A 382 A 351 HIS A 287 HIS.? 12.74 CL CL A 384 A 386 LEU A 294 LEU.? 12.12 CL CL A 384 coo 57.36 53.34 128.83 58.45 50.56 128.34 -27.23 63.29 112.77 -27.13 63.50 115.87 coo 60.60 50.64 133.59 60.63 48.82 132.56 -21.23 59.04 111.08 -21.85 57.11 111.58 coo 63.28 54.23 126.45 63.53 52.07 126.70 -20.50 65.83 113.35 -19.19 64.29 114.19 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 3 3 # 3 A 290 ARG B 247 ARG.? 24.65 CL CL B 384 A 351 HIS B 246 HIS.? 32.95 CL CL B 384 A 386 LEU B 245 LEU.? 33.26 CL CL B 384 coo 57.36 53.34 128.83 58.45 50.56 128.34 4.27 22.84 96.19 1.85 22.99 94.25 coo 60.60 50.64 133.59 60.63 48.82 132.56 10.60 18.26 97.26 11.24 17.08 95.63 coo 63.28 54.23 126.45 63.53 52.07 126.70 7.68 23.61 100.52 6.42 24.38 102.12 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 4 3 # 4 A 290 ARG B 319 ARG^? 9.63 CL CL B 383 A 351 HIS B 287 HIS.? 13.85 CL CL B 382 A 386 LEU B 294 LEU.? 11.10 CL CL B 382 coo 57.36 53.34 128.83 58.45 50.56 128.34 -15.74 45.22 81.80 -15.96 44.19 78.93 coo 60.60 50.64 133.59 60.63 48.82 132.56 -21.22 50.04 83.35 -22.70 48.63 83.80 coo 63.28 54.23 126.45 63.53 52.07 126.70 -16.21 51.60 78.52 -18.22 51.84 77.89 1knp_c00 source 1knp L-ASPARTATE OXIDASE : 4 hits 1knp_c00 naa= 3 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 82 LYS.? 41.47 CL CL A 382 A 74 LYS A 80 LYS^? 36.93 CL CL A 382 A 165 GLU A 23 GLU.? 27.24 CL CL A 382 coo 24.97 5.82 58.78 26.79 1.97 55.46 -24.27 28.84 121.34 -24.33 26.99 125.88 coo 19.46 3.44 61.93 23.95 1.12 60.13 -26.02 34.53 124.81 -22.64 33.14 129.86 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -22.84 44.28 116.17 -23.55 42.53 115.22 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 109 LYS.? 23.73 CL CL A 383 A 74 LYS A 142 LYS.? 24.15 CL CL A 383 A 165 GLU A 146 GLU.? 12.63 CL CL A 383 coo 24.97 5.82 58.78 26.79 1.97 55.46 -45.10 86.58 132.81 -50.69 86.17 134.93 coo 19.46 3.44 61.93 23.95 1.12 60.13 -49.53 84.63 130.17 -55.13 85.19 133.14 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -52.58 70.92 131.34 -54.15 69.93 130.28 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS A 109 LYS.? 23.73 CL CL A 383 A 74 LYS A 142 LYS.? 24.15 CL CL A 383 A 165 GLU A 149 GLU.? 9.19 CL CL A 383 coo 24.97 5.82 58.78 26.79 1.97 55.46 -45.10 86.58 132.81 -50.69 86.17 134.93 coo 19.46 3.44 61.93 23.95 1.12 60.13 -49.53 84.63 130.17 -55.13 85.19 133.14 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -48.79 70.20 130.85 -48.75 71.87 129.52 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS B 82 LYS.? 37.97 CL CL B 382 A 74 LYS B 80 LYS^? 31.45 CL CL B 382 A 165 GLU B 23 GLU.? 22.91 CL CL B 382 coo 24.97 5.82 58.78 26.79 1.97 55.46 -48.91 34.74 87.29 -47.83 32.98 92.37 coo 19.46 3.44 61.93 23.95 1.12 60.13 -43.65 33.60 82.90 -47.69 34.28 78.00 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -35.83 43.78 85.87 -35.49 42.75 87.75 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS B 264 LYS~? 21.76 CL CL B 383 A 74 LYS B 268 LYS~? 13.29 CL CL B 383 A 165 GLU B 135 GLU.? 23.43 CL CL B 383 coo 24.97 5.82 58.78 26.79 1.97 55.46 11.01 31.36 75.69 9.79 34.42 71.26 coo 19.46 3.44 61.93 23.95 1.12 60.13 5.99 32.14 79.72 1.11 32.64 77.72 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 7.28 45.80 70.11 9.12 46.58 70.84 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 A 14 LYS B 268 LYS~? 13.29 CL CL B 383 A 74 LYS B 264 LYS~? 21.76 CL CL B 383 A 165 GLU B 135 GLU.? 23.43 CL CL B 383 coo 24.97 5.82 58.78 26.79 1.97 55.46 5.99 32.14 79.72 1.11 32.64 77.72 coo 19.46 3.44 61.93 23.95 1.12 60.13 11.01 31.36 75.69 9.79 34.42 71.26 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 7.28 45.80 70.11 9.12 46.58 70.84 1kqc_c00 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 6 hits 1kqc_c00 naa= 3 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 80 LYS^? 36.93 CL CL A 382 B 74 LYS A 82 LYS.? 41.47 CL CL A 382 B 165 GLU A 23 GLU.? 27.24 CL CL A 382 coo 4.84 5.09 23.75 3.30 1.39 27.48 -26.02 34.53 124.81 -22.64 33.14 129.86 coo 10.43 2.88 20.75 5.72 0.41 23.95 -24.27 28.84 121.34 -24.33 26.99 125.88 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -22.84 44.28 116.17 -23.55 42.53 115.22 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 82 LYS.? 41.47 CL CL A 382 B 74 LYS A 80 LYS^? 36.93 CL CL A 382 B 165 GLU A 23 GLU.? 27.24 CL CL A 382 coo 4.84 5.09 23.75 3.30 1.39 27.48 -24.27 28.84 121.34 -24.33 26.99 125.88 coo 10.43 2.88 20.75 5.72 0.41 23.95 -26.02 34.53 124.81 -22.64 33.14 129.86 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -22.84 44.28 116.17 -23.55 42.53 115.22 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS A 109 LYS.? 23.73 CL CL A 383 B 74 LYS A 142 LYS.? 24.15 CL CL A 383 B 165 GLU A 149 GLU.? 9.19 CL CL A 383 coo 4.84 5.09 23.75 3.30 1.39 27.48 -45.10 86.58 132.81 -50.69 86.17 134.93 coo 10.43 2.88 20.75 5.72 0.41 23.95 -49.53 84.63 130.17 -55.13 85.19 133.14 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -48.79 70.20 130.85 -48.75 71.87 129.52 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS B 82 LYS.? 37.97 CL CL B 382 B 74 LYS B 80 LYS^? 31.45 CL CL B 382 B 165 GLU B 23 GLU.? 22.91 CL CL B 382 coo 4.84 5.09 23.75 3.30 1.39 27.48 -48.91 34.74 87.29 -47.83 32.98 92.37 coo 10.43 2.88 20.75 5.72 0.41 23.95 -43.65 33.60 82.90 -47.69 34.28 78.00 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 -35.83 43.78 85.87 -35.49 42.75 87.75 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 B 14 LYS B 264 LYS~? 21.76 CL CL B 383 B 74 LYS B 268 LYS~? 13.29 CL CL B 383 B 165 GLU B 135 GLU.? 23.43 CL CL B 383 coo 4.84 5.09 23.75 3.30 1.39 27.48 11.01 31.36 75.69 9.79 34.42 71.26 coo 10.43 2.88 20.75 5.72 0.41 23.95 5.99 32.14 79.72 1.11 32.64 77.72 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 7.28 45.80 70.11 9.12 46.58 70.84 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 B 14 LYS B 268 LYS~? 13.29 CL CL B 383 B 74 LYS B 264 LYS~? 21.76 CL CL B 383 B 165 GLU B 135 GLU.? 23.43 CL CL B 383 coo 4.84 5.09 23.75 3.30 1.39 27.48 5.99 32.14 79.72 1.11 32.64 77.72 coo 10.43 2.88 20.75 5.72 0.41 23.95 11.01 31.36 75.69 9.79 34.42 71.26 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 7.28 45.80 70.11 9.12 46.58 70.84 1kqc_c01 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 6 hits 1kqc_c01 naa= 3 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 C 14 LYS A 80 LYS^? 36.93 CL CL A 382 C 74 LYS A 82 LYS.? 41.47 CL CL A 382 C 165 GLU A 23 GLU.? 27.24 CL CL A 382 coo 17.59 37.25 25.80 19.64 34.15 21.60 -26.02 34.53 124.81 -22.64 33.14 129.86 coo 12.29 34.52 28.11 16.84 32.47 25.43 -24.27 28.84 121.34 -24.33 26.99 125.88 coo 12.06 27.10 15.56 13.23 27.02 13.80 -22.84 44.28 116.17 -23.55 42.53 115.22 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 C 14 LYS A 82 LYS.? 41.47 CL CL A 382 C 74 LYS A 80 LYS^? 36.93 CL CL A 382 C 165 GLU A 23 GLU.? 27.24 CL CL A 382 coo 17.59 37.25 25.80 19.64 34.15 21.60 -24.27 28.84 121.34 -24.33 26.99 125.88 coo 12.29 34.52 28.11 16.84 32.47 25.43 -26.02 34.53 124.81 -22.64 33.14 129.86 coo 12.06 27.10 15.56 13.23 27.02 13.80 -22.84 44.28 116.17 -23.55 42.53 115.22 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 C 14 LYS A 109 LYS.? 23.73 CL CL A 383 C 74 LYS A 142 LYS.? 24.15 CL CL A 383 C 165 GLU A 149 GLU.? 9.19 CL CL A 383 coo 17.59 37.25 25.80 19.64 34.15 21.60 -45.10 86.58 132.81 -50.69 86.17 134.93 coo 12.29 34.52 28.11 16.84 32.47 25.43 -49.53 84.63 130.17 -55.13 85.19 133.14 coo 12.06 27.10 15.56 13.23 27.02 13.80 -48.79 70.20 130.85 -48.75 71.87 129.52 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 C 14 LYS B 82 LYS.? 37.97 CL CL B 382 C 74 LYS B 80 LYS^? 31.45 CL CL B 382 C 165 GLU B 23 GLU.? 22.91 CL CL B 382 coo 17.59 37.25 25.80 19.64 34.15 21.60 -48.91 34.74 87.29 -47.83 32.98 92.37 coo 12.29 34.52 28.11 16.84 32.47 25.43 -43.65 33.60 82.90 -47.69 34.28 78.00 coo 12.06 27.10 15.56 13.23 27.02 13.80 -35.83 43.78 85.87 -35.49 42.75 87.75 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 C 14 LYS B 109 LYS.? 27.05 CL CL B 384 C 74 LYS B 142 LYS.? 25.17 CL CL B 384 C 165 GLU B 149 GLU.? 9.91 CL CL B 384 coo 17.59 37.25 25.80 19.64 34.15 21.60 5.83 26.41 59.87 10.67 23.27 57.97 coo 12.29 34.52 28.11 16.84 32.47 25.43 6.28 23.32 63.35 7.97 19.73 58.68 coo 12.06 27.10 15.56 13.23 27.02 13.80 -6.14 20.54 69.48 -4.10 21.06 69.10 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 C 14 LYS B 142 LYS.? 25.17 CL CL B 384 C 74 LYS B 109 LYS.? 27.05 CL CL B 384 C 165 GLU B 149 GLU.? 9.91 CL CL B 384 coo 17.59 37.25 25.80 19.64 34.15 21.60 6.28 23.32 63.35 7.97 19.73 58.68 coo 12.29 34.52 28.11 16.84 32.47 25.43 5.83 26.41 59.87 10.67 23.27 57.97 coo 12.06 27.10 15.56 13.23 27.02 13.80 -6.14 20.54 69.48 -4.10 21.06 69.10 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 C 14 LYS B 268 LYS~? 13.29 CL CL B 383 C 74 LYS B 264 LYS~? 21.76 CL CL B 383 C 165 GLU B 135 GLU.? 23.43 CL CL B 383 coo 17.59 37.25 25.80 19.64 34.15 21.60 5.99 32.14 79.72 1.11 32.64 77.72 coo 12.29 34.52 28.11 16.84 32.47 25.43 11.01 31.36 75.69 9.79 34.42 71.26 coo 12.06 27.10 15.56 13.23 27.02 13.80 7.28 45.80 70.11 9.12 46.58 70.84 1kqc_c02 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 7 hits 1kqc_c02 naa= 3 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 D 14 LYS A 80 LYS^? 36.93 CL CL A 382 D 74 LYS A 82 LYS.? 41.47 CL CL A 382 D 165 GLU A 23 GLU.? 27.24 CL CL A 382 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -26.02 34.53 124.81 -22.64 33.14 129.86 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -24.27 28.84 121.34 -24.33 26.99 125.88 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -22.84 44.28 116.17 -23.55 42.53 115.22 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 D 14 LYS A 82 LYS.? 41.47 CL CL A 382 D 74 LYS A 80 LYS^? 36.93 CL CL A 382 D 165 GLU A 23 GLU.? 27.24 CL CL A 382 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -24.27 28.84 121.34 -24.33 26.99 125.88 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -26.02 34.53 124.81 -22.64 33.14 129.86 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -22.84 44.28 116.17 -23.55 42.53 115.22 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 D 14 LYS A 109 LYS.? 23.73 CL CL A 383 D 74 LYS A 142 LYS.? 24.15 CL CL A 383 D 165 GLU A 149 GLU.? 9.19 CL CL A 383 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -45.10 86.58 132.81 -50.69 86.17 134.93 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -49.53 84.63 130.17 -55.13 85.19 133.14 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -48.79 70.20 130.85 -48.75 71.87 129.52 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 D 14 LYS B 82 LYS.? 37.97 CL CL B 382 D 74 LYS B 80 LYS^? 31.45 CL CL B 382 D 165 GLU B 23 GLU.? 22.91 CL CL B 382 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -48.91 34.74 87.29 -47.83 32.98 92.37 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -43.65 33.60 82.90 -47.69 34.28 78.00 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 -35.83 43.78 85.87 -35.49 42.75 87.75 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 D 14 LYS B 268 LYS~? 13.29 CL CL B 383 D 74 LYS B 264 LYS~? 21.76 CL CL B 383 D 165 GLU B 135 GLU.? 23.43 CL CL B 383 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 5.99 32.14 79.72 1.11 32.64 77.72 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 11.01 31.36 75.69 9.79 34.42 71.26 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 7.28 45.80 70.11 9.12 46.58 70.84 1kqc_c03 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 5 hits 1kqc_c03 naa= 3 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 1 3 # 1 A 94 LYS A 288 LYS.? 12.57 CL CL A 384 A 197 HIS A 21 HIS.? 26.92 CL CL A 384 A 446 ARG A 20 ARG.? 25.24 CL CL A 384 coo 3.26 62.02 109.14 4.83 57.73 107.38 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 9.48 43.28 113.60 10.05 44.21 111.80 -13.56 47.86 119.72 -11.56 48.42 120.07 coo 12.14 46.28 115.16 13.57 43.60 115.68 -13.35 53.68 120.82 -11.33 55.30 122.50 1kqf_c03 source 1kqf FORMATE DEHYDROGENASE, NITRATE-INDUCIBLE, CYTO: 1 hits 1kqf_c03 naa= 3 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 1 3 # 1 255 ASP A 64 ASP.? 15.21 CL CL A 384 262 LYS A 288 LYS.? 12.57 CL CL A 384 336 ARG B 193 ARG.? 19.02 CL CL A 384 coo 61.88 50.78 12.96 63.84 50.60 13.71 -13.50 61.63 115.26 -13.45 60.20 113.75 coo 63.59 44.40 18.32 63.20 49.74 17.95 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 72.60 57.42 15.86 71.61 56.68 18.70 -14.12 50.83 106.82 -12.70 50.89 109.57 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 2 3 # 2 255 ASP A 171 ASP.? 13.95 CL CL A 382 262 LYS A 128 LYS.? 19.46 CL CL A 382 336 ARG A 13 ARG^? 21.22 CL CL A 382 coo 61.88 50.78 12.96 63.84 50.60 13.71 -21.72 70.05 125.28 -22.57 71.99 125.28 coo 63.59 44.40 18.32 63.20 49.74 17.95 -25.12 72.76 133.10 -20.68 68.32 134.09 coo 72.60 57.42 15.86 71.61 56.68 18.70 -15.61 60.27 127.72 -14.54 62.09 125.47 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 3 3 # 3 255 ASP A 272 ASP~? 14.48 CL CL A 382 262 LYS A 267 LYS~? 27.66 CL CL A 382 336 ARG A 212 ARG.? 30.01 CL CL A 382 coo 61.88 50.78 12.96 63.84 50.60 13.71 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 63.59 44.40 18.32 63.20 49.74 17.95 -49.43 81.28 111.60 -49.39 86.78 108.40 coo 72.60 57.42 15.86 71.61 56.68 18.70 -52.31 71.44 100.68 -54.00 71.15 98.10 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 4 3 # 4 255 ASP B 64 ASP.? 7.14 CL CL B 382 262 LYS B 288 LYS.? 8.84 CL CL B 382 336 ARG A 193 ARG.? 15.01 CL CL B 382 coo 61.88 50.78 12.96 63.84 50.60 13.71 -22.24 55.99 77.05 -23.77 56.03 78.56 coo 63.59 44.40 18.32 63.20 49.74 17.95 -16.76 54.22 83.25 -20.62 56.75 78.99 coo 72.60 57.42 15.86 71.61 56.68 18.70 -30.19 56.43 87.97 -31.59 55.92 85.25 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 5 3 # 5 255 ASP B 171 ASP.? 13.77 CL CL B 383 262 LYS B 128 LYS.? 19.37 CL CL B 383 336 ARG B 13 ARG^? 4.84 CL CL B 382 coo 61.88 50.78 12.96 63.84 50.60 13.71 -14.88 46.75 66.62 -12.79 46.40 66.16 coo 63.59 44.40 18.32 63.20 49.74 17.95 -13.49 41.25 59.55 -18.50 40.98 58.08 coo 72.60 57.42 15.86 71.61 56.68 18.70 -26.14 48.57 68.77 -25.79 51.69 68.63 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 6 3 # 6 255 ASP B 272 ASP~? 14.11 CL CL B 383 262 LYS B 267 LYS~? 27.57 CL CL B 383 336 ARG B 212 ARG.? 28.47 CL CL B 383 coo 61.88 50.78 12.96 63.84 50.60 13.71 0.88 31.47 82.51 1.09 32.47 80.67 coo 63.59 44.40 18.32 63.20 49.74 17.95 9.46 31.45 81.02 15.36 33.08 81.01 coo 72.60 57.42 15.86 71.61 56.68 18.70 3.61 30.30 95.57 4.45 30.88 98.48 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 7 3 # 7 255 ASP B 291 ASP.? 20.64 CL CL B 382 262 LYS B 288 LYS.? 8.84 CL CL B 382 336 ARG B 197 ARG.? 10.56 CL CL A 384 coo 61.88 50.78 12.96 63.84 50.60 13.71 -11.26 60.51 82.59 -9.94 61.37 84.03 coo 63.59 44.40 18.32 63.20 49.74 17.95 -16.76 54.22 83.25 -20.62 56.75 78.99 coo 72.60 57.42 15.86 71.61 56.68 18.70 -11.56 63.68 96.52 -11.06 66.80 96.90 1lam_c00 source 1lam LEUCINE AMINOPEPTIDASE : 7 hits 1lam_c00 naa= 3 ULMN 3 1lci_c00 LUCIFERASE user 1 3 # 1 218 ARG A 24 ARG^? 24.95 CL CL A 382 245 HIS A 287 HIS.? 12.74 CL CL A 384 343 THR A 329 THR^? 14.14 CL CL A 384 coo 18.11 85.25 41.19 18.04 83.33 43.59 -27.53 46.21 115.11 -27.47 43.33 116.18 coo 5.34 86.23 43.48 6.16 87.26 45.12 -21.23 59.04 111.08 -21.85 57.11 111.58 coo 9.06 92.76 42.80 7.04 92.63 42.14 -21.38 53.78 108.30 -19.71 54.59 109.49 ULMN 3 1lci_c00 LUCIFERASE user 2 3 # 2 218 ARG A 212 ARG.? 30.01 CL CL A 382 245 HIS A 246 HIS.? 33.92 CL CL A 383 343 THR A 244 THR.? 37.53 CL CL A 382 coo 18.11 85.25 41.19 18.04 83.33 43.59 -52.31 71.44 100.68 -54.00 71.15 98.10 coo 5.34 86.23 43.48 6.16 87.26 45.12 -65.97 72.19 102.08 -66.87 73.22 103.68 coo 9.06 92.76 42.80 7.04 92.63 42.14 -60.54 73.51 95.50 -59.95 72.82 93.56 ULMN 3 1lci_c00 LUCIFERASE user 3 3 # 3 218 ARG A 290 ARG.? -7.44 CL CL A 384s 245 HIS A 287 HIS.? 12.74 CL CL A 384 343 THR B 194 THR.? 12.32 CL CL A 384 coo 18.11 85.25 41.19 18.04 83.33 43.59 -15.77 66.49 99.38 -13.63 64.23 99.65 coo 5.34 86.23 43.48 6.16 87.26 45.12 -21.23 59.04 111.08 -21.85 57.11 111.58 coo 9.06 92.76 42.80 7.04 92.63 42.14 -14.07 57.99 105.37 -12.38 58.46 106.64 ULMN 3 1lci_c00 LUCIFERASE user 4 3 # 4 218 ARG A 320 ARG^? 16.18 CL CL A 382 245 HIS A 287 HIS.? 12.74 CL CL A 384 343 THR A 329 THR^? 14.14 CL CL A 384 coo 18.11 85.25 41.19 18.04 83.33 43.59 -32.10 56.68 112.17 -32.95 53.99 110.90 coo 5.34 86.23 43.48 6.16 87.26 45.12 -21.23 59.04 111.08 -21.85 57.11 111.58 coo 9.06 92.76 42.80 7.04 92.63 42.14 -21.38 53.78 108.30 -19.71 54.59 109.49 ULMN 3 1lci_c00 LUCIFERASE user 5 3 # 5 218 ARG A 334 ARG^? 9.67 CL CL A 382 245 HIS A 287 HIS.? 12.74 CL CL A 384 343 THR A 331 THR^? 10.31 CL CL A 384 coo 18.11 85.25 41.19 18.04 83.33 43.59 -35.93 61.76 109.91 -34.52 61.40 112.61 coo 5.34 86.23 43.48 6.16 87.26 45.12 -21.23 59.04 111.08 -21.85 57.11 111.58 coo 9.06 92.76 42.80 7.04 92.63 42.14 -26.18 59.17 108.07 -25.19 60.90 109.06 ULMN 3 1lci_c00 LUCIFERASE user 6 3 # 6 218 ARG B 24 ARG^? 24.13 CL CL B 382 245 HIS B 287 HIS.? 13.85 CL CL B 382 343 THR B 329 THR^? 15.42 CL CL B 382 coo 18.11 85.25 41.19 18.04 83.33 43.59 -30.86 40.03 86.77 -33.42 38.25 86.47 coo 5.34 86.23 43.48 6.16 87.26 45.12 -21.22 50.04 83.35 -22.70 48.63 83.80 coo 9.06 92.76 42.80 7.04 92.63 42.14 -24.83 49.33 87.66 -25.34 51.01 86.38 ULMN 3 1lci_c00 LUCIFERASE user 7 3 # 7 218 ARG B 212 ARG.? 28.47 CL CL B 383 245 HIS B 246 HIS.? 32.95 CL CL B 384 343 THR B 244 THR.? 36.65 CL CL B 383 coo 18.11 85.25 41.19 18.04 83.33 43.59 3.61 30.30 95.57 4.45 30.88 98.48 coo 5.34 86.23 43.48 6.16 87.26 45.12 10.60 18.26 97.26 11.24 17.08 95.63 coo 9.06 92.76 42.80 7.04 92.63 42.14 11.74 26.22 101.11 11.25 27.41 102.85 ULMN 3 1lci_c00 LUCIFERASE user 8 3 # 8 218 ARG B 290 ARG.? 12.49 CL CL A 384 245 HIS B 287 HIS.? 13.85 CL CL B 382 343 THR A 194 THR.? 13.30 CL CL B 382 coo 18.11 85.25 41.19 18.04 83.33 43.59 -13.01 59.15 90.41 -14.60 61.38 91.89 coo 5.34 86.23 43.48 6.16 87.26 45.12 -21.22 50.04 83.35 -22.70 48.63 83.80 coo 9.06 92.76 42.80 7.04 92.63 42.14 -23.53 58.32 86.21 -24.61 58.92 84.44 ULMN 3 1lci_c00 LUCIFERASE user 9 3 # 9 218 ARG B 290 ARG.? 12.49 CL CL A 384 245 HIS B 287 HIS.? 13.85 CL CL B 382 343 THR B 331 THR^? 16.17 CL CL B 383 coo 18.11 85.25 41.19 18.04 83.33 43.59 -13.01 59.15 90.41 -14.60 61.38 91.89 coo 5.34 86.23 43.48 6.16 87.26 45.12 -21.22 50.04 83.35 -22.70 48.63 83.80 coo 9.06 92.76 42.80 7.04 92.63 42.14 -18.10 46.86 87.19 -17.24 47.80 85.43 ULMN 3 1lci_c00 LUCIFERASE user 10 3 # 10 218 ARG B 320 ARG^? 13.22 CL CL B 383 245 HIS B 287 HIS.? 13.85 CL CL B 382 343 THR B 329 THR^? 15.42 CL CL B 382 coo 18.11 85.25 41.19 18.04 83.33 43.59 -19.20 39.56 86.12 -20.64 37.04 85.01 coo 5.34 86.23 43.48 6.16 87.26 45.12 -21.22 50.04 83.35 -22.70 48.63 83.80 coo 9.06 92.76 42.80 7.04 92.63 42.14 -24.83 49.33 87.66 -25.34 51.01 86.38 1lci_c00 source 1lci LUCIFERASE : 10 hits 1lci_c00 naa= 3 ULMN 3 1lij_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 35 ALA.? 6.30 CL CL A 382 A 317 GLY A 96 GLY~? 8.65 CL CL A 383 A 318 ASP A 93 ASP^? 5.15 CL CL A 382 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -35.44 63.33 123.80 -35.72 62.35 124.94 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -35.37 62.51 129.12 -35.27 63.21 129.50 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1lij_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA A 95 ALA~? 5.86 CL CL A 382 A 317 GLY A 96 GLY~? 8.65 CL CL A 383 A 318 ASP A 93 ASP^? 5.15 CL CL A 382 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -34.32 65.97 127.91 -34.72 66.23 126.45 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -35.37 62.51 129.12 -35.27 63.21 129.50 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1lij_c01 ADENOSINE KINASE user 3 3 # 3 A 316 ALA B 35 ALA.? 6.30 CL CL B 383 A 317 GLY B 96 GLY~? 8.80 CL CL B 384 A 318 ASP B 93 ASP^? 5.22 CL CL B 383 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -15.02 33.54 74.31 -16.10 32.59 73.63 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -17.52 31.23 69.94 -17.03 31.31 69.27 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1lij_c01 ADENOSINE KINASE user 4 3 # 4 A 316 ALA B 95 ALA~? 5.98 CL CL B 383 A 317 GLY B 96 GLY~? 8.80 CL CL B 384 A 318 ASP B 93 ASP^? 5.22 CL CL B 383 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -14.44 33.46 69.35 -13.59 33.72 70.62 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -17.52 31.23 69.94 -17.03 31.31 69.27 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -17.13 37.76 71.68 -15.50 36.45 72.23 1lij_c01 source 1lij ADENOSINE KINASE : 4 hits 1lij_c01 naa= 3 ULMN 3 1lio_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 35 ALA.? 6.30 CL CL A 382 A 317 GLY A 96 GLY~? 8.65 CL CL A 383 A 318 ASP A 93 ASP^? 5.15 CL CL A 382 coo 27.04 23.54 41.85 25.72 24.19 42.18 -35.44 63.33 123.80 -35.72 62.35 124.94 coo 27.87 23.16 38.17 28.43 22.97 38.87 -35.37 62.51 129.12 -35.27 63.21 129.50 coo 32.11 22.71 40.58 33.42 24.22 39.78 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1lio_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA A 95 ALA~? 5.86 CL CL A 382 A 317 GLY A 96 GLY~? 8.65 CL CL A 383 A 318 ASP A 93 ASP^? 5.15 CL CL A 382 coo 27.04 23.54 41.85 25.72 24.19 42.18 -34.32 65.97 127.91 -34.72 66.23 126.45 coo 27.87 23.16 38.17 28.43 22.97 38.87 -35.37 62.51 129.12 -35.27 63.21 129.50 coo 32.11 22.71 40.58 33.42 24.22 39.78 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1lio_c01 ADENOSINE KINASE user 3 3 # 3 A 316 ALA B 35 ALA.? 6.30 CL CL B 383 A 317 GLY B 96 GLY~? 8.80 CL CL B 384 A 318 ASP B 93 ASP^? 5.22 CL CL B 383 coo 27.04 23.54 41.85 25.72 24.19 42.18 -15.02 33.54 74.31 -16.10 32.59 73.63 coo 27.87 23.16 38.17 28.43 22.97 38.87 -17.52 31.23 69.94 -17.03 31.31 69.27 coo 32.11 22.71 40.58 33.42 24.22 39.78 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1lio_c01 ADENOSINE KINASE user 4 3 # 4 A 316 ALA B 95 ALA~? 5.98 CL CL B 383 A 317 GLY B 96 GLY~? 8.80 CL CL B 384 A 318 ASP B 93 ASP^? 5.22 CL CL B 383 coo 27.04 23.54 41.85 25.72 24.19 42.18 -14.44 33.46 69.35 -13.59 33.72 70.62 coo 27.87 23.16 38.17 28.43 22.97 38.87 -17.52 31.23 69.94 -17.03 31.31 69.27 coo 32.11 22.71 40.58 33.42 24.22 39.78 -17.13 37.76 71.68 -15.50 36.45 72.23 1lio_c01 source 1lio ADENOSINE KINASE : 4 hits 1lio_c01 naa= 3 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 180 ASP.? 19.13 CL CL A 382 A 295 GLU A 135 GLU.? 22.99 CL CL A 382 A 369 ASP A 344 ASP.? 20.56 CL CL A 382 coo 11.74 38.14 80.19 10.63 36.40 80.65 -29.53 80.77 112.24 -28.62 82.54 111.55 coo 16.11 33.72 80.99 14.10 33.54 81.63 -31.98 87.75 115.72 -30.11 88.72 115.32 coo 12.19 31.08 87.29 11.13 32.66 86.38 -40.03 84.87 115.12 -41.94 84.93 114.19 1m53_c03 source 1m53 ISOMALTULOSE SYNTHASE : 1 hits 1m53_c03 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 28 ASP^? 9.02 CL CL A 382 A 265 GLU A 60 GLU^? 17.84 CL CL A 382 A 369 ASP A 39 ASP^? 16.51 CL CL A 382 coo 11.74 38.14 80.19 10.63 36.40 80.65 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 17.36 23.57 72.04 18.68 21.92 71.98 -20.60 62.82 127.64 -18.87 63.84 128.41 coo 12.19 31.08 87.29 11.13 32.66 86.38 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 36 ASP.? -3.33 CL CL A 382s A 265 GLU A 57 GLU.? 23.36 CL CL A 382 A 369 ASP A 39 ASP^? 16.51 CL CL A 382 coo 11.74 38.14 80.19 10.63 36.40 80.65 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 17.36 23.57 72.04 18.68 21.92 71.98 -23.46 53.73 134.86 -22.94 54.54 136.68 coo 12.19 31.08 87.29 11.13 32.66 86.38 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 39 ASP^? 16.51 CL CL A 382 A 265 GLU A 57 GLU.? 23.36 CL CL A 382 A 369 ASP A 36 ASP.? -3.33 CL CL A 382s coo 11.74 38.14 80.19 10.63 36.40 80.65 -29.94 52.12 119.85 -30.97 50.72 120.81 coo 17.36 23.57 72.04 18.68 21.92 71.98 -23.46 53.73 134.86 -22.94 54.54 136.68 coo 12.19 31.08 87.29 11.13 32.66 86.38 -31.47 63.24 120.93 -31.90 65.07 119.91 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP A 39 ASP^? 16.51 CL CL A 382 A 265 GLU A 60 GLU^? 17.84 CL CL A 382 A 369 ASP A 28 ASP^? 9.02 CL CL A 382 coo 11.74 38.14 80.19 10.63 36.40 80.65 -29.94 52.12 119.85 -30.97 50.72 120.81 coo 17.36 23.57 72.04 18.68 21.92 71.98 -20.60 62.82 127.64 -18.87 63.84 128.41 coo 12.19 31.08 87.29 11.13 32.66 86.38 -32.19 59.08 116.32 -33.48 59.98 114.85 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP A 93 ASP^? 5.15 CL CL A 382 A 265 GLU A 18 GLU^? 23.23 CL CL A 382 A 369 ASP A 171 ASP.? 13.95 CL CL A 382 coo 11.74 38.14 80.19 10.63 36.40 80.65 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 17.36 23.57 72.04 18.68 21.92 71.98 -12.62 56.10 125.83 -13.81 57.82 125.60 coo 12.19 31.08 87.29 11.13 32.66 86.38 -21.72 70.05 125.28 -22.57 71.99 125.28 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP A 93 ASP^? 5.15 CL CL A 382 A 265 GLU A 57 GLU.? 23.36 CL CL A 382 A 369 ASP A 171 ASP.? 13.95 CL CL A 382 coo 11.74 38.14 80.19 10.63 36.40 80.65 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 17.36 23.57 72.04 18.68 21.92 71.98 -23.46 53.73 134.86 -22.94 54.54 136.68 coo 12.19 31.08 87.29 11.13 32.66 86.38 -21.72 70.05 125.28 -22.57 71.99 125.28 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP A 171 ASP.? 13.95 CL CL A 382 A 265 GLU A 18 GLU^? 23.23 CL CL A 382 A 369 ASP A 93 ASP^? 5.15 CL CL A 382 coo 11.74 38.14 80.19 10.63 36.40 80.65 -21.72 70.05 125.28 -22.57 71.99 125.28 coo 17.36 23.57 72.04 18.68 21.92 71.98 -12.62 56.10 125.83 -13.81 57.82 125.60 coo 12.19 31.08 87.29 11.13 32.66 86.38 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP A 180 ASP.? 19.13 CL CL A 382 A 265 GLU A 337 GLU^? 21.89 CL CL A 382 A 369 ASP A 344 ASP.? 20.56 CL CL A 382 coo 11.74 38.14 80.19 10.63 36.40 80.65 -29.53 80.77 112.24 -28.62 82.54 111.55 coo 17.36 23.57 72.04 18.68 21.92 71.98 -40.07 74.65 102.17 -42.10 75.18 101.81 coo 12.19 31.08 87.29 11.13 32.66 86.38 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 9 3 # 9 A 241 ASP A 305 ASP^? 16.01 CL CL A 384 A 265 GLU A 337 GLU^? 21.89 CL CL A 382 A 369 ASP A 204 ASP^? 18.76 CL CL A 384 coo 11.74 38.14 80.19 10.63 36.40 80.65 -32.01 65.22 92.45 -32.49 63.34 91.63 coo 17.36 23.57 72.04 18.68 21.92 71.98 -40.07 74.65 102.17 -42.10 75.18 101.81 coo 12.19 31.08 87.29 11.13 32.66 86.38 -37.06 58.40 100.88 -36.30 56.45 100.53 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 10 3 # 10 A 241 ASP A 306 ASP.? 16.66 CL CL A 384 A 265 GLU A 201 GLU.? 12.07 CL CL A 384 A 369 ASP A 311 ASP^? 15.19 CL CL A 384 coo 11.74 38.14 80.19 10.63 36.40 80.65 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 17.36 23.57 72.04 18.68 21.92 71.98 -24.87 56.03 99.70 -24.21 54.93 101.40 coo 12.19 31.08 87.29 11.13 32.66 86.38 -31.19 72.86 91.72 -29.44 73.97 92.12 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 11 3 # 11 A 241 ASP A 344 ASP.? 20.56 CL CL A 382 A 265 GLU A 337 GLU^? 21.89 CL CL A 382 A 369 ASP A 180 ASP.? 19.13 CL CL A 382 coo 11.74 38.14 80.19 10.63 36.40 80.65 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 17.36 23.57 72.04 18.68 21.92 71.98 -40.07 74.65 102.17 -42.10 75.18 101.81 coo 12.19 31.08 87.29 11.13 32.66 86.38 -29.53 80.77 112.24 -28.62 82.54 111.55 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 12 3 # 12 A 241 ASP B 26 ASP^? 16.51 CL CL B 383 A 265 GLU B 18 GLU^? 5.91 CL CL B 382 A 369 ASP B 36 ASP.? -3.35 CL CL B 383s coo 11.74 38.14 80.19 10.63 36.40 80.65 -23.45 39.33 83.60 -24.23 39.48 85.53 coo 17.36 23.57 72.04 18.68 21.92 71.98 -29.91 50.09 69.26 -29.49 51.30 70.99 coo 12.19 31.08 87.29 11.13 32.66 86.38 -15.98 38.04 75.83 -14.00 38.51 76.08 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 13 3 # 13 A 241 ASP B 28 ASP^? 9.00 CL CL B 383 A 265 GLU B 60 GLU^? 11.77 CL CL B 382 A 369 ASP B 39 ASP^? 17.51 CL CL B 383 coo 11.74 38.14 80.19 10.63 36.40 80.65 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 17.36 23.57 72.04 18.68 21.92 71.98 -22.53 44.68 66.99 -22.71 45.90 65.28 coo 12.19 31.08 87.29 11.13 32.66 86.38 -26.18 36.85 80.53 -27.97 36.10 81.34 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 14 3 # 14 A 241 ASP B 36 ASP.? -3.35 CL CL B 383s A 265 GLU B 18 GLU^? 5.91 CL CL B 382 A 369 ASP B 26 ASP^? 16.51 CL CL B 383 coo 11.74 38.14 80.19 10.63 36.40 80.65 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 17.36 23.57 72.04 18.68 21.92 71.98 -29.91 50.09 69.26 -29.49 51.30 70.99 coo 12.19 31.08 87.29 11.13 32.66 86.38 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 15 3 # 15 A 241 ASP B 36 ASP.? -3.35 CL CL B 383s A 265 GLU B 18 GLU^? 5.91 CL CL B 382 A 369 ASP B 39 ASP^? 17.51 CL CL B 383 coo 11.74 38.14 80.19 10.63 36.40 80.65 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 17.36 23.57 72.04 18.68 21.92 71.98 -29.91 50.09 69.26 -29.49 51.30 70.99 coo 12.19 31.08 87.29 11.13 32.66 86.38 -26.18 36.85 80.53 -27.97 36.10 81.34 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 16 3 # 16 A 241 ASP B 36 ASP.? -3.35 CL CL B 383s A 265 GLU B 57 GLU.? 21.35 CL CL B 382 A 369 ASP B 39 ASP^? 17.51 CL CL B 383 coo 11.74 38.14 80.19 10.63 36.40 80.65 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 17.36 23.57 72.04 18.68 21.92 71.98 -31.25 37.00 65.18 -31.15 36.75 63.13 coo 12.19 31.08 87.29 11.13 32.66 86.38 -26.18 36.85 80.53 -27.97 36.10 81.34 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 17 3 # 17 A 241 ASP B 39 ASP^? 17.51 CL CL B 383 A 265 GLU B 18 GLU^? 5.91 CL CL B 382 A 369 ASP B 36 ASP.? -3.35 CL CL B 383s coo 11.74 38.14 80.19 10.63 36.40 80.65 -26.18 36.85 80.53 -27.97 36.10 81.34 coo 17.36 23.57 72.04 18.68 21.92 71.98 -29.91 50.09 69.26 -29.49 51.30 70.99 coo 12.19 31.08 87.29 11.13 32.66 86.38 -15.98 38.04 75.83 -14.00 38.51 76.08 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 18 3 # 18 A 241 ASP B 39 ASP^? 17.51 CL CL B 383 A 265 GLU B 57 GLU.? 21.35 CL CL B 382 A 369 ASP B 36 ASP.? -3.35 CL CL B 383s coo 11.74 38.14 80.19 10.63 36.40 80.65 -26.18 36.85 80.53 -27.97 36.10 81.34 coo 17.36 23.57 72.04 18.68 21.92 71.98 -31.25 37.00 65.18 -31.15 36.75 63.13 coo 12.19 31.08 87.29 11.13 32.66 86.38 -15.98 38.04 75.83 -14.00 38.51 76.08 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 19 3 # 19 A 241 ASP B 39 ASP^? 17.51 CL CL B 383 A 265 GLU B 60 GLU^? 11.77 CL CL B 382 A 369 ASP B 28 ASP^? 9.00 CL CL B 383 coo 11.74 38.14 80.19 10.63 36.40 80.65 -26.18 36.85 80.53 -27.97 36.10 81.34 coo 17.36 23.57 72.04 18.68 21.92 71.98 -22.53 44.68 66.99 -22.71 45.90 65.28 coo 12.19 31.08 87.29 11.13 32.66 86.38 -18.06 38.42 81.61 -16.37 38.03 82.88 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 20 3 # 20 A 241 ASP B 171 ASP.? 13.77 CL CL B 383 A 265 GLU B 18 GLU^? 5.91 CL CL B 382 A 369 ASP B 93 ASP^? 5.22 CL CL B 383 coo 11.74 38.14 80.19 10.63 36.40 80.65 -14.88 46.75 66.62 -12.79 46.40 66.16 coo 17.36 23.57 72.04 18.68 21.92 71.98 -29.91 50.09 69.26 -29.49 51.30 70.99 coo 12.19 31.08 87.29 11.13 32.66 86.38 -17.13 37.76 71.68 -15.50 36.45 72.23 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 20 hits 1m53_c05 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 28 ASP^? 9.02 CL CL A 382 A 279 GLU A 201 GLU.? 12.07 CL CL A 384 A 369 ASP A 93 ASP^? 5.15 CL CL A 382 coo 11.74 38.14 80.19 10.63 36.40 80.65 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 16.54 46.37 63.94 14.77 45.79 62.95 -24.87 56.03 99.70 -24.21 54.93 101.40 coo 12.19 31.08 87.29 11.13 32.66 86.38 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 30 ASP^? -6.81 CL CL A 382s A 279 GLU A 337 GLU^? 21.89 CL CL A 382 A 369 ASP A 93 ASP^? 5.15 CL CL A 382 coo 11.74 38.14 80.19 10.63 36.40 80.65 -35.52 64.63 115.87 -36.96 65.19 114.43 coo 16.54 46.37 63.94 14.77 45.79 62.95 -40.07 74.65 102.17 -42.10 75.18 101.81 coo 12.19 31.08 87.29 11.13 32.66 86.38 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 93 ASP^? 5.15 CL CL A 382 A 279 GLU A 18 GLU^? 23.23 CL CL A 382 A 369 ASP A 30 ASP^? -6.81 CL CL A 382s coo 11.74 38.14 80.19 10.63 36.40 80.65 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 16.54 46.37 63.94 14.77 45.79 62.95 -12.62 56.10 125.83 -13.81 57.82 125.60 coo 12.19 31.08 87.29 11.13 32.66 86.38 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP A 93 ASP^? 5.15 CL CL A 382 A 279 GLU A 149 GLU.? 9.19 CL CL A 383 A 369 ASP A 171 ASP.? 13.95 CL CL A 382 coo 11.74 38.14 80.19 10.63 36.40 80.65 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 16.54 46.37 63.94 14.77 45.79 62.95 -48.79 70.20 130.85 -48.75 71.87 129.52 coo 12.19 31.08 87.29 11.13 32.66 86.38 -21.72 70.05 125.28 -22.57 71.99 125.28 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP B 28 ASP^? 9.00 CL CL B 383 A 279 GLU B 201 GLU^? 17.46 CL CL A 384 A 369 ASP B 93 ASP^? 5.22 CL CL B 383 coo 11.74 38.14 80.19 10.63 36.40 80.65 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 16.54 46.37 63.94 14.77 45.79 62.95 -19.06 50.53 95.26 -20.94 50.61 94.28 coo 12.19 31.08 87.29 11.13 32.66 86.38 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP B 30 ASP^? -6.72 CL CL B 383s A 279 GLU B 337 GLU^? 21.78 CL CL B 383 A 369 ASP B 93 ASP^? 5.22 CL CL B 383 coo 11.74 38.14 80.19 10.63 36.40 80.65 -11.77 37.20 80.70 -10.35 36.55 82.15 coo 16.54 46.37 63.94 14.77 45.79 62.95 2.60 41.45 89.80 4.03 40.00 90.41 coo 12.19 31.08 87.29 11.13 32.66 86.38 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP B 93 ASP^? 5.22 CL CL B 383 A 279 GLU B 149 GLU.? 9.91 CL CL B 384 A 369 ASP B 171 ASP.? 13.77 CL CL B 383 coo 11.74 38.14 80.19 10.63 36.40 80.65 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 16.54 46.37 63.94 14.77 45.79 62.95 -6.14 20.54 69.48 -4.10 21.06 69.10 coo 12.19 31.08 87.29 11.13 32.66 86.38 -14.88 46.75 66.62 -12.79 46.40 66.16 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP B 306 ASP.? 19.57 CL CL A 384 A 279 GLU B 337 GLU^? 21.78 CL CL B 383 A 369 ASP B 195 ASP.? 10.47 CL CL A 384 coo 11.74 38.14 80.19 10.63 36.40 80.65 -4.64 54.84 103.01 -3.71 56.24 101.58 coo 16.54 46.37 63.94 14.77 45.79 62.95 2.60 41.45 89.80 4.03 40.00 90.41 coo 12.19 31.08 87.29 11.13 32.66 86.38 -11.82 59.91 101.57 -11.61 61.10 99.82 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 8 hits 1m53_c06 naa= 3 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 1 3 # 1 A 10 ASP A 233 ASP.? 30.79 CL CL A 383 A 168 ASN A 258 ASN~? 27.57 CL CL A 383 A 241 HIS A 223 HIS.? 29.08 CL CL A 383 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 -64.45 88.75 121.31 -62.88 88.68 122.75 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 -54.65 91.43 120.94 -52.65 90.78 121.44 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 -56.62 90.70 129.56 -55.95 91.22 131.48 1mas_c00 source 1mas INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE : 1 hits 1mas_c00 naa= 3 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 1 3 # 1 B 10 ASP A 233 ASP.? 30.79 CL CL A 383 B 168 ASN A 258 ASN~? 27.57 CL CL A 383 B 241 HIS A 223 HIS.? 29.08 CL CL A 383 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -64.45 88.75 121.31 -62.88 88.68 122.75 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -54.65 91.43 120.94 -52.65 90.78 121.44 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -56.62 90.70 129.56 -55.95 91.22 131.48 1mas_c01 source 1mas INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE : 1 hits 1mas_c01 naa= 3 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 1 3 # 1 159 ARG A 13 ARG^? 21.22 CL CL A 382 229 SER A 11 SER^? 21.10 CL CL A 382 325 GLU A 18 GLU^? 23.23 CL CL A 382 coo 2.54 15.84 18.57 3.24 17.85 16.30 -15.61 60.27 127.72 -14.54 62.09 125.47 coo 10.17 13.48 15.92 9.61 15.76 15.27 -17.58 55.42 121.82 -16.10 56.98 122.78 coo 5.42 13.04 19.75 5.74 13.81 17.79 -12.62 56.10 125.83 -13.81 57.82 125.60 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 2 3 # 2 159 ARG A 13 ARG^? 21.22 CL CL A 382 229 SER A 58 SER^? 17.88 CL CL A 382 325 GLU A 60 GLU^? 17.84 CL CL A 382 coo 2.54 15.84 18.57 3.24 17.85 16.30 -15.61 60.27 127.72 -14.54 62.09 125.47 coo 10.17 13.48 15.92 9.61 15.76 15.27 -24.38 59.07 132.81 -24.91 60.78 134.35 coo 5.42 13.04 19.75 5.74 13.81 17.79 -20.60 62.82 127.64 -18.87 63.84 128.41 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 3 3 # 3 159 ARG A 325 ARG.? 29.26 CL CL A 384 229 SER A 324 SER^? 19.72 CL CL A 384 325 GLU A 23 GLU.? 27.24 CL CL A 382 coo 2.54 15.84 18.57 3.24 17.85 16.30 -22.19 42.21 111.60 -22.86 39.29 112.51 coo 10.17 13.48 15.92 9.61 15.76 15.27 -24.77 48.15 110.31 -26.00 48.61 108.19 coo 5.42 13.04 19.75 5.74 13.81 17.79 -22.84 44.28 116.17 -23.55 42.53 115.22 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 4 3 # 4 159 ARG B 325 ARG.? 19.88 CL CL B 382 229 SER B 324 SER^? 22.60 CL CL B 382 325 GLU B 23 GLU.? 22.91 CL CL B 382 coo 2.54 15.84 18.57 3.24 17.85 16.30 -34.83 46.46 90.24 -34.50 47.08 87.15 coo 10.17 13.48 15.92 9.61 15.76 15.27 -28.77 44.19 89.22 -27.33 44.36 91.21 coo 5.42 13.04 19.75 5.74 13.81 17.79 -35.83 43.78 85.87 -35.49 42.75 87.75 1mbb_c00 source 1mbb URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYLGLUCOSAMI: 4 hits 1mbb_c00 naa= 3 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 3 # 1 164 LYS A 267 LYS~? 27.66 CL CL A 382 166 LYS A 264 LYS~? 22.00 CL CL A 382 324 SER A 182 SER.? 20.74 CL CL A 384 coo 25.93 8.11 25.51 26.40 7.80 19.66 -49.43 81.28 111.60 -49.39 86.78 108.40 coo 27.27 1.43 25.09 29.18 5.25 22.89 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 46.32 14.55 19.93 45.95 12.72 21.27 -28.54 83.33 107.44 -27.66 84.16 109.62 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 2 3 # 2 164 LYS A 267 LYS~? 27.66 CL CL A 382 166 LYS A 264 LYS~? 22.00 CL CL A 382 324 SER A 183 SER.? 17.10 CL CL A 384 coo 25.93 8.11 25.51 26.40 7.80 19.66 -49.43 81.28 111.60 -49.39 86.78 108.40 coo 27.27 1.43 25.09 29.18 5.25 22.89 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 46.32 14.55 19.93 45.95 12.72 21.27 -26.00 80.50 107.95 -26.08 80.05 110.33 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 3 3 # 3 164 LYS A 268 LYS~? 13.60 CL CL A 382 166 LYS A 264 LYS~? 22.00 CL CL A 382 324 SER A 183 SER.? 17.10 CL CL A 384 coo 25.93 8.11 25.51 26.40 7.80 19.66 -47.11 79.10 113.63 -43.53 76.03 116.02 coo 27.27 1.43 25.09 29.18 5.25 22.89 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 46.32 14.55 19.93 45.95 12.72 21.27 -26.00 80.50 107.95 -26.08 80.05 110.33 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 4 3 # 4 164 LYS B 267 LYS~? 27.57 CL CL B 383 166 LYS B 264 LYS~? 21.76 CL CL B 383 324 SER B 183 SER.? 18.84 CL CL B 383 coo 25.93 8.11 25.51 26.40 7.80 19.66 9.46 31.45 81.02 15.36 33.08 81.01 coo 27.27 1.43 25.09 29.18 5.25 22.89 11.01 31.36 75.69 9.79 34.42 71.26 coo 46.32 14.55 19.93 45.95 12.72 21.27 0.48 53.13 78.50 -0.49 51.65 76.91 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 5 3 # 5 164 LYS B 268 LYS~? 13.29 CL CL B 383 166 LYS B 264 LYS~? 21.76 CL CL B 383 324 SER B 183 SER.? 18.84 CL CL B 383 coo 25.93 8.11 25.51 26.40 7.80 19.66 5.99 32.14 79.72 1.11 32.64 77.72 coo 27.27 1.43 25.09 29.18 5.25 22.89 11.01 31.36 75.69 9.79 34.42 71.26 coo 46.32 14.55 19.93 45.95 12.72 21.27 0.48 53.13 78.50 -0.49 51.65 76.91 1mdr_c01 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 5 hits 1mdr_c01 naa= 3 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 1 3 # 1 92 SER A 88 SER^? 22.34 CL CL A 382 201 HIS A 78 HIS^? 30.68 CL CL A 382 250 GLN A 76 GLN^? 24.61 CL CL A 382 coo 38.34 0.72 11.82 37.33 1.15 14.05 -26.75 46.25 123.96 -28.99 45.42 123.71 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 -24.82 39.60 128.09 -23.39 38.20 127.48 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 -26.57 46.46 129.57 -24.86 46.70 130.88 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 2 3 # 2 92 SER B 88 SER^? 22.31 CL CL B 383 201 HIS B 78 HIS^? 26.83 CL CL B 382 250 GLN B 76 GLN^? 22.74 CL CL B 382 coo 38.34 0.72 11.82 37.33 1.15 14.05 -33.45 36.60 78.54 -33.30 34.49 79.66 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 -41.15 34.55 77.14 -42.58 35.82 77.99 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 -34.98 34.32 73.52 -35.81 35.28 71.77 1mla_c00 source 1mla MALONYL-COENZYME A ACYL CARRIER PROTEIN TRANSA: 2 hits 1mla_c00 naa= 3 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 1 3 # 1 32 ASP A 28 ASP^? 9.02 CL CL A 382 35 SER A 29 SER^? 6.92 CL CL A 382 215 ASP A 26 ASP^? 16.59 CL CL A 382 coo 20.97 14.47 32.28 19.66 15.96 31.62 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 16.04 14.72 33.82 17.27 13.71 31.95 -31.31 63.66 116.96 -29.07 63.86 117.79 coo 20.65 22.00 33.80 20.06 20.56 32.39 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 2 3 # 2 32 ASP A 28 ASP^? 9.02 CL CL A 382 35 SER A 37 SER^? 9.11 CL CL A 382 215 ASP A 26 ASP^? 16.59 CL CL A 382 coo 20.97 14.47 32.28 19.66 15.96 31.62 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 16.04 14.72 33.82 17.27 13.71 31.95 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 20.65 22.00 33.80 20.06 20.56 32.39 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 3 3 # 3 32 ASP A 28 ASP^? 9.02 CL CL A 382 35 SER A 37 SER^? 9.11 CL CL A 382 215 ASP A 30 ASP^? -6.81 CL CL A 382s coo 20.97 14.47 32.28 19.66 15.96 31.62 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 16.04 14.72 33.82 17.27 13.71 31.95 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 20.65 22.00 33.80 20.06 20.56 32.39 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 4 3 # 4 32 ASP A 28 ASP^? 9.02 CL CL A 382 35 SER A 37 SER^? 9.11 CL CL A 382 215 ASP A 39 ASP^? 16.51 CL CL A 382 coo 20.97 14.47 32.28 19.66 15.96 31.62 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 16.04 14.72 33.82 17.27 13.71 31.95 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 20.65 22.00 33.80 20.06 20.56 32.39 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 5 3 # 5 32 ASP A 36 ASP.? -3.33 CL CL A 382s 35 SER A 37 SER^? 9.11 CL CL A 382 215 ASP A 30 ASP^? -6.81 CL CL A 382s coo 20.97 14.47 32.28 19.66 15.96 31.62 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 16.04 14.72 33.82 17.27 13.71 31.95 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 20.65 22.00 33.80 20.06 20.56 32.39 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 6 3 # 6 32 ASP A 195 ASP.? 13.29 CL CL A 384 35 SER A 192 SER.? 15.36 CL CL A 384 215 ASP A 306 ASP.? 16.66 CL CL A 384 coo 20.97 14.47 32.28 19.66 15.96 31.62 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 16.04 14.72 33.82 17.27 13.71 31.95 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 20.65 22.00 33.80 20.06 20.56 32.39 -29.63 66.56 87.01 -28.35 68.29 87.20 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 7 3 # 7 32 ASP A 306 ASP.? 16.66 CL CL A 384 35 SER A 192 SER.? 15.36 CL CL A 384 215 ASP A 305 ASP^? 16.01 CL CL A 384 coo 20.97 14.47 32.28 19.66 15.96 31.62 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 16.04 14.72 33.82 17.27 13.71 31.95 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 20.65 22.00 33.80 20.06 20.56 32.39 -32.01 65.22 92.45 -32.49 63.34 91.63 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 8 3 # 8 32 ASP B 28 ASP^? 9.00 CL CL B 383 35 SER B 29 SER^? 6.98 CL CL B 383 215 ASP B 26 ASP^? 16.51 CL CL B 383 coo 20.97 14.47 32.28 19.66 15.96 31.62 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 16.04 14.72 33.82 17.27 13.71 31.95 -14.55 40.12 78.88 -15.61 41.67 77.42 coo 20.65 22.00 33.80 20.06 20.56 32.39 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 9 3 # 9 32 ASP B 28 ASP^? 9.00 CL CL B 383 35 SER B 37 SER^? 9.16 CL CL B 383 215 ASP B 26 ASP^? 16.51 CL CL B 383 coo 20.97 14.47 32.28 19.66 15.96 31.62 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 16.04 14.72 33.82 17.27 13.71 31.95 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 20.65 22.00 33.80 20.06 20.56 32.39 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 10 3 # 10 32 ASP B 28 ASP^? 9.00 CL CL B 383 35 SER B 37 SER^? 9.16 CL CL B 383 215 ASP B 30 ASP^? -6.72 CL CL B 383s coo 20.97 14.47 32.28 19.66 15.96 31.62 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 16.04 14.72 33.82 17.27 13.71 31.95 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 20.65 22.00 33.80 20.06 20.56 32.39 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 11 3 # 11 32 ASP B 28 ASP^? 9.00 CL CL B 383 35 SER B 37 SER^? 9.16 CL CL B 383 215 ASP B 39 ASP^? 17.51 CL CL B 383 coo 20.97 14.47 32.28 19.66 15.96 31.62 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 16.04 14.72 33.82 17.27 13.71 31.95 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 20.65 22.00 33.80 20.06 20.56 32.39 -26.18 36.85 80.53 -27.97 36.10 81.34 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 12 3 # 12 32 ASP B 36 ASP.? -3.35 CL CL B 383s 35 SER B 37 SER^? 9.16 CL CL B 383 215 ASP B 30 ASP^? -6.72 CL CL B 383s coo 20.97 14.47 32.28 19.66 15.96 31.62 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 16.04 14.72 33.82 17.27 13.71 31.95 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 20.65 22.00 33.80 20.06 20.56 32.39 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 13 3 # 13 32 ASP B 195 ASP.? 10.47 CL CL A 384 35 SER B 192 SER.? 13.26 CL CL A 384 215 ASP B 306 ASP.? 19.57 CL CL A 384 coo 20.97 14.47 32.28 19.66 15.96 31.62 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 16.04 14.72 33.82 17.27 13.71 31.95 -11.80 54.65 102.27 -11.20 56.97 103.08 coo 20.65 22.00 33.80 20.06 20.56 32.39 -4.64 54.84 103.01 -3.71 56.24 101.58 1mpp_c04 source 1mpp PEPSIN (RENIN) (E.C.3.4.23.23) : 13 hits 1mpp_c04 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 65 GLY.? 20.01 CL CL A 384 A 501 ASP A 327 ASP.? 19.04 CL CL A 384 B 367 TYR A 346 TYR.? 17.61 CL CL A 382 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -13.27 62.71 120.05 -13.88 62.83 119.56 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -25.74 49.77 105.10 -27.34 48.80 104.08 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -31.44 83.83 114.39 -30.05 82.53 116.45 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY A 178 GLY.? 12.46 CL CL A 382 A 501 ASP A 210 ASP.? 21.69 CL CL A 383 B 367 TYR A 8 TYR.? 12.26 CL CL A 384 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -35.00 78.54 116.42 -34.19 78.65 116.55 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -52.58 64.68 106.89 -53.21 62.78 107.37 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -16.53 57.80 111.57 -17.14 59.34 109.36 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 3 3 # 3 A 465 GLY A 277 GLY~? 20.14 CL CL A 382 A 501 ASP A 36 ASP.? -3.33 CL CL A 382s B 367 TYR B 6 TYR.? 15.73 CL CL B 382 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -46.60 67.89 104.45 -45.85 67.87 104.64 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -31.00 62.22 83.89 -31.26 65.01 83.64 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 4 3 # 4 A 465 GLY A 286 GLY.? 9.30 CL CL A 384 A 501 ASP B 311 ASP^? 24.66 CL CL A 384 B 367 TYR B 6 TYR.? 15.73 CL CL B 382 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -20.05 58.49 106.62 -20.88 58.44 106.59 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 0.41 52.81 97.17 0.37 54.52 95.85 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -31.00 62.22 83.89 -31.26 65.01 83.64 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 5 3 # 5 A 465 GLY A 309 GLY.? 19.85 CL CL A 384 A 501 ASP A 208 ASP.? 21.85 CL CL A 382 B 367 TYR B 25 TYR^? 14.27 CL CL B 382 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -35.24 68.60 88.70 -35.11 68.24 89.40 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -48.25 63.81 104.00 -49.74 63.21 105.24 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -26.62 44.42 81.68 -25.97 47.00 82.31 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 6 3 # 6 A 465 GLY A 318 GLY^? 8.74 CL CL A 382 A 501 ASP A 64 ASP.? 15.21 CL CL A 384 B 367 TYR B 6 TYR.? 15.73 CL CL B 382 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -33.39 65.39 112.09 -32.99 65.64 111.42 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -13.50 61.63 115.26 -13.45 60.20 113.75 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -31.00 62.22 83.89 -31.26 65.01 83.64 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 7 3 # 7 A 465 GLY A 318 GLY^? 8.74 CL CL A 382 A 501 ASP A 100 ASP~? 8.92 CL CL A 383 B 367 TYR A 238 TYR^? 27.75 CL CL A 383 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -33.39 65.39 112.09 -32.99 65.64 111.42 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -39.25 61.23 132.92 -38.42 59.82 131.54 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -54.82 80.30 106.22 -53.19 79.11 104.29 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 8 3 # 8 A 465 GLY A 318 GLY^? 8.74 CL CL A 382 A 501 ASP A 311 ASP^? 15.19 CL CL A 384 B 367 TYR A 6 TYR.? 20.79 CL CL A 384 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -33.39 65.39 112.09 -32.99 65.64 111.42 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -31.19 72.86 91.72 -29.44 73.97 92.12 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -7.05 53.27 108.32 -4.25 53.35 108.15 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 9 3 # 9 A 465 GLY A 328 GLY^? 17.20 CL CL A 384 A 501 ASP A 36 ASP.? -3.33 CL CL A 382s B 367 TYR B 6 TYR.? 15.73 CL CL B 382 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -21.48 50.12 107.21 -22.25 50.36 107.20 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -31.00 62.22 83.89 -31.26 65.01 83.64 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 10 3 # 10 A 465 GLY A 328 GLY^? 17.20 CL CL A 384 A 501 ASP A 291 ASP.? 7.30 CL CL A 384 B 367 TYR B 25 TYR^? 14.27 CL CL B 382 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -21.48 50.12 107.21 -22.25 50.36 107.20 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -15.45 71.21 105.07 -17.40 71.77 105.62 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -26.62 44.42 81.68 -25.97 47.00 82.31 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 11 3 # 11 A 465 GLY A 328 GLY^? 17.20 CL CL A 384 A 501 ASP B 311 ASP^? 24.66 CL CL A 384 B 367 TYR B 6 TYR.? 15.73 CL CL B 382 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -21.48 50.12 107.21 -22.25 50.36 107.20 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 0.41 52.81 97.17 0.37 54.52 95.85 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -31.00 62.22 83.89 -31.26 65.01 83.64 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 12 3 # 12 A 465 GLY A 339 GLY.? 19.32 CL CL A 382 A 501 ASP A 36 ASP.? -3.33 CL CL A 382s B 367 TYR B 6 TYR.? 15.73 CL CL B 382 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -37.15 79.07 105.90 -37.54 78.40 106.05 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -31.00 62.22 83.89 -31.26 65.01 83.64 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 13 3 # 13 A 465 GLY B 65 GLY.? -4.07 CL CL B 382s A 501 ASP B 327 ASP.? 22.34 CL CL A 384 B 367 TYR B 346 TYR.? 17.60 CL CL B 383 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -21.30 55.60 72.20 -21.07 55.03 72.67 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -25.62 46.25 93.54 -25.42 45.53 95.50 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 3.94 45.97 72.94 1.71 46.24 71.30 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 14 3 # 14 A 465 GLY B 277 GLY~? 19.92 CL CL B 383 A 501 ASP B 36 ASP.? -3.35 CL CL B 383s B 367 TYR A 6 TYR.? 20.79 CL CL A 384 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -1.21 33.00 92.27 -1.59 33.59 91.90 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -7.05 53.27 108.32 -4.25 53.35 108.15 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 15 3 # 15 A 465 GLY B 292 GLY.? 13.97 CL CL B 382 A 501 ASP A 311 ASP^? 15.19 CL CL A 384 B 367 TYR A 6 TYR.? 20.79 CL CL A 384 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -15.38 58.60 80.90 -14.73 58.21 81.00 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -31.19 72.86 91.72 -29.44 73.97 92.12 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -7.05 53.27 108.32 -4.25 53.35 108.15 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 16 3 # 16 A 465 GLY B 292 GLY.? 13.97 CL CL B 382 A 501 ASP B 36 ASP.? -3.35 CL CL B 383s B 367 TYR A 6 TYR.? 20.79 CL CL A 384 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -15.38 58.60 80.90 -14.73 58.21 81.00 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -7.05 53.27 108.32 -4.25 53.35 108.15 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 17 3 # 17 A 465 GLY B 292 GLY.? 13.97 CL CL B 382 A 501 ASP B 39 ASP^? 17.51 CL CL B 383 B 367 TYR A 6 TYR.? 20.79 CL CL A 384 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -15.38 58.60 80.90 -14.73 58.21 81.00 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -26.18 36.85 80.53 -27.97 36.10 81.34 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -7.05 53.27 108.32 -4.25 53.35 108.15 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 18 3 # 18 A 465 GLY B 309 GLY.? 25.52 CL CL A 384 A 501 ASP B 208 ASP.? 21.56 CL CL B 383 B 367 TYR A 25 TYR^? 18.63 CL CL A 382 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -1.34 49.50 102.80 -1.84 49.15 102.26 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -23.49 53.13 116.11 -21.60 54.30 114.36 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 19 3 # 19 A 465 GLY B 318 GLY^? 8.69 CL CL B 383 A 501 ASP B 100 ASP~? 8.80 CL CL B 384 B 367 TYR B 238 TYR^? 27.53 CL CL B 384 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -10.95 40.65 83.09 -10.71 41.37 83.45 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -18.20 25.71 68.46 -19.22 26.77 70.02 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 12.27 28.31 87.43 11.42 30.17 89.32 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 20 3 # 20 A 465 GLY B 328 GLY^? 19.77 CL CL B 382 A 501 ASP A 311 ASP^? 15.19 CL CL A 384 B 367 TYR A 6 TYR.? 20.79 CL CL A 384 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -27.69 48.95 90.13 -27.15 48.30 90.26 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -31.19 72.86 91.72 -29.44 73.97 92.12 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -7.05 53.27 108.32 -4.25 53.35 108.15 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 21 3 # 21 A 465 GLY B 328 GLY^? 19.77 CL CL B 382 A 501 ASP B 30 ASP^? -6.72 CL CL B 383s B 367 TYR A 8 TYR.? 12.26 CL CL A 384 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -27.69 48.95 90.13 -27.15 48.30 90.26 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -11.77 37.20 80.70 -10.35 36.55 82.15 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -16.53 57.80 111.57 -17.14 59.34 109.36 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 22 3 # 22 A 465 GLY B 328 GLY^? 19.77 CL CL B 382 A 501 ASP B 36 ASP.? -3.35 CL CL B 383s B 367 TYR A 6 TYR.? 20.79 CL CL A 384 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -27.69 48.95 90.13 -27.15 48.30 90.26 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -7.05 53.27 108.32 -4.25 53.35 108.15 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 23 3 # 23 A 465 GLY B 328 GLY^? 19.77 CL CL B 382 A 501 ASP B 291 ASP.? 20.64 CL CL B 382 B 367 TYR A 25 TYR^? 18.63 CL CL A 382 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -27.69 48.95 90.13 -27.15 48.30 90.26 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -11.26 60.51 82.59 -9.94 61.37 84.03 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -23.49 53.13 116.11 -21.60 54.30 114.36 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 24 3 # 24 A 465 GLY B 339 GLY.? 19.18 CL CL B 383 A 501 ASP B 36 ASP.? -3.35 CL CL B 383s B 367 TYR A 6 TYR.? 20.79 CL CL A 384 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 4.18 43.63 83.95 3.70 43.10 84.20 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -7.05 53.27 108.32 -4.25 53.35 108.15 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 24 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY A 65 GLY.? 20.01 CL CL A 384 D 501 ASP A 327 ASP.? 19.04 CL CL A 384 E 367 TYR A 346 TYR.? 17.61 CL CL A 382 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -13.27 62.71 120.05 -13.88 62.83 119.56 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -25.74 49.77 105.10 -27.34 48.80 104.08 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -31.44 83.83 114.39 -30.05 82.53 116.45 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY A 178 GLY.? 12.46 CL CL A 382 D 501 ASP A 210 ASP.? 21.69 CL CL A 383 E 367 TYR A 8 TYR.? 12.26 CL CL A 384 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -35.00 78.54 116.42 -34.19 78.65 116.55 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -52.58 64.68 106.89 -53.21 62.78 107.37 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -16.53 57.80 111.57 -17.14 59.34 109.36 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 3 3 # 3 D 465 GLY A 277 GLY~? 20.14 CL CL A 382 D 501 ASP A 36 ASP.? -3.33 CL CL A 382s E 367 TYR B 6 TYR.? 15.73 CL CL B 382 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -46.60 67.89 104.45 -45.85 67.87 104.64 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -31.00 62.22 83.89 -31.26 65.01 83.64 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 4 3 # 4 D 465 GLY A 286 GLY.? 9.30 CL CL A 384 D 501 ASP B 311 ASP^? 24.66 CL CL A 384 E 367 TYR B 6 TYR.? 15.73 CL CL B 382 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -20.05 58.49 106.62 -20.88 58.44 106.59 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 0.41 52.81 97.17 0.37 54.52 95.85 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -31.00 62.22 83.89 -31.26 65.01 83.64 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 5 3 # 5 D 465 GLY A 309 GLY.? 19.85 CL CL A 384 D 501 ASP A 208 ASP.? 21.85 CL CL A 382 E 367 TYR B 25 TYR^? 14.27 CL CL B 382 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -35.24 68.60 88.70 -35.11 68.24 89.40 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -48.25 63.81 104.00 -49.74 63.21 105.24 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -26.62 44.42 81.68 -25.97 47.00 82.31 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 6 3 # 6 D 465 GLY A 318 GLY^? 8.74 CL CL A 382 D 501 ASP A 64 ASP.? 15.21 CL CL A 384 E 367 TYR B 6 TYR.? 15.73 CL CL B 382 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -33.39 65.39 112.09 -32.99 65.64 111.42 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -13.50 61.63 115.26 -13.45 60.20 113.75 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -31.00 62.22 83.89 -31.26 65.01 83.64 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 7 3 # 7 D 465 GLY A 318 GLY^? 8.74 CL CL A 382 D 501 ASP A 100 ASP~? 8.92 CL CL A 383 E 367 TYR A 238 TYR^? 27.75 CL CL A 383 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -33.39 65.39 112.09 -32.99 65.64 111.42 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -39.25 61.23 132.92 -38.42 59.82 131.54 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -54.82 80.30 106.22 -53.19 79.11 104.29 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 8 3 # 8 D 465 GLY A 328 GLY^? 17.20 CL CL A 384 D 501 ASP A 30 ASP^? -6.81 CL CL A 382s E 367 TYR B 8 TYR.? 11.88 CL CL B 382 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -21.48 50.12 107.21 -22.25 50.36 107.20 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -35.52 64.63 115.87 -36.96 65.19 114.43 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -23.96 53.72 82.39 -21.76 54.53 83.93 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 9 3 # 9 D 465 GLY A 328 GLY^? 17.20 CL CL A 384 D 501 ASP A 36 ASP.? -3.33 CL CL A 382s E 367 TYR B 6 TYR.? 15.73 CL CL B 382 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -21.48 50.12 107.21 -22.25 50.36 107.20 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -31.00 62.22 83.89 -31.26 65.01 83.64 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 10 3 # 10 D 465 GLY A 328 GLY^? 17.20 CL CL A 384 D 501 ASP A 291 ASP.? 7.30 CL CL A 384 E 367 TYR B 25 TYR^? 14.27 CL CL B 382 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -21.48 50.12 107.21 -22.25 50.36 107.20 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -15.45 71.21 105.07 -17.40 71.77 105.62 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -26.62 44.42 81.68 -25.97 47.00 82.31 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 11 3 # 11 D 465 GLY A 328 GLY^? 17.20 CL CL A 384 D 501 ASP B 311 ASP^? 24.66 CL CL A 384 E 367 TYR B 6 TYR.? 15.73 CL CL B 382 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -21.48 50.12 107.21 -22.25 50.36 107.20 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 0.41 52.81 97.17 0.37 54.52 95.85 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -31.00 62.22 83.89 -31.26 65.01 83.64 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 12 3 # 12 D 465 GLY A 339 GLY.? 19.32 CL CL A 382 D 501 ASP A 36 ASP.? -3.33 CL CL A 382s E 367 TYR B 6 TYR.? 15.73 CL CL B 382 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -37.15 79.07 105.90 -37.54 78.40 106.05 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -31.00 62.22 83.89 -31.26 65.01 83.64 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 13 3 # 13 D 465 GLY B 65 GLY.? -4.07 CL CL B 382s D 501 ASP B 327 ASP.? 22.34 CL CL A 384 E 367 TYR B 346 TYR.? 17.60 CL CL B 383 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -21.30 55.60 72.20 -21.07 55.03 72.67 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -25.62 46.25 93.54 -25.42 45.53 95.50 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 3.94 45.97 72.94 1.71 46.24 71.30 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 14 3 # 14 D 465 GLY B 277 GLY~? 19.92 CL CL B 383 D 501 ASP B 36 ASP.? -3.35 CL CL B 383s E 367 TYR A 6 TYR.? 20.79 CL CL A 384 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -1.21 33.00 92.27 -1.59 33.59 91.90 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -7.05 53.27 108.32 -4.25 53.35 108.15 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 15 3 # 15 D 465 GLY B 286 GLY.? 16.50 CL CL B 382 D 501 ASP A 311 ASP^? 15.19 CL CL A 384 E 367 TYR A 6 TYR.? 20.79 CL CL A 384 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -20.98 52.54 87.27 -20.62 51.84 87.46 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -31.19 72.86 91.72 -29.44 73.97 92.12 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -7.05 53.27 108.32 -4.25 53.35 108.15 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 16 3 # 16 D 465 GLY B 292 GLY.? 13.97 CL CL B 382 D 501 ASP A 311 ASP^? 15.19 CL CL A 384 E 367 TYR A 6 TYR.? 20.79 CL CL A 384 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -15.38 58.60 80.90 -14.73 58.21 81.00 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -31.19 72.86 91.72 -29.44 73.97 92.12 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -7.05 53.27 108.32 -4.25 53.35 108.15 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 17 3 # 17 D 465 GLY B 292 GLY.? 13.97 CL CL B 382 D 501 ASP B 36 ASP.? -3.35 CL CL B 383s E 367 TYR A 6 TYR.? 20.79 CL CL A 384 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -15.38 58.60 80.90 -14.73 58.21 81.00 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -7.05 53.27 108.32 -4.25 53.35 108.15 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 18 3 # 18 D 465 GLY B 292 GLY.? 13.97 CL CL B 382 D 501 ASP B 39 ASP^? 17.51 CL CL B 383 E 367 TYR A 6 TYR.? 20.79 CL CL A 384 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -15.38 58.60 80.90 -14.73 58.21 81.00 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -26.18 36.85 80.53 -27.97 36.10 81.34 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -7.05 53.27 108.32 -4.25 53.35 108.15 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 19 3 # 19 D 465 GLY B 309 GLY.? 25.52 CL CL A 384 D 501 ASP B 208 ASP.? 21.56 CL CL B 383 E 367 TYR A 25 TYR^? 18.63 CL CL A 382 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -1.34 49.50 102.80 -1.84 49.15 102.26 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -23.49 53.13 116.11 -21.60 54.30 114.36 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 20 3 # 20 D 465 GLY B 318 GLY^? 8.69 CL CL B 383 D 501 ASP B 100 ASP~? 8.80 CL CL B 384 E 367 TYR B 238 TYR^? 27.53 CL CL B 384 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -10.95 40.65 83.09 -10.71 41.37 83.45 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -18.20 25.71 68.46 -19.22 26.77 70.02 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 12.27 28.31 87.43 11.42 30.17 89.32 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 21 3 # 21 D 465 GLY B 328 GLY^? 19.77 CL CL B 382 D 501 ASP A 311 ASP^? 15.19 CL CL A 384 E 367 TYR A 6 TYR.? 20.79 CL CL A 384 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -27.69 48.95 90.13 -27.15 48.30 90.26 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -31.19 72.86 91.72 -29.44 73.97 92.12 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -7.05 53.27 108.32 -4.25 53.35 108.15 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 22 3 # 22 D 465 GLY B 328 GLY^? 19.77 CL CL B 382 D 501 ASP B 30 ASP^? -6.72 CL CL B 383s E 367 TYR A 8 TYR.? 12.26 CL CL A 384 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -27.69 48.95 90.13 -27.15 48.30 90.26 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -11.77 37.20 80.70 -10.35 36.55 82.15 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -16.53 57.80 111.57 -17.14 59.34 109.36 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 23 3 # 23 D 465 GLY B 328 GLY^? 19.77 CL CL B 382 D 501 ASP B 36 ASP.? -3.35 CL CL B 383s E 367 TYR A 6 TYR.? 20.79 CL CL A 384 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -27.69 48.95 90.13 -27.15 48.30 90.26 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -7.05 53.27 108.32 -4.25 53.35 108.15 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 24 3 # 24 D 465 GLY B 328 GLY^? 19.77 CL CL B 382 D 501 ASP B 291 ASP.? 20.64 CL CL B 382 E 367 TYR A 25 TYR^? 18.63 CL CL A 382 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -27.69 48.95 90.13 -27.15 48.30 90.26 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -11.26 60.51 82.59 -9.94 61.37 84.03 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -23.49 53.13 116.11 -21.60 54.30 114.36 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 25 3 # 25 D 465 GLY B 339 GLY.? 19.18 CL CL B 383 D 501 ASP B 36 ASP.? -3.35 CL CL B 383s E 367 TYR A 6 TYR.? 20.79 CL CL A 384 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 4.18 43.63 83.95 3.70 43.10 84.20 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -7.05 53.27 108.32 -4.25 53.35 108.15 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 25 hits 1mro_c01 naa= 3 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 3 # 1 A 50 ASP A 64 ASP.? 15.21 CL CL A 384 A 55 TYR A 8 TYR.? 12.26 CL CL A 384 A 84 LYS A 288 LYS.? 12.57 CL CL A 384 coo 11.09 42.89 24.44 11.32 42.06 22.49 -13.50 61.63 115.26 -13.45 60.20 113.75 coo 4.60 40.33 20.42 7.25 39.50 20.05 -16.53 57.80 111.57 -17.14 59.34 109.36 coo 9.71 44.83 15.47 10.13 41.43 19.93 -19.18 64.09 108.25 -14.44 63.70 112.45 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 3 # 2 A 50 ASP B 64 ASP.? 7.14 CL CL B 382 A 55 TYR B 8 TYR.? 11.88 CL CL B 382 A 84 LYS B 288 LYS.? 8.84 CL CL B 382 coo 11.09 42.89 24.44 11.32 42.06 22.49 -22.24 55.99 77.05 -23.77 56.03 78.56 coo 4.60 40.33 20.42 7.25 39.50 20.05 -23.96 53.72 82.39 -21.76 54.53 83.93 coo 9.71 44.83 15.47 10.13 41.43 19.93 -16.76 54.22 83.25 -20.62 56.75 78.99 1mrq_c02 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 2 hits 1mrq_c02 naa= 3 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 1 3 # 1 A 167 LYS A 80 LYS^? 36.93 CL CL A 382 A 169 LYS A 82 LYS.? 41.47 CL CL A 382 A 327 GLU A 86 GLU^? 27.08 CL CL A 382 coo 20.73 15.53 25.54 22.09 15.64 19.40 -26.02 34.53 124.81 -22.64 33.14 129.86 coo 24.31 10.25 23.71 29.02 12.05 20.75 -24.27 28.84 121.34 -24.33 26.99 125.88 coo 21.86 20.40 18.59 22.12 18.33 18.33 -25.92 41.43 120.29 -26.81 40.98 118.43 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 2 3 # 2 A 167 LYS B 80 LYS^? 31.45 CL CL B 382 A 169 LYS B 82 LYS.? 37.97 CL CL B 382 A 327 GLU B 86 GLU^? 25.45 CL CL B 382 coo 20.73 15.53 25.54 22.09 15.64 19.40 -43.65 33.60 82.90 -47.69 34.28 78.00 coo 24.31 10.25 23.71 29.02 12.05 20.75 -48.91 34.74 87.29 -47.83 32.98 92.37 coo 21.86 20.40 18.59 22.12 18.33 18.33 -37.46 36.82 83.59 -36.60 37.35 85.50 1muc_c00 source 1muc MUCONATE LACTONIZING ENZYME : 2 hits 1muc_c00 naa= 3 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 1 3 # 1 B 167 LYS A 80 LYS^? 36.93 CL CL A 382 B 169 LYS A 82 LYS.? 41.47 CL CL A 382 B 327 GLU A 86 GLU^? 27.08 CL CL A 382 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -26.02 34.53 124.81 -22.64 33.14 129.86 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -24.27 28.84 121.34 -24.33 26.99 125.88 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -25.92 41.43 120.29 -26.81 40.98 118.43 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 2 3 # 2 B 167 LYS B 80 LYS^? 31.45 CL CL B 382 B 169 LYS B 82 LYS.? 37.97 CL CL B 382 B 327 GLU B 86 GLU^? 25.45 CL CL B 382 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -43.65 33.60 82.90 -47.69 34.28 78.00 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -48.91 34.74 87.29 -47.83 32.98 92.37 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -37.46 36.82 83.59 -36.60 37.35 85.50 1muc_c01 source 1muc MUCONATE LACTONIZING ENZYME : 2 hits 1muc_c01 naa= 3 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 A 114 HIS A 157 HIS~? 12.03 CL CL A 383 A 197 ASP A 144 ASP.? 19.38 CL CL A 383 A 223 ALA A 103 ALA.? 10.33 CL CL A 383 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -47.82 75.77 126.56 -49.90 76.10 126.41 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -52.89 78.90 131.37 -53.77 80.20 132.79 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -43.22 70.84 135.69 -44.02 71.58 134.57 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 A 114 HIS A 157 HIS~? 12.03 CL CL A 383 A 197 ASP A 144 ASP.? 19.38 CL CL A 383 A 223 ALA A 116 ALA~? 16.96 CL CL A 383 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -47.82 75.77 126.56 -49.90 76.10 126.41 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -52.89 78.90 131.37 -53.77 80.20 132.79 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -38.30 80.83 132.45 -39.59 81.12 131.73 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 A 114 HIS A 157 HIS~? 12.03 CL CL A 383 A 197 ASP A 144 ASP.? 19.38 CL CL A 383 A 223 ALA A 220 ALA^? 24.28 CL CL A 383 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -47.82 75.77 126.56 -49.90 76.10 126.41 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -52.89 78.90 131.37 -53.77 80.20 132.79 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -59.62 83.10 120.76 -58.13 83.57 120.73 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 A 114 HIS A 157 HIS~? 12.03 CL CL A 383 A 197 ASP A 144 ASP.? 19.38 CL CL A 383 A 223 ALA A 261 ALA~? 24.23 CL CL A 383 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -47.82 75.77 126.56 -49.90 76.10 126.41 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -52.89 78.90 131.37 -53.77 80.20 132.79 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -51.30 87.37 119.20 -51.49 87.39 120.67 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 A 114 HIS A 232 HIS.? 26.22 CL CL A 383 A 197 ASP A 233 ASP.? 30.79 CL CL A 383 A 223 ALA A 261 ALA~? 24.23 CL CL A 383 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -64.09 81.45 120.95 -63.65 79.66 121.95 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -64.45 88.75 121.31 -62.88 88.68 122.75 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -51.30 87.37 119.20 -51.49 87.39 120.67 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 A 114 HIS A 308 HIS.? 20.06 CL CL A 384 A 197 ASP A 306 ASP.? 16.66 CL CL A 384 A 223 ALA A 312 ALA^? 16.34 CL CL A 384 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -37.01 64.37 91.64 -38.79 63.83 92.62 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -29.63 66.56 87.01 -28.35 68.29 87.20 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -32.59 73.91 96.33 -34.10 73.68 96.50 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 A 114 HIS B 157 HIS~? 12.80 CL CL B 384 A 197 ASP B 144 ASP.? 18.90 CL CL B 384 A 223 ALA B 103 ALA.? 10.27 CL CL B 384 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 0.17 24.88 70.38 1.86 23.62 70.32 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 1.70 18.75 65.96 3.42 18.04 64.94 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -9.13 23.29 63.46 -7.92 23.41 64.32 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 8 3 # 8 A 114 HIS B 157 HIS~? 12.80 CL CL B 384 A 197 ASP B 144 ASP.? 18.90 CL CL B 384 A 223 ALA B 116 ALA~? 16.91 CL CL B 384 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 0.17 24.88 70.38 1.86 23.62 70.32 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 1.70 18.75 65.96 3.42 18.04 64.94 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -1.44 31.83 60.52 -0.43 31.15 61.47 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 9 3 # 9 A 114 HIS B 157 HIS~? 12.80 CL CL B 384 A 197 ASP B 144 ASP.? 18.90 CL CL B 384 A 223 ALA B 261 ALA~? 23.36 CL CL B 384 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 0.17 24.88 70.38 1.86 23.62 70.32 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 1.70 18.75 65.96 3.42 18.04 64.94 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 12.35 28.11 71.85 11.96 27.24 70.64 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 10 3 # 10 A 114 HIS B 308 HIS.? 26.99 CL CL A 384 A 197 ASP B 306 ASP.? 19.57 CL CL A 384 A 223 ALA B 312 ALA^? 24.95 CL CL B 383 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -5.09 45.35 102.63 -4.80 43.27 102.76 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -4.64 54.84 103.01 -3.71 56.24 101.58 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 0.48 49.99 93.21 0.84 48.52 93.53 1n2t_c02 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 10 hits 1n2t_c02 naa= 3 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 B 114 HIS A 157 HIS~? 12.03 CL CL A 383 B 197 ASP A 144 ASP.? 19.38 CL CL A 383 B 223 ALA A 103 ALA.? 10.33 CL CL A 383 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -47.82 75.77 126.56 -49.90 76.10 126.41 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -52.89 78.90 131.37 -53.77 80.20 132.79 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -43.22 70.84 135.69 -44.02 71.58 134.57 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 B 114 HIS A 157 HIS~? 12.03 CL CL A 383 B 197 ASP A 144 ASP.? 19.38 CL CL A 383 B 223 ALA A 116 ALA~? 16.96 CL CL A 383 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -47.82 75.77 126.56 -49.90 76.10 126.41 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -52.89 78.90 131.37 -53.77 80.20 132.79 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -38.30 80.83 132.45 -39.59 81.12 131.73 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 B 114 HIS A 157 HIS~? 12.03 CL CL A 383 B 197 ASP A 144 ASP.? 19.38 CL CL A 383 B 223 ALA A 220 ALA^? 24.28 CL CL A 383 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -47.82 75.77 126.56 -49.90 76.10 126.41 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -52.89 78.90 131.37 -53.77 80.20 132.79 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -59.62 83.10 120.76 -58.13 83.57 120.73 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 B 114 HIS A 157 HIS~? 12.03 CL CL A 383 B 197 ASP A 144 ASP.? 19.38 CL CL A 383 B 223 ALA A 261 ALA~? 24.23 CL CL A 383 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -47.82 75.77 126.56 -49.90 76.10 126.41 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -52.89 78.90 131.37 -53.77 80.20 132.79 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -51.30 87.37 119.20 -51.49 87.39 120.67 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 B 114 HIS A 232 HIS.? 26.22 CL CL A 383 B 197 ASP A 233 ASP.? 30.79 CL CL A 383 B 223 ALA A 261 ALA~? 24.23 CL CL A 383 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -64.09 81.45 120.95 -63.65 79.66 121.95 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -64.45 88.75 121.31 -62.88 88.68 122.75 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -51.30 87.37 119.20 -51.49 87.39 120.67 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 B 114 HIS A 308 HIS.? 20.06 CL CL A 384 B 197 ASP A 306 ASP.? 16.66 CL CL A 384 B 223 ALA A 312 ALA^? 16.34 CL CL A 384 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -37.01 64.37 91.64 -38.79 63.83 92.62 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -29.63 66.56 87.01 -28.35 68.29 87.20 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -32.59 73.91 96.33 -34.10 73.68 96.50 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 B 114 HIS B 157 HIS~? 12.80 CL CL B 384 B 197 ASP B 144 ASP.? 18.90 CL CL B 384 B 223 ALA B 103 ALA.? 10.27 CL CL B 384 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 0.17 24.88 70.38 1.86 23.62 70.32 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 1.70 18.75 65.96 3.42 18.04 64.94 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -9.13 23.29 63.46 -7.92 23.41 64.32 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 8 3 # 8 B 114 HIS B 157 HIS~? 12.80 CL CL B 384 B 197 ASP B 144 ASP.? 18.90 CL CL B 384 B 223 ALA B 116 ALA~? 16.91 CL CL B 384 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 0.17 24.88 70.38 1.86 23.62 70.32 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 1.70 18.75 65.96 3.42 18.04 64.94 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -1.44 31.83 60.52 -0.43 31.15 61.47 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 9 3 # 9 B 114 HIS B 157 HIS~? 12.80 CL CL B 384 B 197 ASP B 144 ASP.? 18.90 CL CL B 384 B 223 ALA B 261 ALA~? 23.36 CL CL B 384 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 0.17 24.88 70.38 1.86 23.62 70.32 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 1.70 18.75 65.96 3.42 18.04 64.94 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 12.35 28.11 71.85 11.96 27.24 70.64 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 10 3 # 10 B 114 HIS B 308 HIS.? 26.99 CL CL A 384 B 197 ASP B 306 ASP.? 19.57 CL CL A 384 B 223 ALA B 312 ALA^? 24.95 CL CL B 383 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -5.09 45.35 102.63 -4.80 43.27 102.76 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -4.64 54.84 103.01 -3.71 56.24 101.58 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 0.48 49.99 93.21 0.84 48.52 93.53 1n2t_c03 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 10 hits 1n2t_c03 naa= 3 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 1 3 # 1 A 264 HIS A 246 HIS.? 33.92 CL CL A 383 A 290 LYS A 249 LYS^? 20.12 CL CL A 383 A 405 ARG A 212 ARG.? 30.01 CL CL A 382 coo 41.33 25.99 28.05 41.95 26.95 29.80 -65.97 72.19 102.08 -66.87 73.22 103.68 coo 37.11 33.75 31.82 38.72 27.95 29.90 -61.09 73.36 110.22 -57.90 69.98 113.58 coo 42.28 27.98 41.30 43.16 28.14 38.35 -52.31 71.44 100.68 -54.00 71.15 98.10 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 2 3 # 2 A 264 HIS B 246 HIS.? 32.95 CL CL B 384 A 290 LYS B 249 LYS^? 19.48 CL CL B 384 A 405 ARG B 212 ARG.? 28.47 CL CL B 383 coo 41.33 25.99 28.05 41.95 26.95 29.80 10.60 18.26 97.26 11.24 17.08 95.63 coo 37.11 33.75 31.82 38.72 27.95 29.90 7.49 19.68 88.46 2.17 20.34 86.44 coo 42.28 27.98 41.30 43.16 28.14 38.35 3.61 30.30 95.57 4.45 30.88 98.48 1nhx_c00 source 1nhx PHOSPHOENOLPYRUVATE CARBOXYKINASE, CYTOSOLIC : 2 hits 1nhx_c00 naa= 3 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 B 59 GLU A 23 GLU.? 27.24 CL CL A 382 B 128 HIS A 78 HIS^? 30.68 CL CL A 382 C 263 HIS A 19 HIS^? 24.55 CL CL A 382 coo 6.12 5.94 82.00 7.16 6.32 83.81 -22.84 44.28 116.17 -23.55 42.53 115.22 coo 12.51 16.35 80.99 13.16 14.90 82.37 -24.82 39.60 128.09 -23.39 38.20 127.48 coo 11.58 14.94 93.26 12.25 14.03 91.50 -17.70 51.01 127.32 -17.43 50.94 129.40 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 B 59 GLU B 23 GLU.? 22.91 CL CL B 382 B 128 HIS B 19 HIS^? 13.92 CL CL B 382 C 263 HIS B 78 HIS^? 26.83 CL CL B 382 coo 6.12 5.94 82.00 7.16 6.32 83.81 -35.83 43.78 85.87 -35.49 42.75 87.75 coo 12.51 16.35 80.99 13.16 14.90 82.37 -33.46 45.18 72.05 -34.46 43.90 70.71 coo 11.58 14.94 93.26 12.25 14.03 91.50 -41.15 34.55 77.14 -42.58 35.82 77.99 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 3 3 # 3 B 59 GLU B 23 GLU.? 22.91 CL CL B 382 B 128 HIS B 78 HIS^? 26.83 CL CL B 382 C 263 HIS B 19 HIS^? 13.92 CL CL B 382 coo 6.12 5.94 82.00 7.16 6.32 83.81 -35.83 43.78 85.87 -35.49 42.75 87.75 coo 12.51 16.35 80.99 13.16 14.90 82.37 -41.15 34.55 77.14 -42.58 35.82 77.99 coo 11.58 14.94 93.26 12.25 14.03 91.50 -33.46 45.18 72.05 -34.46 43.90 70.71 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 4 3 # 4 B 59 GLU B 57 GLU.? 21.35 CL CL B 382 B 128 HIS B 19 HIS^? 13.92 CL CL B 382 C 263 HIS B 78 HIS^? 26.83 CL CL B 382 coo 6.12 5.94 82.00 7.16 6.32 83.81 -31.25 37.00 65.18 -31.15 36.75 63.13 coo 12.51 16.35 80.99 13.16 14.90 82.37 -33.46 45.18 72.05 -34.46 43.90 70.71 coo 11.58 14.94 93.26 12.25 14.03 91.50 -41.15 34.55 77.14 -42.58 35.82 77.99 1ni4_c00 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 4 hits 1ni4_c00 naa= 3 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 A 263 HIS A 19 HIS^? 24.55 CL CL A 382 D 59 GLU A 23 GLU.? 27.24 CL CL A 382 D 128 HIS A 78 HIS^? 30.68 CL CL A 382 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -17.70 51.01 127.32 -17.43 50.94 129.40 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -22.84 44.28 116.17 -23.55 42.53 115.22 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -24.82 39.60 128.09 -23.39 38.20 127.48 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 A 263 HIS B 19 HIS^? 13.92 CL CL B 382 D 59 GLU B 23 GLU.? 22.91 CL CL B 382 D 128 HIS B 78 HIS^? 26.83 CL CL B 382 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -33.46 45.18 72.05 -34.46 43.90 70.71 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -35.83 43.78 85.87 -35.49 42.75 87.75 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -41.15 34.55 77.14 -42.58 35.82 77.99 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 3 3 # 3 A 263 HIS B 78 HIS^? 26.83 CL CL B 382 D 59 GLU B 23 GLU.? 22.91 CL CL B 382 D 128 HIS B 19 HIS^? 13.92 CL CL B 382 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -41.15 34.55 77.14 -42.58 35.82 77.99 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -35.83 43.78 85.87 -35.49 42.75 87.75 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -33.46 45.18 72.05 -34.46 43.90 70.71 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 4 3 # 4 A 263 HIS B 78 HIS^? 26.83 CL CL B 382 D 59 GLU B 57 GLU.? 21.35 CL CL B 382 D 128 HIS B 19 HIS^? 13.92 CL CL B 382 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -41.15 34.55 77.14 -42.58 35.82 77.99 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -31.25 37.00 65.18 -31.15 36.75 63.13 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -33.46 45.18 72.05 -34.46 43.90 70.71 1ni4_c01 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 4 hits 1ni4_c01 naa= 3 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 1 3 # 1 549 LYS A 118 LYS~? 20.77 CL CL A 382 631 LYS A 268 LYS~? 13.60 CL CL A 382 708 LYS A 128 LYS.? 19.46 CL CL A 382 coo 8.61 33.06 11.15 10.12 29.19 8.82 -33.32 78.46 133.27 -29.10 83.17 132.15 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -47.11 79.10 113.63 -43.53 76.03 116.02 coo 18.16 32.86 9.85 16.06 28.20 13.56 -25.12 72.76 133.10 -20.68 68.32 134.09 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 2 3 # 2 549 LYS A 128 LYS.? 19.46 CL CL A 382 631 LYS A 17 LYS^? 30.54 CL CL A 382 708 LYS A 118 LYS~? 20.77 CL CL A 382 coo 8.61 33.06 11.15 10.12 29.19 8.82 -25.12 72.76 133.10 -20.68 68.32 134.09 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -13.97 54.79 130.31 -12.29 50.22 133.16 coo 18.16 32.86 9.85 16.06 28.20 13.56 -33.32 78.46 133.27 -29.10 83.17 132.15 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 3 3 # 3 549 LYS B 118 LYS~? 18.42 CL CL B 383 631 LYS B 264 LYS~? 21.76 CL CL B 383 708 LYS B 128 LYS.? 19.37 CL CL B 383 coo 8.61 33.06 11.15 10.12 29.19 8.82 -5.67 35.14 59.53 -5.83 40.14 58.40 coo -11.99 27.40 17.14 -13.60 24.52 11.71 11.01 31.36 75.69 9.79 34.42 71.26 coo 18.16 32.86 9.85 16.06 28.20 13.56 -13.49 41.25 59.55 -18.50 40.98 58.08 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 4 3 # 4 549 LYS B 128 LYS.? 19.37 CL CL B 383 631 LYS B 17 LYS^? 18.67 CL CL B 382 708 LYS B 118 LYS~? 18.42 CL CL B 383 coo 8.61 33.06 11.15 10.12 29.19 8.82 -13.49 41.25 59.55 -18.50 40.98 58.08 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -33.42 46.60 66.26 -37.89 44.12 63.72 coo 18.16 32.86 9.85 16.06 28.20 13.56 -5.67 35.14 59.53 -5.83 40.14 58.40 1nsf_c00 source 1nsf N-ETHYLMALEIMIDE SENSITIVE FACTOR : 4 hits 1nsf_c00 naa= 3 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG A 320 ARG^? 16.18 CL CL A 382 A 101 ASP A 28 ASP^? 9.02 CL CL A 382 A 132 ASP A 39 ASP^? 16.51 CL CL A 382 coo 11.61 22.83 17.30 14.06 21.71 15.78 -32.10 56.68 112.17 -32.95 53.99 110.90 coo 11.37 24.94 11.48 12.48 24.45 13.28 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 16.14 18.17 13.37 15.92 19.81 14.71 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG B 320 ARG^? 13.22 CL CL B 383 A 101 ASP B 28 ASP^? 9.00 CL CL B 383 A 132 ASP B 39 ASP^? 17.51 CL CL B 383 coo 11.61 22.83 17.30 14.06 21.71 15.78 -19.20 39.56 86.12 -20.64 37.04 85.01 coo 11.37 24.94 11.48 12.48 24.45 13.28 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 16.14 18.17 13.37 15.92 19.81 14.71 -26.18 36.85 80.53 -27.97 36.10 81.34 1nu3_c00 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 2 hits 1nu3_c00 naa= 3 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG A 320 ARG^? 16.18 CL CL A 382 B 101 ASP A 28 ASP^? 9.02 CL CL A 382 B 132 ASP A 39 ASP^? 16.51 CL CL A 382 coo 11.61 3.43 18.38 9.11 4.29 16.86 -32.10 56.68 112.17 -32.95 53.99 110.90 coo 11.74 0.51 12.98 10.75 1.32 14.67 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 6.93 7.52 14.08 7.18 6.08 15.65 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG B 320 ARG^? 13.22 CL CL B 383 B 101 ASP B 28 ASP^? 9.00 CL CL B 383 B 132 ASP B 39 ASP^? 17.51 CL CL B 383 coo 11.61 3.43 18.38 9.11 4.29 16.86 -19.20 39.56 86.12 -20.64 37.04 85.01 coo 11.74 0.51 12.98 10.75 1.32 14.67 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 6.93 7.52 14.08 7.18 6.08 15.65 -26.18 36.85 80.53 -27.97 36.10 81.34 1nu3_c01 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 2 hits 1nu3_c01 naa= 3 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG A 320 ARG^? 16.18 CL CL A 382 A 101 ASP A 28 ASP^? 9.02 CL CL A 382 A 132 ASP A 39 ASP^? 16.51 CL CL A 382 coo 11.50 22.77 17.24 14.00 21.62 15.86 -32.10 56.68 112.17 -32.95 53.99 110.90 coo 11.19 25.00 11.76 12.16 24.45 13.59 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 16.04 18.11 13.43 15.88 19.70 14.83 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG B 320 ARG^? 13.22 CL CL B 383 A 101 ASP B 28 ASP^? 9.00 CL CL B 383 A 132 ASP B 39 ASP^? 17.51 CL CL B 383 coo 11.50 22.77 17.24 14.00 21.62 15.86 -19.20 39.56 86.12 -20.64 37.04 85.01 coo 11.19 25.00 11.76 12.16 24.45 13.59 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 16.04 18.11 13.43 15.88 19.70 14.83 -26.18 36.85 80.53 -27.97 36.10 81.34 1nww_c02 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 2 hits 1nww_c02 naa= 3 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG A 320 ARG^? 16.18 CL CL A 382 B 101 ASP A 28 ASP^? 9.02 CL CL A 382 B 132 ASP A 39 ASP^? 16.51 CL CL A 382 coo 11.48 3.09 18.25 9.01 4.07 16.77 -32.10 56.68 112.17 -32.95 53.99 110.90 coo 11.83 0.33 13.01 10.88 1.04 14.81 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 6.85 7.33 14.07 7.10 5.88 15.60 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG B 320 ARG^? 13.22 CL CL B 383 B 101 ASP B 28 ASP^? 9.00 CL CL B 383 B 132 ASP B 39 ASP^? 17.51 CL CL B 383 coo 11.48 3.09 18.25 9.01 4.07 16.77 -19.20 39.56 86.12 -20.64 37.04 85.01 coo 11.83 0.33 13.01 10.88 1.04 14.81 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 6.85 7.33 14.07 7.10 5.88 15.60 -26.18 36.85 80.53 -27.97 36.10 81.34 1nww_c03 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 2 hits 1nww_c03 naa= 3 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 1 3 # 1 A 62 SER A 29 SER^? 6.92 CL CL A 382 A 154 ASP A 26 ASP^? 16.59 CL CL A 382 A 261 ARG A 319 ARG^? 9.49 CL CL A 382 coo 16.10 74.10 3.11 17.18 73.52 5.20 -31.31 63.66 116.96 -29.07 63.86 117.79 coo 16.07 84.71 8.14 15.20 82.81 8.14 -29.69 53.68 115.80 -29.91 52.24 114.24 coo 10.59 77.85 4.81 13.09 76.36 5.76 -27.23 63.29 112.77 -27.13 63.50 115.87 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 2 3 # 2 A 62 SER A 29 SER^? 6.92 CL CL A 382 A 154 ASP A 39 ASP^? 16.51 CL CL A 382 A 261 ARG A 320 ARG^? 16.18 CL CL A 382 coo 16.10 74.10 3.11 17.18 73.52 5.20 -31.31 63.66 116.96 -29.07 63.86 117.79 coo 16.07 84.71 8.14 15.20 82.81 8.14 -29.94 52.12 119.85 -30.97 50.72 120.81 coo 10.59 77.85 4.81 13.09 76.36 5.76 -32.10 56.68 112.17 -32.95 53.99 110.90 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 3 3 # 3 A 62 SER A 75 SER^? 18.58 CL CL A 382 A 154 ASP A 39 ASP^? 16.51 CL CL A 382 A 261 ARG A 77 ARG^? 19.95 CL CL A 382 coo 16.10 74.10 3.11 17.18 73.52 5.20 -31.35 50.08 129.54 -32.67 49.67 127.52 coo 16.07 84.71 8.14 15.20 82.81 8.14 -29.94 52.12 119.85 -30.97 50.72 120.81 coo 10.59 77.85 4.81 13.09 76.36 5.76 -32.32 44.63 125.30 -31.80 47.66 125.44 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 4 3 # 4 A 62 SER A 88 SER^? 22.34 CL CL A 382 A 154 ASP A 26 ASP^? 16.59 CL CL A 382 A 261 ARG A 24 ARG^? 24.95 CL CL A 382 coo 16.10 74.10 3.11 17.18 73.52 5.20 -26.75 46.25 123.96 -28.99 45.42 123.71 coo 16.07 84.71 8.14 15.20 82.81 8.14 -29.69 53.68 115.80 -29.91 52.24 114.24 coo 10.59 77.85 4.81 13.09 76.36 5.76 -27.53 46.21 115.11 -27.47 43.33 116.18 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 5 3 # 5 A 62 SER A 90 SER^? 16.73 CL CL A 382 A 154 ASP A 28 ASP^? 9.02 CL CL A 382 A 261 ARG A 92 ARG^? 9.37 CL CL A 383 coo 16.10 74.10 3.11 17.18 73.52 5.20 -29.94 52.31 124.96 -31.33 50.74 123.89 coo 16.07 84.71 8.14 15.20 82.81 8.14 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 10.59 77.85 4.81 13.09 76.36 5.76 -35.59 58.66 126.41 -36.79 59.05 129.24 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 6 3 # 6 A 62 SER A 90 SER^? 16.73 CL CL A 382 A 154 ASP A 36 ASP.? -3.33 CL CL A 382s A 261 ARG A 92 ARG^? 9.37 CL CL A 383 coo 16.10 74.10 3.11 17.18 73.52 5.20 -29.94 52.31 124.96 -31.33 50.74 123.89 coo 16.07 84.71 8.14 15.20 82.81 8.14 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 10.59 77.85 4.81 13.09 76.36 5.76 -35.59 58.66 126.41 -36.79 59.05 129.24 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 7 3 # 7 A 62 SER A 90 SER^? 16.73 CL CL A 382 A 154 ASP A 93 ASP^? 5.15 CL CL A 382 A 261 ARG A 92 ARG^? 9.37 CL CL A 383 coo 16.10 74.10 3.11 17.18 73.52 5.20 -29.94 52.31 124.96 -31.33 50.74 123.89 coo 16.07 84.71 8.14 15.20 82.81 8.14 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 10.59 77.85 4.81 13.09 76.36 5.76 -35.59 58.66 126.41 -36.79 59.05 129.24 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 8 3 # 8 A 62 SER A 196 SER.? 14.25 CL CL A 384 A 154 ASP B 195 ASP.? 10.47 CL CL A 384 A 261 ARG B 290 ARG.? 12.49 CL CL A 384 coo 16.10 74.10 3.11 17.18 73.52 5.20 -19.39 59.32 90.69 -17.16 59.45 89.72 coo 16.07 84.71 8.14 15.20 82.81 8.14 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 10.59 77.85 4.81 13.09 76.36 5.76 -13.01 59.15 90.41 -14.60 61.38 91.89 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 9 3 # 9 A 62 SER A 196 SER.? 14.25 CL CL A 384 A 154 ASP B 291 ASP.? 20.64 CL CL B 382 A 261 ARG A 197 ARG.? 14.16 CL CL A 384 coo 16.10 74.10 3.11 17.18 73.52 5.20 -19.39 59.32 90.69 -17.16 59.45 89.72 coo 16.07 84.71 8.14 15.20 82.81 8.14 -11.26 60.51 82.59 -9.94 61.37 84.03 coo 10.59 77.85 4.81 13.09 76.36 5.76 -16.42 65.00 90.05 -16.47 67.55 88.20 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 10 3 # 10 A 62 SER A 196 SER.? 14.25 CL CL A 384 A 154 ASP B 291 ASP.? 20.64 CL CL B 382 A 261 ARG B 290 ARG.? 12.49 CL CL A 384 coo 16.10 74.10 3.11 17.18 73.52 5.20 -19.39 59.32 90.69 -17.16 59.45 89.72 coo 16.07 84.71 8.14 15.20 82.81 8.14 -11.26 60.51 82.59 -9.94 61.37 84.03 coo 10.59 77.85 4.81 13.09 76.36 5.76 -13.01 59.15 90.41 -14.60 61.38 91.89 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 11 3 # 11 A 62 SER A 214 SER.? 31.20 CL CL A 383 A 154 ASP A 210 ASP.? 21.69 CL CL A 383 A 261 ARG A 212 ARG.? 30.01 CL CL A 382 coo 16.10 74.10 3.11 17.18 73.52 5.20 -59.02 74.87 102.57 -61.42 74.47 102.83 coo 16.07 84.71 8.14 15.20 82.81 8.14 -52.58 64.68 106.89 -53.21 62.78 107.37 coo 10.59 77.85 4.81 13.09 76.36 5.76 -52.31 71.44 100.68 -54.00 71.15 98.10 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 12 3 # 12 A 62 SER A 214 SER.? 31.20 CL CL A 383 A 154 ASP A 210 ASP.? 21.69 CL CL A 383 A 261 ARG A 247 ARG.? 25.12 CL CL A 383 coo 16.10 74.10 3.11 17.18 73.52 5.20 -59.02 74.87 102.57 -61.42 74.47 102.83 coo 16.07 84.71 8.14 15.20 82.81 8.14 -52.58 64.68 106.89 -53.21 62.78 107.37 coo 10.59 77.85 4.81 13.09 76.36 5.76 -59.24 68.01 103.62 -57.26 66.97 105.71 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 13 3 # 13 A 62 SER A 324 SER^? 19.72 CL CL A 384 A 154 ASP A 39 ASP^? 16.51 CL CL A 382 A 261 ARG A 24 ARG^? 24.95 CL CL A 382 coo 16.10 74.10 3.11 17.18 73.52 5.20 -24.77 48.15 110.31 -26.00 48.61 108.19 coo 16.07 84.71 8.14 15.20 82.81 8.14 -29.94 52.12 119.85 -30.97 50.72 120.81 coo 10.59 77.85 4.81 13.09 76.36 5.76 -27.53 46.21 115.11 -27.47 43.33 116.18 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 14 3 # 14 A 62 SER B 29 SER^? 6.98 CL CL B 383 A 154 ASP B 26 ASP^? 16.51 CL CL B 383 A 261 ARG B 319 ARG^? 9.63 CL CL B 383 coo 16.10 74.10 3.11 17.18 73.52 5.20 -14.55 40.12 78.88 -15.61 41.67 77.42 coo 16.07 84.71 8.14 15.20 82.81 8.14 -23.45 39.33 83.60 -24.23 39.48 85.53 coo 10.59 77.85 4.81 13.09 76.36 5.76 -15.74 45.22 81.80 -15.96 44.19 78.93 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 15 3 # 15 A 62 SER B 29 SER^? 6.98 CL CL B 383 A 154 ASP B 39 ASP^? 17.51 CL CL B 383 A 261 ARG B 320 ARG^? 13.22 CL CL B 383 coo 16.10 74.10 3.11 17.18 73.52 5.20 -14.55 40.12 78.88 -15.61 41.67 77.42 coo 16.07 84.71 8.14 15.20 82.81 8.14 -26.18 36.85 80.53 -27.97 36.10 81.34 coo 10.59 77.85 4.81 13.09 76.36 5.76 -19.20 39.56 86.12 -20.64 37.04 85.01 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 16 3 # 16 A 62 SER B 90 SER^? 16.63 CL CL B 383 A 154 ASP B 28 ASP^? 9.00 CL CL B 383 A 261 ARG B 92 ARG^? 9.18 CL CL B 384 coo 16.10 74.10 3.11 17.18 73.52 5.20 -27.25 35.25 76.13 -27.68 33.11 77.15 coo 16.07 84.71 8.14 15.20 82.81 8.14 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 10.59 77.85 4.81 13.09 76.36 5.76 -19.73 31.24 73.98 -19.77 29.09 71.81 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 17 3 # 17 A 62 SER B 90 SER^? 16.63 CL CL B 383 A 154 ASP B 36 ASP.? -3.35 CL CL B 383s A 261 ARG B 92 ARG^? 9.18 CL CL B 384 coo 16.10 74.10 3.11 17.18 73.52 5.20 -27.25 35.25 76.13 -27.68 33.11 77.15 coo 16.07 84.71 8.14 15.20 82.81 8.14 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 10.59 77.85 4.81 13.09 76.36 5.76 -19.73 31.24 73.98 -19.77 29.09 71.81 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 18 3 # 18 A 62 SER B 214 SER.? 30.49 CL CL B 384 A 154 ASP B 210 ASP.? 22.05 CL CL B 384 A 261 ARG B 212 ARG.? 28.47 CL CL B 383 coo 16.10 74.10 3.11 17.18 73.52 5.20 10.35 24.86 94.00 10.52 22.52 94.66 coo 16.07 84.71 8.14 15.20 82.81 8.14 -2.53 25.11 93.69 -2.62 22.87 93.62 coo 10.59 77.85 4.81 13.09 76.36 5.76 3.61 30.30 95.57 4.45 30.88 98.48 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 19 3 # 19 A 62 SER B 214 SER.? 30.49 CL CL B 384 A 154 ASP B 210 ASP.? 22.05 CL CL B 384 A 261 ARG B 247 ARG.? 24.65 CL CL B 384 coo 16.10 74.10 3.11 17.18 73.52 5.20 10.35 24.86 94.00 10.52 22.52 94.66 coo 16.07 84.71 8.14 15.20 82.81 8.14 -2.53 25.11 93.69 -2.62 22.87 93.62 coo 10.59 77.85 4.81 13.09 76.36 5.76 4.27 22.84 96.19 1.85 22.99 94.25 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 20 3 # 20 A 62 SER B 324 SER^? 22.60 CL CL B 382 A 154 ASP B 39 ASP^? 17.51 CL CL B 383 A 261 ARG B 24 ARG^? 24.13 CL CL B 382 coo 16.10 74.10 3.11 17.18 73.52 5.20 -28.77 44.19 89.22 -27.33 44.36 91.21 coo 16.07 84.71 8.14 15.20 82.81 8.14 -26.18 36.85 80.53 -27.97 36.10 81.34 coo 10.59 77.85 4.81 13.09 76.36 5.76 -30.86 40.03 86.77 -33.42 38.25 86.47 1o98_c00 source 1o98 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT PHOSPHOGLY: 20 hits 1o98_c00 naa= 3 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 1 3 # 1 A 1 CYH A 101 CYH~? 11.13 CL CL A 383 A 903 GLU A 332 GLU^? 14.84 CL CL A 382 A 972 LYS A 336 LYS^? 14.72 CL CL A 382 coo 88.42 112.53 24.94 87.72 110.88 27.11 -40.55 64.55 135.33 -37.87 63.85 136.08 coo 61.58 117.15 13.99 62.31 115.51 15.12 -32.41 59.20 107.78 -33.78 57.91 108.78 coo 60.18 107.64 21.53 58.13 110.55 17.14 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 2 3 # 2 A 1 CYH B 101 CYH~? 11.10 CL CL B 384 A 903 GLU B 332 GLU^? 14.76 CL CL B 383 A 972 LYS B 336 LYS^? 14.66 CL CL B 383 coo 88.42 112.53 24.94 87.72 110.88 27.11 -15.29 24.34 65.44 -17.25 26.12 64.31 coo 61.58 117.15 13.99 62.31 115.51 15.12 -15.56 41.56 89.17 -16.27 39.59 89.11 coo 60.18 107.64 21.53 58.13 110.55 17.14 -3.40 41.24 88.18 -4.83 35.96 88.60 1ofd_c02 source 1ofd FERREDOXIN-DEPENDENT GLUTAMATE SYNTHASE 2 : 2 hits 1ofd_c02 naa= 3 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 1 3 # 1 B 1 CYH A 101 CYH~? 11.13 CL CL A 383 B 903 GLU A 332 GLU^? 14.84 CL CL A 382 B 972 LYS A 336 LYS^? 14.72 CL CL A 382 coo 31.47 38.87 24.90 30.94 36.98 26.93 -40.55 64.55 135.33 -37.87 63.85 136.08 coo 4.13 40.53 14.21 5.06 38.89 15.19 -32.41 59.20 107.78 -33.78 57.91 108.78 coo 4.08 30.40 21.12 1.62 33.28 16.83 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 2 3 # 2 B 1 CYH B 101 CYH~? 11.10 CL CL B 384 B 903 GLU B 332 GLU^? 14.76 CL CL B 383 B 972 LYS B 336 LYS^? 14.66 CL CL B 383 coo 31.47 38.87 24.90 30.94 36.98 26.93 -15.29 24.34 65.44 -17.25 26.12 64.31 coo 4.13 40.53 14.21 5.06 38.89 15.19 -15.56 41.56 89.17 -16.27 39.59 89.11 coo 4.08 30.40 21.12 1.62 33.28 16.83 -3.40 41.24 88.18 -4.83 35.96 88.60 1ofd_c03 source 1ofd FERREDOXIN-DEPENDENT GLUTAMATE SYNTHASE 2 : 2 hits 1ofd_c03 naa= 3 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 A 175 LYS A 142 LYS.? 24.15 CL CL A 383 A 208 GLN A 265 GLN~? 18.63 CL CL A 383 A 209 LYS A 264 LYS~? 22.00 CL CL A 382 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -49.53 84.63 130.17 -55.13 85.19 133.14 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -49.86 82.23 119.29 -50.68 81.58 121.15 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -48.92 85.08 115.29 -44.06 86.61 118.76 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 A 175 LYS A 142 LYS.? 24.15 CL CL A 383 A 208 GLN A 265 GLN~? 18.63 CL CL A 383 A 209 LYS A 268 LYS~? 13.60 CL CL A 382 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -49.53 84.63 130.17 -55.13 85.19 133.14 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -49.86 82.23 119.29 -50.68 81.58 121.15 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -47.11 79.10 113.63 -43.53 76.03 116.02 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 3 # 3 A 175 LYS A 235 LYS^? 33.41 CL CL A 383 A 208 GLN A 265 GLN~? 18.63 CL CL A 383 A 209 LYS A 268 LYS~? 13.60 CL CL A 382 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -61.15 85.56 115.05 -65.37 84.74 110.73 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -49.86 82.23 119.29 -50.68 81.58 121.15 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -47.11 79.10 113.63 -43.53 76.03 116.02 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 4 3 # 4 A 175 LYS A 239 LYS^? 36.81 CL CL A 383 A 208 GLN A 263 GLN~? 29.79 CL CL A 383 A 209 LYS A 264 LYS~? 22.00 CL CL A 382 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -57.66 80.60 103.08 -61.70 85.06 101.44 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -52.22 87.13 111.93 -52.86 88.89 110.86 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -48.92 85.08 115.29 -44.06 86.61 118.76 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 5 3 # 5 A 175 LYS A 249 LYS^? 20.12 CL CL A 383 A 208 GLN A 269 GLN~? 16.14 CL CL A 383 A 209 LYS A 268 LYS~? 13.60 CL CL A 382 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -61.09 73.36 110.22 -57.90 69.98 113.58 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -51.90 74.98 113.67 -51.01 73.36 114.78 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -47.11 79.10 113.63 -43.53 76.03 116.02 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 6 3 # 6 A 175 LYS B 142 LYS.? 25.17 CL CL B 384 A 208 GLN B 265 GLN~? 18.67 CL CL B 384 A 209 LYS B 264 LYS~? 21.76 CL CL B 383 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 6.28 23.32 63.35 7.97 19.73 58.68 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 7.44 28.20 73.85 7.44 26.54 72.51 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 11.01 31.36 75.69 9.79 34.42 71.26 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 7 3 # 7 A 175 LYS B 235 LYS.? 32.14 CL CL B 384 A 208 GLN B 265 GLN~? 18.67 CL CL B 384 A 209 LYS B 268 LYS~? 13.29 CL CL B 383 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 16.30 20.77 78.71 18.07 18.48 84.31 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 7.44 28.20 73.85 7.44 26.54 72.51 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 5.99 32.14 79.72 1.11 32.64 77.72 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 8 3 # 8 A 175 LYS B 239 LYS^? 36.78 CL CL B 384 A 208 GLN B 263 GLN~? 29.36 CL CL B 384 A 209 LYS B 264 LYS~? 21.76 CL CL B 383 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 14.68 26.82 90.55 20.12 26.10 92.90 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 15.41 29.16 79.21 17.29 30.13 79.64 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 11.01 31.36 75.69 9.79 34.42 71.26 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 9 3 # 9 A 175 LYS B 249 LYS^? 19.48 CL CL B 384 A 208 GLN B 269 GLN~? 15.69 CL CL B 384 A 209 LYS B 268 LYS~? 13.29 CL CL B 383 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 7.49 19.68 88.46 2.17 20.34 86.44 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 4.24 26.64 82.24 2.13 26.75 81.88 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 5.99 32.14 79.72 1.11 32.64 77.72 1ohh_c06 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 9 hits 1ohh_c06 naa= 3 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 B 175 LYS A 142 LYS.? 24.15 CL CL A 383 B 208 GLN A 265 GLN~? 18.63 CL CL A 383 B 209 LYS A 264 LYS~? 22.00 CL CL A 382 coo 105.03 46.01 19.55 106.59 42.35 15.55 -49.53 84.63 130.17 -55.13 85.19 133.14 coo 113.93 46.99 13.56 113.37 48.52 14.95 -49.86 82.23 119.29 -50.68 81.58 121.15 coo 115.66 49.12 8.60 111.19 49.52 4.73 -48.92 85.08 115.29 -44.06 86.61 118.76 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 B 175 LYS A 235 LYS^? 33.41 CL CL A 383 B 208 GLN A 265 GLN~? 18.63 CL CL A 383 B 209 LYS A 268 LYS~? 13.60 CL CL A 382 coo 105.03 46.01 19.55 106.59 42.35 15.55 -61.15 85.56 115.05 -65.37 84.74 110.73 coo 113.93 46.99 13.56 113.37 48.52 14.95 -49.86 82.23 119.29 -50.68 81.58 121.15 coo 115.66 49.12 8.60 111.19 49.52 4.73 -47.11 79.10 113.63 -43.53 76.03 116.02 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 3 # 3 B 175 LYS A 239 LYS^? 36.81 CL CL A 383 B 208 GLN A 263 GLN~? 29.79 CL CL A 383 B 209 LYS A 264 LYS~? 22.00 CL CL A 382 coo 105.03 46.01 19.55 106.59 42.35 15.55 -57.66 80.60 103.08 -61.70 85.06 101.44 coo 113.93 46.99 13.56 113.37 48.52 14.95 -52.22 87.13 111.93 -52.86 88.89 110.86 coo 115.66 49.12 8.60 111.19 49.52 4.73 -48.92 85.08 115.29 -44.06 86.61 118.76 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 4 3 # 4 B 175 LYS A 249 LYS^? 20.12 CL CL A 383 B 208 GLN A 269 GLN~? 16.14 CL CL A 383 B 209 LYS A 267 LYS~? 27.66 CL CL A 382 coo 105.03 46.01 19.55 106.59 42.35 15.55 -61.09 73.36 110.22 -57.90 69.98 113.58 coo 113.93 46.99 13.56 113.37 48.52 14.95 -51.90 74.98 113.67 -51.01 73.36 114.78 coo 115.66 49.12 8.60 111.19 49.52 4.73 -49.43 81.28 111.60 -49.39 86.78 108.40 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 5 3 # 5 B 175 LYS A 249 LYS^? 20.12 CL CL A 383 B 208 GLN A 269 GLN~? 16.14 CL CL A 383 B 209 LYS A 268 LYS~? 13.60 CL CL A 382 coo 105.03 46.01 19.55 106.59 42.35 15.55 -61.09 73.36 110.22 -57.90 69.98 113.58 coo 113.93 46.99 13.56 113.37 48.52 14.95 -51.90 74.98 113.67 -51.01 73.36 114.78 coo 115.66 49.12 8.60 111.19 49.52 4.73 -47.11 79.10 113.63 -43.53 76.03 116.02 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 6 3 # 6 B 175 LYS B 142 LYS.? 25.17 CL CL B 384 B 208 GLN B 265 GLN~? 18.67 CL CL B 384 B 209 LYS B 264 LYS~? 21.76 CL CL B 383 coo 105.03 46.01 19.55 106.59 42.35 15.55 6.28 23.32 63.35 7.97 19.73 58.68 coo 113.93 46.99 13.56 113.37 48.52 14.95 7.44 28.20 73.85 7.44 26.54 72.51 coo 115.66 49.12 8.60 111.19 49.52 4.73 11.01 31.36 75.69 9.79 34.42 71.26 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 7 3 # 7 B 175 LYS B 235 LYS.? 32.14 CL CL B 384 B 208 GLN B 265 GLN~? 18.67 CL CL B 384 B 209 LYS B 268 LYS~? 13.29 CL CL B 383 coo 105.03 46.01 19.55 106.59 42.35 15.55 16.30 20.77 78.71 18.07 18.48 84.31 coo 113.93 46.99 13.56 113.37 48.52 14.95 7.44 28.20 73.85 7.44 26.54 72.51 coo 115.66 49.12 8.60 111.19 49.52 4.73 5.99 32.14 79.72 1.11 32.64 77.72 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 8 3 # 8 B 175 LYS B 239 LYS^? 36.78 CL CL B 384 B 208 GLN B 263 GLN~? 29.36 CL CL B 384 B 209 LYS B 264 LYS~? 21.76 CL CL B 383 coo 105.03 46.01 19.55 106.59 42.35 15.55 14.68 26.82 90.55 20.12 26.10 92.90 coo 113.93 46.99 13.56 113.37 48.52 14.95 15.41 29.16 79.21 17.29 30.13 79.64 coo 115.66 49.12 8.60 111.19 49.52 4.73 11.01 31.36 75.69 9.79 34.42 71.26 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 9 3 # 9 B 175 LYS B 249 LYS^? 19.48 CL CL B 384 B 208 GLN B 269 GLN~? 15.69 CL CL B 384 B 209 LYS B 267 LYS~? 27.57 CL CL B 383 coo 105.03 46.01 19.55 106.59 42.35 15.55 7.49 19.68 88.46 2.17 20.34 86.44 coo 113.93 46.99 13.56 113.37 48.52 14.95 4.24 26.64 82.24 2.13 26.75 81.88 coo 115.66 49.12 8.60 111.19 49.52 4.73 9.46 31.45 81.02 15.36 33.08 81.01 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 10 3 # 10 B 175 LYS B 249 LYS^? 19.48 CL CL B 384 B 208 GLN B 269 GLN~? 15.69 CL CL B 384 B 209 LYS B 268 LYS~? 13.29 CL CL B 383 coo 105.03 46.01 19.55 106.59 42.35 15.55 7.49 19.68 88.46 2.17 20.34 86.44 coo 113.93 46.99 13.56 113.37 48.52 14.95 4.24 26.64 82.24 2.13 26.75 81.88 coo 115.66 49.12 8.60 111.19 49.52 4.73 5.99 32.14 79.72 1.11 32.64 77.72 1ohh_c07 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 10 hits 1ohh_c07 naa= 3 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 C 175 LYS A 142 LYS.? 24.15 CL CL A 383 C 208 GLN A 265 GLN~? 18.63 CL CL A 383 C 209 LYS A 264 LYS~? 22.00 CL CL A 382 coo 100.54 -2.78 25.52 103.29 2.02 24.05 -49.53 84.63 130.17 -55.13 85.19 133.14 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 -49.86 82.23 119.29 -50.68 81.58 121.15 coo 113.62 1.19 33.65 109.52 3.92 36.47 -48.92 85.08 115.29 -44.06 86.61 118.76 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 C 175 LYS A 239 LYS^? 36.81 CL CL A 383 C 208 GLN A 263 GLN~? 29.79 CL CL A 383 C 209 LYS A 264 LYS~? 22.00 CL CL A 382 coo 100.54 -2.78 25.52 103.29 2.02 24.05 -57.66 80.60 103.08 -61.70 85.06 101.44 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 -52.22 87.13 111.93 -52.86 88.89 110.86 coo 113.62 1.19 33.65 109.52 3.92 36.47 -48.92 85.08 115.29 -44.06 86.61 118.76 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 3 # 3 C 175 LYS A 239 LYS^? 36.81 CL CL A 383 C 208 GLN A 269 GLN~? 16.14 CL CL A 383 C 209 LYS A 268 LYS~? 13.60 CL CL A 382 coo 100.54 -2.78 25.52 103.29 2.02 24.05 -57.66 80.60 103.08 -61.70 85.06 101.44 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 -51.90 74.98 113.67 -51.01 73.36 114.78 coo 113.62 1.19 33.65 109.52 3.92 36.47 -47.11 79.10 113.63 -43.53 76.03 116.02 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 4 3 # 4 C 175 LYS A 249 LYS^? 20.12 CL CL A 383 C 208 GLN A 269 GLN~? 16.14 CL CL A 383 C 209 LYS A 268 LYS~? 13.60 CL CL A 382 coo 100.54 -2.78 25.52 103.29 2.02 24.05 -61.09 73.36 110.22 -57.90 69.98 113.58 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 -51.90 74.98 113.67 -51.01 73.36 114.78 coo 113.62 1.19 33.65 109.52 3.92 36.47 -47.11 79.10 113.63 -43.53 76.03 116.02 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 5 3 # 5 C 175 LYS B 142 LYS.? 25.17 CL CL B 384 C 208 GLN B 265 GLN~? 18.67 CL CL B 384 C 209 LYS B 264 LYS~? 21.76 CL CL B 383 coo 100.54 -2.78 25.52 103.29 2.02 24.05 6.28 23.32 63.35 7.97 19.73 58.68 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 7.44 28.20 73.85 7.44 26.54 72.51 coo 113.62 1.19 33.65 109.52 3.92 36.47 11.01 31.36 75.69 9.79 34.42 71.26 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 6 3 # 6 C 175 LYS B 235 LYS.? 32.14 CL CL B 384 C 208 GLN B 269 GLN~? 15.69 CL CL B 384 C 209 LYS B 268 LYS~? 13.29 CL CL B 383 coo 100.54 -2.78 25.52 103.29 2.02 24.05 16.30 20.77 78.71 18.07 18.48 84.31 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 4.24 26.64 82.24 2.13 26.75 81.88 coo 113.62 1.19 33.65 109.52 3.92 36.47 5.99 32.14 79.72 1.11 32.64 77.72 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 7 3 # 7 C 175 LYS B 239 LYS^? 36.78 CL CL B 384 C 208 GLN B 263 GLN~? 29.36 CL CL B 384 C 209 LYS B 264 LYS~? 21.76 CL CL B 383 coo 100.54 -2.78 25.52 103.29 2.02 24.05 14.68 26.82 90.55 20.12 26.10 92.90 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 15.41 29.16 79.21 17.29 30.13 79.64 coo 113.62 1.19 33.65 109.52 3.92 36.47 11.01 31.36 75.69 9.79 34.42 71.26 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 8 3 # 8 C 175 LYS B 239 LYS^? 36.78 CL CL B 384 C 208 GLN B 269 GLN~? 15.69 CL CL B 384 C 209 LYS B 268 LYS~? 13.29 CL CL B 383 coo 100.54 -2.78 25.52 103.29 2.02 24.05 14.68 26.82 90.55 20.12 26.10 92.90 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 4.24 26.64 82.24 2.13 26.75 81.88 coo 113.62 1.19 33.65 109.52 3.92 36.47 5.99 32.14 79.72 1.11 32.64 77.72 1ohh_c08 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 8 hits 1ohh_c08 naa= 3 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 A 24 ASP A 195 ASP.? 13.29 CL CL A 384 A 146 TYR B 8 TYR.? 11.88 CL CL B 382 A 177 LYS B 288 LYS.? 8.84 CL CL B 382 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 1.87 119.38 16.45 1.41 122.11 16.84 -23.96 53.72 82.39 -21.76 54.53 83.93 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -16.76 54.22 83.25 -20.62 56.75 78.99 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 A 24 ASP B 195 ASP.? 10.47 CL CL A 384 A 146 TYR A 8 TYR.? 12.26 CL CL A 384 A 177 LYS A 288 LYS.? 12.57 CL CL A 384 coo -3.50 124.89 25.05 -2.25 124.77 23.26 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 1.87 119.38 16.45 1.41 122.11 16.84 -16.53 57.80 111.57 -17.14 59.34 109.36 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -19.18 64.09 108.25 -14.44 63.70 112.45 1ok4_c00 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c00 naa= 3 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 B 24 ASP A 195 ASP.? 13.29 CL CL A 384 B 146 TYR B 8 TYR.? 11.88 CL CL B 382 B 177 LYS B 288 LYS.? 8.84 CL CL B 382 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -23.96 53.72 82.39 -21.76 54.53 83.93 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -16.76 54.22 83.25 -20.62 56.75 78.99 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 B 24 ASP B 195 ASP.? 10.47 CL CL A 384 B 146 TYR A 8 TYR.? 12.26 CL CL A 384 B 177 LYS A 288 LYS.? 12.57 CL CL A 384 coo -7.43 109.06 51.23 -5.84 110.54 50.86 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -16.53 57.80 111.57 -17.14 59.34 109.36 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -19.18 64.09 108.25 -14.44 63.70 112.45 1ok4_c01 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c01 naa= 3 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 C 24 ASP A 195 ASP.? 13.29 CL CL A 384 C 146 TYR B 8 TYR.? 11.88 CL CL B 382 C 177 LYS B 288 LYS.? 8.84 CL CL B 382 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -22.13 62.52 88.27 -20.53 63.80 88.70 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -23.96 53.72 82.39 -21.76 54.53 83.93 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -16.76 54.22 83.25 -20.62 56.75 78.99 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 C 24 ASP B 195 ASP.? 10.47 CL CL A 384 C 146 TYR A 8 TYR.? 12.26 CL CL A 384 C 177 LYS A 288 LYS.? 12.57 CL CL A 384 coo -13.49 79.65 43.90 -12.13 80.29 45.45 -11.82 59.91 101.57 -11.61 61.10 99.82 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -16.53 57.80 111.57 -17.14 59.34 109.36 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -19.18 64.09 108.25 -14.44 63.70 112.45 1ok4_c02 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c02 naa= 3 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 D 24 ASP A 195 ASP.? 13.29 CL CL A 384 D 146 TYR B 8 TYR.? 11.88 CL CL B 382 D 177 LYS B 288 LYS.? 8.84 CL CL B 382 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -22.13 62.52 88.27 -20.53 63.80 88.70 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -23.96 53.72 82.39 -21.76 54.53 83.93 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -16.76 54.22 83.25 -20.62 56.75 78.99 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 D 24 ASP B 195 ASP.? 10.47 CL CL A 384 D 146 TYR A 8 TYR.? 12.26 CL CL A 384 D 177 LYS A 288 LYS.? 12.57 CL CL A 384 coo -13.44 77.36 13.12 -12.53 75.97 14.48 -11.82 59.91 101.57 -11.61 61.10 99.82 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -16.53 57.80 111.57 -17.14 59.34 109.36 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -19.18 64.09 108.25 -14.44 63.70 112.45 1ok4_c03 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c03 naa= 3 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 E 24 ASP A 195 ASP.? 13.29 CL CL A 384 E 146 TYR B 8 TYR.? 11.88 CL CL B 382 E 177 LYS B 288 LYS.? 8.84 CL CL B 382 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -22.13 62.52 88.27 -20.53 63.80 88.70 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -23.96 53.72 82.39 -21.76 54.53 83.93 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -16.76 54.22 83.25 -20.62 56.75 78.99 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 E 24 ASP B 195 ASP.? 10.47 CL CL A 384 E 146 TYR A 8 TYR.? 12.26 CL CL A 384 E 177 LYS A 288 LYS.? 12.57 CL CL A 384 coo -7.12 105.25 1.43 -6.30 103.34 0.77 -11.82 59.91 101.57 -11.61 61.10 99.82 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -16.53 57.80 111.57 -17.14 59.34 109.36 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -19.18 64.09 108.25 -14.44 63.70 112.45 1ok4_c04 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c04 naa= 3 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 F 24 ASP A 195 ASP.? 13.29 CL CL A 384 F 146 TYR B 8 TYR.? 11.88 CL CL B 382 F 177 LYS B 288 LYS.? 8.84 CL CL B 382 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -22.13 62.52 88.27 -20.53 63.80 88.70 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -23.96 53.72 82.39 -21.76 54.53 83.93 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -16.76 54.22 83.25 -20.62 56.75 78.99 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 F 24 ASP B 195 ASP.? 10.47 CL CL A 384 F 146 TYR A 8 TYR.? 12.26 CL CL A 384 F 177 LYS A 288 LYS.? 12.57 CL CL A 384 coo -44.75 128.15 10.28 -45.68 129.67 11.55 -11.82 59.91 101.57 -11.61 61.10 99.82 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -16.53 57.80 111.57 -17.14 59.34 109.36 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -19.18 64.09 108.25 -14.44 63.70 112.45 1ok4_c05 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c05 naa= 3 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 G 24 ASP A 195 ASP.? 13.29 CL CL A 384 G 146 TYR B 8 TYR.? 11.88 CL CL B 382 G 177 LYS B 288 LYS.? 8.84 CL CL B 382 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -22.13 62.52 88.27 -20.53 63.80 88.70 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -23.96 53.72 82.39 -21.76 54.53 83.93 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -16.76 54.22 83.25 -20.62 56.75 78.99 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 G 24 ASP B 195 ASP.? 10.47 CL CL A 384 G 146 TYR A 8 TYR.? 12.26 CL CL A 384 G 177 LYS A 288 LYS.? 12.57 CL CL A 384 coo -44.97 128.78 41.20 -46.32 128.26 42.83 -11.82 59.91 101.57 -11.61 61.10 99.82 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -16.53 57.80 111.57 -17.14 59.34 109.36 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -19.18 64.09 108.25 -14.44 63.70 112.45 1ok4_c06 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c06 naa= 3 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 H 24 ASP A 195 ASP.? 13.29 CL CL A 384 H 146 TYR B 8 TYR.? 11.88 CL CL B 382 H 177 LYS B 288 LYS.? 8.84 CL CL B 382 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -22.13 62.52 88.27 -20.53 63.80 88.70 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -23.96 53.72 82.39 -21.76 54.53 83.93 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -16.76 54.22 83.25 -20.62 56.75 78.99 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 H 24 ASP B 195 ASP.? 10.47 CL CL A 384 H 146 TYR A 8 TYR.? 12.26 CL CL A 384 H 177 LYS A 288 LYS.? 12.57 CL CL A 384 coo -51.11 100.30 51.41 -52.67 98.82 51.12 -11.82 59.91 101.57 -11.61 61.10 99.82 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -16.53 57.80 111.57 -17.14 59.34 109.36 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -19.18 64.09 108.25 -14.44 63.70 112.45 1ok4_c07 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c07 naa= 3 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 I 24 ASP A 195 ASP.? 13.29 CL CL A 384 I 146 TYR B 8 TYR.? 11.88 CL CL B 382 I 177 LYS B 288 LYS.? 8.84 CL CL B 382 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -22.13 62.52 88.27 -20.53 63.80 88.70 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -23.96 53.72 82.39 -21.76 54.53 83.93 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -16.76 54.22 83.25 -20.62 56.75 78.99 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 I 24 ASP B 195 ASP.? 10.47 CL CL A 384 I 146 TYR A 8 TYR.? 12.26 CL CL A 384 I 177 LYS A 288 LYS.? 12.57 CL CL A 384 coo -54.65 81.97 26.87 -55.88 81.89 25.07 -11.82 59.91 101.57 -11.61 61.10 99.82 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -16.53 57.80 111.57 -17.14 59.34 109.36 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -19.18 64.09 108.25 -14.44 63.70 112.45 1ok4_c08 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c08 naa= 3 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 J 24 ASP A 195 ASP.? 13.29 CL CL A 384 J 146 TYR B 8 TYR.? 11.88 CL CL B 382 J 177 LYS B 288 LYS.? 8.84 CL CL B 382 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -22.13 62.52 88.27 -20.53 63.80 88.70 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -23.96 53.72 82.39 -21.76 54.53 83.93 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -16.76 54.22 83.25 -20.62 56.75 78.99 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 J 24 ASP B 195 ASP.? 10.47 CL CL A 384 J 146 TYR A 8 TYR.? 12.26 CL CL A 384 J 177 LYS A 288 LYS.? 12.57 CL CL A 384 coo -50.64 99.08 1.52 -51.52 100.83 0.67 -11.82 59.91 101.57 -11.61 61.10 99.82 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -16.53 57.80 111.57 -17.14 59.34 109.36 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -19.18 64.09 108.25 -14.44 63.70 112.45 1ok4_c09 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c09 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP A 208 ASP.? 21.85 CL CL A 382 A 96 GLU A 337 GLU^? 21.89 CL CL A 382 A 132 LYS A 336 LYS^? 14.72 CL CL A 382 coo 31.23 12.29 16.44 30.82 11.56 18.39 -48.25 63.81 104.00 -49.74 63.21 105.24 coo 26.82 3.20 24.36 27.99 4.86 24.98 -40.07 74.65 102.17 -42.10 75.18 101.81 coo 29.99 0.62 22.18 30.38 6.69 20.81 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1onr_c00 TRANSALDOLASE B user 2 3 # 2 A 17 ASP A 272 ASP~? 14.48 CL CL A 382 A 96 GLU A 337 GLU^? 21.89 CL CL A 382 A 132 LYS A 336 LYS^? 14.72 CL CL A 382 coo 31.23 12.29 16.44 30.82 11.56 18.39 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 26.82 3.20 24.36 27.99 4.86 24.98 -40.07 74.65 102.17 -42.10 75.18 101.81 coo 29.99 0.62 22.18 30.38 6.69 20.81 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1onr_c00 TRANSALDOLASE B user 3 3 # 3 A 17 ASP B 208 ASP.? 21.56 CL CL B 383 A 96 GLU B 337 GLU^? 21.78 CL CL B 383 A 132 LYS B 336 LYS^? 14.66 CL CL B 383 coo 31.23 12.29 16.44 30.82 11.56 18.39 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 26.82 3.20 24.36 27.99 4.86 24.98 2.60 41.45 89.80 4.03 40.00 90.41 coo 29.99 0.62 22.18 30.38 6.69 20.81 -3.40 41.24 88.18 -4.83 35.96 88.60 ULMN 3 1onr_c00 TRANSALDOLASE B user 4 3 # 4 A 17 ASP B 272 ASP~? 14.11 CL CL B 383 A 96 GLU B 337 GLU^? 21.78 CL CL B 383 A 132 LYS B 336 LYS^? 14.66 CL CL B 383 coo 31.23 12.29 16.44 30.82 11.56 18.39 0.88 31.47 82.51 1.09 32.47 80.67 coo 26.82 3.20 24.36 27.99 4.86 24.98 2.60 41.45 89.80 4.03 40.00 90.41 coo 29.99 0.62 22.18 30.38 6.69 20.81 -3.40 41.24 88.18 -4.83 35.96 88.60 1onr_c00 source 1onr TRANSALDOLASE B : 4 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP A 208 ASP.? 21.85 CL CL A 382 B 96 GLU A 337 GLU^? 21.89 CL CL A 382 B 132 LYS A 336 LYS^? 14.72 CL CL A 382 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -48.25 63.81 104.00 -49.74 63.21 105.24 coo 26.69 48.45 7.18 27.85 50.13 7.74 -40.07 74.65 102.17 -42.10 75.18 101.81 coo 29.82 45.80 5.07 30.26 51.81 3.56 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1onr_c01 TRANSALDOLASE B user 2 3 # 2 B 17 ASP A 272 ASP~? 14.48 CL CL A 382 B 96 GLU A 337 GLU^? 21.89 CL CL A 382 B 132 LYS A 336 LYS^? 14.72 CL CL A 382 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 26.69 48.45 7.18 27.85 50.13 7.74 -40.07 74.65 102.17 -42.10 75.18 101.81 coo 29.82 45.80 5.07 30.26 51.81 3.56 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1onr_c01 TRANSALDOLASE B user 3 3 # 3 B 17 ASP B 208 ASP.? 21.56 CL CL B 383 B 96 GLU B 337 GLU^? 21.78 CL CL B 383 B 132 LYS B 336 LYS^? 14.66 CL CL B 383 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 26.69 48.45 7.18 27.85 50.13 7.74 2.60 41.45 89.80 4.03 40.00 90.41 coo 29.82 45.80 5.07 30.26 51.81 3.56 -3.40 41.24 88.18 -4.83 35.96 88.60 ULMN 3 1onr_c01 TRANSALDOLASE B user 4 3 # 4 B 17 ASP B 272 ASP~? 14.11 CL CL B 383 B 96 GLU B 337 GLU^? 21.78 CL CL B 383 B 132 LYS B 336 LYS^? 14.66 CL CL B 383 coo 31.16 57.31 -0.94 30.73 56.64 1.01 0.88 31.47 82.51 1.09 32.47 80.67 coo 26.69 48.45 7.18 27.85 50.13 7.74 2.60 41.45 89.80 4.03 40.00 90.41 coo 29.82 45.80 5.07 30.26 51.81 3.56 -3.40 41.24 88.18 -4.83 35.96 88.60 1onr_c01 source 1onr TRANSALDOLASE B : 4 hits 1onr_c01 naa= 3 ULMN 3 1opm_c00 1.14.17.0003 user 1 3 # 1 A 108 HIS A 157 HIS~? 12.03 CL CL A 383 A 170 GLN A 153 GLN~? 5.15 CL CL A 383 A 242 HIS A 165 HIS^? 7.64 CL CL A 382 coo 36.16 34.36 39.40 38.12 34.09 40.00 -47.82 75.77 126.56 -49.90 76.10 126.41 coo 40.85 35.41 43.73 41.85 33.73 42.88 -45.94 68.13 127.54 -47.43 66.98 128.54 coo 40.72 26.15 37.61 42.10 27.69 37.19 -39.19 73.43 119.40 -40.10 71.56 119.72 1opm_c00 source 1opm 1.14.17.0003 : 1 hits 1opm_c00 naa= 3 ULMN 3 1oyg_c00 LEVANSUCRASE user 1 3 # 1 A 86 ASP A 30 ASP^? -6.81 CL CL A 382s A 247 ASP A 28 ASP^? 9.02 CL CL A 382 A 342 GLU A 332 GLU^? 14.84 CL CL A 382 coo 44.36 35.68 9.71 43.29 36.20 11.51 -35.52 64.63 115.87 -36.96 65.19 114.43 coo 41.40 28.81 12.91 40.82 30.90 12.97 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 40.37 33.11 18.06 39.99 34.93 17.06 -32.41 59.20 107.78 -33.78 57.91 108.78 ULMN 3 1oyg_c00 LEVANSUCRASE user 2 3 # 2 A 86 ASP A 195 ASP.? 13.29 CL CL A 384 A 247 ASP A 306 ASP.? 16.66 CL CL A 384 A 342 GLU A 307 GLU.? 18.04 CL CL B 382 coo 44.36 35.68 9.71 43.29 36.20 11.51 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 41.40 28.81 12.91 40.82 30.90 12.97 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 40.37 33.11 18.06 39.99 34.93 17.06 -31.95 61.22 87.08 -31.47 59.40 88.12 ULMN 3 1oyg_c00 LEVANSUCRASE user 3 3 # 3 A 86 ASP B 30 ASP^? -6.72 CL CL B 383s A 247 ASP B 28 ASP^? 9.00 CL CL B 383 A 342 GLU B 332 GLU^? 14.76 CL CL B 383 coo 44.36 35.68 9.71 43.29 36.20 11.51 -11.77 37.20 80.70 -10.35 36.55 82.15 coo 41.40 28.81 12.91 40.82 30.90 12.97 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 40.37 33.11 18.06 39.99 34.93 17.06 -15.56 41.56 89.17 -16.27 39.59 89.11 1oyg_c00 source 1oyg LEVANSUCRASE : 3 hits 1oyg_c00 naa= 3 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 1 3 # 1 A 102 ASP A 144 ASP.? 19.38 CL CL A 383 A 167 LYS A 142 LYS.? 24.15 CL CL A 383 A 201 LYS A 109 LYS.? 23.73 CL CL A 383 coo 26.53 8.31 20.37 28.45 8.41 19.40 -52.89 78.90 131.37 -53.77 80.20 132.79 coo 24.92 6.08 13.38 27.75 4.33 18.83 -49.53 84.63 130.17 -55.13 85.19 133.14 coo 29.08 5.53 11.69 30.46 5.61 17.93 -45.10 86.58 132.81 -50.69 86.17 134.93 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 2 3 # 2 A 102 ASP A 272 ASP~? 14.48 CL CL A 382 A 167 LYS A 268 LYS~? 13.60 CL CL A 382 A 201 LYS A 267 LYS~? 27.66 CL CL A 382 coo 26.53 8.31 20.37 28.45 8.41 19.40 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 24.92 6.08 13.38 27.75 4.33 18.83 -47.11 79.10 113.63 -43.53 76.03 116.02 coo 29.08 5.53 11.69 30.46 5.61 17.93 -49.43 81.28 111.60 -49.39 86.78 108.40 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 3 3 # 3 A 102 ASP A 344 ASP.? 20.56 CL CL A 382 A 167 LYS A 264 LYS~? 22.00 CL CL A 382 A 201 LYS A 267 LYS~? 27.66 CL CL A 382 coo 26.53 8.31 20.37 28.45 8.41 19.40 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 24.92 6.08 13.38 27.75 4.33 18.83 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 29.08 5.53 11.69 30.46 5.61 17.93 -49.43 81.28 111.60 -49.39 86.78 108.40 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 4 3 # 4 A 102 ASP A 344 ASP.? 20.56 CL CL A 382 A 167 LYS A 264 LYS~? 22.00 CL CL A 382 A 201 LYS A 268 LYS~? 13.60 CL CL A 382 coo 26.53 8.31 20.37 28.45 8.41 19.40 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 24.92 6.08 13.38 27.75 4.33 18.83 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 29.08 5.53 11.69 30.46 5.61 17.93 -47.11 79.10 113.63 -43.53 76.03 116.02 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 5 3 # 5 A 102 ASP A 344 ASP.? 20.56 CL CL A 382 A 167 LYS A 268 LYS~? 13.60 CL CL A 382 A 201 LYS A 264 LYS~? 22.00 CL CL A 382 coo 26.53 8.31 20.37 28.45 8.41 19.40 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 24.92 6.08 13.38 27.75 4.33 18.83 -47.11 79.10 113.63 -43.53 76.03 116.02 coo 29.08 5.53 11.69 30.46 5.61 17.93 -48.92 85.08 115.29 -44.06 86.61 118.76 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 6 3 # 6 A 102 ASP A 344 ASP.? 20.56 CL CL A 382 A 167 LYS A 268 LYS~? 13.60 CL CL A 382 A 201 LYS A 267 LYS~? 27.66 CL CL A 382 coo 26.53 8.31 20.37 28.45 8.41 19.40 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 24.92 6.08 13.38 27.75 4.33 18.83 -47.11 79.10 113.63 -43.53 76.03 116.02 coo 29.08 5.53 11.69 30.46 5.61 17.93 -49.43 81.28 111.60 -49.39 86.78 108.40 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 7 3 # 7 A 102 ASP B 144 ASP.? 18.90 CL CL B 384 A 167 LYS B 142 LYS.? 25.17 CL CL B 384 A 201 LYS B 109 LYS.? 27.05 CL CL B 384 coo 26.53 8.31 20.37 28.45 8.41 19.40 1.70 18.75 65.96 3.42 18.04 64.94 coo 24.92 6.08 13.38 27.75 4.33 18.83 6.28 23.32 63.35 7.97 19.73 58.68 coo 29.08 5.53 11.69 30.46 5.61 17.93 5.83 26.41 59.87 10.67 23.27 57.97 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 8 3 # 8 A 102 ASP B 257 ASP.? 23.04 CL CL B 384 A 167 LYS B 142 LYS.? 25.17 CL CL B 384 A 201 LYS B 109 LYS.? 27.05 CL CL B 384 coo 26.53 8.31 20.37 28.45 8.41 19.40 12.38 23.16 66.89 10.36 22.88 66.20 coo 24.92 6.08 13.38 27.75 4.33 18.83 6.28 23.32 63.35 7.97 19.73 58.68 coo 29.08 5.53 11.69 30.46 5.61 17.93 5.83 26.41 59.87 10.67 23.27 57.97 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 9 3 # 9 A 102 ASP B 272 ASP~? 14.11 CL CL B 383 A 167 LYS B 268 LYS~? 13.29 CL CL B 383 A 201 LYS B 267 LYS~? 27.57 CL CL B 383 coo 26.53 8.31 20.37 28.45 8.41 19.40 0.88 31.47 82.51 1.09 32.47 80.67 coo 24.92 6.08 13.38 27.75 4.33 18.83 5.99 32.14 79.72 1.11 32.64 77.72 coo 29.08 5.53 11.69 30.46 5.61 17.93 9.46 31.45 81.02 15.36 33.08 81.01 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 10 3 # 10 A 102 ASP B 344 ASP.? 20.04 CL CL B 383 A 167 LYS B 264 LYS~? 21.76 CL CL B 383 A 201 LYS B 267 LYS~? 27.57 CL CL B 383 coo 26.53 8.31 20.37 28.45 8.41 19.40 7.59 38.09 74.22 8.59 36.72 75.50 coo 24.92 6.08 13.38 27.75 4.33 18.83 11.01 31.36 75.69 9.79 34.42 71.26 coo 29.08 5.53 11.69 30.46 5.61 17.93 9.46 31.45 81.02 15.36 33.08 81.01 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 11 3 # 11 A 102 ASP B 344 ASP.? 20.04 CL CL B 383 A 167 LYS B 264 LYS~? 21.76 CL CL B 383 A 201 LYS B 268 LYS~? 13.29 CL CL B 383 coo 26.53 8.31 20.37 28.45 8.41 19.40 7.59 38.09 74.22 8.59 36.72 75.50 coo 24.92 6.08 13.38 27.75 4.33 18.83 11.01 31.36 75.69 9.79 34.42 71.26 coo 29.08 5.53 11.69 30.46 5.61 17.93 5.99 32.14 79.72 1.11 32.64 77.72 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 12 3 # 12 A 102 ASP B 344 ASP.? 20.04 CL CL B 383 A 167 LYS B 268 LYS~? 13.29 CL CL B 383 A 201 LYS B 264 LYS~? 21.76 CL CL B 383 coo 26.53 8.31 20.37 28.45 8.41 19.40 7.59 38.09 74.22 8.59 36.72 75.50 coo 24.92 6.08 13.38 27.75 4.33 18.83 5.99 32.14 79.72 1.11 32.64 77.72 coo 29.08 5.53 11.69 30.46 5.61 17.93 11.01 31.36 75.69 9.79 34.42 71.26 ULMN 3 1p1x_c00 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 13 3 # 13 A 102 ASP B 344 ASP.? 20.04 CL CL B 383 A 167 LYS B 268 LYS~? 13.29 CL CL B 383 A 201 LYS B 267 LYS~? 27.57 CL CL B 383 coo 26.53 8.31 20.37 28.45 8.41 19.40 7.59 38.09 74.22 8.59 36.72 75.50 coo 24.92 6.08 13.38 27.75 4.33 18.83 5.99 32.14 79.72 1.11 32.64 77.72 coo 29.08 5.53 11.69 30.46 5.61 17.93 9.46 31.45 81.02 15.36 33.08 81.01 1p1x_c00 source 1p1x DEOXYRIBOSE-PHOSPHATE ALDOLASE : 13 hits 1p1x_c00 naa= 3 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 1 3 # 1 B1102 ASP A 144 ASP.? 19.38 CL CL A 383 B1167 LYS A 142 LYS.? 24.15 CL CL A 383 B1201 LYS A 109 LYS.? 23.73 CL CL A 383 coo 26.10 12.11 49.61 24.19 12.48 50.51 -52.89 78.90 131.37 -53.77 80.20 132.79 coo 27.70 11.69 56.92 24.82 8.55 52.12 -49.53 84.63 130.17 -55.13 85.19 133.14 coo 23.50 11.64 58.67 22.19 10.19 52.59 -45.10 86.58 132.81 -50.69 86.17 134.93 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 2 3 # 2 B1102 ASP A 272 ASP~? 14.48 CL CL A 382 B1167 LYS A 268 LYS~? 13.60 CL CL A 382 B1201 LYS A 267 LYS~? 27.66 CL CL A 382 coo 26.10 12.11 49.61 24.19 12.48 50.51 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 27.70 11.69 56.92 24.82 8.55 52.12 -47.11 79.10 113.63 -43.53 76.03 116.02 coo 23.50 11.64 58.67 22.19 10.19 52.59 -49.43 81.28 111.60 -49.39 86.78 108.40 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 3 3 # 3 B1102 ASP A 344 ASP.? 20.56 CL CL A 382 B1167 LYS A 264 LYS~? 22.00 CL CL A 382 B1201 LYS A 267 LYS~? 27.66 CL CL A 382 coo 26.10 12.11 49.61 24.19 12.48 50.51 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 27.70 11.69 56.92 24.82 8.55 52.12 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 23.50 11.64 58.67 22.19 10.19 52.59 -49.43 81.28 111.60 -49.39 86.78 108.40 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 4 3 # 4 B1102 ASP A 344 ASP.? 20.56 CL CL A 382 B1167 LYS A 264 LYS~? 22.00 CL CL A 382 B1201 LYS A 268 LYS~? 13.60 CL CL A 382 coo 26.10 12.11 49.61 24.19 12.48 50.51 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 27.70 11.69 56.92 24.82 8.55 52.12 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 23.50 11.64 58.67 22.19 10.19 52.59 -47.11 79.10 113.63 -43.53 76.03 116.02 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 5 3 # 5 B1102 ASP A 344 ASP.? 20.56 CL CL A 382 B1167 LYS A 268 LYS~? 13.60 CL CL A 382 B1201 LYS A 264 LYS~? 22.00 CL CL A 382 coo 26.10 12.11 49.61 24.19 12.48 50.51 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 27.70 11.69 56.92 24.82 8.55 52.12 -47.11 79.10 113.63 -43.53 76.03 116.02 coo 23.50 11.64 58.67 22.19 10.19 52.59 -48.92 85.08 115.29 -44.06 86.61 118.76 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 6 3 # 6 B1102 ASP A 344 ASP.? 20.56 CL CL A 382 B1167 LYS A 268 LYS~? 13.60 CL CL A 382 B1201 LYS A 267 LYS~? 27.66 CL CL A 382 coo 26.10 12.11 49.61 24.19 12.48 50.51 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 27.70 11.69 56.92 24.82 8.55 52.12 -47.11 79.10 113.63 -43.53 76.03 116.02 coo 23.50 11.64 58.67 22.19 10.19 52.59 -49.43 81.28 111.60 -49.39 86.78 108.40 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 7 3 # 7 B1102 ASP B 144 ASP.? 18.90 CL CL B 384 B1167 LYS B 142 LYS.? 25.17 CL CL B 384 B1201 LYS B 109 LYS.? 27.05 CL CL B 384 coo 26.10 12.11 49.61 24.19 12.48 50.51 1.70 18.75 65.96 3.42 18.04 64.94 coo 27.70 11.69 56.92 24.82 8.55 52.12 6.28 23.32 63.35 7.97 19.73 58.68 coo 23.50 11.64 58.67 22.19 10.19 52.59 5.83 26.41 59.87 10.67 23.27 57.97 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 8 3 # 8 B1102 ASP B 257 ASP.? 23.04 CL CL B 384 B1167 LYS B 142 LYS.? 25.17 CL CL B 384 B1201 LYS B 109 LYS.? 27.05 CL CL B 384 coo 26.10 12.11 49.61 24.19 12.48 50.51 12.38 23.16 66.89 10.36 22.88 66.20 coo 27.70 11.69 56.92 24.82 8.55 52.12 6.28 23.32 63.35 7.97 19.73 58.68 coo 23.50 11.64 58.67 22.19 10.19 52.59 5.83 26.41 59.87 10.67 23.27 57.97 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 9 3 # 9 B1102 ASP B 272 ASP~? 14.11 CL CL B 383 B1167 LYS B 268 LYS~? 13.29 CL CL B 383 B1201 LYS B 267 LYS~? 27.57 CL CL B 383 coo 26.10 12.11 49.61 24.19 12.48 50.51 0.88 31.47 82.51 1.09 32.47 80.67 coo 27.70 11.69 56.92 24.82 8.55 52.12 5.99 32.14 79.72 1.11 32.64 77.72 coo 23.50 11.64 58.67 22.19 10.19 52.59 9.46 31.45 81.02 15.36 33.08 81.01 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 10 3 # 10 B1102 ASP B 344 ASP.? 20.04 CL CL B 383 B1167 LYS B 264 LYS~? 21.76 CL CL B 383 B1201 LYS B 267 LYS~? 27.57 CL CL B 383 coo 26.10 12.11 49.61 24.19 12.48 50.51 7.59 38.09 74.22 8.59 36.72 75.50 coo 27.70 11.69 56.92 24.82 8.55 52.12 11.01 31.36 75.69 9.79 34.42 71.26 coo 23.50 11.64 58.67 22.19 10.19 52.59 9.46 31.45 81.02 15.36 33.08 81.01 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 11 3 # 11 B1102 ASP B 344 ASP.? 20.04 CL CL B 383 B1167 LYS B 264 LYS~? 21.76 CL CL B 383 B1201 LYS B 268 LYS~? 13.29 CL CL B 383 coo 26.10 12.11 49.61 24.19 12.48 50.51 7.59 38.09 74.22 8.59 36.72 75.50 coo 27.70 11.69 56.92 24.82 8.55 52.12 11.01 31.36 75.69 9.79 34.42 71.26 coo 23.50 11.64 58.67 22.19 10.19 52.59 5.99 32.14 79.72 1.11 32.64 77.72 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 12 3 # 12 B1102 ASP B 344 ASP.? 20.04 CL CL B 383 B1167 LYS B 268 LYS~? 13.29 CL CL B 383 B1201 LYS B 264 LYS~? 21.76 CL CL B 383 coo 26.10 12.11 49.61 24.19 12.48 50.51 7.59 38.09 74.22 8.59 36.72 75.50 coo 27.70 11.69 56.92 24.82 8.55 52.12 5.99 32.14 79.72 1.11 32.64 77.72 coo 23.50 11.64 58.67 22.19 10.19 52.59 11.01 31.36 75.69 9.79 34.42 71.26 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 13 3 # 13 B1102 ASP B 344 ASP.? 20.04 CL CL B 383 B1167 LYS B 268 LYS~? 13.29 CL CL B 383 B1201 LYS B 267 LYS~? 27.57 CL CL B 383 coo 26.10 12.11 49.61 24.19 12.48 50.51 7.59 38.09 74.22 8.59 36.72 75.50 coo 27.70 11.69 56.92 24.82 8.55 52.12 5.99 32.14 79.72 1.11 32.64 77.72 coo 23.50 11.64 58.67 22.19 10.19 52.59 9.46 31.45 81.02 15.36 33.08 81.01 1p1x_c01 source 1p1x DEOXYRIBOSE-PHOSPHATE ALDOLASE : 13 hits 1p1x_c01 naa= 3 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 1 3 # 1 A 16 TYR B 25 TYR^? 14.27 CL CL B 382 A 38 GLU B 23 GLU.? 22.91 CL CL B 382 A 46 TRP B 22 TRP.? 12.71 CL CL B 382 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 -26.62 44.42 81.68 -25.97 47.00 82.31 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 -35.83 43.78 85.87 -35.49 42.75 87.75 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 -30.24 47.05 78.99 -31.39 44.39 76.36 1p7m_c00 source 1p7m DNA-3-METHYLADENINE GLYCOSYLASE I : 1 hits 1p7m_c00 naa= 3 ULMN 3 1pd2_c02 HEMATOPOIETIC PROSTAGLADIN D SYNTHASuser 1 3 # 1 1 8 TYR A 8 TYR.? 12.26 CL CL A 384 1 14 ARG B 193 ARG.? 19.02 CL CL A 384 1 104 TRP B 191 TRP^? 18.38 CL CL A 384 coo -6.26 36.66 22.35 -5.62 38.66 24.20 -16.53 57.80 111.57 -17.14 59.34 109.36 coo -1.84 42.97 23.45 -1.37 45.90 22.68 -14.12 50.83 106.82 -12.70 50.89 109.57 coo -2.17 45.44 30.78 -5.80 46.76 31.55 -10.49 50.73 102.31 -13.97 49.16 101.58 1pd2_c02 source 1pd2 HEMATOPOIETIC PROSTAGLADIN D SYNTHASE : 1 hits 1pd2_c02 naa= 3 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 A 630 SER A 161 SER~? 16.95 CL CL A 383 A 709 ASP A 144 ASP.? 19.38 CL CL A 383 A 740 HIS A 157 HIS~? 12.03 CL CL A 383 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -45.55 81.13 122.60 -44.57 82.20 124.58 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 -52.89 78.90 131.37 -53.77 80.20 132.79 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -47.82 75.77 126.56 -49.90 76.10 126.41 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 A 630 SER B 161 SER~? 16.65 CL CL B 384 A 709 ASP B 144 ASP.? 18.90 CL CL B 384 A 740 HIS B 157 HIS~? 12.80 CL CL B 384 coo -7.09 7.44 6.22 -7.53 5.14 5.59 4.53 29.49 70.92 4.35 29.43 68.47 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 1.70 18.75 65.96 3.42 18.04 64.94 coo -8.70 2.86 9.96 -8.03 3.92 8.29 0.17 24.88 70.38 1.86 23.62 70.32 1pfq_c02 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 2 hits 1pfq_c02 naa= 3 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 B 630 SER A 161 SER~? 16.95 CL CL A 383 B 709 ASP A 144 ASP.? 19.38 CL CL A 383 B 740 HIS A 157 HIS~? 12.03 CL CL A 383 coo 4.44 13.29 37.64 6.01 11.66 38.49 -45.55 81.13 122.60 -44.57 82.20 124.58 coo 10.26 2.81 31.69 11.64 4.30 32.43 -52.89 78.90 131.37 -53.77 80.20 132.79 coo 8.57 10.09 34.47 7.10 10.73 35.82 -47.82 75.77 126.56 -49.90 76.10 126.41 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 B 630 SER B 161 SER~? 16.65 CL CL B 384 B 709 ASP B 144 ASP.? 18.90 CL CL B 384 B 740 HIS B 157 HIS~? 12.80 CL CL B 384 coo 4.44 13.29 37.64 6.01 11.66 38.49 4.53 29.49 70.92 4.35 29.43 68.47 coo 10.26 2.81 31.69 11.64 4.30 32.43 1.70 18.75 65.96 3.42 18.04 64.94 coo 8.57 10.09 34.47 7.10 10.73 35.82 0.17 24.88 70.38 1.86 23.62 70.32 1pfq_c03 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 2 hits 1pfq_c03 naa= 3 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 1 3 # 1 A 225 HIS A 287 HIS.? 12.74 CL CL A 384 A 259 TYR A 25 TYR^? 18.63 CL CL A 382 A 552 ASP B 30 ASP^? -6.72 CL CL B 383s coo 11.34 95.90 25.54 12.13 96.42 23.67 -21.23 59.04 111.08 -21.85 57.11 111.58 coo 14.91 97.39 18.63 13.39 95.60 20.20 -23.49 53.13 116.11 -21.60 54.30 114.36 coo 46.37 82.54 38.83 45.97 84.66 38.77 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 2 3 # 2 A 225 HIS A 287 HIS.? 12.74 CL CL A 384 A 259 TYR A 25 TYR^? 18.63 CL CL A 382 A 552 ASP B 39 ASP^? 17.51 CL CL B 383 coo 11.34 95.90 25.54 12.13 96.42 23.67 -21.23 59.04 111.08 -21.85 57.11 111.58 coo 14.91 97.39 18.63 13.39 95.60 20.20 -23.49 53.13 116.11 -21.60 54.30 114.36 coo 46.37 82.54 38.83 45.97 84.66 38.77 -26.18 36.85 80.53 -27.97 36.10 81.34 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 3 3 # 3 A 225 HIS B 287 HIS.? 13.85 CL CL B 382 A 259 TYR B 25 TYR^? 14.27 CL CL B 382 A 552 ASP A 30 ASP^? -6.81 CL CL A 382s coo 11.34 95.90 25.54 12.13 96.42 23.67 -21.22 50.04 83.35 -22.70 48.63 83.80 coo 14.91 97.39 18.63 13.39 95.60 20.20 -26.62 44.42 81.68 -25.97 47.00 82.31 coo 46.37 82.54 38.83 45.97 84.66 38.77 -35.52 64.63 115.87 -36.96 65.19 114.43 1pj5_c00 source 1pj5 N,N-DIMETHYLGLYCINE OXIDASE : 3 hits 1pj5_c00 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 95 ALA~? 5.86 CL CL A 382 A 126 LEU A 168 LEU^? 6.56 CL CL A 382 A 158 GLU A 169 GLU.? 11.07 CL CL A 382 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -34.32 65.97 127.91 -34.72 66.23 126.45 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -30.53 68.45 124.73 -31.34 69.14 126.59 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -27.31 72.85 122.01 -26.32 74.11 120.63 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA A 95 ALA~? 5.86 CL CL A 382 A 126 LEU A 174 LEU^? 10.06 CL CL A 382 A 158 GLU A 169 GLU.? 11.07 CL CL A 382 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -34.32 65.97 127.91 -34.72 66.23 126.45 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -31.51 73.25 128.15 -33.68 73.07 128.16 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -27.31 72.85 122.01 -26.32 74.11 120.63 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 A 70 ALA A 129 ALA.? 16.38 CL CL A 382 A 126 LEU A 174 LEU^? 10.06 CL CL A 382 A 158 GLU A 169 GLU.? 11.07 CL CL A 382 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -26.10 75.72 130.84 -24.98 76.19 129.93 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -31.51 73.25 128.15 -33.68 73.07 128.16 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -27.31 72.85 122.01 -26.32 74.11 120.63 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 A 70 ALA A 271 ALA~? 18.46 CL CL A 382 A 126 LEU A 275 LEU~? 15.03 CL CL A 382 A 158 GLU A 276 GLU~? 16.10 CL CL A 383 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -46.19 76.51 109.39 -45.19 77.53 109.91 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -42.94 71.56 108.70 -41.37 73.02 108.92 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -46.62 67.79 110.40 -48.46 68.09 111.43 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 A 70 ALA B 271 ALA~? 18.20 CL CL B 383 A 126 LEU B 275 LEU~? 14.82 CL CL B 383 A 158 GLU B 276 GLU~? 15.94 CL CL B 384 coo -2.29 37.66 144.73 -1.46 37.12 145.87 4.76 33.88 84.20 5.07 34.78 82.98 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -0.68 35.60 86.07 -0.26 37.33 84.87 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -2.79 30.63 87.01 -2.36 28.59 86.68 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 A 70 ALA B 271 ALA~? 18.20 CL CL B 383 A 126 LEU B 275 LEU~? 14.82 CL CL B 383 A 158 GLU B 337 GLU^? 21.78 CL CL B 383 coo -2.29 37.66 144.73 -1.46 37.12 145.87 4.76 33.88 84.20 5.07 34.78 82.98 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -0.68 35.60 86.07 -0.26 37.33 84.87 coo -0.83 29.57 149.77 -0.39 31.47 148.95 2.60 41.45 89.80 4.03 40.00 90.41 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 6 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 95 ALA~? 5.86 CL CL A 382 B 126 LEU A 168 LEU^? 6.56 CL CL A 382 B 158 GLU A 169 GLU.? 11.07 CL CL A 382 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -34.32 65.97 127.91 -34.72 66.23 126.45 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -30.53 68.45 124.73 -31.34 69.14 126.59 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -27.31 72.85 122.01 -26.32 74.11 120.63 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA A 95 ALA~? 5.86 CL CL A 382 B 126 LEU A 174 LEU^? 10.06 CL CL A 382 B 158 GLU A 169 GLU.? 11.07 CL CL A 382 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -34.32 65.97 127.91 -34.72 66.23 126.45 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -31.51 73.25 128.15 -33.68 73.07 128.16 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -27.31 72.85 122.01 -26.32 74.11 120.63 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 B 70 ALA A 129 ALA.? 16.38 CL CL A 382 B 126 LEU A 174 LEU^? 10.06 CL CL A 382 B 158 GLU A 169 GLU.? 11.07 CL CL A 382 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -26.10 75.72 130.84 -24.98 76.19 129.93 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -31.51 73.25 128.15 -33.68 73.07 128.16 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -27.31 72.85 122.01 -26.32 74.11 120.63 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 B 70 ALA A 271 ALA~? 18.46 CL CL A 382 B 126 LEU A 275 LEU~? 15.03 CL CL A 382 B 158 GLU A 276 GLU~? 16.10 CL CL A 383 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -46.19 76.51 109.39 -45.19 77.53 109.91 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -42.94 71.56 108.70 -41.37 73.02 108.92 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -46.62 67.79 110.40 -48.46 68.09 111.43 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 B 70 ALA B 271 ALA~? 18.20 CL CL B 383 B 126 LEU B 275 LEU~? 14.82 CL CL B 383 B 158 GLU B 276 GLU~? 15.94 CL CL B 384 coo -39.79 4.61 147.27 -39.61 5.56 148.47 4.76 33.88 84.20 5.07 34.78 82.98 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -0.68 35.60 86.07 -0.26 37.33 84.87 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -2.79 30.63 87.01 -2.36 28.59 86.68 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 5 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 95 ALA~? 5.86 CL CL A 382 C 126 LEU A 168 LEU^? 6.56 CL CL A 382 C 158 GLU A 169 GLU.? 11.07 CL CL A 382 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -34.32 65.97 127.91 -34.72 66.23 126.45 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -30.53 68.45 124.73 -31.34 69.14 126.59 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -27.31 72.85 122.01 -26.32 74.11 120.63 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA A 129 ALA.? 16.38 CL CL A 382 C 126 LEU A 174 LEU^? 10.06 CL CL A 382 C 158 GLU A 169 GLU.? 11.07 CL CL A 382 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -26.10 75.72 130.84 -24.98 76.19 129.93 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -31.51 73.25 128.15 -33.68 73.07 128.16 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -27.31 72.85 122.01 -26.32 74.11 120.63 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 C 70 ALA A 271 ALA~? 18.46 CL CL A 382 C 126 LEU A 275 LEU~? 15.03 CL CL A 382 C 158 GLU A 276 GLU~? 16.10 CL CL A 383 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -46.19 76.51 109.39 -45.19 77.53 109.91 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -42.94 71.56 108.70 -41.37 73.02 108.92 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -46.62 67.79 110.40 -48.46 68.09 111.43 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 C 70 ALA A 271 ALA~? 18.46 CL CL A 382 C 126 LEU A 275 LEU~? 15.03 CL CL A 382 C 158 GLU A 337 GLU^? 21.89 CL CL A 382 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -46.19 76.51 109.39 -45.19 77.53 109.91 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -42.94 71.56 108.70 -41.37 73.02 108.92 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -40.07 74.65 102.17 -42.10 75.18 101.81 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 C 70 ALA B 271 ALA~? 18.20 CL CL B 383 C 126 LEU B 275 LEU~? 14.82 CL CL B 383 C 158 GLU B 276 GLU~? 15.94 CL CL B 384 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 4.76 33.88 84.20 5.07 34.78 82.98 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -0.68 35.60 86.07 -0.26 37.33 84.87 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -2.79 30.63 87.01 -2.36 28.59 86.68 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 C 70 ALA B 271 ALA~? 18.20 CL CL B 383 C 126 LEU B 275 LEU~? 14.82 CL CL B 383 C 158 GLU B 337 GLU^? 21.78 CL CL B 383 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 4.76 33.88 84.20 5.07 34.78 82.98 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -0.68 35.60 86.07 -0.26 37.33 84.87 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 2.60 41.45 89.80 4.03 40.00 90.41 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 6 hits 1pjh_c02 naa= 3 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 1 3 # 1 A 248 ASP A 64 ASP.? 15.21 CL CL A 384 A 270 LYS A 288 LYS.? 12.57 CL CL A 384 A 382 MET A 69 MET^? 8.78 CL CL A 382 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -13.50 61.63 115.26 -13.45 60.20 113.75 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -19.18 64.09 108.25 -14.44 63.70 112.45 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -24.82 63.57 122.75 -28.23 61.02 122.16 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 2 3 # 2 A 248 ASP A 180 ASP.? 19.13 CL CL A 382 A 270 LYS A 133 LYS^? 12.95 CL CL A 382 A 382 MET A 317 MET^? 9.59 CL CL A 382 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -29.53 80.77 112.24 -28.62 82.54 111.55 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -30.69 80.61 120.28 -26.75 77.00 119.43 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -34.51 68.89 111.14 -37.31 70.75 112.30 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 3 3 # 3 A 248 ASP B 64 ASP.? 7.14 CL CL B 382 A 270 LYS B 288 LYS.? 8.84 CL CL B 382 A 382 MET B 69 MET^? 8.86 CL CL B 383 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -22.24 55.99 77.05 -23.77 56.03 78.56 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -16.76 54.22 83.25 -20.62 56.75 78.99 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -18.92 43.37 72.28 -19.57 39.87 74.69 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 4 3 # 4 A 248 ASP B 180 ASP.? 19.08 CL CL B 383 A 270 LYS B 133 LYS^? 13.08 CL CL B 383 A 382 MET B 317 MET^? 9.57 CL CL B 383 coo -27.63 121.99 45.48 -26.66 123.86 45.68 0.82 48.22 75.52 2.17 49.73 74.84 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -0.84 43.73 69.01 -5.56 47.16 71.00 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -7.17 41.06 82.82 -4.62 38.66 81.83 1pjq_c02 source 1pjq SIROHEME SYNTHASE : 4 hits 1pjq_c02 naa= 3 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 1 3 # 1 B 248 ASP A 64 ASP.? 15.21 CL CL A 384 B 270 LYS A 288 LYS.? 12.57 CL CL A 384 B 382 MET A 69 MET^? 8.78 CL CL A 382 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -13.50 61.63 115.26 -13.45 60.20 113.75 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -19.18 64.09 108.25 -14.44 63.70 112.45 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -24.82 63.57 122.75 -28.23 61.02 122.16 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 2 3 # 2 B 248 ASP A 180 ASP.? 19.13 CL CL A 382 B 270 LYS A 133 LYS^? 12.95 CL CL A 382 B 382 MET A 317 MET^? 9.59 CL CL A 382 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -29.53 80.77 112.24 -28.62 82.54 111.55 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -30.69 80.61 120.28 -26.75 77.00 119.43 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -34.51 68.89 111.14 -37.31 70.75 112.30 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 3 3 # 3 B 248 ASP A 272 ASP~? 14.48 CL CL A 382 B 270 LYS A 268 LYS~? 13.60 CL CL A 382 B 382 MET A 317 MET^? 9.59 CL CL A 382 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -46.67 73.24 112.92 -45.43 74.19 114.38 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -47.11 79.10 113.63 -43.53 76.03 116.02 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -34.51 68.89 111.14 -37.31 70.75 112.30 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 4 3 # 4 B 248 ASP B 64 ASP.? 7.14 CL CL B 382 B 270 LYS B 288 LYS.? 8.84 CL CL B 382 B 382 MET B 69 MET^? 8.86 CL CL B 383 coo -11.82 154.51 43.38 -12.86 152.74 43.79 -22.24 55.99 77.05 -23.77 56.03 78.56 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -16.76 54.22 83.25 -20.62 56.75 78.99 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -18.92 43.37 72.28 -19.57 39.87 74.69 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 5 3 # 5 B 248 ASP B 180 ASP.? 19.08 CL CL B 383 B 270 LYS B 133 LYS^? 13.08 CL CL B 383 B 382 MET B 317 MET^? 9.57 CL CL B 383 coo -11.82 154.51 43.38 -12.86 152.74 43.79 0.82 48.22 75.52 2.17 49.73 74.84 coo -5.09 158.39 43.41 -0.74 158.80 47.15 -0.84 43.73 69.01 -5.56 47.16 71.00 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -7.17 41.06 82.82 -4.62 38.66 81.83 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 6 3 # 6 B 248 ASP B 272 ASP~? 14.11 CL CL B 383 B 270 LYS B 268 LYS~? 13.29 CL CL B 383 B 382 MET B 317 MET^? 9.57 CL CL B 383 coo -11.82 154.51 43.38 -12.86 152.74 43.79 0.88 31.47 82.51 1.09 32.47 80.67 coo -5.09 158.39 43.41 -0.74 158.80 47.15 5.99 32.14 79.72 1.11 32.64 77.72 coo -2.79 145.52 50.38 -5.75 148.14 51.66 -7.17 41.06 82.82 -4.62 38.66 81.83 1pjq_c03 source 1pjq SIROHEME SYNTHASE : 6 hits 1pjq_c03 naa= 3 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 1 3 # 1 111 GLN A 76 GLN^? 24.61 CL CL A 382 294 GLU A 57 GLU.? 23.36 CL CL A 382 304 ARG A 77 ARG^? 19.95 CL CL A 382 coo 15.89 18.45 46.53 15.82 16.91 48.02 -26.57 46.46 129.57 -24.86 46.70 130.88 coo 22.84 13.44 52.91 20.84 13.18 52.38 -23.46 53.73 134.86 -22.94 54.54 136.68 coo 8.71 17.11 46.51 7.23 17.64 49.20 -32.32 44.63 125.30 -31.80 47.66 125.44 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 2 3 # 2 111 GLN A 330 GLN^? 14.80 CL CL A 384 294 GLU B 201 GLU^? 17.46 CL CL A 384 304 ARG A 202 ARG^? 19.65 CL CL A 384 coo 15.89 18.45 46.53 15.82 16.91 48.02 -24.70 54.33 105.30 -26.34 53.14 104.66 coo 22.84 13.44 52.91 20.84 13.18 52.38 -19.06 50.53 95.26 -20.94 50.61 94.28 coo 8.71 17.11 46.51 7.23 17.64 49.20 -32.39 54.22 100.96 -34.65 53.06 99.24 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 3 3 # 3 111 GLN B 76 GLN^? 22.74 CL CL B 382 294 GLU B 57 GLU.? 21.35 CL CL B 382 304 ARG B 77 ARG^? 27.48 CL CL B 383 coo 15.89 18.45 46.53 15.82 16.91 48.02 -34.98 34.32 73.52 -35.81 35.28 71.77 coo 22.84 13.44 52.91 20.84 13.18 52.38 -31.25 37.00 65.18 -31.15 36.75 63.13 coo 8.71 17.11 46.51 7.23 17.64 49.20 -35.60 30.51 80.72 -37.43 31.47 83.02 1pmi_c00 source 1pmi PHOSPHOMANNOSE ISOMERASE : 3 hits 1pmi_c00 naa= 3 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 1 3 # 1 B 1 SER A 161 SER~? 16.95 CL CL A 383 B 69 ALA A 159 ALA~? 12.04 CL CL A 382 B 241 ASN A 160 ASN~? 11.40 CL CL A 383 coo 13.24 41.94 33.13 13.08 39.54 33.17 -45.55 81.13 122.60 -44.57 82.20 124.58 coo 9.15 37.89 36.69 10.55 37.76 37.22 -40.97 78.44 123.91 -40.05 77.14 123.62 coo 10.91 43.03 38.47 11.81 41.82 36.93 -44.47 76.84 121.01 -43.38 75.08 120.31 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 2 3 # 2 B 1 SER B 161 SER~? 16.65 CL CL B 384 B 69 ALA B 159 ALA~? 12.15 CL CL B 383 B 241 ASN B 160 ASN~? 11.23 CL CL B 384 coo 13.24 41.94 33.13 13.08 39.54 33.17 4.53 29.49 70.92 4.35 29.43 68.47 coo 9.15 37.89 36.69 10.55 37.76 37.22 0.19 32.47 69.55 -1.13 33.12 70.03 coo 10.91 43.03 38.47 11.81 41.82 36.93 0.91 30.00 73.77 -0.90 30.65 74.84 1pnl_c00 source 1pnl PENICILLIN AMIDOHYDROLASE : 2 hits 1pnl_c00 naa= 3 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 A 74 ASN B 199 ASN.? 15.74 CL CL A 384 A 192 ASP B 311 ASP^? 24.66 CL CL A 384 A 195 HIS B 302 HIS^? 23.99 CL CL A 384 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -14.23 54.82 92.98 -12.33 56.04 93.07 coo 2.03 47.14 19.75 1.72 46.26 21.64 0.41 52.81 97.17 0.37 54.52 95.85 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -2.27 54.46 91.30 -1.20 55.23 92.93 1pp4_c02 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 1 hits 1pp4_c02 naa= 3 ULMN 3 1pyl_c00 RIBONUCLEASE user 1 3 # 1 A 56 GLU A 86 GLU^? 27.08 CL CL A 382 A 67 ARG A 77 ARG^? 19.95 CL CL A 382 A 86 HIS A 78 HIS^? 30.68 CL CL A 382 coo 18.15 3.28 18.56 20.10 2.92 19.20 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 21.52 6.83 26.64 21.22 5.53 23.85 -32.32 44.63 125.30 -31.80 47.66 125.44 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -24.82 39.60 128.09 -23.39 38.20 127.48 ULMN 3 1pyl_c00 RIBONUCLEASE user 2 3 # 2 A 56 GLU A 86 GLU^? 27.08 CL CL A 382 A 67 ARG A 85 ARG^? 33.58 CL CL A 382 A 86 HIS A 78 HIS^? 30.68 CL CL A 382 coo 18.15 3.28 18.56 20.10 2.92 19.20 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 21.52 6.83 26.64 21.22 5.53 23.85 -20.06 35.34 124.61 -20.05 37.26 127.03 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -24.82 39.60 128.09 -23.39 38.20 127.48 ULMN 3 1pyl_c00 RIBONUCLEASE user 3 3 # 3 A 56 GLU A 215 GLU^? 33.84 CL CL A 383 A 67 ARG A 247 ARG.? 25.12 CL CL A 383 A 86 HIS A 246 HIS.? 33.92 CL CL A 383 coo 18.15 3.28 18.56 20.10 2.92 19.20 -61.95 78.59 103.72 -63.72 79.79 103.76 coo 21.52 6.83 26.64 21.22 5.53 23.85 -59.24 68.01 103.62 -57.26 66.97 105.71 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -65.97 72.19 102.08 -66.87 73.22 103.68 ULMN 3 1pyl_c00 RIBONUCLEASE user 4 3 # 4 A 56 GLU B 215 GLU^? 32.93 CL CL B 384 A 67 ARG B 247 ARG.? 24.65 CL CL B 384 A 86 HIS B 246 HIS.? 32.95 CL CL B 384 coo 18.15 3.28 18.56 20.10 2.92 19.20 14.09 22.76 92.11 15.77 21.48 91.87 coo 21.52 6.83 26.64 21.22 5.53 23.85 4.27 22.84 96.19 1.85 22.99 94.25 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 10.60 18.26 97.26 11.24 17.08 95.63 1pyl_c00 source 1pyl RIBONUCLEASE : 4 hits 1pyl_c00 naa= 3 ULMN 3 1pyl_c01 RIBONUCLEASE user 1 3 # 1 B 56 GLU A 86 GLU^? 27.08 CL CL A 382 B 67 ARG A 77 ARG^? 19.95 CL CL A 382 B 86 HIS A 78 HIS^? 30.68 CL CL A 382 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -32.32 44.63 125.30 -31.80 47.66 125.44 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -24.82 39.60 128.09 -23.39 38.20 127.48 ULMN 3 1pyl_c01 RIBONUCLEASE user 2 3 # 2 B 56 GLU A 215 GLU^? 33.84 CL CL A 383 B 67 ARG A 247 ARG.? 25.12 CL CL A 383 B 86 HIS A 246 HIS.? 33.92 CL CL A 383 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -61.95 78.59 103.72 -63.72 79.79 103.76 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -59.24 68.01 103.62 -57.26 66.97 105.71 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -65.97 72.19 102.08 -66.87 73.22 103.68 ULMN 3 1pyl_c01 RIBONUCLEASE user 3 3 # 3 B 56 GLU B 215 GLU^? 32.93 CL CL B 384 B 67 ARG B 247 ARG.? 24.65 CL CL B 384 B 86 HIS B 246 HIS.? 32.95 CL CL B 384 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 14.09 22.76 92.11 15.77 21.48 91.87 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 4.27 22.84 96.19 1.85 22.99 94.25 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 10.60 18.26 97.26 11.24 17.08 95.63 1pyl_c01 source 1pyl RIBONUCLEASE : 3 hits 1pyl_c01 naa= 3 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 A 48 LEU A 114 LEU~? 18.11 CL CL A 382 A 58 ASP A 115 ASP~? 22.59 CL CL A 382 A 120 LYS A 109 LYS.? 23.73 CL CL A 383 coo 34.02 69.29 75.26 34.82 67.82 76.74 -33.06 83.37 128.45 -30.99 82.55 128.34 coo 34.46 72.45 78.57 32.82 72.75 77.28 -35.38 84.29 133.21 -33.68 85.51 133.25 coo 28.96 77.64 81.19 29.05 74.53 77.51 -45.10 86.58 132.81 -50.69 86.17 134.93 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 A 48 LEU A 114 LEU~? 18.11 CL CL A 382 A 58 ASP A 115 ASP~? 22.59 CL CL A 382 A 120 LYS A 119 LYS~? 19.74 CL CL A 383 coo 34.02 69.29 75.26 34.82 67.82 76.74 -33.06 83.37 128.45 -30.99 82.55 128.34 coo 34.46 72.45 78.57 32.82 72.75 77.28 -35.38 84.29 133.21 -33.68 85.51 133.25 coo 28.96 77.64 81.19 29.05 74.53 77.51 -35.93 78.09 135.99 -38.76 78.15 140.81 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 3 3 # 3 A 48 LEU A 275 LEU~? 15.03 CL CL A 382 A 58 ASP A 272 ASP~? 14.48 CL CL A 382 A 120 LYS A 267 LYS~? 27.66 CL CL A 382 coo 34.02 69.29 75.26 34.82 67.82 76.74 -42.94 71.56 108.70 -41.37 73.02 108.92 coo 34.46 72.45 78.57 32.82 72.75 77.28 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 28.96 77.64 81.19 29.05 74.53 77.51 -49.43 81.28 111.60 -49.39 86.78 108.40 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 4 3 # 4 A 48 LEU B 114 LEU~? 17.91 CL CL B 383 A 58 ASP B 115 ASP~? 22.59 CL CL B 383 A 120 LYS B 119 LYS~? 21.97 CL CL B 384 coo 34.02 69.29 75.26 34.82 67.82 76.74 -0.09 38.53 61.55 -1.61 40.11 61.25 coo 34.46 72.45 78.57 32.82 72.75 77.28 0.29 34.85 57.65 0.95 36.59 56.65 coo 28.96 77.64 81.19 29.05 74.53 77.51 -5.81 31.71 57.90 -4.87 29.30 52.77 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 5 3 # 5 A 48 LEU B 275 LEU~? 14.82 CL CL B 383 A 58 ASP B 272 ASP~? 14.11 CL CL B 383 A 120 LYS B 267 LYS~? 27.57 CL CL B 383 coo 34.02 69.29 75.26 34.82 67.82 76.74 -0.68 35.60 86.07 -0.26 37.33 84.87 coo 34.46 72.45 78.57 32.82 72.75 77.28 0.88 31.47 82.51 1.09 32.47 80.67 coo 28.96 77.64 81.19 29.05 74.53 77.51 9.46 31.45 81.02 15.36 33.08 81.01 1pym_c00 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 5 hits 1pym_c00 naa= 3 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 B 48 LEU A 114 LEU~? 18.11 CL CL A 382 B 58 ASP A 115 ASP~? 22.59 CL CL A 382 B 120 LYS A 109 LYS.? 23.73 CL CL A 383 coo 54.50 104.32 58.69 55.83 105.69 59.81 -33.06 83.37 128.45 -30.99 82.55 128.34 coo 57.63 101.19 59.83 56.60 100.89 57.99 -35.38 84.29 133.21 -33.68 85.51 133.25 coo 61.58 95.88 55.22 58.18 99.30 54.71 -45.10 86.58 132.81 -50.69 86.17 134.93 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 B 48 LEU A 114 LEU~? 18.11 CL CL A 382 B 58 ASP A 115 ASP~? 22.59 CL CL A 382 B 120 LYS A 119 LYS~? 19.74 CL CL A 383 coo 54.50 104.32 58.69 55.83 105.69 59.81 -33.06 83.37 128.45 -30.99 82.55 128.34 coo 57.63 101.19 59.83 56.60 100.89 57.99 -35.38 84.29 133.21 -33.68 85.51 133.25 coo 61.58 95.88 55.22 58.18 99.30 54.71 -35.93 78.09 135.99 -38.76 78.15 140.81 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 3 3 # 3 B 48 LEU A 275 LEU~? 15.03 CL CL A 382 B 58 ASP A 272 ASP~? 14.48 CL CL A 382 B 120 LYS A 267 LYS~? 27.66 CL CL A 382 coo 54.50 104.32 58.69 55.83 105.69 59.81 -42.94 71.56 108.70 -41.37 73.02 108.92 coo 57.63 101.19 59.83 56.60 100.89 57.99 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 61.58 95.88 55.22 58.18 99.30 54.71 -49.43 81.28 111.60 -49.39 86.78 108.40 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 4 3 # 4 B 48 LEU B 114 LEU~? 17.91 CL CL B 383 B 58 ASP B 115 ASP~? 22.59 CL CL B 383 B 120 LYS B 119 LYS~? 21.97 CL CL B 384 coo 54.50 104.32 58.69 55.83 105.69 59.81 -0.09 38.53 61.55 -1.61 40.11 61.25 coo 57.63 101.19 59.83 56.60 100.89 57.99 0.29 34.85 57.65 0.95 36.59 56.65 coo 61.58 95.88 55.22 58.18 99.30 54.71 -5.81 31.71 57.90 -4.87 29.30 52.77 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 5 3 # 5 B 48 LEU B 275 LEU~? 14.82 CL CL B 383 B 58 ASP B 272 ASP~? 14.11 CL CL B 383 B 120 LYS B 267 LYS~? 27.57 CL CL B 383 coo 54.50 104.32 58.69 55.83 105.69 59.81 -0.68 35.60 86.07 -0.26 37.33 84.87 coo 57.63 101.19 59.83 56.60 100.89 57.99 0.88 31.47 82.51 1.09 32.47 80.67 coo 61.58 95.88 55.22 58.18 99.30 54.71 9.46 31.45 81.02 15.36 33.08 81.01 1pym_c01 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 5 hits 1pym_c01 naa= 3 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 36 ASP.? -3.33 CL CL A 382s A 68 ALA A 35 ALA.? 6.30 CL CL A 382 A 72 LEU A 168 LEU^? 6.56 CL CL A 382 coo 46.76 7.59 18.65 45.27 6.01 18.52 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 48.88 4.35 16.59 48.73 5.09 15.20 -35.44 63.33 123.80 -35.72 62.35 124.94 coo 53.89 6.25 15.09 52.88 7.92 14.14 -30.53 68.45 124.73 -31.34 69.14 126.59 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 3 # 2 A 67 ASP A 93 ASP^? 5.15 CL CL A 382 A 68 ALA A 95 ALA~? 5.86 CL CL A 382 A 72 LEU A 98 LEU~? 8.71 CL CL A 383 coo 46.76 7.59 18.65 45.27 6.01 18.52 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 48.88 4.35 16.59 48.73 5.09 15.20 -34.32 65.97 127.91 -34.72 66.23 126.45 coo 53.89 6.25 15.09 52.88 7.92 14.14 -37.29 68.02 130.67 -35.86 69.32 131.72 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 3 3 # 3 A 67 ASP A 115 ASP~? 22.59 CL CL A 382 A 68 ALA A 116 ALA~? 16.96 CL CL A 383 A 72 LEU A 120 LEU~? 12.41 CL CL A 383 coo 46.76 7.59 18.65 45.27 6.01 18.52 -35.38 84.29 133.21 -33.68 85.51 133.25 coo 48.88 4.35 16.59 48.73 5.09 15.20 -38.30 80.83 132.45 -39.59 81.12 131.73 coo 53.89 6.25 15.09 52.88 7.92 14.14 -38.37 74.84 133.38 -40.40 75.42 132.92 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 4 3 # 4 A 67 ASP A 115 ASP~? 22.59 CL CL A 382 A 68 ALA A 116 ALA~? 16.96 CL CL A 383 A 72 LEU A 140 LEU.? 18.91 CL CL A 383 coo 46.76 7.59 18.65 45.27 6.01 18.52 -35.38 84.29 133.21 -33.68 85.51 133.25 coo 48.88 4.35 16.59 48.73 5.09 15.20 -38.30 80.83 132.45 -39.59 81.12 131.73 coo 53.89 6.25 15.09 52.88 7.92 14.14 -43.10 84.80 128.94 -41.55 83.58 127.89 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 5 3 # 5 A 67 ASP A 272 ASP~? 14.48 CL CL A 382 A 68 ALA A 271 ALA~? 18.46 CL CL A 382 A 72 LEU A 270 LEU~? 23.55 CL CL A 383 coo 46.76 7.59 18.65 45.27 6.01 18.52 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 48.88 4.35 16.59 48.73 5.09 15.20 -46.19 76.51 109.39 -45.19 77.53 109.91 coo 53.89 6.25 15.09 52.88 7.92 14.14 -50.44 78.04 108.85 -52.50 78.70 108.33 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 6 3 # 6 A 67 ASP A 344 ASP.? 20.56 CL CL A 382 A 68 ALA A 345 ALA.? 15.79 CL CL A 382 A 72 LEU A 164 LEU.? 14.50 CL CL A 382 coo 46.76 7.59 18.65 45.27 6.01 18.52 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 48.88 4.35 16.59 48.73 5.09 15.20 -35.83 83.37 115.92 -35.32 81.91 116.06 coo 53.89 6.25 15.09 52.88 7.92 14.14 -38.43 80.00 120.74 -37.29 81.90 120.38 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 7 3 # 7 A 67 ASP B 36 ASP.? -3.35 CL CL B 383s A 68 ALA B 35 ALA.? 6.30 CL CL B 383 A 72 LEU B 168 LEU^? 6.98 CL CL B 383 coo 46.76 7.59 18.65 45.27 6.01 18.52 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 48.88 4.35 16.59 48.73 5.09 15.20 -15.02 33.54 74.31 -16.10 32.59 73.63 coo 53.89 6.25 15.09 52.88 7.92 14.14 -12.86 38.79 70.27 -14.13 38.93 68.38 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 8 3 # 8 A 67 ASP B 115 ASP~? 22.59 CL CL B 383 A 68 ALA B 116 ALA~? 16.91 CL CL B 384 A 72 LEU B 120 LEU~? 12.41 CL CL B 384 coo 46.76 7.59 18.65 45.27 6.01 18.52 0.29 34.85 57.65 0.95 36.59 56.65 coo 48.88 4.35 16.59 48.73 5.09 15.20 -1.44 31.83 60.52 -0.43 31.15 61.47 coo 53.89 6.25 15.09 52.88 7.92 14.14 -6.66 29.89 62.35 -5.45 28.16 62.91 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 9 3 # 9 A 67 ASP B 115 ASP~? 22.59 CL CL B 383 A 68 ALA B 116 ALA~? 16.91 CL CL B 384 A 72 LEU B 140 LEU.? 18.58 CL CL B 384 coo 46.76 7.59 18.65 45.27 6.01 18.52 0.29 34.85 57.65 0.95 36.59 56.65 coo 48.88 4.35 16.59 48.73 5.09 15.20 -1.44 31.83 60.52 -0.43 31.15 61.47 coo 53.89 6.25 15.09 52.88 7.92 14.14 4.98 29.77 63.33 3.22 30.61 64.22 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 10 3 # 10 A 67 ASP B 272 ASP~? 14.11 CL CL B 383 A 68 ALA B 271 ALA~? 18.20 CL CL B 383 A 72 LEU B 270 LEU~? 23.21 CL CL B 383 coo 46.76 7.59 18.65 45.27 6.01 18.52 0.88 31.47 82.51 1.09 32.47 80.67 coo 48.88 4.35 16.59 48.73 5.09 15.20 4.76 33.88 84.20 5.07 34.78 82.98 coo 53.89 6.25 15.09 52.88 7.92 14.14 7.84 30.73 84.95 9.38 29.37 85.70 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 11 3 # 11 A 67 ASP B 344 ASP.? 20.04 CL CL B 383 A 68 ALA B 345 ALA.? 15.71 CL CL B 383 A 72 LEU B 164 LEU.? 14.42 CL CL B 383 coo 46.76 7.59 18.65 45.27 6.01 18.52 7.59 38.09 74.22 8.59 36.72 75.50 coo 48.88 4.35 16.59 48.73 5.09 15.20 4.64 41.37 73.03 3.24 41.54 73.45 coo 53.89 6.25 15.09 52.88 7.92 14.14 1.48 36.51 71.18 2.78 38.06 70.40 1q6l_c05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 11 hits 1q6l_c05 naa= 3 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 1 3 # 1 A 396 ARG A 197 ARG.? 14.16 CL CL A 384 A 581 ARG B 290 ARG.? 12.49 CL CL A 384 A 713 ARG A 290 ARG.? -7.44 CL CL A 384s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -16.42 65.00 90.05 -16.47 67.55 88.20 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -13.01 59.15 90.41 -14.60 61.38 91.89 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -15.77 66.49 99.38 -13.63 64.23 99.65 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 2 3 # 2 A 396 ARG A 320 ARG^? 16.18 CL CL A 382 A 581 ARG A 334 ARG^? 9.67 CL CL A 382 A 713 ARG A 202 ARG^? 19.65 CL CL A 384 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -32.10 56.68 112.17 -32.95 53.99 110.90 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -35.93 61.76 109.91 -34.52 61.40 112.61 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -32.39 54.22 100.96 -34.65 53.06 99.24 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 3 3 # 3 A 396 ARG A 320 ARG^? 16.18 CL CL A 382 A 581 ARG A 334 ARG^? 9.67 CL CL A 382 A 713 ARG A 319 ARG^? 9.49 CL CL A 382 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -32.10 56.68 112.17 -32.95 53.99 110.90 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -35.93 61.76 109.91 -34.52 61.40 112.61 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -27.23 63.29 112.77 -27.13 63.50 115.87 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 4 3 # 4 A 396 ARG B 290 ARG.? 12.49 CL CL A 384 A 581 ARG A 197 ARG.? 14.16 CL CL A 384 A 713 ARG A 290 ARG.? -7.44 CL CL A 384s coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -13.01 59.15 90.41 -14.60 61.38 91.89 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -16.42 65.00 90.05 -16.47 67.55 88.20 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -15.77 66.49 99.38 -13.63 64.23 99.65 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 5 3 # 5 A 396 ARG B 320 ARG^? 13.22 CL CL B 383 A 581 ARG B 334 ARG^? 9.65 CL CL B 383 A 713 ARG B 202 ARG^? 25.52 CL CL B 383 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -19.20 39.56 86.12 -20.64 37.04 85.01 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -12.53 38.39 87.32 -14.06 38.36 84.61 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -17.65 42.54 97.41 -16.79 41.14 100.03 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 6 3 # 6 A 396 ARG B 334 ARG^? 9.65 CL CL B 383 A 581 ARG B 320 ARG^? 13.22 CL CL B 383 A 713 ARG B 202 ARG^? 25.52 CL CL B 383 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 -12.53 38.39 87.32 -14.06 38.36 84.61 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 -19.20 39.56 86.12 -20.64 37.04 85.01 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 -17.65 42.54 97.41 -16.79 41.14 100.03 1qb4_c01 source 1qb4 PHOSPHOENOLPYRUVATE CARBOXYLASE : 6 hits 1qb4_c01 naa= 3 ULMN 3 1qfl_c00 ACETOACETYL-COA THIOLASE user 1 3 # 1 A 348 HIS A 19 HIS^? 24.55 CL CL A 382 A 378 CYH A 59 CYH^? 15.29 CL CL A 382 A 380 GLY A 15 GLY.? 24.36 CL CL A 382 coo 28.93 -15.66 12.20 27.40 -15.25 10.79 -17.70 51.01 127.32 -17.43 50.94 129.40 coo 22.08 -17.67 5.57 22.76 -18.91 8.05 -22.72 58.93 129.41 -24.70 57.69 127.81 coo 18.19 -14.51 10.52 18.01 -14.23 9.79 -16.89 56.94 134.05 -16.70 56.94 133.22 ULMN 3 1qfl_c00 ACETOACETYL-COA THIOLASE user 2 3 # 2 A 348 HIS B 19 HIS^? 13.92 CL CL B 382 A 378 CYH B 59 CYH^? 15.58 CL CL B 383 A 380 GLY B 15 GLY.? 16.45 CL CL B 382 coo 28.93 -15.66 12.20 27.40 -15.25 10.79 -33.46 45.18 72.05 -34.46 43.90 70.71 coo 22.08 -17.67 5.57 22.76 -18.91 8.05 -25.66 41.31 67.81 -25.65 39.78 70.09 coo 18.19 -14.51 10.52 18.01 -14.23 9.79 -31.19 42.55 63.28 -31.02 43.21 63.76 ULMN 3 1qfl_c00 ACETOACETYL-COA THIOLASE user 3 3 # 3 A 348 HIS B 19 HIS^? 13.92 CL CL B 382 A 378 CYH B 59 CYH^? 15.58 CL CL B 383 A 380 GLY B 16 GLY.? 13.71 CL CL B 382 coo 28.93 -15.66 12.20 27.40 -15.25 10.79 -33.46 45.18 72.05 -34.46 43.90 70.71 coo 22.08 -17.67 5.57 22.76 -18.91 8.05 -25.66 41.31 67.81 -25.65 39.78 70.09 coo 18.19 -14.51 10.52 18.01 -14.23 9.79 -31.15 46.32 63.21 -31.52 45.86 63.71 1qfl_c00 source 1qfl ACETOACETYL-COA THIOLASE : 3 hits 1qfl_c00 naa= 3 ULMN 3 1qfl_c01 ACETOACETYL-COA THIOLASE user 1 3 # 1 B 348 HIS A 19 HIS^? 24.55 CL CL A 382 B 378 CYH A 59 CYH^? 15.29 CL CL A 382 B 380 GLY A 15 GLY.? 24.36 CL CL A 382 coo 13.24 15.55 12.21 14.75 15.10 10.80 -17.70 51.01 127.32 -17.43 50.94 129.40 coo 20.14 17.58 5.68 19.50 18.95 7.99 -22.72 58.93 129.41 -24.70 57.69 127.81 coo 24.06 14.49 10.58 24.24 14.15 9.79 -16.89 56.94 134.05 -16.70 56.94 133.22 ULMN 3 1qfl_c01 ACETOACETYL-COA THIOLASE user 2 3 # 2 B 348 HIS B 19 HIS^? 13.92 CL CL B 382 B 378 CYH B 59 CYH^? 15.58 CL CL B 383 B 380 GLY B 15 GLY.? 16.45 CL CL B 382 coo 13.24 15.55 12.21 14.75 15.10 10.80 -33.46 45.18 72.05 -34.46 43.90 70.71 coo 20.14 17.58 5.68 19.50 18.95 7.99 -25.66 41.31 67.81 -25.65 39.78 70.09 coo 24.06 14.49 10.58 24.24 14.15 9.79 -31.19 42.55 63.28 -31.02 43.21 63.76 ULMN 3 1qfl_c01 ACETOACETYL-COA THIOLASE user 3 3 # 3 B 348 HIS B 19 HIS^? 13.92 CL CL B 382 B 378 CYH B 59 CYH^? 15.58 CL CL B 383 B 380 GLY B 16 GLY.? 13.71 CL CL B 382 coo 13.24 15.55 12.21 14.75 15.10 10.80 -33.46 45.18 72.05 -34.46 43.90 70.71 coo 20.14 17.58 5.68 19.50 18.95 7.99 -25.66 41.31 67.81 -25.65 39.78 70.09 coo 24.06 14.49 10.58 24.24 14.15 9.79 -31.15 46.32 63.21 -31.52 45.86 63.71 1qfl_c01 source 1qfl ACETOACETYL-COA THIOLASE : 3 hits 1qfl_c01 naa= 3 ULMN 3 1qfl_c02 ACETOACETYL-COA THIOLASE user 1 3 # 1 C 348 HIS A 19 HIS^? 24.55 CL CL A 382 C 378 CYH A 59 CYH^? 15.29 CL CL A 382 C 380 GLY A 15 GLY.? 24.36 CL CL A 382 coo 39.92 0.27 55.80 38.80 1.56 57.03 -17.70 51.01 127.32 -17.43 50.94 129.40 coo 38.90 7.44 62.34 40.19 7.59 59.85 -22.72 58.93 129.41 -24.70 57.69 127.81 coo 34.29 9.51 57.55 33.93 9.43 58.29 -16.89 56.94 134.05 -16.70 56.94 133.22 ULMN 3 1qfl_c02 ACETOACETYL-COA THIOLASE user 2 3 # 2 C 348 HIS B 19 HIS^? 13.92 CL CL B 382 C 378 CYH B 59 CYH^? 15.58 CL CL B 383 C 380 GLY B 15 GLY.? 16.45 CL CL B 382 coo 39.92 0.27 55.80 38.80 1.56 57.03 -33.46 45.18 72.05 -34.46 43.90 70.71 coo 38.90 7.44 62.34 40.19 7.59 59.85 -25.66 41.31 67.81 -25.65 39.78 70.09 coo 34.29 9.51 57.55 33.93 9.43 58.29 -31.19 42.55 63.28 -31.02 43.21 63.76 ULMN 3 1qfl_c02 ACETOACETYL-COA THIOLASE user 3 3 # 3 C 348 HIS B 19 HIS^? 13.92 CL CL B 382 C 378 CYH B 59 CYH^? 15.58 CL CL B 383 C 380 GLY B 16 GLY.? 13.71 CL CL B 382 coo 39.92 0.27 55.80 38.80 1.56 57.03 -33.46 45.18 72.05 -34.46 43.90 70.71 coo 38.90 7.44 62.34 40.19 7.59 59.85 -25.66 41.31 67.81 -25.65 39.78 70.09 coo 34.29 9.51 57.55 33.93 9.43 58.29 -31.15 46.32 63.21 -31.52 45.86 63.71 1qfl_c02 source 1qfl ACETOACETYL-COA THIOLASE : 3 hits 1qfl_c02 naa= 3 ULMN 3 1qfl_c03 ACETOACETYL-COA THIOLASE user 1 3 # 1 D 348 HIS A 19 HIS^? 24.55 CL CL A 382 D 378 CYH A 59 CYH^? 15.29 CL CL A 382 D 380 GLY A 15 GLY.? 24.36 CL CL A 382 coo 4.85 0.61 57.13 5.96 -0.63 58.38 -17.70 51.01 127.32 -17.43 50.94 129.40 coo 6.41 -6.55 63.64 4.67 -6.39 61.44 -22.72 58.93 129.41 -24.70 57.69 127.81 coo 10.63 -8.62 58.57 11.08 -8.54 59.30 -16.89 56.94 134.05 -16.70 56.94 133.22 ULMN 3 1qfl_c03 ACETOACETYL-COA THIOLASE user 2 3 # 2 D 348 HIS B 19 HIS^? 13.92 CL CL B 382 D 378 CYH B 59 CYH^? 15.58 CL CL B 383 D 380 GLY B 15 GLY.? 16.45 CL CL B 382 coo 4.85 0.61 57.13 5.96 -0.63 58.38 -33.46 45.18 72.05 -34.46 43.90 70.71 coo 6.41 -6.55 63.64 4.67 -6.39 61.44 -25.66 41.31 67.81 -25.65 39.78 70.09 coo 10.63 -8.62 58.57 11.08 -8.54 59.30 -31.19 42.55 63.28 -31.02 43.21 63.76 ULMN 3 1qfl_c03 ACETOACETYL-COA THIOLASE user 3 3 # 3 D 348 HIS B 19 HIS^? 13.92 CL CL B 382 D 378 CYH B 59 CYH^? 15.58 CL CL B 383 D 380 GLY B 16 GLY.? 13.71 CL CL B 382 coo 4.85 0.61 57.13 5.96 -0.63 58.38 -33.46 45.18 72.05 -34.46 43.90 70.71 coo 6.41 -6.55 63.64 4.67 -6.39 61.44 -25.66 41.31 67.81 -25.65 39.78 70.09 coo 10.63 -8.62 58.57 11.08 -8.54 59.30 -31.15 46.32 63.21 -31.52 45.86 63.71 1qfl_c03 source 1qfl ACETOACETYL-COA THIOLASE : 3 hits 1qfl_c03 naa= 3 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 155 HIS A 246 HIS.? 33.92 CL CL A 383 A 236 ASP A 208 ASP.? 21.85 CL CL A 382 A 261 LYS A 336 LYS^? 14.72 CL CL A 382 coo 55.45 46.76 42.08 57.34 46.16 42.75 -65.97 72.19 102.08 -66.87 73.22 103.68 coo 48.87 29.19 44.63 49.10 27.34 43.63 -48.25 63.81 104.00 -49.74 63.21 105.24 coo 47.58 17.35 41.83 51.40 20.85 40.83 -37.43 70.02 105.34 -41.47 67.12 107.58 1qgn_c00 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c00 naa= 3 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 155 HIS A 246 HIS.? 33.92 CL CL A 383 B 236 ASP A 208 ASP.? 21.85 CL CL A 382 B 261 LYS A 336 LYS^? 14.72 CL CL A 382 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -65.97 72.19 102.08 -66.87 73.22 103.68 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -48.25 63.81 104.00 -49.74 63.21 105.24 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 155 HIS B 246 HIS.? 32.95 CL CL B 384 B 236 ASP B 208 ASP.? 21.56 CL CL B 383 B 261 LYS B 336 LYS^? 14.66 CL CL B 383 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 10.60 18.26 97.26 11.24 17.08 95.63 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -3.40 41.24 88.18 -4.83 35.96 88.60 1qgn_c01 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c01 naa= 3 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 155 HIS A 246 HIS.? 33.92 CL CL A 383 C 236 ASP A 208 ASP.? 21.85 CL CL A 382 C 261 LYS A 336 LYS^? 14.72 CL CL A 382 coo 55.11 47.10 12.61 53.44 47.85 11.58 -65.97 72.19 102.08 -66.87 73.22 103.68 coo 45.78 31.11 9.51 44.25 30.06 10.53 -48.25 63.81 104.00 -49.74 63.21 105.24 coo 37.54 22.37 12.10 37.83 27.55 13.24 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 155 HIS B 246 HIS.? 32.95 CL CL B 384 C 236 ASP B 208 ASP.? 21.56 CL CL B 383 C 261 LYS B 336 LYS^? 14.66 CL CL B 383 coo 55.11 47.10 12.61 53.44 47.85 11.58 10.60 18.26 97.26 11.24 17.08 95.63 coo 45.78 31.11 9.51 44.25 30.06 10.53 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 37.54 22.37 12.10 37.83 27.55 13.24 -3.40 41.24 88.18 -4.83 35.96 88.60 1qgn_c02 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c02 naa= 3 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 155 HIS A 246 HIS.? 33.92 CL CL A 383 D 236 ASP A 208 ASP.? 21.85 CL CL A 382 D 261 LYS A 336 LYS^? 14.72 CL CL A 382 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -65.97 72.19 102.08 -66.87 73.22 103.68 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -48.25 63.81 104.00 -49.74 63.21 105.24 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -37.43 70.02 105.34 -41.47 67.12 107.58 1qgn_c03 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c03 naa= 3 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 155 HIS A 246 HIS.? 33.92 CL CL A 383 E 236 ASP A 208 ASP.? 21.85 CL CL A 382 E 261 LYS A 336 LYS^? 14.72 CL CL A 382 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -65.97 72.19 102.08 -66.87 73.22 103.68 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -48.25 63.81 104.00 -49.74 63.21 105.24 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -37.43 70.02 105.34 -41.47 67.12 107.58 1qgn_c04 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c04 naa= 3 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 155 HIS A 246 HIS.? 33.92 CL CL A 383 F 236 ASP A 208 ASP.? 21.85 CL CL A 382 F 261 LYS A 336 LYS^? 14.72 CL CL A 382 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -65.97 72.19 102.08 -66.87 73.22 103.68 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -48.25 63.81 104.00 -49.74 63.21 105.24 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 155 HIS B 246 HIS.? 32.95 CL CL B 384 F 236 ASP B 208 ASP.? 21.56 CL CL B 383 F 261 LYS B 336 LYS^? 14.66 CL CL B 383 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 10.60 18.26 97.26 11.24 17.08 95.63 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -3.40 41.24 88.18 -4.83 35.96 88.60 1qgn_c05 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c05 naa= 3 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 155 HIS A 246 HIS.? 33.92 CL CL A 383 G 236 ASP A 208 ASP.? 21.85 CL CL A 382 G 261 LYS A 336 LYS^? 14.72 CL CL A 382 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -65.97 72.19 102.08 -66.87 73.22 103.68 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -48.25 63.81 104.00 -49.74 63.21 105.24 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -37.43 70.02 105.34 -41.47 67.12 107.58 1qgn_c06 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c06 naa= 3 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 155 HIS A 246 HIS.? 33.92 CL CL A 383 H 236 ASP A 208 ASP.? 21.85 CL CL A 382 H 261 LYS A 336 LYS^? 14.72 CL CL A 382 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -65.97 72.19 102.08 -66.87 73.22 103.68 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -48.25 63.81 104.00 -49.74 63.21 105.24 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -37.43 70.02 105.34 -41.47 67.12 107.58 1qgn_c07 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c07 naa= 3 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 238 TYR^? 27.75 CL CL A 383 E 236 ASP A 240 ASP.? 30.06 CL CL A 382 E 261 LYS A 249 LYS^? 20.12 CL CL A 383 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -54.82 80.30 106.22 -53.19 79.11 104.29 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -54.36 78.15 100.29 -55.09 76.20 100.68 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -61.09 73.36 110.22 -57.90 69.98 113.58 1qgn_c12 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c12 naa= 3 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 238 TYR^? 27.75 CL CL A 383 F 236 ASP A 240 ASP.? 30.06 CL CL A 382 F 261 LYS A 249 LYS^? 20.12 CL CL A 383 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -54.82 80.30 106.22 -53.19 79.11 104.29 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -54.36 78.15 100.29 -55.09 76.20 100.68 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -61.09 73.36 110.22 -57.90 69.98 113.58 1qgn_c13 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c13 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG A 300 ARG^? 15.75 CL CL A 384 C 163 TYR A 346 TYR.? 17.61 CL CL A 382 C 236 ASP A 344 ASP.? 20.56 CL CL A 382 coo 39.01 29.77 22.02 37.48 31.30 19.84 -30.16 77.29 106.40 -29.79 78.90 103.79 coo 39.51 34.34 13.63 37.63 32.61 14.79 -31.44 83.83 114.39 -30.05 82.53 116.45 coo 45.78 31.11 9.51 44.25 30.06 10.53 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 110 ARG A 319 ARG^? 9.49 CL CL A 382 C 163 TYR A 25 TYR^? 18.63 CL CL A 382 C 236 ASP A 39 ASP^? 16.51 CL CL A 382 coo 39.01 29.77 22.02 37.48 31.30 19.84 -27.23 63.29 112.77 -27.13 63.50 115.87 coo 39.51 34.34 13.63 37.63 32.61 14.79 -23.49 53.13 116.11 -21.60 54.30 114.36 coo 45.78 31.11 9.51 44.25 30.06 10.53 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 110 ARG B 300 ARG^? 21.49 CL CL B 383 C 163 TYR B 346 TYR.? 17.60 CL CL B 383 C 236 ASP B 344 ASP.? 20.04 CL CL B 383 coo 39.01 29.77 22.02 37.48 31.30 19.84 0.10 48.73 83.03 1.88 51.20 83.58 coo 39.51 34.34 13.63 37.63 32.61 14.79 3.94 45.97 72.94 1.71 46.24 71.30 coo 45.78 31.11 9.51 44.25 30.06 10.53 7.59 38.09 74.22 8.59 36.72 75.50 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 110 ARG B 319 ARG^? 9.63 CL CL B 383 C 163 TYR B 25 TYR^? 14.27 CL CL B 382 C 236 ASP B 39 ASP^? 17.51 CL CL B 383 coo 39.01 29.77 22.02 37.48 31.30 19.84 -15.74 45.22 81.80 -15.96 44.19 78.93 coo 39.51 34.34 13.63 37.63 32.61 14.79 -26.62 44.42 81.68 -25.97 47.00 82.31 coo 45.78 31.11 9.51 44.25 30.06 10.53 -26.18 36.85 80.53 -27.97 36.10 81.34 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG A 300 ARG^? 15.75 CL CL A 384 D 163 TYR A 346 TYR.? 17.61 CL CL A 382 D 236 ASP A 344 ASP.? 20.56 CL CL A 382 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -30.16 77.29 106.40 -29.79 78.90 103.79 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -31.44 83.83 114.39 -30.05 82.53 116.45 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 110 ARG A 319 ARG^? 9.49 CL CL A 382 D 163 TYR A 25 TYR^? 18.63 CL CL A 382 D 236 ASP A 39 ASP^? 16.51 CL CL A 382 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -27.23 63.29 112.77 -27.13 63.50 115.87 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -23.49 53.13 116.11 -21.60 54.30 114.36 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 110 ARG B 300 ARG^? 21.49 CL CL B 383 D 163 TYR B 346 TYR.? 17.60 CL CL B 383 D 236 ASP B 344 ASP.? 20.04 CL CL B 383 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 0.10 48.73 83.03 1.88 51.20 83.58 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 3.94 45.97 72.94 1.71 46.24 71.30 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 7.59 38.09 74.22 8.59 36.72 75.50 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 110 ARG B 319 ARG^? 9.63 CL CL B 383 D 163 TYR B 25 TYR^? 14.27 CL CL B 382 D 236 ASP B 39 ASP^? 17.51 CL CL B 383 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -15.74 45.22 81.80 -15.96 44.19 78.93 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -26.62 44.42 81.68 -25.97 47.00 82.31 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -26.18 36.85 80.53 -27.97 36.10 81.34 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 25 TYR^? 18.63 CL CL A 382 A 236 ASP A 39 ASP^? 16.51 CL CL A 382 C 110 ARG A 319 ARG^? 9.49 CL CL A 382 coo 55.48 26.51 40.65 55.39 23.99 39.43 -23.49 53.13 116.11 -21.60 54.30 114.36 coo 48.87 29.19 44.63 49.10 27.34 43.63 -29.94 52.12 119.85 -30.97 50.72 120.81 coo 52.39 23.42 32.10 54.51 23.27 34.29 -27.23 63.29 112.77 -27.13 63.50 115.87 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR A 346 TYR.? 17.61 CL CL A 382 A 236 ASP A 344 ASP.? 20.56 CL CL A 382 C 110 ARG A 300 ARG^? 15.75 CL CL A 384 coo 55.48 26.51 40.65 55.39 23.99 39.43 -31.44 83.83 114.39 -30.05 82.53 116.45 coo 48.87 29.19 44.63 49.10 27.34 43.63 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 52.39 23.42 32.10 54.51 23.27 34.29 -30.16 77.29 106.40 -29.79 78.90 103.79 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR B 25 TYR^? 14.27 CL CL B 382 A 236 ASP B 39 ASP^? 17.51 CL CL B 383 C 110 ARG B 319 ARG^? 9.63 CL CL B 383 coo 55.48 26.51 40.65 55.39 23.99 39.43 -26.62 44.42 81.68 -25.97 47.00 82.31 coo 48.87 29.19 44.63 49.10 27.34 43.63 -26.18 36.85 80.53 -27.97 36.10 81.34 coo 52.39 23.42 32.10 54.51 23.27 34.29 -15.74 45.22 81.80 -15.96 44.19 78.93 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 163 TYR B 346 TYR.? 17.60 CL CL B 383 A 236 ASP B 344 ASP.? 20.04 CL CL B 383 C 110 ARG B 300 ARG^? 21.49 CL CL B 383 coo 55.48 26.51 40.65 55.39 23.99 39.43 3.94 45.97 72.94 1.71 46.24 71.30 coo 48.87 29.19 44.63 49.10 27.34 43.63 7.59 38.09 74.22 8.59 36.72 75.50 coo 52.39 23.42 32.10 54.51 23.27 34.29 0.10 48.73 83.03 1.88 51.20 83.58 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 8 TYR.? 12.26 CL CL A 384 B 236 ASP A 64 ASP.? 15.21 CL CL A 384 D 110 ARG B 193 ARG.? 19.02 CL CL A 384 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -16.53 57.80 111.57 -17.14 59.34 109.36 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -13.50 61.63 115.26 -13.45 60.20 113.75 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -14.12 50.83 106.82 -12.70 50.89 109.57 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR A 25 TYR^? 18.63 CL CL A 382 B 236 ASP A 39 ASP^? 16.51 CL CL A 382 D 110 ARG A 319 ARG^? 9.49 CL CL A 382 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -23.49 53.13 116.11 -21.60 54.30 114.36 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -29.94 52.12 119.85 -30.97 50.72 120.81 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -27.23 63.29 112.77 -27.13 63.50 115.87 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR A 346 TYR.? 17.61 CL CL A 382 B 236 ASP A 344 ASP.? 20.56 CL CL A 382 D 110 ARG A 300 ARG^? 15.75 CL CL A 384 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -31.44 83.83 114.39 -30.05 82.53 116.45 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -30.16 77.29 106.40 -29.79 78.90 103.79 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 163 TYR B 25 TYR^? 14.27 CL CL B 382 B 236 ASP B 39 ASP^? 17.51 CL CL B 383 D 110 ARG B 319 ARG^? 9.63 CL CL B 383 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -26.62 44.42 81.68 -25.97 47.00 82.31 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -26.18 36.85 80.53 -27.97 36.10 81.34 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -15.74 45.22 81.80 -15.96 44.19 78.93 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 163 TYR B 346 TYR.? 17.60 CL CL B 383 B 236 ASP B 344 ASP.? 20.04 CL CL B 383 D 110 ARG B 300 ARG^? 21.49 CL CL B 383 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 3.94 45.97 72.94 1.71 46.24 71.30 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 7.59 38.09 74.22 8.59 36.72 75.50 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 0.10 48.73 83.03 1.88 51.20 83.58 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG A 300 ARG^? 15.75 CL CL A 384 G 163 TYR A 346 TYR.? 17.61 CL CL A 382 G 236 ASP A 344 ASP.? 20.56 CL CL A 382 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -30.16 77.29 106.40 -29.79 78.90 103.79 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -31.44 83.83 114.39 -30.05 82.53 116.45 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 110 ARG A 319 ARG^? 9.49 CL CL A 382 G 163 TYR A 25 TYR^? 18.63 CL CL A 382 G 236 ASP A 39 ASP^? 16.51 CL CL A 382 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -27.23 63.29 112.77 -27.13 63.50 115.87 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -23.49 53.13 116.11 -21.60 54.30 114.36 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 110 ARG B 300 ARG^? 21.49 CL CL B 383 G 163 TYR B 346 TYR.? 17.60 CL CL B 383 G 236 ASP B 344 ASP.? 20.04 CL CL B 383 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 0.10 48.73 83.03 1.88 51.20 83.58 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 3.94 45.97 72.94 1.71 46.24 71.30 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 7.59 38.09 74.22 8.59 36.72 75.50 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 110 ARG B 319 ARG^? 9.63 CL CL B 383 G 163 TYR B 25 TYR^? 14.27 CL CL B 382 G 236 ASP B 39 ASP^? 17.51 CL CL B 383 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -15.74 45.22 81.80 -15.96 44.19 78.93 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -26.62 44.42 81.68 -25.97 47.00 82.31 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -26.18 36.85 80.53 -27.97 36.10 81.34 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 300 ARG^? 15.75 CL CL A 384 H 163 TYR A 346 TYR.? 17.61 CL CL A 382 H 236 ASP A 344 ASP.? 20.56 CL CL A 382 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -30.16 77.29 106.40 -29.79 78.90 103.79 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -31.44 83.83 114.39 -30.05 82.53 116.45 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 110 ARG A 319 ARG^? 9.49 CL CL A 382 H 163 TYR A 25 TYR^? 18.63 CL CL A 382 H 236 ASP A 39 ASP^? 16.51 CL CL A 382 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -27.23 63.29 112.77 -27.13 63.50 115.87 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -23.49 53.13 116.11 -21.60 54.30 114.36 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 110 ARG B 193 ARG.? 19.02 CL CL A 384 H 163 TYR A 8 TYR.? 12.26 CL CL A 384 H 236 ASP A 64 ASP.? 15.21 CL CL A 384 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -14.12 50.83 106.82 -12.70 50.89 109.57 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -16.53 57.80 111.57 -17.14 59.34 109.36 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -13.50 61.63 115.26 -13.45 60.20 113.75 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 110 ARG B 300 ARG^? 21.49 CL CL B 383 H 163 TYR B 346 TYR.? 17.60 CL CL B 383 H 236 ASP B 344 ASP.? 20.04 CL CL B 383 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 0.10 48.73 83.03 1.88 51.20 83.58 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 3.94 45.97 72.94 1.71 46.24 71.30 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 7.59 38.09 74.22 8.59 36.72 75.50 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 110 ARG B 319 ARG^? 9.63 CL CL B 383 H 163 TYR B 25 TYR^? 14.27 CL CL B 382 H 236 ASP B 39 ASP^? 17.51 CL CL B 383 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -15.74 45.22 81.80 -15.96 44.19 78.93 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -26.62 44.42 81.68 -25.97 47.00 82.31 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -26.18 36.85 80.53 -27.97 36.10 81.34 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 8 TYR.? 12.26 CL CL A 384 E 236 ASP A 64 ASP.? 15.21 CL CL A 384 G 110 ARG B 193 ARG.? 19.02 CL CL A 384 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -16.53 57.80 111.57 -17.14 59.34 109.36 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -13.50 61.63 115.26 -13.45 60.20 113.75 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -14.12 50.83 106.82 -12.70 50.89 109.57 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR A 25 TYR^? 18.63 CL CL A 382 E 236 ASP A 39 ASP^? 16.51 CL CL A 382 G 110 ARG A 319 ARG^? 9.49 CL CL A 382 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -23.49 53.13 116.11 -21.60 54.30 114.36 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -29.94 52.12 119.85 -30.97 50.72 120.81 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -27.23 63.29 112.77 -27.13 63.50 115.87 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR A 346 TYR.? 17.61 CL CL A 382 E 236 ASP A 344 ASP.? 20.56 CL CL A 382 G 110 ARG A 300 ARG^? 15.75 CL CL A 384 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -31.44 83.83 114.39 -30.05 82.53 116.45 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -30.16 77.29 106.40 -29.79 78.90 103.79 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 163 TYR B 25 TYR^? 14.27 CL CL B 382 E 236 ASP B 39 ASP^? 17.51 CL CL B 383 G 110 ARG B 319 ARG^? 9.63 CL CL B 383 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -26.62 44.42 81.68 -25.97 47.00 82.31 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -26.18 36.85 80.53 -27.97 36.10 81.34 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -15.74 45.22 81.80 -15.96 44.19 78.93 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 163 TYR B 346 TYR.? 17.60 CL CL B 383 E 236 ASP B 344 ASP.? 20.04 CL CL B 383 G 110 ARG B 300 ARG^? 21.49 CL CL B 383 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 3.94 45.97 72.94 1.71 46.24 71.30 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 7.59 38.09 74.22 8.59 36.72 75.50 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 0.10 48.73 83.03 1.88 51.20 83.58 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 5 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 25 TYR^? 18.63 CL CL A 382 F 236 ASP A 39 ASP^? 16.51 CL CL A 382 H 110 ARG A 319 ARG^? 9.49 CL CL A 382 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -23.49 53.13 116.11 -21.60 54.30 114.36 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -29.94 52.12 119.85 -30.97 50.72 120.81 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -27.23 63.29 112.77 -27.13 63.50 115.87 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR A 346 TYR.? 17.61 CL CL A 382 F 236 ASP A 344 ASP.? 20.56 CL CL A 382 H 110 ARG A 300 ARG^? 15.75 CL CL A 384 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -31.44 83.83 114.39 -30.05 82.53 116.45 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -30.16 77.29 106.40 -29.79 78.90 103.79 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR B 25 TYR^? 14.27 CL CL B 382 F 236 ASP B 39 ASP^? 17.51 CL CL B 383 H 110 ARG B 319 ARG^? 9.63 CL CL B 383 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -26.62 44.42 81.68 -25.97 47.00 82.31 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -26.18 36.85 80.53 -27.97 36.10 81.34 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -15.74 45.22 81.80 -15.96 44.19 78.93 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 163 TYR B 346 TYR.? 17.60 CL CL B 383 F 236 ASP B 344 ASP.? 20.04 CL CL B 383 H 110 ARG B 300 ARG^? 21.49 CL CL B 383 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 3.94 45.97 72.94 1.71 46.24 71.30 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 7.59 38.09 74.22 8.59 36.72 75.50 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 0.10 48.73 83.03 1.88 51.20 83.58 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1qgn_c23 naa= 3 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 1 3 # 1 A 49 ASP A 171 ASP.? 13.95 CL CL A 382 A 147 THR A 173 THR.? 13.13 CL CL A 382 A 294 ASP A 36 ASP.? -3.33 CL CL A 382s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -21.72 70.05 125.28 -22.57 71.99 125.28 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -26.89 72.55 127.11 -25.69 74.31 126.61 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -31.47 63.24 120.93 -31.90 65.07 119.91 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 2 3 # 2 A 49 ASP A 204 ASP^? 18.76 CL CL A 384 A 147 THR A 283 THR^? 13.40 CL CL A 384 A 294 ASP A 305 ASP^? 16.01 CL CL A 384 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -37.06 58.40 100.88 -36.30 56.45 100.53 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -28.94 58.76 103.11 -29.59 56.83 103.84 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -32.01 65.22 92.45 -32.49 63.34 91.63 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 3 3 # 3 A 49 ASP A 204 ASP^? 18.76 CL CL A 384 A 147 THR A 283 THR^? 13.40 CL CL A 384 A 294 ASP A 327 ASP.? 19.04 CL CL A 384 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -37.06 58.40 100.88 -36.30 56.45 100.53 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -28.94 58.76 103.11 -29.59 56.83 103.84 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -25.74 49.77 105.10 -27.34 48.80 104.08 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 4 3 # 4 A 49 ASP A 291 ASP.? 7.30 CL CL A 384 A 147 THR A 289 THR.? 4.96 CL CL A 384 A 294 ASP A 64 ASP.? 15.21 CL CL A 384 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -15.45 71.21 105.07 -17.40 71.77 105.62 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -19.38 66.54 105.44 -19.89 68.46 106.21 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -13.50 61.63 115.26 -13.45 60.20 113.75 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 5 3 # 5 A 49 ASP A 291 ASP.? 7.30 CL CL A 384 A 147 THR A 289 THR.? 4.96 CL CL A 384 A 294 ASP B 195 ASP.? 10.47 CL CL A 384 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -15.45 71.21 105.07 -17.40 71.77 105.62 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -19.38 66.54 105.44 -19.89 68.46 106.21 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 6 3 # 6 A 49 ASP A 327 ASP.? 19.04 CL CL A 384 A 147 THR A 329 THR^? 14.14 CL CL A 384 A 294 ASP A 26 ASP^? 16.59 CL CL A 382 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -25.74 49.77 105.10 -27.34 48.80 104.08 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -21.38 53.78 108.30 -19.71 54.59 109.49 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 7 3 # 7 A 49 ASP A 344 ASP.? 20.56 CL CL A 382 A 147 THR A 342 THR.? 12.75 CL CL A 382 A 294 ASP A 338 ASP.? 17.28 CL CL A 384 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -39.29 79.06 113.77 -38.09 77.69 114.94 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -35.06 76.37 102.96 -33.50 77.52 103.78 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 8 3 # 8 A 49 ASP B 171 ASP.? 13.77 CL CL B 383 A 147 THR B 173 THR.? 13.07 CL CL B 383 A 294 ASP B 36 ASP.? -3.35 CL CL B 383s coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -14.88 46.75 66.62 -12.79 46.40 66.16 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -11.33 42.23 65.51 -10.11 43.97 64.96 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -15.98 38.04 75.83 -14.00 38.51 76.08 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 9 3 # 9 A 49 ASP B 204 ASP^? 22.18 CL CL B 383 A 147 THR B 283 THR^? 20.21 CL CL B 383 A 294 ASP B 305 ASP^? 21.59 CL CL A 384 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -12.38 39.84 96.49 -14.33 39.98 97.22 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -16.17 46.19 92.40 -17.74 44.83 92.78 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -6.28 49.81 99.79 -7.51 49.10 101.38 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 10 3 # 10 A 49 ASP B 204 ASP^? 22.18 CL CL B 383 A 147 THR B 283 THR^? 20.21 CL CL B 383 A 294 ASP B 327 ASP.? 22.34 CL CL A 384 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -12.38 39.84 96.49 -14.33 39.98 97.22 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -16.17 46.19 92.40 -17.74 44.83 92.78 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -25.62 46.25 93.54 -25.42 45.53 95.50 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 11 3 # 11 A 49 ASP B 208 ASP.? 21.56 CL CL B 383 A 147 THR B 279 THR^? 15.64 CL CL B 383 A 294 ASP B 272 ASP~? 14.11 CL CL B 383 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -5.97 38.16 91.98 -7.29 37.14 90.58 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 0.88 31.47 82.51 1.09 32.47 80.67 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 12 3 # 12 A 49 ASP B 272 ASP~? 14.11 CL CL B 383 A 147 THR B 342 THR.? 12.70 CL CL B 383 A 294 ASP B 338 ASP.? 19.77 CL CL B 383 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 0.88 31.47 82.51 1.09 32.47 80.67 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 2.93 38.40 77.77 1.00 38.51 76.85 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 1.84 46.00 86.98 1.86 47.25 85.31 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 13 3 # 13 A 49 ASP B 291 ASP.? 20.64 CL CL B 382 A 147 THR B 289 THR.? 17.67 CL CL B 382 A 294 ASP A 195 ASP.? 13.29 CL CL A 384 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -11.26 60.51 82.59 -9.94 61.37 84.03 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -13.61 55.64 84.71 -12.04 55.51 83.26 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 14 3 # 14 A 49 ASP B 291 ASP.? 20.64 CL CL B 382 A 147 THR B 289 THR.? 17.67 CL CL B 382 A 294 ASP B 64 ASP.? 7.14 CL CL B 382 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -11.26 60.51 82.59 -9.94 61.37 84.03 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -13.61 55.64 84.71 -12.04 55.51 83.26 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -22.24 55.99 77.05 -23.77 56.03 78.56 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 15 3 # 15 A 49 ASP B 327 ASP.? 22.34 CL CL A 384 A 147 THR B 329 THR^? 15.42 CL CL B 382 A 294 ASP B 26 ASP^? 16.51 CL CL B 383 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -25.62 46.25 93.54 -25.42 45.53 95.50 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -24.83 49.33 87.66 -25.34 51.01 86.38 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 16 3 # 16 A 49 ASP B 344 ASP.? 20.04 CL CL B 383 A 147 THR B 342 THR.? 12.70 CL CL B 383 A 294 ASP B 180 ASP.? 19.08 CL CL B 383 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 7.59 38.09 74.22 8.59 36.72 75.50 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 2.93 38.40 77.77 1.00 38.51 76.85 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 0.82 48.22 75.52 2.17 49.73 74.84 1qgx_c02 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 16 hits 1qgx_c02 naa= 3 ULMN 3 1qho_c04 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 180 ASP.? 19.13 CL CL A 382 A 256 GLU A 135 GLU.? 22.99 CL CL A 382 A 329 ASP A 344 ASP.? 20.56 CL CL A 382 coo 28.46 69.88 26.74 30.40 70.70 26.53 -29.53 80.77 112.24 -28.62 82.54 111.55 coo 30.54 71.65 32.58 31.73 72.26 30.92 -31.98 87.75 115.72 -30.11 88.72 115.32 coo 37.87 70.12 31.80 36.61 69.74 30.15 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 1qho_c04 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 210 ASP.? 21.69 CL CL A 383 A 256 GLU A 276 GLU~? 16.10 CL CL A 383 A 329 ASP A 272 ASP~? 14.48 CL CL A 382 coo 28.46 69.88 26.74 30.40 70.70 26.53 -52.58 64.68 106.89 -53.21 62.78 107.37 coo 30.54 71.65 32.58 31.73 72.26 30.92 -46.62 67.79 110.40 -48.46 68.09 111.43 coo 37.87 70.12 31.80 36.61 69.74 30.15 -46.67 73.24 112.92 -45.43 74.19 114.38 ULMN 3 1qho_c04 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 272 ASP~? 14.48 CL CL A 382 A 256 GLU A 276 GLU~? 16.10 CL CL A 383 A 329 ASP A 210 ASP.? 21.69 CL CL A 383 coo 28.46 69.88 26.74 30.40 70.70 26.53 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 30.54 71.65 32.58 31.73 72.26 30.92 -46.62 67.79 110.40 -48.46 68.09 111.43 coo 37.87 70.12 31.80 36.61 69.74 30.15 -52.58 64.68 106.89 -53.21 62.78 107.37 ULMN 3 1qho_c04 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP B 204 ASP^? 22.18 CL CL B 383 A 256 GLU B 206 GLU^? 19.18 CL CL B 383 A 329 ASP B 208 ASP.? 21.56 CL CL B 383 coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.38 39.84 96.49 -14.33 39.98 97.22 coo 30.54 71.65 32.58 31.73 72.26 30.92 -9.17 35.76 95.82 -10.61 34.74 94.62 coo 37.87 70.12 31.80 36.61 69.74 30.15 -4.03 30.56 94.79 -4.11 28.51 94.21 1qho_c04 source 1qho ALPHA-AMYLASE : 4 hits 1qho_c04 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 26 ASP^? 16.59 CL CL A 382 A 261 ASP A 100 ASP~? 8.92 CL CL A 383 A 329 ASP A 36 ASP.? -3.33 CL CL A 382s coo 28.46 69.88 26.74 30.40 70.70 26.53 -29.69 53.68 115.80 -29.91 52.24 114.24 coo 34.02 79.89 42.60 34.73 78.01 41.86 -39.25 61.23 132.92 -38.42 59.82 131.54 coo 37.87 70.12 31.80 36.61 69.74 30.15 -31.47 63.24 120.93 -31.90 65.07 119.91 ULMN 3 1qho_c05 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 36 ASP.? -3.33 CL CL A 382s A 261 ASP A 64 ASP.? 15.21 CL CL A 384 A 329 ASP A 171 ASP.? 13.95 CL CL A 382 coo 28.46 69.88 26.74 30.40 70.70 26.53 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 34.02 79.89 42.60 34.73 78.01 41.86 -13.50 61.63 115.26 -13.45 60.20 113.75 coo 37.87 70.12 31.80 36.61 69.74 30.15 -21.72 70.05 125.28 -22.57 71.99 125.28 ULMN 3 1qho_c05 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 36 ASP.? -3.33 CL CL A 382s A 261 ASP A 327 ASP.? 19.04 CL CL A 384 A 329 ASP A 39 ASP^? 16.51 CL CL A 382 coo 28.46 69.88 26.74 30.40 70.70 26.53 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 34.02 79.89 42.60 34.73 78.01 41.86 -25.74 49.77 105.10 -27.34 48.80 104.08 coo 37.87 70.12 31.80 36.61 69.74 30.15 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1qho_c05 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP A 39 ASP^? 16.51 CL CL A 382 A 261 ASP A 100 ASP~? 8.92 CL CL A 383 A 329 ASP A 36 ASP.? -3.33 CL CL A 382s coo 28.46 69.88 26.74 30.40 70.70 26.53 -29.94 52.12 119.85 -30.97 50.72 120.81 coo 34.02 79.89 42.60 34.73 78.01 41.86 -39.25 61.23 132.92 -38.42 59.82 131.54 coo 37.87 70.12 31.80 36.61 69.74 30.15 -31.47 63.24 120.93 -31.90 65.07 119.91 ULMN 3 1qho_c05 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP A 93 ASP^? 5.15 CL CL A 382 A 261 ASP A 64 ASP.? 15.21 CL CL A 384 A 329 ASP A 171 ASP.? 13.95 CL CL A 382 coo 28.46 69.88 26.74 30.40 70.70 26.53 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 34.02 79.89 42.60 34.73 78.01 41.86 -13.50 61.63 115.26 -13.45 60.20 113.75 coo 37.87 70.12 31.80 36.61 69.74 30.15 -21.72 70.05 125.28 -22.57 71.99 125.28 ULMN 3 1qho_c05 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP A 100 ASP~? 8.92 CL CL A 383 A 261 ASP A 26 ASP^? 16.59 CL CL A 382 A 329 ASP A 93 ASP^? 5.15 CL CL A 382 coo 28.46 69.88 26.74 30.40 70.70 26.53 -39.25 61.23 132.92 -38.42 59.82 131.54 coo 34.02 79.89 42.60 34.73 78.01 41.86 -29.69 53.68 115.80 -29.91 52.24 114.24 coo 37.87 70.12 31.80 36.61 69.74 30.15 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1qho_c05 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP A 171 ASP.? 13.95 CL CL A 382 A 261 ASP A 26 ASP^? 16.59 CL CL A 382 A 329 ASP A 93 ASP^? 5.15 CL CL A 382 coo 28.46 69.88 26.74 30.40 70.70 26.53 -21.72 70.05 125.28 -22.57 71.99 125.28 coo 34.02 79.89 42.60 34.73 78.01 41.86 -29.69 53.68 115.80 -29.91 52.24 114.24 coo 37.87 70.12 31.80 36.61 69.74 30.15 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1qho_c05 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP A 171 ASP.? 13.95 CL CL A 382 A 261 ASP A 100 ASP~? 8.92 CL CL A 383 A 329 ASP A 36 ASP.? -3.33 CL CL A 382s coo 28.46 69.88 26.74 30.40 70.70 26.53 -21.72 70.05 125.28 -22.57 71.99 125.28 coo 34.02 79.89 42.60 34.73 78.01 41.86 -39.25 61.23 132.92 -38.42 59.82 131.54 coo 37.87 70.12 31.80 36.61 69.74 30.15 -31.47 63.24 120.93 -31.90 65.07 119.91 ULMN 3 1qho_c05 ALPHA-AMYLASE user 9 3 # 9 A 228 ASP A 180 ASP.? 19.13 CL CL A 382 A 261 ASP A 272 ASP~? 14.48 CL CL A 382 A 329 ASP A 338 ASP.? 17.28 CL CL A 384 coo 28.46 69.88 26.74 30.40 70.70 26.53 -29.53 80.77 112.24 -28.62 82.54 111.55 coo 34.02 79.89 42.60 34.73 78.01 41.86 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 37.87 70.12 31.80 36.61 69.74 30.15 -35.06 76.37 102.96 -33.50 77.52 103.78 ULMN 3 1qho_c05 ALPHA-AMYLASE user 10 3 # 10 A 228 ASP A 180 ASP.? 19.13 CL CL A 382 A 261 ASP A 272 ASP~? 14.48 CL CL A 382 A 329 ASP A 344 ASP.? 20.56 CL CL A 382 coo 28.46 69.88 26.74 30.40 70.70 26.53 -29.53 80.77 112.24 -28.62 82.54 111.55 coo 34.02 79.89 42.60 34.73 78.01 41.86 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 37.87 70.12 31.80 36.61 69.74 30.15 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 1qho_c05 ALPHA-AMYLASE user 11 3 # 11 A 228 ASP A 204 ASP^? 18.76 CL CL A 384 A 261 ASP A 338 ASP.? 17.28 CL CL A 384 A 329 ASP A 305 ASP^? 16.01 CL CL A 384 coo 28.46 69.88 26.74 30.40 70.70 26.53 -37.06 58.40 100.88 -36.30 56.45 100.53 coo 34.02 79.89 42.60 34.73 78.01 41.86 -35.06 76.37 102.96 -33.50 77.52 103.78 coo 37.87 70.12 31.80 36.61 69.74 30.15 -32.01 65.22 92.45 -32.49 63.34 91.63 ULMN 3 1qho_c05 ALPHA-AMYLASE user 12 3 # 12 A 228 ASP A 210 ASP.? 21.69 CL CL A 383 A 261 ASP A 30 ASP^? -6.81 CL CL A 382s A 329 ASP A 272 ASP~? 14.48 CL CL A 382 coo 28.46 69.88 26.74 30.40 70.70 26.53 -52.58 64.68 106.89 -53.21 62.78 107.37 coo 34.02 79.89 42.60 34.73 78.01 41.86 -35.52 64.63 115.87 -36.96 65.19 114.43 coo 37.87 70.12 31.80 36.61 69.74 30.15 -46.67 73.24 112.92 -45.43 74.19 114.38 ULMN 3 1qho_c05 ALPHA-AMYLASE user 13 3 # 13 A 228 ASP A 210 ASP.? 21.69 CL CL A 383 A 261 ASP A 338 ASP.? 17.28 CL CL A 384 A 329 ASP A 272 ASP~? 14.48 CL CL A 382 coo 28.46 69.88 26.74 30.40 70.70 26.53 -52.58 64.68 106.89 -53.21 62.78 107.37 coo 34.02 79.89 42.60 34.73 78.01 41.86 -35.06 76.37 102.96 -33.50 77.52 103.78 coo 37.87 70.12 31.80 36.61 69.74 30.15 -46.67 73.24 112.92 -45.43 74.19 114.38 ULMN 3 1qho_c05 ALPHA-AMYLASE user 14 3 # 14 A 228 ASP A 291 ASP.? 7.30 CL CL A 384 A 261 ASP A 195 ASP.? 13.29 CL CL A 384 A 329 ASP B 195 ASP.? 10.47 CL CL A 384 coo 28.46 69.88 26.74 30.40 70.70 26.53 -15.45 71.21 105.07 -17.40 71.77 105.62 coo 34.02 79.89 42.60 34.73 78.01 41.86 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 37.87 70.12 31.80 36.61 69.74 30.15 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1qho_c05 ALPHA-AMYLASE user 15 3 # 15 A 228 ASP A 305 ASP^? 16.01 CL CL A 384 A 261 ASP A 327 ASP.? 19.04 CL CL A 384 A 329 ASP A 204 ASP^? 18.76 CL CL A 384 coo 28.46 69.88 26.74 30.40 70.70 26.53 -32.01 65.22 92.45 -32.49 63.34 91.63 coo 34.02 79.89 42.60 34.73 78.01 41.86 -25.74 49.77 105.10 -27.34 48.80 104.08 coo 37.87 70.12 31.80 36.61 69.74 30.15 -37.06 58.40 100.88 -36.30 56.45 100.53 ULMN 3 1qho_c05 ALPHA-AMYLASE user 16 3 # 16 A 228 ASP A 327 ASP.? 19.04 CL CL A 384 A 261 ASP B 204 ASP^? 22.18 CL CL B 383 A 329 ASP B 327 ASP.? 22.34 CL CL A 384 coo 28.46 69.88 26.74 30.40 70.70 26.53 -25.74 49.77 105.10 -27.34 48.80 104.08 coo 34.02 79.89 42.60 34.73 78.01 41.86 -12.38 39.84 96.49 -14.33 39.98 97.22 coo 37.87 70.12 31.80 36.61 69.74 30.15 -25.62 46.25 93.54 -25.42 45.53 95.50 ULMN 3 1qho_c05 ALPHA-AMYLASE user 17 3 # 17 A 228 ASP B 26 ASP^? 16.51 CL CL B 383 A 261 ASP B 100 ASP~? 8.80 CL CL B 384 A 329 ASP B 36 ASP.? -3.35 CL CL B 383s coo 28.46 69.88 26.74 30.40 70.70 26.53 -23.45 39.33 83.60 -24.23 39.48 85.53 coo 34.02 79.89 42.60 34.73 78.01 41.86 -18.20 25.71 68.46 -19.22 26.77 70.02 coo 37.87 70.12 31.80 36.61 69.74 30.15 -15.98 38.04 75.83 -14.00 38.51 76.08 ULMN 3 1qho_c05 ALPHA-AMYLASE user 18 3 # 18 A 228 ASP B 36 ASP.? -3.35 CL CL B 383s A 261 ASP B 204 ASP^? 22.18 CL CL B 383 A 329 ASP B 26 ASP^? 16.51 CL CL B 383 coo 28.46 69.88 26.74 30.40 70.70 26.53 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 34.02 79.89 42.60 34.73 78.01 41.86 -12.38 39.84 96.49 -14.33 39.98 97.22 coo 37.87 70.12 31.80 36.61 69.74 30.15 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1qho_c05 ALPHA-AMYLASE user 19 3 # 19 A 228 ASP B 39 ASP^? 17.51 CL CL B 383 A 261 ASP B 100 ASP~? 8.80 CL CL B 384 A 329 ASP B 36 ASP.? -3.35 CL CL B 383s coo 28.46 69.88 26.74 30.40 70.70 26.53 -26.18 36.85 80.53 -27.97 36.10 81.34 coo 34.02 79.89 42.60 34.73 78.01 41.86 -18.20 25.71 68.46 -19.22 26.77 70.02 coo 37.87 70.12 31.80 36.61 69.74 30.15 -15.98 38.04 75.83 -14.00 38.51 76.08 ULMN 3 1qho_c05 ALPHA-AMYLASE user 20 3 # 20 A 228 ASP B 93 ASP^? 5.22 CL CL B 383 A 261 ASP B 64 ASP.? 7.14 CL CL B 382 A 329 ASP B 171 ASP.? 13.77 CL CL B 383 coo 28.46 69.88 26.74 30.40 70.70 26.53 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 34.02 79.89 42.60 34.73 78.01 41.86 -22.24 55.99 77.05 -23.77 56.03 78.56 coo 37.87 70.12 31.80 36.61 69.74 30.15 -14.88 46.75 66.62 -12.79 46.40 66.16 ULMN 3 1qho_c05 ALPHA-AMYLASE user 21 3 # 21 A 228 ASP B 100 ASP~? 8.80 CL CL B 384 A 261 ASP B 26 ASP^? 16.51 CL CL B 383 A 329 ASP B 93 ASP^? 5.22 CL CL B 383 coo 28.46 69.88 26.74 30.40 70.70 26.53 -18.20 25.71 68.46 -19.22 26.77 70.02 coo 34.02 79.89 42.60 34.73 78.01 41.86 -23.45 39.33 83.60 -24.23 39.48 85.53 coo 37.87 70.12 31.80 36.61 69.74 30.15 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1qho_c05 ALPHA-AMYLASE user 22 3 # 22 A 228 ASP B 171 ASP.? 13.77 CL CL B 383 A 261 ASP B 26 ASP^? 16.51 CL CL B 383 A 329 ASP B 93 ASP^? 5.22 CL CL B 383 coo 28.46 69.88 26.74 30.40 70.70 26.53 -14.88 46.75 66.62 -12.79 46.40 66.16 coo 34.02 79.89 42.60 34.73 78.01 41.86 -23.45 39.33 83.60 -24.23 39.48 85.53 coo 37.87 70.12 31.80 36.61 69.74 30.15 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1qho_c05 ALPHA-AMYLASE user 23 3 # 23 A 228 ASP B 180 ASP.? 19.08 CL CL B 383 A 261 ASP B 272 ASP~? 14.11 CL CL B 383 A 329 ASP B 338 ASP.? 19.77 CL CL B 383 coo 28.46 69.88 26.74 30.40 70.70 26.53 0.82 48.22 75.52 2.17 49.73 74.84 coo 34.02 79.89 42.60 34.73 78.01 41.86 0.88 31.47 82.51 1.09 32.47 80.67 coo 37.87 70.12 31.80 36.61 69.74 30.15 1.84 46.00 86.98 1.86 47.25 85.31 ULMN 3 1qho_c05 ALPHA-AMYLASE user 24 3 # 24 A 228 ASP B 204 ASP^? 22.18 CL CL B 383 A 261 ASP B 272 ASP~? 14.11 CL CL B 383 A 329 ASP B 208 ASP.? 21.56 CL CL B 383 coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.38 39.84 96.49 -14.33 39.98 97.22 coo 34.02 79.89 42.60 34.73 78.01 41.86 0.88 31.47 82.51 1.09 32.47 80.67 coo 37.87 70.12 31.80 36.61 69.74 30.15 -4.03 30.56 94.79 -4.11 28.51 94.21 ULMN 3 1qho_c05 ALPHA-AMYLASE user 25 3 # 25 A 228 ASP B 204 ASP^? 22.18 CL CL B 383 A 261 ASP B 338 ASP.? 19.77 CL CL B 383 A 329 ASP B 305 ASP^? 21.59 CL CL A 384 coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.38 39.84 96.49 -14.33 39.98 97.22 coo 34.02 79.89 42.60 34.73 78.01 41.86 1.84 46.00 86.98 1.86 47.25 85.31 coo 37.87 70.12 31.80 36.61 69.74 30.15 -6.28 49.81 99.79 -7.51 49.10 101.38 ULMN 3 1qho_c05 ALPHA-AMYLASE user 26 3 # 26 A 228 ASP B 208 ASP.? 21.56 CL CL B 383 A 261 ASP B 28 ASP^? 9.00 CL CL B 383 A 329 ASP B 204 ASP^? 22.18 CL CL B 383 coo 28.46 69.88 26.74 30.40 70.70 26.53 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 34.02 79.89 42.60 34.73 78.01 41.86 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 37.87 70.12 31.80 36.61 69.74 30.15 -12.38 39.84 96.49 -14.33 39.98 97.22 ULMN 3 1qho_c05 ALPHA-AMYLASE user 27 3 # 27 A 228 ASP B 291 ASP.? 20.64 CL CL B 382 A 261 ASP B 195 ASP.? 10.47 CL CL A 384 A 329 ASP A 195 ASP.? 13.29 CL CL A 384 coo 28.46 69.88 26.74 30.40 70.70 26.53 -11.26 60.51 82.59 -9.94 61.37 84.03 coo 34.02 79.89 42.60 34.73 78.01 41.86 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 37.87 70.12 31.80 36.61 69.74 30.15 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1qho_c05 ALPHA-AMYLASE user 28 3 # 28 A 228 ASP B 305 ASP^? 21.59 CL CL A 384 A 261 ASP A 64 ASP.? 15.21 CL CL A 384 A 329 ASP B 195 ASP.? 10.47 CL CL A 384 coo 28.46 69.88 26.74 30.40 70.70 26.53 -6.28 49.81 99.79 -7.51 49.10 101.38 coo 34.02 79.89 42.60 34.73 78.01 41.86 -13.50 61.63 115.26 -13.45 60.20 113.75 coo 37.87 70.12 31.80 36.61 69.74 30.15 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1qho_c05 ALPHA-AMYLASE user 29 3 # 29 A 228 ASP B 305 ASP^? 21.59 CL CL A 384 A 261 ASP B 327 ASP.? 22.34 CL CL A 384 A 329 ASP B 204 ASP^? 22.18 CL CL B 383 coo 28.46 69.88 26.74 30.40 70.70 26.53 -6.28 49.81 99.79 -7.51 49.10 101.38 coo 34.02 79.89 42.60 34.73 78.01 41.86 -25.62 46.25 93.54 -25.42 45.53 95.50 coo 37.87 70.12 31.80 36.61 69.74 30.15 -12.38 39.84 96.49 -14.33 39.98 97.22 ULMN 3 1qho_c05 ALPHA-AMYLASE user 30 3 # 30 A 228 ASP B 327 ASP.? 22.34 CL CL A 384 A 261 ASP A 204 ASP^? 18.76 CL CL A 384 A 329 ASP A 327 ASP.? 19.04 CL CL A 384 coo 28.46 69.88 26.74 30.40 70.70 26.53 -25.62 46.25 93.54 -25.42 45.53 95.50 coo 34.02 79.89 42.60 34.73 78.01 41.86 -37.06 58.40 100.88 -36.30 56.45 100.53 coo 37.87 70.12 31.80 36.61 69.74 30.15 -25.74 49.77 105.10 -27.34 48.80 104.08 ULMN 3 1qho_c05 ALPHA-AMYLASE user 31 3 # 31 A 228 ASP B 344 ASP.? 20.04 CL CL B 383 A 261 ASP B 30 ASP^? -6.72 CL CL B 383s A 329 ASP B 272 ASP~? 14.11 CL CL B 383 coo 28.46 69.88 26.74 30.40 70.70 26.53 7.59 38.09 74.22 8.59 36.72 75.50 coo 34.02 79.89 42.60 34.73 78.01 41.86 -11.77 37.20 80.70 -10.35 36.55 82.15 coo 37.87 70.12 31.80 36.61 69.74 30.15 0.88 31.47 82.51 1.09 32.47 80.67 ULMN 3 1qho_c05 ALPHA-AMYLASE user 32 3 # 32 A 228 ASP B 344 ASP.? 20.04 CL CL B 383 A 261 ASP B 240 ASP.? 29.22 CL CL B 383 A 329 ASP B 272 ASP~? 14.11 CL CL B 383 coo 28.46 69.88 26.74 30.40 70.70 26.53 7.59 38.09 74.22 8.59 36.72 75.50 coo 34.02 79.89 42.60 34.73 78.01 41.86 11.35 28.88 93.27 10.37 30.59 94.07 coo 37.87 70.12 31.80 36.61 69.74 30.15 0.88 31.47 82.51 1.09 32.47 80.67 1qho_c05 source 1qho ALPHA-AMYLASE : 32 hits 1qho_c05 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 26 ASP^? 16.59 CL CL A 382 A 260 ASP A 204 ASP^? 18.76 CL CL A 384 A 329 ASP A 30 ASP^? -6.81 CL CL A 382s coo 28.46 69.88 26.74 30.40 70.70 26.53 -29.69 53.68 115.80 -29.91 52.24 114.24 coo 30.73 81.29 37.61 31.23 82.07 35.69 -37.06 58.40 100.88 -36.30 56.45 100.53 coo 37.87 70.12 31.80 36.61 69.74 30.15 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1qho_c07 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 26 ASP^? 16.59 CL CL A 382 A 260 ASP A 204 ASP^? 18.76 CL CL A 384 A 329 ASP A 327 ASP.? 19.04 CL CL A 384 coo 28.46 69.88 26.74 30.40 70.70 26.53 -29.69 53.68 115.80 -29.91 52.24 114.24 coo 30.73 81.29 37.61 31.23 82.07 35.69 -37.06 58.40 100.88 -36.30 56.45 100.53 coo 37.87 70.12 31.80 36.61 69.74 30.15 -25.74 49.77 105.10 -27.34 48.80 104.08 ULMN 3 1qho_c07 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 30 ASP^? -6.81 CL CL A 382s A 260 ASP A 39 ASP^? 16.51 CL CL A 382 A 329 ASP A 93 ASP^? 5.15 CL CL A 382 coo 28.46 69.88 26.74 30.40 70.70 26.53 -35.52 64.63 115.87 -36.96 65.19 114.43 coo 30.73 81.29 37.61 31.23 82.07 35.69 -29.94 52.12 119.85 -30.97 50.72 120.81 coo 37.87 70.12 31.80 36.61 69.74 30.15 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1qho_c07 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP A 210 ASP.? 21.69 CL CL A 383 A 260 ASP A 240 ASP.? 30.06 CL CL A 382 A 329 ASP A 272 ASP~? 14.48 CL CL A 382 coo 28.46 69.88 26.74 30.40 70.70 26.53 -52.58 64.68 106.89 -53.21 62.78 107.37 coo 30.73 81.29 37.61 31.23 82.07 35.69 -54.36 78.15 100.29 -55.09 76.20 100.68 coo 37.87 70.12 31.80 36.61 69.74 30.15 -46.67 73.24 112.92 -45.43 74.19 114.38 ULMN 3 1qho_c07 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP A 272 ASP~? 14.48 CL CL A 382 A 260 ASP A 240 ASP.? 30.06 CL CL A 382 A 329 ASP A 210 ASP.? 21.69 CL CL A 383 coo 28.46 69.88 26.74 30.40 70.70 26.53 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 30.73 81.29 37.61 31.23 82.07 35.69 -54.36 78.15 100.29 -55.09 76.20 100.68 coo 37.87 70.12 31.80 36.61 69.74 30.15 -52.58 64.68 106.89 -53.21 62.78 107.37 ULMN 3 1qho_c07 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP A 291 ASP.? 7.30 CL CL A 384 A 260 ASP A 64 ASP.? 15.21 CL CL A 384 A 329 ASP B 195 ASP.? 10.47 CL CL A 384 coo 28.46 69.88 26.74 30.40 70.70 26.53 -15.45 71.21 105.07 -17.40 71.77 105.62 coo 30.73 81.29 37.61 31.23 82.07 35.69 -13.50 61.63 115.26 -13.45 60.20 113.75 coo 37.87 70.12 31.80 36.61 69.74 30.15 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1qho_c07 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP B 26 ASP^? 16.51 CL CL B 383 A 260 ASP B 204 ASP^? 22.18 CL CL B 383 A 329 ASP B 30 ASP^? -6.72 CL CL B 383s coo 28.46 69.88 26.74 30.40 70.70 26.53 -23.45 39.33 83.60 -24.23 39.48 85.53 coo 30.73 81.29 37.61 31.23 82.07 35.69 -12.38 39.84 96.49 -14.33 39.98 97.22 coo 37.87 70.12 31.80 36.61 69.74 30.15 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1qho_c07 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP B 26 ASP^? 16.51 CL CL B 383 A 260 ASP B 204 ASP^? 22.18 CL CL B 383 A 329 ASP B 327 ASP.? 22.34 CL CL A 384 coo 28.46 69.88 26.74 30.40 70.70 26.53 -23.45 39.33 83.60 -24.23 39.48 85.53 coo 30.73 81.29 37.61 31.23 82.07 35.69 -12.38 39.84 96.49 -14.33 39.98 97.22 coo 37.87 70.12 31.80 36.61 69.74 30.15 -25.62 46.25 93.54 -25.42 45.53 95.50 ULMN 3 1qho_c07 ALPHA-AMYLASE user 9 3 # 9 A 228 ASP B 30 ASP^? -6.72 CL CL B 383s A 260 ASP B 39 ASP^? 17.51 CL CL B 383 A 329 ASP B 93 ASP^? 5.22 CL CL B 383 coo 28.46 69.88 26.74 30.40 70.70 26.53 -11.77 37.20 80.70 -10.35 36.55 82.15 coo 30.73 81.29 37.61 31.23 82.07 35.69 -26.18 36.85 80.53 -27.97 36.10 81.34 coo 37.87 70.12 31.80 36.61 69.74 30.15 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1qho_c07 ALPHA-AMYLASE user 10 3 # 10 A 228 ASP B 208 ASP.? 21.56 CL CL B 383 A 260 ASP B 30 ASP^? -6.72 CL CL B 383s A 329 ASP B 204 ASP^? 22.18 CL CL B 383 coo 28.46 69.88 26.74 30.40 70.70 26.53 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 30.73 81.29 37.61 31.23 82.07 35.69 -11.77 37.20 80.70 -10.35 36.55 82.15 coo 37.87 70.12 31.80 36.61 69.74 30.15 -12.38 39.84 96.49 -14.33 39.98 97.22 ULMN 3 1qho_c07 ALPHA-AMYLASE user 11 3 # 11 A 228 ASP B 272 ASP~? 14.11 CL CL B 383 A 260 ASP B 338 ASP.? 19.77 CL CL B 383 A 329 ASP B 344 ASP.? 20.04 CL CL B 383 coo 28.46 69.88 26.74 30.40 70.70 26.53 0.88 31.47 82.51 1.09 32.47 80.67 coo 30.73 81.29 37.61 31.23 82.07 35.69 1.84 46.00 86.98 1.86 47.25 85.31 coo 37.87 70.12 31.80 36.61 69.74 30.15 7.59 38.09 74.22 8.59 36.72 75.50 ULMN 3 1qho_c07 ALPHA-AMYLASE user 12 3 # 12 A 228 ASP B 306 ASP.? 19.57 CL CL A 384 A 260 ASP A 64 ASP.? 15.21 CL CL A 384 A 329 ASP B 195 ASP.? 10.47 CL CL A 384 coo 28.46 69.88 26.74 30.40 70.70 26.53 -4.64 54.84 103.01 -3.71 56.24 101.58 coo 30.73 81.29 37.61 31.23 82.07 35.69 -13.50 61.63 115.26 -13.45 60.20 113.75 coo 37.87 70.12 31.80 36.61 69.74 30.15 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1qho_c07 ALPHA-AMYLASE user 13 3 # 13 A 228 ASP B 344 ASP.? 20.04 CL CL B 383 A 260 ASP B 338 ASP.? 19.77 CL CL B 383 A 329 ASP B 272 ASP~? 14.11 CL CL B 383 coo 28.46 69.88 26.74 30.40 70.70 26.53 7.59 38.09 74.22 8.59 36.72 75.50 coo 30.73 81.29 37.61 31.23 82.07 35.69 1.84 46.00 86.98 1.86 47.25 85.31 coo 37.87 70.12 31.80 36.61 69.74 30.15 0.88 31.47 82.51 1.09 32.47 80.67 1qho_c07 source 1qho ALPHA-AMYLASE : 13 hits 1qho_c07 naa= 3 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 A 51 ALA A 154 ALA~? 9.30 CL CL A 383 A 148 HIS A 157 HIS~? 12.03 CL CL A 383 A 163 ASP A 144 ASP.? 19.38 CL CL A 383 coo 1.42 19.18 21.84 1.11 19.57 23.28 -44.22 73.23 129.68 -43.96 73.28 131.23 coo 0.71 19.67 27.92 2.43 19.16 26.83 -47.82 75.77 126.56 -49.90 76.10 126.41 coo 7.15 16.22 27.50 6.15 18.00 27.94 -52.89 78.90 131.37 -53.77 80.20 132.79 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 A 51 ALA A 220 ALA^? 24.28 CL CL A 383 A 148 HIS A 232 HIS.? 26.22 CL CL A 383 A 163 ASP A 233 ASP.? 30.79 CL CL A 383 coo 1.42 19.18 21.84 1.11 19.57 23.28 -59.62 83.10 120.76 -58.13 83.57 120.73 coo 0.71 19.67 27.92 2.43 19.16 26.83 -64.09 81.45 120.95 -63.65 79.66 121.95 coo 7.15 16.22 27.50 6.15 18.00 27.94 -64.45 88.75 121.31 -62.88 88.68 122.75 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 A 51 ALA B 154 ALA~? 9.41 CL CL B 384 A 148 HIS B 157 HIS~? 12.80 CL CL B 384 A 163 ASP B 144 ASP.? 18.90 CL CL B 384 coo 1.42 19.18 21.84 1.11 19.57 23.28 -4.85 25.78 67.69 -5.32 25.38 66.32 coo 0.71 19.67 27.92 2.43 19.16 26.83 0.17 24.88 70.38 1.86 23.62 70.32 coo 7.15 16.22 27.50 6.15 18.00 27.94 1.70 18.75 65.96 3.42 18.04 64.94 1qol_c00 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 3 hits 1qol_c00 naa= 3 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 B 51 ALA A 154 ALA~? 9.30 CL CL A 383 B 148 HIS A 157 HIS~? 12.03 CL CL A 383 B 163 ASP A 144 ASP.? 19.38 CL CL A 383 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -44.22 73.23 129.68 -43.96 73.28 131.23 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -47.82 75.77 126.56 -49.90 76.10 126.41 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -52.89 78.90 131.37 -53.77 80.20 132.79 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 B 51 ALA A 220 ALA^? 24.28 CL CL A 383 B 148 HIS A 232 HIS.? 26.22 CL CL A 383 B 163 ASP A 233 ASP.? 30.79 CL CL A 383 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -59.62 83.10 120.76 -58.13 83.57 120.73 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -64.09 81.45 120.95 -63.65 79.66 121.95 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -64.45 88.75 121.31 -62.88 88.68 122.75 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 B 51 ALA B 154 ALA~? 9.41 CL CL B 384 B 148 HIS B 157 HIS~? 12.80 CL CL B 384 B 163 ASP B 144 ASP.? 18.90 CL CL B 384 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -4.85 25.78 67.69 -5.32 25.38 66.32 coo -33.17 20.01 48.16 -34.95 19.37 49.06 0.17 24.88 70.38 1.86 23.62 70.32 coo -39.82 16.62 48.85 -38.59 18.24 48.48 1.70 18.75 65.96 3.42 18.04 64.94 1qol_c01 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 3 hits 1qol_c01 naa= 3 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 C 51 ALA A 154 ALA~? 9.30 CL CL A 383 C 148 HIS A 157 HIS~? 12.03 CL CL A 383 C 163 ASP A 144 ASP.? 19.38 CL CL A 383 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -44.22 73.23 129.68 -43.96 73.28 131.23 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -47.82 75.77 126.56 -49.90 76.10 126.41 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -52.89 78.90 131.37 -53.77 80.20 132.79 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 C 51 ALA A 220 ALA^? 24.28 CL CL A 383 C 148 HIS A 232 HIS.? 26.22 CL CL A 383 C 163 ASP A 233 ASP.? 30.79 CL CL A 383 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -59.62 83.10 120.76 -58.13 83.57 120.73 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -64.09 81.45 120.95 -63.65 79.66 121.95 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -64.45 88.75 121.31 -62.88 88.68 122.75 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 C 51 ALA B 154 ALA~? 9.41 CL CL B 384 C 148 HIS B 157 HIS~? 12.80 CL CL B 384 C 163 ASP B 144 ASP.? 18.90 CL CL B 384 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -4.85 25.78 67.69 -5.32 25.38 66.32 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 0.17 24.88 70.38 1.86 23.62 70.32 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 1.70 18.75 65.96 3.42 18.04 64.94 1qol_c02 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 3 hits 1qol_c02 naa= 3 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 D 51 ALA A 154 ALA~? 9.30 CL CL A 383 D 148 HIS A 157 HIS~? 12.03 CL CL A 383 D 163 ASP A 144 ASP.? 19.38 CL CL A 383 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -44.22 73.23 129.68 -43.96 73.28 131.23 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -47.82 75.77 126.56 -49.90 76.10 126.41 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -52.89 78.90 131.37 -53.77 80.20 132.79 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 D 51 ALA A 220 ALA^? 24.28 CL CL A 383 D 148 HIS A 232 HIS.? 26.22 CL CL A 383 D 163 ASP A 233 ASP.? 30.79 CL CL A 383 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -59.62 83.10 120.76 -58.13 83.57 120.73 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -64.09 81.45 120.95 -63.65 79.66 121.95 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -64.45 88.75 121.31 -62.88 88.68 122.75 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 D 51 ALA B 154 ALA~? 9.41 CL CL B 384 D 148 HIS B 157 HIS~? 12.80 CL CL B 384 D 163 ASP B 144 ASP.? 18.90 CL CL B 384 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -4.85 25.78 67.69 -5.32 25.38 66.32 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 0.17 24.88 70.38 1.86 23.62 70.32 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 1.70 18.75 65.96 3.42 18.04 64.94 1qol_c03 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 3 hits 1qol_c03 naa= 3 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 E 51 ALA A 220 ALA^? 24.28 CL CL A 383 E 148 HIS A 232 HIS.? 26.22 CL CL A 383 E 163 ASP A 233 ASP.? 30.79 CL CL A 383 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -59.62 83.10 120.76 -58.13 83.57 120.73 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -64.09 81.45 120.95 -63.65 79.66 121.95 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -64.45 88.75 121.31 -62.88 88.68 122.75 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 E 51 ALA B 154 ALA~? 9.41 CL CL B 384 E 148 HIS B 157 HIS~? 12.80 CL CL B 384 E 163 ASP B 144 ASP.? 18.90 CL CL B 384 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -4.85 25.78 67.69 -5.32 25.38 66.32 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 0.17 24.88 70.38 1.86 23.62 70.32 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 1.70 18.75 65.96 3.42 18.04 64.94 1qol_c04 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 2 hits 1qol_c04 naa= 3 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 F 51 ALA A 154 ALA~? 9.30 CL CL A 383 F 148 HIS A 157 HIS~? 12.03 CL CL A 383 F 163 ASP A 144 ASP.? 19.38 CL CL A 383 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -44.22 73.23 129.68 -43.96 73.28 131.23 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -47.82 75.77 126.56 -49.90 76.10 126.41 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -52.89 78.90 131.37 -53.77 80.20 132.79 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 F 51 ALA A 220 ALA^? 24.28 CL CL A 383 F 148 HIS A 232 HIS.? 26.22 CL CL A 383 F 163 ASP A 233 ASP.? 30.79 CL CL A 383 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -59.62 83.10 120.76 -58.13 83.57 120.73 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -64.09 81.45 120.95 -63.65 79.66 121.95 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -64.45 88.75 121.31 -62.88 88.68 122.75 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 F 51 ALA B 154 ALA~? 9.41 CL CL B 384 F 148 HIS B 157 HIS~? 12.80 CL CL B 384 F 163 ASP B 144 ASP.? 18.90 CL CL B 384 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -4.85 25.78 67.69 -5.32 25.38 66.32 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 0.17 24.88 70.38 1.86 23.62 70.32 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 1.70 18.75 65.96 3.42 18.04 64.94 1qol_c05 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 3 hits 1qol_c05 naa= 3 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 G 51 ALA A 220 ALA^? 24.28 CL CL A 383 G 148 HIS A 232 HIS.? 26.22 CL CL A 383 G 163 ASP A 233 ASP.? 30.79 CL CL A 383 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -59.62 83.10 120.76 -58.13 83.57 120.73 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -64.09 81.45 120.95 -63.65 79.66 121.95 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -64.45 88.75 121.31 -62.88 88.68 122.75 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 G 51 ALA B 154 ALA~? 9.41 CL CL B 384 G 148 HIS B 157 HIS~? 12.80 CL CL B 384 G 163 ASP B 144 ASP.? 18.90 CL CL B 384 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -4.85 25.78 67.69 -5.32 25.38 66.32 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 0.17 24.88 70.38 1.86 23.62 70.32 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 1.70 18.75 65.96 3.42 18.04 64.94 1qol_c06 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 2 hits 1qol_c06 naa= 3 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 H 51 ALA A 154 ALA~? 9.30 CL CL A 383 H 148 HIS A 157 HIS~? 12.03 CL CL A 383 H 163 ASP A 144 ASP.? 19.38 CL CL A 383 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -44.22 73.23 129.68 -43.96 73.28 131.23 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -47.82 75.77 126.56 -49.90 76.10 126.41 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -52.89 78.90 131.37 -53.77 80.20 132.79 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 H 51 ALA A 220 ALA^? 24.28 CL CL A 383 H 148 HIS A 232 HIS.? 26.22 CL CL A 383 H 163 ASP A 233 ASP.? 30.79 CL CL A 383 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -59.62 83.10 120.76 -58.13 83.57 120.73 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -64.09 81.45 120.95 -63.65 79.66 121.95 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -64.45 88.75 121.31 -62.88 88.68 122.75 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 H 51 ALA B 154 ALA~? 9.41 CL CL B 384 H 148 HIS B 157 HIS~? 12.80 CL CL B 384 H 163 ASP B 144 ASP.? 18.90 CL CL B 384 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -4.85 25.78 67.69 -5.32 25.38 66.32 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 0.17 24.88 70.38 1.86 23.62 70.32 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 1.70 18.75 65.96 3.42 18.04 64.94 1qol_c07 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 3 hits 1qol_c07 naa= 3 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 1 3 # 1 A 145 THR B 194 THR.? 12.32 CL CL A 384 A 182 TYR A 8 TYR.? 12.26 CL CL A 384 A 186 LYS A 288 LYS.? 12.57 CL CL A 384 coo 69.38 87.38 24.64 71.11 88.47 25.40 -14.07 57.99 105.37 -12.38 58.46 106.64 coo 73.61 90.42 31.12 71.36 89.66 29.64 -16.53 57.80 111.57 -17.14 59.34 109.36 coo 73.54 84.00 28.64 69.01 86.68 29.71 -19.18 64.09 108.25 -14.44 63.70 112.45 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 2 3 # 2 A 145 THR B 331 THR^? 16.17 CL CL B 383 A 182 TYR B 8 TYR.? 11.88 CL CL B 382 A 186 LYS B 288 LYS.? 8.84 CL CL B 382 coo 69.38 87.38 24.64 71.11 88.47 25.40 -18.10 46.86 87.19 -17.24 47.80 85.43 coo 73.61 90.42 31.12 71.36 89.66 29.64 -23.96 53.72 82.39 -21.76 54.53 83.93 coo 73.54 84.00 28.64 69.01 86.68 29.71 -16.76 54.22 83.25 -20.62 56.75 78.99 1qrr_c01 source 1qrr SULFOLIPID BIOSYNTHESIS (SQD1) PROTEIN : 2 hits 1qrr_c01 naa= 3 ULMN 3 1qrz_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS A 78 HIS^? 30.68 CL CL A 382 A 646 ASP A 53 ASP.? 25.38 CL CL A 382 A 741 SER A 88 SER^? 22.34 CL CL A 382 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -24.82 39.60 128.09 -23.39 38.20 127.48 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -25.09 46.58 135.54 -27.02 47.57 135.30 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -26.75 46.25 123.96 -28.99 45.42 123.71 ULMN 3 1qrz_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS A 157 HIS~? 12.03 CL CL A 383 A 646 ASP A 144 ASP.? 19.38 CL CL A 383 A 741 SER A 161 SER~? 16.95 CL CL A 383 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -47.82 75.77 126.56 -49.90 76.10 126.41 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -52.89 78.90 131.37 -53.77 80.20 132.79 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -45.55 81.13 122.60 -44.57 82.20 124.58 ULMN 3 1qrz_c12 PLASMINOGEN user 3 3 # 3 A 603 HIS B 78 HIS^? 26.83 CL CL B 382 A 646 ASP B 53 ASP.? 25.44 CL CL B 384 A 741 SER B 88 SER^? 22.31 CL CL B 383 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -41.15 34.55 77.14 -42.58 35.82 77.99 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -37.14 32.94 67.80 -35.44 31.68 68.05 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -33.45 36.60 78.54 -33.30 34.49 79.66 ULMN 3 1qrz_c12 PLASMINOGEN user 4 3 # 4 A 603 HIS B 157 HIS~? 12.80 CL CL B 384 A 646 ASP B 144 ASP.? 18.90 CL CL B 384 A 741 SER B 161 SER~? 16.65 CL CL B 384 coo -20.72 2.99 34.37 -21.94 1.82 35.61 0.17 24.88 70.38 1.86 23.62 70.32 coo -18.83 7.68 26.86 -20.89 7.78 26.56 1.70 18.75 65.96 3.42 18.04 64.94 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 4.53 29.49 70.92 4.35 29.43 68.47 1qrz_c12 source 1qrz PLASMINOGEN : 4 hits 1qrz_c12 naa= 3 ULMN 3 1qrz_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS A 78 HIS^? 30.68 CL CL A 382 B 646 ASP A 53 ASP.? 25.38 CL CL A 382 B 741 SER A 88 SER^? 22.34 CL CL A 382 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -24.82 39.60 128.09 -23.39 38.20 127.48 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -25.09 46.58 135.54 -27.02 47.57 135.30 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -26.75 46.25 123.96 -28.99 45.42 123.71 ULMN 3 1qrz_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS A 157 HIS~? 12.03 CL CL A 383 B 646 ASP A 144 ASP.? 19.38 CL CL A 383 B 741 SER A 161 SER~? 16.95 CL CL A 383 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -47.82 75.77 126.56 -49.90 76.10 126.41 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -52.89 78.90 131.37 -53.77 80.20 132.79 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -45.55 81.13 122.60 -44.57 82.20 124.58 ULMN 3 1qrz_c13 PLASMINOGEN user 3 3 # 3 B 603 HIS B 78 HIS^? 26.83 CL CL B 382 B 646 ASP B 53 ASP.? 25.44 CL CL B 384 B 741 SER B 88 SER^? 22.31 CL CL B 383 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -41.15 34.55 77.14 -42.58 35.82 77.99 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -37.14 32.94 67.80 -35.44 31.68 68.05 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -33.45 36.60 78.54 -33.30 34.49 79.66 ULMN 3 1qrz_c13 PLASMINOGEN user 4 3 # 4 B 603 HIS B 157 HIS~? 12.80 CL CL B 384 B 646 ASP B 144 ASP.? 18.90 CL CL B 384 B 741 SER B 161 SER~? 16.65 CL CL B 384 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 0.17 24.88 70.38 1.86 23.62 70.32 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 1.70 18.75 65.96 3.42 18.04 64.94 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 4.53 29.49 70.92 4.35 29.43 68.47 1qrz_c13 source 1qrz PLASMINOGEN : 4 hits 1qrz_c13 naa= 3 ULMN 3 1qrz_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS A 78 HIS^? 30.68 CL CL A 382 C 646 ASP A 53 ASP.? 25.38 CL CL A 382 C 741 SER A 88 SER^? 22.34 CL CL A 382 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -24.82 39.60 128.09 -23.39 38.20 127.48 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -25.09 46.58 135.54 -27.02 47.57 135.30 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -26.75 46.25 123.96 -28.99 45.42 123.71 ULMN 3 1qrz_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS A 157 HIS~? 12.03 CL CL A 383 C 646 ASP A 144 ASP.? 19.38 CL CL A 383 C 741 SER A 161 SER~? 16.95 CL CL A 383 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -47.82 75.77 126.56 -49.90 76.10 126.41 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -52.89 78.90 131.37 -53.77 80.20 132.79 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -45.55 81.13 122.60 -44.57 82.20 124.58 ULMN 3 1qrz_c14 PLASMINOGEN user 3 3 # 3 C 603 HIS B 78 HIS^? 26.83 CL CL B 382 C 646 ASP B 53 ASP.? 25.44 CL CL B 384 C 741 SER B 88 SER^? 22.31 CL CL B 383 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -41.15 34.55 77.14 -42.58 35.82 77.99 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -37.14 32.94 67.80 -35.44 31.68 68.05 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -33.45 36.60 78.54 -33.30 34.49 79.66 ULMN 3 1qrz_c14 PLASMINOGEN user 4 3 # 4 C 603 HIS B 157 HIS~? 12.80 CL CL B 384 C 646 ASP B 144 ASP.? 18.90 CL CL B 384 C 741 SER B 161 SER~? 16.65 CL CL B 384 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 0.17 24.88 70.38 1.86 23.62 70.32 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 1.70 18.75 65.96 3.42 18.04 64.94 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 4.53 29.49 70.92 4.35 29.43 68.47 1qrz_c14 source 1qrz PLASMINOGEN : 4 hits 1qrz_c14 naa= 3 ULMN 3 1qrz_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 78 HIS^? 30.68 CL CL A 382 D 646 ASP A 53 ASP.? 25.38 CL CL A 382 D 741 SER A 88 SER^? 22.34 CL CL A 382 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -24.82 39.60 128.09 -23.39 38.20 127.48 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -25.09 46.58 135.54 -27.02 47.57 135.30 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -26.75 46.25 123.96 -28.99 45.42 123.71 ULMN 3 1qrz_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS A 157 HIS~? 12.03 CL CL A 383 D 646 ASP A 144 ASP.? 19.38 CL CL A 383 D 741 SER A 161 SER~? 16.95 CL CL A 383 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -47.82 75.77 126.56 -49.90 76.10 126.41 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -52.89 78.90 131.37 -53.77 80.20 132.79 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -45.55 81.13 122.60 -44.57 82.20 124.58 ULMN 3 1qrz_c15 PLASMINOGEN user 3 3 # 3 D 603 HIS B 78 HIS^? 26.83 CL CL B 382 D 646 ASP B 53 ASP.? 25.44 CL CL B 384 D 741 SER B 88 SER^? 22.31 CL CL B 383 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -41.15 34.55 77.14 -42.58 35.82 77.99 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -37.14 32.94 67.80 -35.44 31.68 68.05 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -33.45 36.60 78.54 -33.30 34.49 79.66 ULMN 3 1qrz_c15 PLASMINOGEN user 4 3 # 4 D 603 HIS B 157 HIS~? 12.80 CL CL B 384 D 646 ASP B 144 ASP.? 18.90 CL CL B 384 D 741 SER B 161 SER~? 16.65 CL CL B 384 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 0.17 24.88 70.38 1.86 23.62 70.32 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 1.70 18.75 65.96 3.42 18.04 64.94 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 4.53 29.49 70.92 4.35 29.43 68.47 1qrz_c15 source 1qrz PLASMINOGEN : 4 hits 1qrz_c15 naa= 3 ULMN 3 1qrz_c20 PLASMINOGEN user 1 3 # 1 A 603 HIS A 157 HIS~? 12.03 CL CL A 383 A 646 ASP A 144 ASP.? 19.38 CL CL A 383 A 739 GLY A 163 GLY.? 16.53 CL CL A 382 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -47.82 75.77 126.56 -49.90 76.10 126.41 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -52.89 78.90 131.37 -53.77 80.20 132.79 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -42.13 81.34 118.16 -41.70 81.26 118.87 ULMN 3 1qrz_c20 PLASMINOGEN user 2 3 # 2 A 603 HIS A 165 HIS^? 7.64 CL CL A 382 A 646 ASP A 30 ASP^? -6.81 CL CL A 382s A 739 GLY A 339 GLY.? 19.32 CL CL A 382 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -39.19 73.43 119.40 -40.10 71.56 119.72 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -35.52 64.63 115.87 -36.96 65.19 114.43 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -37.15 79.07 105.90 -37.54 78.40 106.05 ULMN 3 1qrz_c20 PLASMINOGEN user 3 3 # 3 A 603 HIS A 165 HIS^? 7.64 CL CL A 382 A 646 ASP A 272 ASP~? 14.48 CL CL A 382 A 739 GLY A 298 GLY.? 11.45 CL CL A 382 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -39.19 73.43 119.40 -40.10 71.56 119.72 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -46.67 73.24 112.92 -45.43 74.19 114.38 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -29.84 73.06 112.32 -29.55 72.57 111.73 ULMN 3 1qrz_c20 PLASMINOGEN user 4 3 # 4 A 603 HIS A 165 HIS^? 7.64 CL CL A 382 A 646 ASP A 272 ASP~? 14.48 CL CL A 382 A 739 GLY A 318 GLY^? 8.74 CL CL A 382 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -39.19 73.43 119.40 -40.10 71.56 119.72 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -46.67 73.24 112.92 -45.43 74.19 114.38 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -33.39 65.39 112.09 -32.99 65.64 111.42 ULMN 3 1qrz_c20 PLASMINOGEN user 5 3 # 5 A 603 HIS A 302 HIS^? 11.51 CL CL A 384 A 646 ASP A 338 ASP.? 17.28 CL CL A 384 A 739 GLY A 309 GLY.? 19.85 CL CL A 384 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -27.17 73.50 97.06 -27.34 73.92 95.02 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -35.06 76.37 102.96 -33.50 77.52 103.78 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -35.24 68.60 88.70 -35.11 68.24 89.40 ULMN 3 1qrz_c20 PLASMINOGEN user 6 3 # 6 A 603 HIS B 157 HIS~? 12.80 CL CL B 384 A 646 ASP B 144 ASP.? 18.90 CL CL B 384 A 739 GLY B 110 GLY.? 24.37 CL CL B 384 coo -20.72 2.99 34.37 -21.94 1.82 35.61 0.17 24.88 70.38 1.86 23.62 70.32 coo -18.83 7.68 26.86 -20.89 7.78 26.56 1.70 18.75 65.96 3.42 18.04 64.94 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 7.47 29.44 58.24 6.74 29.50 58.60 ULMN 3 1qrz_c20 PLASMINOGEN user 7 3 # 7 A 603 HIS B 165 HIS^? 7.69 CL CL B 383 A 646 ASP B 30 ASP^? -6.72 CL CL B 383s A 739 GLY B 339 GLY.? 19.18 CL CL B 383 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -3.45 34.55 75.15 -4.91 33.27 75.93 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -11.77 37.20 80.70 -10.35 36.55 82.15 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 4.18 43.63 83.95 3.70 43.10 84.20 ULMN 3 1qrz_c20 PLASMINOGEN user 8 3 # 8 A 603 HIS B 165 HIS^? 7.69 CL CL B 383 A 646 ASP B 272 ASP~? 14.11 CL CL B 383 A 739 GLY B 298 GLY.? 11.52 CL CL B 383 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -3.45 34.55 75.15 -4.91 33.27 75.93 coo -18.83 7.68 26.86 -20.89 7.78 26.56 0.88 31.47 82.51 1.09 32.47 80.67 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -5.74 45.82 78.88 -6.06 46.14 79.52 ULMN 3 1qrz_c20 PLASMINOGEN user 9 3 # 9 A 603 HIS B 165 HIS^? 7.69 CL CL B 383 A 646 ASP B 272 ASP~? 14.11 CL CL B 383 A 739 GLY B 318 GLY^? 8.69 CL CL B 383 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -3.45 34.55 75.15 -4.91 33.27 75.93 coo -18.83 7.68 26.86 -20.89 7.78 26.56 0.88 31.47 82.51 1.09 32.47 80.67 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -10.95 40.65 83.09 -10.71 41.37 83.45 ULMN 3 1qrz_c20 PLASMINOGEN user 10 3 # 10 A 603 HIS B 302 HIS^? 23.99 CL CL A 384 A 646 ASP B 338 ASP.? 19.77 CL CL B 383 A 739 GLY B 309 GLY.? 25.52 CL CL A 384 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -2.27 54.46 91.30 -1.20 55.23 92.93 coo -18.83 7.68 26.86 -20.89 7.78 26.56 1.84 46.00 86.98 1.86 47.25 85.31 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -1.34 49.50 102.80 -1.84 49.15 102.26 1qrz_c20 source 1qrz PLASMINOGEN : 10 hits 1qrz_c20 naa= 3 ULMN 3 1qrz_c21 PLASMINOGEN user 1 3 # 1 B 603 HIS A 165 HIS^? 7.64 CL CL A 382 B 646 ASP A 30 ASP^? -6.81 CL CL A 382s B 739 GLY A 339 GLY.? 19.32 CL CL A 382 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -39.19 73.43 119.40 -40.10 71.56 119.72 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -35.52 64.63 115.87 -36.96 65.19 114.43 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -37.15 79.07 105.90 -37.54 78.40 106.05 ULMN 3 1qrz_c21 PLASMINOGEN user 2 3 # 2 B 603 HIS A 165 HIS^? 7.64 CL CL A 382 B 646 ASP A 272 ASP~? 14.48 CL CL A 382 B 739 GLY A 298 GLY.? 11.45 CL CL A 382 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -39.19 73.43 119.40 -40.10 71.56 119.72 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -46.67 73.24 112.92 -45.43 74.19 114.38 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -29.84 73.06 112.32 -29.55 72.57 111.73 ULMN 3 1qrz_c21 PLASMINOGEN user 3 3 # 3 B 603 HIS A 165 HIS^? 7.64 CL CL A 382 B 646 ASP A 272 ASP~? 14.48 CL CL A 382 B 739 GLY A 318 GLY^? 8.74 CL CL A 382 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -39.19 73.43 119.40 -40.10 71.56 119.72 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -46.67 73.24 112.92 -45.43 74.19 114.38 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -33.39 65.39 112.09 -32.99 65.64 111.42 ULMN 3 1qrz_c21 PLASMINOGEN user 4 3 # 4 B 603 HIS A 302 HIS^? 11.51 CL CL A 384 B 646 ASP A 311 ASP^? 15.19 CL CL A 384 B 739 GLY A 339 GLY.? 19.32 CL CL A 382 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -27.17 73.50 97.06 -27.34 73.92 95.02 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -31.19 72.86 91.72 -29.44 73.97 92.12 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -37.15 79.07 105.90 -37.54 78.40 106.05 ULMN 3 1qrz_c21 PLASMINOGEN user 5 3 # 5 B 603 HIS A 302 HIS^? 11.51 CL CL A 384 B 646 ASP A 338 ASP.? 17.28 CL CL A 384 B 739 GLY A 309 GLY.? 19.85 CL CL A 384 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -27.17 73.50 97.06 -27.34 73.92 95.02 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -35.06 76.37 102.96 -33.50 77.52 103.78 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -35.24 68.60 88.70 -35.11 68.24 89.40 ULMN 3 1qrz_c21 PLASMINOGEN user 6 3 # 6 B 603 HIS B 157 HIS~? 12.80 CL CL B 384 B 646 ASP B 144 ASP.? 18.90 CL CL B 384 B 739 GLY B 110 GLY.? 24.37 CL CL B 384 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 0.17 24.88 70.38 1.86 23.62 70.32 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 1.70 18.75 65.96 3.42 18.04 64.94 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 7.47 29.44 58.24 6.74 29.50 58.60 ULMN 3 1qrz_c21 PLASMINOGEN user 7 3 # 7 B 603 HIS B 165 HIS^? 7.69 CL CL B 383 B 646 ASP B 30 ASP^? -6.72 CL CL B 383s B 739 GLY B 339 GLY.? 19.18 CL CL B 383 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -3.45 34.55 75.15 -4.91 33.27 75.93 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -11.77 37.20 80.70 -10.35 36.55 82.15 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 4.18 43.63 83.95 3.70 43.10 84.20 ULMN 3 1qrz_c21 PLASMINOGEN user 8 3 # 8 B 603 HIS B 165 HIS^? 7.69 CL CL B 383 B 646 ASP B 272 ASP~? 14.11 CL CL B 383 B 739 GLY B 298 GLY.? 11.52 CL CL B 383 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -3.45 34.55 75.15 -4.91 33.27 75.93 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 0.88 31.47 82.51 1.09 32.47 80.67 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -5.74 45.82 78.88 -6.06 46.14 79.52 ULMN 3 1qrz_c21 PLASMINOGEN user 9 3 # 9 B 603 HIS B 165 HIS^? 7.69 CL CL B 383 B 646 ASP B 272 ASP~? 14.11 CL CL B 383 B 739 GLY B 318 GLY^? 8.69 CL CL B 383 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -3.45 34.55 75.15 -4.91 33.27 75.93 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 0.88 31.47 82.51 1.09 32.47 80.67 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -10.95 40.65 83.09 -10.71 41.37 83.45 ULMN 3 1qrz_c21 PLASMINOGEN user 10 3 # 10 B 603 HIS B 302 HIS^? 23.99 CL CL A 384 B 646 ASP B 338 ASP.? 19.77 CL CL B 383 B 739 GLY B 309 GLY.? 25.52 CL CL A 384 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -2.27 54.46 91.30 -1.20 55.23 92.93 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 1.84 46.00 86.98 1.86 47.25 85.31 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -1.34 49.50 102.80 -1.84 49.15 102.26 1qrz_c21 source 1qrz PLASMINOGEN : 10 hits 1qrz_c21 naa= 3 ULMN 3 1qrz_c22 PLASMINOGEN user 1 3 # 1 C 603 HIS A 157 HIS~? 12.03 CL CL A 383 C 646 ASP A 144 ASP.? 19.38 CL CL A 383 C 739 GLY A 163 GLY.? 16.53 CL CL A 382 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -47.82 75.77 126.56 -49.90 76.10 126.41 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -52.89 78.90 131.37 -53.77 80.20 132.79 coo 7.82 1.25 3.03 7.30 1.31 3.65 -42.13 81.34 118.16 -41.70 81.26 118.87 ULMN 3 1qrz_c22 PLASMINOGEN user 2 3 # 2 C 603 HIS A 165 HIS^? 7.64 CL CL A 382 C 646 ASP A 30 ASP^? -6.81 CL CL A 382s C 739 GLY A 339 GLY.? 19.32 CL CL A 382 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -39.19 73.43 119.40 -40.10 71.56 119.72 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -35.52 64.63 115.87 -36.96 65.19 114.43 coo 7.82 1.25 3.03 7.30 1.31 3.65 -37.15 79.07 105.90 -37.54 78.40 106.05 ULMN 3 1qrz_c22 PLASMINOGEN user 3 3 # 3 C 603 HIS A 165 HIS^? 7.64 CL CL A 382 C 646 ASP A 272 ASP~? 14.48 CL CL A 382 C 739 GLY A 298 GLY.? 11.45 CL CL A 382 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -39.19 73.43 119.40 -40.10 71.56 119.72 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 7.82 1.25 3.03 7.30 1.31 3.65 -29.84 73.06 112.32 -29.55 72.57 111.73 ULMN 3 1qrz_c22 PLASMINOGEN user 4 3 # 4 C 603 HIS A 165 HIS^? 7.64 CL CL A 382 C 646 ASP A 272 ASP~? 14.48 CL CL A 382 C 739 GLY A 318 GLY^? 8.74 CL CL A 382 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -39.19 73.43 119.40 -40.10 71.56 119.72 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 7.82 1.25 3.03 7.30 1.31 3.65 -33.39 65.39 112.09 -32.99 65.64 111.42 ULMN 3 1qrz_c22 PLASMINOGEN user 5 3 # 5 C 603 HIS A 302 HIS^? 11.51 CL CL A 384 C 646 ASP A 338 ASP.? 17.28 CL CL A 384 C 739 GLY A 309 GLY.? 19.85 CL CL A 384 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -27.17 73.50 97.06 -27.34 73.92 95.02 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -35.06 76.37 102.96 -33.50 77.52 103.78 coo 7.82 1.25 3.03 7.30 1.31 3.65 -35.24 68.60 88.70 -35.11 68.24 89.40 ULMN 3 1qrz_c22 PLASMINOGEN user 6 3 # 6 C 603 HIS B 157 HIS~? 12.80 CL CL B 384 C 646 ASP B 144 ASP.? 18.90 CL CL B 384 C 739 GLY B 110 GLY.? 24.37 CL CL B 384 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 0.17 24.88 70.38 1.86 23.62 70.32 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 1.70 18.75 65.96 3.42 18.04 64.94 coo 7.82 1.25 3.03 7.30 1.31 3.65 7.47 29.44 58.24 6.74 29.50 58.60 ULMN 3 1qrz_c22 PLASMINOGEN user 7 3 # 7 C 603 HIS B 165 HIS^? 7.69 CL CL B 383 C 646 ASP B 30 ASP^? -6.72 CL CL B 383s C 739 GLY B 339 GLY.? 19.18 CL CL B 383 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -3.45 34.55 75.15 -4.91 33.27 75.93 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -11.77 37.20 80.70 -10.35 36.55 82.15 coo 7.82 1.25 3.03 7.30 1.31 3.65 4.18 43.63 83.95 3.70 43.10 84.20 ULMN 3 1qrz_c22 PLASMINOGEN user 8 3 # 8 C 603 HIS B 165 HIS^? 7.69 CL CL B 383 C 646 ASP B 272 ASP~? 14.11 CL CL B 383 C 739 GLY B 298 GLY.? 11.52 CL CL B 383 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -3.45 34.55 75.15 -4.91 33.27 75.93 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 0.88 31.47 82.51 1.09 32.47 80.67 coo 7.82 1.25 3.03 7.30 1.31 3.65 -5.74 45.82 78.88 -6.06 46.14 79.52 ULMN 3 1qrz_c22 PLASMINOGEN user 9 3 # 9 C 603 HIS B 165 HIS^? 7.69 CL CL B 383 C 646 ASP B 272 ASP~? 14.11 CL CL B 383 C 739 GLY B 318 GLY^? 8.69 CL CL B 383 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -3.45 34.55 75.15 -4.91 33.27 75.93 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 0.88 31.47 82.51 1.09 32.47 80.67 coo 7.82 1.25 3.03 7.30 1.31 3.65 -10.95 40.65 83.09 -10.71 41.37 83.45 ULMN 3 1qrz_c22 PLASMINOGEN user 10 3 # 10 C 603 HIS B 302 HIS^? 23.99 CL CL A 384 C 646 ASP B 338 ASP.? 19.77 CL CL B 383 C 739 GLY B 309 GLY.? 25.52 CL CL A 384 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -2.27 54.46 91.30 -1.20 55.23 92.93 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 1.84 46.00 86.98 1.86 47.25 85.31 coo 7.82 1.25 3.03 7.30 1.31 3.65 -1.34 49.50 102.80 -1.84 49.15 102.26 1qrz_c22 source 1qrz PLASMINOGEN : 10 hits 1qrz_c22 naa= 3 ULMN 3 1qrz_c23 PLASMINOGEN user 1 3 # 1 D 603 HIS A 157 HIS~? 12.03 CL CL A 383 D 646 ASP A 144 ASP.? 19.38 CL CL A 383 D 739 GLY A 163 GLY.? 16.53 CL CL A 382 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -47.82 75.77 126.56 -49.90 76.10 126.41 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -52.89 78.90 131.37 -53.77 80.20 132.79 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -42.13 81.34 118.16 -41.70 81.26 118.87 ULMN 3 1qrz_c23 PLASMINOGEN user 2 3 # 2 D 603 HIS A 165 HIS^? 7.64 CL CL A 382 D 646 ASP A 30 ASP^? -6.81 CL CL A 382s D 739 GLY A 339 GLY.? 19.32 CL CL A 382 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -39.19 73.43 119.40 -40.10 71.56 119.72 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -35.52 64.63 115.87 -36.96 65.19 114.43 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -37.15 79.07 105.90 -37.54 78.40 106.05 ULMN 3 1qrz_c23 PLASMINOGEN user 3 3 # 3 D 603 HIS A 165 HIS^? 7.64 CL CL A 382 D 646 ASP A 272 ASP~? 14.48 CL CL A 382 D 739 GLY A 298 GLY.? 11.45 CL CL A 382 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -39.19 73.43 119.40 -40.10 71.56 119.72 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -46.67 73.24 112.92 -45.43 74.19 114.38 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -29.84 73.06 112.32 -29.55 72.57 111.73 ULMN 3 1qrz_c23 PLASMINOGEN user 4 3 # 4 D 603 HIS A 165 HIS^? 7.64 CL CL A 382 D 646 ASP A 272 ASP~? 14.48 CL CL A 382 D 739 GLY A 318 GLY^? 8.74 CL CL A 382 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -39.19 73.43 119.40 -40.10 71.56 119.72 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -46.67 73.24 112.92 -45.43 74.19 114.38 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -33.39 65.39 112.09 -32.99 65.64 111.42 ULMN 3 1qrz_c23 PLASMINOGEN user 5 3 # 5 D 603 HIS A 302 HIS^? 11.51 CL CL A 384 D 646 ASP A 338 ASP.? 17.28 CL CL A 384 D 739 GLY A 309 GLY.? 19.85 CL CL A 384 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -27.17 73.50 97.06 -27.34 73.92 95.02 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -35.06 76.37 102.96 -33.50 77.52 103.78 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -35.24 68.60 88.70 -35.11 68.24 89.40 ULMN 3 1qrz_c23 PLASMINOGEN user 6 3 # 6 D 603 HIS B 157 HIS~? 12.80 CL CL B 384 D 646 ASP B 144 ASP.? 18.90 CL CL B 384 D 739 GLY B 110 GLY.? 24.37 CL CL B 384 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 0.17 24.88 70.38 1.86 23.62 70.32 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 1.70 18.75 65.96 3.42 18.04 64.94 coo -45.82 1.31 41.67 -46.38 1.39 42.31 7.47 29.44 58.24 6.74 29.50 58.60 ULMN 3 1qrz_c23 PLASMINOGEN user 7 3 # 7 D 603 HIS B 165 HIS^? 7.69 CL CL B 383 D 646 ASP B 30 ASP^? -6.72 CL CL B 383s D 739 GLY B 339 GLY.? 19.18 CL CL B 383 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -3.45 34.55 75.15 -4.91 33.27 75.93 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -11.77 37.20 80.70 -10.35 36.55 82.15 coo -45.82 1.31 41.67 -46.38 1.39 42.31 4.18 43.63 83.95 3.70 43.10 84.20 ULMN 3 1qrz_c23 PLASMINOGEN user 8 3 # 8 D 603 HIS B 165 HIS^? 7.69 CL CL B 383 D 646 ASP B 272 ASP~? 14.11 CL CL B 383 D 739 GLY B 298 GLY.? 11.52 CL CL B 383 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -3.45 34.55 75.15 -4.91 33.27 75.93 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 0.88 31.47 82.51 1.09 32.47 80.67 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -5.74 45.82 78.88 -6.06 46.14 79.52 ULMN 3 1qrz_c23 PLASMINOGEN user 9 3 # 9 D 603 HIS B 165 HIS^? 7.69 CL CL B 383 D 646 ASP B 272 ASP~? 14.11 CL CL B 383 D 739 GLY B 318 GLY^? 8.69 CL CL B 383 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -3.45 34.55 75.15 -4.91 33.27 75.93 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 0.88 31.47 82.51 1.09 32.47 80.67 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -10.95 40.65 83.09 -10.71 41.37 83.45 ULMN 3 1qrz_c23 PLASMINOGEN user 10 3 # 10 D 603 HIS B 302 HIS^? 23.99 CL CL A 384 D 646 ASP B 338 ASP.? 19.77 CL CL B 383 D 739 GLY B 309 GLY.? 25.52 CL CL A 384 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -2.27 54.46 91.30 -1.20 55.23 92.93 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 1.84 46.00 86.98 1.86 47.25 85.31 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -1.34 49.50 102.80 -1.84 49.15 102.26 1qrz_c23 source 1qrz PLASMINOGEN : 10 hits 1qrz_c23 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 31 PHE.? 7.34 CL CL A 382 A 201 ASP A 30 ASP^? -6.81 CL CL A 382s A 227 LYS A 336 LYS^? 14.72 CL CL A 382 coo 23.39 49.81 32.16 21.33 51.68 32.26 -34.44 71.03 115.62 -32.10 72.45 115.10 coo 25.52 45.12 37.98 23.98 46.65 37.85 -35.52 64.63 115.87 -36.96 65.19 114.43 coo 12.68 46.83 36.69 18.26 48.67 34.51 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 1qz9_c02 KYNURENINASE user 2 3 # 2 A 129 PHE A 97 PHE~? 13.64 CL CL A 383 A 201 ASP A 93 ASP^? 5.15 CL CL A 382 A 227 LYS A 128 LYS.? 19.46 CL CL A 382 coo 23.39 49.81 32.16 21.33 51.68 32.26 -33.26 63.92 133.83 -31.10 62.40 134.75 coo 25.52 45.12 37.98 23.98 46.65 37.85 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 12.68 46.83 36.69 18.26 48.67 34.51 -25.12 72.76 133.10 -20.68 68.32 134.09 ULMN 3 1qz9_c02 KYNURENINASE user 3 3 # 3 A 129 PHE A 213 PHE.? 23.30 CL CL A 383 A 201 ASP A 240 ASP.? 30.06 CL CL A 382 A 227 LYS A 267 LYS~? 27.66 CL CL A 382 coo 23.39 49.81 32.16 21.33 51.68 32.26 -56.84 71.96 107.29 -56.22 69.93 109.07 coo 25.52 45.12 37.98 23.98 46.65 37.85 -54.36 78.15 100.29 -55.09 76.20 100.68 coo 12.68 46.83 36.69 18.26 48.67 34.51 -49.43 81.28 111.60 -49.39 86.78 108.40 ULMN 3 1qz9_c02 KYNURENINASE user 4 3 # 4 A 129 PHE B 31 PHE.? 7.44 CL CL B 383 A 201 ASP B 30 ASP^? -6.72 CL CL B 383s A 227 LYS B 336 LYS^? 14.66 CL CL B 383 coo 23.39 49.81 32.16 21.33 51.68 32.26 -6.42 39.91 78.10 -6.19 42.61 77.46 coo 25.52 45.12 37.98 23.98 46.65 37.85 -11.77 37.20 80.70 -10.35 36.55 82.15 coo 12.68 46.83 36.69 18.26 48.67 34.51 -3.40 41.24 88.18 -4.83 35.96 88.60 ULMN 3 1qz9_c02 KYNURENINASE user 5 3 # 5 A 129 PHE B 97 PHE~? 13.75 CL CL B 384 A 201 ASP B 93 ASP^? 5.22 CL CL B 383 A 227 LYS B 128 LYS.? 19.37 CL CL B 383 coo 23.39 49.81 32.16 21.33 51.68 32.26 -18.35 31.53 64.75 -20.77 32.66 63.92 coo 25.52 45.12 37.98 23.98 46.65 37.85 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 12.68 46.83 36.69 18.26 48.67 34.51 -13.49 41.25 59.55 -18.50 40.98 58.08 ULMN 3 1qz9_c02 KYNURENINASE user 6 3 # 6 A 129 PHE B 213 PHE.? 22.76 CL CL B 384 A 201 ASP B 240 ASP.? 29.22 CL CL B 383 A 227 LYS B 267 LYS~? 27.57 CL CL B 383 coo 23.39 49.81 32.16 21.33 51.68 32.26 5.57 24.21 90.55 3.01 23.56 89.66 coo 25.52 45.12 37.98 23.98 46.65 37.85 11.35 28.88 93.27 10.37 30.59 94.07 coo 12.68 46.83 36.69 18.26 48.67 34.51 9.46 31.45 81.02 15.36 33.08 81.01 ULMN 3 1qz9_c02 KYNURENINASE user 7 3 # 7 A 129 PHE B 213 PHE.? 22.76 CL CL B 384 A 201 ASP B 240 ASP.? 29.22 CL CL B 383 A 227 LYS B 268 LYS~? 13.29 CL CL B 383 coo 23.39 49.81 32.16 21.33 51.68 32.26 5.57 24.21 90.55 3.01 23.56 89.66 coo 25.52 45.12 37.98 23.98 46.65 37.85 11.35 28.88 93.27 10.37 30.59 94.07 coo 12.68 46.83 36.69 18.26 48.67 34.51 5.99 32.14 79.72 1.11 32.64 77.72 1qz9_c02 source 1qz9 KYNURENINASE : 7 hits 1qz9_c02 naa= 3 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 1 3 # 1 A 10 ASP A 115 ASP~? 22.59 CL CL A 382 A 186 ASN A 137 ASN.? 20.69 CL CL A 382 A 260 ALA A 159 ALA~? 12.04 CL CL A 382 coo 11.81 33.10 11.71 13.07 31.45 11.40 -35.38 84.29 133.21 -33.68 85.51 133.25 coo 11.43 26.53 7.41 13.01 27.56 8.43 -34.02 87.53 125.36 -34.12 86.44 127.15 coo 21.53 26.33 6.96 20.26 25.69 7.52 -40.97 78.44 123.91 -40.05 77.14 123.62 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 2 3 # 2 A 10 ASP A 144 ASP.? 19.38 CL CL A 383 A 186 ASN A 107 ASN.? 21.78 CL CL A 383 A 260 ALA A 116 ALA~? 16.96 CL CL A 383 coo 11.81 33.10 11.71 13.07 31.45 11.40 -52.89 78.90 131.37 -53.77 80.20 132.79 coo 11.43 26.53 7.41 13.01 27.56 8.43 -46.65 82.65 137.36 -47.85 84.12 136.41 coo 21.53 26.33 6.96 20.26 25.69 7.52 -38.30 80.83 132.45 -39.59 81.12 131.73 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 3 3 # 3 A 10 ASP A 208 ASP.? 21.85 CL CL A 382 A 186 ASN A 211 ASN.? 19.04 CL CL A 383 A 260 ALA A 271 ALA~? 18.46 CL CL A 382 coo 11.81 33.10 11.71 13.07 31.45 11.40 -48.25 63.81 104.00 -49.74 63.21 105.24 coo 11.43 26.53 7.41 13.01 27.56 8.43 -52.26 68.83 108.54 -52.87 67.63 110.20 coo 21.53 26.33 6.96 20.26 25.69 7.52 -46.19 76.51 109.39 -45.19 77.53 109.91 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 4 3 # 4 A 10 ASP A 344 ASP.? 20.56 CL CL A 382 A 186 ASN A 136 ASN.? 24.08 CL CL A 382 A 260 ALA A 139 ALA.? 25.02 CL CL A 383 coo 11.81 33.10 11.71 13.07 31.45 11.40 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 11.43 26.53 7.41 13.01 27.56 8.43 -35.51 89.43 120.39 -34.74 90.84 118.94 coo 21.53 26.33 6.96 20.26 25.69 7.52 -40.71 88.88 128.05 -41.16 90.27 128.57 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 5 3 # 5 A 10 ASP B 115 ASP~? 22.59 CL CL B 383 A 186 ASN B 137 ASN.? 20.58 CL CL B 383 A 260 ALA B 159 ALA~? 12.15 CL CL B 383 coo 11.81 33.10 11.71 13.07 31.45 11.40 0.29 34.85 57.65 0.95 36.59 56.65 coo 11.43 26.53 7.41 13.01 27.56 8.43 4.73 40.06 62.46 3.35 38.78 61.44 coo 21.53 26.33 6.96 20.26 25.69 7.52 0.19 32.47 69.55 -1.13 33.12 70.03 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 6 3 # 6 A 10 ASP B 144 ASP.? 18.90 CL CL B 384 A 186 ASN B 107 ASN.? 22.13 CL CL B 384 A 260 ALA B 116 ALA~? 16.91 CL CL B 384 coo 11.81 33.10 11.71 13.07 31.45 11.40 1.70 18.75 65.96 3.42 18.04 64.94 coo 11.43 26.53 7.41 13.01 27.56 8.43 2.05 22.81 57.51 4.16 22.93 58.02 coo 21.53 26.33 6.96 20.26 25.69 7.52 -1.44 31.83 60.52 -0.43 31.15 61.47 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 7 3 # 7 A 10 ASP B 208 ASP.? 21.56 CL CL B 383 A 186 ASN B 211 ASN.? 18.42 CL CL B 384 A 260 ALA B 271 ALA~? 18.20 CL CL B 383 coo 11.81 33.10 11.71 13.07 31.45 11.40 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 11.43 26.53 7.41 13.01 27.56 8.43 0.47 26.95 89.73 -0.82 25.48 88.80 coo 21.53 26.33 6.96 20.26 25.69 7.52 4.76 33.88 84.20 5.07 34.78 82.98 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 8 3 # 8 A 10 ASP B 272 ASP~? 14.11 CL CL B 383 A 186 ASN B 160 ASN~? 11.23 CL CL B 384 A 260 ALA B 345 ALA.? 15.71 CL CL B 383 coo 11.81 33.10 11.71 13.07 31.45 11.40 0.88 31.47 82.51 1.09 32.47 80.67 coo 11.43 26.53 7.41 13.01 27.56 8.43 0.91 30.00 73.77 -0.90 30.65 74.84 coo 21.53 26.33 6.96 20.26 25.69 7.52 4.64 41.37 73.03 3.24 41.54 73.45 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 9 3 # 9 A 10 ASP B 344 ASP.? 20.04 CL CL B 383 A 186 ASN B 136 ASN.? 22.72 CL CL B 383 A 260 ALA B 139 ALA.? 24.76 CL CL B 384 coo 11.81 33.10 11.71 13.07 31.45 11.40 7.59 38.09 74.22 8.59 36.72 75.50 coo 11.43 26.53 7.41 13.01 27.56 8.43 8.54 41.97 65.49 9.14 40.38 66.80 coo 21.53 26.33 6.96 20.26 25.69 7.52 7.74 33.30 61.71 8.87 32.96 60.68 1r4f_c00 source 1r4f IAG-NUCLEOSIDE HYDROLASE : 9 hits 1r4f_c00 naa= 3 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 1 3 # 1 A 608 ASP A 305 ASP^? 16.01 CL CL A 384 A 610 HIS A 308 HIS.? 20.06 CL CL A 384 A 661 HIS A 302 HIS^? 11.51 CL CL A 384 coo 75.99 81.56 1.86 73.91 81.34 2.28 -32.01 65.22 92.45 -32.49 63.34 91.63 coo 71.04 78.84 0.46 71.54 76.90 1.02 -37.01 64.37 91.64 -38.79 63.83 92.62 coo 75.40 81.38 12.06 74.88 79.42 12.63 -27.17 73.50 97.06 -27.34 73.92 95.02 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 2 3 # 2 A 608 ASP A 311 ASP^? 15.19 CL CL A 384 A 610 HIS A 302 HIS^? 11.51 CL CL A 384 A 661 HIS A 308 HIS.? 20.06 CL CL A 384 coo 75.99 81.56 1.86 73.91 81.34 2.28 -31.19 72.86 91.72 -29.44 73.97 92.12 coo 71.04 78.84 0.46 71.54 76.90 1.02 -27.17 73.50 97.06 -27.34 73.92 95.02 coo 75.40 81.38 12.06 74.88 79.42 12.63 -37.01 64.37 91.64 -38.79 63.83 92.62 1req_c10 source 1req METHYLMALONYL-COA MUTASE : 2 hits 1req_c10 naa= 3 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 1 3 # 1 C 608 ASP A 305 ASP^? 16.01 CL CL A 384 C 610 HIS A 308 HIS.? 20.06 CL CL A 384 C 661 HIS A 302 HIS^? 11.51 CL CL A 384 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -32.01 65.22 92.45 -32.49 63.34 91.63 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -37.01 64.37 91.64 -38.79 63.83 92.62 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -27.17 73.50 97.06 -27.34 73.92 95.02 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 2 3 # 2 C 608 ASP A 311 ASP^? 15.19 CL CL A 384 C 610 HIS A 302 HIS^? 11.51 CL CL A 384 C 661 HIS A 308 HIS.? 20.06 CL CL A 384 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -31.19 72.86 91.72 -29.44 73.97 92.12 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -27.17 73.50 97.06 -27.34 73.92 95.02 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -37.01 64.37 91.64 -38.79 63.83 92.62 1req_c11 source 1req METHYLMALONYL-COA MUTASE : 2 hits 1req_c11 naa= 3 ULMN 3 1rgq_c01 NS4A PEPTIDE user 1 3 # 1 B 60 HIS A 157 HIS~? 12.03 CL CL A 383 B 84 ASP A 144 ASP.? 19.38 CL CL A 383 B 140 GLY A 163 GLY.? 16.53 CL CL A 382 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -47.82 75.77 126.56 -49.90 76.10 126.41 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -52.89 78.90 131.37 -53.77 80.20 132.79 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -42.13 81.34 118.16 -41.70 81.26 118.87 1rgq_c01 source 1rgq NS4A PEPTIDE : 1 hits 1rgq_c01 naa= 3 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 1 3 # 1 32 ASP A 28 ASP^? 9.02 CL CL A 382 35 SER A 29 SER^? 6.92 CL CL A 382 215 ASP A 26 ASP^? 16.59 CL CL A 382 coo 11.85 17.24 72.81 11.09 15.37 72.36 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 12.20 12.71 75.45 13.69 13.84 74.03 -31.31 63.66 116.96 -29.07 63.86 117.79 coo 5.22 15.03 71.43 7.19 14.88 70.83 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 2 3 # 2 32 ASP A 28 ASP^? 9.02 CL CL A 382 35 SER A 37 SER^? 9.11 CL CL A 382 215 ASP A 26 ASP^? 16.59 CL CL A 382 coo 11.85 17.24 72.81 11.09 15.37 72.36 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 12.20 12.71 75.45 13.69 13.84 74.03 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 5.22 15.03 71.43 7.19 14.88 70.83 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 3 3 # 3 32 ASP A 28 ASP^? 9.02 CL CL A 382 35 SER A 37 SER^? 9.11 CL CL A 382 215 ASP A 30 ASP^? -6.81 CL CL A 382s coo 11.85 17.24 72.81 11.09 15.37 72.36 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 12.20 12.71 75.45 13.69 13.84 74.03 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 5.22 15.03 71.43 7.19 14.88 70.83 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 4 3 # 4 32 ASP A 28 ASP^? 9.02 CL CL A 382 35 SER A 37 SER^? 9.11 CL CL A 382 215 ASP A 39 ASP^? 16.51 CL CL A 382 coo 11.85 17.24 72.81 11.09 15.37 72.36 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 12.20 12.71 75.45 13.69 13.84 74.03 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 5.22 15.03 71.43 7.19 14.88 70.83 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 5 3 # 5 32 ASP A 36 ASP.? -3.33 CL CL A 382s 35 SER A 37 SER^? 9.11 CL CL A 382 215 ASP A 30 ASP^? -6.81 CL CL A 382s coo 11.85 17.24 72.81 11.09 15.37 72.36 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 12.20 12.71 75.45 13.69 13.84 74.03 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 5.22 15.03 71.43 7.19 14.88 70.83 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 6 3 # 6 32 ASP A 195 ASP.? 13.29 CL CL A 384 35 SER A 192 SER.? 15.36 CL CL A 384 215 ASP A 306 ASP.? 16.66 CL CL A 384 coo 11.85 17.24 72.81 11.09 15.37 72.36 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 12.20 12.71 75.45 13.69 13.84 74.03 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 5.22 15.03 71.43 7.19 14.88 70.83 -29.63 66.56 87.01 -28.35 68.29 87.20 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 7 3 # 7 32 ASP A 306 ASP.? 16.66 CL CL A 384 35 SER A 192 SER.? 15.36 CL CL A 384 215 ASP A 305 ASP^? 16.01 CL CL A 384 coo 11.85 17.24 72.81 11.09 15.37 72.36 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 12.20 12.71 75.45 13.69 13.84 74.03 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 5.22 15.03 71.43 7.19 14.88 70.83 -32.01 65.22 92.45 -32.49 63.34 91.63 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 8 3 # 8 32 ASP B 28 ASP^? 9.00 CL CL B 383 35 SER B 29 SER^? 6.98 CL CL B 383 215 ASP B 26 ASP^? 16.51 CL CL B 383 coo 11.85 17.24 72.81 11.09 15.37 72.36 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 12.20 12.71 75.45 13.69 13.84 74.03 -14.55 40.12 78.88 -15.61 41.67 77.42 coo 5.22 15.03 71.43 7.19 14.88 70.83 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 9 3 # 9 32 ASP B 28 ASP^? 9.00 CL CL B 383 35 SER B 37 SER^? 9.16 CL CL B 383 215 ASP B 26 ASP^? 16.51 CL CL B 383 coo 11.85 17.24 72.81 11.09 15.37 72.36 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 12.20 12.71 75.45 13.69 13.84 74.03 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 5.22 15.03 71.43 7.19 14.88 70.83 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 10 3 # 10 32 ASP B 28 ASP^? 9.00 CL CL B 383 35 SER B 37 SER^? 9.16 CL CL B 383 215 ASP B 30 ASP^? -6.72 CL CL B 383s coo 11.85 17.24 72.81 11.09 15.37 72.36 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 12.20 12.71 75.45 13.69 13.84 74.03 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 5.22 15.03 71.43 7.19 14.88 70.83 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 11 3 # 11 32 ASP B 28 ASP^? 9.00 CL CL B 383 35 SER B 37 SER^? 9.16 CL CL B 383 215 ASP B 39 ASP^? 17.51 CL CL B 383 coo 11.85 17.24 72.81 11.09 15.37 72.36 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 12.20 12.71 75.45 13.69 13.84 74.03 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 5.22 15.03 71.43 7.19 14.88 70.83 -26.18 36.85 80.53 -27.97 36.10 81.34 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 12 3 # 12 32 ASP B 36 ASP.? -3.35 CL CL B 383s 35 SER B 37 SER^? 9.16 CL CL B 383 215 ASP B 30 ASP^? -6.72 CL CL B 383s coo 11.85 17.24 72.81 11.09 15.37 72.36 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 12.20 12.71 75.45 13.69 13.84 74.03 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 5.22 15.03 71.43 7.19 14.88 70.83 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 13 3 # 13 32 ASP B 195 ASP.? 10.47 CL CL A 384 35 SER B 192 SER.? 13.26 CL CL A 384 215 ASP B 306 ASP.? 19.57 CL CL A 384 coo 11.85 17.24 72.81 11.09 15.37 72.36 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 12.20 12.71 75.45 13.69 13.84 74.03 -11.80 54.65 102.27 -11.20 56.97 103.08 coo 5.22 15.03 71.43 7.19 14.88 70.83 -4.64 54.84 103.01 -3.71 56.24 101.58 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 14 3 # 14 32 ASP B 306 ASP.? 19.57 CL CL A 384 35 SER B 192 SER.? 13.26 CL CL A 384 215 ASP B 305 ASP^? 21.59 CL CL A 384 coo 11.85 17.24 72.81 11.09 15.37 72.36 -4.64 54.84 103.01 -3.71 56.24 101.58 coo 12.20 12.71 75.45 13.69 13.84 74.03 -11.80 54.65 102.27 -11.20 56.97 103.08 coo 5.22 15.03 71.43 7.19 14.88 70.83 -6.28 49.81 99.79 -7.51 49.10 101.38 1rne_c04 source 1rne RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) (E.: 14 hits 1rne_c04 naa= 3 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 A 137 GLU A 206 GLU^? 19.04 CL CL A 382 A 288 HIS A 165 HIS^? 7.64 CL CL A 382 A 329 LYS A 133 LYS^? 12.95 CL CL A 382 coo 29.27 18.78 14.99 27.16 18.62 14.76 -42.05 60.33 102.60 -42.22 59.82 104.62 coo 49.52 10.06 10.36 50.99 9.65 8.92 -39.19 73.43 119.40 -40.10 71.56 119.72 coo 57.80 12.92 13.83 53.77 8.42 12.15 -30.69 80.61 120.28 -26.75 77.00 119.43 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 A 137 GLU B 169 GLU.? 11.31 CL CL B 383 A 288 HIS B 157 HIS~? 12.80 CL CL B 384 A 329 LYS B 142 LYS.? 25.17 CL CL B 384 coo 29.27 18.78 14.99 27.16 18.62 14.76 -9.49 44.22 70.62 -8.22 45.44 69.57 coo 49.52 10.06 10.36 50.99 9.65 8.92 0.17 24.88 70.38 1.86 23.62 70.32 coo 57.80 12.92 13.83 53.77 8.42 12.15 6.28 23.32 63.35 7.97 19.73 58.68 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 A 137 GLU B 206 GLU^? 19.18 CL CL B 383 A 288 HIS B 165 HIS^? 7.69 CL CL B 383 A 329 LYS B 133 LYS^? 13.08 CL CL B 383 coo 29.27 18.78 14.99 27.16 18.62 14.76 -9.17 35.76 95.82 -10.61 34.74 94.62 coo 49.52 10.06 10.36 50.99 9.65 8.92 -3.45 34.55 75.15 -4.91 33.27 75.93 coo 57.80 12.92 13.83 53.77 8.42 12.15 -0.84 43.73 69.01 -5.56 47.16 71.00 1roz_c00 source 1roz DEOXYHYPUSINE SYNTHASE : 3 hits 1roz_c00 naa= 3 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 B 137 GLU A 206 GLU^? 19.04 CL CL A 382 B 288 HIS A 165 HIS^? 7.64 CL CL A 382 B 329 LYS A 133 LYS^? 12.95 CL CL A 382 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -42.05 60.33 102.60 -42.22 59.82 104.62 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -39.19 73.43 119.40 -40.10 71.56 119.72 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -30.69 80.61 120.28 -26.75 77.00 119.43 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 B 137 GLU B 206 GLU^? 19.18 CL CL B 383 B 288 HIS B 165 HIS^? 7.69 CL CL B 383 B 329 LYS B 133 LYS^? 13.08 CL CL B 383 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -9.17 35.76 95.82 -10.61 34.74 94.62 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -3.45 34.55 75.15 -4.91 33.27 75.93 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -0.84 43.73 69.01 -5.56 47.16 71.00 1roz_c01 source 1roz DEOXYHYPUSINE SYNTHASE : 2 hits 1roz_c01 naa= 3 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 1 3 # 1 A 104 ILE A 205 ILE^? 19.40 CL CL A 384 A 106 HIS A 308 HIS.? 20.06 CL CL A 384 A 142 ASP A 305 ASP^? 16.01 CL CL A 384 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -39.43 62.92 97.96 -38.96 64.22 97.37 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -37.01 64.37 91.64 -38.79 63.83 92.62 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -32.01 65.22 92.45 -32.49 63.34 91.63 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 2 3 # 2 A 104 ILE B 205 ILE^? 23.76 CL CL B 383 A 106 HIS B 308 HIS.? 26.99 CL CL A 384 A 142 ASP B 305 ASP^? 21.59 CL CL A 384 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -6.81 40.48 98.20 -5.75 41.47 98.33 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -5.09 45.35 102.63 -4.80 43.27 102.76 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -6.28 49.81 99.79 -7.51 49.10 101.38 1s3i_c00 source 1s3i 10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE : 2 hits 1s3i_c00 naa= 3 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP A 311 ASP^? 15.19 CL CL A 384 64 HIS A 302 HIS^? 11.51 CL CL A 384 155 ASN A 199 ASN.? 4.96 CL CL A 384 coo 80.16 73.25 62.48 80.01 71.25 61.82 -31.19 72.86 91.72 -29.44 73.97 92.12 coo 78.27 67.69 61.83 79.58 67.76 60.19 -27.17 73.50 97.06 -27.34 73.92 95.02 coo 80.34 61.88 52.75 81.25 63.19 54.35 -21.75 61.84 97.70 -22.73 63.77 98.21 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 2 3 # 2 32 ASP B 311 ASP^? 24.66 CL CL A 384 64 HIS B 302 HIS^? 23.99 CL CL A 384 155 ASN B 199 ASN.? 15.74 CL CL A 384 coo 80.16 73.25 62.48 80.01 71.25 61.82 0.41 52.81 97.17 0.37 54.52 95.85 coo 78.27 67.69 61.83 79.58 67.76 60.19 -2.27 54.46 91.30 -1.20 55.23 92.93 coo 80.34 61.88 52.75 81.25 63.19 54.35 -14.23 54.82 92.98 -12.33 56.04 93.07 1sca_c01 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 2 hits 1sca_c01 naa= 3 ULMN 3 1sll_c00 SIALIDASE L user 1 3 # 1 318 ASP A 327 ASP.? 19.04 CL CL A 384 595 GLU A 23 GLU.? 27.24 CL CL A 382 713 TYR A 25 TYR^? 18.63 CL CL A 382 coo 5.64 2.82 38.49 4.59 4.19 37.25 -25.74 49.77 105.10 -27.34 48.80 104.08 coo 4.35 13.73 37.63 3.39 12.18 36.55 -22.84 44.28 116.17 -23.55 42.53 115.22 coo 3.76 10.25 31.38 3.16 9.87 34.10 -23.49 53.13 116.11 -21.60 54.30 114.36 1sll_c00 source 1sll SIALIDASE L : 1 hits 1sll_c00 naa= 3 ULMN 3 1sme_c04 PLASMEPSIN II user 1 3 # 1 A 34 ASP A 28 ASP^? 9.02 CL CL A 382 A 37 SER A 29 SER^? 6.92 CL CL A 382 A 214 ASP A 26 ASP^? 16.59 CL CL A 382 coo 51.75 60.57 19.10 52.05 60.90 21.19 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 51.10 65.11 20.73 52.62 63.74 19.42 -31.31 63.66 116.96 -29.07 63.86 117.79 coo 48.59 58.89 25.78 50.13 59.74 24.61 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1sme_c04 PLASMEPSIN II user 2 3 # 2 A 34 ASP A 28 ASP^? 9.02 CL CL A 382 A 37 SER A 37 SER^? 9.11 CL CL A 382 A 214 ASP A 26 ASP^? 16.59 CL CL A 382 coo 51.75 60.57 19.10 52.05 60.90 21.19 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 51.10 65.11 20.73 52.62 63.74 19.42 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 48.59 58.89 25.78 50.13 59.74 24.61 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1sme_c04 PLASMEPSIN II user 3 3 # 3 A 34 ASP A 28 ASP^? 9.02 CL CL A 382 A 37 SER A 37 SER^? 9.11 CL CL A 382 A 214 ASP A 30 ASP^? -6.81 CL CL A 382s coo 51.75 60.57 19.10 52.05 60.90 21.19 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 51.10 65.11 20.73 52.62 63.74 19.42 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 48.59 58.89 25.78 50.13 59.74 24.61 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1sme_c04 PLASMEPSIN II user 4 3 # 4 A 34 ASP A 28 ASP^? 9.02 CL CL A 382 A 37 SER A 37 SER^? 9.11 CL CL A 382 A 214 ASP A 39 ASP^? 16.51 CL CL A 382 coo 51.75 60.57 19.10 52.05 60.90 21.19 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 51.10 65.11 20.73 52.62 63.74 19.42 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 48.59 58.89 25.78 50.13 59.74 24.61 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1sme_c04 PLASMEPSIN II user 5 3 # 5 A 34 ASP A 36 ASP.? -3.33 CL CL A 382s A 37 SER A 37 SER^? 9.11 CL CL A 382 A 214 ASP A 30 ASP^? -6.81 CL CL A 382s coo 51.75 60.57 19.10 52.05 60.90 21.19 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 51.10 65.11 20.73 52.62 63.74 19.42 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 48.59 58.89 25.78 50.13 59.74 24.61 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1sme_c04 PLASMEPSIN II user 6 3 # 6 A 34 ASP A 195 ASP.? 13.29 CL CL A 384 A 37 SER A 192 SER.? 15.36 CL CL A 384 A 214 ASP A 306 ASP.? 16.66 CL CL A 384 coo 51.75 60.57 19.10 52.05 60.90 21.19 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 51.10 65.11 20.73 52.62 63.74 19.42 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 48.59 58.89 25.78 50.13 59.74 24.61 -29.63 66.56 87.01 -28.35 68.29 87.20 ULMN 3 1sme_c04 PLASMEPSIN II user 7 3 # 7 A 34 ASP B 28 ASP^? 9.00 CL CL B 383 A 37 SER B 29 SER^? 6.98 CL CL B 383 A 214 ASP B 26 ASP^? 16.51 CL CL B 383 coo 51.75 60.57 19.10 52.05 60.90 21.19 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 51.10 65.11 20.73 52.62 63.74 19.42 -14.55 40.12 78.88 -15.61 41.67 77.42 coo 48.59 58.89 25.78 50.13 59.74 24.61 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1sme_c04 PLASMEPSIN II user 8 3 # 8 A 34 ASP B 28 ASP^? 9.00 CL CL B 383 A 37 SER B 37 SER^? 9.16 CL CL B 383 A 214 ASP B 26 ASP^? 16.51 CL CL B 383 coo 51.75 60.57 19.10 52.05 60.90 21.19 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 51.10 65.11 20.73 52.62 63.74 19.42 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 48.59 58.89 25.78 50.13 59.74 24.61 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1sme_c04 PLASMEPSIN II user 9 3 # 9 A 34 ASP B 28 ASP^? 9.00 CL CL B 383 A 37 SER B 37 SER^? 9.16 CL CL B 383 A 214 ASP B 30 ASP^? -6.72 CL CL B 383s coo 51.75 60.57 19.10 52.05 60.90 21.19 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 51.10 65.11 20.73 52.62 63.74 19.42 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 48.59 58.89 25.78 50.13 59.74 24.61 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1sme_c04 PLASMEPSIN II user 10 3 # 10 A 34 ASP B 28 ASP^? 9.00 CL CL B 383 A 37 SER B 37 SER^? 9.16 CL CL B 383 A 214 ASP B 39 ASP^? 17.51 CL CL B 383 coo 51.75 60.57 19.10 52.05 60.90 21.19 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 51.10 65.11 20.73 52.62 63.74 19.42 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 48.59 58.89 25.78 50.13 59.74 24.61 -26.18 36.85 80.53 -27.97 36.10 81.34 ULMN 3 1sme_c04 PLASMEPSIN II user 11 3 # 11 A 34 ASP B 36 ASP.? -3.35 CL CL B 383s A 37 SER B 37 SER^? 9.16 CL CL B 383 A 214 ASP B 30 ASP^? -6.72 CL CL B 383s coo 51.75 60.57 19.10 52.05 60.90 21.19 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 51.10 65.11 20.73 52.62 63.74 19.42 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 48.59 58.89 25.78 50.13 59.74 24.61 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1sme_c04 PLASMEPSIN II user 12 3 # 12 A 34 ASP B 195 ASP.? 10.47 CL CL A 384 A 37 SER B 192 SER.? 13.26 CL CL A 384 A 214 ASP B 306 ASP.? 19.57 CL CL A 384 coo 51.75 60.57 19.10 52.05 60.90 21.19 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 51.10 65.11 20.73 52.62 63.74 19.42 -11.80 54.65 102.27 -11.20 56.97 103.08 coo 48.59 58.89 25.78 50.13 59.74 24.61 -4.64 54.84 103.01 -3.71 56.24 101.58 1sme_c04 source 1sme PLASMEPSIN II : 12 hits 1sme_c04 naa= 3 ULMN 3 1sme_c05 PLASMEPSIN II user 1 3 # 1 B 34 ASP A 28 ASP^? 9.02 CL CL A 382 B 37 SER A 29 SER^? 6.92 CL CL A 382 B 214 ASP A 26 ASP^? 16.59 CL CL A 382 coo 17.69 97.58 52.73 17.33 97.19 54.77 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 20.67 100.44 55.84 20.21 98.51 54.45 -31.31 63.66 116.96 -29.07 63.86 117.79 coo 12.41 98.71 58.47 14.37 98.17 58.05 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1sme_c05 PLASMEPSIN II user 2 3 # 2 B 34 ASP A 28 ASP^? 9.02 CL CL A 382 B 37 SER A 37 SER^? 9.11 CL CL A 382 B 214 ASP A 26 ASP^? 16.59 CL CL A 382 coo 17.69 97.58 52.73 17.33 97.19 54.77 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 20.67 100.44 55.84 20.21 98.51 54.45 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 12.41 98.71 58.47 14.37 98.17 58.05 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1sme_c05 PLASMEPSIN II user 3 3 # 3 B 34 ASP A 28 ASP^? 9.02 CL CL A 382 B 37 SER A 37 SER^? 9.11 CL CL A 382 B 214 ASP A 30 ASP^? -6.81 CL CL A 382s coo 17.69 97.58 52.73 17.33 97.19 54.77 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 20.67 100.44 55.84 20.21 98.51 54.45 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 12.41 98.71 58.47 14.37 98.17 58.05 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1sme_c05 PLASMEPSIN II user 4 3 # 4 B 34 ASP A 28 ASP^? 9.02 CL CL A 382 B 37 SER A 37 SER^? 9.11 CL CL A 382 B 214 ASP A 39 ASP^? 16.51 CL CL A 382 coo 17.69 97.58 52.73 17.33 97.19 54.77 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 20.67 100.44 55.84 20.21 98.51 54.45 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 12.41 98.71 58.47 14.37 98.17 58.05 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1sme_c05 PLASMEPSIN II user 5 3 # 5 B 34 ASP A 36 ASP.? -3.33 CL CL A 382s B 37 SER A 37 SER^? 9.11 CL CL A 382 B 214 ASP A 30 ASP^? -6.81 CL CL A 382s coo 17.69 97.58 52.73 17.33 97.19 54.77 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 20.67 100.44 55.84 20.21 98.51 54.45 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 12.41 98.71 58.47 14.37 98.17 58.05 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 1sme_c05 PLASMEPSIN II user 6 3 # 6 B 34 ASP A 195 ASP.? 13.29 CL CL A 384 B 37 SER A 192 SER.? 15.36 CL CL A 384 B 214 ASP A 306 ASP.? 16.66 CL CL A 384 coo 17.69 97.58 52.73 17.33 97.19 54.77 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 20.67 100.44 55.84 20.21 98.51 54.45 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 12.41 98.71 58.47 14.37 98.17 58.05 -29.63 66.56 87.01 -28.35 68.29 87.20 ULMN 3 1sme_c05 PLASMEPSIN II user 7 3 # 7 B 34 ASP A 306 ASP.? 16.66 CL CL A 384 B 37 SER A 192 SER.? 15.36 CL CL A 384 B 214 ASP A 305 ASP^? 16.01 CL CL A 384 coo 17.69 97.58 52.73 17.33 97.19 54.77 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 20.67 100.44 55.84 20.21 98.51 54.45 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 12.41 98.71 58.47 14.37 98.17 58.05 -32.01 65.22 92.45 -32.49 63.34 91.63 ULMN 3 1sme_c05 PLASMEPSIN II user 8 3 # 8 B 34 ASP B 28 ASP^? 9.00 CL CL B 383 B 37 SER B 37 SER^? 9.16 CL CL B 383 B 214 ASP B 30 ASP^? -6.72 CL CL B 383s coo 17.69 97.58 52.73 17.33 97.19 54.77 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 20.67 100.44 55.84 20.21 98.51 54.45 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 12.41 98.71 58.47 14.37 98.17 58.05 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1sme_c05 PLASMEPSIN II user 9 3 # 9 B 34 ASP B 28 ASP^? 9.00 CL CL B 383 B 37 SER B 37 SER^? 9.16 CL CL B 383 B 214 ASP B 39 ASP^? 17.51 CL CL B 383 coo 17.69 97.58 52.73 17.33 97.19 54.77 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 20.67 100.44 55.84 20.21 98.51 54.45 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 12.41 98.71 58.47 14.37 98.17 58.05 -26.18 36.85 80.53 -27.97 36.10 81.34 ULMN 3 1sme_c05 PLASMEPSIN II user 10 3 # 10 B 34 ASP B 36 ASP.? -3.35 CL CL B 383s B 37 SER B 37 SER^? 9.16 CL CL B 383 B 214 ASP B 30 ASP^? -6.72 CL CL B 383s coo 17.69 97.58 52.73 17.33 97.19 54.77 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 20.67 100.44 55.84 20.21 98.51 54.45 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 12.41 98.71 58.47 14.37 98.17 58.05 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1sme_c05 PLASMEPSIN II user 11 3 # 11 B 34 ASP B 195 ASP.? 10.47 CL CL A 384 B 37 SER B 192 SER.? 13.26 CL CL A 384 B 214 ASP B 306 ASP.? 19.57 CL CL A 384 coo 17.69 97.58 52.73 17.33 97.19 54.77 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 20.67 100.44 55.84 20.21 98.51 54.45 -11.80 54.65 102.27 -11.20 56.97 103.08 coo 12.41 98.71 58.47 14.37 98.17 58.05 -4.64 54.84 103.01 -3.71 56.24 101.58 1sme_c05 source 1sme PLASMEPSIN II : 11 hits 1sme_c05 naa= 3 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP A 272 ASP~? 14.48 CL CL A 382 E 168 LYS A 268 LYS~? 13.60 CL CL A 382 E 201 THR A 342 THR.? 12.75 CL CL A 382 coo 5.36 16.20 22.10 3.88 17.00 23.31 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 5.06 22.32 18.11 1.02 22.08 22.74 -47.11 79.10 113.63 -43.53 76.03 116.02 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -39.29 79.06 113.77 -38.09 77.69 114.94 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 2 3 # 2 E 166 ASP B 64 ASP.? 7.14 CL CL B 382 E 168 LYS B 288 LYS.? 8.84 CL CL B 382 E 201 THR A 194 THR.? 13.30 CL CL B 382 coo 5.36 16.20 22.10 3.88 17.00 23.31 -22.24 55.99 77.05 -23.77 56.03 78.56 coo 5.06 22.32 18.11 1.02 22.08 22.74 -16.76 54.22 83.25 -20.62 56.75 78.99 coo -1.79 18.29 19.05 -1.19 20.28 19.71 -23.53 58.32 86.21 -24.61 58.92 84.44 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 3 3 # 3 E 166 ASP B 272 ASP~? 14.11 CL CL B 383 E 168 LYS B 268 LYS~? 13.29 CL CL B 383 E 201 THR B 342 THR.? 12.70 CL CL B 383 coo 5.36 16.20 22.10 3.88 17.00 23.31 0.88 31.47 82.51 1.09 32.47 80.67 coo 5.06 22.32 18.11 1.02 22.08 22.74 5.99 32.14 79.72 1.11 32.64 77.72 coo -1.79 18.29 19.05 -1.19 20.28 19.71 2.93 38.40 77.77 1.00 38.51 76.85 1stc_c02 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 3 hits 1stc_c02 naa= 3 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 1 3 # 1 B 8 HIS A 19 HIS^? 24.55 CL CL A 382 B 80 GLU A 18 GLU^? 23.23 CL CL A 382 B 223 ARG A 202 ARG^? 19.65 CL CL A 384 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -17.70 51.01 127.32 -17.43 50.94 129.40 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -12.62 56.10 125.83 -13.81 57.82 125.60 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -32.39 54.22 100.96 -34.65 53.06 99.24 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 2 3 # 2 B 8 HIS A 19 HIS^? 24.55 CL CL A 382 B 80 GLU A 18 GLU^? 23.23 CL CL A 382 B 223 ARG B 202 ARG^? 25.52 CL CL B 383 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -17.70 51.01 127.32 -17.43 50.94 129.40 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -12.62 56.10 125.83 -13.81 57.82 125.60 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -17.65 42.54 97.41 -16.79 41.14 100.03 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 3 3 # 3 B 8 HIS B 19 HIS^? 13.92 CL CL B 382 B 80 GLU B 18 GLU^? 5.91 CL CL B 382 B 223 ARG A 202 ARG^? 19.65 CL CL A 384 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -33.46 45.18 72.05 -34.46 43.90 70.71 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -29.91 50.09 69.26 -29.49 51.30 70.99 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -32.39 54.22 100.96 -34.65 53.06 99.24 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 4 3 # 4 B 8 HIS B 19 HIS^? 13.92 CL CL B 382 B 80 GLU B 18 GLU^? 5.91 CL CL B 382 B 223 ARG B 202 ARG^? 25.52 CL CL B 383 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -33.46 45.18 72.05 -34.46 43.90 70.71 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -29.91 50.09 69.26 -29.49 51.30 70.99 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -17.65 42.54 97.41 -16.79 41.14 100.03 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 5 3 # 5 B 8 HIS B 308 HIS.? 26.99 CL CL A 384 B 80 GLU B 307 GLU.? 20.03 CL CL A 384 B 223 ARG B 24 ARG^? 24.13 CL CL B 382 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -5.09 45.35 102.63 -4.80 43.27 102.76 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -8.15 49.66 106.11 -10.31 49.68 106.12 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -30.86 40.03 86.77 -33.42 38.25 86.47 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 6 3 # 6 B 8 HIS B 308 HIS.? 26.99 CL CL A 384 B 80 GLU B 307 GLU.? 20.03 CL CL A 384 B 223 ARG B 325 ARG.? 19.88 CL CL B 382 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -5.09 45.35 102.63 -4.80 43.27 102.76 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -8.15 49.66 106.11 -10.31 49.68 106.12 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -34.83 46.46 90.24 -34.50 47.08 87.15 1t0u_c01 source 1t0u URIDINE PHOSPHORYLASE : 6 hits 1t0u_c01 naa= 3 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 1 3 # 1 A 261 GLY A 56 GLY.? 19.88 CL CL A 382 B 17 GLN A 76 GLN^? 24.61 CL CL A 382 B 140 GLU A 57 GLU.? 23.36 CL CL A 382 coo 61.49 19.86 5.96 61.52 19.46 5.16 -28.63 54.28 134.84 -27.95 54.18 134.45 coo 63.76 11.90 7.93 65.18 13.07 6.77 -26.57 46.46 129.57 -24.86 46.70 130.88 coo 66.44 19.00 7.38 67.69 17.67 8.37 -23.46 53.73 134.86 -22.94 54.54 136.68 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 2 3 # 2 A 261 GLY A 148 GLY.? 11.08 CL CL A 383 B 17 GLN A 105 GLN.? 15.43 CL CL A 383 B 140 GLU A 146 GLU.? 12.63 CL CL A 383 coo 61.49 19.86 5.96 61.52 19.46 5.16 -49.51 66.91 135.22 -49.43 67.62 134.85 coo 63.76 11.90 7.93 65.18 13.07 6.77 -48.66 74.56 138.50 -49.02 75.36 136.52 coo 66.44 19.00 7.38 67.69 17.67 8.37 -52.58 70.92 131.34 -54.15 69.93 130.28 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 3 3 # 3 A 261 GLY A 148 GLY.? 11.08 CL CL A 383 B 17 GLN A 105 GLN.? 15.43 CL CL A 383 B 140 GLU A 149 GLU.? 9.19 CL CL A 383 coo 61.49 19.86 5.96 61.52 19.46 5.16 -49.51 66.91 135.22 -49.43 67.62 134.85 coo 63.76 11.90 7.93 65.18 13.07 6.77 -48.66 74.56 138.50 -49.02 75.36 136.52 coo 66.44 19.00 7.38 67.69 17.67 8.37 -48.79 70.20 130.85 -48.75 71.87 129.52 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 4 3 # 4 A 261 GLY A 148 GLY.? 11.08 CL CL A 383 B 17 GLN A 153 GLN~? 5.15 CL CL A 383 B 140 GLU A 146 GLU.? 12.63 CL CL A 383 coo 61.49 19.86 5.96 61.52 19.46 5.16 -49.51 66.91 135.22 -49.43 67.62 134.85 coo 63.76 11.90 7.93 65.18 13.07 6.77 -45.94 68.13 127.54 -47.43 66.98 128.54 coo 66.44 19.00 7.38 67.69 17.67 8.37 -52.58 70.92 131.34 -54.15 69.93 130.28 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 5 3 # 5 A 261 GLY B 56 GLY.? 19.89 CL CL B 383 B 17 GLN B 76 GLN^? 22.74 CL CL B 382 B 140 GLU B 57 GLU.? 21.35 CL CL B 382 coo 61.49 19.86 5.96 61.52 19.46 5.16 -28.65 32.56 66.30 -28.87 33.28 66.56 coo 63.76 11.90 7.93 65.18 13.07 6.77 -34.98 34.32 73.52 -35.81 35.28 71.77 coo 66.44 19.00 7.38 67.69 17.67 8.37 -31.25 37.00 65.18 -31.15 36.75 63.13 1t4c_c02 source 1t4c FORMYL-COENZYME A TRANSFERASE : 5 hits 1t4c_c02 naa= 3 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 A 144 HIS B 308 HIS.? 26.99 CL CL A 384 A 174 ASP B 311 ASP^? 24.66 CL CL A 384 A 404 TYR A 6 TYR.? 20.79 CL CL A 384 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -5.09 45.35 102.63 -4.80 43.27 102.76 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 0.41 52.81 97.17 0.37 54.52 95.85 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -7.05 53.27 108.32 -4.25 53.35 108.15 1ti6_c06 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_c06 naa= 3 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 C 144 HIS B 308 HIS.? 26.99 CL CL A 384 C 174 ASP B 311 ASP^? 24.66 CL CL A 384 C 404 TYR A 6 TYR.? 20.79 CL CL A 384 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -5.09 45.35 102.63 -4.80 43.27 102.76 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 0.41 52.81 97.17 0.37 54.52 95.85 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -7.05 53.27 108.32 -4.25 53.35 108.15 1ti6_c07 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_c07 naa= 3 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 E 144 HIS B 308 HIS.? 26.99 CL CL A 384 E 174 ASP B 311 ASP^? 24.66 CL CL A 384 E 404 TYR A 6 TYR.? 20.79 CL CL A 384 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -5.09 45.35 102.63 -4.80 43.27 102.76 coo -3.55-105.39 83.13 -5.21-106.24 82.09 0.41 52.81 97.17 0.37 54.52 95.85 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -7.05 53.27 108.32 -4.25 53.35 108.15 1ti6_c08 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_c08 naa= 3 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 G 144 HIS B 308 HIS.? 26.99 CL CL A 384 G 174 ASP B 311 ASP^? 24.66 CL CL A 384 G 404 TYR A 6 TYR.? 20.79 CL CL A 384 coo 60.48-101.16 45.95 60.56-101.20 43.85 -5.09 45.35 102.63 -4.80 43.27 102.76 coo 58.10-108.15 40.62 59.57-106.86 41.51 0.41 52.81 97.17 0.37 54.52 95.85 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -7.05 53.27 108.32 -4.25 53.35 108.15 1ti6_c09 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_c09 naa= 3 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 I 144 HIS B 308 HIS.? 26.99 CL CL A 384 I 174 ASP B 311 ASP^? 24.66 CL CL A 384 I 404 TYR A 6 TYR.? 20.79 CL CL A 384 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -5.09 45.35 102.63 -4.80 43.27 102.76 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 0.41 52.81 97.17 0.37 54.52 95.85 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -7.05 53.27 108.32 -4.25 53.35 108.15 1ti6_c10 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_c10 naa= 3 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 K 144 HIS B 308 HIS.? 26.99 CL CL A 384 K 174 ASP B 311 ASP^? 24.66 CL CL A 384 K 404 TYR A 6 TYR.? 20.79 CL CL A 384 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -5.09 45.35 102.63 -4.80 43.27 102.76 coo 102.36 30.86 6.31 102.45 29.08 5.12 0.41 52.81 97.17 0.37 54.52 95.85 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -7.05 53.27 108.32 -4.25 53.35 108.15 1ti6_c11 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_c11 naa= 3 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 1 3 # 1 A 250 ALA A 35 ALA.? 6.30 CL CL A 382 A 251 GLY A 96 GLY~? 8.65 CL CL A 383 A 252 ASP A 93 ASP^? 5.15 CL CL A 382 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -35.44 63.33 123.80 -35.72 62.35 124.94 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -35.37 62.51 129.12 -35.27 63.21 129.50 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 2 3 # 2 A 250 ALA A 95 ALA~? 5.86 CL CL A 382 A 251 GLY A 96 GLY~? 8.65 CL CL A 383 A 252 ASP A 93 ASP^? 5.15 CL CL A 382 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -34.32 65.97 127.91 -34.72 66.23 126.45 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -35.37 62.51 129.12 -35.27 63.21 129.50 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 3 3 # 3 A 250 ALA B 35 ALA.? 6.30 CL CL B 383 A 251 GLY B 96 GLY~? 8.80 CL CL B 384 A 252 ASP B 93 ASP^? 5.22 CL CL B 383 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -15.02 33.54 74.31 -16.10 32.59 73.63 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -17.52 31.23 69.94 -17.03 31.31 69.27 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 4 3 # 4 A 250 ALA B 95 ALA~? 5.98 CL CL B 383 A 251 GLY B 96 GLY~? 8.80 CL CL B 384 A 252 ASP B 93 ASP^? 5.22 CL CL B 383 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -14.44 33.46 69.35 -13.59 33.72 70.62 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -17.52 31.23 69.94 -17.03 31.31 69.27 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -17.13 37.76 71.68 -15.50 36.45 72.23 1tz3_c02 source 1tz3 PUTATIVE SUGAR KINASE : 4 hits 1tz3_c02 naa= 3 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 1 3 # 1 B 250 ALA A 35 ALA.? 6.30 CL CL A 382 B 251 GLY A 96 GLY~? 8.65 CL CL A 383 B 252 ASP A 93 ASP^? 5.15 CL CL A 382 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -35.44 63.33 123.80 -35.72 62.35 124.94 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -35.37 62.51 129.12 -35.27 63.21 129.50 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 2 3 # 2 B 250 ALA A 95 ALA~? 5.86 CL CL A 382 B 251 GLY A 96 GLY~? 8.65 CL CL A 383 B 252 ASP A 93 ASP^? 5.15 CL CL A 382 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -34.32 65.97 127.91 -34.72 66.23 126.45 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -35.37 62.51 129.12 -35.27 63.21 129.50 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 3 3 # 3 B 250 ALA B 35 ALA.? 6.30 CL CL B 383 B 251 GLY B 96 GLY~? 8.80 CL CL B 384 B 252 ASP B 93 ASP^? 5.22 CL CL B 383 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -15.02 33.54 74.31 -16.10 32.59 73.63 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -17.52 31.23 69.94 -17.03 31.31 69.27 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 4 3 # 4 B 250 ALA B 95 ALA~? 5.98 CL CL B 383 B 251 GLY B 96 GLY~? 8.80 CL CL B 384 B 252 ASP B 93 ASP^? 5.22 CL CL B 383 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -14.44 33.46 69.35 -13.59 33.72 70.62 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -17.52 31.23 69.94 -17.03 31.31 69.27 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -17.13 37.76 71.68 -15.50 36.45 72.23 1tz3_c03 source 1tz3 PUTATIVE SUGAR KINASE : 4 hits 1tz3_c03 naa= 3 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 A 46 GLU A 135 GLU.? 22.99 CL CL A 382 A 126 LYS A 133 LYS^? 12.95 CL CL A 382 A 171 ALA A 345 ALA.? 15.79 CL CL A 382 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -31.98 87.75 115.72 -30.11 88.72 115.32 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -30.69 80.61 120.28 -26.75 77.00 119.43 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -35.83 83.37 115.92 -35.32 81.91 116.06 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 A 46 GLU B 135 GLU.? 23.43 CL CL B 383 A 126 LYS B 133 LYS^? 13.08 CL CL B 383 A 171 ALA B 345 ALA.? 15.71 CL CL B 383 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 7.28 45.80 70.11 9.12 46.58 70.84 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -0.84 43.73 69.01 -5.56 47.16 71.00 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 4.64 41.37 73.03 3.24 41.54 73.45 1uf7_c00 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 2 hits 1uf7_c00 naa= 3 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 B 46 GLU A 135 GLU.? 22.99 CL CL A 382 B 126 LYS A 133 LYS^? 12.95 CL CL A 382 B 171 ALA A 345 ALA.? 15.79 CL CL A 382 coo 20.47 87.42 16.54 20.16 87.17 14.45 -31.98 87.75 115.72 -30.11 88.72 115.32 coo 24.73 94.37 14.59 21.08 89.84 11.98 -30.69 80.61 120.28 -26.75 77.00 119.43 coo 24.38 86.32 12.71 22.88 86.54 12.71 -35.83 83.37 115.92 -35.32 81.91 116.06 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 B 46 GLU B 135 GLU.? 23.43 CL CL B 383 B 126 LYS B 133 LYS^? 13.08 CL CL B 383 B 171 ALA B 345 ALA.? 15.71 CL CL B 383 coo 20.47 87.42 16.54 20.16 87.17 14.45 7.28 45.80 70.11 9.12 46.58 70.84 coo 24.73 94.37 14.59 21.08 89.84 11.98 -0.84 43.73 69.01 -5.56 47.16 71.00 coo 24.38 86.32 12.71 22.88 86.54 12.71 4.64 41.37 73.03 3.24 41.54 73.45 1uf7_c01 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 2 hits 1uf7_c01 naa= 3 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 180 ASP.? 19.13 CL CL A 382 255 GLU A 135 GLU.? 22.99 CL CL A 382 329 ASP A 344 ASP.? 20.56 CL CL A 382 coo 49.16 35.16 15.19 51.08 34.43 15.65 -29.53 80.77 112.24 -28.62 82.54 111.55 coo 52.57 37.12 10.17 53.37 35.95 11.75 -31.98 87.75 115.72 -30.11 88.72 115.32 coo 59.16 37.82 13.95 57.63 37.03 15.12 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 210 ASP.? 21.69 CL CL A 383 255 GLU A 276 GLU~? 16.10 CL CL A 383 329 ASP A 272 ASP~? 14.48 CL CL A 382 coo 49.16 35.16 15.19 51.08 34.43 15.65 -52.58 64.68 106.89 -53.21 62.78 107.37 coo 52.57 37.12 10.17 53.37 35.95 11.75 -46.62 67.79 110.40 -48.46 68.09 111.43 coo 59.16 37.82 13.95 57.63 37.03 15.12 -46.67 73.24 112.92 -45.43 74.19 114.38 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 272 ASP~? 14.48 CL CL A 382 255 GLU A 276 GLU~? 16.10 CL CL A 383 329 ASP A 210 ASP.? 21.69 CL CL A 383 coo 49.16 35.16 15.19 51.08 34.43 15.65 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 52.57 37.12 10.17 53.37 35.95 11.75 -46.62 67.79 110.40 -48.46 68.09 111.43 coo 59.16 37.82 13.95 57.63 37.03 15.12 -52.58 64.68 106.89 -53.21 62.78 107.37 1uok_c03 source 1uok OLIGO-1,6-GLUCOSIDASE : 3 hits 1uok_c03 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 36 ASP.? -3.33 CL CL A 382s 218 GLU A 307 GLU.? 18.04 CL CL B 382 329 ASP A 26 ASP^? 16.59 CL CL A 382 coo 49.16 35.16 15.19 51.08 34.43 15.65 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 70.09 11.71 8.46 70.56 12.89 6.77 -31.95 61.22 87.08 -31.47 59.40 88.12 coo 59.16 37.82 13.95 57.63 37.03 15.12 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 36 ASP.? -3.33 CL CL A 382s 218 GLU B 201 GLU^? 17.46 CL CL A 384 329 ASP A 39 ASP^? 16.51 CL CL A 382 coo 49.16 35.16 15.19 51.08 34.43 15.65 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 70.09 11.71 8.46 70.56 12.89 6.77 -19.06 50.53 95.26 -20.94 50.61 94.28 coo 59.16 37.82 13.95 57.63 37.03 15.12 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 93 ASP^? 5.15 CL CL A 382 218 GLU B 307 GLU.? 20.03 CL CL A 384 329 ASP A 28 ASP^? 9.02 CL CL A 382 coo 49.16 35.16 15.19 51.08 34.43 15.65 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 70.09 11.71 8.46 70.56 12.89 6.77 -8.15 49.66 106.11 -10.31 49.68 106.12 coo 59.16 37.82 13.95 57.63 37.03 15.12 -32.19 59.08 116.32 -33.48 59.98 114.85 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 100 ASP~? 8.92 CL CL A 383 218 GLU A 337 GLU^? 21.89 CL CL A 382 329 ASP A 93 ASP^? 5.15 CL CL A 382 coo 49.16 35.16 15.19 51.08 34.43 15.65 -39.25 61.23 132.92 -38.42 59.82 131.54 coo 70.09 11.71 8.46 70.56 12.89 6.77 -40.07 74.65 102.17 -42.10 75.18 101.81 coo 59.16 37.82 13.95 57.63 37.03 15.12 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP A 144 ASP.? 19.38 CL CL A 383 218 GLU A 337 GLU^? 21.89 CL CL A 382 329 ASP A 257 ASP.? 24.30 CL CL A 383 coo 49.16 35.16 15.19 51.08 34.43 15.65 -52.89 78.90 131.37 -53.77 80.20 132.79 coo 70.09 11.71 8.46 70.56 12.89 6.77 -40.07 74.65 102.17 -42.10 75.18 101.81 coo 59.16 37.82 13.95 57.63 37.03 15.12 -55.05 88.25 125.09 -55.04 86.55 126.35 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP A 180 ASP.? 19.13 CL CL A 382 218 GLU A 215 GLU^? 33.84 CL CL A 383 329 ASP A 338 ASP.? 17.28 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -29.53 80.77 112.24 -28.62 82.54 111.55 coo 70.09 11.71 8.46 70.56 12.89 6.77 -61.95 78.59 103.72 -63.72 79.79 103.76 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.06 76.37 102.96 -33.50 77.52 103.78 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP A 195 ASP.? 13.29 CL CL A 384 218 GLU A 276 GLU~? 16.10 CL CL A 383 329 ASP A 306 ASP.? 16.66 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 70.09 11.71 8.46 70.56 12.89 6.77 -46.62 67.79 110.40 -48.46 68.09 111.43 coo 59.16 37.82 13.95 57.63 37.03 15.12 -29.63 66.56 87.01 -28.35 68.29 87.20 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP A 195 ASP.? 13.29 CL CL A 384 218 GLU B 86 GLU^? 25.45 CL CL B 382 329 ASP A 305 ASP^? 16.01 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 70.09 11.71 8.46 70.56 12.89 6.77 -37.46 36.82 83.59 -36.60 37.35 85.50 coo 59.16 37.82 13.95 57.63 37.03 15.12 -32.01 65.22 92.45 -32.49 63.34 91.63 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP A 204 ASP^? 18.76 CL CL A 384 218 GLU B 18 GLU^? 5.91 CL CL B 382 329 ASP A 305 ASP^? 16.01 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -37.06 58.40 100.88 -36.30 56.45 100.53 coo 70.09 11.71 8.46 70.56 12.89 6.77 -29.91 50.09 69.26 -29.49 51.30 70.99 coo 59.16 37.82 13.95 57.63 37.03 15.12 -32.01 65.22 92.45 -32.49 63.34 91.63 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP A 233 ASP.? 30.79 CL CL A 383 218 GLU A 337 GLU^? 21.89 CL CL A 382 329 ASP A 257 ASP.? 24.30 CL CL A 383 coo 49.16 35.16 15.19 51.08 34.43 15.65 -64.45 88.75 121.31 -62.88 88.68 122.75 coo 70.09 11.71 8.46 70.56 12.89 6.77 -40.07 74.65 102.17 -42.10 75.18 101.81 coo 59.16 37.82 13.95 57.63 37.03 15.12 -55.05 88.25 125.09 -55.04 86.55 126.35 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 11 3 # 11 199 ASP A 257 ASP.? 24.30 CL CL A 383 218 GLU A 169 GLU.? 11.07 CL CL A 382 329 ASP A 144 ASP.? 19.38 CL CL A 383 coo 49.16 35.16 15.19 51.08 34.43 15.65 -55.05 88.25 125.09 -55.04 86.55 126.35 coo 70.09 11.71 8.46 70.56 12.89 6.77 -27.31 72.85 122.01 -26.32 74.11 120.63 coo 59.16 37.82 13.95 57.63 37.03 15.12 -52.89 78.90 131.37 -53.77 80.20 132.79 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 12 3 # 12 199 ASP A 272 ASP~? 14.48 CL CL A 382 218 GLU A 201 GLU.? 12.07 CL CL A 384 329 ASP A 210 ASP.? 21.69 CL CL A 383 coo 49.16 35.16 15.19 51.08 34.43 15.65 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 70.09 11.71 8.46 70.56 12.89 6.77 -24.87 56.03 99.70 -24.21 54.93 101.40 coo 59.16 37.82 13.95 57.63 37.03 15.12 -52.58 64.68 106.89 -53.21 62.78 107.37 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 13 3 # 13 199 ASP A 272 ASP~? 14.48 CL CL A 382 218 GLU A 307 GLU.? 18.04 CL CL B 382 329 ASP A 210 ASP.? 21.69 CL CL A 383 coo 49.16 35.16 15.19 51.08 34.43 15.65 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 70.09 11.71 8.46 70.56 12.89 6.77 -31.95 61.22 87.08 -31.47 59.40 88.12 coo 59.16 37.82 13.95 57.63 37.03 15.12 -52.58 64.68 106.89 -53.21 62.78 107.37 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 14 3 # 14 199 ASP A 305 ASP^? 16.01 CL CL A 384 218 GLU A 169 GLU.? 11.07 CL CL A 382 329 ASP A 204 ASP^? 18.76 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -32.01 65.22 92.45 -32.49 63.34 91.63 coo 70.09 11.71 8.46 70.56 12.89 6.77 -27.31 72.85 122.01 -26.32 74.11 120.63 coo 59.16 37.82 13.95 57.63 37.03 15.12 -37.06 58.40 100.88 -36.30 56.45 100.53 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 15 3 # 15 199 ASP A 305 ASP^? 16.01 CL CL A 384 218 GLU B 60 GLU^? 11.77 CL CL B 382 329 ASP A 195 ASP.? 13.29 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -32.01 65.22 92.45 -32.49 63.34 91.63 coo 70.09 11.71 8.46 70.56 12.89 6.77 -22.53 44.68 66.99 -22.71 45.90 65.28 coo 59.16 37.82 13.95 57.63 37.03 15.12 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 16 3 # 16 199 ASP A 305 ASP^? 16.01 CL CL A 384 218 GLU B 86 GLU^? 25.45 CL CL B 382 329 ASP A 195 ASP.? 13.29 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -32.01 65.22 92.45 -32.49 63.34 91.63 coo 70.09 11.71 8.46 70.56 12.89 6.77 -37.46 36.82 83.59 -36.60 37.35 85.50 coo 59.16 37.82 13.95 57.63 37.03 15.12 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 17 3 # 17 199 ASP A 305 ASP^? 16.01 CL CL A 384 218 GLU B 86 GLU^? 25.45 CL CL B 382 329 ASP A 204 ASP^? 18.76 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -32.01 65.22 92.45 -32.49 63.34 91.63 coo 70.09 11.71 8.46 70.56 12.89 6.77 -37.46 36.82 83.59 -36.60 37.35 85.50 coo 59.16 37.82 13.95 57.63 37.03 15.12 -37.06 58.40 100.88 -36.30 56.45 100.53 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 18 3 # 18 199 ASP A 305 ASP^? 16.01 CL CL A 384 218 GLU B 307 GLU.? 20.03 CL CL A 384 329 ASP A 204 ASP^? 18.76 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -32.01 65.22 92.45 -32.49 63.34 91.63 coo 70.09 11.71 8.46 70.56 12.89 6.77 -8.15 49.66 106.11 -10.31 49.68 106.12 coo 59.16 37.82 13.95 57.63 37.03 15.12 -37.06 58.40 100.88 -36.30 56.45 100.53 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 19 3 # 19 199 ASP A 306 ASP.? 16.66 CL CL A 384 218 GLU B 60 GLU^? 11.77 CL CL B 382 329 ASP A 195 ASP.? 13.29 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 70.09 11.71 8.46 70.56 12.89 6.77 -22.53 44.68 66.99 -22.71 45.90 65.28 coo 59.16 37.82 13.95 57.63 37.03 15.12 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 20 3 # 20 199 ASP A 306 ASP.? 16.66 CL CL A 384 218 GLU B 86 GLU^? 25.45 CL CL B 382 329 ASP A 195 ASP.? 13.29 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 70.09 11.71 8.46 70.56 12.89 6.77 -37.46 36.82 83.59 -36.60 37.35 85.50 coo 59.16 37.82 13.95 57.63 37.03 15.12 -22.13 62.52 88.27 -20.53 63.80 88.70 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 21 3 # 21 199 ASP A 311 ASP^? 15.19 CL CL A 384 218 GLU A 215 GLU^? 33.84 CL CL A 383 329 ASP A 338 ASP.? 17.28 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -31.19 72.86 91.72 -29.44 73.97 92.12 coo 70.09 11.71 8.46 70.56 12.89 6.77 -61.95 78.59 103.72 -63.72 79.79 103.76 coo 59.16 37.82 13.95 57.63 37.03 15.12 -35.06 76.37 102.96 -33.50 77.52 103.78 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 22 3 # 22 199 ASP A 327 ASP.? 19.04 CL CL A 384 218 GLU B 337 GLU^? 21.78 CL CL B 383 329 ASP B 327 ASP.? 22.34 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -25.74 49.77 105.10 -27.34 48.80 104.08 coo 70.09 11.71 8.46 70.56 12.89 6.77 2.60 41.45 89.80 4.03 40.00 90.41 coo 59.16 37.82 13.95 57.63 37.03 15.12 -25.62 46.25 93.54 -25.42 45.53 95.50 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 23 3 # 23 199 ASP A 338 ASP.? 17.28 CL CL A 384 218 GLU A 149 GLU.? 9.19 CL CL A 383 329 ASP A 180 ASP.? 19.13 CL CL A 382 coo 49.16 35.16 15.19 51.08 34.43 15.65 -35.06 76.37 102.96 -33.50 77.52 103.78 coo 70.09 11.71 8.46 70.56 12.89 6.77 -48.79 70.20 130.85 -48.75 71.87 129.52 coo 59.16 37.82 13.95 57.63 37.03 15.12 -29.53 80.77 112.24 -28.62 82.54 111.55 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 24 3 # 24 199 ASP B 36 ASP.? -3.35 CL CL B 383s 218 GLU A 201 GLU.? 12.07 CL CL A 384 329 ASP B 39 ASP^? 17.51 CL CL B 383 coo 49.16 35.16 15.19 51.08 34.43 15.65 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 70.09 11.71 8.46 70.56 12.89 6.77 -24.87 56.03 99.70 -24.21 54.93 101.40 coo 59.16 37.82 13.95 57.63 37.03 15.12 -26.18 36.85 80.53 -27.97 36.10 81.34 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 25 3 # 25 199 ASP B 36 ASP.? -3.35 CL CL B 383s 218 GLU B 307 GLU.? 20.03 CL CL A 384 329 ASP B 26 ASP^? 16.51 CL CL B 383 coo 49.16 35.16 15.19 51.08 34.43 15.65 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 70.09 11.71 8.46 70.56 12.89 6.77 -8.15 49.66 106.11 -10.31 49.68 106.12 coo 59.16 37.82 13.95 57.63 37.03 15.12 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 26 3 # 26 199 ASP B 93 ASP^? 5.22 CL CL B 383 218 GLU A 307 GLU.? 18.04 CL CL B 382 329 ASP B 28 ASP^? 9.00 CL CL B 383 coo 49.16 35.16 15.19 51.08 34.43 15.65 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 70.09 11.71 8.46 70.56 12.89 6.77 -31.95 61.22 87.08 -31.47 59.40 88.12 coo 59.16 37.82 13.95 57.63 37.03 15.12 -18.06 38.42 81.61 -16.37 38.03 82.88 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 27 3 # 27 199 ASP B 93 ASP^? 5.22 CL CL B 383 218 GLU A 307 GLU.? 18.04 CL CL B 382 329 ASP B 171 ASP.? 13.77 CL CL B 383 coo 49.16 35.16 15.19 51.08 34.43 15.65 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 70.09 11.71 8.46 70.56 12.89 6.77 -31.95 61.22 87.08 -31.47 59.40 88.12 coo 59.16 37.82 13.95 57.63 37.03 15.12 -14.88 46.75 66.62 -12.79 46.40 66.16 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 28 3 # 28 199 ASP B 195 ASP.? 10.47 CL CL A 384 218 GLU A 206 GLU^? 19.04 CL CL A 382 329 ASP A 291 ASP.? 7.30 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 70.09 11.71 8.46 70.56 12.89 6.77 -42.05 60.33 102.60 -42.22 59.82 104.62 coo 59.16 37.82 13.95 57.63 37.03 15.12 -15.45 71.21 105.07 -17.40 71.77 105.62 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 29 3 # 29 199 ASP B 195 ASP.? 10.47 CL CL A 384 218 GLU B 276 GLU~? 15.94 CL CL B 384 329 ASP B 306 ASP.? 19.57 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 70.09 11.71 8.46 70.56 12.89 6.77 -2.79 30.63 87.01 -2.36 28.59 86.68 coo 59.16 37.82 13.95 57.63 37.03 15.12 -4.64 54.84 103.01 -3.71 56.24 101.58 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 30 3 # 30 199 ASP B 204 ASP^? 22.18 CL CL B 383 218 GLU A 18 GLU^? 23.23 CL CL A 382 329 ASP B 305 ASP^? 21.59 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -12.38 39.84 96.49 -14.33 39.98 97.22 coo 70.09 11.71 8.46 70.56 12.89 6.77 -12.62 56.10 125.83 -13.81 57.82 125.60 coo 59.16 37.82 13.95 57.63 37.03 15.12 -6.28 49.81 99.79 -7.51 49.10 101.38 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 31 3 # 31 199 ASP B 257 ASP.? 23.04 CL CL B 384 218 GLU B 169 GLU.? 11.31 CL CL B 383 329 ASP B 144 ASP.? 18.90 CL CL B 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 12.38 23.16 66.89 10.36 22.88 66.20 coo 70.09 11.71 8.46 70.56 12.89 6.77 -9.49 44.22 70.62 -8.22 45.44 69.57 coo 59.16 37.82 13.95 57.63 37.03 15.12 1.70 18.75 65.96 3.42 18.04 64.94 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 32 3 # 32 199 ASP B 305 ASP^? 21.59 CL CL A 384 218 GLU A 60 GLU^? 17.84 CL CL A 382 329 ASP B 195 ASP.? 10.47 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -6.28 49.81 99.79 -7.51 49.10 101.38 coo 70.09 11.71 8.46 70.56 12.89 6.77 -20.60 62.82 127.64 -18.87 63.84 128.41 coo 59.16 37.82 13.95 57.63 37.03 15.12 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 33 3 # 33 199 ASP B 305 ASP^? 21.59 CL CL A 384 218 GLU A 307 GLU.? 18.04 CL CL B 382 329 ASP B 204 ASP^? 22.18 CL CL B 383 coo 49.16 35.16 15.19 51.08 34.43 15.65 -6.28 49.81 99.79 -7.51 49.10 101.38 coo 70.09 11.71 8.46 70.56 12.89 6.77 -31.95 61.22 87.08 -31.47 59.40 88.12 coo 59.16 37.82 13.95 57.63 37.03 15.12 -12.38 39.84 96.49 -14.33 39.98 97.22 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 34 3 # 34 199 ASP B 306 ASP.? 19.57 CL CL A 384 218 GLU A 60 GLU^? 17.84 CL CL A 382 329 ASP B 195 ASP.? 10.47 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -4.64 54.84 103.01 -3.71 56.24 101.58 coo 70.09 11.71 8.46 70.56 12.89 6.77 -20.60 62.82 127.64 -18.87 63.84 128.41 coo 59.16 37.82 13.95 57.63 37.03 15.12 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 35 3 # 35 199 ASP B 306 ASP.? 19.57 CL CL A 384 218 GLU A 86 GLU^? 27.08 CL CL A 382 329 ASP B 195 ASP.? 10.47 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -4.64 54.84 103.01 -3.71 56.24 101.58 coo 70.09 11.71 8.46 70.56 12.89 6.77 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 59.16 37.82 13.95 57.63 37.03 15.12 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 36 3 # 36 199 ASP B 327 ASP.? 22.34 CL CL A 384 218 GLU A 337 GLU^? 21.89 CL CL A 382 329 ASP A 327 ASP.? 19.04 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -25.62 46.25 93.54 -25.42 45.53 95.50 coo 70.09 11.71 8.46 70.56 12.89 6.77 -40.07 74.65 102.17 -42.10 75.18 101.81 coo 59.16 37.82 13.95 57.63 37.03 15.12 -25.74 49.77 105.10 -27.34 48.80 104.08 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 37 3 # 37 199 ASP B 338 ASP.? 19.77 CL CL B 383 218 GLU B 149 GLU.? 9.91 CL CL B 384 329 ASP B 180 ASP.? 19.08 CL CL B 383 coo 49.16 35.16 15.19 51.08 34.43 15.65 1.84 46.00 86.98 1.86 47.25 85.31 coo 70.09 11.71 8.46 70.56 12.89 6.77 -6.14 20.54 69.48 -4.10 21.06 69.10 coo 59.16 37.82 13.95 57.63 37.03 15.12 0.82 48.22 75.52 2.17 49.73 74.84 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 37 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 26 ASP^? 16.59 CL CL A 382 242 GLU A 57 GLU.? 23.36 CL CL A 382 329 ASP A 327 ASP.? 19.04 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -29.69 53.68 115.80 -29.91 52.24 114.24 coo 30.42 34.74 5.00 29.09 35.09 3.38 -23.46 53.73 134.86 -22.94 54.54 136.68 coo 59.16 37.82 13.95 57.63 37.03 15.12 -25.74 49.77 105.10 -27.34 48.80 104.08 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 26 ASP^? 16.59 CL CL A 382 242 GLU A 169 GLU.? 11.07 CL CL A 382 329 ASP A 327 ASP.? 19.04 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -29.69 53.68 115.80 -29.91 52.24 114.24 coo 30.42 34.74 5.00 29.09 35.09 3.38 -27.31 72.85 122.01 -26.32 74.11 120.63 coo 59.16 37.82 13.95 57.63 37.03 15.12 -25.74 49.77 105.10 -27.34 48.80 104.08 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 36 ASP.? -3.33 CL CL A 382s 242 GLU A 149 GLU.? 9.19 CL CL A 383 329 ASP A 26 ASP^? 16.59 CL CL A 382 coo 49.16 35.16 15.19 51.08 34.43 15.65 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 30.42 34.74 5.00 29.09 35.09 3.38 -48.79 70.20 130.85 -48.75 71.87 129.52 coo 59.16 37.82 13.95 57.63 37.03 15.12 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 36 ASP.? -3.33 CL CL A 382s 242 GLU A 149 GLU.? 9.19 CL CL A 383 329 ASP A 39 ASP^? 16.51 CL CL A 382 coo 49.16 35.16 15.19 51.08 34.43 15.65 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 30.42 34.74 5.00 29.09 35.09 3.38 -48.79 70.20 130.85 -48.75 71.87 129.52 coo 59.16 37.82 13.95 57.63 37.03 15.12 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP A 93 ASP^? 5.15 CL CL A 382 242 GLU A 23 GLU.? 27.24 CL CL A 382 329 ASP A 100 ASP~? 8.92 CL CL A 383 coo 49.16 35.16 15.19 51.08 34.43 15.65 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 30.42 34.74 5.00 29.09 35.09 3.38 -22.84 44.28 116.17 -23.55 42.53 115.22 coo 59.16 37.82 13.95 57.63 37.03 15.12 -39.25 61.23 132.92 -38.42 59.82 131.54 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP A 93 ASP^? 5.15 CL CL A 382 242 GLU A 86 GLU^? 27.08 CL CL A 382 329 ASP A 171 ASP.? 13.95 CL CL A 382 coo 49.16 35.16 15.19 51.08 34.43 15.65 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 30.42 34.74 5.00 29.09 35.09 3.38 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 59.16 37.82 13.95 57.63 37.03 15.12 -21.72 70.05 125.28 -22.57 71.99 125.28 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP A 93 ASP^? 5.15 CL CL A 382 242 GLU A 276 GLU~? 16.10 CL CL A 383 329 ASP A 171 ASP.? 13.95 CL CL A 382 coo 49.16 35.16 15.19 51.08 34.43 15.65 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 30.42 34.74 5.00 29.09 35.09 3.38 -46.62 67.79 110.40 -48.46 68.09 111.43 coo 59.16 37.82 13.95 57.63 37.03 15.12 -21.72 70.05 125.28 -22.57 71.99 125.28 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP A 195 ASP.? 13.29 CL CL A 384 242 GLU B 332 GLU^? 14.76 CL CL B 383 329 ASP A 305 ASP^? 16.01 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 30.42 34.74 5.00 29.09 35.09 3.38 -15.56 41.56 89.17 -16.27 39.59 89.11 coo 59.16 37.82 13.95 57.63 37.03 15.12 -32.01 65.22 92.45 -32.49 63.34 91.63 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP A 195 ASP.? 13.29 CL CL A 384 242 GLU B 332 GLU^? 14.76 CL CL B 383 329 ASP A 306 ASP.? 16.66 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 30.42 34.74 5.00 29.09 35.09 3.38 -15.56 41.56 89.17 -16.27 39.59 89.11 coo 59.16 37.82 13.95 57.63 37.03 15.12 -29.63 66.56 87.01 -28.35 68.29 87.20 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP A 272 ASP~? 14.48 CL CL A 382 242 GLU A 135 GLU.? 22.99 CL CL A 382 329 ASP A 210 ASP.? 21.69 CL CL A 383 coo 49.16 35.16 15.19 51.08 34.43 15.65 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 30.42 34.74 5.00 29.09 35.09 3.38 -31.98 87.75 115.72 -30.11 88.72 115.32 coo 59.16 37.82 13.95 57.63 37.03 15.12 -52.58 64.68 106.89 -53.21 62.78 107.37 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 11 3 # 11 199 ASP A 272 ASP~? 14.48 CL CL A 382 242 GLU A 169 GLU.? 11.07 CL CL A 382 329 ASP A 210 ASP.? 21.69 CL CL A 383 coo 49.16 35.16 15.19 51.08 34.43 15.65 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 30.42 34.74 5.00 29.09 35.09 3.38 -27.31 72.85 122.01 -26.32 74.11 120.63 coo 59.16 37.82 13.95 57.63 37.03 15.12 -52.58 64.68 106.89 -53.21 62.78 107.37 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 12 3 # 12 199 ASP A 291 ASP.? 7.30 CL CL A 384 242 GLU A 169 GLU.? 11.07 CL CL A 382 329 ASP B 195 ASP.? 10.47 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -15.45 71.21 105.07 -17.40 71.77 105.62 coo 30.42 34.74 5.00 29.09 35.09 3.38 -27.31 72.85 122.01 -26.32 74.11 120.63 coo 59.16 37.82 13.95 57.63 37.03 15.12 -11.82 59.91 101.57 -11.61 61.10 99.82 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 13 3 # 13 199 ASP A 327 ASP.? 19.04 CL CL A 384 242 GLU A 307 GLU.? 18.04 CL CL B 382 329 ASP A 26 ASP^? 16.59 CL CL A 382 coo 49.16 35.16 15.19 51.08 34.43 15.65 -25.74 49.77 105.10 -27.34 48.80 104.08 coo 30.42 34.74 5.00 29.09 35.09 3.38 -31.95 61.22 87.08 -31.47 59.40 88.12 coo 59.16 37.82 13.95 57.63 37.03 15.12 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 14 3 # 14 199 ASP A 327 ASP.? 19.04 CL CL A 384 242 GLU B 23 GLU.? 22.91 CL CL B 382 329 ASP A 26 ASP^? 16.59 CL CL A 382 coo 49.16 35.16 15.19 51.08 34.43 15.65 -25.74 49.77 105.10 -27.34 48.80 104.08 coo 30.42 34.74 5.00 29.09 35.09 3.38 -35.83 43.78 85.87 -35.49 42.75 87.75 coo 59.16 37.82 13.95 57.63 37.03 15.12 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 15 3 # 15 199 ASP A 338 ASP.? 17.28 CL CL A 384 242 GLU A 169 GLU.? 11.07 CL CL A 382 329 ASP A 311 ASP^? 15.19 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -35.06 76.37 102.96 -33.50 77.52 103.78 coo 30.42 34.74 5.00 29.09 35.09 3.38 -27.31 72.85 122.01 -26.32 74.11 120.63 coo 59.16 37.82 13.95 57.63 37.03 15.12 -31.19 72.86 91.72 -29.44 73.97 92.12 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 16 3 # 16 199 ASP A 338 ASP.? 17.28 CL CL A 384 242 GLU A 307 GLU.? 18.04 CL CL B 382 329 ASP A 180 ASP.? 19.13 CL CL A 382 coo 49.16 35.16 15.19 51.08 34.43 15.65 -35.06 76.37 102.96 -33.50 77.52 103.78 coo 30.42 34.74 5.00 29.09 35.09 3.38 -31.95 61.22 87.08 -31.47 59.40 88.12 coo 59.16 37.82 13.95 57.63 37.03 15.12 -29.53 80.77 112.24 -28.62 82.54 111.55 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 17 3 # 17 199 ASP A 344 ASP.? 20.56 CL CL A 382 242 GLU A 149 GLU.? 9.19 CL CL A 383 329 ASP A 180 ASP.? 19.13 CL CL A 382 coo 49.16 35.16 15.19 51.08 34.43 15.65 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 30.42 34.74 5.00 29.09 35.09 3.38 -48.79 70.20 130.85 -48.75 71.87 129.52 coo 59.16 37.82 13.95 57.63 37.03 15.12 -29.53 80.77 112.24 -28.62 82.54 111.55 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 18 3 # 18 199 ASP B 26 ASP^? 16.51 CL CL B 383 242 GLU A 201 GLU.? 12.07 CL CL A 384 329 ASP B 30 ASP^? -6.72 CL CL B 383s coo 49.16 35.16 15.19 51.08 34.43 15.65 -23.45 39.33 83.60 -24.23 39.48 85.53 coo 30.42 34.74 5.00 29.09 35.09 3.38 -24.87 56.03 99.70 -24.21 54.93 101.40 coo 59.16 37.82 13.95 57.63 37.03 15.12 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 19 3 # 19 199 ASP B 26 ASP^? 16.51 CL CL B 383 242 GLU A 201 GLU.? 12.07 CL CL A 384 329 ASP B 36 ASP.? -3.35 CL CL B 383s coo 49.16 35.16 15.19 51.08 34.43 15.65 -23.45 39.33 83.60 -24.23 39.48 85.53 coo 30.42 34.74 5.00 29.09 35.09 3.38 -24.87 56.03 99.70 -24.21 54.93 101.40 coo 59.16 37.82 13.95 57.63 37.03 15.12 -15.98 38.04 75.83 -14.00 38.51 76.08 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 20 3 # 20 199 ASP B 26 ASP^? 16.51 CL CL B 383 242 GLU B 57 GLU.? 21.35 CL CL B 382 329 ASP B 327 ASP.? 22.34 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -23.45 39.33 83.60 -24.23 39.48 85.53 coo 30.42 34.74 5.00 29.09 35.09 3.38 -31.25 37.00 65.18 -31.15 36.75 63.13 coo 59.16 37.82 13.95 57.63 37.03 15.12 -25.62 46.25 93.54 -25.42 45.53 95.50 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 21 3 # 21 199 ASP B 26 ASP^? 16.51 CL CL B 383 242 GLU B 276 GLU~? 15.94 CL CL B 384 329 ASP B 327 ASP.? 22.34 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -23.45 39.33 83.60 -24.23 39.48 85.53 coo 30.42 34.74 5.00 29.09 35.09 3.38 -2.79 30.63 87.01 -2.36 28.59 86.68 coo 59.16 37.82 13.95 57.63 37.03 15.12 -25.62 46.25 93.54 -25.42 45.53 95.50 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 22 3 # 22 199 ASP B 30 ASP^? -6.72 CL CL B 383s 242 GLU B 149 GLU.? 9.91 CL CL B 384 329 ASP B 26 ASP^? 16.51 CL CL B 383 coo 49.16 35.16 15.19 51.08 34.43 15.65 -11.77 37.20 80.70 -10.35 36.55 82.15 coo 30.42 34.74 5.00 29.09 35.09 3.38 -6.14 20.54 69.48 -4.10 21.06 69.10 coo 59.16 37.82 13.95 57.63 37.03 15.12 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 23 3 # 23 199 ASP B 36 ASP.? -3.35 CL CL B 383s 242 GLU B 149 GLU.? 9.91 CL CL B 384 329 ASP B 26 ASP^? 16.51 CL CL B 383 coo 49.16 35.16 15.19 51.08 34.43 15.65 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 30.42 34.74 5.00 29.09 35.09 3.38 -6.14 20.54 69.48 -4.10 21.06 69.10 coo 59.16 37.82 13.95 57.63 37.03 15.12 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 24 3 # 24 199 ASP B 93 ASP^? 5.22 CL CL B 383 242 GLU B 276 GLU~? 15.94 CL CL B 384 329 ASP B 171 ASP.? 13.77 CL CL B 383 coo 49.16 35.16 15.19 51.08 34.43 15.65 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 30.42 34.74 5.00 29.09 35.09 3.38 -2.79 30.63 87.01 -2.36 28.59 86.68 coo 59.16 37.82 13.95 57.63 37.03 15.12 -14.88 46.75 66.62 -12.79 46.40 66.16 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 25 3 # 25 199 ASP B 195 ASP.? 10.47 CL CL A 384 242 GLU A 332 GLU^? 14.84 CL CL A 382 329 ASP B 305 ASP^? 21.59 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 30.42 34.74 5.00 29.09 35.09 3.38 -32.41 59.20 107.78 -33.78 57.91 108.78 coo 59.16 37.82 13.95 57.63 37.03 15.12 -6.28 49.81 99.79 -7.51 49.10 101.38 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 26 3 # 26 199 ASP B 195 ASP.? 10.47 CL CL A 384 242 GLU A 332 GLU^? 14.84 CL CL A 382 329 ASP B 306 ASP.? 19.57 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 30.42 34.74 5.00 29.09 35.09 3.38 -32.41 59.20 107.78 -33.78 57.91 108.78 coo 59.16 37.82 13.95 57.63 37.03 15.12 -4.64 54.84 103.01 -3.71 56.24 101.58 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 27 3 # 27 199 ASP B 327 ASP.? 22.34 CL CL A 384 242 GLU B 307 GLU.? 20.03 CL CL A 384 329 ASP B 26 ASP^? 16.51 CL CL B 383 coo 49.16 35.16 15.19 51.08 34.43 15.65 -25.62 46.25 93.54 -25.42 45.53 95.50 coo 30.42 34.74 5.00 29.09 35.09 3.38 -8.15 49.66 106.11 -10.31 49.68 106.12 coo 59.16 37.82 13.95 57.63 37.03 15.12 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 28 3 # 28 199 ASP B 338 ASP.? 19.77 CL CL B 383 242 GLU B 169 GLU.? 11.31 CL CL B 383 329 ASP B 311 ASP^? 24.66 CL CL A 384 coo 49.16 35.16 15.19 51.08 34.43 15.65 1.84 46.00 86.98 1.86 47.25 85.31 coo 30.42 34.74 5.00 29.09 35.09 3.38 -9.49 44.22 70.62 -8.22 45.44 69.57 coo 59.16 37.82 13.95 57.63 37.03 15.12 0.41 52.81 97.17 0.37 54.52 95.85 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 29 3 # 29 199 ASP B 338 ASP.? 19.77 CL CL B 383 242 GLU B 307 GLU.? 20.03 CL CL A 384 329 ASP B 180 ASP.? 19.08 CL CL B 383 coo 49.16 35.16 15.19 51.08 34.43 15.65 1.84 46.00 86.98 1.86 47.25 85.31 coo 30.42 34.74 5.00 29.09 35.09 3.38 -8.15 49.66 106.11 -10.31 49.68 106.12 coo 59.16 37.82 13.95 57.63 37.03 15.12 0.82 48.22 75.52 2.17 49.73 74.84 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 30 3 # 30 199 ASP B 344 ASP.? 20.04 CL CL B 383 242 GLU B 149 GLU.? 9.91 CL CL B 384 329 ASP B 180 ASP.? 19.08 CL CL B 383 coo 49.16 35.16 15.19 51.08 34.43 15.65 7.59 38.09 74.22 8.59 36.72 75.50 coo 30.42 34.74 5.00 29.09 35.09 3.38 -6.14 20.54 69.48 -4.10 21.06 69.10 coo 59.16 37.82 13.95 57.63 37.03 15.12 0.82 48.22 75.52 2.17 49.73 74.84 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 30 hits 1uok_c05 naa= 3 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 1 3 # 1 A 581 GLU A 86 GLU^? 27.08 CL CL A 382 A 596 ARG A 24 ARG^? 24.95 CL CL A 382 A 647 ARG A 325 ARG.? 29.26 CL CL A 384 coo 69.13 32.20 28.58 68.39 32.96 30.44 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 70.89 37.31 29.70 69.54 36.29 32.39 -27.53 46.21 115.11 -27.47 43.33 116.18 coo 66.09 40.54 34.70 66.92 37.69 35.49 -22.19 42.21 111.60 -22.86 39.29 112.51 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 2 3 # 2 A 581 GLU A 337 GLU^? 21.89 CL CL A 382 A 596 ARG A 274 ARG~? 23.93 CL CL A 382 A 647 ARG A 212 ARG.? 30.01 CL CL A 382 coo 69.13 32.20 28.58 68.39 32.96 30.44 -40.07 74.65 102.17 -42.10 75.18 101.81 coo 70.89 37.31 29.70 69.54 36.29 32.39 -45.43 76.09 104.31 -44.66 77.94 101.95 coo 66.09 40.54 34.70 66.92 37.69 35.49 -52.31 71.44 100.68 -54.00 71.15 98.10 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 3 3 # 3 A 581 GLU B 337 GLU^? 21.78 CL CL B 383 A 596 ARG B 274 ARG~? 23.83 CL CL B 383 A 647 ARG B 212 ARG.? 28.47 CL CL B 383 coo 69.13 32.20 28.58 68.39 32.96 30.44 2.60 41.45 89.80 4.03 40.00 90.41 coo 70.89 37.31 29.70 69.54 36.29 32.39 5.51 36.33 89.03 7.35 38.65 89.98 coo 66.09 40.54 34.70 66.92 37.69 35.49 3.61 30.30 95.57 4.45 30.88 98.48 1v0e_c00 source 1v0e ENDO-ALPHA-SIALIDASE : 3 hits 1v0e_c00 naa= 3 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 1 3 # 1 B 581 GLU A 86 GLU^? 27.08 CL CL A 382 B 596 ARG A 24 ARG^? 24.95 CL CL A 382 B 647 ARG A 325 ARG.? 29.26 CL CL A 384 coo 38.22 57.83 70.36 36.82 56.74 69.18 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 34.24 60.89 68.08 33.31 57.93 67.63 -27.53 46.21 115.11 -27.47 43.33 116.18 coo 31.43 57.38 61.97 31.90 55.58 64.41 -22.19 42.21 111.60 -22.86 39.29 112.51 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 2 3 # 2 B 581 GLU A 337 GLU^? 21.89 CL CL A 382 B 596 ARG A 274 ARG~? 23.93 CL CL A 382 B 647 ARG A 212 ARG.? 30.01 CL CL A 382 coo 38.22 57.83 70.36 36.82 56.74 69.18 -40.07 74.65 102.17 -42.10 75.18 101.81 coo 34.24 60.89 68.08 33.31 57.93 67.63 -45.43 76.09 104.31 -44.66 77.94 101.95 coo 31.43 57.38 61.97 31.90 55.58 64.41 -52.31 71.44 100.68 -54.00 71.15 98.10 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 3 3 # 3 B 581 GLU B 337 GLU^? 21.78 CL CL B 383 B 596 ARG B 274 ARG~? 23.83 CL CL B 383 B 647 ARG B 212 ARG.? 28.47 CL CL B 383 coo 38.22 57.83 70.36 36.82 56.74 69.18 2.60 41.45 89.80 4.03 40.00 90.41 coo 34.24 60.89 68.08 33.31 57.93 67.63 5.51 36.33 89.03 7.35 38.65 89.98 coo 31.43 57.38 61.97 31.90 55.58 64.41 3.61 30.30 95.57 4.45 30.88 98.48 1v0e_c01 source 1v0e ENDO-ALPHA-SIALIDASE : 3 hits 1v0e_c01 naa= 3 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 1 3 # 1 C 581 GLU A 86 GLU^? 27.08 CL CL A 382 C 596 ARG A 24 ARG^? 24.95 CL CL A 382 C 647 ARG A 325 ARG.? 29.26 CL CL A 384 coo 11.31 31.26 27.00 13.31 30.71 26.58 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 13.44 32.78 22.07 15.56 30.91 23.37 -27.53 46.21 115.11 -27.47 43.33 116.18 coo 21.00 33.35 22.82 19.83 30.82 24.09 -22.19 42.21 111.60 -22.86 39.29 112.51 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 2 3 # 2 C 581 GLU A 337 GLU^? 21.89 CL CL A 382 C 596 ARG A 274 ARG~? 23.93 CL CL A 382 C 647 ARG A 212 ARG.? 30.01 CL CL A 382 coo 11.31 31.26 27.00 13.31 30.71 26.58 -40.07 74.65 102.17 -42.10 75.18 101.81 coo 13.44 32.78 22.07 15.56 30.91 23.37 -45.43 76.09 104.31 -44.66 77.94 101.95 coo 21.00 33.35 22.82 19.83 30.82 24.09 -52.31 71.44 100.68 -54.00 71.15 98.10 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 3 3 # 3 C 581 GLU B 337 GLU^? 21.78 CL CL B 383 C 596 ARG B 274 ARG~? 23.83 CL CL B 383 C 647 ARG B 212 ARG.? 28.47 CL CL B 383 coo 11.31 31.26 27.00 13.31 30.71 26.58 2.60 41.45 89.80 4.03 40.00 90.41 coo 13.44 32.78 22.07 15.56 30.91 23.37 5.51 36.33 89.03 7.35 38.65 89.98 coo 21.00 33.35 22.82 19.83 30.82 24.09 3.61 30.30 95.57 4.45 30.88 98.48 1v0e_c02 source 1v0e ENDO-ALPHA-SIALIDASE : 3 hits 1v0e_c02 naa= 3 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 1 3 # 1 D 581 GLU A 86 GLU^? 27.08 CL CL A 382 D 596 ARG A 24 ARG^? 24.95 CL CL A 382 D 647 ARG A 325 ARG.? 29.26 CL CL A 384 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -25.92 41.43 120.29 -26.81 40.98 118.43 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -27.53 46.21 115.11 -27.47 43.33 116.18 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -22.19 42.21 111.60 -22.86 39.29 112.51 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 2 3 # 2 D 581 GLU A 337 GLU^? 21.89 CL CL A 382 D 596 ARG A 274 ARG~? 23.93 CL CL A 382 D 647 ARG A 212 ARG.? 30.01 CL CL A 382 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 -40.07 74.65 102.17 -42.10 75.18 101.81 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 -45.43 76.09 104.31 -44.66 77.94 101.95 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 -52.31 71.44 100.68 -54.00 71.15 98.10 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 3 3 # 3 D 581 GLU B 337 GLU^? 21.78 CL CL B 383 D 596 ARG B 274 ARG~? 23.83 CL CL B 383 D 647 ARG B 212 ARG.? 28.47 CL CL B 383 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 2.60 41.45 89.80 4.03 40.00 90.41 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 5.51 36.33 89.03 7.35 38.65 89.98 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 3.61 30.30 95.57 4.45 30.88 98.48 1v0e_c03 source 1v0e ENDO-ALPHA-SIALIDASE : 3 hits 1v0e_c03 naa= 3 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 1 3 # 1 E 581 GLU A 86 GLU^? 27.08 CL CL A 382 E 596 ARG A 24 ARG^? 24.95 CL CL A 382 E 647 ARG A 325 ARG.? 29.26 CL CL A 384 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 -27.53 46.21 115.11 -27.47 43.33 116.18 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 -22.19 42.21 111.60 -22.86 39.29 112.51 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 2 3 # 2 E 581 GLU B 337 GLU^? 21.78 CL CL B 383 E 596 ARG B 274 ARG~? 23.83 CL CL B 383 E 647 ARG B 212 ARG.? 28.47 CL CL B 383 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 2.60 41.45 89.80 4.03 40.00 90.41 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 5.51 36.33 89.03 7.35 38.65 89.98 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 3.61 30.30 95.57 4.45 30.88 98.48 1v0e_c04 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c04 naa= 3 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 1 3 # 1 F 581 GLU A 86 GLU^? 27.08 CL CL A 382 F 596 ARG A 24 ARG^? 24.95 CL CL A 382 F 647 ARG A 325 ARG.? 29.26 CL CL A 384 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 -25.92 41.43 120.29 -26.81 40.98 118.43 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 -27.53 46.21 115.11 -27.47 43.33 116.18 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 -22.19 42.21 111.60 -22.86 39.29 112.51 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 2 3 # 2 F 581 GLU B 337 GLU^? 21.78 CL CL B 383 F 596 ARG B 274 ARG~? 23.83 CL CL B 383 F 647 ARG B 212 ARG.? 28.47 CL CL B 383 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 2.60 41.45 89.80 4.03 40.00 90.41 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 5.51 36.33 89.03 7.35 38.65 89.98 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 3.61 30.30 95.57 4.45 30.88 98.48 1v0e_c05 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c05 naa= 3 ULMN 3 1vzx_c02 2.04.01.0087 user 1 3 # 1 A 314 TYR A 6 TYR.? 20.79 CL CL A 384 A 317 GLU B 307 GLU.? 20.03 CL CL A 384 A 365 ARG A 20 ARG.? 25.24 CL CL A 384 coo 1.77 6.56 57.05 3.05 7.44 59.37 -7.05 53.27 108.32 -4.25 53.35 108.15 coo 3.06 2.85 52.79 4.83 3.89 53.24 -8.15 49.66 106.11 -10.31 49.68 106.12 coo 3.82 17.09 49.56 4.09 14.32 50.84 -13.35 53.68 120.82 -11.33 55.30 122.50 ULMN 3 1vzx_c02 2.04.01.0087 user 2 3 # 2 A 314 TYR B 238 TYR^? 27.53 CL CL B 384 A 317 GLU B 215 GLU^? 32.93 CL CL B 384 A 365 ARG B 212 ARG.? 28.47 CL CL B 383 coo 1.77 6.56 57.05 3.05 7.44 59.37 12.27 28.31 87.43 11.42 30.17 89.32 coo 3.06 2.85 52.79 4.83 3.89 53.24 14.09 22.76 92.11 15.77 21.48 91.87 coo 3.82 17.09 49.56 4.09 14.32 50.84 3.61 30.30 95.57 4.45 30.88 98.48 ULMN 3 1vzx_c02 2.04.01.0087 user 3 3 # 3 A 314 TYR B 346 TYR.? 17.60 CL CL B 383 A 317 GLU B 135 GLU.? 23.43 CL CL B 383 A 365 ARG B 300 ARG^? 21.49 CL CL B 383 coo 1.77 6.56 57.05 3.05 7.44 59.37 3.94 45.97 72.94 1.71 46.24 71.30 coo 3.06 2.85 52.79 4.83 3.89 53.24 7.28 45.80 70.11 9.12 46.58 70.84 coo 3.82 17.09 49.56 4.09 14.32 50.84 0.10 48.73 83.03 1.88 51.20 83.58 1vzx_c02 source 1vzx 2.04.01.0087 : 3 hits 1vzx_c02 naa= 3 ULMN 3 1vzx_c03 2.04.01.0087 user 1 3 # 1 B1314 TYR A 6 TYR.? 20.79 CL CL A 384 B1317 GLU B 307 GLU.? 20.03 CL CL A 384 B1365 ARG A 20 ARG.? 25.24 CL CL A 384 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -7.05 53.27 108.32 -4.25 53.35 108.15 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -8.15 49.66 106.11 -10.31 49.68 106.12 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -13.35 53.68 120.82 -11.33 55.30 122.50 ULMN 3 1vzx_c03 2.04.01.0087 user 2 3 # 2 B1314 TYR B 238 TYR^? 27.53 CL CL B 384 B1317 GLU B 215 GLU^? 32.93 CL CL B 384 B1365 ARG B 212 ARG.? 28.47 CL CL B 383 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 12.27 28.31 87.43 11.42 30.17 89.32 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 14.09 22.76 92.11 15.77 21.48 91.87 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 3.61 30.30 95.57 4.45 30.88 98.48 ULMN 3 1vzx_c03 2.04.01.0087 user 3 3 # 3 B1314 TYR B 346 TYR.? 17.60 CL CL B 383 B1317 GLU B 135 GLU.? 23.43 CL CL B 383 B1365 ARG B 300 ARG^? 21.49 CL CL B 383 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 3.94 45.97 72.94 1.71 46.24 71.30 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 7.28 45.80 70.11 9.12 46.58 70.84 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 0.10 48.73 83.03 1.88 51.20 83.58 1vzx_c03 source 1vzx 2.04.01.0087 : 3 hits 1vzx_c03 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 238 TYR^? 27.75 CL CL A 383 A 40 ASP A 272 ASP~? 14.48 CL CL A 382 A 103 LEU A 270 LEU~? 23.55 CL CL A 383 coo 12.09 16.13 10.57 11.28 18.80 10.73 -54.82 80.30 106.22 -53.19 79.11 104.29 coo 7.55 25.51 14.34 9.65 25.73 14.24 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 11.83 18.73 16.99 10.99 19.71 15.26 -50.44 78.04 108.85 -52.50 78.70 108.33 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR B 238 TYR^? 27.53 CL CL B 384 A 40 ASP B 272 ASP~? 14.11 CL CL B 383 A 103 LEU B 270 LEU~? 23.21 CL CL B 383 coo 12.09 16.13 10.57 11.28 18.80 10.73 12.27 28.31 87.43 11.42 30.17 89.32 coo 7.55 25.51 14.34 9.65 25.73 14.24 0.88 31.47 82.51 1.09 32.47 80.67 coo 11.83 18.73 16.99 10.99 19.71 15.26 7.84 30.73 84.95 9.38 29.37 85.70 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 2 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 238 TYR^? 27.75 CL CL A 383 B 40 ASP A 272 ASP~? 14.48 CL CL A 382 B 103 LEU A 270 LEU~? 23.55 CL CL A 383 coo 14.25 20.09 37.35 13.48 17.40 37.38 -54.82 80.30 106.22 -53.19 79.11 104.29 coo 9.39 10.77 34.53 11.50 10.63 34.41 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 12.89 17.60 31.13 12.34 16.51 32.90 -50.44 78.04 108.85 -52.50 78.70 108.33 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR B 238 TYR^? 27.53 CL CL B 384 B 40 ASP B 272 ASP~? 14.11 CL CL B 383 B 103 LEU B 270 LEU~? 23.21 CL CL B 383 coo 14.25 20.09 37.35 13.48 17.40 37.38 12.27 28.31 87.43 11.42 30.17 89.32 coo 9.39 10.77 34.53 11.50 10.63 34.41 0.88 31.47 82.51 1.09 32.47 80.67 coo 12.89 17.60 31.13 12.34 16.51 32.90 7.84 30.73 84.95 9.38 29.37 85.70 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 2 hits 1vzz_c01 naa= 3 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 1 3 # 1 A 105 HIS A 165 HIS^? 7.64 CL CL A 382 A 169 ASP A 344 ASP.? 20.56 CL CL A 382 A 288 GLU A 135 GLU.? 22.99 CL CL A 382 coo 67.72 35.99 30.87 69.77 36.13 31.33 -39.19 73.43 119.40 -40.10 71.56 119.72 coo 73.17 30.66 22.56 72.87 30.30 20.46 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 74.06 28.51 15.92 73.77 29.56 17.73 -31.98 87.75 115.72 -30.11 88.72 115.32 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 2 3 # 2 A 105 HIS A 302 HIS^? 11.51 CL CL A 384 A 169 ASP A 305 ASP^? 16.01 CL CL A 384 A 288 GLU A 307 GLU.? 18.04 CL CL B 382 coo 67.72 35.99 30.87 69.77 36.13 31.33 -27.17 73.50 97.06 -27.34 73.92 95.02 coo 73.17 30.66 22.56 72.87 30.30 20.46 -32.01 65.22 92.45 -32.49 63.34 91.63 coo 74.06 28.51 15.92 73.77 29.56 17.73 -31.95 61.22 87.08 -31.47 59.40 88.12 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 3 3 # 3 A 105 HIS A 302 HIS^? 11.51 CL CL A 384 A 169 ASP A 306 ASP.? 16.66 CL CL A 384 A 288 GLU A 307 GLU.? 18.04 CL CL B 382 coo 67.72 35.99 30.87 69.77 36.13 31.33 -27.17 73.50 97.06 -27.34 73.92 95.02 coo 73.17 30.66 22.56 72.87 30.30 20.46 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 74.06 28.51 15.92 73.77 29.56 17.73 -31.95 61.22 87.08 -31.47 59.40 88.12 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 4 3 # 4 A 105 HIS A 308 HIS.? 20.06 CL CL A 384 A 169 ASP A 204 ASP^? 18.76 CL CL A 384 A 288 GLU A 332 GLU^? 14.84 CL CL A 382 coo 67.72 35.99 30.87 69.77 36.13 31.33 -37.01 64.37 91.64 -38.79 63.83 92.62 coo 73.17 30.66 22.56 72.87 30.30 20.46 -37.06 58.40 100.88 -36.30 56.45 100.53 coo 74.06 28.51 15.92 73.77 29.56 17.73 -32.41 59.20 107.78 -33.78 57.91 108.78 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 5 3 # 5 A 105 HIS B 165 HIS^? 7.69 CL CL B 383 A 169 ASP B 344 ASP.? 20.04 CL CL B 383 A 288 GLU B 135 GLU.? 23.43 CL CL B 383 coo 67.72 35.99 30.87 69.77 36.13 31.33 -3.45 34.55 75.15 -4.91 33.27 75.93 coo 73.17 30.66 22.56 72.87 30.30 20.46 7.59 38.09 74.22 8.59 36.72 75.50 coo 74.06 28.51 15.92 73.77 29.56 17.73 7.28 45.80 70.11 9.12 46.58 70.84 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 6 3 # 6 A 105 HIS B 302 HIS^? 23.99 CL CL A 384 A 169 ASP B 305 ASP^? 21.59 CL CL A 384 A 288 GLU B 307 GLU.? 20.03 CL CL A 384 coo 67.72 35.99 30.87 69.77 36.13 31.33 -2.27 54.46 91.30 -1.20 55.23 92.93 coo 73.17 30.66 22.56 72.87 30.30 20.46 -6.28 49.81 99.79 -7.51 49.10 101.38 coo 74.06 28.51 15.92 73.77 29.56 17.73 -8.15 49.66 106.11 -10.31 49.68 106.12 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 7 3 # 7 A 105 HIS B 302 HIS^? 23.99 CL CL A 384 A 169 ASP B 306 ASP.? 19.57 CL CL A 384 A 288 GLU B 307 GLU.? 20.03 CL CL A 384 coo 67.72 35.99 30.87 69.77 36.13 31.33 -2.27 54.46 91.30 -1.20 55.23 92.93 coo 73.17 30.66 22.56 72.87 30.30 20.46 -4.64 54.84 103.01 -3.71 56.24 101.58 coo 74.06 28.51 15.92 73.77 29.56 17.73 -8.15 49.66 106.11 -10.31 49.68 106.12 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 8 3 # 8 A 105 HIS B 308 HIS.? 26.99 CL CL A 384 A 169 ASP B 204 ASP^? 22.18 CL CL B 383 A 288 GLU B 332 GLU^? 14.76 CL CL B 383 coo 67.72 35.99 30.87 69.77 36.13 31.33 -5.09 45.35 102.63 -4.80 43.27 102.76 coo 73.17 30.66 22.56 72.87 30.30 20.46 -12.38 39.84 96.49 -14.33 39.98 97.22 coo 74.06 28.51 15.92 73.77 29.56 17.73 -15.56 41.56 89.17 -16.27 39.59 89.11 1w1o_c00 source 1w1o CYTOKININ DEHYDROGENASE 1 : 8 hits 1w1o_c00 naa= 3 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 183 GLY A 141 GLY.? 21.64 CL CL A 383 B 419 GLY A 110 GLY.? 23.75 CL CL A 383 B 420 ALA A 139 ALA.? 25.02 CL CL A 383 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -47.00 86.61 128.15 -46.60 85.98 128.53 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -42.92 88.53 131.83 -42.63 88.59 132.69 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -40.71 88.88 128.05 -41.16 90.27 128.57 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 183 GLY A 177 GLY^? 12.19 CL CL A 382 B 419 GLY A 178 GLY.? 12.46 CL CL A 382 B 420 ALA A 179 ALA.? 13.90 CL CL A 382 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -34.43 78.99 120.11 -35.00 78.45 120.07 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -35.00 78.54 116.42 -34.19 78.65 116.55 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -33.44 78.17 113.04 -34.16 77.56 111.82 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 3 3 # 3 A 183 GLY A 177 GLY^? 12.19 CL CL A 382 B 419 GLY A 178 GLY.? 12.46 CL CL A 382 B 420 ALA A 345 ALA.? 15.79 CL CL A 382 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -34.43 78.99 120.11 -35.00 78.45 120.07 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -35.00 78.54 116.42 -34.19 78.65 116.55 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -35.83 83.37 115.92 -35.32 81.91 116.06 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 4 3 # 4 A 183 GLY A 178 GLY.? 12.46 CL CL A 382 B 419 GLY A 177 GLY^? 12.19 CL CL A 382 B 420 ALA A 134 ALA.? 16.76 CL CL A 382 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -35.00 78.54 116.42 -34.19 78.65 116.55 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -34.43 78.99 120.11 -35.00 78.45 120.07 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -32.59 83.69 119.08 -33.95 83.53 119.76 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 5 3 # 5 A 183 GLY B 177 GLY^? 12.21 CL CL B 383 B 419 GLY B 178 GLY.? 12.55 CL CL B 383 B 420 ALA B 179 ALA.? 13.78 CL CL B 383 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -0.75 40.04 70.93 -0.92 39.38 71.34 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 0.20 40.92 74.47 -0.03 41.61 74.05 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 0.07 43.70 77.00 0.03 43.44 78.44 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 6 3 # 6 A 183 GLY B 177 GLY^? 12.21 CL CL B 383 B 419 GLY B 178 GLY.? 12.55 CL CL B 383 B 420 ALA B 345 ALA.? 15.71 CL CL B 383 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -0.75 40.04 70.93 -0.92 39.38 71.34 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 0.20 40.92 74.47 -0.03 41.61 74.05 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 4.64 41.37 73.03 3.24 41.54 73.45 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 7 3 # 7 A 183 GLY B 178 GLY.? 12.55 CL CL B 383 B 419 GLY B 177 GLY^? 12.21 CL CL B 383 B 420 ALA B 134 ALA.? 16.91 CL CL B 383 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 0.20 40.92 74.47 -0.03 41.61 74.05 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -0.75 40.04 70.93 -0.92 39.38 71.34 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 2.93 43.20 69.35 3.38 41.77 69.44 1xny_c00 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 7 hits 1xny_c00 naa= 3 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 420 ALA A 159 ALA~? 12.04 CL CL A 382 B 182 GLY A 178 GLY.? 12.46 CL CL A 382 B 183 GLY A 177 GLY^? 12.19 CL CL A 382 coo 38.36-101.47-135.52 39.62-101.29-136.35 -40.97 78.44 123.91 -40.05 77.14 123.62 coo 41.93-102.35-126.87 41.52-101.89-126.30 -35.00 78.54 116.42 -34.19 78.65 116.55 coo 38.37-101.99-128.11 38.63-102.24-127.37 -34.43 78.99 120.11 -35.00 78.45 120.07 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 420 ALA B 159 ALA~? 12.15 CL CL B 383 B 182 GLY B 178 GLY.? 12.55 CL CL B 383 B 183 GLY B 177 GLY^? 12.21 CL CL B 383 coo 38.36-101.47-135.52 39.62-101.29-136.35 0.19 32.47 69.55 -1.13 33.12 70.03 coo 41.93-102.35-126.87 41.52-101.89-126.30 0.20 40.92 74.47 -0.03 41.61 74.05 coo 38.37-101.99-128.11 38.63-102.24-127.37 -0.75 40.04 70.93 -0.92 39.38 71.34 1xny_c01 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 2 hits 1xny_c01 naa= 3 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 1 3 # 1 B 137 GLY A 43 GLY.? 28.96 CL CL A 382 B 175 ARG A 24 ARG^? 24.95 CL CL A 382 B 242 TYR A 25 TYR^? 18.63 CL CL A 382 coo 99.45 58.28 3.33 99.57 58.61 4.10 -21.75 40.92 119.11 -20.99 41.17 119.03 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -27.53 46.21 115.11 -27.47 43.33 116.18 coo 100.93 69.04 4.38 99.52 68.48 2.09 -23.49 53.13 116.11 -21.60 54.30 114.36 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 2 3 # 2 B 137 GLY A 285 GLY^? 9.46 CL CL A 384 B 175 ARG B 193 ARG.? 19.02 CL CL A 384 B 242 TYR A 8 TYR.? 12.26 CL CL A 384 coo 99.45 58.28 3.33 99.57 58.61 4.10 -22.09 57.26 103.59 -22.19 58.16 103.73 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -14.12 50.83 106.82 -12.70 50.89 109.57 coo 100.93 69.04 4.38 99.52 68.48 2.09 -16.53 57.80 111.57 -17.14 59.34 109.36 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 3 3 # 3 B 137 GLY A 298 GLY.? 11.45 CL CL A 382 B 175 ARG A 300 ARG^? 15.75 CL CL A 384 B 242 TYR A 346 TYR.? 17.61 CL CL A 382 coo 99.45 58.28 3.33 99.57 58.61 4.10 -29.84 73.06 112.32 -29.55 72.57 111.73 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -30.16 77.29 106.40 -29.79 78.90 103.79 coo 100.93 69.04 4.38 99.52 68.48 2.09 -31.44 83.83 114.39 -30.05 82.53 116.45 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 4 3 # 4 B 137 GLY A 328 GLY^? 17.20 CL CL A 384 B 175 ARG A 24 ARG^? 24.95 CL CL A 382 B 242 TYR A 25 TYR^? 18.63 CL CL A 382 coo 99.45 58.28 3.33 99.57 58.61 4.10 -21.48 50.12 107.21 -22.25 50.36 107.20 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -27.53 46.21 115.11 -27.47 43.33 116.18 coo 100.93 69.04 4.38 99.52 68.48 2.09 -23.49 53.13 116.11 -21.60 54.30 114.36 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 5 3 # 5 B 137 GLY A 328 GLY^? 17.20 CL CL A 384 B 175 ARG B 193 ARG.? 19.02 CL CL A 384 B 242 TYR A 8 TYR.? 12.26 CL CL A 384 coo 99.45 58.28 3.33 99.57 58.61 4.10 -21.48 50.12 107.21 -22.25 50.36 107.20 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -14.12 50.83 106.82 -12.70 50.89 109.57 coo 100.93 69.04 4.38 99.52 68.48 2.09 -16.53 57.80 111.57 -17.14 59.34 109.36 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 6 3 # 6 B 137 GLY A 339 GLY.? 19.32 CL CL A 382 B 175 ARG A 300 ARG^? 15.75 CL CL A 384 B 242 TYR A 346 TYR.? 17.61 CL CL A 382 coo 99.45 58.28 3.33 99.57 58.61 4.10 -37.15 79.07 105.90 -37.54 78.40 106.05 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -30.16 77.29 106.40 -29.79 78.90 103.79 coo 100.93 69.04 4.38 99.52 68.48 2.09 -31.44 83.83 114.39 -30.05 82.53 116.45 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 7 3 # 7 B 137 GLY B 328 GLY^? 19.77 CL CL B 382 B 175 ARG A 193 ARG.? 15.01 CL CL B 382 B 242 TYR B 8 TYR.? 11.88 CL CL B 382 coo 99.45 58.28 3.33 99.57 58.61 4.10 -27.69 48.95 90.13 -27.15 48.30 90.26 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -30.19 56.43 87.97 -31.59 55.92 85.25 coo 100.93 69.04 4.38 99.52 68.48 2.09 -23.96 53.72 82.39 -21.76 54.53 83.93 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 8 3 # 8 B 137 GLY B 328 GLY^? 19.77 CL CL B 382 B 175 ARG B 24 ARG^? 24.13 CL CL B 382 B 242 TYR B 25 TYR^? 14.27 CL CL B 382 coo 99.45 58.28 3.33 99.57 58.61 4.10 -27.69 48.95 90.13 -27.15 48.30 90.26 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -30.86 40.03 86.77 -33.42 38.25 86.47 coo 100.93 69.04 4.38 99.52 68.48 2.09 -26.62 44.42 81.68 -25.97 47.00 82.31 1xva_c03 source 1xva GLYCINE N-METHYLTRANSFERASE : 8 hits 1xva_c03 naa= 3 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 80 LYS^? 36.93 CL CL A 382 A 74 LYS A 82 LYS.? 41.47 CL CL A 382 A 165 GLU A 23 GLU.? 27.24 CL CL A 382 coo 18.28 7.83 36.39 22.82 8.75 39.52 -26.02 34.53 124.81 -22.64 33.14 129.86 coo 14.16 13.09 37.03 20.00 12.44 37.49 -24.27 28.84 121.34 -24.33 26.99 125.88 coo 22.22 16.06 48.76 23.94 15.33 49.78 -22.84 44.28 116.17 -23.55 42.53 115.22 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 82 LYS.? 41.47 CL CL A 382 A 74 LYS A 80 LYS^? 36.93 CL CL A 382 A 165 GLU A 23 GLU.? 27.24 CL CL A 382 coo 18.28 7.83 36.39 22.82 8.75 39.52 -24.27 28.84 121.34 -24.33 26.99 125.88 coo 14.16 13.09 37.03 20.00 12.44 37.49 -26.02 34.53 124.81 -22.64 33.14 129.86 coo 22.22 16.06 48.76 23.94 15.33 49.78 -22.84 44.28 116.17 -23.55 42.53 115.22 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS A 109 LYS.? 23.73 CL CL A 383 A 74 LYS A 142 LYS.? 24.15 CL CL A 383 A 165 GLU A 149 GLU.? 9.19 CL CL A 383 coo 18.28 7.83 36.39 22.82 8.75 39.52 -45.10 86.58 132.81 -50.69 86.17 134.93 coo 14.16 13.09 37.03 20.00 12.44 37.49 -49.53 84.63 130.17 -55.13 85.19 133.14 coo 22.22 16.06 48.76 23.94 15.33 49.78 -48.79 70.20 130.85 -48.75 71.87 129.52 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS B 82 LYS.? 37.97 CL CL B 382 A 74 LYS B 80 LYS^? 31.45 CL CL B 382 A 165 GLU B 23 GLU.? 22.91 CL CL B 382 coo 18.28 7.83 36.39 22.82 8.75 39.52 -48.91 34.74 87.29 -47.83 32.98 92.37 coo 14.16 13.09 37.03 20.00 12.44 37.49 -43.65 33.60 82.90 -47.69 34.28 78.00 coo 22.22 16.06 48.76 23.94 15.33 49.78 -35.83 43.78 85.87 -35.49 42.75 87.75 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS B 268 LYS~? 13.29 CL CL B 383 A 74 LYS B 264 LYS~? 21.76 CL CL B 383 A 165 GLU B 135 GLU.? 23.43 CL CL B 383 coo 18.28 7.83 36.39 22.82 8.75 39.52 5.99 32.14 79.72 1.11 32.64 77.72 coo 14.16 13.09 37.03 20.00 12.44 37.49 11.01 31.36 75.69 9.79 34.42 71.26 coo 22.22 16.06 48.76 23.94 15.33 49.78 7.28 45.80 70.11 9.12 46.58 70.84 1ylu_c00 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 5 hits 1ylu_c00 naa= 3 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 80 LYS^? 36.93 CL CL A 382 B 74 LYS A 82 LYS.? 41.47 CL CL A 382 B 165 GLU A 23 GLU.? 27.24 CL CL A 382 coo 13.51 0.92 76.10 12.98 6.13 74.68 -26.02 34.53 124.81 -22.64 33.14 129.86 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -24.27 28.84 121.34 -24.33 26.99 125.88 coo 21.39 11.56 68.52 20.24 13.13 67.73 -22.84 44.28 116.17 -23.55 42.53 115.22 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 82 LYS.? 41.47 CL CL A 382 B 74 LYS A 80 LYS^? 36.93 CL CL A 382 B 165 GLU A 23 GLU.? 27.24 CL CL A 382 coo 13.51 0.92 76.10 12.98 6.13 74.68 -24.27 28.84 121.34 -24.33 26.99 125.88 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -26.02 34.53 124.81 -22.64 33.14 129.86 coo 21.39 11.56 68.52 20.24 13.13 67.73 -22.84 44.28 116.17 -23.55 42.53 115.22 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS A 109 LYS.? 23.73 CL CL A 383 B 74 LYS A 142 LYS.? 24.15 CL CL A 383 B 165 GLU A 149 GLU.? 9.19 CL CL A 383 coo 13.51 0.92 76.10 12.98 6.13 74.68 -45.10 86.58 132.81 -50.69 86.17 134.93 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -49.53 84.63 130.17 -55.13 85.19 133.14 coo 21.39 11.56 68.52 20.24 13.13 67.73 -48.79 70.20 130.85 -48.75 71.87 129.52 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS B 82 LYS.? 37.97 CL CL B 382 B 74 LYS B 80 LYS^? 31.45 CL CL B 382 B 165 GLU B 23 GLU.? 22.91 CL CL B 382 coo 13.51 0.92 76.10 12.98 6.13 74.68 -48.91 34.74 87.29 -47.83 32.98 92.37 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -43.65 33.60 82.90 -47.69 34.28 78.00 coo 21.39 11.56 68.52 20.24 13.13 67.73 -35.83 43.78 85.87 -35.49 42.75 87.75 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 B 14 LYS B 109 LYS.? 27.05 CL CL B 384 B 74 LYS B 142 LYS.? 25.17 CL CL B 384 B 165 GLU B 149 GLU.? 9.91 CL CL B 384 coo 13.51 0.92 76.10 12.98 6.13 74.68 5.83 26.41 59.87 10.67 23.27 57.97 coo 19.89 -0.55 76.51 17.10 4.32 77.43 6.28 23.32 63.35 7.97 19.73 58.68 coo 21.39 11.56 68.52 20.24 13.13 67.73 -6.14 20.54 69.48 -4.10 21.06 69.10 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 B 14 LYS B 142 LYS.? 25.17 CL CL B 384 B 74 LYS B 109 LYS.? 27.05 CL CL B 384 B 165 GLU B 149 GLU.? 9.91 CL CL B 384 coo 13.51 0.92 76.10 12.98 6.13 74.68 6.28 23.32 63.35 7.97 19.73 58.68 coo 19.89 -0.55 76.51 17.10 4.32 77.43 5.83 26.41 59.87 10.67 23.27 57.97 coo 21.39 11.56 68.52 20.24 13.13 67.73 -6.14 20.54 69.48 -4.10 21.06 69.10 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 B 14 LYS B 268 LYS~? 13.29 CL CL B 383 B 74 LYS B 264 LYS~? 21.76 CL CL B 383 B 165 GLU B 135 GLU.? 23.43 CL CL B 383 coo 13.51 0.92 76.10 12.98 6.13 74.68 5.99 32.14 79.72 1.11 32.64 77.72 coo 19.89 -0.55 76.51 17.10 4.32 77.43 11.01 31.36 75.69 9.79 34.42 71.26 coo 21.39 11.56 68.52 20.24 13.13 67.73 7.28 45.80 70.11 9.12 46.58 70.84 1ylu_c01 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 7 hits 1ylu_c01 naa= 3 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP A 171 ASP.? 13.95 CL CL A 382 A 371 LYS A 128 LYS.? 19.46 CL CL A 382 A 407 THR A 173 THR.? 13.13 CL CL A 382 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -21.72 70.05 125.28 -22.57 71.99 125.28 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -25.12 72.76 133.10 -20.68 68.32 134.09 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -26.89 72.55 127.11 -25.69 74.31 126.61 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 2 3 # 2 A 369 ASP B 171 ASP.? 13.77 CL CL B 383 A 371 LYS B 128 LYS.? 19.37 CL CL B 383 A 407 THR B 173 THR.? 13.07 CL CL B 383 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -14.88 46.75 66.62 -12.79 46.40 66.16 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -13.49 41.25 59.55 -18.50 40.98 58.08 coo -8.38 36.02 19.06 -8.83 34.10 19.89 -11.33 42.23 65.51 -10.11 43.97 64.96 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 3 3 # 3 A 369 ASP B 272 ASP~? 14.11 CL CL B 383 A 371 LYS B 268 LYS~? 13.29 CL CL B 383 A 407 THR B 342 THR.? 12.70 CL CL B 383 coo -5.17 31.09 15.73 -7.07 31.12 16.73 0.88 31.47 82.51 1.09 32.47 80.67 coo -4.43 30.92 22.89 -6.61 31.91 19.71 5.99 32.14 79.72 1.11 32.64 77.72 coo -8.38 36.02 19.06 -8.83 34.10 19.89 2.93 38.40 77.77 1.00 38.51 76.85 ULMN 3 1zrz_c02 PROTEIN KINASE C, IOTA user 4 3 # 4 A 369 ASP B 344 ASP.? 20.04 CL CL B 383 A 371 LYS B 268 LYS~? 13.29 CL CL B 383 A 407 THR B 342 THR.? 12.70 CL CL B 383 coo -5.17 31.09 15.73 -7.07 31.12 16.73 7.59 38.09 74.22 8.59 36.72 75.50 coo -4.43 30.92 22.89 -6.61 31.91 19.71 5.99 32.14 79.72 1.11 32.64 77.72 coo -8.38 36.02 19.06 -8.83 34.10 19.89 2.93 38.40 77.77 1.00 38.51 76.85 1zrz_c02 source 1zrz PROTEIN KINASE C, IOTA : 4 hits 1zrz_c02 naa= 3 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 1 3 # 1 142 TRP A 124 TRP.? 13.06 CL CL A 383 223 ASP A 100 ASP~? 8.92 CL CL A 383 258 ALA A 154 ALA~? 9.30 CL CL A 383 coo 128.40 33.01 26.67 128.12 36.28 28.81 -33.14 66.39 136.47 -36.57 68.26 136.24 coo 127.91 41.73 23.55 129.18 40.35 24.44 -39.25 61.23 132.92 -38.42 59.82 131.54 coo 141.00 37.49 25.74 139.80 37.53 24.78 -44.22 73.23 129.68 -43.96 73.28 131.23 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 2 3 # 2 142 TRP A 152 TRP~? 5.72 CL CL A 383 223 ASP A 93 ASP^? 5.15 CL CL A 382 258 ALA A 121 ALA~? 14.04 CL CL A 382 coo 128.40 33.01 26.67 128.12 36.28 28.81 -40.45 68.27 125.25 -36.75 69.50 125.42 coo 127.91 41.73 23.55 129.18 40.35 24.44 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 141.00 37.49 25.74 139.80 37.53 24.78 -34.13 73.19 134.02 -33.25 73.56 132.86 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 3 3 # 3 142 TRP A 152 TRP~? 5.72 CL CL A 383 223 ASP A 100 ASP~? 8.92 CL CL A 383 258 ALA A 121 ALA~? 14.04 CL CL A 382 coo 128.40 33.01 26.67 128.12 36.28 28.81 -40.45 68.27 125.25 -36.75 69.50 125.42 coo 127.91 41.73 23.55 129.18 40.35 24.44 -39.25 61.23 132.92 -38.42 59.82 131.54 coo 141.00 37.49 25.74 139.80 37.53 24.78 -34.13 73.19 134.02 -33.25 73.56 132.86 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 4 3 # 4 142 TRP A 167 TRP^? 7.35 CL CL A 382 223 ASP A 93 ASP^? 5.15 CL CL A 382 258 ALA A 121 ALA~? 14.04 CL CL A 382 coo 128.40 33.01 26.67 128.12 36.28 28.81 -31.10 71.99 120.30 -32.79 75.13 118.77 coo 127.91 41.73 23.55 129.18 40.35 24.44 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 141.00 37.49 25.74 139.80 37.53 24.78 -34.13 73.19 134.02 -33.25 73.56 132.86 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 5 3 # 5 142 TRP A 167 TRP^? 7.35 CL CL A 382 223 ASP A 93 ASP^? 5.15 CL CL A 382 258 ALA A 129 ALA.? 16.38 CL CL A 382 coo 128.40 33.01 26.67 128.12 36.28 28.81 -31.10 71.99 120.30 -32.79 75.13 118.77 coo 127.91 41.73 23.55 129.18 40.35 24.44 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 141.00 37.49 25.74 139.80 37.53 24.78 -26.10 75.72 130.84 -24.98 76.19 129.93 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 6 3 # 6 142 TRP A 167 TRP^? 7.35 CL CL A 382 223 ASP A 171 ASP.? 13.95 CL CL A 382 258 ALA A 121 ALA~? 14.04 CL CL A 382 coo 128.40 33.01 26.67 128.12 36.28 28.81 -31.10 71.99 120.30 -32.79 75.13 118.77 coo 127.91 41.73 23.55 129.18 40.35 24.44 -21.72 70.05 125.28 -22.57 71.99 125.28 coo 141.00 37.49 25.74 139.80 37.53 24.78 -34.13 73.19 134.02 -33.25 73.56 132.86 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 7 3 # 7 142 TRP A 207 TRP^? 23.82 CL CL A 384 223 ASP A 208 ASP.? 21.85 CL CL A 382 258 ALA A 271 ALA~? 18.46 CL CL A 382 coo 128.40 33.01 26.67 128.12 36.28 28.81 -44.76 66.72 97.91 -42.73 64.04 95.92 coo 127.91 41.73 23.55 129.18 40.35 24.44 -48.25 63.81 104.00 -49.74 63.21 105.24 coo 141.00 37.49 25.74 139.80 37.53 24.78 -46.19 76.51 109.39 -45.19 77.53 109.91 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 8 3 # 8 142 TRP A 341 TRP.? 10.34 CL CL A 382 223 ASP A 344 ASP.? 20.56 CL CL A 382 258 ALA A 266 ALA~? 23.08 CL CL A 383 coo 128.40 33.01 26.67 128.12 36.28 28.81 -39.95 74.25 113.33 -36.58 74.16 115.41 coo 127.91 41.73 23.55 129.18 40.35 24.44 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 141.00 37.49 25.74 139.80 37.53 24.78 -52.27 80.65 114.02 -53.41 81.50 113.45 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 9 3 # 9 142 TRP B 124 TRP.? 13.18 CL CL B 384 223 ASP B 100 ASP~? 8.80 CL CL B 384 258 ALA B 154 ALA~? 9.41 CL CL B 384 coo 128.40 33.01 26.67 128.12 36.28 28.81 -17.12 31.02 61.48 -14.06 28.59 61.85 coo 127.91 41.73 23.55 129.18 40.35 24.44 -18.20 25.71 68.46 -19.22 26.77 70.02 coo 141.00 37.49 25.74 139.80 37.53 24.78 -4.85 25.78 67.69 -5.32 25.38 66.32 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 10 3 # 10 142 TRP B 152 TRP~? 5.87 CL CL B 384 223 ASP B 93 ASP^? 5.22 CL CL B 383 258 ALA B 121 ALA~? 14.04 CL CL B 383 coo 128.40 33.01 26.67 128.12 36.28 28.81 -9.27 29.84 72.50 -9.68 33.36 70.78 coo 127.91 41.73 23.55 129.18 40.35 24.44 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 141.00 37.49 25.74 139.80 37.53 24.78 -10.03 32.78 61.15 -9.75 34.17 61.77 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 11 3 # 11 142 TRP B 152 TRP~? 5.87 CL CL B 384 223 ASP B 100 ASP~? 8.80 CL CL B 384 258 ALA B 121 ALA~? 14.04 CL CL B 383 coo 128.40 33.01 26.67 128.12 36.28 28.81 -9.27 29.84 72.50 -9.68 33.36 70.78 coo 127.91 41.73 23.55 129.18 40.35 24.44 -18.20 25.71 68.46 -19.22 26.77 70.02 coo 141.00 37.49 25.74 139.80 37.53 24.78 -10.03 32.78 61.15 -9.75 34.17 61.77 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 12 3 # 12 142 TRP B 167 TRP^? 7.30 CL CL B 383 223 ASP B 93 ASP^? 5.22 CL CL B 383 258 ALA B 121 ALA~? 14.04 CL CL B 383 coo 128.40 33.01 26.67 128.12 36.28 28.81 -8.26 40.92 72.83 -4.37 40.96 73.30 coo 127.91 41.73 23.55 129.18 40.35 24.44 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 141.00 37.49 25.74 139.80 37.53 24.78 -10.03 32.78 61.15 -9.75 34.17 61.77 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 13 3 # 13 142 TRP B 167 TRP^? 7.30 CL CL B 383 223 ASP B 93 ASP^? 5.22 CL CL B 383 258 ALA B 129 ALA.? 16.15 CL CL B 383 coo 128.40 33.01 26.67 128.12 36.28 28.81 -8.26 40.92 72.83 -4.37 40.96 73.30 coo 127.91 41.73 23.55 129.18 40.35 24.44 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 141.00 37.49 25.74 139.80 37.53 24.78 -10.00 42.14 60.76 -9.74 43.56 61.15 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 14 3 # 14 142 TRP B 167 TRP^? 7.30 CL CL B 383 223 ASP B 171 ASP.? 13.77 CL CL B 383 258 ALA B 121 ALA~? 14.04 CL CL B 383 coo 128.40 33.01 26.67 128.12 36.28 28.81 -8.26 40.92 72.83 -4.37 40.96 73.30 coo 127.91 41.73 23.55 129.18 40.35 24.44 -14.88 46.75 66.62 -12.79 46.40 66.16 coo 141.00 37.49 25.74 139.80 37.53 24.78 -10.03 32.78 61.15 -9.75 34.17 61.77 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 15 3 # 15 142 TRP B 207 TRP^? 25.29 CL CL B 383 223 ASP B 208 ASP.? 21.56 CL CL B 383 258 ALA B 271 ALA~? 18.20 CL CL B 383 coo 128.40 33.01 26.67 128.12 36.28 28.81 -1.19 37.06 97.92 -3.78 38.84 100.32 coo 127.91 41.73 23.55 129.18 40.35 24.44 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 141.00 37.49 25.74 139.80 37.53 24.78 4.76 33.88 84.20 5.07 34.78 82.98 2aat_c01 source 2aat ASPARTATE AMINOTRANSFERASE (E.C.2.6.1.1) MUTAN: 15 hits 2aat_c01 naa= 3 ULMN 3 2acu_c01 ALDOSE REDUCTASE (E.C.1.1.1.21) MUTAuser 1 3 # 1 A 43 ASP A 233 ASP.? 30.79 CL CL A 383 A 48 HIS A 232 HIS.? 26.22 CL CL A 383 A 77 LYS A 235 LYS^? 33.41 CL CL A 383 coo 13.04 30.41 72.50 12.95 30.65 70.36 -64.45 88.75 121.31 -62.88 88.68 122.75 coo 12.77 23.50 68.33 13.58 25.42 68.49 -64.09 81.45 120.95 -63.65 79.66 121.95 coo 7.53 29.84 65.06 12.29 29.41 67.79 -61.15 85.56 115.05 -65.37 84.74 110.73 2acu_c01 source 2acu ALDOSE REDUCTASE (E.C.1.1.1.21) MUTANT WITH TY: 1 hits 2acu_c01 naa= 3 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 1 3 # 1 A 105 ASN A 136 ASN.? 24.08 CL CL A 382 A 106 PRO A 347 PRO.? 22.55 CL CL A 382 A 108 TYR A 346 TYR.? 17.61 CL CL A 382 coo 34.91 38.94 20.48 33.53 38.20 19.00 -35.51 89.43 120.39 -34.74 90.84 118.94 coo 36.18 33.51 20.99 37.11 35.33 20.14 -36.59 88.39 113.21 -35.13 87.26 111.87 coo 33.01 33.46 15.68 31.96 34.97 17.80 -31.44 83.83 114.39 -30.05 82.53 116.45 2adm_c00 source 2adm ADENINE-N6-DNA-METHYLTRANSFERASE TAQI : 1 hits 2adm_c00 naa= 3 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 1 3 # 1 B 105 ASN A 136 ASN.? 24.08 CL CL A 382 B 106 PRO A 347 PRO.? 22.55 CL CL A 382 B 108 TYR A 346 TYR.? 17.61 CL CL A 382 coo 5.98 38.14 46.94 7.30 38.92 45.46 -35.51 89.43 120.39 -34.74 90.84 118.94 coo 4.66 43.53 47.47 3.74 41.73 46.59 -36.59 88.39 113.21 -35.13 87.26 111.87 coo 7.86 43.80 42.15 8.87 42.26 44.27 -31.44 83.83 114.39 -30.05 82.53 116.45 2adm_c01 source 2adm ADENINE-N6-DNA-METHYLTRANSFERASE TAQI : 1 hits 2adm_c01 naa= 3 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 180 ASP.? 19.13 CL CL A 382 219 GLU A 135 GLU.? 22.99 CL CL A 382 294 ASP A 344 ASP.? 20.56 CL CL A 382 coo 27.89 102.52 14.98 29.35 101.92 13.57 -29.53 80.77 112.24 -28.62 82.54 111.55 coo 25.84 105.87 9.06 27.86 105.55 8.74 -31.98 87.75 115.72 -30.11 88.72 115.32 coo 33.16 106.80 7.72 33.34 104.87 6.92 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP A 344 ASP.? 20.56 CL CL A 382 219 GLU A 135 GLU.? 22.99 CL CL A 382 294 ASP A 180 ASP.? 19.13 CL CL A 382 coo 27.89 102.52 14.98 29.35 101.92 13.57 -40.03 84.87 115.12 -41.94 84.93 114.19 coo 25.84 105.87 9.06 27.86 105.55 8.74 -31.98 87.75 115.72 -30.11 88.72 115.32 coo 33.16 106.80 7.72 33.34 104.87 6.92 -29.53 80.77 112.24 -28.62 82.54 111.55 2amg_c02 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 2 hits 2amg_c02 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 26 ASP^? 16.59 CL CL A 382 231 ASP A 53 ASP.? 25.38 CL CL A 382 294 ASP A 36 ASP.? -3.33 CL CL A 382s coo 27.89 102.52 14.98 29.35 101.92 13.57 -29.69 53.68 115.80 -29.91 52.24 114.24 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -25.09 46.58 135.54 -27.02 47.57 135.30 coo 33.16 106.80 7.72 33.34 104.87 6.92 -31.47 63.24 120.93 -31.90 65.07 119.91 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP A 26 ASP^? 16.59 CL CL A 382 231 ASP A 208 ASP.? 21.85 CL CL A 382 294 ASP A 36 ASP.? -3.33 CL CL A 382s coo 27.89 102.52 14.98 29.35 101.92 13.57 -29.69 53.68 115.80 -29.91 52.24 114.24 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -48.25 63.81 104.00 -49.74 63.21 105.24 coo 33.16 106.80 7.72 33.34 104.87 6.92 -31.47 63.24 120.93 -31.90 65.07 119.91 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP A 28 ASP^? 9.02 CL CL A 382 231 ASP A 291 ASP.? 7.30 CL CL A 384 294 ASP A 93 ASP^? 5.15 CL CL A 382 coo 27.89 102.52 14.98 29.35 101.92 13.57 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -15.45 71.21 105.07 -17.40 71.77 105.62 coo 33.16 106.80 7.72 33.34 104.87 6.92 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP A 28 ASP^? 9.02 CL CL A 382 231 ASP A 338 ASP.? 17.28 CL CL A 384 294 ASP A 93 ASP^? 5.15 CL CL A 382 coo 27.89 102.52 14.98 29.35 101.92 13.57 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -35.06 76.37 102.96 -33.50 77.52 103.78 coo 33.16 106.80 7.72 33.34 104.87 6.92 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP A 30 ASP^? -6.81 CL CL A 382s 231 ASP A 291 ASP.? 7.30 CL CL A 384 294 ASP A 93 ASP^? 5.15 CL CL A 382 coo 27.89 102.52 14.98 29.35 101.92 13.57 -35.52 64.63 115.87 -36.96 65.19 114.43 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -15.45 71.21 105.07 -17.40 71.77 105.62 coo 33.16 106.80 7.72 33.34 104.87 6.92 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 3 # 6 193 ASP A 36 ASP.? -3.33 CL CL A 382s 231 ASP A 208 ASP.? 21.85 CL CL A 382 294 ASP A 26 ASP^? 16.59 CL CL A 382 coo 27.89 102.52 14.98 29.35 101.92 13.57 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -48.25 63.81 104.00 -49.74 63.21 105.24 coo 33.16 106.80 7.72 33.34 104.87 6.92 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 3 # 7 193 ASP A 36 ASP.? -3.33 CL CL A 382s 231 ASP A 291 ASP.? 7.30 CL CL A 384 294 ASP A 26 ASP^? 16.59 CL CL A 382 coo 27.89 102.52 14.98 29.35 101.92 13.57 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -15.45 71.21 105.07 -17.40 71.77 105.62 coo 33.16 106.80 7.72 33.34 104.87 6.92 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 8 3 # 8 193 ASP A 93 ASP^? 5.15 CL CL A 382 231 ASP A 53 ASP.? 25.38 CL CL A 382 294 ASP A 28 ASP^? 9.02 CL CL A 382 coo 27.89 102.52 14.98 29.35 101.92 13.57 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -25.09 46.58 135.54 -27.02 47.57 135.30 coo 33.16 106.80 7.72 33.34 104.87 6.92 -32.19 59.08 116.32 -33.48 59.98 114.85 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 9 3 # 9 193 ASP A 93 ASP^? 5.15 CL CL A 382 231 ASP A 53 ASP.? 25.38 CL CL A 382 294 ASP A 171 ASP.? 13.95 CL CL A 382 coo 27.89 102.52 14.98 29.35 101.92 13.57 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -25.09 46.58 135.54 -27.02 47.57 135.30 coo 33.16 106.80 7.72 33.34 104.87 6.92 -21.72 70.05 125.28 -22.57 71.99 125.28 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 10 3 # 10 193 ASP A 93 ASP^? 5.15 CL CL A 382 231 ASP A 115 ASP~? 22.59 CL CL A 382 294 ASP A 30 ASP^? -6.81 CL CL A 382s coo 27.89 102.52 14.98 29.35 101.92 13.57 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -35.38 84.29 133.21 -33.68 85.51 133.25 coo 33.16 106.80 7.72 33.34 104.87 6.92 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 11 3 # 11 193 ASP A 171 ASP.? 13.95 CL CL A 382 231 ASP A 115 ASP~? 22.59 CL CL A 382 294 ASP A 93 ASP^? 5.15 CL CL A 382 coo 27.89 102.52 14.98 29.35 101.92 13.57 -21.72 70.05 125.28 -22.57 71.99 125.28 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -35.38 84.29 133.21 -33.68 85.51 133.25 coo 33.16 106.80 7.72 33.34 104.87 6.92 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 12 3 # 12 193 ASP A 171 ASP.? 13.95 CL CL A 382 231 ASP A 291 ASP.? 7.30 CL CL A 384 294 ASP A 93 ASP^? 5.15 CL CL A 382 coo 27.89 102.52 14.98 29.35 101.92 13.57 -21.72 70.05 125.28 -22.57 71.99 125.28 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -15.45 71.21 105.07 -17.40 71.77 105.62 coo 33.16 106.80 7.72 33.34 104.87 6.92 -30.23 63.77 124.99 -32.09 64.66 124.54 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 13 3 # 13 193 ASP A 180 ASP.? 19.13 CL CL A 382 231 ASP A 93 ASP^? 5.15 CL CL A 382 294 ASP A 338 ASP.? 17.28 CL CL A 384 coo 27.89 102.52 14.98 29.35 101.92 13.57 -29.53 80.77 112.24 -28.62 82.54 111.55 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 33.16 106.80 7.72 33.34 104.87 6.92 -35.06 76.37 102.96 -33.50 77.52 103.78 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 14 3 # 14 193 ASP A 180 ASP.? 19.13 CL CL A 382 231 ASP A 93 ASP^? 5.15 CL CL A 382 294 ASP A 344 ASP.? 20.56 CL CL A 382 coo 27.89 102.52 14.98 29.35 101.92 13.57 -29.53 80.77 112.24 -28.62 82.54 111.55 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 33.16 106.80 7.72 33.34 104.87 6.92 -40.03 84.87 115.12 -41.94 84.93 114.19 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 15 3 # 15 193 ASP A 195 ASP.? 13.29 CL CL A 384 231 ASP A 327 ASP.? 19.04 CL CL A 384 294 ASP A 306 ASP.? 16.66 CL CL A 384 coo 27.89 102.52 14.98 29.35 101.92 13.57 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -25.74 49.77 105.10 -27.34 48.80 104.08 coo 33.16 106.80 7.72 33.34 104.87 6.92 -29.63 66.56 87.01 -28.35 68.29 87.20 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 16 3 # 16 193 ASP A 257 ASP.? 24.30 CL CL A 383 231 ASP A 272 ASP~? 14.48 CL CL A 382 294 ASP A 233 ASP.? 30.79 CL CL A 383 coo 27.89 102.52 14.98 29.35 101.92 13.57 -55.05 88.25 125.09 -55.04 86.55 126.35 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 33.16 106.80 7.72 33.34 104.87 6.92 -64.45 88.75 121.31 -62.88 88.68 122.75 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 17 3 # 17 193 ASP A 306 ASP.? 16.66 CL CL A 384 231 ASP B 195 ASP.? 10.47 CL CL A 384 294 ASP A 311 ASP^? 15.19 CL CL A 384 coo 27.89 102.52 14.98 29.35 101.92 13.57 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 33.16 106.80 7.72 33.34 104.87 6.92 -31.19 72.86 91.72 -29.44 73.97 92.12 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 18 3 # 18 193 ASP A 311 ASP^? 15.19 CL CL A 384 231 ASP A 208 ASP.? 21.85 CL CL A 382 294 ASP A 306 ASP.? 16.66 CL CL A 384 coo 27.89 102.52 14.98 29.35 101.92 13.57 -31.19 72.86 91.72 -29.44 73.97 92.12 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -48.25 63.81 104.00 -49.74 63.21 105.24 coo 33.16 106.80 7.72 33.34 104.87 6.92 -29.63 66.56 87.01 -28.35 68.29 87.20 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 19 3 # 19 193 ASP B 26 ASP^? 16.51 CL CL B 383 231 ASP B 53 ASP.? 25.44 CL CL B 384 294 ASP B 36 ASP.? -3.35 CL CL B 383s coo 27.89 102.52 14.98 29.35 101.92 13.57 -23.45 39.33 83.60 -24.23 39.48 85.53 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -37.14 32.94 67.80 -35.44 31.68 68.05 coo 33.16 106.80 7.72 33.34 104.87 6.92 -15.98 38.04 75.83 -14.00 38.51 76.08 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 20 3 # 20 193 ASP B 26 ASP^? 16.51 CL CL B 383 231 ASP B 208 ASP.? 21.56 CL CL B 383 294 ASP B 36 ASP.? -3.35 CL CL B 383s coo 27.89 102.52 14.98 29.35 101.92 13.57 -23.45 39.33 83.60 -24.23 39.48 85.53 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 33.16 106.80 7.72 33.34 104.87 6.92 -15.98 38.04 75.83 -14.00 38.51 76.08 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 21 3 # 21 193 ASP B 26 ASP^? 16.51 CL CL B 383 231 ASP B 291 ASP.? 20.64 CL CL B 382 294 ASP B 36 ASP.? -3.35 CL CL B 383s coo 27.89 102.52 14.98 29.35 101.92 13.57 -23.45 39.33 83.60 -24.23 39.48 85.53 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -11.26 60.51 82.59 -9.94 61.37 84.03 coo 33.16 106.80 7.72 33.34 104.87 6.92 -15.98 38.04 75.83 -14.00 38.51 76.08 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 22 3 # 22 193 ASP B 28 ASP^? 9.00 CL CL B 383 231 ASP B 291 ASP.? 20.64 CL CL B 382 294 ASP B 93 ASP^? 5.22 CL CL B 383 coo 27.89 102.52 14.98 29.35 101.92 13.57 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -11.26 60.51 82.59 -9.94 61.37 84.03 coo 33.16 106.80 7.72 33.34 104.87 6.92 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 23 3 # 23 193 ASP B 28 ASP^? 9.00 CL CL B 383 231 ASP B 338 ASP.? 19.77 CL CL B 383 294 ASP B 93 ASP^? 5.22 CL CL B 383 coo 27.89 102.52 14.98 29.35 101.92 13.57 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 14.74 93.05 -1.00 14.30 94.22 0.73 1.84 46.00 86.98 1.86 47.25 85.31 coo 33.16 106.80 7.72 33.34 104.87 6.92 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 24 3 # 24 193 ASP B 30 ASP^? -6.72 CL CL B 383s 231 ASP B 291 ASP.? 20.64 CL CL B 382 294 ASP B 93 ASP^? 5.22 CL CL B 383 coo 27.89 102.52 14.98 29.35 101.92 13.57 -11.77 37.20 80.70 -10.35 36.55 82.15 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -11.26 60.51 82.59 -9.94 61.37 84.03 coo 33.16 106.80 7.72 33.34 104.87 6.92 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 25 3 # 25 193 ASP B 30 ASP^? -6.72 CL CL B 383s 231 ASP B 327 ASP.? 22.34 CL CL A 384 294 ASP B 93 ASP^? 5.22 CL CL B 383 coo 27.89 102.52 14.98 29.35 101.92 13.57 -11.77 37.20 80.70 -10.35 36.55 82.15 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -25.62 46.25 93.54 -25.42 45.53 95.50 coo 33.16 106.80 7.72 33.34 104.87 6.92 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 26 3 # 26 193 ASP B 36 ASP.? -3.35 CL CL B 383s 231 ASP B 208 ASP.? 21.56 CL CL B 383 294 ASP B 26 ASP^? 16.51 CL CL B 383 coo 27.89 102.52 14.98 29.35 101.92 13.57 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 33.16 106.80 7.72 33.34 104.87 6.92 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 27 3 # 27 193 ASP B 36 ASP.? -3.35 CL CL B 383s 231 ASP B 291 ASP.? 20.64 CL CL B 382 294 ASP B 26 ASP^? 16.51 CL CL B 383 coo 27.89 102.52 14.98 29.35 101.92 13.57 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -11.26 60.51 82.59 -9.94 61.37 84.03 coo 33.16 106.80 7.72 33.34 104.87 6.92 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 28 3 # 28 193 ASP B 36 ASP.? -3.35 CL CL B 383s 231 ASP B 338 ASP.? 19.77 CL CL B 383 294 ASP B 26 ASP^? 16.51 CL CL B 383 coo 27.89 102.52 14.98 29.35 101.92 13.57 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 14.74 93.05 -1.00 14.30 94.22 0.73 1.84 46.00 86.98 1.86 47.25 85.31 coo 33.16 106.80 7.72 33.34 104.87 6.92 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 29 3 # 29 193 ASP B 93 ASP^? 5.22 CL CL B 383 231 ASP B 53 ASP.? 25.44 CL CL B 384 294 ASP B 28 ASP^? 9.00 CL CL B 383 coo 27.89 102.52 14.98 29.35 101.92 13.57 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -37.14 32.94 67.80 -35.44 31.68 68.05 coo 33.16 106.80 7.72 33.34 104.87 6.92 -18.06 38.42 81.61 -16.37 38.03 82.88 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 30 3 # 30 193 ASP B 93 ASP^? 5.22 CL CL B 383 231 ASP B 53 ASP.? 25.44 CL CL B 384 294 ASP B 171 ASP.? 13.77 CL CL B 383 coo 27.89 102.52 14.98 29.35 101.92 13.57 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -37.14 32.94 67.80 -35.44 31.68 68.05 coo 33.16 106.80 7.72 33.34 104.87 6.92 -14.88 46.75 66.62 -12.79 46.40 66.16 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 31 3 # 31 193 ASP B 93 ASP^? 5.22 CL CL B 383 231 ASP B 115 ASP~? 22.59 CL CL B 383 294 ASP B 30 ASP^? -6.72 CL CL B 383s coo 27.89 102.52 14.98 29.35 101.92 13.57 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 14.74 93.05 -1.00 14.30 94.22 0.73 0.29 34.85 57.65 0.95 36.59 56.65 coo 33.16 106.80 7.72 33.34 104.87 6.92 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 32 3 # 32 193 ASP B 171 ASP.? 13.77 CL CL B 383 231 ASP B 291 ASP.? 20.64 CL CL B 382 294 ASP B 93 ASP^? 5.22 CL CL B 383 coo 27.89 102.52 14.98 29.35 101.92 13.57 -14.88 46.75 66.62 -12.79 46.40 66.16 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -11.26 60.51 82.59 -9.94 61.37 84.03 coo 33.16 106.80 7.72 33.34 104.87 6.92 -17.13 37.76 71.68 -15.50 36.45 72.23 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 33 3 # 33 193 ASP B 180 ASP.? 19.08 CL CL B 383 231 ASP B 93 ASP^? 5.22 CL CL B 383 294 ASP B 338 ASP.? 19.77 CL CL B 383 coo 27.89 102.52 14.98 29.35 101.92 13.57 0.82 48.22 75.52 2.17 49.73 74.84 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 33.16 106.80 7.72 33.34 104.87 6.92 1.84 46.00 86.98 1.86 47.25 85.31 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 34 3 # 34 193 ASP B 195 ASP.? 10.47 CL CL A 384 231 ASP B 327 ASP.? 22.34 CL CL A 384 294 ASP B 306 ASP.? 19.57 CL CL A 384 coo 27.89 102.52 14.98 29.35 101.92 13.57 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -25.62 46.25 93.54 -25.42 45.53 95.50 coo 33.16 106.80 7.72 33.34 104.87 6.92 -4.64 54.84 103.01 -3.71 56.24 101.58 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 35 3 # 35 193 ASP B 306 ASP.? 19.57 CL CL A 384 231 ASP A 195 ASP.? 13.29 CL CL A 384 294 ASP B 311 ASP^? 24.66 CL CL A 384 coo 27.89 102.52 14.98 29.35 101.92 13.57 -4.64 54.84 103.01 -3.71 56.24 101.58 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 33.16 106.80 7.72 33.34 104.87 6.92 0.41 52.81 97.17 0.37 54.52 95.85 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 36 3 # 36 193 ASP B 311 ASP^? 24.66 CL CL A 384 231 ASP B 208 ASP.? 21.56 CL CL B 383 294 ASP B 306 ASP.? 19.57 CL CL A 384 coo 27.89 102.52 14.98 29.35 101.92 13.57 0.41 52.81 97.17 0.37 54.52 95.85 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -4.03 30.56 94.79 -4.11 28.51 94.21 coo 33.16 106.80 7.72 33.34 104.87 6.92 -4.64 54.84 103.01 -3.71 56.24 101.58 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 36 hits 2amg_c06 naa= 3 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 1 3 # 1 35 ASP A 28 ASP^? 9.02 CL CL A 382 38 SER A 29 SER^? 6.92 CL CL A 382 218 ASP A 26 ASP^? 16.59 CL CL A 382 coo 41.14 58.72 105.19 42.39 59.85 103.92 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 46.04 57.35 103.96 44.97 58.52 105.78 -31.31 63.66 116.96 -29.07 63.86 117.79 coo 41.33 60.20 97.63 42.00 60.96 99.49 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 2 3 # 2 35 ASP A 28 ASP^? 9.02 CL CL A 382 38 SER A 37 SER^? 9.11 CL CL A 382 218 ASP A 26 ASP^? 16.59 CL CL A 382 coo 41.14 58.72 105.19 42.39 59.85 103.92 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 46.04 57.35 103.96 44.97 58.52 105.78 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 41.33 60.20 97.63 42.00 60.96 99.49 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 3 3 # 3 35 ASP A 28 ASP^? 9.02 CL CL A 382 38 SER A 37 SER^? 9.11 CL CL A 382 218 ASP A 30 ASP^? -6.81 CL CL A 382s coo 41.14 58.72 105.19 42.39 59.85 103.92 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 46.04 57.35 103.96 44.97 58.52 105.78 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 41.33 60.20 97.63 42.00 60.96 99.49 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 4 3 # 4 35 ASP A 28 ASP^? 9.02 CL CL A 382 38 SER A 37 SER^? 9.11 CL CL A 382 218 ASP A 39 ASP^? 16.51 CL CL A 382 coo 41.14 58.72 105.19 42.39 59.85 103.92 -32.19 59.08 116.32 -33.48 59.98 114.85 coo 46.04 57.35 103.96 44.97 58.52 105.78 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 41.33 60.20 97.63 42.00 60.96 99.49 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 5 3 # 5 35 ASP A 36 ASP.? -3.33 CL CL A 382s 38 SER A 37 SER^? 9.11 CL CL A 382 218 ASP A 30 ASP^? -6.81 CL CL A 382s coo 41.14 58.72 105.19 42.39 59.85 103.92 -31.47 63.24 120.93 -31.90 65.07 119.91 coo 46.04 57.35 103.96 44.97 58.52 105.78 -31.72 58.75 121.63 -33.32 57.82 120.12 coo 41.33 60.20 97.63 42.00 60.96 99.49 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 6 3 # 6 35 ASP A 195 ASP.? 13.29 CL CL A 384 38 SER A 192 SER.? 15.36 CL CL A 384 218 ASP A 306 ASP.? 16.66 CL CL A 384 coo 41.14 58.72 105.19 42.39 59.85 103.92 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 46.04 57.35 103.96 44.97 58.52 105.78 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 41.33 60.20 97.63 42.00 60.96 99.49 -29.63 66.56 87.01 -28.35 68.29 87.20 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 7 3 # 7 35 ASP A 306 ASP.? 16.66 CL CL A 384 38 SER A 192 SER.? 15.36 CL CL A 384 218 ASP A 305 ASP^? 16.01 CL CL A 384 coo 41.14 58.72 105.19 42.39 59.85 103.92 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 46.04 57.35 103.96 44.97 58.52 105.78 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 41.33 60.20 97.63 42.00 60.96 99.49 -32.01 65.22 92.45 -32.49 63.34 91.63 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 8 3 # 8 35 ASP B 28 ASP^? 9.00 CL CL B 383 38 SER B 29 SER^? 6.98 CL CL B 383 218 ASP B 26 ASP^? 16.51 CL CL B 383 coo 41.14 58.72 105.19 42.39 59.85 103.92 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 46.04 57.35 103.96 44.97 58.52 105.78 -14.55 40.12 78.88 -15.61 41.67 77.42 coo 41.33 60.20 97.63 42.00 60.96 99.49 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 9 3 # 9 35 ASP B 28 ASP^? 9.00 CL CL B 383 38 SER B 37 SER^? 9.16 CL CL B 383 218 ASP B 26 ASP^? 16.51 CL CL B 383 coo 41.14 58.72 105.19 42.39 59.85 103.92 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 46.04 57.35 103.96 44.97 58.52 105.78 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 41.33 60.20 97.63 42.00 60.96 99.49 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 10 3 # 10 35 ASP B 28 ASP^? 9.00 CL CL B 383 38 SER B 37 SER^? 9.16 CL CL B 383 218 ASP B 30 ASP^? -6.72 CL CL B 383s coo 41.14 58.72 105.19 42.39 59.85 103.92 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 46.04 57.35 103.96 44.97 58.52 105.78 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 41.33 60.20 97.63 42.00 60.96 99.49 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 11 3 # 11 35 ASP B 28 ASP^? 9.00 CL CL B 383 38 SER B 37 SER^? 9.16 CL CL B 383 218 ASP B 39 ASP^? 17.51 CL CL B 383 coo 41.14 58.72 105.19 42.39 59.85 103.92 -18.06 38.42 81.61 -16.37 38.03 82.88 coo 46.04 57.35 103.96 44.97 58.52 105.78 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 41.33 60.20 97.63 42.00 60.96 99.49 -26.18 36.85 80.53 -27.97 36.10 81.34 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 12 3 # 12 35 ASP B 36 ASP.? -3.35 CL CL B 383s 38 SER B 37 SER^? 9.16 CL CL B 383 218 ASP B 30 ASP^? -6.72 CL CL B 383s coo 41.14 58.72 105.19 42.39 59.85 103.92 -15.98 38.04 75.83 -14.00 38.51 76.08 coo 46.04 57.35 103.96 44.97 58.52 105.78 -19.96 36.46 76.97 -19.82 35.54 79.16 coo 41.33 60.20 97.63 42.00 60.96 99.49 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 13 3 # 13 35 ASP B 195 ASP.? 10.47 CL CL A 384 38 SER B 192 SER.? 13.26 CL CL A 384 218 ASP B 306 ASP.? 19.57 CL CL A 384 coo 41.14 58.72 105.19 42.39 59.85 103.92 -11.82 59.91 101.57 -11.61 61.10 99.82 coo 46.04 57.35 103.96 44.97 58.52 105.78 -11.80 54.65 102.27 -11.20 56.97 103.08 coo 41.33 60.20 97.63 42.00 60.96 99.49 -4.64 54.84 103.01 -3.71 56.24 101.58 2apr_c04 source 2apr ACID PROTEINASE (RHIZOPUSPEPSIN) (E.C.3.4.23.6: 13 hits 2apr_c04 naa= 3 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 1 3 # 1 B 46 HIS A 21 HIS.? 26.92 CL CL A 384 B 163 ALA A 9 ALA.? 20.02 CL CL A 384 B 182 SER A 11 SER^? 21.10 CL CL A 382 coo 30.42 1.98 4.36 29.07 0.41 4.68 -13.56 47.86 119.72 -11.56 48.42 120.07 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -13.87 55.96 116.46 -12.58 56.43 117.23 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -17.58 55.42 121.82 -16.10 56.98 122.78 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 2 3 # 2 B 46 HIS A 157 HIS~? 12.03 CL CL A 383 B 163 ALA A 159 ALA~? 12.04 CL CL A 382 B 182 SER A 161 SER~? 16.95 CL CL A 383 coo 30.42 1.98 4.36 29.07 0.41 4.68 -47.82 75.77 126.56 -49.90 76.10 126.41 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -40.97 78.44 123.91 -40.05 77.14 123.62 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -45.55 81.13 122.60 -44.57 82.20 124.58 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 3 3 # 3 B 46 HIS B 21 HIS.? 12.39 CL CL B 382 B 163 ALA B 9 ALA.? 5.05 CL CL B 382 B 182 SER B 11 SER^? 4.09 CL CL B 382 coo 30.42 1.98 4.36 29.07 0.41 4.68 -35.26 51.10 78.45 -35.36 53.13 77.89 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -27.19 54.08 77.54 -26.99 55.10 76.37 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -27.63 49.84 73.72 -27.05 52.31 73.59 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 4 3 # 4 B 46 HIS B 157 HIS~? 12.80 CL CL B 384 B 163 ALA B 159 ALA~? 12.15 CL CL B 383 B 182 SER B 161 SER~? 16.65 CL CL B 384 coo 30.42 1.98 4.36 29.07 0.41 4.68 0.17 24.88 70.38 1.86 23.62 70.32 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 0.19 32.47 69.55 -1.13 33.12 70.03 coo 24.00 -0.17 2.07 24.51 1.00 0.04 4.53 29.49 70.92 4.35 29.43 68.47 2bhg_c02 source 2bhg FOOT-AND-MOUTH DISEASE VIRUS 3C PROTEASE : 4 hits 2bhg_c02 naa= 3 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 1 3 # 1 A 14 ARG A 77 ARG^? 19.95 CL CL A 382 A 161 ASP A 26 ASP^? 16.59 CL CL A 382 A 174 TYR A 25 TYR^? 18.63 CL CL A 382 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -32.32 44.63 125.30 -31.80 47.66 125.44 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -29.69 53.68 115.80 -29.91 52.24 114.24 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -23.49 53.13 116.11 -21.60 54.30 114.36 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 2 3 # 2 A 14 ARG A 197 ARG.? 14.16 CL CL A 384 A 161 ASP A 306 ASP.? 16.66 CL CL A 384 A 174 TYR B 6 TYR.? 15.73 CL CL B 382 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -16.42 65.00 90.05 -16.47 67.55 88.20 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -31.00 62.22 83.89 -31.26 65.01 83.64 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 3 3 # 3 A 14 ARG A 197 ARG.? 14.16 CL CL A 384 A 161 ASP B 64 ASP.? 7.14 CL CL B 382 A 174 TYR B 8 TYR.? 11.88 CL CL B 382 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -16.42 65.00 90.05 -16.47 67.55 88.20 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -22.24 55.99 77.05 -23.77 56.03 78.56 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -23.96 53.72 82.39 -21.76 54.53 83.93 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 4 3 # 4 A 14 ARG A 290 ARG.? -7.44 CL CL A 384s A 161 ASP A 64 ASP.? 15.21 CL CL A 384 A 174 TYR A 8 TYR.? 12.26 CL CL A 384 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -15.77 66.49 99.38 -13.63 64.23 99.65 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -13.50 61.63 115.26 -13.45 60.20 113.75 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -16.53 57.80 111.57 -17.14 59.34 109.36 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 5 3 # 5 A 14 ARG A 334 ARG^? 9.67 CL CL A 382 A 161 ASP A 39 ASP^? 16.51 CL CL A 382 A 174 TYR A 25 TYR^? 18.63 CL CL A 382 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -35.93 61.76 109.91 -34.52 61.40 112.61 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -29.94 52.12 119.85 -30.97 50.72 120.81 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -23.49 53.13 116.11 -21.60 54.30 114.36 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 6 3 # 6 A 14 ARG B 13 ARG^? 4.84 CL CL B 382 A 161 ASP B 39 ASP^? 17.51 CL CL B 383 A 174 TYR B 25 TYR^? 14.27 CL CL B 382 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -26.14 48.57 68.77 -25.79 51.69 68.63 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -26.18 36.85 80.53 -27.97 36.10 81.34 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -26.62 44.42 81.68 -25.97 47.00 82.31 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 7 3 # 7 A 14 ARG B 77 ARG^? 27.48 CL CL B 383 A 161 ASP B 26 ASP^? 16.51 CL CL B 383 A 174 TYR B 25 TYR^? 14.27 CL CL B 382 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -35.60 30.51 80.72 -37.43 31.47 83.02 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -23.45 39.33 83.60 -24.23 39.48 85.53 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -26.62 44.42 81.68 -25.97 47.00 82.31 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 8 3 # 8 A 14 ARG B 290 ARG.? 12.49 CL CL A 384 A 161 ASP B 64 ASP.? 7.14 CL CL B 382 A 174 TYR B 8 TYR.? 11.88 CL CL B 382 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -13.01 59.15 90.41 -14.60 61.38 91.89 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -22.24 55.99 77.05 -23.77 56.03 78.56 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -23.96 53.72 82.39 -21.76 54.53 83.93 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 9 3 # 9 A 14 ARG B 334 ARG^? 9.65 CL CL B 383 A 161 ASP B 39 ASP^? 17.51 CL CL B 383 A 174 TYR B 25 TYR^? 14.27 CL CL B 382 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -12.53 38.39 87.32 -14.06 38.36 84.61 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -26.18 36.85 80.53 -27.97 36.10 81.34 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -26.62 44.42 81.68 -25.97 47.00 82.31 2c7v_c08 source 2c7v PTERIDINE REDUCTASE : 9 hits 2c7v_c08 naa= 3 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 1 3 # 1 B 14 ARG A 77 ARG^? 19.95 CL CL A 382 B 161 ASP A 26 ASP^? 16.59 CL CL A 382 B 174 TYR A 25 TYR^? 18.63 CL CL A 382 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -32.32 44.63 125.30 -31.80 47.66 125.44 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -29.69 53.68 115.80 -29.91 52.24 114.24 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -23.49 53.13 116.11 -21.60 54.30 114.36 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 2 3 # 2 B 14 ARG A 197 ARG.? 14.16 CL CL A 384 B 161 ASP A 306 ASP.? 16.66 CL CL A 384 B 174 TYR B 6 TYR.? 15.73 CL CL B 382 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -16.42 65.00 90.05 -16.47 67.55 88.20 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -29.63 66.56 87.01 -28.35 68.29 87.20 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -31.00 62.22 83.89 -31.26 65.01 83.64 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 3 3 # 3 B 14 ARG A 197 ARG.? 14.16 CL CL A 384 B 161 ASP B 64 ASP.? 7.14 CL CL B 382 B 174 TYR B 8 TYR.? 11.88 CL CL B 382 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -16.42 65.00 90.05 -16.47 67.55 88.20 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -22.24 55.99 77.05 -23.77 56.03 78.56 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -23.96 53.72 82.39 -21.76 54.53 83.93 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 4 3 # 4 B 14 ARG A 290 ARG.? -7.44 CL CL A 384s B 161 ASP A 64 ASP.? 15.21 CL CL A 384 B 174 TYR A 8 TYR.? 12.26 CL CL A 384 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -15.77 66.49 99.38 -13.63 64.23 99.65 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -13.50 61.63 115.26 -13.45 60.20 113.75 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -16.53 57.80 111.57 -17.14 59.34 109.36 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 5 3 # 5 B 14 ARG A 334 ARG^? 9.67 CL CL A 382 B 161 ASP A 39 ASP^? 16.51 CL CL A 382 B 174 TYR A 25 TYR^? 18.63 CL CL A 382 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -35.93 61.76 109.91 -34.52 61.40 112.61 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -29.94 52.12 119.85 -30.97 50.72 120.81 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -23.49 53.13 116.11 -21.60 54.30 114.36 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 6 3 # 6 B 14 ARG B 13 ARG^? 4.84 CL CL B 382 B 161 ASP B 39 ASP^? 17.51 CL CL B 383 B 174 TYR B 25 TYR^? 14.27 CL CL B 382 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -26.14 48.57 68.77 -25.79 51.69 68.63 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -26.18 36.85 80.53 -27.97 36.10 81.34 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -26.62 44.42 81.68 -25.97 47.00 82.31 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 7 3 # 7 B 14 ARG B 77 ARG^? 27.48 CL CL B 383 B 161 ASP B 26 ASP^? 16.51 CL CL B 383 B 174 TYR B 25 TYR^? 14.27 CL CL B 382 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -35.60 30.51 80.72 -37.43 31.47 83.02 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -23.45 39.33 83.60 -24.23 39.48 85.53 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -26.62 44.42 81.68 -25.97 47.00 82.31 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 8 3 # 8 B 14 ARG B 290 ARG.? 12.49 CL CL A 384 B 161 ASP B 64 ASP.? 7.14 CL CL B 382 B 174 TYR B 8 TYR.? 11.88 CL CL B 382 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -13.01 59.15 90.41 -14.60 61.38 91.89 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -22.24 55.99 77.05 -23.77 56.03 78.56 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -23.96 53.72 82.39 -21.76 54.53 83.93 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 9 3 # 9 B 14 ARG B 334 ARG^? 9.65 CL CL B 383 B 161 ASP B 39 ASP^? 17.51 CL CL B 383 B 174 TYR B 25 TYR^? 14.27 CL CL B 382 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -12.53 38.39 87.32 -14.06 38.36 84.61 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -26.18 36.85 80.53 -27.97 36.10 81.34 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -26.62 44.42 81.68 -25.97 47.00 82.31 2c7v_c09 source 2c7v PTERIDINE REDUCTASE : 9 hits 2c7v_c09 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG A 77 ARG^? 19.95 CL CL A 382 C 161 ASP A 26 ASP^? 16.59 CL CL A 382 C 174 TYR A 25 TYR^? 18.63 CL CL A 382 coo 2.84 19.43 40.34 1.59 20.35 37.65 -32.32 44.63 125.30 -31.80 47.66 125.44 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -29.69 53.68 115.80 -29.91 52.24 114.24 coo 5.94 13.28 27.17 3.53 13.05 28.58 -23.49 53.13 116.11 -21.60 54.30 114.36 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 2 3 # 2 C 14 ARG A 197 ARG.? 14.16 CL CL A 384 C 161 ASP A 306 ASP.? 16.66 CL CL A 384 C 174 TYR B 6 TYR.? 15.73 CL CL B 382 coo 2.84 19.43 40.34 1.59 20.35 37.65 -16.42 65.00 90.05 -16.47 67.55 88.20 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -29.63 66.56 87.01 -28.35 68.29 87.20 coo 5.94 13.28 27.17 3.53 13.05 28.58 -31.00 62.22 83.89 -31.26 65.01 83.64 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 3 3 # 3 C 14 ARG A 197 ARG.? 14.16 CL CL A 384 C 161 ASP B 64 ASP.? 7.14 CL CL B 382 C 174 TYR B 8 TYR.? 11.88 CL CL B 382 coo 2.84 19.43 40.34 1.59 20.35 37.65 -16.42 65.00 90.05 -16.47 67.55 88.20 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -22.24 55.99 77.05 -23.77 56.03 78.56 coo 5.94 13.28 27.17 3.53 13.05 28.58 -23.96 53.72 82.39 -21.76 54.53 83.93 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 4 3 # 4 C 14 ARG A 290 ARG.? -7.44 CL CL A 384s C 161 ASP A 64 ASP.? 15.21 CL CL A 384 C 174 TYR A 8 TYR.? 12.26 CL CL A 384 coo 2.84 19.43 40.34 1.59 20.35 37.65 -15.77 66.49 99.38 -13.63 64.23 99.65 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -13.50 61.63 115.26 -13.45 60.20 113.75 coo 5.94 13.28 27.17 3.53 13.05 28.58 -16.53 57.80 111.57 -17.14 59.34 109.36 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 5 3 # 5 C 14 ARG A 334 ARG^? 9.67 CL CL A 382 C 161 ASP A 39 ASP^? 16.51 CL CL A 382 C 174 TYR A 25 TYR^? 18.63 CL CL A 382 coo 2.84 19.43 40.34 1.59 20.35 37.65 -35.93 61.76 109.91 -34.52 61.40 112.61 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -29.94 52.12 119.85 -30.97 50.72 120.81 coo 5.94 13.28 27.17 3.53 13.05 28.58 -23.49 53.13 116.11 -21.60 54.30 114.36 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 6 3 # 6 C 14 ARG B 13 ARG^? 4.84 CL CL B 382 C 161 ASP B 39 ASP^? 17.51 CL CL B 383 C 174 TYR B 25 TYR^? 14.27 CL CL B 382 coo 2.84 19.43 40.34 1.59 20.35 37.65 -26.14 48.57 68.77 -25.79 51.69 68.63 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -26.18 36.85 80.53 -27.97 36.10 81.34 coo 5.94 13.28 27.17 3.53 13.05 28.58 -26.62 44.42 81.68 -25.97 47.00 82.31 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 7 3 # 7 C 14 ARG B 77 ARG^? 27.48 CL CL B 383 C 161 ASP B 26 ASP^? 16.51 CL CL B 383 C 174 TYR B 25 TYR^? 14.27 CL CL B 382 coo 2.84 19.43 40.34 1.59 20.35 37.65 -35.60 30.51 80.72 -37.43 31.47 83.02 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -23.45 39.33 83.60 -24.23 39.48 85.53 coo 5.94 13.28 27.17 3.53 13.05 28.58 -26.62 44.42 81.68 -25.97 47.00 82.31 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 8 3 # 8 C 14 ARG B 290 ARG.? 12.49 CL CL A 384 C 161 ASP B 64 ASP.? 7.14 CL CL B 382 C 174 TYR B 8 TYR.? 11.88 CL CL B 382 coo 2.84 19.43 40.34 1.59 20.35 37.65 -13.01 59.15 90.41 -14.60 61.38 91.89 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -22.24 55.99 77.05 -23.77 56.03 78.56 coo 5.94 13.28 27.17 3.53 13.05 28.58 -23.96 53.72 82.39 -21.76 54.53 83.93 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 9 3 # 9 C 14 ARG B 334 ARG^? 9.65 CL CL B 383 C 161 ASP B 39 ASP^? 17.51 CL CL B 383 C 174 TYR B 25 TYR^? 14.27 CL CL B 382 coo 2.84 19.43 40.34 1.59 20.35 37.65 -12.53 38.39 87.32 -14.06 38.36 84.61 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -26.18 36.85 80.53 -27.97 36.10 81.34 coo 5.94 13.28 27.17 3.53 13.05 28.58 -26.62 44.42 81.68 -25.97 47.00 82.31 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 9 hits 2c7v_c10 naa= 3 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 1 3 # 1 D 14 ARG A 77 ARG^? 19.95 CL CL A 382 D 161 ASP A 26 ASP^? 16.59 CL CL A 382 D 174 TYR A 25 TYR^? 18.63 CL CL A 382 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -32.32 44.63 125.30 -31.80 47.66 125.44 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -29.69 53.68 115.80 -29.91 52.24 114.24 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -23.49 53.13 116.11 -21.60 54.30 114.36 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 2 3 # 2 D 14 ARG A 197 ARG.? 14.16 CL CL A 384 D 161 ASP A 306 ASP.? 16.66 CL CL A 384 D 174 TYR B 6 TYR.? 15.73 CL CL B 382 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -16.42 65.00 90.05 -16.47 67.55 88.20 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -29.63 66.56 87.01 -28.35 68.29 87.20 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -31.00 62.22 83.89 -31.26 65.01 83.64 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 3 3 # 3 D 14 ARG A 197 ARG.? 14.16 CL CL A 384 D 161 ASP B 64 ASP.? 7.14 CL CL B 382 D 174 TYR B 8 TYR.? 11.88 CL CL B 382 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -16.42 65.00 90.05 -16.47 67.55 88.20 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -22.24 55.99 77.05 -23.77 56.03 78.56 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -23.96 53.72 82.39 -21.76 54.53 83.93 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 4 3 # 4 D 14 ARG A 290 ARG.? -7.44 CL CL A 384s D 161 ASP A 64 ASP.? 15.21 CL CL A 384 D 174 TYR A 8 TYR.? 12.26 CL CL A 384 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -15.77 66.49 99.38 -13.63 64.23 99.65 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -13.50 61.63 115.26 -13.45 60.20 113.75 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -16.53 57.80 111.57 -17.14 59.34 109.36 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 5 3 # 5 D 14 ARG A 334 ARG^? 9.67 CL CL A 382 D 161 ASP A 39 ASP^? 16.51 CL CL A 382 D 174 TYR A 25 TYR^? 18.63 CL CL A 382 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -35.93 61.76 109.91 -34.52 61.40 112.61 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -29.94 52.12 119.85 -30.97 50.72 120.81 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -23.49 53.13 116.11 -21.60 54.30 114.36 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 6 3 # 6 D 14 ARG B 13 ARG^? 4.84 CL CL B 382 D 161 ASP B 39 ASP^? 17.51 CL CL B 383 D 174 TYR B 25 TYR^? 14.27 CL CL B 382 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -26.14 48.57 68.77 -25.79 51.69 68.63 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -26.18 36.85 80.53 -27.97 36.10 81.34 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -26.62 44.42 81.68 -25.97 47.00 82.31 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 7 3 # 7 D 14 ARG B 77 ARG^? 27.48 CL CL B 383 D 161 ASP B 26 ASP^? 16.51 CL CL B 383 D 174 TYR B 25 TYR^? 14.27 CL CL B 382 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -35.60 30.51 80.72 -37.43 31.47 83.02 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -23.45 39.33 83.60 -24.23 39.48 85.53 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -26.62 44.42 81.68 -25.97 47.00 82.31 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 8 3 # 8 D 14 ARG B 290 ARG.? 12.49 CL CL A 384 D 161 ASP B 64 ASP.? 7.14 CL CL B 382 D 174 TYR B 8 TYR.? 11.88 CL CL B 382 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -13.01 59.15 90.41 -14.60 61.38 91.89 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -22.24 55.99 77.05 -23.77 56.03 78.56 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -23.96 53.72 82.39 -21.76 54.53 83.93 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 9 3 # 9 D 14 ARG B 334 ARG^? 9.65 CL CL B 383 D 161 ASP B 39 ASP^? 17.51 CL CL B 383 D 174 TYR B 25 TYR^? 14.27 CL CL B 382 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -12.53 38.39 87.32 -14.06 38.36 84.61 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -26.18 36.85 80.53 -27.97 36.10 81.34 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -26.62 44.42 81.68 -25.97 47.00 82.31 2c7v_c11 source 2c7v PTERIDINE REDUCTASE : 9 hits 2c7v_c11 naa= 3 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 1 3 # 1 A 197 ASP A 272 ASP~? 14.48 CL CL A 382 A 233 GLU A 276 GLU~? 16.10 CL CL A 383 A 300 ASN A 211 ASN.? 19.04 CL CL A 383 coo 12.51 17.07 49.46 12.44 16.89 47.35 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 6.52 19.14 48.16 7.77 18.42 46.61 -46.62 67.79 110.40 -48.46 68.09 111.43 coo 9.30 22.40 41.76 10.10 20.96 40.36 -52.26 68.83 108.54 -52.87 67.63 110.20 2cpu_c01 source 2cpu ALPHA-AMYLASE : 1 hits 2cpu_c01 naa= 3 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 1 3 # 1 A 182 LYS A 264 LYS~? 22.00 CL CL A 382 A 184 LYS A 267 LYS~? 27.66 CL CL A 382 A 345 ASP A 257 ASP.? 24.30 CL CL A 383 coo 5.98 42.76 7.73 10.19 38.62 9.02 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 2.77 37.17 4.99 6.33 34.76 8.06 -49.43 81.28 111.60 -49.39 86.78 108.40 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -55.05 88.25 125.09 -55.04 86.55 126.35 2dw7_c32 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c32 naa= 3 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 1 3 # 1 B 182 LYS A 264 LYS~? 22.00 CL CL A 382 B 184 LYS A 267 LYS~? 27.66 CL CL A 382 B 345 ASP A 257 ASP.? 24.30 CL CL A 383 coo 38.76 2.27 4.00 34.00 5.99 4.37 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 40.63 7.13 9.06 35.85 7.36 8.95 -49.43 81.28 111.60 -49.39 86.78 108.40 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -55.05 88.25 125.09 -55.04 86.55 126.35 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 2 3 # 2 B 182 LYS A 264 LYS~? 22.00 CL CL A 382 B 184 LYS A 268 LYS~? 13.60 CL CL A 382 B 345 ASP A 257 ASP.? 24.30 CL CL A 383 coo 38.76 2.27 4.00 34.00 5.99 4.37 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 40.63 7.13 9.06 35.85 7.36 8.95 -47.11 79.10 113.63 -43.53 76.03 116.02 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -55.05 88.25 125.09 -55.04 86.55 126.35 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 3 3 # 3 B 182 LYS A 267 LYS~? 27.66 CL CL A 382 B 184 LYS A 264 LYS~? 22.00 CL CL A 382 B 345 ASP A 240 ASP.? 30.06 CL CL A 382 coo 38.76 2.27 4.00 34.00 5.99 4.37 -49.43 81.28 111.60 -49.39 86.78 108.40 coo 40.63 7.13 9.06 35.85 7.36 8.95 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -54.36 78.15 100.29 -55.09 76.20 100.68 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 4 3 # 4 B 182 LYS A 268 LYS~? 13.60 CL CL A 382 B 184 LYS A 264 LYS~? 22.00 CL CL A 382 B 345 ASP A 240 ASP.? 30.06 CL CL A 382 coo 38.76 2.27 4.00 34.00 5.99 4.37 -47.11 79.10 113.63 -43.53 76.03 116.02 coo 40.63 7.13 9.06 35.85 7.36 8.95 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -54.36 78.15 100.29 -55.09 76.20 100.68 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 5 3 # 5 B 182 LYS B 264 LYS~? 21.76 CL CL B 383 B 184 LYS B 267 LYS~? 27.57 CL CL B 383 B 345 ASP B 257 ASP.? 23.04 CL CL B 384 coo 38.76 2.27 4.00 34.00 5.99 4.37 11.01 31.36 75.69 9.79 34.42 71.26 coo 40.63 7.13 9.06 35.85 7.36 8.95 9.46 31.45 81.02 15.36 33.08 81.01 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 12.38 23.16 66.89 10.36 22.88 66.20 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 6 3 # 6 B 182 LYS B 264 LYS~? 21.76 CL CL B 383 B 184 LYS B 268 LYS~? 13.29 CL CL B 383 B 345 ASP B 257 ASP.? 23.04 CL CL B 384 coo 38.76 2.27 4.00 34.00 5.99 4.37 11.01 31.36 75.69 9.79 34.42 71.26 coo 40.63 7.13 9.06 35.85 7.36 8.95 5.99 32.14 79.72 1.11 32.64 77.72 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 12.38 23.16 66.89 10.36 22.88 66.20 2dw7_c33 source 2dw7 BLL6730 PROTEIN : 6 hits 2dw7_c33 naa= 3 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 1 3 # 1 C 182 LYS A 264 LYS~? 22.00 CL CL A 382 C 184 LYS A 267 LYS~? 27.66 CL CL A 382 C 345 ASP A 257 ASP.? 24.30 CL CL A 383 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 0.95 12.72 73.51 1.58 12.72 68.31 -49.43 81.28 111.60 -49.39 86.78 108.40 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -55.05 88.25 125.09 -55.04 86.55 126.35 2dw7_c34 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c34 naa= 3 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 1 3 # 1 D 182 LYS A 264 LYS~? 22.00 CL CL A 382 D 184 LYS A 267 LYS~? 27.66 CL CL A 382 D 345 ASP A 257 ASP.? 24.30 CL CL A 383 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -49.43 81.28 111.60 -49.39 86.78 108.40 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -55.05 88.25 125.09 -55.04 86.55 126.35 2dw7_c35 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c35 naa= 3 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 1 3 # 1 E 182 LYS A 264 LYS~? 22.00 CL CL A 382 E 184 LYS A 267 LYS~? 27.66 CL CL A 382 E 345 ASP A 257 ASP.? 24.30 CL CL A 383 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -48.92 85.08 115.29 -44.06 86.61 118.76 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -49.43 81.28 111.60 -49.39 86.78 108.40 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -55.05 88.25 125.09 -55.04 86.55 126.35 2dw7_c36 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c36 naa= 3 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 1 3 # 1 F 182 LYS A 264 LYS~? 22.00 CL CL A 382 F 184 LYS A 267 LYS~? 27.66 CL CL A 382 F 345 ASP A 257 ASP.? 24.30 CL CL A 383 coo 10.64 34.02 91.30 6.30 35.60 95.11 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 13.75 39.76 94.12 11.42 37.23 97.89 -49.43 81.28 111.60 -49.39 86.78 108.40 coo 16.35 26.90 99.56 16.81 25.90 97.75 -55.05 88.25 125.09 -55.04 86.55 126.35 2dw7_c37 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c37 naa= 3 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 1 3 # 1 G 182 LYS A 264 LYS~? 22.00 CL CL A 382 G 184 LYS A 267 LYS~? 27.66 CL CL A 382 G 345 ASP A 257 ASP.? 24.30 CL CL A 383 coo 39.68 42.04 76.11 43.42 46.43 74.96 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 36.69 47.69 78.93 39.38 50.40 75.35 -49.43 81.28 111.60 -49.39 86.78 108.40 coo 33.43 44.37 65.47 33.10 42.30 65.37 -55.05 88.25 125.09 -55.04 86.55 126.35 2dw7_c38 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c38 naa= 3 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 1 3 # 1 H 182 LYS A 264 LYS~? 22.00 CL CL A 382 H 184 LYS A 267 LYS~? 27.66 CL CL A 382 H 345 ASP A 257 ASP.? 24.30 CL CL A 383 coo 71.58 83.18 80.51 66.88 79.77 79.84 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 73.65 78.64 75.66 68.14 79.07 75.04 -49.43 81.28 111.60 -49.39 86.78 108.40 coo 67.43 90.73 71.39 68.27 92.30 72.52 -55.05 88.25 125.09 -55.04 86.55 126.35 2dw7_c39 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c39 naa= 3 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 1 3 # 1 I 182 LYS A 264 LYS~? 22.00 CL CL A 382 I 184 LYS A 267 LYS~? 27.66 CL CL A 382 I 345 ASP A 257 ASP.? 24.30 CL CL A 383 coo 60.20 96.92 42.53 57.60 93.13 38.67 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 54.31 95.46 46.01 55.34 91.59 42.65 -49.43 81.28 111.60 -49.39 86.78 108.40 coo 66.35 87.81 48.53 68.10 89.01 48.77 -55.05 88.25 125.09 -55.04 86.55 126.35 2dw7_c40 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c40 naa= 3 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 1 3 # 1 J 182 LYS A 264 LYS~? 22.00 CL CL A 382 J 184 LYS A 267 LYS~? 27.66 CL CL A 382 J 345 ASP A 257 ASP.? 24.30 CL CL A 383 coo 25.22 70.55 14.03 27.64 73.07 18.65 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 31.73 69.87 11.50 32.73 70.19 16.40 -49.43 81.28 111.60 -49.39 86.78 108.40 coo 25.87 58.42 18.79 23.95 58.54 17.90 -55.05 88.25 125.09 -55.04 86.55 126.35 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 2 3 # 2 J 182 LYS A 264 LYS~? 22.00 CL CL A 382 J 184 LYS A 268 LYS~? 13.60 CL CL A 382 J 345 ASP A 257 ASP.? 24.30 CL CL A 383 coo 25.22 70.55 14.03 27.64 73.07 18.65 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 31.73 69.87 11.50 32.73 70.19 16.40 -47.11 79.10 113.63 -43.53 76.03 116.02 coo 25.87 58.42 18.79 23.95 58.54 17.90 -55.05 88.25 125.09 -55.04 86.55 126.35 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 3 3 # 3 J 182 LYS B 264 LYS~? 21.76 CL CL B 383 J 184 LYS B 267 LYS~? 27.57 CL CL B 383 J 345 ASP B 257 ASP.? 23.04 CL CL B 384 coo 25.22 70.55 14.03 27.64 73.07 18.65 11.01 31.36 75.69 9.79 34.42 71.26 coo 31.73 69.87 11.50 32.73 70.19 16.40 9.46 31.45 81.02 15.36 33.08 81.01 coo 25.87 58.42 18.79 23.95 58.54 17.90 12.38 23.16 66.89 10.36 22.88 66.20 2dw7_c41 source 2dw7 BLL6730 PROTEIN : 3 hits 2dw7_c41 naa= 3 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 1 3 # 1 K 182 LYS A 264 LYS~? 22.00 CL CL A 382 K 184 LYS A 267 LYS~? 27.66 CL CL A 382 K 345 ASP A 257 ASP.? 24.30 CL CL A 383 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -49.43 81.28 111.60 -49.39 86.78 108.40 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -55.05 88.25 125.09 -55.04 86.55 126.35 2dw7_c42 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c42 naa= 3 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 1 3 # 1 L 182 LYS A 264 LYS~? 22.00 CL CL A 382 L 184 LYS A 267 LYS~? 27.66 CL CL A 382 L 345 ASP A 257 ASP.? 24.30 CL CL A 383 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -49.43 81.28 111.60 -49.39 86.78 108.40 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -55.05 88.25 125.09 -55.04 86.55 126.35 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 2 3 # 2 L 182 LYS A 264 LYS~? 22.00 CL CL A 382 L 184 LYS A 268 LYS~? 13.60 CL CL A 382 L 345 ASP A 257 ASP.? 24.30 CL CL A 383 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -47.11 79.10 113.63 -43.53 76.03 116.02 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -55.05 88.25 125.09 -55.04 86.55 126.35 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 3 3 # 3 L 182 LYS A 267 LYS~? 27.66 CL CL A 382 L 184 LYS A 264 LYS~? 22.00 CL CL A 382 L 345 ASP A 240 ASP.? 30.06 CL CL A 382 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -49.43 81.28 111.60 -49.39 86.78 108.40 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -54.36 78.15 100.29 -55.09 76.20 100.68 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 4 3 # 4 L 182 LYS A 268 LYS~? 13.60 CL CL A 382 L 184 LYS A 264 LYS~? 22.00 CL CL A 382 L 345 ASP A 240 ASP.? 30.06 CL CL A 382 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -47.11 79.10 113.63 -43.53 76.03 116.02 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -54.36 78.15 100.29 -55.09 76.20 100.68 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 5 3 # 5 L 182 LYS B 264 LYS~? 21.76 CL CL B 383 L 184 LYS B 267 LYS~? 27.57 CL CL B 383 L 345 ASP B 257 ASP.? 23.04 CL CL B 384 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 11.01 31.36 75.69 9.79 34.42 71.26 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 9.46 31.45 81.02 15.36 33.08 81.01 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 12.38 23.16 66.89 10.36 22.88 66.20 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 6 3 # 6 L 182 LYS B 264 LYS~? 21.76 CL CL B 383 L 184 LYS B 268 LYS~? 13.29 CL CL B 383 L 345 ASP B 257 ASP.? 23.04 CL CL B 384 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 11.01 31.36 75.69 9.79 34.42 71.26 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 5.99 32.14 79.72 1.11 32.64 77.72 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 12.38 23.16 66.89 10.36 22.88 66.20 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 7 3 # 7 L 182 LYS B 267 LYS~? 27.57 CL CL B 383 L 184 LYS B 264 LYS~? 21.76 CL CL B 383 L 345 ASP B 240 ASP.? 29.22 CL CL B 383 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 9.46 31.45 81.02 15.36 33.08 81.01 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 11.01 31.36 75.69 9.79 34.42 71.26 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 11.35 28.88 93.27 10.37 30.59 94.07 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 8 3 # 8 L 182 LYS B 268 LYS~? 13.29 CL CL B 383 L 184 LYS B 264 LYS~? 21.76 CL CL B 383 L 345 ASP B 240 ASP.? 29.22 CL CL B 383 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 5.99 32.14 79.72 1.11 32.64 77.72 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 11.01 31.36 75.69 9.79 34.42 71.26 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 11.35 28.88 93.27 10.37 30.59 94.07 2dw7_c43 source 2dw7 BLL6730 PROTEIN : 8 hits 2dw7_c43 naa= 3 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 1 3 # 1 M 182 LYS A 264 LYS~? 22.00 CL CL A 382 M 184 LYS A 267 LYS~? 27.66 CL CL A 382 M 345 ASP A 257 ASP.? 24.30 CL CL A 383 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -48.92 85.08 115.29 -44.06 86.61 118.76 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -49.43 81.28 111.60 -49.39 86.78 108.40 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -55.05 88.25 125.09 -55.04 86.55 126.35 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 2 3 # 2 M 182 LYS A 264 LYS~? 22.00 CL CL A 382 M 184 LYS A 268 LYS~? 13.60 CL CL A 382 M 345 ASP A 257 ASP.? 24.30 CL CL A 383 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -48.92 85.08 115.29 -44.06 86.61 118.76 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -47.11 79.10 113.63 -43.53 76.03 116.02 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -55.05 88.25 125.09 -55.04 86.55 126.35 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 3 3 # 3 M 182 LYS A 267 LYS~? 27.66 CL CL A 382 M 184 LYS A 264 LYS~? 22.00 CL CL A 382 M 345 ASP A 240 ASP.? 30.06 CL CL A 382 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -49.43 81.28 111.60 -49.39 86.78 108.40 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -48.92 85.08 115.29 -44.06 86.61 118.76 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -54.36 78.15 100.29 -55.09 76.20 100.68 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 4 3 # 4 M 182 LYS A 268 LYS~? 13.60 CL CL A 382 M 184 LYS A 264 LYS~? 22.00 CL CL A 382 M 345 ASP A 240 ASP.? 30.06 CL CL A 382 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -47.11 79.10 113.63 -43.53 76.03 116.02 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -48.92 85.08 115.29 -44.06 86.61 118.76 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -54.36 78.15 100.29 -55.09 76.20 100.68 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 5 3 # 5 M 182 LYS B 264 LYS~? 21.76 CL CL B 383 M 184 LYS B 267 LYS~? 27.57 CL CL B 383 M 345 ASP B 257 ASP.? 23.04 CL CL B 384 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 11.01 31.36 75.69 9.79 34.42 71.26 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 9.46 31.45 81.02 15.36 33.08 81.01 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 12.38 23.16 66.89 10.36 22.88 66.20 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 6 3 # 6 M 182 LYS B 264 LYS~? 21.76 CL CL B 383 M 184 LYS B 268 LYS~? 13.29 CL CL B 383 M 345 ASP B 257 ASP.? 23.04 CL CL B 384 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 11.01 31.36 75.69 9.79 34.42 71.26 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 5.99 32.14 79.72 1.11 32.64 77.72 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 12.38 23.16 66.89 10.36 22.88 66.20 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 7 3 # 7 M 182 LYS B 267 LYS~? 27.57 CL CL B 383 M 184 LYS B 264 LYS~? 21.76 CL CL B 383 M 345 ASP B 240 ASP.? 29.22 CL CL B 383 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 9.46 31.45 81.02 15.36 33.08 81.01 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 11.01 31.36 75.69 9.79 34.42 71.26 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 11.35 28.88 93.27 10.37 30.59 94.07 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 8 3 # 8 M 182 LYS B 268 LYS~? 13.29 CL CL B 383 M 184 LYS B 264 LYS~? 21.76 CL CL B 383 M 345 ASP B 240 ASP.? 29.22 CL CL B 383 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 5.99 32.14 79.72 1.11 32.64 77.72 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 11.01 31.36 75.69 9.79 34.42 71.26 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 11.35 28.88 93.27 10.37 30.59 94.07 2dw7_c44 source 2dw7 BLL6730 PROTEIN : 8 hits 2dw7_c44 naa= 3 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 1 3 # 1 O 182 LYS A 264 LYS~? 22.00 CL CL A 382 O 184 LYS A 267 LYS~? 27.66 CL CL A 382 O 345 ASP A 257 ASP.? 24.30 CL CL A 383 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -49.43 81.28 111.60 -49.39 86.78 108.40 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -55.05 88.25 125.09 -55.04 86.55 126.35 2dw7_c46 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c46 naa= 3 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 1 3 # 1 P 182 LYS A 264 LYS~? 22.00 CL CL A 382 P 184 LYS A 267 LYS~? 27.66 CL CL A 382 P 345 ASP A 257 ASP.? 24.30 CL CL A 383 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -49.43 81.28 111.60 -49.39 86.78 108.40 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -55.05 88.25 125.09 -55.04 86.55 126.35 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 2 3 # 2 P 182 LYS A 264 LYS~? 22.00 CL CL A 382 P 184 LYS A 268 LYS~? 13.60 CL CL A 382 P 345 ASP A 257 ASP.? 24.30 CL CL A 383 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -47.11 79.10 113.63 -43.53 76.03 116.02 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -55.05 88.25 125.09 -55.04 86.55 126.35 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 3 3 # 3 P 182 LYS A 267 LYS~? 27.66 CL CL A 382 P 184 LYS A 264 LYS~? 22.00 CL CL A 382 P 345 ASP A 240 ASP.? 30.06 CL CL A 382 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -49.43 81.28 111.60 -49.39 86.78 108.40 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -54.36 78.15 100.29 -55.09 76.20 100.68 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 4 3 # 4 P 182 LYS A 268 LYS~? 13.60 CL CL A 382 P 184 LYS A 264 LYS~? 22.00 CL CL A 382 P 345 ASP A 240 ASP.? 30.06 CL CL A 382 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -47.11 79.10 113.63 -43.53 76.03 116.02 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -54.36 78.15 100.29 -55.09 76.20 100.68 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 5 3 # 5 P 182 LYS B 264 LYS~? 21.76 CL CL B 383 P 184 LYS B 267 LYS~? 27.57 CL CL B 383 P 345 ASP B 257 ASP.? 23.04 CL CL B 384 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 11.01 31.36 75.69 9.79 34.42 71.26 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 9.46 31.45 81.02 15.36 33.08 81.01 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 12.38 23.16 66.89 10.36 22.88 66.20 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 6 3 # 6 P 182 LYS B 264 LYS~? 21.76 CL CL B 383 P 184 LYS B 268 LYS~? 13.29 CL CL B 383 P 345 ASP B 257 ASP.? 23.04 CL CL B 384 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 11.01 31.36 75.69 9.79 34.42 71.26 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 5.99 32.14 79.72 1.11 32.64 77.72 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 12.38 23.16 66.89 10.36 22.88 66.20 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 7 3 # 7 P 182 LYS B 267 LYS~? 27.57 CL CL B 383 P 184 LYS B 264 LYS~? 21.76 CL CL B 383 P 345 ASP B 240 ASP.? 29.22 CL CL B 383 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 9.46 31.45 81.02 15.36 33.08 81.01 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 11.01 31.36 75.69 9.79 34.42 71.26 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 11.35 28.88 93.27 10.37 30.59 94.07 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 8 3 # 8 P 182 LYS B 268 LYS~? 13.29 CL CL B 383 P 184 LYS B 264 LYS~? 21.76 CL CL B 383 P 345 ASP B 240 ASP.? 29.22 CL CL B 383 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 5.99 32.14 79.72 1.11 32.64 77.72 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 11.01 31.36 75.69 9.79 34.42 71.26 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 11.35 28.88 93.27 10.37 30.59 94.07 2dw7_c47 source 2dw7 BLL6730 PROTEIN : 8 hits 2dw7_c47 naa= 3 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 150 TYR A 181 TYR.? 17.32 CL CL A 382 A 245 ASP A 344 ASP.? 20.56 CL CL A 382 A 273 LYS A 133 LYS^? 12.95 CL CL A 382 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -33.79 79.99 107.82 -35.55 78.08 108.89 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -40.03 84.87 115.12 -41.94 84.93 114.19 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -30.69 80.61 120.28 -26.75 77.00 119.43 2gsa_c02 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 1 hits 2gsa_c02 naa= 3 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 1 3 # 1 B 137 SER A 222 SER.? 30.25 CL CL A 383 B 158 HIS A 223 HIS.? 29.08 CL CL A 383 B 208 ASN A 258 ASN~? 27.57 CL CL A 383 coo 50.29 50.10 71.46 47.85 50.06 71.46 -59.78 88.32 124.78 -60.21 90.11 123.17 coo 48.67 45.40 71.68 47.67 46.90 70.60 -56.62 90.70 129.56 -55.95 91.22 131.48 coo 48.91 49.12 65.17 47.29 49.14 66.54 -54.65 91.43 120.94 -52.65 90.78 121.44 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 2 3 # 2 B 137 SER B 161 SER~? 16.65 CL CL B 384 B 158 HIS B 157 HIS~? 12.80 CL CL B 384 B 208 ASN B 160 ASN~? 11.23 CL CL B 384 coo 50.29 50.10 71.46 47.85 50.06 71.46 4.53 29.49 70.92 4.35 29.43 68.47 coo 48.67 45.40 71.68 47.67 46.90 70.60 0.17 24.88 70.38 1.86 23.62 70.32 coo 48.91 49.12 65.17 47.29 49.14 66.54 0.91 30.00 73.77 -0.90 30.65 74.84 2hdh_c02 source 2hdh L-3-HYDROXYACYL COA DEHYDROGENASE : 2 hits 2hdh_c02 naa= 3 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 A 311 HIS A 19 HIS^? 24.55 CL CL A 382 A 341 GLU A 18 GLU^? 23.23 CL CL A 382 A 356 HIS A 21 HIS.? 26.92 CL CL A 384 coo 121.00 36.37 19.26 121.57 38.37 19.56 -17.70 51.01 127.32 -17.43 50.94 129.40 coo 125.72 32.70 19.75 124.44 34.16 18.84 -12.62 56.10 125.83 -13.81 57.82 125.60 coo 124.34 41.73 25.55 123.79 42.60 23.72 -13.56 47.86 119.72 -11.56 48.42 120.07 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 2 3 # 2 A 311 HIS B 19 HIS^? 13.92 CL CL B 382 A 341 GLU B 18 GLU^? 5.91 CL CL B 382 A 356 HIS B 21 HIS.? 12.39 CL CL B 382 coo 121.00 36.37 19.26 121.57 38.37 19.56 -33.46 45.18 72.05 -34.46 43.90 70.71 coo 125.72 32.70 19.75 124.44 34.16 18.84 -29.91 50.09 69.26 -29.49 51.30 70.99 coo 124.34 41.73 25.55 123.79 42.60 23.72 -35.26 51.10 78.45 -35.36 53.13 77.89 2isd_c00 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 2 hits 2isd_c00 naa= 3 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 B 311 HIS A 19 HIS^? 24.55 CL CL A 382 B 341 GLU A 18 GLU^? 23.23 CL CL A 382 B 356 HIS A 21 HIS.? 26.92 CL CL A 384 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -17.70 51.01 127.32 -17.43 50.94 129.40 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -12.62 56.10 125.83 -13.81 57.82 125.60 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -13.56 47.86 119.72 -11.56 48.42 120.07 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 2 3 # 2 B 311 HIS B 19 HIS^? 13.92 CL CL B 382 B 341 GLU B 18 GLU^? 5.91 CL CL B 382 B 356 HIS B 21 HIS.? 12.39 CL CL B 382 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -33.46 45.18 72.05 -34.46 43.90 70.71 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -29.91 50.09 69.26 -29.49 51.30 70.99 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -35.26 51.10 78.45 -35.36 53.13 77.89 2isd_c01 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 2 hits 2isd_c01 naa= 3 ULMN 3 2jxr_c04 LIGAND CP-081282 user 1 3 # 1 A 32 ASP A 28 ASP^? 9.02 CL CL A 382 A 35 SER A 29 SER^? 6.92 CL CL A 382 A 215 ASP A 26 ASP^? 16.59 CL CL A 382 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -32.19 59.08 116.32 -33.48 59.98 114.85 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -31.31 63.66 116.96 -29.07 63.86 117.79 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 2jxr_c04 LIGAND CP-081282 user 2 3 # 2 A 32 ASP A 28 ASP^? 9.02 CL CL A 382 A 35 SER A 37 SER^? 9.11 CL CL A 382 A 215 ASP A 26 ASP^? 16.59 CL CL A 382 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -32.19 59.08 116.32 -33.48 59.98 114.85 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -31.72 58.75 121.63 -33.32 57.82 120.12 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -29.69 53.68 115.80 -29.91 52.24 114.24 ULMN 3 2jxr_c04 LIGAND CP-081282 user 3 3 # 3 A 32 ASP A 28 ASP^? 9.02 CL CL A 382 A 35 SER A 37 SER^? 9.11 CL CL A 382 A 215 ASP A 30 ASP^? -6.81 CL CL A 382s coo -14.00 61.45 43.99 -14.19 63.14 42.84 -32.19 59.08 116.32 -33.48 59.98 114.85 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -31.72 58.75 121.63 -33.32 57.82 120.12 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 2jxr_c04 LIGAND CP-081282 user 4 3 # 4 A 32 ASP A 28 ASP^? 9.02 CL CL A 382 A 35 SER A 37 SER^? 9.11 CL CL A 382 A 215 ASP A 39 ASP^? 16.51 CL CL A 382 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -32.19 59.08 116.32 -33.48 59.98 114.85 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -31.72 58.75 121.63 -33.32 57.82 120.12 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -29.94 52.12 119.85 -30.97 50.72 120.81 ULMN 3 2jxr_c04 LIGAND CP-081282 user 5 3 # 5 A 32 ASP A 36 ASP.? -3.33 CL CL A 382s A 35 SER A 37 SER^? 9.11 CL CL A 382 A 215 ASP A 30 ASP^? -6.81 CL CL A 382s coo -14.00 61.45 43.99 -14.19 63.14 42.84 -31.47 63.24 120.93 -31.90 65.07 119.91 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -31.72 58.75 121.63 -33.32 57.82 120.12 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -35.52 64.63 115.87 -36.96 65.19 114.43 ULMN 3 2jxr_c04 LIGAND CP-081282 user 6 3 # 6 A 32 ASP A 195 ASP.? 13.29 CL CL A 384 A 35 SER A 192 SER.? 15.36 CL CL A 384 A 215 ASP A 306 ASP.? 16.66 CL CL A 384 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -22.13 62.52 88.27 -20.53 63.80 88.70 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -26.48 60.82 89.96 -25.15 61.33 88.02 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -29.63 66.56 87.01 -28.35 68.29 87.20 ULMN 3 2jxr_c04 LIGAND CP-081282 user 7 3 # 7 A 32 ASP A 306 ASP.? 16.66 CL CL A 384 A 35 SER A 192 SER.? 15.36 CL CL A 384 A 215 ASP A 305 ASP^? 16.01 CL CL A 384 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -29.63 66.56 87.01 -28.35 68.29 87.20 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -26.48 60.82 89.96 -25.15 61.33 88.02 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -32.01 65.22 92.45 -32.49 63.34 91.63 ULMN 3 2jxr_c04 LIGAND CP-081282 user 8 3 # 8 A 32 ASP B 28 ASP^? 9.00 CL CL B 383 A 35 SER B 29 SER^? 6.98 CL CL B 383 A 215 ASP B 26 ASP^? 16.51 CL CL B 383 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -18.06 38.42 81.61 -16.37 38.03 82.88 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -14.55 40.12 78.88 -15.61 41.67 77.42 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 2jxr_c04 LIGAND CP-081282 user 9 3 # 9 A 32 ASP B 28 ASP^? 9.00 CL CL B 383 A 35 SER B 37 SER^? 9.16 CL CL B 383 A 215 ASP B 26 ASP^? 16.51 CL CL B 383 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -18.06 38.42 81.61 -16.37 38.03 82.88 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -19.96 36.46 76.97 -19.82 35.54 79.16 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -23.45 39.33 83.60 -24.23 39.48 85.53 ULMN 3 2jxr_c04 LIGAND CP-081282 user 10 3 # 10 A 32 ASP B 28 ASP^? 9.00 CL CL B 383 A 35 SER B 37 SER^? 9.16 CL CL B 383 A 215 ASP B 30 ASP^? -6.72 CL CL B 383s coo -14.00 61.45 43.99 -14.19 63.14 42.84 -18.06 38.42 81.61 -16.37 38.03 82.88 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -19.96 36.46 76.97 -19.82 35.54 79.16 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 2jxr_c04 LIGAND CP-081282 user 11 3 # 11 A 32 ASP B 28 ASP^? 9.00 CL CL B 383 A 35 SER B 37 SER^? 9.16 CL CL B 383 A 215 ASP B 39 ASP^? 17.51 CL CL B 383 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -18.06 38.42 81.61 -16.37 38.03 82.88 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -19.96 36.46 76.97 -19.82 35.54 79.16 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -26.18 36.85 80.53 -27.97 36.10 81.34 ULMN 3 2jxr_c04 LIGAND CP-081282 user 12 3 # 12 A 32 ASP B 36 ASP.? -3.35 CL CL B 383s A 35 SER B 37 SER^? 9.16 CL CL B 383 A 215 ASP B 30 ASP^? -6.72 CL CL B 383s coo -14.00 61.45 43.99 -14.19 63.14 42.84 -15.98 38.04 75.83 -14.00 38.51 76.08 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -19.96 36.46 76.97 -19.82 35.54 79.16 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -11.77 37.20 80.70 -10.35 36.55 82.15 ULMN 3 2jxr_c04 LIGAND CP-081282 user 13 3 # 13 A 32 ASP B 195 ASP.? 10.47 CL CL A 384 A 35 SER B 192 SER.? 13.26 CL CL A 384 A 215 ASP B 306 ASP.? 19.57 CL CL A 384 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -11.82 59.91 101.57 -11.61 61.10 99.82 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -11.80 54.65 102.27 -11.20 56.97 103.08 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -4.64 54.84 103.01 -3.71 56.24 101.58 2jxr_c04 source 2jxr LIGAND CP-081282 : 13 hits 2jxr_c04 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 97 PHE~? 13.64 CL CL A 383 A 263 ASP A 93 ASP^? 5.15 CL CL A 382 A 292 LYS A 128 LYS.? 19.46 CL CL A 382 coo 51.51 50.32 16.39 52.13 49.68 13.75 -33.26 63.92 133.83 -31.10 62.40 134.75 coo 54.43 44.82 23.74 55.21 45.06 21.80 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 63.95 45.30 16.71 59.11 49.15 16.05 -25.12 72.76 133.10 -20.68 68.32 134.09 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 177 PHE A 213 PHE.? 23.30 CL CL A 383 A 263 ASP A 240 ASP.? 30.06 CL CL A 382 A 292 LYS A 267 LYS~? 27.66 CL CL A 382 coo 51.51 50.32 16.39 52.13 49.68 13.75 -56.84 71.96 107.29 -56.22 69.93 109.07 coo 54.43 44.82 23.74 55.21 45.06 21.80 -54.36 78.15 100.29 -55.09 76.20 100.68 coo 63.95 45.30 16.71 59.11 49.15 16.05 -49.43 81.28 111.60 -49.39 86.78 108.40 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 177 PHE B 97 PHE~? 13.75 CL CL B 384 A 263 ASP B 93 ASP^? 5.22 CL CL B 383 A 292 LYS B 128 LYS.? 19.37 CL CL B 383 coo 51.51 50.32 16.39 52.13 49.68 13.75 -18.35 31.53 64.75 -20.77 32.66 63.92 coo 54.43 44.82 23.74 55.21 45.06 21.80 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 63.95 45.30 16.71 59.11 49.15 16.05 -13.49 41.25 59.55 -18.50 40.98 58.08 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 A 177 PHE B 213 PHE.? 22.76 CL CL B 384 A 263 ASP B 240 ASP.? 29.22 CL CL B 383 A 292 LYS B 267 LYS~? 27.57 CL CL B 383 coo 51.51 50.32 16.39 52.13 49.68 13.75 5.57 24.21 90.55 3.01 23.56 89.66 coo 54.43 44.82 23.74 55.21 45.06 21.80 11.35 28.88 93.27 10.37 30.59 94.07 coo 63.95 45.30 16.71 59.11 49.15 16.05 9.46 31.45 81.02 15.36 33.08 81.01 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 4 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 97 PHE~? 13.64 CL CL A 383 B 263 ASP A 93 ASP^? 5.15 CL CL A 382 B 292 LYS A 128 LYS.? 19.46 CL CL A 382 coo 49.99 26.05 6.28 51.46 26.87 8.49 -33.26 63.92 133.83 -31.10 62.40 134.75 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 60.53 31.67 0.97 57.79 27.51 3.63 -25.12 72.76 133.10 -20.68 68.32 134.09 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 177 PHE A 213 PHE.? 23.30 CL CL A 383 B 263 ASP A 240 ASP.? 30.06 CL CL A 382 B 292 LYS A 267 LYS~? 27.66 CL CL A 382 coo 49.99 26.05 6.28 51.46 26.87 8.49 -56.84 71.96 107.29 -56.22 69.93 109.07 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -54.36 78.15 100.29 -55.09 76.20 100.68 coo 60.53 31.67 0.97 57.79 27.51 3.63 -49.43 81.28 111.60 -49.39 86.78 108.40 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 B 177 PHE B 97 PHE~? 13.75 CL CL B 384 B 263 ASP B 93 ASP^? 5.22 CL CL B 383 B 292 LYS B 128 LYS.? 19.37 CL CL B 383 coo 49.99 26.05 6.28 51.46 26.87 8.49 -18.35 31.53 64.75 -20.77 32.66 63.92 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 60.53 31.67 0.97 57.79 27.51 3.63 -13.49 41.25 59.55 -18.50 40.98 58.08 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 B 177 PHE B 213 PHE.? 22.76 CL CL B 384 B 263 ASP B 240 ASP.? 29.22 CL CL B 383 B 292 LYS B 267 LYS~? 27.57 CL CL B 383 coo 49.99 26.05 6.28 51.46 26.87 8.49 5.57 24.21 90.55 3.01 23.56 89.66 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 11.35 28.88 93.27 10.37 30.59 94.07 coo 60.53 31.67 0.97 57.79 27.51 3.63 9.46 31.45 81.02 15.36 33.08 81.01 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 4 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 97 PHE~? 13.64 CL CL A 383 C 263 ASP A 93 ASP^? 5.15 CL CL A 382 C 292 LYS A 128 LYS.? 19.46 CL CL A 382 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -33.26 63.92 133.83 -31.10 62.40 134.75 coo 19.84 12.02 9.33 18.68 11.23 7.75 -30.23 63.77 124.99 -32.09 64.66 124.54 coo 12.82 3.49 4.98 17.80 5.59 1.90 -25.12 72.76 133.10 -20.68 68.32 134.09 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE A 213 PHE.? 23.30 CL CL A 383 C 263 ASP A 240 ASP.? 30.06 CL CL A 382 C 292 LYS A 267 LYS~? 27.66 CL CL A 382 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -56.84 71.96 107.29 -56.22 69.93 109.07 coo 19.84 12.02 9.33 18.68 11.23 7.75 -54.36 78.15 100.29 -55.09 76.20 100.68 coo 12.82 3.49 4.98 17.80 5.59 1.90 -49.43 81.28 111.60 -49.39 86.78 108.40 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 177 PHE B 97 PHE~? 13.75 CL CL B 384 C 263 ASP B 93 ASP^? 5.22 CL CL B 383 C 292 LYS B 128 LYS.? 19.37 CL CL B 383 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -18.35 31.53 64.75 -20.77 32.66 63.92 coo 19.84 12.02 9.33 18.68 11.23 7.75 -17.13 37.76 71.68 -15.50 36.45 72.23 coo 12.82 3.49 4.98 17.80 5.59 1.90 -13.49 41.25 59.55 -18.50 40.98 58.08 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 C 177 PHE B 213 PHE.? 22.76 CL CL B 384 C 263 ASP B 240 ASP.? 29.22 CL CL B 383 C 292 LYS B 267 LYS~? 27.57 CL CL B 383 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 5.57 24.21 90.55 3.01 23.56 89.66 coo 19.84 12.02 9.33 18.68 11.23 7.75 11.35 28.88 93.27 10.37 30.59 94.07 coo 12.82 3.49 4.98 17.80 5.59 1.90 9.46 31.45 81.02 15.36 33.08 81.01 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 4 hits 2oat_c05 naa= 3 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 178 TRP A 191 TRP^? 15.13 CL CL A 384 A 263 ASP A 195 ASP.? 13.29 CL CL A 384 A 292 LYS B 288 LYS.? 8.84 CL CL B 382 coo 48.96 45.07 19.49 48.62 41.39 18.16 -30.01 60.84 91.30 -29.83 57.58 93.47 coo 54.43 44.82 23.74 55.21 45.06 21.80 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 63.95 45.30 16.71 59.11 49.15 16.05 -16.76 54.22 83.25 -20.62 56.75 78.99 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 178 TRP A 273 TRP~? 19.00 CL CL A 383 A 263 ASP A 272 ASP~? 14.48 CL CL A 382 A 292 LYS A 264 LYS~? 22.00 CL CL A 382 coo 48.96 45.07 19.49 48.62 41.39 18.16 -50.89 71.02 111.12 -54.05 73.34 111.49 coo 54.43 44.82 23.74 55.21 45.06 21.80 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 63.95 45.30 16.71 59.11 49.15 16.05 -48.92 85.08 115.29 -44.06 86.61 118.76 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 178 TRP A 273 TRP~? 19.00 CL CL A 383 A 263 ASP A 272 ASP~? 14.48 CL CL A 382 A 292 LYS A 336 LYS^? 14.72 CL CL A 382 coo 48.96 45.07 19.49 48.62 41.39 18.16 -50.89 71.02 111.12 -54.05 73.34 111.49 coo 54.43 44.82 23.74 55.21 45.06 21.80 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 63.95 45.30 16.71 59.11 49.15 16.05 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 A 178 TRP A 341 TRP.? 10.34 CL CL A 382 A 263 ASP A 272 ASP~? 14.48 CL CL A 382 A 292 LYS A 264 LYS~? 22.00 CL CL A 382 coo 48.96 45.07 19.49 48.62 41.39 18.16 -39.95 74.25 113.33 -36.58 74.16 115.41 coo 54.43 44.82 23.74 55.21 45.06 21.80 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 63.95 45.30 16.71 59.11 49.15 16.05 -48.92 85.08 115.29 -44.06 86.61 118.76 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 A 178 TRP B 273 TRP~? 18.41 CL CL B 384 A 263 ASP B 272 ASP~? 14.11 CL CL B 383 A 292 LYS B 264 LYS~? 21.76 CL CL B 383 coo 48.96 45.07 19.49 48.62 41.39 18.16 1.07 27.51 86.17 4.21 25.26 85.33 coo 54.43 44.82 23.74 55.21 45.06 21.80 0.88 31.47 82.51 1.09 32.47 80.67 coo 63.95 45.30 16.71 59.11 49.15 16.05 11.01 31.36 75.69 9.79 34.42 71.26 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 A 178 TRP B 273 TRP~? 18.41 CL CL B 384 A 263 ASP B 272 ASP~? 14.11 CL CL B 383 A 292 LYS B 336 LYS^? 14.66 CL CL B 383 coo 48.96 45.07 19.49 48.62 41.39 18.16 1.07 27.51 86.17 4.21 25.26 85.33 coo 54.43 44.82 23.74 55.21 45.06 21.80 0.88 31.47 82.51 1.09 32.47 80.67 coo 63.95 45.30 16.71 59.11 49.15 16.05 -3.40 41.24 88.18 -4.83 35.96 88.60 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 A 178 TRP B 341 TRP.? 10.39 CL CL B 383 A 263 ASP B 272 ASP~? 14.11 CL CL B 383 A 292 LYS B 264 LYS~? 21.76 CL CL B 383 coo 48.96 45.07 19.49 48.62 41.39 18.16 -0.76 36.74 80.33 -2.75 38.82 77.66 coo 54.43 44.82 23.74 55.21 45.06 21.80 0.88 31.47 82.51 1.09 32.47 80.67 coo 63.95 45.30 16.71 59.11 49.15 16.05 11.01 31.36 75.69 9.79 34.42 71.26 2oat_c06 source 2oat ORNITHINE AMINOTRANSFERASE : 7 hits 2oat_c06 naa= 3 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 178 TRP A 191 TRP^? 15.13 CL CL A 384 B 263 ASP A 195 ASP.? 13.29 CL CL A 384 B 292 LYS B 288 LYS.? 8.84 CL CL B 382 coo 45.83 31.15 4.65 45.88 34.74 6.24 -30.01 60.84 91.30 -29.83 57.58 93.47 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 60.53 31.67 0.97 57.79 27.51 3.63 -16.76 54.22 83.25 -20.62 56.75 78.99 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 178 TRP A 273 TRP~? 19.00 CL CL A 383 B 263 ASP A 272 ASP~? 14.48 CL CL A 382 B 292 LYS A 264 LYS~? 22.00 CL CL A 382 coo 45.83 31.15 4.65 45.88 34.74 6.24 -50.89 71.02 111.12 -54.05 73.34 111.49 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 60.53 31.67 0.97 57.79 27.51 3.63 -48.92 85.08 115.29 -44.06 86.61 118.76 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 B 178 TRP A 273 TRP~? 19.00 CL CL A 383 B 263 ASP A 272 ASP~? 14.48 CL CL A 382 B 292 LYS A 336 LYS^? 14.72 CL CL A 382 coo 45.83 31.15 4.65 45.88 34.74 6.24 -50.89 71.02 111.12 -54.05 73.34 111.49 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 60.53 31.67 0.97 57.79 27.51 3.63 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 B 178 TRP A 341 TRP.? 10.34 CL CL A 382 B 263 ASP A 272 ASP~? 14.48 CL CL A 382 B 292 LYS A 264 LYS~? 22.00 CL CL A 382 coo 45.83 31.15 4.65 45.88 34.74 6.24 -39.95 74.25 113.33 -36.58 74.16 115.41 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 60.53 31.67 0.97 57.79 27.51 3.63 -48.92 85.08 115.29 -44.06 86.61 118.76 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 B 178 TRP B 273 TRP~? 18.41 CL CL B 384 B 263 ASP B 272 ASP~? 14.11 CL CL B 383 B 292 LYS B 264 LYS~? 21.76 CL CL B 383 coo 45.83 31.15 4.65 45.88 34.74 6.24 1.07 27.51 86.17 4.21 25.26 85.33 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 0.88 31.47 82.51 1.09 32.47 80.67 coo 60.53 31.67 0.97 57.79 27.51 3.63 11.01 31.36 75.69 9.79 34.42 71.26 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 B 178 TRP B 273 TRP~? 18.41 CL CL B 384 B 263 ASP B 272 ASP~? 14.11 CL CL B 383 B 292 LYS B 336 LYS^? 14.66 CL CL B 383 coo 45.83 31.15 4.65 45.88 34.74 6.24 1.07 27.51 86.17 4.21 25.26 85.33 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 0.88 31.47 82.51 1.09 32.47 80.67 coo 60.53 31.67 0.97 57.79 27.51 3.63 -3.40 41.24 88.18 -4.83 35.96 88.60 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 B 178 TRP B 341 TRP.? 10.39 CL CL B 383 B 263 ASP B 272 ASP~? 14.11 CL CL B 383 B 292 LYS B 264 LYS~? 21.76 CL CL B 383 coo 45.83 31.15 4.65 45.88 34.74 6.24 -0.76 36.74 80.33 -2.75 38.82 77.66 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 0.88 31.47 82.51 1.09 32.47 80.67 coo 60.53 31.67 0.97 57.79 27.51 3.63 11.01 31.36 75.69 9.79 34.42 71.26 2oat_c07 source 2oat ORNITHINE AMINOTRANSFERASE : 7 hits 2oat_c07 naa= 3 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 178 TRP A 191 TRP^? 15.13 CL CL A 384 C 263 ASP A 195 ASP.? 13.29 CL CL A 384 C 292 LYS B 288 LYS.? 8.84 CL CL B 382 coo 20.52 16.65 4.15 17.32 18.91 4.39 -30.01 60.84 91.30 -29.83 57.58 93.47 coo 19.84 12.02 9.33 18.68 11.23 7.75 -22.13 62.52 88.27 -20.53 63.80 88.70 coo 12.82 3.49 4.98 17.80 5.59 1.90 -16.76 54.22 83.25 -20.62 56.75 78.99 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 178 TRP A 273 TRP~? 19.00 CL CL A 383 C 263 ASP A 272 ASP~? 14.48 CL CL A 382 C 292 LYS A 264 LYS~? 22.00 CL CL A 382 coo 20.52 16.65 4.15 17.32 18.91 4.39 -50.89 71.02 111.12 -54.05 73.34 111.49 coo 19.84 12.02 9.33 18.68 11.23 7.75 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 12.82 3.49 4.98 17.80 5.59 1.90 -48.92 85.08 115.29 -44.06 86.61 118.76 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 178 TRP A 273 TRP~? 19.00 CL CL A 383 C 263 ASP A 272 ASP~? 14.48 CL CL A 382 C 292 LYS A 336 LYS^? 14.72 CL CL A 382 coo 20.52 16.65 4.15 17.32 18.91 4.39 -50.89 71.02 111.12 -54.05 73.34 111.49 coo 19.84 12.02 9.33 18.68 11.23 7.75 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 12.82 3.49 4.98 17.80 5.59 1.90 -37.43 70.02 105.34 -41.47 67.12 107.58 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 C 178 TRP A 341 TRP.? 10.34 CL CL A 382 C 263 ASP A 272 ASP~? 14.48 CL CL A 382 C 292 LYS A 264 LYS~? 22.00 CL CL A 382 coo 20.52 16.65 4.15 17.32 18.91 4.39 -39.95 74.25 113.33 -36.58 74.16 115.41 coo 19.84 12.02 9.33 18.68 11.23 7.75 -46.67 73.24 112.92 -45.43 74.19 114.38 coo 12.82 3.49 4.98 17.80 5.59 1.90 -48.92 85.08 115.29 -44.06 86.61 118.76 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 C 178 TRP B 273 TRP~? 18.41 CL CL B 384 C 263 ASP B 272 ASP~? 14.11 CL CL B 383 C 292 LYS B 264 LYS~? 21.76 CL CL B 383 coo 20.52 16.65 4.15 17.32 18.91 4.39 1.07 27.51 86.17 4.21 25.26 85.33 coo 19.84 12.02 9.33 18.68 11.23 7.75 0.88 31.47 82.51 1.09 32.47 80.67 coo 12.82 3.49 4.98 17.80 5.59 1.90 11.01 31.36 75.69 9.79 34.42 71.26 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 C 178 TRP B 273 TRP~? 18.41 CL CL B 384 C 263 ASP B 272 ASP~? 14.11 CL CL B 383 C 292 LYS B 336 LYS^? 14.66 CL CL B 383 coo 20.52 16.65 4.15 17.32 18.91 4.39 1.07 27.51 86.17 4.21 25.26 85.33 coo 19.84 12.02 9.33 18.68 11.23 7.75 0.88 31.47 82.51 1.09 32.47 80.67 coo 12.82 3.49 4.98 17.80 5.59 1.90 -3.40 41.24 88.18 -4.83 35.96 88.60 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 C 178 TRP B 341 TRP.? 10.39 CL CL B 383 C 263 ASP B 272 ASP~? 14.11 CL CL B 383 C 292 LYS B 264 LYS~? 21.76 CL CL B 383 coo 20.52 16.65 4.15 17.32 18.91 4.39 -0.76 36.74 80.33 -2.75 38.82 77.66 coo 19.84 12.02 9.33 18.68 11.23 7.75 0.88 31.47 82.51 1.09 32.47 80.67 coo 12.82 3.49 4.98 17.80 5.59 1.90 11.01 31.36 75.69 9.79 34.42 71.26 2oat_c08 source 2oat ORNITHINE AMINOTRANSFERASE : 7 hits 2oat_c08 naa= 3 ULMN 3 2phk_c02 MC-PEPTIDE user 1 3 # 1 A 149 ASP A 171 ASP.? 13.95 CL CL A 382 A 151 LYS A 128 LYS.? 19.46 CL CL A 382 A 186 THR A 173 THR.? 13.13 CL CL A 382 coo 41.42 17.90 44.98 43.39 18.36 45.61 -21.72 70.05 125.28 -22.57 71.99 125.28 coo 45.75 16.58 39.61 47.43 18.26 45.54 -25.12 72.76 133.10 -20.68 68.32 134.09 coo 45.88 23.02 44.72 46.99 21.16 44.68 -26.89 72.55 127.11 -25.69 74.31 126.61 ULMN 3 2phk_c02 MC-PEPTIDE user 2 3 # 2 A 149 ASP B 272 ASP~? 14.11 CL CL B 383 A 151 LYS B 267 LYS~? 27.57 CL CL B 383 A 186 THR B 342 THR.? 12.70 CL CL B 383 coo 41.42 17.90 44.98 43.39 18.36 45.61 0.88 31.47 82.51 1.09 32.47 80.67 coo 45.75 16.58 39.61 47.43 18.26 45.54 9.46 31.45 81.02 15.36 33.08 81.01 coo 45.88 23.02 44.72 46.99 21.16 44.68 2.93 38.40 77.77 1.00 38.51 76.85 ULMN 3 2phk_c02 MC-PEPTIDE user 3 3 # 3 A 149 ASP B 272 ASP~? 14.11 CL CL B 383 A 151 LYS B 268 LYS~? 13.29 CL CL B 383 A 186 THR B 342 THR.? 12.70 CL CL B 383 coo 41.42 17.90 44.98 43.39 18.36 45.61 0.88 31.47 82.51 1.09 32.47 80.67 coo 45.75 16.58 39.61 47.43 18.26 45.54 5.99 32.14 79.72 1.11 32.64 77.72 coo 45.88 23.02 44.72 46.99 21.16 44.68 2.93 38.40 77.77 1.00 38.51 76.85 ULMN 3 2phk_c02 MC-PEPTIDE user 4 3 # 4 A 149 ASP B 344 ASP.? 20.04 CL CL B 383 A 151 LYS B 268 LYS~? 13.29 CL CL B 383 A 186 THR B 342 THR.? 12.70 CL CL B 383 coo 41.42 17.90 44.98 43.39 18.36 45.61 7.59 38.09 74.22 8.59 36.72 75.50 coo 45.75 16.58 39.61 47.43 18.26 45.54 5.99 32.14 79.72 1.11 32.64 77.72 coo 45.88 23.02 44.72 46.99 21.16 44.68 2.93 38.40 77.77 1.00 38.51 76.85 2phk_c02 source 2phk MC-PEPTIDE : 4 hits 2phk_c02 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 26 ASP^? 16.59 CL CL A 382 166 GLY A 7 GLY.? 16.09 CL CL A 384 169 GLU B 307 GLU.? 20.03 CL CL A 384 coo 8.28 6.87 1.62 10.08 5.77 1.34 -29.69 53.68 115.80 -29.91 52.24 114.24 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -12.90 54.74 109.89 -12.31 54.99 110.52 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -8.15 49.66 106.11 -10.31 49.68 106.12 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 28 ASP^? 9.02 CL CL A 382 166 GLY A 285 GLY^? 9.46 CL CL A 384 169 GLU B 201 GLU^? 17.46 CL CL A 384 coo 8.28 6.87 1.62 10.08 5.77 1.34 -32.19 59.08 116.32 -33.48 59.98 114.85 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -22.09 57.26 103.59 -22.19 58.16 103.73 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -19.06 50.53 95.26 -20.94 50.61 94.28 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP A 30 ASP^? -6.81 CL CL A 382s 166 GLY A 74 GLY^? 16.51 CL CL A 382 169 GLU A 57 GLU.? 23.36 CL CL A 382 coo 8.28 6.87 1.62 10.08 5.77 1.34 -35.52 64.63 115.87 -36.96 65.19 114.43 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -31.70 53.74 130.27 -31.13 53.19 130.05 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -23.46 53.73 134.86 -22.94 54.54 136.68 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP A 36 ASP.? -3.33 CL CL A 382s 166 GLY A 178 GLY.? 12.46 CL CL A 382 169 GLU A 135 GLU.? 22.99 CL CL A 382 coo 8.28 6.87 1.62 10.08 5.77 1.34 -31.47 63.24 120.93 -31.90 65.07 119.91 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -35.00 78.54 116.42 -34.19 78.65 116.55 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -31.98 87.75 115.72 -30.11 88.72 115.32 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP A 36 ASP.? -3.33 CL CL A 382s 166 GLY A 286 GLY.? 9.30 CL CL A 384 169 GLU A 201 GLU.? 12.07 CL CL A 384 coo 8.28 6.87 1.62 10.08 5.77 1.34 -31.47 63.24 120.93 -31.90 65.07 119.91 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -20.05 58.49 106.62 -20.88 58.44 106.59 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -24.87 56.03 99.70 -24.21 54.93 101.40 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP A 39 ASP^? 16.51 CL CL A 382 166 GLY A 7 GLY.? 16.09 CL CL A 384 169 GLU B 307 GLU.? 20.03 CL CL A 384 coo 8.28 6.87 1.62 10.08 5.77 1.34 -29.94 52.12 119.85 -30.97 50.72 120.81 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -12.90 54.74 109.89 -12.31 54.99 110.52 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -8.15 49.66 106.11 -10.31 49.68 106.12 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 7 3 # 7 141 ASP A 39 ASP^? 16.51 CL CL A 382 166 GLY A 285 GLY^? 9.46 CL CL A 384 169 GLU B 201 GLU^? 17.46 CL CL A 384 coo 8.28 6.87 1.62 10.08 5.77 1.34 -29.94 52.12 119.85 -30.97 50.72 120.81 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -22.09 57.26 103.59 -22.19 58.16 103.73 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -19.06 50.53 95.26 -20.94 50.61 94.28 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 8 3 # 8 141 ASP A 64 ASP.? 15.21 CL CL A 384 166 GLY A 16 GLY.? 25.17 CL CL A 382 169 GLU A 57 GLU.? 23.36 CL CL A 382 coo 8.28 6.87 1.62 10.08 5.77 1.34 -13.50 61.63 115.26 -13.45 60.20 113.75 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -13.92 58.16 131.98 -14.38 57.51 131.82 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -23.46 53.73 134.86 -22.94 54.54 136.68 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 9 3 # 9 141 ASP A 64 ASP.? 15.21 CL CL A 384 166 GLY A 71 GLY^? 11.87 CL CL A 382 169 GLU A 57 GLU.? 23.36 CL CL A 382 coo 8.28 6.87 1.62 10.08 5.77 1.34 -13.50 61.63 115.26 -13.45 60.20 113.75 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -27.35 61.47 128.32 -26.64 61.26 128.60 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -23.46 53.73 134.86 -22.94 54.54 136.68 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 10 3 # 10 141 ASP A 93 ASP^? 5.15 CL CL A 382 166 GLY A 177 GLY^? 12.19 CL CL A 382 169 GLU A 135 GLU.? 22.99 CL CL A 382 coo 8.28 6.87 1.62 10.08 5.77 1.34 -30.23 63.77 124.99 -32.09 64.66 124.54 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -34.43 78.99 120.11 -35.00 78.45 120.07 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -31.98 87.75 115.72 -30.11 88.72 115.32 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 11 3 # 11 141 ASP A 93 ASP^? 5.15 CL CL A 382 166 GLY A 178 GLY.? 12.46 CL CL A 382 169 GLU A 135 GLU.? 22.99 CL CL A 382 coo 8.28 6.87 1.62 10.08 5.77 1.34 -30.23 63.77 124.99 -32.09 64.66 124.54 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -35.00 78.54 116.42 -34.19 78.65 116.55 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -31.98 87.75 115.72 -30.11 88.72 115.32 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 12 3 # 12 141 ASP A 115 ASP~? 22.59 CL CL A 382 166 GLY A 172 GLY.? 11.19 CL CL A 382 169 GLU A 60 GLU^? 17.84 CL CL A 382 coo 8.28 6.87 1.62 10.08 5.77 1.34 -35.38 84.29 133.21 -33.68 85.51 133.25 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -25.92 68.80 127.33 -25.78 69.49 126.95 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -20.60 62.82 127.64 -18.87 63.84 128.41 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 13 3 # 13 141 ASP A 180 ASP.? 19.13 CL CL A 382 166 GLY A 172 GLY.? 11.19 CL CL A 382 169 GLU A 60 GLU^? 17.84 CL CL A 382 coo 8.28 6.87 1.62 10.08 5.77 1.34 -29.53 80.77 112.24 -28.62 82.54 111.55 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -25.92 68.80 127.33 -25.78 69.49 126.95 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -20.60 62.82 127.64 -18.87 63.84 128.41 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 14 3 # 14 141 ASP A 195 ASP.? 13.29 CL CL A 384 166 GLY B 65 GLY.? -4.07 CL CL B 382s 169 GLU B 18 GLU^? 5.91 CL CL B 382 coo 8.28 6.87 1.62 10.08 5.77 1.34 -22.13 62.52 88.27 -20.53 63.80 88.70 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -21.30 55.60 72.20 -21.07 55.03 72.67 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -29.91 50.09 69.26 -29.49 51.30 70.99 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 15 3 # 15 141 ASP A 204 ASP^? 18.76 CL CL A 384 166 GLY A 328 GLY^? 17.20 CL CL A 384 169 GLU A 23 GLU.? 27.24 CL CL A 382 coo 8.28 6.87 1.62 10.08 5.77 1.34 -37.06 58.40 100.88 -36.30 56.45 100.53 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -21.48 50.12 107.21 -22.25 50.36 107.20 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -22.84 44.28 116.17 -23.55 42.53 115.22 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 16 3 # 16 141 ASP A 291 ASP.? 7.30 CL CL A 384 166 GLY A 65 GLY.? 20.01 CL CL A 384 169 GLU A 18 GLU^? 23.23 CL CL A 382 coo 8.28 6.87 1.62 10.08 5.77 1.34 -15.45 71.21 105.07 -17.40 71.77 105.62 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -13.27 62.71 120.05 -13.88 62.83 119.56 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -12.62 56.10 125.83 -13.81 57.82 125.60 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 17 3 # 17 141 ASP A 291 ASP.? 7.30 CL CL A 384 166 GLY A 65 GLY.? 20.01 CL CL A 384 169 GLU A 60 GLU^? 17.84 CL CL A 382 coo 8.28 6.87 1.62 10.08 5.77 1.34 -15.45 71.21 105.07 -17.40 71.77 105.62 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -13.27 62.71 120.05 -13.88 62.83 119.56 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -20.60 62.82 127.64 -18.87 63.84 128.41 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 18 3 # 18 141 ASP A 306 ASP.? 16.66 CL CL A 384 166 GLY B 328 GLY^? 19.77 CL CL B 382 169 GLU B 23 GLU.? 22.91 CL CL B 382 coo 8.28 6.87 1.62 10.08 5.77 1.34 -29.63 66.56 87.01 -28.35 68.29 87.20 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -27.69 48.95 90.13 -27.15 48.30 90.26 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -35.83 43.78 85.87 -35.49 42.75 87.75 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 19 3 # 19 141 ASP B 28 ASP^? 9.00 CL CL B 383 166 GLY B 285 GLY^? 18.43 CL CL A 384 169 GLU A 201 GLU.? 12.07 CL CL A 384 coo 8.28 6.87 1.62 10.08 5.77 1.34 -18.06 38.42 81.61 -16.37 38.03 82.88 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -20.19 51.54 90.83 -19.46 51.66 90.42 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -24.87 56.03 99.70 -24.21 54.93 101.40 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 20 3 # 20 141 ASP B 30 ASP^? -6.72 CL CL B 383s 166 GLY B 74 GLY^? 16.45 CL CL B 383 169 GLU B 57 GLU.? 21.35 CL CL B 382 coo 8.28 6.87 1.62 10.08 5.77 1.34 -11.77 37.20 80.70 -10.35 36.55 82.15 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -26.68 31.63 71.52 -27.33 32.04 71.74 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -31.25 37.00 65.18 -31.15 36.75 63.13 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 21 3 # 21 141 ASP B 36 ASP.? -3.35 CL CL B 383s 166 GLY B 177 GLY^? 12.21 CL CL B 383 169 GLU B 135 GLU.? 23.43 CL CL B 383 coo 8.28 6.87 1.62 10.08 5.77 1.34 -15.98 38.04 75.83 -14.00 38.51 76.08 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -0.75 40.04 70.93 -0.92 39.38 71.34 coo -16.67 7.89 2.78 -17.65 6.56 1.49 7.28 45.80 70.11 9.12 46.58 70.84 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 22 3 # 22 141 ASP B 36 ASP.? -3.35 CL CL B 383s 166 GLY B 178 GLY.? 12.55 CL CL B 383 169 GLU B 135 GLU.? 23.43 CL CL B 383 coo 8.28 6.87 1.62 10.08 5.77 1.34 -15.98 38.04 75.83 -14.00 38.51 76.08 coo -8.58 13.22 3.21 -8.90 13.15 4.05 0.20 40.92 74.47 -0.03 41.61 74.05 coo -16.67 7.89 2.78 -17.65 6.56 1.49 7.28 45.80 70.11 9.12 46.58 70.84 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 23 3 # 23 141 ASP B 36 ASP.? -3.35 CL CL B 383s 166 GLY B 286 GLY.? 16.50 CL CL B 382 169 GLU B 201 GLU^? 17.46 CL CL A 384 coo 8.28 6.87 1.62 10.08 5.77 1.34 -15.98 38.04 75.83 -14.00 38.51 76.08 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -20.98 52.54 87.27 -20.62 51.84 87.46 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -19.06 50.53 95.26 -20.94 50.61 94.28 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 24 3 # 24 141 ASP B 64 ASP.? 7.14 CL CL B 382 166 GLY B 16 GLY.? 13.71 CL CL B 382 169 GLU B 57 GLU.? 21.35 CL CL B 382 coo 8.28 6.87 1.62 10.08 5.77 1.34 -22.24 55.99 77.05 -23.77 56.03 78.56 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -31.15 46.32 63.21 -31.52 45.86 63.71 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -31.25 37.00 65.18 -31.15 36.75 63.13 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 25 3 # 25 141 ASP B 64 ASP.? 7.14 CL CL B 382 166 GLY B 71 GLY^? 12.01 CL CL B 383 169 GLU B 57 GLU.? 21.35 CL CL B 382 coo 8.28 6.87 1.62 10.08 5.77 1.34 -22.24 55.99 77.05 -23.77 56.03 78.56 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -21.31 38.41 68.97 -21.84 38.86 68.63 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -31.25 37.00 65.18 -31.15 36.75 63.13 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 26 3 # 26 141 ASP B 93 ASP^? 5.22 CL CL B 383 166 GLY B 177 GLY^? 12.21 CL CL B 383 169 GLU B 135 GLU.? 23.43 CL CL B 383 coo 8.28 6.87 1.62 10.08 5.77 1.34 -17.13 37.76 71.68 -15.50 36.45 72.23 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -0.75 40.04 70.93 -0.92 39.38 71.34 coo -16.67 7.89 2.78 -17.65 6.56 1.49 7.28 45.80 70.11 9.12 46.58 70.84 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 27 3 # 27 141 ASP B 93 ASP^? 5.22 CL CL B 383 166 GLY B 178 GLY.? 12.55 CL CL B 383 169 GLU B 135 GLU.? 23.43 CL CL B 383 coo 8.28 6.87 1.62 10.08 5.77 1.34 -17.13 37.76 71.68 -15.50 36.45 72.23 coo -8.58 13.22 3.21 -8.90 13.15 4.05 0.20 40.92 74.47 -0.03 41.61 74.05 coo -16.67 7.89 2.78 -17.65 6.56 1.49 7.28 45.80 70.11 9.12 46.58 70.84 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 28 3 # 28 141 ASP B 115 ASP~? 22.59 CL CL B 383 166 GLY B 172 GLY.? 11.11 CL CL B 383 169 GLU B 60 GLU^? 11.77 CL CL B 382 coo 8.28 6.87 1.62 10.08 5.77 1.34 0.29 34.85 57.65 0.95 36.59 56.65 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -14.97 41.92 66.55 -14.33 42.42 66.54 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -22.53 44.68 66.99 -22.71 45.90 65.28 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 29 3 # 29 141 ASP B 180 ASP.? 19.08 CL CL B 383 166 GLY B 172 GLY.? 11.11 CL CL B 383 169 GLU B 60 GLU^? 11.77 CL CL B 382 coo 8.28 6.87 1.62 10.08 5.77 1.34 0.82 48.22 75.52 2.17 49.73 74.84 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -14.97 41.92 66.55 -14.33 42.42 66.54 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -22.53 44.68 66.99 -22.71 45.90 65.28 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 30 3 # 30 141 ASP B 195 ASP.? 10.47 CL CL A 384 166 GLY A 65 GLY.? 20.01 CL CL A 384 169 GLU A 18 GLU^? 23.23 CL CL A 382 coo 8.28 6.87 1.62 10.08 5.77 1.34 -11.82 59.91 101.57 -11.61 61.10 99.82 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -13.27 62.71 120.05 -13.88 62.83 119.56 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -12.62 56.10 125.83 -13.81 57.82 125.60 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 31 3 # 31 141 ASP B 204 ASP^? 22.18 CL CL B 383 166 GLY B 298 GLY.? 11.52 CL CL B 383 169 GLU B 169 GLU.? 11.31 CL CL B 383 coo 8.28 6.87 1.62 10.08 5.77 1.34 -12.38 39.84 96.49 -14.33 39.98 97.22 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -5.74 45.82 78.88 -6.06 46.14 79.52 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -9.49 44.22 70.62 -8.22 45.44 69.57 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 32 3 # 32 141 ASP B 204 ASP^? 22.18 CL CL B 383 166 GLY B 328 GLY^? 19.77 CL CL B 382 169 GLU B 23 GLU.? 22.91 CL CL B 382 coo 8.28 6.87 1.62 10.08 5.77 1.34 -12.38 39.84 96.49 -14.33 39.98 97.22 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -27.69 48.95 90.13 -27.15 48.30 90.26 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -35.83 43.78 85.87 -35.49 42.75 87.75 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 33 3 # 33 141 ASP B 305 ASP^? 21.59 CL CL A 384 166 GLY A 328 GLY^? 17.20 CL CL A 384 169 GLU A 23 GLU.? 27.24 CL CL A 382 coo 8.28 6.87 1.62 10.08 5.77 1.34 -6.28 49.81 99.79 -7.51 49.10 101.38 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -21.48 50.12 107.21 -22.25 50.36 107.20 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -22.84 44.28 116.17 -23.55 42.53 115.22 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 34 3 # 34 141 ASP B 306 ASP.? 19.57 CL CL A 384 166 GLY A 328 GLY^? 17.20 CL CL A 384 169 GLU A 23 GLU.? 27.24 CL CL A 382 coo 8.28 6.87 1.62 10.08 5.77 1.34 -4.64 54.84 103.01 -3.71 56.24 101.58 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -21.48 50.12 107.21 -22.25 50.36 107.20 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -22.84 44.28 116.17 -23.55 42.53 115.22 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 34 hits 2tdt_c00 naa= 3 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 A 59 ARG A 13 ARG^? 21.22 CL CL A 382 A 130 SER A 58 SER^? 17.88 CL CL A 382 A 159 LYS A 17 LYS^? 30.54 CL CL A 382 coo 18.35 45.84 20.99 16.20 47.83 21.89 -15.61 60.27 127.72 -14.54 62.09 125.47 coo 15.14 43.67 10.77 15.61 44.43 13.04 -24.38 59.07 132.81 -24.91 60.78 134.35 coo 11.57 48.49 22.18 13.51 49.99 17.21 -13.97 54.79 130.31 -12.29 50.22 133.16 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 A 59 ARG A 85 ARG^? 33.58 CL CL A 382 A 130 SER A 88 SER^? 22.34 CL CL A 382 A 159 LYS A 80 LYS^? 36.93 CL CL A 382 coo 18.35 45.84 20.99 16.20 47.83 21.89 -20.06 35.34 124.61 -20.05 37.26 127.03 coo 15.14 43.67 10.77 15.61 44.43 13.04 -26.75 46.25 123.96 -28.99 45.42 123.71 coo 11.57 48.49 22.18 13.51 49.99 17.21 -26.02 34.53 124.81 -22.64 33.14 129.86 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 3 3 # 3 A 59 ARG B 13 ARG^? 4.84 CL CL B 382 A 130 SER B 58 SER^? 18.06 CL CL B 383 A 159 LYS B 17 LYS^? 18.67 CL CL B 382 coo 18.35 45.84 20.99 16.20 47.83 21.89 -26.14 48.57 68.77 -25.79 51.69 68.63 coo 15.14 43.67 10.77 15.61 44.43 13.04 -25.70 38.53 65.32 -24.63 37.89 63.26 coo 11.57 48.49 22.18 13.51 49.99 17.21 -33.42 46.60 66.26 -37.89 44.12 63.72 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 4 3 # 4 A 59 ARG B 85 ARG^? 26.72 CL CL B 382 A 130 SER B 88 SER^? 22.31 CL CL B 383 A 159 LYS B 80 LYS^? 31.45 CL CL B 382 coo 18.35 45.84 20.99 16.20 47.83 21.89 -45.61 37.84 80.13 -46.20 40.84 79.69 coo 15.14 43.67 10.77 15.61 44.43 13.04 -33.45 36.60 78.54 -33.30 34.49 79.66 coo 11.57 48.49 22.18 13.51 49.99 17.21 -43.65 33.60 82.90 -47.69 34.28 78.00 2tps_c00 source 2tps THIAMIN PHOSPHATE SYNTHASE : 4 hits 2tps_c00 naa= 3 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 B 59 ARG A 13 ARG^? 21.22 CL CL A 382 B 130 SER A 58 SER^? 17.88 CL CL A 382 B 159 LYS A 17 LYS^? 30.54 CL CL A 382 coo 58.72 31.58 20.45 60.80 29.39 20.94 -15.61 60.27 127.72 -14.54 62.09 125.47 coo 61.66 35.17 10.39 61.29 34.14 12.56 -24.38 59.07 132.81 -24.91 60.78 134.35 coo 65.38 28.77 21.17 63.49 28.03 16.12 -13.97 54.79 130.31 -12.29 50.22 133.16 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 B 59 ARG A 85 ARG^? 33.58 CL CL A 382 B 130 SER A 88 SER^? 22.34 CL CL A 382 B 159 LYS A 80 LYS^? 36.93 CL CL A 382 coo 58.72 31.58 20.45 60.80 29.39 20.94 -20.06 35.34 124.61 -20.05 37.26 127.03 coo 61.66 35.17 10.39 61.29 34.14 12.56 -26.75 46.25 123.96 -28.99 45.42 123.71 coo 65.38 28.77 21.17 63.49 28.03 16.12 -26.02 34.53 124.81 -22.64 33.14 129.86 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 3 3 # 3 B 59 ARG B 13 ARG^? 4.84 CL CL B 382 B 130 SER B 58 SER^? 18.06 CL CL B 383 B 159 LYS B 17 LYS^? 18.67 CL CL B 382 coo 58.72 31.58 20.45 60.80 29.39 20.94 -26.14 48.57 68.77 -25.79 51.69 68.63 coo 61.66 35.17 10.39 61.29 34.14 12.56 -25.70 38.53 65.32 -24.63 37.89 63.26 coo 65.38 28.77 21.17 63.49 28.03 16.12 -33.42 46.60 66.26 -37.89 44.12 63.72 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 4 3 # 4 B 59 ARG B 85 ARG^? 26.72 CL CL B 382 B 130 SER B 88 SER^? 22.31 CL CL B 383 B 159 LYS B 80 LYS^? 31.45 CL CL B 382 coo 58.72 31.58 20.45 60.80 29.39 20.94 -45.61 37.84 80.13 -46.20 40.84 79.69 coo 61.66 35.17 10.39 61.29 34.14 12.56 -33.45 36.60 78.54 -33.30 34.49 79.66 coo 65.38 28.77 21.17 63.49 28.03 16.12 -43.65 33.60 82.90 -47.69 34.28 78.00 2tps_c01 source 2tps THIAMIN PHOSPHATE SYNTHASE : 4 hits 2tps_c01 naa= 3 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 1 3 # 1 71 ARG B 212 ARG.? 28.47 CL CL B 383 127 ARG B 247 ARG.? 24.65 CL CL B 384 270 GLU B 215 GLU^? 32.93 CL CL B 384 coo -1.14 25.72 1.64 0.76 28.10 1.50 3.61 30.30 95.57 4.45 30.88 98.48 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 4.27 22.84 96.19 1.85 22.99 94.25 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 14.09 22.76 92.11 15.77 21.48 91.87 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 2 3 # 2 71 ARG B 212 ARG.? 28.47 CL CL B 383 127 ARG B 247 ARG.? 24.65 CL CL B 384 270 GLU B 276 GLU~? 15.94 CL CL B 384 coo -1.14 25.72 1.64 0.76 28.10 1.50 3.61 30.30 95.57 4.45 30.88 98.48 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 4.27 22.84 96.19 1.85 22.99 94.25 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -2.79 30.63 87.01 -2.36 28.59 86.68 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 3 3 # 3 71 ARG B 247 ARG.? 24.65 CL CL B 384 127 ARG B 212 ARG.? 28.47 CL CL B 383 270 GLU B 215 GLU^? 32.93 CL CL B 384 coo -1.14 25.72 1.64 0.76 28.10 1.50 4.27 22.84 96.19 1.85 22.99 94.25 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 3.61 30.30 95.57 4.45 30.88 98.48 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 14.09 22.76 92.11 15.77 21.48 91.87 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 4 3 # 4 71 ARG B 247 ARG.? 24.65 CL CL B 384 127 ARG B 212 ARG.? 28.47 CL CL B 383 270 GLU B 276 GLU~? 15.94 CL CL B 384 coo -1.14 25.72 1.64 0.76 28.10 1.50 4.27 22.84 96.19 1.85 22.99 94.25 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 3.61 30.30 95.57 4.45 30.88 98.48 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -2.79 30.63 87.01 -2.36 28.59 86.68 5cpa_c01 source 5cpa CARBOXYPEPTIDASE A=ALPHA= (COX) (E.C.3.4.17.1): 4 hits 5cpa_c01 naa= 3 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 1 3 # 1 A 81 ASP A 208 ASP.? 21.85 CL CL A 382 A 99 GLY A 277 GLY~? 20.14 CL CL A 382 A 125 ASN A 211 ASN.? 19.04 CL CL A 383 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 -48.25 63.81 104.00 -49.74 63.21 105.24 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 -46.60 67.89 104.45 -45.85 67.87 104.64 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 -52.26 68.83 108.54 -52.87 67.63 110.20 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 2 3 # 2 A 81 ASP B 208 ASP.? 21.56 CL CL B 383 A 99 GLY B 277 GLY~? 19.92 CL CL B 383 A 125 ASN B 211 ASN.? 18.42 CL CL B 384 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 -4.03 30.56 94.79 -4.11 28.51 94.21 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 -1.21 33.00 92.27 -1.59 33.59 91.90 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 0.47 26.95 89.73 -0.82 25.48 88.80 1hkd_p00 source 1hkd PEA LECTIN ALPHA CHAIN : 2 hits 1hkd_p00 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 107 ASN.? 21.78 CL CL A 383 coo 5.80 63.03 55.85 5.52 65.03 56.45 -46.65 82.65 137.36 -47.85 84.12 136.41 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 136 ASN.? 24.08 CL CL A 382 coo 5.80 63.03 55.85 5.52 65.03 56.45 -35.51 89.43 120.39 -34.74 90.84 118.94 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 137 ASN.? 20.69 CL CL A 382 coo 5.80 63.03 55.85 5.52 65.03 56.45 -34.02 87.53 125.36 -34.12 86.44 127.15 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 160 ASN~? 11.40 CL CL A 383 coo 5.80 63.03 55.85 5.52 65.03 56.45 -44.47 76.84 121.01 -43.38 75.08 120.31 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN A 199 ASN.? 4.96 CL CL A 384 coo 5.80 63.03 55.85 5.52 65.03 56.45 -21.75 61.84 97.70 -22.73 63.77 98.21 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN A 211 ASN.? 19.04 CL CL A 383 coo 5.80 63.03 55.85 5.52 65.03 56.45 -52.26 68.83 108.54 -52.87 67.63 110.20 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN A 258 ASN~? 27.57 CL CL A 383 coo 5.80 63.03 55.85 5.52 65.03 56.45 -54.65 91.43 120.94 -52.65 90.78 121.44 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN B 107 ASN.? 22.13 CL CL B 384 coo 5.80 63.03 55.85 5.52 65.03 56.45 2.05 22.81 57.51 4.16 22.93 58.02 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN B 136 ASN.? 22.72 CL CL B 383 coo 5.80 63.03 55.85 5.52 65.03 56.45 8.54 41.97 65.49 9.14 40.38 66.80 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN B 137 ASN.? 20.58 CL CL B 383 coo 5.80 63.03 55.85 5.52 65.03 56.45 4.73 40.06 62.46 3.35 38.78 61.44 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 11 1 # 11 A 461 ASN B 160 ASN~? 11.23 CL CL B 384 coo 5.80 63.03 55.85 5.52 65.03 56.45 0.91 30.00 73.77 -0.90 30.65 74.84 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 12 1 # 12 A 461 ASN B 199 ASN.? 15.74 CL CL A 384 coo 5.80 63.03 55.85 5.52 65.03 56.45 -14.23 54.82 92.98 -12.33 56.04 93.07 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 13 1 # 13 A 461 ASN B 211 ASN.? 18.42 CL CL B 384 coo 5.80 63.03 55.85 5.52 65.03 56.45 0.47 26.95 89.73 -0.82 25.48 88.80 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 14 1 # 14 A 461 ASN B 258 ASN.? 28.97 CL CL B 384 coo 5.80 63.03 55.85 5.52 65.03 56.45 15.59 26.49 68.84 17.44 27.50 69.35 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 14 hits 1kbk_p00 naa= 1 ULMN 3 2p3i_p00 VP4 user 1 3 # 1 A 101 ARG A 212 ARG.? 30.01 CL CL A 382 A 188 TYR A 238 TYR^? 27.75 CL CL A 383 A 190 SER A 214 SER.? 31.20 CL CL A 383 coo 37.69 7.64 13.51 38.82 8.84 16.11 -52.31 71.44 100.68 -54.00 71.15 98.10 coo 47.14 12.10 13.73 48.75 12.33 16.01 -54.82 80.30 106.22 -53.19 79.11 104.29 coo 43.77 6.93 15.46 45.49 7.21 17.11 -59.02 74.87 102.57 -61.42 74.47 102.83 ULMN 3 2p3i_p00 VP4 user 2 3 # 2 A 101 ARG A 300 ARG^? 15.75 CL CL A 384 A 188 TYR A 346 TYR.? 17.61 CL CL A 382 A 190 SER A 182 SER.? 20.74 CL CL A 384 coo 37.69 7.64 13.51 38.82 8.84 16.11 -30.16 77.29 106.40 -29.79 78.90 103.79 coo 47.14 12.10 13.73 48.75 12.33 16.01 -31.44 83.83 114.39 -30.05 82.53 116.45 coo 43.77 6.93 15.46 45.49 7.21 17.11 -28.54 83.33 107.44 -27.66 84.16 109.62 ULMN 3 2p3i_p00 VP4 user 3 3 # 3 A 101 ARG A 325 ARG.? 29.26 CL CL A 384 A 188 TYR A 25 TYR^? 18.63 CL CL A 382 A 190 SER A 324 SER^? 19.72 CL CL A 384 coo 37.69 7.64 13.51 38.82 8.84 16.11 -22.19 42.21 111.60 -22.86 39.29 112.51 coo 47.14 12.10 13.73 48.75 12.33 16.01 -23.49 53.13 116.11 -21.60 54.30 114.36 coo 43.77 6.93 15.46 45.49 7.21 17.11 -24.77 48.15 110.31 -26.00 48.61 108.19 ULMN 3 2p3i_p00 VP4 user 4 3 # 4 A 101 ARG B 300 ARG^? 21.49 CL CL B 383 A 188 TYR B 346 TYR.? 17.60 CL CL B 383 A 190 SER B 182 SER.? 21.98 CL CL B 383 coo 37.69 7.64 13.51 38.82 8.84 16.11 0.10 48.73 83.03 1.88 51.20 83.58 coo 47.14 12.10 13.73 48.75 12.33 16.01 3.94 45.97 72.94 1.71 46.24 71.30 coo 43.77 6.93 15.46 45.49 7.21 17.11 3.87 51.50 78.45 3.77 52.23 76.11 ULMN 3 2p3i_p00 VP4 user 5 3 # 5 A 101 ARG B 325 ARG.? 19.88 CL CL B 382 A 188 TYR B 25 TYR^? 14.27 CL CL B 382 A 190 SER B 324 SER^? 22.60 CL CL B 382 coo 37.69 7.64 13.51 38.82 8.84 16.11 -34.83 46.46 90.24 -34.50 47.08 87.15 coo 47.14 12.10 13.73 48.75 12.33 16.01 -26.62 44.42 81.68 -25.97 47.00 82.31 coo 43.77 6.93 15.46 45.49 7.21 17.11 -28.77 44.19 89.22 -27.33 44.36 91.21 2p3i_p00 source 2p3i VP4 : 5 hits 2p3i_p00 naa= 3 ULMN 3 1b01_d00 GENE REGULATION/DNA user 1 3 # 1 B 4 ARG A 193 ARG.? 15.01 CL CL B 382 B 6 THR B 329 THR^? 15.42 CL CL B 382 B 8 THR B 331 THR^? 16.17 CL CL B 383 coo 40.52 16.08 100.90 37.97 16.41 102.60 -30.19 56.43 87.97 -31.59 55.92 85.25 coo 36.11 13.64 95.03 34.54 14.86 95.91 -24.83 49.33 87.66 -25.34 51.01 86.38 coo 32.72 8.05 92.39 31.25 9.11 91.35 -18.10 46.86 87.19 -17.24 47.80 85.43 ULMN 3 1b01_d00 GENE REGULATION/DNA user 2 3 # 2 B 4 ARG A 202 ARG^? 19.65 CL CL A 384 B 6 THR A 281 THR^? 16.66 CL CL A 384 B 8 THR A 279 THR^? 15.90 CL CL A 382 coo 40.52 16.08 100.90 37.97 16.41 102.60 -32.39 54.22 100.96 -34.65 53.06 99.24 coo 36.11 13.64 95.03 34.54 14.86 95.91 -34.83 61.90 103.55 -35.70 60.62 105.09 coo 32.72 8.05 92.39 31.25 9.11 91.35 -40.03 65.40 103.95 -40.07 64.36 105.87 ULMN 3 1b01_d00 GENE REGULATION/DNA user 3 3 # 3 B 4 ARG B 193 ARG.? 19.02 CL CL A 384 B 6 THR A 329 THR^? 14.14 CL CL A 384 B 8 THR A 331 THR^? 10.31 CL CL A 384 coo 40.52 16.08 100.90 37.97 16.41 102.60 -14.12 50.83 106.82 -12.70 50.89 109.57 coo 36.11 13.64 95.03 34.54 14.86 95.91 -21.38 53.78 108.30 -19.71 54.59 109.49 coo 32.72 8.05 92.39 31.25 9.11 91.35 -26.18 59.17 108.07 -25.19 60.90 109.06 ULMN 3 1b01_d00 GENE REGULATION/DNA user 4 3 # 4 B 4 ARG B 202 ARG^? 25.52 CL CL B 383 B 6 THR B 281 THR^? 16.75 CL CL B 383 B 8 THR B 279 THR^? 15.64 CL CL B 383 coo 40.52 16.08 100.90 37.97 16.41 102.60 -17.65 42.54 97.41 -16.79 41.14 100.03 coo 36.11 13.64 95.03 34.54 14.86 95.91 -11.01 41.80 92.41 -12.17 40.05 91.86 coo 32.72 8.05 92.39 31.25 9.11 91.35 -5.97 38.16 91.98 -7.29 37.14 90.58 ULMN 3 1b01_d00 GENE REGULATION/DNA user 5 3 # 5 B 4 ARG B 247 ARG.? 24.65 CL CL B 384 B 6 THR B 244 THR.? 36.65 CL CL B 383 B 8 THR B 242 THR.? 33.18 CL CL B 383 coo 40.52 16.08 100.90 37.97 16.41 102.60 4.27 22.84 96.19 1.85 22.99 94.25 coo 36.11 13.64 95.03 34.54 14.86 95.91 11.74 26.22 101.11 11.25 27.41 102.85 coo 32.72 8.05 92.39 31.25 9.11 91.35 12.86 31.45 98.38 12.27 33.54 98.54 1b01_d00 source 1b01 GENE REGULATION/DNA : 5 hits 1b01_d00 naa= 3 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 1 3 # 1 A 9 GLN B 269 GLN~? 15.69 CL CL B 384 A 11 ASN B 211 ASN.? 18.42 CL CL B 384 A 13 ARG B 212 ARG.? 28.47 CL CL B 383 coo 33.45 2.10 7.21 34.51 1.09 5.67 4.24 26.64 82.24 2.13 26.75 81.88 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 0.47 26.95 89.73 -0.82 25.48 88.80 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 3.61 30.30 95.57 4.45 30.88 98.48 1bdv_d00 source 1bdv GENE REGULATION/DNA : 1 hits 1bdv_d00 naa= 3 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 8 TYR.? 12.26 CL CL A 384 I 306 VAL A 10 VAL^? 19.01 CL CL A 384 I 308 VAL A 61 VAL^? 14.54 CL CL A 382 coo 26.18 35.24 6.87 24.33 35.18 8.97 -16.53 57.80 111.57 -17.14 59.34 109.36 coo 23.55 29.53 9.81 23.15 27.39 10.24 -17.33 55.92 118.06 -19.16 55.97 116.87 coo 16.43 30.18 9.35 15.05 30.67 11.01 -21.58 59.57 122.87 -23.27 58.66 121.81 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR A 8 TYR.? 12.26 CL CL A 384 I 306 VAL A 10 VAL^? 19.01 CL CL A 384 I 308 VAL A 62 VAL^? 18.14 CL CL A 382 coo 26.18 35.24 6.87 24.33 35.18 8.97 -16.53 57.80 111.57 -17.14 59.34 109.36 coo 23.55 29.53 9.81 23.15 27.39 10.24 -17.33 55.92 118.06 -19.16 55.97 116.87 coo 16.43 30.18 9.35 15.05 30.67 11.01 -18.34 60.50 121.09 -16.79 61.16 122.57 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 3 3 # 3 I 303 TYR A 25 TYR^? 18.63 CL CL A 382 I 306 VAL A 10 VAL^? 19.01 CL CL A 384 I 308 VAL A 12 VAL^? 18.58 CL CL A 382 coo 26.18 35.24 6.87 24.33 35.18 8.97 -23.49 53.13 116.11 -21.60 54.30 114.36 coo 23.55 29.53 9.81 23.15 27.39 10.24 -17.33 55.92 118.06 -19.16 55.97 116.87 coo 16.43 30.18 9.35 15.05 30.67 11.01 -19.98 55.50 124.75 -21.91 54.50 124.99 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 4 3 # 4 I 303 TYR A 25 TYR^? 18.63 CL CL A 382 I 306 VAL A 10 VAL^? 19.01 CL CL A 384 I 308 VAL A 61 VAL^? 14.54 CL CL A 382 coo 26.18 35.24 6.87 24.33 35.18 8.97 -23.49 53.13 116.11 -21.60 54.30 114.36 coo 23.55 29.53 9.81 23.15 27.39 10.24 -17.33 55.92 118.06 -19.16 55.97 116.87 coo 16.43 30.18 9.35 15.05 30.67 11.01 -21.58 59.57 122.87 -23.27 58.66 121.81 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 5 3 # 5 I 303 TYR A 25 TYR^? 18.63 CL CL A 382 I 306 VAL A 10 VAL^? 19.01 CL CL A 384 I 308 VAL A 62 VAL^? 18.14 CL CL A 382 coo 26.18 35.24 6.87 24.33 35.18 8.97 -23.49 53.13 116.11 -21.60 54.30 114.36 coo 23.55 29.53 9.81 23.15 27.39 10.24 -17.33 55.92 118.06 -19.16 55.97 116.87 coo 16.43 30.18 9.35 15.05 30.67 11.01 -18.34 60.50 121.09 -16.79 61.16 122.57 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 6 3 # 6 I 303 TYR A 238 TYR^? 27.75 CL CL A 383 I 306 VAL A 216 VAL^? 25.62 CL CL A 383 I 308 VAL A 251 VAL^? 20.90 CL CL A 383 coo 26.18 35.24 6.87 24.33 35.18 8.97 -54.82 80.30 106.22 -53.19 79.11 104.29 coo 23.55 29.53 9.81 23.15 27.39 10.24 -59.01 77.46 108.79 -57.33 76.25 109.48 coo 16.43 30.18 9.35 15.05 30.67 11.01 -58.99 75.77 115.94 -56.93 75.11 115.44 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 7 3 # 7 I 303 TYR B 8 TYR.? 11.88 CL CL B 382 I 306 VAL B 10 VAL^? 8.85 CL CL B 382 I 308 VAL B 12 VAL^? 10.38 CL CL B 382 coo 26.18 35.24 6.87 24.33 35.18 8.97 -23.96 53.72 82.39 -21.76 54.53 83.93 coo 23.55 29.53 9.81 23.15 27.39 10.24 -26.72 50.24 77.32 -26.04 48.81 78.87 coo 16.43 30.18 9.35 15.05 30.67 11.01 -27.81 46.39 72.24 -27.99 44.56 73.33 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 8 3 # 8 I 303 TYR B 8 TYR.? 11.88 CL CL B 382 I 306 VAL B 10 VAL^? 8.85 CL CL B 382 I 308 VAL B 61 VAL^? 10.73 CL CL B 382 coo 26.18 35.24 6.87 24.33 35.18 8.97 -23.96 53.72 82.39 -21.76 54.53 83.93 coo 23.55 29.53 9.81 23.15 27.39 10.24 -26.72 50.24 77.32 -26.04 48.81 78.87 coo 16.43 30.18 9.35 15.05 30.67 11.01 -23.32 45.79 72.66 -23.39 44.41 74.45 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 9 3 # 9 I 303 TYR B 8 TYR.? 11.88 CL CL B 382 I 306 VAL B 10 VAL^? 8.85 CL CL B 382 I 308 VAL B 62 VAL^? 6.02 CL CL B 382 coo 26.18 35.24 6.87 24.33 35.18 8.97 -23.96 53.72 82.39 -21.76 54.53 83.93 coo 23.55 29.53 9.81 23.15 27.39 10.24 -26.72 50.24 77.32 -26.04 48.81 78.87 coo 16.43 30.18 9.35 15.05 30.67 11.01 -22.61 49.46 73.08 -23.32 50.43 71.18 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 10 3 # 10 I 303 TYR B 25 TYR^? 14.27 CL CL B 382 I 306 VAL B 10 VAL^? 8.85 CL CL B 382 I 308 VAL B 12 VAL^? 10.38 CL CL B 382 coo 26.18 35.24 6.87 24.33 35.18 8.97 -26.62 44.42 81.68 -25.97 47.00 82.31 coo 23.55 29.53 9.81 23.15 27.39 10.24 -26.72 50.24 77.32 -26.04 48.81 78.87 coo 16.43 30.18 9.35 15.05 30.67 11.01 -27.81 46.39 72.24 -27.99 44.56 73.33 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 11 3 # 11 I 303 TYR B 25 TYR^? 14.27 CL CL B 382 I 306 VAL B 10 VAL^? 8.85 CL CL B 382 I 308 VAL B 61 VAL^? 10.73 CL CL B 382 coo 26.18 35.24 6.87 24.33 35.18 8.97 -26.62 44.42 81.68 -25.97 47.00 82.31 coo 23.55 29.53 9.81 23.15 27.39 10.24 -26.72 50.24 77.32 -26.04 48.81 78.87 coo 16.43 30.18 9.35 15.05 30.67 11.01 -23.32 45.79 72.66 -23.39 44.41 74.45 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 12 3 # 12 I 303 TYR B 25 TYR^? 14.27 CL CL B 382 I 306 VAL B 10 VAL^? 8.85 CL CL B 382 I 308 VAL B 62 VAL^? 6.02 CL CL B 382 coo 26.18 35.24 6.87 24.33 35.18 8.97 -26.62 44.42 81.68 -25.97 47.00 82.31 coo 23.55 29.53 9.81 23.15 27.39 10.24 -26.72 50.24 77.32 -26.04 48.81 78.87 coo 16.43 30.18 9.35 15.05 30.67 11.01 -22.61 49.46 73.08 -23.32 50.43 71.18 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 13 3 # 13 I 303 TYR B 238 TYR^? 27.53 CL CL B 384 I 306 VAL B 216 VAL^? 24.94 CL CL B 384 I 308 VAL B 251 VAL^? 20.07 CL CL B 384 coo 26.18 35.24 6.87 24.33 35.18 8.97 12.27 28.31 87.43 11.42 30.17 89.32 coo 23.55 29.53 9.81 23.15 27.39 10.24 10.52 23.04 87.34 8.64 24.08 86.89 coo 16.43 30.18 9.35 15.05 30.67 11.01 6.84 19.80 81.78 5.62 21.68 81.92 1cqt_d00 source 1cqt GENE REGULATION/DNA : 13 hits 1cqt_d00 naa= 3 ULMN 3 1emh_d00 HYDROLASE/DNA user 1 3 # 1 A 271 PRO A 52 PRO.? 28.54 CL CL A 382 A 272 LEU A 87 LEU^? 25.88 CL CL A 382 A 276 ARG A 85 ARG^? 33.58 CL CL A 382 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -19.17 46.24 131.98 -20.49 44.89 133.25 coo 10.97 0.43 16.73 11.31 2.11 18.06 -23.18 43.60 125.38 -22.79 45.16 126.94 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -20.06 35.34 124.61 -20.05 37.26 127.03 ULMN 3 1emh_d00 HYDROLASE/DNA user 2 3 # 2 A 271 PRO A 297 PRO.? 8.38 CL CL A 382 A 272 LEU A 299 LEU.? 10.71 CL CL A 384 A 276 ARG A 300 ARG^? 15.75 CL CL A 384 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -30.58 67.43 114.39 -29.32 68.86 113.23 coo 10.97 0.43 16.73 11.31 2.11 18.06 -26.58 71.67 109.01 -24.70 71.52 110.03 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -30.16 77.29 106.40 -29.79 78.90 103.79 ULMN 3 1emh_d00 HYDROLASE/DNA user 3 3 # 3 A 271 PRO A 297 PRO.? 8.38 CL CL A 382 A 272 LEU A 316 LEU^? 11.94 CL CL A 384 A 276 ARG A 300 ARG^? 15.75 CL CL A 384 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -30.58 67.43 114.39 -29.32 68.86 113.23 coo 10.97 0.43 16.73 11.31 2.11 18.06 -30.45 69.26 108.51 -29.59 67.27 108.68 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -30.16 77.29 106.40 -29.79 78.90 103.79 ULMN 3 1emh_d00 HYDROLASE/DNA user 4 3 # 4 A 271 PRO B 52 PRO.? 22.57 CL CL B 382 A 272 LEU B 87 LEU^? 21.66 CL CL B 382 A 276 ARG B 85 ARG^? 26.72 CL CL B 382 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -39.25 39.15 69.94 -40.05 37.09 69.40 coo 10.97 0.43 16.73 11.31 2.11 18.06 -37.61 38.36 77.35 -37.44 37.97 75.15 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -45.61 37.84 80.13 -46.20 40.84 79.69 ULMN 3 1emh_d00 HYDROLASE/DNA user 5 3 # 5 A 271 PRO B 297 PRO.? 8.56 CL CL B 383 A 272 LEU B 299 LEU.? 15.29 CL CL B 383 A 276 ARG B 300 ARG^? 21.49 CL CL B 383 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -10.95 42.88 79.53 -9.83 44.84 79.61 coo 10.97 0.43 16.73 11.31 2.11 18.06 -7.09 49.81 81.40 -8.48 50.80 80.04 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 0.10 48.73 83.03 1.88 51.20 83.58 ULMN 3 1emh_d00 HYDROLASE/DNA user 6 3 # 6 A 271 PRO B 297 PRO.? 8.56 CL CL B 383 A 272 LEU B 316 LEU^? 12.95 CL CL B 383 A 276 ARG B 300 ARG^? 21.49 CL CL B 383 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -10.95 42.88 79.53 -9.83 44.84 79.61 coo 10.97 0.43 16.73 11.31 2.11 18.06 -7.83 45.76 83.74 -9.90 45.84 84.36 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 0.10 48.73 83.03 1.88 51.20 83.58 1emh_d00 source 1emh HYDROLASE/DNA : 6 hits 1emh_d00 naa= 3 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 1 3 # 1 C 70 ARG A 13 ARG^? 21.22 CL CL A 382 C 71 LYS A 17 LYS^? 30.54 CL CL A 382 C 72 VAL A 14 VAL^? 21.39 CL CL A 382 coo 23.89 33.54 29.21 26.59 34.86 28.68 -15.61 60.27 127.72 -14.54 62.09 125.47 coo 25.82 26.89 29.68 23.33 22.98 25.84 -13.97 54.79 130.31 -12.29 50.22 133.16 coo 28.86 29.08 30.37 28.04 31.02 29.93 -19.01 56.20 130.97 -20.69 54.82 131.33 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 2 3 # 2 C 70 ARG B 13 ARG^? 4.84 CL CL B 382 C 71 LYS B 17 LYS^? 18.67 CL CL B 382 C 72 VAL B 14 VAL^? 14.99 CL CL B 382 coo 23.89 33.54 29.21 26.59 34.86 28.68 -26.14 48.57 68.77 -25.79 51.69 68.63 coo 25.82 26.89 29.68 23.33 22.98 25.84 -33.42 46.60 66.26 -37.89 44.12 63.72 coo 28.86 29.08 30.37 28.04 31.02 29.93 -29.95 42.68 66.90 -30.31 40.99 68.30 1hwt_d00 source 1hwt GENE REGULATION/DNA : 2 hits 1hwt_d00 naa= 3 ULMN 4 1kx5_d03 STRUCTURAL PROTEIN/DNA user 1 4 # 1 G 5 LYS A 268 LYS~? 13.60 CL CL A 382 G 13 LYS A 336 LYS^? 14.72 CL CL A 382 G 42 ARG A 92 ARG^? 9.37 CL CL A 383 G 77 ARG B 24 ARG^? 24.13 CL CL B 382 coo 49.14 40.97 -14.96 48.29 43.12 -10.00 -47.11 79.10 113.63 -43.53 76.03 116.02 coo 61.00 51.09 -9.44 63.25 53.14 -4.71 -37.43 70.02 105.34 -41.47 67.12 107.58 coo 39.46 58.80 1.48 39.21 55.92 0.43 -35.59 58.66 126.41 -36.79 59.05 129.24 coo 76.41 82.78 -7.59 79.44 82.43 -7.90 -30.86 40.03 86.77 -33.42 38.25 86.47 ULMN 4 1kx5_d03 STRUCTURAL PROTEIN/DNA user 2 4 # 2 G 5 LYS B 268 LYS~? 13.29 CL CL B 383 G 13 LYS B 336 LYS^? 14.66 CL CL B 383 G 42 ARG B 92 ARG^? 9.18 CL CL B 384 G 77 ARG A 24 ARG^? 24.95 CL CL A 382 coo 49.14 40.97 -14.96 48.29 43.12 -10.00 5.99 32.14 79.72 1.11 32.64 77.72 coo 61.00 51.09 -9.44 63.25 53.14 -4.71 -3.40 41.24 88.18 -4.83 35.96 88.60 coo 39.46 58.80 1.48 39.21 55.92 0.43 -19.73 31.24 73.98 -19.77 29.09 71.81 coo 76.41 82.78 -7.59 79.44 82.43 -7.90 -27.53 46.21 115.11 -27.47 43.33 116.18 1kx5_d03 source 1kx5 STRUCTURAL PROTEIN/DNA : 2 hits 1kx5_d03 naa= 4 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 1 3 # 1 D 23 LYS A 288 LYS.? 12.57 CL CL A 384 D 25 THR B 194 THR.? 12.32 CL CL A 384 D 27 SER B 192 SER.? 13.26 CL CL A 384 coo 86.60 33.38 44.00 87.05 39.52 42.71 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 81.20 31.58 48.03 79.23 32.24 47.54 -14.07 57.99 105.37 -12.38 58.46 106.64 coo 79.09 29.82 54.20 77.17 28.90 53.05 -11.80 54.65 102.27 -11.20 56.97 103.08 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 2 3 # 2 D 23 LYS B 288 LYS.? 8.84 CL CL B 382 D 25 THR A 194 THR.? 13.30 CL CL B 382 D 27 SER A 192 SER.? 15.36 CL CL A 384 coo 86.60 33.38 44.00 87.05 39.52 42.71 -16.76 54.22 83.25 -20.62 56.75 78.99 coo 81.20 31.58 48.03 79.23 32.24 47.54 -23.53 58.32 86.21 -24.61 58.92 84.44 coo 79.09 29.82 54.20 77.17 28.90 53.05 -26.48 60.82 89.96 -25.15 61.33 88.02 1mjo_d00 source 1mjo TRANSCRIPTION/DNA : 2 hits 1mjo_d00 naa= 3 ULMN 4 1mnm_d00 TRANSCRIPTION/DNA user 1 4 # 1 A 19 ARG A 274 ARG~? 23.93 CL CL A 382 A 30 THR A 250 THR^? 26.09 CL CL A 383 A 34 VAL A 216 VAL^? 25.62 CL CL A 383 A 38 LYS A 239 LYS^? 36.81 CL CL A 383 coo 30.09 31.19 5.41 30.53 28.24 4.72 -45.43 76.09 104.31 -44.66 77.94 101.95 coo 19.67 42.24 -1.18 20.37 41.83 -3.18 -61.67 75.47 113.25 -63.75 75.29 113.93 coo 18.16 36.88 2.14 19.60 35.97 0.73 -59.01 77.46 108.79 -57.33 76.25 109.48 coo 16.75 32.35 6.21 21.42 30.93 2.22 -57.66 80.60 103.08 -61.70 85.06 101.44 ULMN 4 1mnm_d00 TRANSCRIPTION/DNA user 2 4 # 2 A 19 ARG B 212 ARG.? 28.47 CL CL B 383 A 30 THR B 250 THR^? 25.32 CL CL B 384 A 34 VAL B 216 VAL^? 24.94 CL CL B 384 A 38 LYS B 239 LYS^? 36.78 CL CL B 384 coo 30.09 31.19 5.41 30.53 28.24 4.72 3.61 30.30 95.57 4.45 30.88 98.48 coo 19.67 42.24 -1.18 20.37 41.83 -3.18 8.39 18.49 84.99 9.57 16.79 84.51 coo 18.16 36.88 2.14 19.60 35.97 0.73 10.52 23.04 87.34 8.64 24.08 86.89 coo 16.75 32.35 6.21 21.42 30.93 2.22 14.68 26.82 90.55 20.12 26.10 92.90 ULMN 4 1mnm_d00 TRANSCRIPTION/DNA user 3 4 # 3 A 19 ARG B 274 ARG~? 23.83 CL CL B 383 A 30 THR B 250 THR^? 25.32 CL CL B 384 A 34 VAL B 216 VAL^? 24.94 CL CL B 384 A 38 LYS B 239 LYS^? 36.78 CL CL B 384 coo 30.09 31.19 5.41 30.53 28.24 4.72 5.51 36.33 89.03 7.35 38.65 89.98 coo 19.67 42.24 -1.18 20.37 41.83 -3.18 8.39 18.49 84.99 9.57 16.79 84.51 coo 18.16 36.88 2.14 19.60 35.97 0.73 10.52 23.04 87.34 8.64 24.08 86.89 coo 16.75 32.35 6.21 21.42 30.93 2.22 14.68 26.82 90.55 20.12 26.10 92.90 1mnm_d00 source 1mnm TRANSCRIPTION/DNA : 3 hits 1mnm_d00 naa= 4 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 1 3 # 1 A 40 LYS B 109 LYS.? 27.05 CL CL B 384 A 41 LYS B 142 LYS.? 25.17 CL CL B 384 A 42 ILE B 143 ILE.? 15.40 CL CL B 384 coo 36.07 63.73 124.22 32.72 60.75 122.39 5.83 26.41 59.87 10.67 23.27 57.97 coo 38.49 66.12 125.64 35.69 66.71 131.25 6.28 23.32 63.35 7.97 19.73 58.68 coo 41.08 63.27 123.17 40.13 62.43 122.44 2.30 24.62 65.72 2.44 25.07 67.19 1pyi_d00 source 1pyi PROTEIN (PYRIMIDINE PATHWAY REGULATOR 1) : 1 hits 1pyi_d00 naa= 3 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 563 LYS B 17 LYS^? 18.67 CL CL B 382 A 564 VAL B 14 VAL^? 14.99 CL CL B 382 A 568 ARG B 13 ARG^? 4.84 CL CL B 382 coo -6.60 80.79 55.64 -8.55 79.48 61.01 -33.42 46.60 66.26 -37.89 44.12 63.72 coo -9.25 78.14 55.31 -11.11 77.94 56.39 -29.95 42.68 66.90 -30.31 40.99 68.30 coo -12.31 74.86 52.32 -13.99 74.91 54.92 -26.14 48.57 68.77 -25.79 51.69 68.63 1r4i_d00 source 1r4i TRANSCRIPTION/DNA : 1 hits 1r4i_d00 naa= 3 ULMN 3 2bsq_d00 TRANSCRIPTION user 1 3 # 1 E 3 SER A 58 SER^? 17.88 CL CL A 382 E 5 VAL A 14 VAL^? 21.39 CL CL A 382 E 7 ARG A 13 ARG^? 21.22 CL CL A 382 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -24.38 59.07 132.81 -24.91 60.78 134.35 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -19.01 56.20 130.97 -20.69 54.82 131.33 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -15.61 60.27 127.72 -14.54 62.09 125.47 ULMN 3 2bsq_d00 TRANSCRIPTION user 2 3 # 2 E 3 SER A 90 SER^? 16.73 CL CL A 382 E 5 VAL A 41 VAL^? 22.69 CL CL A 382 E 7 ARG A 24 ARG^? 24.95 CL CL A 382 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -29.94 52.31 124.96 -31.33 50.74 123.89 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -24.83 46.67 120.04 -26.42 45.37 119.30 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -27.53 46.21 115.11 -27.47 43.33 116.18 ULMN 3 2bsq_d00 TRANSCRIPTION user 3 3 # 3 E 3 SER B 58 SER^? 18.06 CL CL B 383 E 5 VAL B 14 VAL^? 14.99 CL CL B 382 E 7 ARG B 13 ARG^? 4.84 CL CL B 382 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -25.70 38.53 65.32 -24.63 37.89 63.26 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -29.95 42.68 66.90 -30.31 40.99 68.30 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -26.14 48.57 68.77 -25.79 51.69 68.63 ULMN 3 2bsq_d00 TRANSCRIPTION user 4 3 # 4 E 3 SER B 90 SER^? 16.63 CL CL B 383 E 5 VAL B 41 VAL^? 20.36 CL CL B 382 E 7 ARG B 24 ARG^? 24.13 CL CL B 382 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -27.25 35.25 76.13 -27.68 33.11 77.15 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -32.76 40.19 80.92 -33.24 38.95 82.64 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -30.86 40.03 86.77 -33.42 38.25 86.47 2bsq_d00 source 2bsq TRANSCRIPTION : 4 hits 2bsq_d00 naa= 3 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 B 34 SER A 161 SER~? 16.95 CL CL A 383 B 37 ASN A 160 ASN~? 11.40 CL CL A 383 B 45 THR A 150 THR~? 4.16 CL CL A 383 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -45.55 81.13 122.60 -44.57 82.20 124.58 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -44.47 76.84 121.01 -43.38 75.08 120.31 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -43.99 67.57 132.08 -44.02 66.23 130.30 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 B 34 SER B 161 SER~? 16.65 CL CL B 384 B 37 ASN B 160 ASN~? 11.23 CL CL B 384 B 45 THR B 150 THR~? 4.38 CL CL B 384 coo -19.49 41.97 71.08 -17.37 40.80 71.17 4.53 29.49 70.92 4.35 29.43 68.47 coo -23.05 39.62 69.74 -22.86 39.59 67.61 0.91 30.00 73.77 -0.90 30.65 74.84 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -10.60 23.36 68.09 -11.46 23.86 70.00 2z3x_d00 source 2z3x DNA BINDING PROTEIN/DNA : 2 hits 2z3x_d00 naa= 3 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 18 SER A 11 SER^? 21.10 CL CL A 382 A 20 HIS A 19 HIS^? 24.55 CL CL A 382 A 22 LEU A 87 LEU^? 25.88 CL CL A 382 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -17.58 55.42 121.82 -16.10 56.98 122.78 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -17.70 51.01 127.32 -17.43 50.94 129.40 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -23.18 43.60 125.38 -22.79 45.16 126.94 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 18 SER B 11 SER^? 4.09 CL CL B 382 A 20 HIS B 19 HIS^? 13.92 CL CL B 382 A 22 LEU B 54 LEU.? 19.33 CL CL B 382 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -27.63 49.84 73.72 -27.05 52.31 73.59 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -33.46 45.18 72.05 -34.46 43.90 70.71 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -33.23 37.32 69.22 -34.33 39.18 69.09 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 A 18 SER B 11 SER^? 4.09 CL CL B 382 A 20 HIS B 19 HIS^? 13.92 CL CL B 382 A 22 LEU B 87 LEU^? 21.66 CL CL B 382 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -27.63 49.84 73.72 -27.05 52.31 73.59 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -33.46 45.18 72.05 -34.46 43.90 70.71 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -37.61 38.36 77.35 -37.44 37.97 75.15 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 A 18 SER B 11 SER^? 4.09 CL CL B 382 A 20 HIS B 19 HIS^? 13.92 CL CL B 382 A 22 LEU B 89 LEU^? 18.66 CL CL B 382 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -27.63 49.84 73.72 -27.05 52.31 73.59 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -33.46 45.18 72.05 -34.46 43.90 70.71 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -30.76 37.74 74.88 -32.34 38.38 73.55 3gxq_d00 source 3gxq DNA BINDING PROTEIN/DNA : 4 hits 3gxq_d00 naa= 3 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 1 2 # 1 246 SER A 11 SER^? 21.10 CL CL A 382 360 GLU A 18 GLU^? 23.23 CL CL A 382 coo -2.27 5.01 11.02 -1.56 7.27 11.54 -17.58 55.42 121.82 -16.10 56.98 122.78 coo 3.38 8.39 11.51 1.79 8.22 12.92 -12.62 56.10 125.83 -13.81 57.82 125.60 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 2 2 # 2 246 SER A 55 SER.? 23.04 CL CL A 383 360 GLU A 57 GLU.? 23.36 CL CL A 382 coo -2.27 5.01 11.02 -1.56 7.27 11.54 -27.78 51.03 133.17 -28.81 49.24 134.52 coo 3.38 8.39 11.51 1.79 8.22 12.92 -23.46 53.73 134.86 -22.94 54.54 136.68 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 3 2 # 3 246 SER A 58 SER^? 17.88 CL CL A 382 360 GLU A 57 GLU.? 23.36 CL CL A 382 coo -2.27 5.01 11.02 -1.56 7.27 11.54 -24.38 59.07 132.81 -24.91 60.78 134.35 coo 3.38 8.39 11.51 1.79 8.22 12.92 -23.46 53.73 134.86 -22.94 54.54 136.68 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 4 2 # 4 246 SER A 58 SER^? 17.88 CL CL A 382 360 GLU A 60 GLU^? 17.84 CL CL A 382 coo -2.27 5.01 11.02 -1.56 7.27 11.54 -24.38 59.07 132.81 -24.91 60.78 134.35 coo 3.38 8.39 11.51 1.79 8.22 12.92 -20.60 62.82 127.64 -18.87 63.84 128.41 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 5 2 # 5 246 SER A 84 SER^? 34.22 CL CL A 382 360 GLU A 86 GLU^? 27.08 CL CL A 382 coo -2.27 5.01 11.02 -1.56 7.27 11.54 -23.40 34.46 119.76 -25.32 33.97 118.30 coo 3.38 8.39 11.51 1.79 8.22 12.92 -25.92 41.43 120.29 -26.81 40.98 118.43 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 6 2 # 6 246 SER A 88 SER^? 22.34 CL CL A 382 360 GLU A 86 GLU^? 27.08 CL CL A 382 coo -2.27 5.01 11.02 -1.56 7.27 11.54 -26.75 46.25 123.96 -28.99 45.42 123.71 coo 3.38 8.39 11.51 1.79 8.22 12.92 -25.92 41.43 120.29 -26.81 40.98 118.43 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 7 2 # 7 246 SER A 102 SER.? 10.64 CL CL A 383 360 GLU A 149 GLU.? 9.19 CL CL A 383 coo -2.27 5.01 11.02 -1.56 7.27 11.54 -43.16 67.12 136.34 -45.34 66.31 136.69 coo 3.38 8.39 11.51 1.79 8.22 12.92 -48.79 70.20 130.85 -48.75 71.87 129.52 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 8 2 # 8 246 SER A 192 SER.? 15.36 CL CL A 384 360 GLU A 307 GLU.? 18.04 CL CL B 382 coo -2.27 5.01 11.02 -1.56 7.27 11.54 -26.48 60.82 89.96 -25.15 61.33 88.02 coo 3.38 8.39 11.51 1.79 8.22 12.92 -31.95 61.22 87.08 -31.47 59.40 88.12 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 9 2 # 9 246 SER A 214 SER.? 31.20 CL CL A 383 360 GLU A 215 GLU^? 33.84 CL CL A 383 coo -2.27 5.01 11.02 -1.56 7.27 11.54 -59.02 74.87 102.57 -61.42 74.47 102.83 coo 3.38 8.39 11.51 1.79 8.22 12.92 -61.95 78.59 103.72 -63.72 79.79 103.76 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 10 2 # 10 246 SER A 324 SER^? 19.72 CL CL A 384 360 GLU A 23 GLU.? 27.24 CL CL A 382 coo -2.27 5.01 11.02 -1.56 7.27 11.54 -24.77 48.15 110.31 -26.00 48.61 108.19 coo 3.38 8.39 11.51 1.79 8.22 12.92 -22.84 44.28 116.17 -23.55 42.53 115.22 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 11 2 # 11 246 SER B 11 SER^? 4.09 CL CL B 382 360 GLU B 18 GLU^? 5.91 CL CL B 382 coo -2.27 5.01 11.02 -1.56 7.27 11.54 -27.63 49.84 73.72 -27.05 52.31 73.59 coo 3.38 8.39 11.51 1.79 8.22 12.92 -29.91 50.09 69.26 -29.49 51.30 70.99 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 12 2 # 12 246 SER B 55 SER.? 22.28 CL CL B 384 360 GLU B 57 GLU.? 21.35 CL CL B 382 coo -2.27 5.01 11.02 -1.56 7.27 11.54 -31.36 33.02 68.90 -32.51 30.85 68.96 coo 3.38 8.39 11.51 1.79 8.22 12.92 -31.25 37.00 65.18 -31.15 36.75 63.13 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 13 2 # 13 246 SER B 58 SER^? 18.06 CL CL B 383 360 GLU B 57 GLU.? 21.35 CL CL B 382 coo -2.27 5.01 11.02 -1.56 7.27 11.54 -25.70 38.53 65.32 -24.63 37.89 63.26 coo 3.38 8.39 11.51 1.79 8.22 12.92 -31.25 37.00 65.18 -31.15 36.75 63.13 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 14 2 # 14 246 SER B 58 SER^? 18.06 CL CL B 383 360 GLU B 60 GLU^? 11.77 CL CL B 382 coo -2.27 5.01 11.02 -1.56 7.27 11.54 -25.70 38.53 65.32 -24.63 37.89 63.26 coo 3.38 8.39 11.51 1.79 8.22 12.92 -22.53 44.68 66.99 -22.71 45.90 65.28 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 15 2 # 15 246 SER B 84 SER.? 30.17 CL CL B 382 360 GLU B 86 GLU^? 25.45 CL CL B 382 coo -2.27 5.01 11.02 -1.56 7.27 11.54 -43.97 37.95 86.39 -42.48 36.42 87.54 coo 3.38 8.39 11.51 1.79 8.22 12.92 -37.46 36.82 83.59 -36.60 37.35 85.50 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 16 2 # 16 246 SER B 88 SER^? 22.31 CL CL B 383 360 GLU B 86 GLU^? 25.45 CL CL B 382 coo -2.27 5.01 11.02 -1.56 7.27 11.54 -33.45 36.60 78.54 -33.30 34.49 79.66 coo 3.38 8.39 11.51 1.79 8.22 12.92 -37.46 36.82 83.59 -36.60 37.35 85.50 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 17 2 # 17 246 SER B 102 SER.? 11.35 CL CL B 384 360 GLU B 149 GLU.? 9.91 CL CL B 384 coo -2.27 5.01 11.02 -1.56 7.27 11.54 -12.47 21.91 64.46 -13.46 19.75 64.64 coo 3.38 8.39 11.51 1.79 8.22 12.92 -6.14 20.54 69.48 -4.10 21.06 69.10 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 18 2 # 18 246 SER B 192 SER.? 13.26 CL CL A 384 360 GLU B 307 GLU.? 20.03 CL CL A 384 coo -2.27 5.01 11.02 -1.56 7.27 11.54 -11.80 54.65 102.27 -11.20 56.97 103.08 coo 3.38 8.39 11.51 1.79 8.22 12.92 -8.15 49.66 106.11 -10.31 49.68 106.12 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 19 2 # 19 246 SER B 214 SER.? 30.49 CL CL B 384 360 GLU B 215 GLU^? 32.93 CL CL B 384 coo -2.27 5.01 11.02 -1.56 7.27 11.54 10.35 24.86 94.00 10.52 22.52 94.66 coo 3.38 8.39 11.51 1.79 8.22 12.92 14.09 22.76 92.11 15.77 21.48 91.87 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 20 2 # 20 246 SER B 324 SER^? 22.60 CL CL B 382 360 GLU B 23 GLU.? 22.91 CL CL B 382 coo -2.27 5.01 11.02 -1.56 7.27 11.54 -28.77 44.19 89.22 -27.33 44.36 91.21 coo 3.38 8.39 11.51 1.79 8.22 12.92 -35.83 43.78 85.87 -35.49 42.75 87.75 1oxa_c00 source 1oxa CYTOCHROME P450 ERYF : 20 hits 1oxa_c00 naa= 2 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 1 2 # 1 X 16 LYS A 133 LYS^? 12.95 CL CL A 382 X 119 ASN A 136 ASN.? 24.08 CL CL A 382 coo 9.69 63.83 35.55 11.00 62.83 41.36 -30.69 80.61 120.28 -26.75 77.00 119.43 coo 11.13 57.62 41.98 10.56 59.50 42.87 -35.51 89.43 120.39 -34.74 90.84 118.94 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 2 2 # 2 X 16 LYS A 133 LYS^? 12.95 CL CL A 382 X 119 ASN A 137 ASN.? 20.69 CL CL A 382 coo 9.69 63.83 35.55 11.00 62.83 41.36 -30.69 80.61 120.28 -26.75 77.00 119.43 coo 11.13 57.62 41.98 10.56 59.50 42.87 -34.02 87.53 125.36 -34.12 86.44 127.15 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 3 2 # 3 X 16 LYS A 142 LYS.? 24.15 CL CL A 383 X 119 ASN A 107 ASN.? 21.78 CL CL A 383 coo 9.69 63.83 35.55 11.00 62.83 41.36 -49.53 84.63 130.17 -55.13 85.19 133.14 coo 11.13 57.62 41.98 10.56 59.50 42.87 -46.65 82.65 137.36 -47.85 84.12 136.41 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 4 2 # 4 X 16 LYS A 235 LYS^? 33.41 CL CL A 383 X 119 ASN A 258 ASN~? 27.57 CL CL A 383 coo 9.69 63.83 35.55 11.00 62.83 41.36 -61.15 85.56 115.05 -65.37 84.74 110.73 coo 11.13 57.62 41.98 10.56 59.50 42.87 -54.65 91.43 120.94 -52.65 90.78 121.44 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 5 2 # 5 X 16 LYS A 249 LYS^? 20.12 CL CL A 383 X 119 ASN A 211 ASN.? 19.04 CL CL A 383 coo 9.69 63.83 35.55 11.00 62.83 41.36 -61.09 73.36 110.22 -57.90 69.98 113.58 coo 11.13 57.62 41.98 10.56 59.50 42.87 -52.26 68.83 108.54 -52.87 67.63 110.20 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 6 2 # 6 X 16 LYS A 264 LYS~? 22.00 CL CL A 382 X 119 ASN A 160 ASN~? 11.40 CL CL A 383 coo 9.69 63.83 35.55 11.00 62.83 41.36 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 11.13 57.62 41.98 10.56 59.50 42.87 -44.47 76.84 121.01 -43.38 75.08 120.31 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 7 2 # 7 X 16 LYS A 264 LYS~? 22.00 CL CL A 382 X 119 ASN A 258 ASN~? 27.57 CL CL A 383 coo 9.69 63.83 35.55 11.00 62.83 41.36 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 11.13 57.62 41.98 10.56 59.50 42.87 -54.65 91.43 120.94 -52.65 90.78 121.44 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 8 2 # 8 X 16 LYS A 268 LYS~? 13.60 CL CL A 382 X 119 ASN A 160 ASN~? 11.40 CL CL A 383 coo 9.69 63.83 35.55 11.00 62.83 41.36 -47.11 79.10 113.63 -43.53 76.03 116.02 coo 11.13 57.62 41.98 10.56 59.50 42.87 -44.47 76.84 121.01 -43.38 75.08 120.31 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 9 2 # 9 X 16 LYS A 288 LYS.? 12.57 CL CL A 384 X 119 ASN A 199 ASN.? 4.96 CL CL A 384 coo 9.69 63.83 35.55 11.00 62.83 41.36 -19.18 64.09 108.25 -14.44 63.70 112.45 coo 11.13 57.62 41.98 10.56 59.50 42.87 -21.75 61.84 97.70 -22.73 63.77 98.21 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 10 2 # 10 X 16 LYS B 133 LYS^? 13.08 CL CL B 383 X 119 ASN B 136 ASN.? 22.72 CL CL B 383 coo 9.69 63.83 35.55 11.00 62.83 41.36 -0.84 43.73 69.01 -5.56 47.16 71.00 coo 11.13 57.62 41.98 10.56 59.50 42.87 8.54 41.97 65.49 9.14 40.38 66.80 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 11 2 # 11 X 16 LYS B 133 LYS^? 13.08 CL CL B 383 X 119 ASN B 137 ASN.? 20.58 CL CL B 383 coo 9.69 63.83 35.55 11.00 62.83 41.36 -0.84 43.73 69.01 -5.56 47.16 71.00 coo 11.13 57.62 41.98 10.56 59.50 42.87 4.73 40.06 62.46 3.35 38.78 61.44 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 12 2 # 12 X 16 LYS B 142 LYS.? 25.17 CL CL B 384 X 119 ASN B 107 ASN.? 22.13 CL CL B 384 coo 9.69 63.83 35.55 11.00 62.83 41.36 6.28 23.32 63.35 7.97 19.73 58.68 coo 11.13 57.62 41.98 10.56 59.50 42.87 2.05 22.81 57.51 4.16 22.93 58.02 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 13 2 # 13 X 16 LYS B 249 LYS^? 19.48 CL CL B 384 X 119 ASN B 211 ASN.? 18.42 CL CL B 384 coo 9.69 63.83 35.55 11.00 62.83 41.36 7.49 19.68 88.46 2.17 20.34 86.44 coo 11.13 57.62 41.98 10.56 59.50 42.87 0.47 26.95 89.73 -0.82 25.48 88.80 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 14 2 # 14 X 16 LYS B 264 LYS~? 21.76 CL CL B 383 X 119 ASN B 160 ASN~? 11.23 CL CL B 384 coo 9.69 63.83 35.55 11.00 62.83 41.36 11.01 31.36 75.69 9.79 34.42 71.26 coo 11.13 57.62 41.98 10.56 59.50 42.87 0.91 30.00 73.77 -0.90 30.65 74.84 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 15 2 # 15 X 16 LYS B 264 LYS~? 21.76 CL CL B 383 X 119 ASN B 258 ASN.? 28.97 CL CL B 384 coo 9.69 63.83 35.55 11.00 62.83 41.36 11.01 31.36 75.69 9.79 34.42 71.26 coo 11.13 57.62 41.98 10.56 59.50 42.87 15.59 26.49 68.84 17.44 27.50 69.35 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 16 2 # 16 X 16 LYS B 268 LYS~? 13.29 CL CL B 383 X 119 ASN B 160 ASN~? 11.23 CL CL B 384 coo 9.69 63.83 35.55 11.00 62.83 41.36 5.99 32.14 79.72 1.11 32.64 77.72 coo 11.13 57.62 41.98 10.56 59.50 42.87 0.91 30.00 73.77 -0.90 30.65 74.84 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 17 2 # 17 X 16 LYS B 288 LYS.? 8.84 CL CL B 382 X 119 ASN B 199 ASN.? 15.74 CL CL A 384 coo 9.69 63.83 35.55 11.00 62.83 41.36 -16.76 54.22 83.25 -20.62 56.75 78.99 coo 11.13 57.62 41.98 10.56 59.50 42.87 -14.23 54.82 92.98 -12.33 56.04 93.07 1pae_c00 source 1pae NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSOLIC : 17 hits 1pae_c00 naa= 2 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 1 2 # 1 X 16 LYS A 133 LYS^? 12.95 CL CL A 382 X 56 TYR A 181 TYR.? 17.32 CL CL A 382 coo 9.69 63.83 35.55 11.00 62.83 41.36 -30.69 80.61 120.28 -26.75 77.00 119.43 coo 10.51 70.44 44.57 10.41 68.10 43.00 -33.79 79.99 107.82 -35.55 78.08 108.89 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 2 2 # 2 X 16 LYS A 235 LYS^? 33.41 CL CL A 383 X 56 TYR A 238 TYR^? 27.75 CL CL A 383 coo 9.69 63.83 35.55 11.00 62.83 41.36 -61.15 85.56 115.05 -65.37 84.74 110.73 coo 10.51 70.44 44.57 10.41 68.10 43.00 -54.82 80.30 106.22 -53.19 79.11 104.29 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 3 2 # 3 X 16 LYS A 249 LYS^? 20.12 CL CL A 383 X 56 TYR A 238 TYR^? 27.75 CL CL A 383 coo 9.69 63.83 35.55 11.00 62.83 41.36 -61.09 73.36 110.22 -57.90 69.98 113.58 coo 10.51 70.44 44.57 10.41 68.10 43.00 -54.82 80.30 106.22 -53.19 79.11 104.29 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 4 2 # 4 X 16 LYS A 264 LYS~? 22.00 CL CL A 382 X 56 TYR A 238 TYR^? 27.75 CL CL A 383 coo 9.69 63.83 35.55 11.00 62.83 41.36 -48.92 85.08 115.29 -44.06 86.61 118.76 coo 10.51 70.44 44.57 10.41 68.10 43.00 -54.82 80.30 106.22 -53.19 79.11 104.29 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 5 2 # 5 X 16 LYS A 268 LYS~? 13.60 CL CL A 382 X 56 TYR A 238 TYR^? 27.75 CL CL A 383 coo 9.69 63.83 35.55 11.00 62.83 41.36 -47.11 79.10 113.63 -43.53 76.03 116.02 coo 10.51 70.44 44.57 10.41 68.10 43.00 -54.82 80.30 106.22 -53.19 79.11 104.29 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 6 2 # 6 X 16 LYS A 336 LYS^? 14.72 CL CL A 382 X 56 TYR A 181 TYR.? 17.32 CL CL A 382 coo 9.69 63.83 35.55 11.00 62.83 41.36 -37.43 70.02 105.34 -41.47 67.12 107.58 coo 10.51 70.44 44.57 10.41 68.10 43.00 -33.79 79.99 107.82 -35.55 78.08 108.89 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 7 2 # 7 X 16 LYS B 133 LYS^? 13.08 CL CL B 383 X 56 TYR B 181 TYR.? 17.17 CL CL B 383 coo 9.69 63.83 35.55 11.00 62.83 41.36 -0.84 43.73 69.01 -5.56 47.16 71.00 coo 10.51 70.44 44.57 10.41 68.10 43.00 3.07 45.96 80.85 1.96 43.49 81.23 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 8 2 # 8 X 16 LYS B 235 LYS.? 32.14 CL CL B 384 X 56 TYR B 238 TYR^? 27.53 CL CL B 384 coo 9.69 63.83 35.55 11.00 62.83 41.36 16.30 20.77 78.71 18.07 18.48 84.31 coo 10.51 70.44 44.57 10.41 68.10 43.00 12.27 28.31 87.43 11.42 30.17 89.32 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 9 2 # 9 X 16 LYS B 249 LYS^? 19.48 CL CL B 384 X 56 TYR B 238 TYR^? 27.53 CL CL B 384 coo 9.69 63.83 35.55 11.00 62.83 41.36 7.49 19.68 88.46 2.17 20.34 86.44 coo 10.51 70.44 44.57 10.41 68.10 43.00 12.27 28.31 87.43 11.42 30.17 89.32 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 10 2 # 10 X 16 LYS B 264 LYS~? 21.76 CL CL B 383 X 56 TYR B 238 TYR^? 27.53 CL CL B 384 coo 9.69 63.83 35.55 11.00 62.83 41.36 11.01 31.36 75.69 9.79 34.42 71.26 coo 10.51 70.44 44.57 10.41 68.10 43.00 12.27 28.31 87.43 11.42 30.17 89.32 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 11 2 # 11 X 16 LYS B 268 LYS~? 13.29 CL CL B 383 X 56 TYR B 238 TYR^? 27.53 CL CL B 384 coo 9.69 63.83 35.55 11.00 62.83 41.36 5.99 32.14 79.72 1.11 32.64 77.72 coo 10.51 70.44 44.57 10.41 68.10 43.00 12.27 28.31 87.43 11.42 30.17 89.32 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 12 2 # 12 X 16 LYS B 336 LYS^? 14.66 CL CL B 383 X 56 TYR B 181 TYR.? 17.17 CL CL B 383 coo 9.69 63.83 35.55 11.00 62.83 41.36 -3.40 41.24 88.18 -4.83 35.96 88.60 coo 10.51 70.44 44.57 10.41 68.10 43.00 3.07 45.96 80.85 1.96 43.49 81.23 1pae_c01 source 1pae NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSOLIC : 12 hits 1pae_c01 naa= 2 ULMN 2 1pbg_c02 6-PHOSPHO-BETA-D-GALACTOSIDASE user 1 2 # 1 A 160 GLU A 23 GLU.? 27.24 CL CL A 382 A 375 GLU A 86 GLU^? 27.08 CL CL A 382 coo 63.94 10.02 33.47 64.31 8.24 32.38 -22.84 44.28 116.17 -23.55 42.53 115.22 coo 61.89 10.05 27.30 63.60 9.39 28.40 -25.92 41.43 120.29 -26.81 40.98 118.43 ULMN 2 1pbg_c02 6-PHOSPHO-BETA-D-GALACTOSIDASE user 2 2 # 2 A 160 GLU A 86 GLU^? 27.08 CL CL A 382 A 375 GLU A 23 GLU.? 27.24 CL CL A 382 coo 63.94 10.02 33.47 64.31 8.24 32.38 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 61.89 10.05 27.30 63.60 9.39 28.40 -22.84 44.28 116.17 -23.55 42.53 115.22 ULMN 2 1pbg_c02 6-PHOSPHO-BETA-D-GALACTOSIDASE user 3 2 # 3 A 160 GLU B 23 GLU.? 22.91 CL CL B 382 A 375 GLU B 86 GLU^? 25.45 CL CL B 382 coo 63.94 10.02 33.47 64.31 8.24 32.38 -35.83 43.78 85.87 -35.49 42.75 87.75 coo 61.89 10.05 27.30 63.60 9.39 28.40 -37.46 36.82 83.59 -36.60 37.35 85.50 ULMN 2 1pbg_c02 6-PHOSPHO-BETA-D-GALACTOSIDASE user 4 2 # 4 A 160 GLU B 86 GLU^? 25.45 CL CL B 382 A 375 GLU B 23 GLU.? 22.91 CL CL B 382 coo 63.94 10.02 33.47 64.31 8.24 32.38 -37.46 36.82 83.59 -36.60 37.35 85.50 coo 61.89 10.05 27.30 63.60 9.39 28.40 -35.83 43.78 85.87 -35.49 42.75 87.75 ULMN 2 1pbg_c02 6-PHOSPHO-BETA-D-GALACTOSIDASE user 5 2 # 5 A 160 GLU B 146 GLU.? 15.61 CL CL B 384 A 375 GLU B 149 GLU.? 9.91 CL CL B 384 coo 63.94 10.02 33.47 64.31 8.24 32.38 -2.82 16.82 69.01 -1.28 15.52 68.26 coo 61.89 10.05 27.30 63.60 9.39 28.40 -6.14 20.54 69.48 -4.10 21.06 69.10 ULMN 2 1pbg_c02 6-PHOSPHO-BETA-D-GALACTOSIDASE user 6 2 # 6 A 160 GLU B 149 GLU.? 9.91 CL CL B 384 A 375 GLU B 146 GLU.? 15.61 CL CL B 384 coo 63.94 10.02 33.47 64.31 8.24 32.38 -6.14 20.54 69.48 -4.10 21.06 69.10 coo 61.89 10.05 27.30 63.60 9.39 28.40 -2.82 16.82 69.01 -1.28 15.52 68.26 1pbg_c02 source 1pbg 6-PHOSPHO-BETA-D-GALACTOSIDASE : 6 hits 1pbg_c02 naa= 2 ULMN 2 1pbg_c03 6-PHOSPHO-BETA-D-GALACTOSIDASE user 1 2 # 1 B 160 GLU A 23 GLU.? 27.24 CL CL A 382 B 375 GLU A 86 GLU^? 27.08 CL CL A 382 coo 23.66 16.69 85.20 24.17 18.76 84.94 -22.84 44.28 116.17 -23.55 42.53 115.22 coo 21.67 20.74 89.92 23.35 20.55 88.67 -25.92 41.43 120.29 -26.81 40.98 118.43 ULMN 2 1pbg_c03 6-PHOSPHO-BETA-D-GALACTOSIDASE user 2 2 # 2 B 160 GLU A 86 GLU^? 27.08 CL CL A 382 B 375 GLU A 23 GLU.? 27.24 CL CL A 382 coo 23.66 16.69 85.20 24.17 18.76 84.94 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 21.67 20.74 89.92 23.35 20.55 88.67 -22.84 44.28 116.17 -23.55 42.53 115.22 ULMN 2 1pbg_c03 6-PHOSPHO-BETA-D-GALACTOSIDASE user 3 2 # 3 B 160 GLU B 23 GLU.? 22.91 CL CL B 382 B 375 GLU B 86 GLU^? 25.45 CL CL B 382 coo 23.66 16.69 85.20 24.17 18.76 84.94 -35.83 43.78 85.87 -35.49 42.75 87.75 coo 21.67 20.74 89.92 23.35 20.55 88.67 -37.46 36.82 83.59 -36.60 37.35 85.50 ULMN 2 1pbg_c03 6-PHOSPHO-BETA-D-GALACTOSIDASE user 4 2 # 4 B 160 GLU B 86 GLU^? 25.45 CL CL B 382 B 375 GLU B 23 GLU.? 22.91 CL CL B 382 coo 23.66 16.69 85.20 24.17 18.76 84.94 -37.46 36.82 83.59 -36.60 37.35 85.50 coo 21.67 20.74 89.92 23.35 20.55 88.67 -35.83 43.78 85.87 -35.49 42.75 87.75 ULMN 2 1pbg_c03 6-PHOSPHO-BETA-D-GALACTOSIDASE user 5 2 # 5 B 160 GLU B 146 GLU.? 15.61 CL CL B 384 B 375 GLU B 149 GLU.? 9.91 CL CL B 384 coo 23.66 16.69 85.20 24.17 18.76 84.94 -2.82 16.82 69.01 -1.28 15.52 68.26 coo 21.67 20.74 89.92 23.35 20.55 88.67 -6.14 20.54 69.48 -4.10 21.06 69.10 ULMN 2 1pbg_c03 6-PHOSPHO-BETA-D-GALACTOSIDASE user 6 2 # 6 B 160 GLU B 149 GLU.? 9.91 CL CL B 384 B 375 GLU B 146 GLU.? 15.61 CL CL B 384 coo 23.66 16.69 85.20 24.17 18.76 84.94 -6.14 20.54 69.48 -4.10 21.06 69.10 coo 21.67 20.74 89.92 23.35 20.55 88.67 -2.82 16.82 69.01 -1.28 15.52 68.26 1pbg_c03 source 1pbg 6-PHOSPHO-BETA-D-GALACTOSIDASE : 6 hits 1pbg_c03 naa= 2 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 1 2 # 1 A 160 GLU A 18 GLU^? 23.23 CL CL A 382 A 269 GLU A 201 GLU.? 12.07 CL CL A 384 coo 63.94 10.02 33.47 64.31 8.24 32.38 -12.62 56.10 125.83 -13.81 57.82 125.60 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -24.87 56.03 99.70 -24.21 54.93 101.40 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 2 2 # 2 A 160 GLU A 18 GLU^? 23.23 CL CL A 382 A 269 GLU A 332 GLU^? 14.84 CL CL A 382 coo 63.94 10.02 33.47 64.31 8.24 32.38 -12.62 56.10 125.83 -13.81 57.82 125.60 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -32.41 59.20 107.78 -33.78 57.91 108.78 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 3 2 # 3 A 160 GLU A 23 GLU.? 27.24 CL CL A 382 A 269 GLU A 206 GLU^? 19.04 CL CL A 382 coo 63.94 10.02 33.47 64.31 8.24 32.38 -22.84 44.28 116.17 -23.55 42.53 115.22 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -42.05 60.33 102.60 -42.22 59.82 104.62 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 4 2 # 4 A 160 GLU A 23 GLU.? 27.24 CL CL A 382 A 269 GLU B 206 GLU^? 19.18 CL CL B 383 coo 63.94 10.02 33.47 64.31 8.24 32.38 -22.84 44.28 116.17 -23.55 42.53 115.22 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -9.17 35.76 95.82 -10.61 34.74 94.62 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 5 2 # 5 A 160 GLU A 23 GLU.? 27.24 CL CL A 382 A 269 GLU B 332 GLU^? 14.76 CL CL B 383 coo 63.94 10.02 33.47 64.31 8.24 32.38 -22.84 44.28 116.17 -23.55 42.53 115.22 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -15.56 41.56 89.17 -16.27 39.59 89.11 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 6 2 # 6 A 160 GLU A 60 GLU^? 17.84 CL CL A 382 A 269 GLU B 307 GLU.? 20.03 CL CL A 384 coo 63.94 10.02 33.47 64.31 8.24 32.38 -20.60 62.82 127.64 -18.87 63.84 128.41 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -8.15 49.66 106.11 -10.31 49.68 106.12 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 7 2 # 7 A 160 GLU A 86 GLU^? 27.08 CL CL A 382 A 269 GLU A 201 GLU.? 12.07 CL CL A 384 coo 63.94 10.02 33.47 64.31 8.24 32.38 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -24.87 56.03 99.70 -24.21 54.93 101.40 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 8 2 # 8 A 160 GLU A 86 GLU^? 27.08 CL CL A 382 A 269 GLU B 201 GLU^? 17.46 CL CL A 384 coo 63.94 10.02 33.47 64.31 8.24 32.38 -25.92 41.43 120.29 -26.81 40.98 118.43 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -19.06 50.53 95.26 -20.94 50.61 94.28 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 9 2 # 9 A 160 GLU A 135 GLU.? 22.99 CL CL A 382 A 269 GLU A 149 GLU.? 9.19 CL CL A 383 coo 63.94 10.02 33.47 64.31 8.24 32.38 -31.98 87.75 115.72 -30.11 88.72 115.32 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -48.79 70.20 130.85 -48.75 71.87 129.52 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 10 2 # 10 A 160 GLU A 135 GLU.? 22.99 CL CL A 382 A 269 GLU A 276 GLU~? 16.10 CL CL A 383 coo 63.94 10.02 33.47 64.31 8.24 32.38 -31.98 87.75 115.72 -30.11 88.72 115.32 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -46.62 67.79 110.40 -48.46 68.09 111.43 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 11 2 # 11 A 160 GLU A 146 GLU.? 12.63 CL CL A 383 A 269 GLU A 169 GLU.? 11.07 CL CL A 382 coo 63.94 10.02 33.47 64.31 8.24 32.38 -52.58 70.92 131.34 -54.15 69.93 130.28 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -27.31 72.85 122.01 -26.32 74.11 120.63 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 12 2 # 12 A 160 GLU A 149 GLU.? 9.19 CL CL A 383 A 269 GLU A 135 GLU.? 22.99 CL CL A 382 coo 63.94 10.02 33.47 64.31 8.24 32.38 -48.79 70.20 130.85 -48.75 71.87 129.52 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -31.98 87.75 115.72 -30.11 88.72 115.32 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 13 2 # 13 A 160 GLU A 169 GLU.? 11.07 CL CL A 382 A 269 GLU A 146 GLU.? 12.63 CL CL A 383 coo 63.94 10.02 33.47 64.31 8.24 32.38 -27.31 72.85 122.01 -26.32 74.11 120.63 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -52.58 70.92 131.34 -54.15 69.93 130.28 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 14 2 # 14 A 160 GLU A 169 GLU.? 11.07 CL CL A 382 A 269 GLU A 201 GLU.? 12.07 CL CL A 384 coo 63.94 10.02 33.47 64.31 8.24 32.38 -27.31 72.85 122.01 -26.32 74.11 120.63 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -24.87 56.03 99.70 -24.21 54.93 101.40 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 15 2 # 15 A 160 GLU A 169 GLU.? 11.07 CL CL A 382 A 269 GLU A 206 GLU^? 19.04 CL CL A 382 coo 63.94 10.02 33.47 64.31 8.24 32.38 -27.31 72.85 122.01 -26.32 74.11 120.63 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -42.05 60.33 102.60 -42.22 59.82 104.62 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 16 2 # 16 A 160 GLU A 201 GLU.? 12.07 CL CL A 384 A 269 GLU A 18 GLU^? 23.23 CL CL A 382 coo 63.94 10.02 33.47 64.31 8.24 32.38 -24.87 56.03 99.70 -24.21 54.93 101.40 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -12.62 56.10 125.83 -13.81 57.82 125.60 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 17 2 # 17 A 160 GLU A 201 GLU.? 12.07 CL CL A 384 A 269 GLU A 86 GLU^? 27.08 CL CL A 382 coo 63.94 10.02 33.47 64.31 8.24 32.38 -24.87 56.03 99.70 -24.21 54.93 101.40 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -25.92 41.43 120.29 -26.81 40.98 118.43 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 18 2 # 18 A 160 GLU A 201 GLU.? 12.07 CL CL A 384 A 269 GLU A 169 GLU.? 11.07 CL CL A 382 coo 63.94 10.02 33.47 64.31 8.24 32.38 -24.87 56.03 99.70 -24.21 54.93 101.40 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -27.31 72.85 122.01 -26.32 74.11 120.63 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 19 2 # 19 A 160 GLU A 201 GLU.? 12.07 CL CL A 384 A 269 GLU A 276 GLU~? 16.10 CL CL A 383